Citrus Sinensis ID: 040134
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.950 | 0.850 | 0.431 | 1e-161 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.955 | 0.816 | 0.328 | 1e-100 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.907 | 0.815 | 0.330 | 9e-96 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.926 | 0.844 | 0.335 | 5e-91 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.876 | 0.819 | 0.317 | 1e-82 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.899 | 0.816 | 0.320 | 1e-82 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.908 | 0.817 | 0.328 | 5e-81 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.873 | 0.746 | 0.297 | 2e-73 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.940 | 0.825 | 0.281 | 9e-72 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.881 | 0.779 | 0.293 | 3e-69 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 569 bits (1466), Expect = e-161, Method: Compositional matrix adjust.
Identities = 329/762 (43%), Positives = 449/762 (58%), Gaps = 54/762 (7%)
Query: 19 SNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPA----PRGSQVKL 74
S+ WRSPSG+FAFGF I D F L+IWFDKI +KTIVW A + P GS+V L
Sbjct: 47 SSSWRSPSGDFAFGFRKIQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTL 106
Query: 75 TNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLL---GGDSNPI-WESFKEPTD 130
T G LV+ DP+G ELW+ GS S DDGNFVL DS+ + W SF+ PTD
Sbjct: 107 TADGGLVIADPRGQELWRALSGGSVSR-GRFTDDGNFVLFRDGSEDSDEVLWSSFENPTD 165
Query: 131 TLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSW--- 187
TLLP Q + N++SRRT+ ++ GRF L+++GNL+L S++ T D+Y +
Sbjct: 166 TLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYES 225
Query: 188 -NSEAWNADSQLIFDRAGYIYI-KKGNQRIYNLTKIGTRSMQ-DFYIMARIDYDGVFRQY 244
++ N QL+F+++G IY+ ++ N R + S+ FYI G
Sbjct: 226 NTNDPNNPGIQLVFNQSGEIYVLQRNNSRFVVKDRDPDFSIAAPFYIST-----GFLLST 280
Query: 245 THPKYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICAEINGE-PKCLCPDNYSY 303
PK A + +D + +G+ ACGYN+IC+ N + PKC CP+ +
Sbjct: 281 IIPK--EARRIVGGCLLGLCRDNMCSPDDALGNMACGYNNICSLGNNKRPKCECPERFVL 338
Query: 304 LNQSDTSQGCKPNFPLPSCQ-DNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQT 362
+ S+ C P+F + +C+ +N L +F + E T+WP DY+ + +
Sbjct: 339 KDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYAN--YDEER 396
Query: 363 CEQLCREDCFCAAAIYNGDY---CWKKKYPLSNGRRSTSVNRIALVKVPKVDVSKLLEKK 419
C+ C DC CAA I+ + CWKKK+PLS+G RS + +KV ++ +
Sbjct: 397 CKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTG 456
Query: 420 DQST----LVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLL-----RSVSSPSAT-- 468
+++ L++ +LLG+S F+ IF S + K + R + +AT
Sbjct: 457 NRAKKLDWLIIACSVLLGTSAFV----IFDTSCSYRKTKKSKNMMKNQARDIGRTTATTT 512
Query: 469 ----NVRSFTYKELEEATRGFRQILGRGAFGTVYKGVL--ASDSKRFVAIKKLDKVEQQG 522
N+R FTY EL EATR F + LGRGAFG VYKG L A S+ VA+KKLD+++
Sbjct: 513 ANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDN 572
Query: 523 EKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV 582
EKEF+ EV VIGQ HHKNLVRL+GFC+EG +++VYE++ G+LA+FLF RP W R
Sbjct: 573 EKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRK 632
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642
IA IARG++YLHEECS QIIHCDIKPQNILLD+Y+TPRISDFGLAKLLL QT T
Sbjct: 633 NIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTL-T 691
Query: 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC 702
IRGT GY APEWFR + IT KVDVYS+GV+LLE++CCK +V L++W Y C
Sbjct: 692 NIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDC 748
Query: 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ L+ L E+D E ND++ VER V +A+WCIQE+ +RP
Sbjct: 749 FRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRP 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-100, Method: Compositional matrix adjust.
Identities = 263/801 (32%), Positives = 393/801 (49%), Gaps = 89/801 (11%)
Query: 1 VAKAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIP-EKTIVWS 59
+A +I L S L A++ + W S +G FA GF D FLL+IWF ++P + TIVWS
Sbjct: 24 LATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDPTIVWS 83
Query: 60 ANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGD-- 117
N + P + + ++L +G LVL D Q +W A M + GNF+LLG +
Sbjct: 84 PNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVT 142
Query: 118 SNP-IWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELS---SV 173
+ P IW+SF +P+DTLLP Q L + +TS + + + +L+++ +L L ++
Sbjct: 143 AGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLK-MLQQHTSLSLGLTYNI 201
Query: 174 SLTTQVVYDVYWSW-NSEAWNADSQLIFDRAGYIYIKKGNQRI-------------YNLT 219
+L Y YWS + D + D G I G I N
Sbjct: 202 NLDPHANYS-YWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNYN 260
Query: 220 KIGTRSMQDFYIMARI--DYDGVFRQYTHPKYETACNFTWRMEERIPQDICVAITGDIGS 277
+ ++ R+ + +G R Y +++ N + + +P+ V+ DI +
Sbjct: 261 NSSNLGLTKNPVLRRLVLENNGNLRLY---RWDNDMNGS---SQWVPEWAAVSNPCDI-A 313
Query: 278 GACGYNSICA--EINGEPKCLCPDNYSYLNQSDTSQGCKPNFPL-PSCQDNGWETKYNEL 334
G CG N +C CLC L + ++ C N L C+ N N
Sbjct: 314 GICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESN---INRNGS 369
Query: 335 VDFKSYENTDWPLSDYDL--QIGNGVNRQTCEQLCREDCFCAAAIYNGD----YCWKKKY 388
+ + T++ S+ + I + N + C ++C DC C A++Y D YCW K
Sbjct: 370 FKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKS 429
Query: 389 PLSNGRRSTS----VNRIALVKVPKVDVSKLLEKKDQSTL---VLVICLLLGSSVFLNIL 441
G R V A P + + + L VLVI +++G +
Sbjct: 430 LNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVG-------M 482
Query: 442 LIFAISVAAYLFYHKKLLRSVSSPSATNV------RSFTYKELEEATRGFRQILGRGAFG 495
L+ + L+Y+ R++ + ++ SFTY++L+ T F Q+LG G FG
Sbjct: 483 LVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFG 542
Query: 496 TVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555
TVYKG +A ++ VA+K+LD+ GE+EF TEV+ IG HH NLVRL G+C E HRL
Sbjct: 543 TVYKGTVAGET--LVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRL 600
Query: 556 LVYEYMSNGSLASFLFGITRP----DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQ 611
LVYEYM NGSL ++F + DW R +IA A+G+ Y HE+C +IIHCDIKP+
Sbjct: 601 LVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPE 660
Query: 612 NILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFG 671
NILLDD F P++SDFGLAK++ E + T IRGT GY APEW ITVK DVYS+G
Sbjct: 661 NILLDDNFCPKVSDFGLAKMMGREHSHVV-TMIRGTRGYLAPEWVSNRPITVKADVYSYG 719
Query: 672 VLLLELICCKSSVVFGTTNPEEALMDWVYRCY--------IGKNLDKLAENDEEVKNDLK 723
+LLLE++ + ++ + W Y+ + K L +AE +E VK
Sbjct: 720 MLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVK---- 775
Query: 724 RVERLVMVALWCIQEDASLRP 744
+ VA WCIQ++ S+RP
Sbjct: 776 ----ALKVAFWCIQDEVSMRP 792
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 260/787 (33%), Positives = 373/787 (47%), Gaps = 111/787 (14%)
Query: 5 ANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWF-DKIPEKTIVWSANGD 63
+ I L S + A+ + W SP+ F+ F + + FL A+ F +P +WSA
Sbjct: 25 STIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWSAGTV 80
Query: 64 DPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWE 123
D RGS ++L SG L L + G +W D + +++D G F+LL S P+W
Sbjct: 81 DS--RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWS 137
Query: 124 SFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDV 183
SF PTDT++ Q N T+ + +G + F L+ +GNL L
Sbjct: 138 SFDNPTDTIVQSQ------NFTAGKILR---SGLYSFQLERSGNLTLR------------ 176
Query: 184 YWSWNSEA--WN-----------ADSQLIFDRAGYIYIKKGN-----QRIYNLTKIGTRS 225
WN+ A WN + +L G + I + N + +Y+ G
Sbjct: 177 ---WNTSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYS----GDYG 229
Query: 226 MQDFYIMARIDYDGVFRQYTHPKYETA-CNFTWRMEERIPQDICVAITGDIGSGACGYNS 284
+ + ++D DG R Y+ + N W D C+ G CG
Sbjct: 230 DSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSA-----VDQCLVY------GYCGNFG 278
Query: 285 ICAEINGEPKCLCPD-NYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENT 343
IC+ + P C CP N+ +++ +D +GCK L C N T +LV + +
Sbjct: 279 ICSYNDTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGN---TTMLDLVHTRLFTYE 335
Query: 344 DWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYNGD---YCWKKKYPLS--NGRRSTS 398
D P S+ C C C A++ D CW+K +P S G + S
Sbjct: 336 DDPNSESFF-----AGSSPCRANCLSSVLCLASVSMSDGSGNCWQK-HPGSFFTGYQWPS 389
Query: 399 VNRIALVKVPKVDVSKLLEK--KDQSTLVLVICLLLGSSVFLNILLIFAISVAAY----- 451
V + VKV V+ LE+ K V ++ +V +L + A+ + +
Sbjct: 390 VPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCR 449
Query: 452 -------LFYHKKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLAS 504
L H LL S FTYKEL+ T+ F++ LG G FGTVY+GVL +
Sbjct: 450 KNPRFGTLSSHYTLLEYASGAPV----QFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTN 505
Query: 505 DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNG 564
+ VA+K+L+ +EQ GEK+FR EV+ I THH NLVRL+GFC +G HRLLVYE+M NG
Sbjct: 506 --RTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNG 562
Query: 565 SLASFLFGITRPD---WNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP 621
SL +FLF W R IA G A+G+ YLHEEC I+HCDIKP+NIL+DD F
Sbjct: 563 SLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA 622
Query: 622 RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
++SDFGLAKLL + + + +RGT GY APEW IT K DVYS+G++LLEL+ K
Sbjct: 623 KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGK 682
Query: 682 SSVVFGTTNPEEALMDWVYRCYIGKN----LDKLAENDEEVKNDLKRVERLVMVALWCIQ 737
+ + W Y + N LD D+ V D+++V R+V + WCIQ
Sbjct: 683 RNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTV--DMEQVMRMVKTSFWCIQ 740
Query: 738 EDASLRP 744
E RP
Sbjct: 741 EQPLQRP 747
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 336 bits (861), Expect = 5e-91, Method: Compositional matrix adjust.
Identities = 275/820 (33%), Positives = 393/820 (47%), Gaps = 130/820 (15%)
Query: 7 INLESSLLA-TKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIP-----EKTIVWSA 60
+ L SSL+ + +S+ +S G F+ GF+ + F ++W+ K KTIVWSA
Sbjct: 32 LPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTH-AFTFSVWYSKTEAAAANNKTIVWSA 90
Query: 61 NGDDPA-PRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSW---ATMQDDGNFVLLGG 116
N D P R S + L G +VL D G +W+ DG+ + A + D GN V+
Sbjct: 91 NPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRA--DGNNFTGVQRARLLDTGNLVIEDS 148
Query: 117 DSNPIWESFKEPTDTLLPGQILNSPINI---TSRRTQHNYSTGRFRFLLKENGNLELSSV 173
N +W+SF PTDT LP Q++ + + T R+ NY FRF +LS +
Sbjct: 149 GGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYI---FRFS-------DLSVL 198
Query: 174 SLTTQV--VYDVYWSWNSEAWNADSQLIFD-RAGYIYIKKGNQRIYNLTKIGTRSMQDFY 230
SL V V D+YW + D L D R Y + R+ LT G + DF
Sbjct: 199 SLIYHVPQVSDIYWP------DPDQNLYQDGRNQY-----NSTRLGMLTDSGVLASSDFA 247
Query: 231 ----IMAR-----------IDYDGVFRQYTHPKYETACNFTWRMEERIPQDICVAITGDI 275
++A +D DG R Y+ + +W + VA+T
Sbjct: 248 DGQALVASDVGPGVKRRLTLDPDGNLRLYSM----NDSDGSWSVS-------MVAMTQPC 296
Query: 276 G-SGACGYNSICAEINGEPKCLCPDNYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNEL 334
G CG N IC + P C CP Y+ N + ++GC N +Y++
Sbjct: 297 NIHGLCGPNGIC-HYSPTPTCSCPPGYATRNPGNWTEGCMAIV-------NTTCDRYDKR 348
Query: 335 -VDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYN--GDYCWKKKYPLS 391
+ F NTD+ SD + V+ +TC +C DC C Y C+ K Y S
Sbjct: 349 SMRFVRLPNTDFWGSDQQHLLS--VSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFS 406
Query: 392 NGRRSTSVNRIALVKVPK-VDVSK-LLEKKD--QSTLVLVICLLLGSSV----------- 436
TS R +K+P V VS L+ + D S + C + S+
Sbjct: 407 GRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTG 466
Query: 437 -----------FLNILLIFAISVA--AYLFYHKKLLRSVS--------SPSATNVRSFTY 475
F+ + +S A+ F K+ LR +N R ++Y
Sbjct: 467 GGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSY 526
Query: 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ 535
+EL +ATR F+ LGRG GTVYKGVL D R VA+KKL+ V +QG++ F+ E+SVIG+
Sbjct: 527 RELVKATRKFKVELGRGESGTVYKGVLEDD--RHVAVKKLENV-RQGKEVFQAELSVIGR 583
Query: 536 THHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF---GITRPDWNQRVQIAFGIARGL 592
+H NLVR+ GFC EG HRLLV EY+ NGSLA+ LF G DW R IA G+A+GL
Sbjct: 584 INHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGL 643
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLH EC +IHCD+KP+NILLD F P+I+DFGL KLL + + +RGT+GY A
Sbjct: 644 AYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIA 703
Query: 653 PEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKN---- 707
PEW IT KVDVYS+GV+LLEL+ + S + G T+ +++ + R K
Sbjct: 704 PEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEE 763
Query: 708 ---LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+D ++ + + L+ +A+ C++ED S RP
Sbjct: 764 QSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRP 803
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 239/753 (31%), Positives = 356/753 (47%), Gaps = 100/753 (13%)
Query: 29 FAFGFHHIDNQDV-FLLAIWFDKIPEKTIVWSANGDDPA--PRGSQVKLTNSGELVLYDP 85
F GF N + L I + +P T VW AN P P S ++LT++G L++ +
Sbjct: 40 FRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTGYLIVSNL 99
Query: 86 QGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINIT 145
+ +WQ + + + GN +L+ D +P+W+SF PTDT LPG + +T
Sbjct: 100 RDGVVWQTDNKQPGTDFR-FSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAMT 158
Query: 146 SRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD---VYWS---WNSEAWNADSQLI 199
S R+ + S G + L + N Q+VY YWS W EA+ ++
Sbjct: 159 SWRSLFDPSPGFYSLRLSPSFN--------EFQLVYKGTTPYWSTGNWTGEAFVGVPEMT 210
Query: 200 FDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARID-------------YDGVFRQYTH 246
YIY ++ T + +YI+ +D +G +QYT
Sbjct: 211 IP---YIYR-------FHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTW 260
Query: 247 PKYETACNFTWRMEERIPQDICVA--ITGDIGSGACGYNSICAEINGEPKCLCPDNYSYL 304
+ N W P+D C + G +G + CA I G P N +
Sbjct: 261 DPQTQSWNMFWLQ----PEDPCRVYNLCGQLGFCSSELLKPCACIRG----FRPRNDAAW 312
Query: 305 NQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGN-GVNRQTC 363
D S GC+ D+G ++ E V Y D D+++ V++ +C
Sbjct: 313 RSDDYSDGCRRE-----NGDSGEKSDTFEAVGDLRY--------DGDVKMSRLQVSKSSC 359
Query: 364 EQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRSTSVNRIALVKVPKVDVSKLLEKKDQST 423
+ C + C + + +++ +I L + SK + S
Sbjct: 360 AKTCLGNSSCVGFYH---------------KEKSNLCKILLESPNNLKNSK----GNISK 400
Query: 424 LVLVICLLLGS-SVFLNILLIFAISVAAYLFYHKKLLRSVSSPSATNVRSFTYKELEEAT 482
++++C ++GS SV LL+ I + K + + N++ F++KEL+ AT
Sbjct: 401 SIIILCSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSAT 460
Query: 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
GF +G G FG V+KG L S FVA+K+L++ GE EFR EV IG H NLV
Sbjct: 461 NGFSDKVGHGGFGAVFKGTLPGSST-FVAVKRLER-PGSGESEFRAEVCTIGNIQHVNLV 518
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEEC 599
RL GFC E HRLLVY+YM GSL+S+L T P W R +IA G A+G+ YLHE C
Sbjct: 519 RLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLSWETRFRIALGTAKGIAYLHEGC 577
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
IIHCDIKP+NILLD + ++SDFGLAKLL + ++ T +RGT GY APEW
Sbjct: 578 RDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT-MRGTWGYVAPEWISGL 636
Query: 660 SITVKVDVYSFGVLLLELICCKSSVVFGT-------TNPEEALM-DWVYRCYIGKNLDKL 711
IT K DVYSFG+ LLELI + +V+ + T PE+ W R I N+D +
Sbjct: 637 PITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSV 696
Query: 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
++ + + + V R+ VA+WCIQ++ +RP
Sbjct: 697 VDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRP 729
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 240/749 (32%), Positives = 360/749 (48%), Gaps = 79/749 (10%)
Query: 30 AFGFHHIDNQD-VFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGH 88
AFGF + QD V L + ++WSAN P + ++G +V+ +G
Sbjct: 54 AFGFGFVTTQDSVTLFTLSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVM---EGT 110
Query: 89 ELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRR 148
E+W+ G +S ++D GN V++ D IWESF PTDTL+ Q + +TS
Sbjct: 111 EVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSP 170
Query: 149 TQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYI 208
+ N + L ++G++ LS SLT QV YWS NA ++I G +
Sbjct: 171 SSSNMTYA----LEIKSGDMVLSVNSLTPQV----YWSMA----NARERIINKDGGVVTS 218
Query: 209 KK--GNQ-RIYNLTKI-------GTRSMQDFYIMARIDYDGVFRQYTHPKYETACNFTWR 258
GN R ++ ++ + +A + +GV +A + +
Sbjct: 219 SSLLGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADSS-- 276
Query: 259 MEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSYLNQSDTSQGCKPNFP 318
+IP D+C CG +C+ G C C S +SD G P
Sbjct: 277 --TKIPSDLCGTPE------PCGPYYVCS---GSKVCGCVSGLSRA-RSDCKTGITS--P 322
Query: 319 LPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIY 378
+DN T +LV + + D+ Y + +C++ C +C C +
Sbjct: 323 CKKTKDNA--TLPLQLV--SAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFF 378
Query: 379 NGDY--CWKKKYPLSNGRRSTSVNR----IALVKVPKVDVSKLLEKKDQSTLVLVICLLL 432
C+ Y G TS N ++ +K+ +D + +++
Sbjct: 379 QNSSGNCFLFDYI---GSFKTSGNGGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIV 435
Query: 433 GSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPSATN-----------VRSFTYKELEEA 481
+VF+ +LIF VA + KK++ S+ +R F YK+L+ A
Sbjct: 436 VVTVFIIAVLIF---VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIR-FAYKDLQSA 491
Query: 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL 541
T F LG+G FG+VY+G L S+ +A+KKL+ + QG+KEFR EVS+IG HH +L
Sbjct: 492 TNNFSVKLGQGGFGSVYEGTLPDGSR--LAVKKLEGI-GQGKKEFRAEVSIIGSIHHLHL 548
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGLMYLHE 597
VRL GFC EG HRLL YE++S GSL ++F G DW+ R IA G A+GL YLHE
Sbjct: 549 VRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHE 608
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+C +I+HCDIKP+NILLDD F ++SDFGLAKL+ EQ+ T +RGT GY APEW
Sbjct: 609 DCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTT-MRGTRGYLAPEWIT 667
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY-RCYIGKNLDKLAENDE 716
+I+ K DVYS+G++LLELI + + T+ + + + + GK +D + +
Sbjct: 668 NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMK 727
Query: 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745
V +RV+R + ALWCIQED RP
Sbjct: 728 NVDVTDERVQRAMKTALWCIQEDMQTRPS 756
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 5e-81, Method: Compositional matrix adjust.
Identities = 250/762 (32%), Positives = 365/762 (47%), Gaps = 85/762 (11%)
Query: 24 SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDP-APRGSQVKLTNSGELVL 82
S G + GF + F + +W+ ++ + TI+W AN D + + S V ++G L+L
Sbjct: 40 SSDGTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLIL 98
Query: 83 YDPQGHE-LWQKPKDGSKSSWA---TMQDDGNFVLLGGDS----NPIWESFKEPTDTLLP 134
D +W + + S A +QDDGN VL G S N +W+SF P DT LP
Sbjct: 99 LDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLP 158
Query: 135 GQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWS-----WNS 189
G + +RT + ++ L E+ + L S+ L Y + W+ W+S
Sbjct: 159 GVKIR-----LDKRTGKSQRLTSWKSL--EDPSPGLFSLELDESTAYKILWNGSNEYWSS 211
Query: 190 EAWNADSQLIFD-----RAGYIYIKKGNQRIYNLTKIG--TRSMQDFYIMAR--IDYDGV 240
WN S+ IFD R YIY N ++ T T S+ + ++R +D G
Sbjct: 212 GPWNPQSR-IFDSVPEMRLNYIY----NFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQ 266
Query: 241 FRQYTHPKYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLCPDN 300
+Q+T + A N W P+ C CG IC++ EP C CP
Sbjct: 267 IKQFTWLEGNKAWNLFWSQ----PRQQCQVYR------YCGSFGICSD-KSEPFCRCPQG 315
Query: 301 YSYLNQSD-----TSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIG 355
+ ++Q D S GC L + G ++ L + K +N++ L+ L I
Sbjct: 316 FRPMSQKDWDLKDYSAGCVRKTELQCSR--GDINQFFRLPNMKLADNSE-VLTRTSLSI- 371
Query: 356 NGVNRQTCEQLCREDCFCAAAIYN--GDYC--WKKK-YPLSNGRRSTSVNRIALVKVPKV 410
C C+ DC C A Y+ C W K L S I +++
Sbjct: 372 -------CASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAAS 424
Query: 411 DVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPSATNV 470
DV + + L+ +LGS L ++++ + V L Y ++ T +
Sbjct: 425 DVPNVGASGKSNNKGLIFGAVLGS---LGVIVLVLLVVILILRYRRRKRMRGEKGDGT-L 480
Query: 471 RSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
+F+Y+EL+ AT+ F LG G FG+V+KG L S +A+K+L+ + Q GEK+FRTEV
Sbjct: 481 SAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD--IAVKRLEGISQ-GEKQFRTEV 537
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD-----WNQRVQIA 585
IG H NLVRL GFC EG +LLVY+YM NGSL S LF + W R QIA
Sbjct: 538 VTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIA 597
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
G ARGL YLH+EC IIHCDIKP+NILLD F P+++DFGLAKL+ + ++ T +R
Sbjct: 598 LGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTT-MR 656
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705
GT GY APEW +IT K DVYS+G++L EL+ + + W +
Sbjct: 657 GTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWA-ATILT 715
Query: 706 KNLDKLAENDEEVKN---DLKRVERLVMVALWCIQEDASLRP 744
K+ D + D ++ D++ V R VA WCIQ++ S RP
Sbjct: 716 KDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRP 757
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 223/750 (29%), Positives = 341/750 (45%), Gaps = 99/750 (13%)
Query: 55 TIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGH-ELWQKPKDGSKSSWATMQDDGNFVL 113
+ +WS+N D P + LT G V+ D + +W P S + D GN +L
Sbjct: 84 STIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLL 143
Query: 114 LGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSV 173
L + +WESF PTD+++ GQ L + ++ ++ ++STG ++FL+ E+ L
Sbjct: 144 LDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGL----- 198
Query: 174 SLTTQVVYDVYWSWNSEA-WNADSQ-----LIFDRAGYIYIKKGNQRIYNLTKIGTRSMQ 227
Q YW N DS L +G + + + + ++
Sbjct: 199 ---MQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVV--VVRVALPPSS 253
Query: 228 DFYIMARIDYDGVFRQYTHPKYETACNFTWRMEE-RIPQDICVAITGDIGSGACGYNSIC 286
DF + A++D G F F+ M+ +IP CG +C
Sbjct: 254 DFRV-AKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPF-------------VCGKLGLC 299
Query: 287 AEINGEP--KCLCPDNYSYLNQSDTSQG-CKP---NFPLP-SCQDNGWETKYNELVDFKS 339
N C CPD + D +G C P + LP SC+ Y EL S
Sbjct: 300 NLDNASENQSCSCPDEM----RMDAGKGVCVPVSQSLSLPVSCEAR--NISYLELGLGVS 353
Query: 340 YENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYNGD----YCWKKKYPLSNGRR 395
Y +T + + +G+ C +C ++C C Y Y K + + +
Sbjct: 354 YFSTH-----FTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVK 408
Query: 396 STSVNRIALVKVPKVDVSKL-------LEKKDQSTLVLVICLLLGSSVFLNILL-IFAIS 447
++ N L+ K+ + K + S V+ + LL S FL I L +
Sbjct: 409 NSPENH-DLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWR 467
Query: 448 VAAYLFYHKKLLRSVSSPSATNV------------RSFTYKELEEATRGFRQILGRGAFG 495
A + Y + V+ P + + F ++ELE+AT F+ +G G FG
Sbjct: 468 RCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFG 527
Query: 496 TVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555
+VYKG L ++ +A+KK+ G +EF TE+++IG H NLV+L GFC G L
Sbjct: 528 SVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLL 585
Query: 556 LVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613
LVYEYM++GSL LF P +W +R IA G ARGL YLH C +IIHCD+KP+NI
Sbjct: 586 LVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENI 645
Query: 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVL 673
LL D+F P+ISDFGL+KLL E++ T +RGT GY APEW A+I+ K DVYS+G++
Sbjct: 646 LLHDHFQPKISDFGLSKLLNQEESSLFTT-MRGTRGYLAPEWITNAAISEKADVYSYGMV 704
Query: 674 LLELICCKSSVVFGTTNPE-------------EALMDWVYRCYIGKNLD------KLAEN 714
LLEL+ + + F + + VY ++ +LA+
Sbjct: 705 LLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADP 764
Query: 715 DEEVKNDLKRVERLVMVALWCIQEDASLRP 744
E + + E+LV +AL C+ E+ +LRP
Sbjct: 765 RLEGRVTSQEAEKLVRIALCCVHEEPALRP 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (694), Expect = 9e-72, Method: Compositional matrix adjust.
Identities = 227/807 (28%), Positives = 358/807 (44%), Gaps = 106/807 (13%)
Query: 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGD 63
A I SL + P SP F GF + L IW+ I +K +VW AN
Sbjct: 26 ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRA 85
Query: 64 DPAPRGSQV-KLTNSGELVLYDPQGHELWQKPKDGSKSS----WATMQDDGNFVLLGGDS 118
P S V ++N G LVL D + +W + S ++ ++ D GNFVL D+
Sbjct: 86 TPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETDT 145
Query: 119 N-PIWESFKEPTDTLLPG-QILNSPIN-----ITSRRTQHNYSTGRFRFLLKENGNLELS 171
+ PIWESF PTDT LP ++ +P S R++ + S G + + +G E+
Sbjct: 146 DRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEI- 204
Query: 172 SVSLTTQVVYDVYWS------WNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRS 225
V W W S WN+ IF + + + L+ +
Sbjct: 205 -----------VLWEGNKTRKWRSGQWNS---AIFTGIPNMSLLTNYLYGFKLSSPPDET 250
Query: 226 MQDFYIMARIDYDGVFR---QYTHPKYETACNFT---WRMEERIPQDICVAITGDIGSGA 279
++ D + R Y + E N T W + P C
Sbjct: 251 GSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN------R 304
Query: 280 CGYNSICAEINGEPKCLCPDNYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKS 339
CG IC C C Y ++ + S+GC+ PL C+ N +E + KS
Sbjct: 305 CGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPL-KCERN-ISVGEDEFLTLKS 362
Query: 340 YENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAA-AIYNGDYCWKKKYPLSNGRRSTS 398
+ D+ + +++L V+ + C + C +C C A ++ G C L + ++ +
Sbjct: 363 VKLPDFEIPEHNL-----VDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQQFEA 417
Query: 399 VNRIALVKVPKVDVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKK- 457
+++ +V + ++ + +++ +L+G ++LI ++ + F KK
Sbjct: 418 GGSSLHIRLADSEVGE----NRKTKIAVIVAVLVG------VILIGIFALLLWRFKRKKD 467
Query: 458 ------------------LLRSVSSPSA----------------TNVRSFTYKELEEATR 483
L +S + SA + + F+ + AT
Sbjct: 468 VSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATN 527
Query: 484 GF--RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL 541
F LGRG FG VYKGVL + R +A+K+L QG EF+ E+ +I + H+NL
Sbjct: 528 DFCKENELGRGGFGPVYKGVL--EDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNL 585
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEE 598
VRLLG C EG+ ++LVYEYM N SL FLF T+ DW R I GIARGL+YLH +
Sbjct: 586 VRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRD 645
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
+IIH D+K N+LLD P+ISDFG+A++ Q +A + GT GY +PE+ +
Sbjct: 646 SRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAME 705
Query: 659 ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718
+VK DVYSFGVLLLE++ K + ++ +L+ + + Y ++L + V
Sbjct: 706 GLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSE-HGSLIGYAWYLYTHGRSEELVDPKIRV 764
Query: 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745
+ R + VA+ C+Q+ A+ RP
Sbjct: 765 TCSKREALRCIHVAMLCVQDSAAERPN 791
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 236/804 (29%), Positives = 362/804 (45%), Gaps = 147/804 (18%)
Query: 24 SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83
SPS F GF + + + L IW+ IP +T VW AN D+P + + LV++
Sbjct: 46 SPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLKISGNNLVIF 105
Query: 84 DPQGHELWQKPKDGS---KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQIL-- 138
D +W G A + D+GNF+L ++ +W+SF PTDTLL L
Sbjct: 106 DQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNNRLLWQSFDFPTDTLLAEMKLGW 165
Query: 139 --NSPIN--ITSRRTQHNYSTGRFRFLLKEN--------------------GNLELSSVS 174
+ N + S +T + S+G F L+ + + SSV
Sbjct: 166 DQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVP 225
Query: 175 LTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMAR 234
T QV Y VY + K+ Y + K + Y
Sbjct: 226 GTIQVDYMVY-------------------NFTASKEEVTYSYRINKT------NLYSRLY 260
Query: 235 IDYDGVFRQYTHPKYETACNFTWRMEERIPQDIC--VAITGDIGSGACGYNSICAEINGE 292
++ G+ ++ T +ET +W+ P+D+C + G+ G C NS+
Sbjct: 261 LNSAGLLQRLTW--FETTQ--SWKQLWYSPKDLCDNYKVCGNFG--YCDSNSL------- 307
Query: 293 PKCLCPDNYSYLNQS-----DTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPL 347
P C C + +N+ D S GC L SC T+ K + D
Sbjct: 308 PNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRL-SCDGRDGFTR------LKRMKLPDTTA 360
Query: 348 SDYDLQIGNGVNRQTCEQLCREDCFCAA----AIYNGD---YCWKKKYPLSNGRRSTSVN 400
+ D +IG V C++ C EDC C A I NG W ++ + + R
Sbjct: 361 TIVDREIGLKV----CKERCLEDCNCTAFANADIRNGGSGCVIWTRE--ILDMRNYAKGG 414
Query: 401 RIALVKVPKVDVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLR 460
+ V++ ++ K ++ ++GSS+ ++ILL+ +S + F+ +K R
Sbjct: 415 QDLYVRLAAAELEDKRIKNEK---------IIGSSIGVSILLL--LSFVIFHFWKRKQKR 463
Query: 461 SVS--SPSATNVRS--------------FTYKELEE---------------ATRGFRQ-- 487
S++ +P+ VRS +T KE + AT F
Sbjct: 464 SITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDN 523
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGF 547
LG+G FG VYKG L D K +A+K+L K+ QG EF EV +I + H NLVRLLG
Sbjct: 524 KLGQGGFGIVYKGRLL-DGKE-IAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGC 581
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEECSTQII 604
C + ++L+YEY+ N SL S LF TR +W +R I GIARGL+YLH++ +II
Sbjct: 582 CVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRII 641
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H D+K N+LLD TP+ISDFG+A++ E+T+A + GT GY +PE+ ++K
Sbjct: 642 HRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMK 701
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN----LDKLAENDEEVKN 720
DV+SFGVLLLE+I K + F +N + L+ +V+R + N +D + + K
Sbjct: 702 SDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKF 761
Query: 721 DLKRVERLVMVALWCIQEDASLRP 744
+ R + + L C+QE A RP
Sbjct: 762 PTHEILRCIQIGLLCVQERAEDRP 785
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | ||||||
| 356532279 | 813 | PREDICTED: G-type lectin S-receptor-like | 0.974 | 0.892 | 0.584 | 0.0 | |
| 356542403 | 831 | PREDICTED: G-type lectin S-receptor-like | 0.982 | 0.880 | 0.559 | 0.0 | |
| 359487483 | 819 | PREDICTED: LOW QUALITY PROTEIN: G-type l | 0.985 | 0.896 | 0.567 | 0.0 | |
| 225450342 | 793 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.912 | 0.546 | 0.0 | |
| 225450348 | 793 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.912 | 0.544 | 0.0 | |
| 147860684 | 910 | hypothetical protein VITISV_030378 [Viti | 0.971 | 0.795 | 0.544 | 0.0 | |
| 359487480 | 793 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.912 | 0.539 | 0.0 | |
| 225435578 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.977 | 0.915 | 0.511 | 0.0 | |
| 359487487 | 808 | PREDICTED: G-type lectin S-receptor-like | 0.981 | 0.904 | 0.517 | 0.0 | |
| 255544748 | 797 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.978 | 0.914 | 0.516 | 0.0 |
| >gi|356532279|ref|XP_003534701.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/758 (58%), Positives = 554/758 (73%), Gaps = 32/758 (4%)
Query: 6 NINLESSLLATKDSNPWRSPSGEFAFGFHHI--DNQDVF-LLAIWFDKIPEKTIVWSA-N 61
N++L SSL+ + W SPSG FAFGF + DN++ +LA+WF K P +TIVW A
Sbjct: 34 NVDLNSSLVT---NGTWNSPSGHFAFGFQSVLFDNKEFMSVLAVWFAKDPNRTIVWYAKQ 90
Query: 62 GDDPA-PRGSQVKLTNSGELVLYDPQGHELWQKPKDGSK---SSWATMQDDGNFVLLGGD 117
PA P GS V LTN G +V+ DP+GHE+W +P++ + S A+M D+G+FVLL
Sbjct: 91 KQSPAFPSGSTVNLTNKG-IVVNDPKGHEMWHRPENNTTIALVSCASMLDNGSFVLLDES 149
Query: 118 SNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLEL------S 171
+WESF+EPTDT+LPGQ L P +R + ++ G F + + NL L S
Sbjct: 150 GKQVWESFEEPTDTILPGQNLAKPKTFRARESDTSFYNGGFELSWQNDSNLVLYYSPQSS 209
Query: 172 SVSLTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYI 231
+ + YW+ + + +SQL FD +G +YIK + +++I ++F+
Sbjct: 210 DDQASQSPTGEAYWA--TGTFKTESQLFFDESGRMYIKNDTGTV--ISEITYSGPEEFFY 265
Query: 232 MARIDYDGVFRQYTHPKYET----ACNFTW-RMEERIPQDICVAITGDIGSGACGYNSIC 286
MARID DGVFR Y HPK E +C+ W + ++ PQDIC++ T G+ CGYNS C
Sbjct: 266 MARIDPDGVFRLYRHPKGENTVADSCSSGWWSVVQQYPQDICLSFTKQTGNVICGYNSYC 325
Query: 287 AEINGEPKCLCPDNYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWP 346
ING+P+C CPD+YS + D GC+P+FPLPSC +GWE + +LVDFK Y N DWP
Sbjct: 326 ITINGKPECECPDHYSSF-EHDNLTGCRPDFPLPSCNKDGWE-QNKDLVDFKEYTNLDWP 383
Query: 347 LSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRSTSVNRIALVK 406
LSDYD + +++ C+Q C EDCFCA AIY CWKKKYP SNGR+ +V RIALVK
Sbjct: 384 LSDYDKLVATAMDKDMCKQKCLEDCFCAVAIYGEGQCWKKKYPFSNGRKHPNVTRIALVK 443
Query: 407 VPKVDVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPS 466
VPK D+ + ++Q+TLVLVI +LLGSSVFLN+LL A+ VA ++FYHK+LL + +
Sbjct: 444 VPKRDLDR--GGREQTTLVLVISILLGSSVFLNVLLFVALFVAFFIFYHKRLLNNPKLSA 501
Query: 467 ATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF 526
AT +RSFTYKELEEAT GF+Q+LGRGAFGTVYKGVL SD+ R+VA+K+LDKV Q+GEKEF
Sbjct: 502 AT-IRSFTYKELEEATTGFKQMLGRGAFGTVYKGVLTSDTSRYVAVKRLDKVVQEGEKEF 560
Query: 527 RTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF 586
+TEVSVIGQTHH+NLVRLLG+CDEG+HRLLVYE+MSNGSLASFLFGI+RP WNQRVQIA
Sbjct: 561 KTEVSVIGQTHHRNLVRLLGYCDEGEHRLLVYEHMSNGSLASFLFGISRPHWNQRVQIAL 620
Query: 587 GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
GIARGL YLHEECSTQIIHCDIKPQNILLD+ FTPRI+DFGLAKLLLAEQ++AA+TG+RG
Sbjct: 621 GIARGLTYLHEECSTQIIHCDIKPQNILLDELFTPRIADFGLAKLLLAEQSKAAKTGLRG 680
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706
T+GYFAPEWFRKASIT K+DVYSFGV+LLE+ICCKSSV F N EEAL+DW YRCY
Sbjct: 681 TIGYFAPEWFRKASITTKIDVYSFGVVLLEIICCKSSVAFAMANDEEALIDWAYRCYSQG 740
Query: 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ KL ENDEE KND+KRVE+ VMVA+WCIQED SLRP
Sbjct: 741 KVAKLVENDEEAKNDIKRVEKHVMVAIWCIQEDPSLRP 778
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542403|ref|XP_003539656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/772 (55%), Positives = 547/772 (70%), Gaps = 40/772 (5%)
Query: 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFL--LAIWFDKIPEKTIVWSAN 61
A +I+L S+L+ ++ W SPSG FAFGF ++ + F+ LA+WF K P +TIVW A
Sbjct: 34 ANSIHLNSTLVT---NHTWNSPSGLFAFGFQNVLSNKEFMSVLAVWFPKDPHRTIVWYAK 90
Query: 62 GDDPA-----------------PRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKS--SW 102
+ P S VKLTN G +VLYD G E+W +PK+ S +
Sbjct: 91 YKQTSDLGTMHAVSSMQKSLAFPSDSTVKLTNKG-IVLYDQNGQEMWHRPKNNSIALVRC 149
Query: 103 ATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLL 162
A+M D GNFVLL +WESF+EPTDT LPGQIL P + +R + ++ G F
Sbjct: 150 ASMLDSGNFVLLDETGKHVWESFEEPTDTFLPGQILAKPKSFRARHSNTSFYDGSFELAW 209
Query: 163 KENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIG 222
+ + N L S + V + YW+ + +++ +S L+F+ +G++YIK+ N + ++
Sbjct: 210 QSDYNFVLY-YSPQSSVTREAYWATQTNSYD-ESLLVFNESGHMYIKRSNTGKV-IREVL 266
Query: 223 TRSMQDFYIMARIDYDGVFRQYTHPK-----YETACNFTWRMEERIPQDICVAITGDIGS 277
++F MARID DG+FR Y H K ++ + W + +R P+DIC++IT G+
Sbjct: 267 YGGSEEFLYMARIDPDGLFRLYRHRKDDDTIADSCSSGWWSVVDRYPKDICLSITMQTGN 326
Query: 278 GACGYNSICAEINGEPKCLCPDNYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDF 337
CGYNS C ING P C CPD +S + + + C+P+FPLPSC +GWE +LVDF
Sbjct: 327 AICGYNSYCITINGNPSCECPDIFSSFDHDNNLKTCRPDFPLPSCNKDGWEQN-KDLVDF 385
Query: 338 KSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRST 397
K Y+N DWPLSDYD +G +++ C Q C EDCFCA AIY CWKKKYPLSNGR+
Sbjct: 386 KEYQNLDWPLSDYDKLVGTAMDKDMCRQKCLEDCFCAVAIYGEGQCWKKKYPLSNGRKHP 445
Query: 398 SVNRIALVKVPKVDVSK-----LLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYL 452
+V RIALVK+PK ++K L ++QST+VLVI +LLGSSVFLN++L+ A+ A Y+
Sbjct: 446 NVTRIALVKIPKTGLNKDGTGSLGNGREQSTIVLVISILLGSSVFLNVILLVALFAAFYI 505
Query: 453 FYHKKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAI 512
FYHKKLL S + +AT +R +TYKELEEAT GF+Q+LGRGAFGTVYKGVL SD+ R+VA+
Sbjct: 506 FYHKKLLNSPNLSAAT-IRYYTYKELEEATTGFKQMLGRGAFGTVYKGVLKSDTSRYVAV 564
Query: 513 KKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG 572
K+LDKV Q+GEKEF+TEVSVIGQTHH+NLVRLLG+CDE +HRLLVYEYM+NGSLA FLFG
Sbjct: 565 KRLDKVVQEGEKEFKTEVSVIGQTHHRNLVRLLGYCDEEEHRLLVYEYMNNGSLACFLFG 624
Query: 573 ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632
I+RP WNQRVQIA GIARGL YLHEECSTQIIHCDIKPQNILLD+ FTPRI+DFGLAKLL
Sbjct: 625 ISRPHWNQRVQIALGIARGLTYLHEECSTQIIHCDIKPQNILLDELFTPRIADFGLAKLL 684
Query: 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
LAEQ++A +TG+RGTVGYFAPEWFRKASIT KVDVYSFGV+LLE+ICCKSSV F + E
Sbjct: 685 LAEQSKATKTGLRGTVGYFAPEWFRKASITTKVDVYSFGVVLLEIICCKSSVSFAMASEE 744
Query: 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
E L+DW YRCY + KL ENDEE K D+KRVE+ VMVA+WCIQED SLRP
Sbjct: 745 ETLIDWAYRCYSQGKVAKLVENDEEAKKDIKRVEKHVMVAIWCIQEDPSLRP 796
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487483|ref|XP_002269019.2| PREDICTED: LOW QUALITY PROTEIN: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2200), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/753 (56%), Positives = 542/753 (71%), Gaps = 19/753 (2%)
Query: 7 INLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPA 66
I L SSL+A+ +S+ WRSPSGEFA GFH + NQ +FLLAIWF+KIPEKT+VW ANGD+PA
Sbjct: 31 IRLGSSLIASDNSSSWRSPSGEFALGFHQLGNQSLFLLAIWFEKIPEKTLVWYANGDNPA 90
Query: 67 PRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSN-PIWESF 125
P+GS+V+LT+ G+ +L DP+G E+W+ K + S ATM D GNFVL + N +WESF
Sbjct: 91 PKGSKVELTSDGQFMLRDPKGEEIWRPQKADNIVSHATMLDTGNFVLEDRNQNLTVWESF 150
Query: 126 KEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYW 185
K P +T+LP Q+L + S++++ NYS GRF+ L+ G+LEL +V + Y+ Y+
Sbjct: 151 KNPVNTILPTQVLELGGTLYSQKSESNYSKGRFQLRLQPGGSLELITVDPESGTAYEAYY 210
Query: 186 SWNS-----EAWNADSQLIFDRAGYIYI--KKGNQRIYNLTKIGTRSMQDFYIMARIDYD 238
NS + ++ ++IFD +G IY+ + G + N+ T S Y A +D+D
Sbjct: 211 RSNSIFVAPNSGDSVERMIFDESGRIYVLLRNGTGTV-NIASGSTSSSGGHYYRATLDHD 269
Query: 239 GVFRQYTHPKYETACNFT-WRMEERIPQDICVAITGDIGSGACGYNSIC-AEINGEPKCL 296
GVFR Y K + N + W + + P DIC A +GSG CG+NS C + G P+CL
Sbjct: 270 GVFRLYNRDKKVGSHNTSSWSVMKNTPYDICDATPSSLGSGICGFNSYCIVDEEGLPQCL 329
Query: 297 CPDNYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGN 356
CPD YS+L+ SD QGCKPNF LPSCQ +GWE + V+F+ T+WPLSDY LQ G
Sbjct: 330 CPDEYSHLDPSDRKQGCKPNFELPSCQKDGWEGN-KDAVEFRELAATNWPLSDYQLQRGP 388
Query: 357 GVNRQTCEQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRSTSVNR--IALVKVPKVDVSK 414
+++ C+Q C++DC CA AI+ GD CWKKK PLSNGR S + AL+KVPK + +
Sbjct: 389 DFDKEKCKQSCKDDCLCAVAIHGGDMCWKKKLPLSNGRHSKIAFKYTTALIKVPKNNATP 448
Query: 415 LLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKK--LLRSVSSPSATN-VR 471
+D+STL LV ++ GSS F N+ L+ AI A + KK L+SVSS AT VR
Sbjct: 449 RC--RDKSTLTLVGSVIFGSSAFFNLFLLSAILGVAVFCHQKKPTKLKSVSSRFATTIVR 506
Query: 472 SFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVS 531
+++Y+ELE AT GF++ LGRGAFGTVYKGVLASD VA+KKLDKV Q+GEKEF TEV+
Sbjct: 507 TYSYRELEVATHGFKEKLGRGAFGTVYKGVLASDPGGAVAVKKLDKVIQEGEKEFETEVA 566
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARG 591
IGQTHH+NLV LLG+C+EG+HRLLVYE+MSNGSLA+ LFGI+RP+W+QRVQIA GIARG
Sbjct: 567 AIGQTHHRNLVGLLGYCNEGEHRLLVYEFMSNGSLANLLFGISRPEWSQRVQIASGIARG 626
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
LMYLHEEC TQIIHCDIKPQNILLDD+FTPRISDFGLAKLLLA+QT+ RTGIRGT+GYF
Sbjct: 627 LMYLHEECRTQIIHCDIKPQNILLDDHFTPRISDFGLAKLLLADQTRITRTGIRGTIGYF 686
Query: 652 APEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711
APEWFRK SIT KVDVYS+G +LLE+ICCKSSVVFG EEAL DW Y CY+G L+++
Sbjct: 687 APEWFRKGSITAKVDVYSYGGMLLEMICCKSSVVFGDNEEEEALTDWAYECYMGGKLEEM 746
Query: 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
E+DEE + D+KRVE +V VA WCIQED RP
Sbjct: 747 VEDDEEARKDMKRVETMVKVAFWCIQEDPGRRP 779
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225450342|ref|XP_002268770.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/749 (54%), Positives = 533/749 (71%), Gaps = 25/749 (3%)
Query: 13 LLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQV 72
+ A++DS SPSGEFAFGF+ + +Q +FLLAIWF+ IPEKT+VW ANGD+PAP+GS++
Sbjct: 25 ITASQDSPRCVSPSGEFAFGFYRLGSQSLFLLAIWFENIPEKTLVWYANGDNPAPKGSKL 84
Query: 73 KLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSN-PIWESFKEPTDT 131
+LT+ G+ +L DPQG E+W+ + + A M D GNFVL + N +W+SF+ P +T
Sbjct: 85 ELTSDGQFILSDPQGKEIWRPQNSVTAVTHAAMLDTGNFVLENRNQNLTVWQSFQNPANT 144
Query: 132 LLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWS-WNSE 190
+LP Q L + S+++ +YS GRF+ +K GNL L+++ + YDVY+S + S+
Sbjct: 145 ILPTQTLEIGGTMYSQQSNSSYSKGRFQLQMKAGGNLVLNTLDPESGKAYDVYYSIYTSD 204
Query: 191 AWNADS---QLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHP 247
A N+ + +LIFD +G IY+ N N+T G+ D+Y A +D DGVFR Y
Sbjct: 205 AANSSNSGLRLIFDESGGIYVLLRNGGTVNITS-GSSLTGDYYYRATLDQDGVFRLYNRD 263
Query: 248 KYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICA-EINGEPKCLCPDNYSYLNQ 306
T+ W + + IP +IC ++GSG CG+NS C+ + G P CLCPD YS+L+
Sbjct: 264 NSSTS----WSVVKNIPDNICTVTPSNLGSGICGFNSYCSIDGRGLPDCLCPDGYSHLDP 319
Query: 307 SDTSQGCKPNFPLPSCQD--NGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCE 364
D QGCKPNF LPSCQ +GWE + VDF+ ++ +WPLSDY LQ G N++ C+
Sbjct: 320 LDRKQGCKPNFELPSCQTAVDGWEAD-KDAVDFRELKDVNWPLSDYQLQEGPEFNKEKCK 378
Query: 365 QLCREDCFCAAAIYNGD-YCWKKKYPLSNGRRSTSVNRI----ALVKVPKVDVSKLLEKK 419
Q C++DC C AIYN + CWKKK+PLSNGR + N + AL+KV ++ +
Sbjct: 379 QSCKDDCLCVVAIYNTENQCWKKKFPLSNGRHEPTQNVLQYTTALIKV-RIKNDTIERCP 437
Query: 420 DQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLL--RSVSSP-SATNVRSFTYK 476
D+STL+LV +LLGSSVF N+ L+ AI AA FY+KKL+ +SVSS T+VR+++YK
Sbjct: 438 DKSTLILVGSVLLGSSVFFNLFLLLAIPAAALFFYNKKLMNIQSVSSKFPTTSVRTYSYK 497
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
ELEEAT GF++ LGRGAFGTVYKGVLASD+ RFVA+KKLDKV Q+GEKEF+TEV+VIGQT
Sbjct: 498 ELEEATGGFKEKLGRGAFGTVYKGVLASDAGRFVAVKKLDKVVQEGEKEFKTEVTVIGQT 557
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
HH+NLV LLG+CD+G HRLLVYEYM+NGSLA LFGI+ PDW+QR+QIAF IA+GLMYLH
Sbjct: 558 HHRNLVSLLGYCDQGVHRLLVYEYMNNGSLADLLFGISTPDWSQRLQIAFKIAKGLMYLH 617
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
EECST IIHCDIKP+NILLD+Y TPRISDFGLAKLL+ + T+ T IRGT GY APEWF
Sbjct: 618 EECSTPIIHCDIKPENILLDEYLTPRISDFGLAKLLIRDHTRTLTT-IRGTKGYVAPEWF 676
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKNLDKLAEND 715
R IT KVDVYS+GV+LLE+I C+ SV N EEA++ DW Y CY G LDKL +ND
Sbjct: 677 RSKPITAKVDVYSYGVMLLEIISCRKSVHSQPENEEEAILADWAYDCYRGHRLDKLVKND 736
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
+E D+ +ER+VMVA+WCIQED SLRP
Sbjct: 737 DEAGKDMGMLERVVMVAIWCIQEDPSLRP 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225450348|ref|XP_002268928.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/749 (54%), Positives = 535/749 (71%), Gaps = 25/749 (3%)
Query: 13 LLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQV 72
+ A+ +S SPSGEFAFGF+ + +Q +FLLAIWF+KIPEKT+VW ANGD+PAP+GS++
Sbjct: 25 ITASNNSPRCVSPSGEFAFGFYRLGSQSLFLLAIWFEKIPEKTLVWYANGDNPAPKGSKL 84
Query: 73 KLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSN-PIWESFKEPTDT 131
+LT+ G+ +L DPQG E+W+ + + A M D GNFVL + N +W+SF+ P +T
Sbjct: 85 ELTSDGQFILSDPQGKEIWRPQNSVTAVTHAAMLDTGNFVLENRNQNLTVWQSFQNPANT 144
Query: 132 LLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE- 190
+LP Q L + S+++ +YS GRF+ ++ GNL L+++ + YDVY+S N+
Sbjct: 145 ILPTQTLEIGGTMYSQQSNSSYSKGRFQLQMEAGGNLVLNTLDPESGKAYDVYYSSNTND 204
Query: 191 ---AWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHP 247
+ N+ ++IFD +G IY+ N N+ G+ D+Y A +D DGVFR Y
Sbjct: 205 AANSGNSGQRVIFDESGSIYVLLRNGGTVNIAS-GSSLTGDYYYRATLDQDGVFRLYNRD 263
Query: 248 KYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICA-EINGEPKCLCPDNYSYLNQ 306
T+ W + + IP +IC ++GSG CG+NS C+ + G P CLCPD YS+L+
Sbjct: 264 NSSTS----WSVVKNIPDNICTVTPSNLGSGICGFNSYCSIDGRGLPDCLCPDGYSHLDP 319
Query: 307 SDTSQGCKPNFPLPSCQD--NGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCE 364
D QGCKPNF LPSCQ +GWE + V+F+ ++ +WPLSDY LQ G N++ C+
Sbjct: 320 LDRKQGCKPNFELPSCQTAVDGWEAN-KDAVEFRELKDVNWPLSDYQLQEGPEFNKEKCK 378
Query: 365 QLCREDCFCAAAIYNGD-YCWKKKYPLSNGRRSTSVNRI----ALVKVPKVDVSKLLEKK 419
Q C++DC C AIYN D CWKKK+P+SNGR + N + AL+KV ++ +
Sbjct: 379 QSCKDDCLCVVAIYNTDNQCWKKKFPVSNGRHEPTQNVLQYTTALIKV-RIKNDTIERCP 437
Query: 420 DQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKL--LRSVSSPSAT-NVRSFTYK 476
D+STL+LV +LLGSSV N+ L+ AI AA FY+KKL LRSVSS AT +VR+++YK
Sbjct: 438 DKSTLILVGSVLLGSSVLFNLFLLLAIPAAALFFYNKKLMNLRSVSSIFATTSVRTYSYK 497
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
EL+EAT GF++ LGRGAFGTVYKGVLASD+ RFVA+KKLDKV Q+GEKEF+TEV+VIG+T
Sbjct: 498 ELDEATCGFKEKLGRGAFGTVYKGVLASDAGRFVAVKKLDKVVQEGEKEFKTEVTVIGRT 557
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
HH+NLV LLG+CD+G HRLLVYEYM+NGSLA LFGI+ PDW+QR+QIAFGIA+GLMYLH
Sbjct: 558 HHRNLVSLLGYCDQGVHRLLVYEYMNNGSLADLLFGISTPDWSQRLQIAFGIAKGLMYLH 617
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
EECST IIHCDIKP+NILLD+Y TPRISDFGLAKLL+ +QT+A T IRGT GY APEWF
Sbjct: 618 EECSTPIIHCDIKPENILLDEYLTPRISDFGLAKLLMRDQTRALTT-IRGTKGYVAPEWF 676
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKNLDKLAEND 715
R ITVKVDVYS+GV+LLE+I C+ SV N EEA++ DW Y CY G LDKL +ND
Sbjct: 677 RSKPITVKVDVYSYGVMLLEIISCRKSVHSQPENDEEAILTDWAYDCYRGHRLDKLVKND 736
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
+EV+ + +ER+VMVA+WCIQED SLRP
Sbjct: 737 DEVRKYMGMLERVVMVAIWCIQEDPSLRP 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147860684|emb|CAN83565.1| hypothetical protein VITISV_030378 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2010), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/749 (54%), Positives = 535/749 (71%), Gaps = 25/749 (3%)
Query: 13 LLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQV 72
+ A+ +S SPSGEFAFGF+ + +Q +FLLAIWF+KIPEKT+VW ANGD+PAP+GS++
Sbjct: 142 ITASNNSPRCVSPSGEFAFGFYRLGSQSLFLLAIWFEKIPEKTLVWYANGDNPAPKGSKL 201
Query: 73 KLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSN-PIWESFKEPTDT 131
+LT+ G+ +L DPQG E+W+ + + A M D GNFVL + N +W+SF+ P +T
Sbjct: 202 ELTSDGQFILSDPQGKEIWRPQNSVTAVTHAAMLDTGNFVLENRNQNLTVWQSFQNPANT 261
Query: 132 LLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE- 190
+LP Q L + S+++ +YS GRF+ ++ GNL L+++ + YDVY+S N+
Sbjct: 262 ILPTQTLEIGGTMYSQQSNSSYSKGRFQLQMEAGGNLVLNTLDPESGKAYDVYYSSNTND 321
Query: 191 ---AWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHP 247
+ N+ ++IFD +G IY+ N N+ G+ D+Y A +D DGVFR Y
Sbjct: 322 AANSGNSGQRVIFDESGSIYVLLRNGGTVNIAS-GSSLTGDYYYRATLDQDGVFRLYNRD 380
Query: 248 KYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICA-EINGEPKCLCPDNYSYLNQ 306
T+ W + + IP +IC ++GSG CG+NS C+ + G P CLCPD YS+L+
Sbjct: 381 NSSTS----WSVVKNIPDNICTVTPSNLGSGICGFNSYCSIDGRGLPDCLCPDGYSHLDP 436
Query: 307 SDTSQGCKPNFPLPSCQD--NGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCE 364
D QGCKPNF LPSCQ +GWE + V+F+ ++ +WPLSDY LQ G N++ C+
Sbjct: 437 LDRKQGCKPNFELPSCQTAVDGWEAN-KDAVEFRELKDVNWPLSDYQLQEGPEFNKEKCK 495
Query: 365 QLCREDCFCAAAIYNGD-YCWKKKYPLSNGRRSTSVNRI----ALVKVPKVDVSKLLEKK 419
Q C++DC C AIYN D CWKKK+P+SNGR + N + AL+KV ++ +
Sbjct: 496 QSCKDDCLCVVAIYNTDNQCWKKKFPVSNGRHEPTQNVLQYTTALIKV-RIKNDTIERCP 554
Query: 420 DQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKL--LRSVSSPSAT-NVRSFTYK 476
D+STL+LV +LLGSSV N+ L+ AI AA FY+KKL LRSVSS AT +VR+++YK
Sbjct: 555 DKSTLILVGSVLLGSSVLFNLFLLLAIPAAALFFYNKKLMNLRSVSSIFATTSVRTYSYK 614
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
EL+EAT GF++ LGRGAFGTVYKGVLASD+ RFVA+KKLDKV Q+GEKEF+TEV+VIG+T
Sbjct: 615 ELDEATCGFKEKLGRGAFGTVYKGVLASDAGRFVAVKKLDKVVQEGEKEFKTEVTVIGRT 674
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
HH+NLV LLG+CD+G HRLLVYEYM+NGSLA LFGI+ PDW+QR+QIAFGIA+GLMYLH
Sbjct: 675 HHRNLVSLLGYCDQGVHRLLVYEYMNNGSLADLLFGISTPDWSQRLQIAFGIAKGLMYLH 734
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
EECST IIHCDIKP+NILLD+Y TPRISDFGLAKLL+ +QT+A T IRGT GY APEWF
Sbjct: 735 EECSTPIIHCDIKPENILLDEYLTPRISDFGLAKLLMRDQTRALTT-IRGTKGYVAPEWF 793
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKNLDKLAEND 715
R ITVKVDVYS+GV+LLE+I C+ SV N EEA++ DW Y CY G LDKL +ND
Sbjct: 794 RSKPITVKVDVYSYGVMLLEIISCRKSVHSQPENDEEAILTDWAYDCYRGHRLDKLVKND 853
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
+EV+ + +ER+VMVA+WCIQED SLRP
Sbjct: 854 DEVRKYMGMLERVVMVAIWCIQEDPSLRP 882
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487480|ref|XP_002268890.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/749 (53%), Positives = 529/749 (70%), Gaps = 25/749 (3%)
Query: 13 LLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQV 72
+ A+ DS SPSGEFAFGF+ + +Q +FLLAIWF+KIPEKT+VW ANGD+PAP+GS++
Sbjct: 25 ITASNDSPRCVSPSGEFAFGFYRLGSQSLFLLAIWFEKIPEKTLVWYANGDNPAPKGSKL 84
Query: 73 KLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSN-PIWESFKEPTDT 131
+LT+ G+ +L DPQG E+W+ + + A M D GNFVL + N +W+SF+ P +T
Sbjct: 85 ELTSDGQFILSDPQGKEIWRPQNSVTAVTHAAMLDTGNFVLENRNQNLTVWQSFQNPANT 144
Query: 132 LLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE- 190
+LP Q L + S+++ +YS GRF+ ++ GNL L+++ + YDVY+S N+
Sbjct: 145 ILPTQTLEIGGTMYSQQSNSSYSKGRFQLQMEAGGNLVLNTLDPESGKAYDVYYSSNTND 204
Query: 191 ---AWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHP 247
+ N+ ++IFD +G IY+ N N+ G+ D+Y A +D DGVFR Y
Sbjct: 205 TANSSNSGQRVIFDESGSIYVLLRNGGTVNIAS-GSSLTGDYYYRATLDQDGVFRLYNRD 263
Query: 248 KYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICA-EINGEPKCLCPDNYSYLNQ 306
T+ W + + IP +IC ++GSG CG+NS C+ + G P CLCPD YS+L+
Sbjct: 264 NSSTS----WSVVKNIPDNICTVTPSNLGSGICGFNSYCSIDGRGMPDCLCPDGYSHLDP 319
Query: 307 SDTSQGCKPNFPLPSCQD--NGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCE 364
D QGCKPNF LPSCQ +GW+ + VDF + +WPLSDY LQ G N++ C+
Sbjct: 320 LDRKQGCKPNFELPSCQTAVDGWKAN-KDAVDFSELKGVNWPLSDYQLQKGPEFNKEKCK 378
Query: 365 QLCREDCFCAAAIYN-GDYCWKKKYPLSNGRRSTSVN----RIALVKVPKVDVSKLLEKK 419
Q C++DC C AIYN + CWKKK+PLSNGR + N AL+KV ++ +
Sbjct: 379 QSCKDDCLCVVAIYNTNNQCWKKKFPLSNGRHEPTQNVFEYSTALIKV-RIKNDTIERCP 437
Query: 420 DQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLL--RSVSSP-SATNVRSFTYK 476
D+STL+LV +LLGSSVF N+ L+ AI AA FY+KKL+ +SVSS T+VR+++YK
Sbjct: 438 DKSTLILVGSVLLGSSVFFNLFLLLAIPAAALFFYNKKLMNIQSVSSKFPTTSVRTYSYK 497
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
ELEEAT GF++ LGRGAFGTVYKGVLASD+ RFVA+KKLDKV Q+GEKEF+TEV+VIG+T
Sbjct: 498 ELEEATGGFKEKLGRGAFGTVYKGVLASDAGRFVAVKKLDKVVQEGEKEFKTEVTVIGRT 557
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
HH+NLV LLG+CD+G HRLLVYE+M+NGSLA FLFGI+ P+W+QR+QIAFGIA+GLMYLH
Sbjct: 558 HHRNLVSLLGYCDQGVHRLLVYEHMNNGSLADFLFGISTPEWSQRLQIAFGIAKGLMYLH 617
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
EECST IIHCDIKP+NILLD+Y TPRISDFGLAKLL+ + T+ T IRGT GY APEWF
Sbjct: 618 EECSTPIIHCDIKPENILLDEYLTPRISDFGLAKLLMRDHTRTLTT-IRGTKGYVAPEWF 676
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKNLDKLAEND 715
R IT KVDVYS+GV+LLE+I C+ SV N EEA++ DW Y CY G LDKL +ND
Sbjct: 677 RSKPITAKVDVYSYGVMLLEIISCRKSVHSQPENEEEAILADWAYDCYRGHRLDKLVKND 736
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
+E D+ +ER+VMVA+WCIQED SLRP
Sbjct: 737 DEAGKDMGMLERVVMVAIWCIQEDPSLRP 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435578|ref|XP_002283186.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1887), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/753 (51%), Positives = 493/753 (65%), Gaps = 25/753 (3%)
Query: 5 ANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDD 64
+NI L SSL A + + W SPSGEFAFGF + FLLAIWF+KIPEKTI+WSANG+
Sbjct: 27 SNITLGSSLTAQNNGSFWASPSGEFAFGFQQV-GAGGFLLAIWFNKIPEKTIIWSANGNS 85
Query: 65 PAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWES 124
R S V+LT G+LVL DP+G ++W GS S+A M D GNFVL+G DS +WES
Sbjct: 86 LGQRRSIVQLTADGQLVLTDPKGKQIWDA---GSGVSYAAMVDTGNFVLVGQDSVTLWES 142
Query: 125 FKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVY 184
F EPTDT+LP Q LN + +R ++ NYS GRF F L+ +GNL + + Y
Sbjct: 143 FGEPTDTILPTQELNQGGKLVARFSETNYSNGRFMFTLQADGNLVMYTRDFPMDSTNFAY 202
Query: 185 WSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQY 244
WS ++ + Q+IF+++GYI + N+ I NL S +DFY A ++YDGVFRQY
Sbjct: 203 WS--TQTVGSGFQVIFNQSGYIVLTARNKSILNLVSSSETSTEDFYQRAILEYDGVFRQY 260
Query: 245 THPKYETACNFTWRM----EERIPQDICVAITGDIGSGACGYNSICAEINGE-PKCLCPD 299
+PK + + W M IP +IC+ IT + G GACG+NS C + + P C CP
Sbjct: 261 VYPKSAGSSSGRWPMAWSPSPSIPGNICMRITENTGGGACGFNSYCILGDDQRPNCKCPT 320
Query: 300 NYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVN 359
Y +L+QSD GCK NF +C ET + F+ NTDWPLSDY V+
Sbjct: 321 GYDFLDQSDKMSGCKQNFVTQNCDQASRET---DQFYFQEMPNTDWPLSDYGYF--QPVS 375
Query: 360 RQTCEQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRSTSVNRIALVKVPKVDVSKL---- 415
C + C DCFCA AI+ CWKKK PLSNGR SV AL+K+ + + +
Sbjct: 376 EDWCREACLTDCFCAVAIFRDGNCWKKKIPLSNGRIDPSVGGKALIKLRQGNSTTKPGDG 435
Query: 416 -LEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKK--LLRSVSSPSATNVRS 472
KK QSTL+L +LLGSSVFLN L A + + F ++K +L + S N+RS
Sbjct: 436 DSNKKHQSTLILTGSVLLGSSVFLNFLFFLATVLFIFRFNNRKTKMLHTYLSTLGMNLRS 495
Query: 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSV 532
FTY EL+EAT GF++ LGRGAF TVYKGVLA + + VA+KK +K+ ++ E+EF+TEV
Sbjct: 496 FTYNELDEATDGFKEELGRGAFATVYKGVLAYEKGKLVAVKKFEKMMRENEQEFQTEVKA 555
Query: 533 IGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGL 592
IGQT+HKNLV+LLGFC EG+HRLLVYE+MSNGSL FLFG +RP+W++R+QIAFGIARGL
Sbjct: 556 IGQTNHKNLVQLLGFCKEGEHRLLVYEFMSNGSLEKFLFGNSRPNWHKRIQIAFGIARGL 615
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLHEECSTQIIHCDIKPQNILLDD F+ RISDFGLAKLL +QT+ GY A
Sbjct: 616 FYLHEECSTQIIHCDIKPQNILLDDSFSARISDFGLAKLLKTDQTRTTTGIRGTK-GYVA 674
Query: 653 PEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKNLDKL 711
PEWF+ ITVKVDVYSFG+LLLELICC+ ++ F + + ++ DW Y CY G L+ L
Sbjct: 675 PEWFKSMPITVKVDVYSFGILLLELICCRKNLEFEAKDETQMILADWAYDCYKGGLLEVL 734
Query: 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
D+E ++KR+E+ VM+A+WCIQED SLRP
Sbjct: 735 VGYDQEAIVEMKRLEKFVMIAIWCIQEDPSLRP 767
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487487|ref|XP_002269067.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/757 (51%), Positives = 504/757 (66%), Gaps = 26/757 (3%)
Query: 7 INLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPA 66
I L SSL+A+ +S+ WRSPSGEFAFGFH + NQ++FLLAIWFDKIPEKT+ W ANGD+PA
Sbjct: 31 IRLGSSLIASDNSSSWRSPSGEFAFGFHQLGNQNLFLLAIWFDKIPEKTLAWYANGDNPA 90
Query: 67 PRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNP--IWES 124
P GS+V+LT+ G+L+L DP+G E+W+ + + A M D GNF L+ GD N +WES
Sbjct: 91 PEGSKVELTSDGQLILNDPKGDEIWRPQTTLNGVTHAYMLDAGNFALVNGDQNSTHVWES 150
Query: 125 FKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVY 184
FK P DT+LP Q+L ++SR+ + NYS GRF+ L +GNL L++ L T YD Y
Sbjct: 151 FKNPVDTVLPTQVLEIGGTVSSRQAESNYSKGRFQLRLLPDGNLVLNTFDLQTNTAYDAY 210
Query: 185 -WSWNSEAWN---ADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGV 240
WS +A N + ++IFD G++Y+ + L S +Y A +D+DGV
Sbjct: 211 YWSKTYDAANRSNSGERVIFDELGHLYVVLQSGDNVTLKSGSAESTGGYYYRATLDFDGV 270
Query: 241 FRQYTHPKYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICA-EINGEPKCLCPD 299
FR YT PK ++ N +W +P+DIC I GD+G G+CG+NS C + +G P C C
Sbjct: 271 FRIYTRPKLQS--NGSWVPFWYVPKDICSEIGGDLGGGSCGFNSYCVPDSSGRPACECLP 328
Query: 300 NYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVN 359
+ + + GCK N C+ G + +L + N WP S + + ++
Sbjct: 329 GFFPADPHNKLNGCKHNL-TQKCEAGG--SNMEDLYQKREVSNLFWP-SSANFEKKESLS 384
Query: 360 RQTCEQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRSTSVNRIALVKVPKVDVSK----- 414
C C DC C A++ C KKK PLSNGR S LVKVP+ D
Sbjct: 385 EDLCWTSCLYDCNCVVAVHKEGTCRKKKMPLSNGRVDWSTRGKTLVKVPRYDAFSGETPF 444
Query: 415 ----LLEKKDQSTLVLVICLLLGSSVFLNILLIFAIS-VAAYLFYHKKLLRSVSSPSATN 469
+KK+Q T +LV +LLGSSVFLN LL+ AIS V +Y ++ L SS TN
Sbjct: 445 RDPIREKKKEQGTFILVGSILLGSSVFLNFLLVAAISLVRSYPSQKRRELTRASSILETN 504
Query: 470 VRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRF-VAIKKLDKVEQQGEKEFRT 528
+RSFTY+EL++A GFR+ LGRGAFGTVYKGVL+S S VA+KKLDK+ Q+GE+EF+T
Sbjct: 505 IRSFTYEELKQAADGFREELGRGAFGTVYKGVLSSSSSGTQVAVKKLDKLVQEGEREFKT 564
Query: 529 EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGI 588
EV I THHKNLVRL+GFCDEG H+LLVYE+M NG+LASFLFG + PDW R Q+AFG+
Sbjct: 565 EVRTIAMTHHKNLVRLIGFCDEGPHKLLVYEFMCNGTLASFLFGSSAPDWKIRTQMAFGV 624
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
ARGLMYLHEECSTQIIHCDIKPQN+LLDD FT RISDFGLAKLL+++QT+ T IRGT
Sbjct: 625 ARGLMYLHEECSTQIIHCDIKPQNVLLDDSFTARISDFGLAKLLMSDQTRTL-TAIRGTK 683
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKN 707
GY APEWFR IT KVDVYS+GV+LLE+I C+ + F T N EEA++ DW Y CY G
Sbjct: 684 GYVAPEWFRSKPITAKVDVYSYGVMLLEIISCRKCIDFQTENEEEAILTDWAYDCYRGHR 743
Query: 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
LDKL END++ +ND++R+E+LVMVA+WCIQED SLRP
Sbjct: 744 LDKLVENDDDARNDMRRLEKLVMVAIWCIQEDPSLRP 780
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544748|ref|XP_002513435.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223547343|gb|EEF48838.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/755 (51%), Positives = 496/755 (65%), Gaps = 26/755 (3%)
Query: 6 NINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDP 65
NI+L SSL A KD + W SPSG+FAFGF +D ++ +LLAIWF+++PEKTIVWSAN ++
Sbjct: 24 NISLGSSLTAQKDDSFWVSPSGDFAFGFQLVD-KNGYLLAIWFNEVPEKTIVWSANRNNL 82
Query: 66 APRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESF 125
RGS+V+LT G LVL D +LW S+A M D GNFVL DS +WESF
Sbjct: 83 VGRGSKVQLTTDGRLVLNDQSNRQLWSANSAADGVSYAAMLDTGNFVLADKDSITLWESF 142
Query: 126 KEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYW 185
EPTDT+LP Q ++ + +R ++ NYS GRF+F+L+ +GNL L + YW
Sbjct: 143 DEPTDTILPTQTMDQGGELIARYSETNYSDGRFKFMLQTDGNLLLYTRKYPLDTSNAAYW 202
Query: 186 SWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYT 245
S + + Q+IF+++GYI + N I N S +DFY A ID+DGVFR Y
Sbjct: 203 S-TQTSIGSGFQVIFNQSGYIILIARNGSILNDVFSNEASTRDFYQRATIDHDGVFRHYV 261
Query: 246 HPKYETACN----FTWRMEERIPQDICVAITGDIGSGACGYNSICAEINGE-PKCLCPDN 300
+PK T+ W + IP +IC+ I G+ GSGACG+NS C + + P C CP
Sbjct: 262 YPKNATSSAGKWPLAWTVLSFIPGNICMRIGGETGSGACGFNSYCRLGDDQRPNCQCPPG 321
Query: 301 YSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNR 360
++ L+ +D S+GCK NF +C ET +L++ NTDWPLSDY + + V
Sbjct: 322 HTLLDPNDESKGCKQNFVAQNCDAESQETDSFDLMEMP---NTDWPLSDY--EYFDTVTE 376
Query: 361 QTCEQLCREDCFCAAAIYNGDYCWKKKYPLSNGRRSTSVNRIALVKVPKVD----VSKLL 416
C Q C DC+C+ AIY CWKKK PLSNGR SV AL+KV + + +
Sbjct: 377 DWCRQACLSDCYCSVAIYRNQGCWKKKIPLSNGRMDPSVGGKALIKVRRDNSTSGATSCY 436
Query: 417 EKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPS-----ATNVR 471
+KKDQSTL+L+ + LGSSVFLN+LL+ A V Y + +K + P A N R
Sbjct: 437 KKKDQSTLILIGSVFLGSSVFLNVLLLVATLVFFYRWSRQK--SKIVQPHTQVMLAMNPR 494
Query: 472 SFTYKELEEATRGFRQILGRGAFGTVYKGV-LASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
SFTY ELE AT GF++ LG GAFGTVYKGV + S+S +F+A+KKL KV +GEKEF TEV
Sbjct: 495 SFTYNELEVATGGFKEELGSGAFGTVYKGVVIESNSTKFIAVKKLKKVVAEGEKEFETEV 554
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR 590
+IG T+HKNL +LLGFC+EG HR+LVYEYMSNG LA FLFG +RP+W +R+QIAFGIAR
Sbjct: 555 DIIGGTNHKNLAKLLGFCNEGQHRMLVYEYMSNGCLADFLFGDSRPNWYKRMQIAFGIAR 614
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
GL YLHEECS+QIIHCDIKPQN+LLD+ T RISDFGLAKLL +Q+Q T IRGT GY
Sbjct: 615 GLSYLHEECSSQIIHCDIKPQNVLLDESLTARISDFGLAKLLKTDQSQTM-TAIRGTKGY 673
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM-DWVYRCYIGKNLD 709
APEWFR IT KVDVYSFG+LLLELICCK SV T ++ DW Y Y +++
Sbjct: 674 VAPEWFRNMPITSKVDVYSFGILLLELICCKRSVEKDTKERYPIILADWAYDRYKEGSVN 733
Query: 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
L E+DEE +D+KRVER VMVA+WCIQ+D SLRP
Sbjct: 734 LLVEDDEEATDDVKRVERFVMVAMWCIQDDPSLRP 768
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.869 | 0.781 | 0.348 | 9.6e-89 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.907 | 0.816 | 0.330 | 1.1e-85 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.897 | 0.814 | 0.328 | 3.9e-83 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.285 | 0.244 | 0.495 | 1.3e-77 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.613 | 0.556 | 0.329 | 3.5e-71 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.620 | 0.583 | 0.322 | 2.6e-69 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.920 | 0.852 | 0.292 | 1.2e-67 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.361 | 0.316 | 0.407 | 1.3e-67 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.935 | 0.861 | 0.291 | 1.5e-67 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.379 | 0.332 | 0.395 | 1.6e-66 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
Identities = 249/714 (34%), Positives = 363/714 (50%)
Query: 57 VWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGG 116
+WSA D RGS ++L SG L L + G +W D + +++D G F+LL
Sbjct: 74 IWSAGTVDS--RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNN 130
Query: 117 DSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLT 176
S P+W SF PTDT++ Q N T+ + + G + F L+ +GNL L
Sbjct: 131 RSVPVWSSFDNPTDTIVQSQ------NFTAGKILRS---GLYSFQLERSGNLTLR---WN 178
Query: 177 TQVVYDVYWSWNSEAWNADS-QLIFDRAGYIYIKKGNQRI-YNLTKIGTRSMQDFYIMAR 234
T +Y + +S + N S +L G + I + N + G + + +
Sbjct: 179 TSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLK 238
Query: 235 IDYDGVFRQYTHPKYETA-CNFTWRMEERIPQDICVAITGDIGSGACGYNSICAEINGEP 293
+D DG R Y+ + N W ++ C+ G CG IC+ + P
Sbjct: 239 LDDDGNLRIYSSASRNSGPVNAHWSAVDQ-----CLVY------GYCGNFGICSYNDTNP 287
Query: 294 KCLCPD-NYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDL 352
C CP N+ +++ +D +GCK L C N T +LV + + D P S+
Sbjct: 288 ICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGN---TTMLDLVHTRLFTYEDDPNSE-SF 343
Query: 353 QIGNGVNRQTCEQLCREDCFCAAAIYNGD-YCWKKKYPLS--NGRRSTSVNRIALVKVPK 409
G+ R C L C + ++ +G CW+K +P S G + SV + VKV
Sbjct: 344 FAGSSPCRANC--LSSVLCLASVSMSDGSGNCWQK-HPGSFFTGYQWPSVPSTSYVKVCG 400
Query: 410 VDVSKLLEK--KDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLR--SVSS- 464
V+ LE+ K V ++ +V +L + A+ + + +K R ++SS
Sbjct: 401 PVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSH 460
Query: 465 ------PSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV 518
S V+ FTYKEL+ T+ F++ LG G FGTVY+GVL + + VA+K+L+ +
Sbjct: 461 YTLLEYASGAPVQ-FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTN--RTVVAVKQLEGI 517
Query: 519 EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD- 577
EQ GEK+FR EV+ I THH NLVRL+GFC +G HRLLVYE+M NGSL +FLF
Sbjct: 518 EQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKF 576
Query: 578 --WNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
W R IA G A+G+ YLHEEC I+HCDIKP+NIL+DD F ++SDFGLAKLL +
Sbjct: 577 LTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPK 636
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSV-VFGTTNPEEA 694
+ + +RGT GY APEW IT K DVYS+G++LLEL+ K + V TN ++
Sbjct: 637 DNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKF 696
Query: 695 LMDWVYRCYIGKN----LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ W Y + N LD D+ V D+++V R+V + WCIQE RP
Sbjct: 697 SI-WAYEEFEKGNTKAILDTRLSEDQTV--DMEQVMRMVKTSFWCIQEQPLQRP 747
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 1.1e-85, P = 1.1e-85
Identities = 252/763 (33%), Positives = 368/763 (48%)
Query: 24 SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDP-APRGSQVKLTNSGELVL 82
S G + GF + F + +W+ ++ + TI+W AN D + + S V ++G L+L
Sbjct: 40 SSDGTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLIL 98
Query: 83 YDPQGHE-LWQKPKDGSKSSWA---TMQDDGNFVL-LGGDS---NPIWESFKEPTDTLLP 134
D +W + + S A +QDDGN VL GG S N +W+SF P DT LP
Sbjct: 99 LDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLP 158
Query: 135 GQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWS-----WNS 189
G + +RT + ++ L E+ + L S+ L Y + W+ W+S
Sbjct: 159 GVKIR-----LDKRTGKSQRLTSWKSL--EDPSPGLFSLELDESTAYKILWNGSNEYWSS 211
Query: 190 EAWNADSQLIFD-----RAGYIYIKKGNQRIYNLTKIG--TRSMQDFYIMAR--IDYDGV 240
WN S+ IFD R YIY N ++ T T S+ + ++R +D G
Sbjct: 212 GPWNPQSR-IFDSVPEMRLNYIY----NFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQ 266
Query: 241 FRQYTHPKYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLCPDN 300
+Q+T + A N W P+ C CG IC++ EP C CP
Sbjct: 267 IKQFTWLEGNKAWNLFWSQ----PRQQCQVYR------YCGSFGICSD-KSEPFCRCPQG 315
Query: 301 YSYLNQSDT-----SQGCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIG 355
+ ++Q D S GC L C G ++ L + K +N++ L+ L I
Sbjct: 316 FRPMSQKDWDLKDYSAGCVRKTEL-QCS-RGDINQFFRLPNMKLADNSE-VLTRTSLSI- 371
Query: 356 NGVNRQTCEQLCREDCFCAAAIYN--GDYC--WKKKY-PLSNGRRSTSVNRIALVKVPKV 410
C C+ DC C A Y+ C W K L S I +++
Sbjct: 372 -------CASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAAS 424
Query: 411 DVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPSATNV 470
DV + + L+ +LGS + ++L+ I + Y +K +R +
Sbjct: 425 DVPNVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYR--RRKRMRGEKGDGTLS- 481
Query: 471 RSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
+F+Y+EL+ AT+ F LG G FG+V+KG L S +A+K+L+ + Q GEK+FRTEV
Sbjct: 482 -AFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD--IAVKRLEGISQ-GEKQFRTEV 537
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD------WNQRVQI 584
IG H NLVRL GFC EG +LLVY+YM NGSL S LF + + + W R QI
Sbjct: 538 VTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLF-LNQVEEKIVLGWKLRFQI 596
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
A G ARGL YLH+EC IIHCDIKP+NILLD F P+++DFGLAKL+ + ++ T +
Sbjct: 597 ALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTT-M 655
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI 704
RGT GY APEW +IT K DVYS+G++L EL+ + + W +
Sbjct: 656 RGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWA-ATIL 714
Query: 705 GKNLDKLAENDEEVKND---LKRVERLVMVALWCIQEDASLRP 744
K+ D + D ++ D ++ V R VA WCIQ++ S RP
Sbjct: 715 TKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRP 757
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
Identities = 248/756 (32%), Positives = 373/756 (49%)
Query: 26 SGEFAFGFHHIDNQD---VFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVL 82
S AFGF + QD +F L+I K K ++WSAN P + ++G +V+
Sbjct: 50 SNNSAFGFGFVTTQDSVTLFTLSI-IHKSSTK-LIWSANRASPVSNSDKFVFDDNGNVVM 107
Query: 83 YDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPI 142
+G E+W+ G +S ++D GN V++ D IWESF PTDTL+ Q +
Sbjct: 108 ---EGTEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGM 164
Query: 143 NITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFDR 202
+TS + N + + +K +G++ LS SLT QV YWS NA ++I
Sbjct: 165 KLTSSPSSSNMT---YALEIK-SGDMVLSVNSLTPQV----YWSMA----NARERIINKD 212
Query: 203 AGYIYIKK--GNQ-RIYNLTKI-------GTRSMQDFYIMARIDYDGVFRQYTHPKYETA 252
G + GN R ++ ++ + +A + +GV +A
Sbjct: 213 GGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASA 272
Query: 253 CNFTWRMEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSYLNQSDTSQG 312
+ + +IP D+C T + CG +C+ G C C S +SD G
Sbjct: 273 ADSS----TKIPSDLCG--TPE----PCGPYYVCS---GSKVCGCVSGLSRA-RSDCKTG 318
Query: 313 CKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCF 372
P +DN T +LV + + D+ Y + +C++ C +C
Sbjct: 319 ITS--PCKKTKDNA--TLPLQLVS--AGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCS 372
Query: 373 CAAAIYNGDY--CWKKKYPLSNGRRSTSVNR----IALVKVPKVDVSKLLEKKDQSTLVL 426
C + C+ Y G TS N ++ +K+ +D
Sbjct: 373 CLGLFFQNSSGNCFLFDYI---GSFKTSGNGGSGFVSYIKIASTGSGGGDNGEDDGKHFP 429
Query: 427 VICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPSAT------NVRS----FTYK 476
+ +++ +VF+ +LIF VA + KK++ S+ N+ F YK
Sbjct: 430 YVVIIVVVTVFIIAVLIF---VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYK 486
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
+L+ AT F LG+G FG+VY+G L S+ +A+KKL+ + Q G+KEFR EVS+IG
Sbjct: 487 DLQSATNNFSVKLGQGGFGSVYEGTLPDGSR--LAVKKLEGIGQ-GKKEFRAEVSIIGSI 543
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGL 592
HH +LVRL GFC EG HRLL YE++S GSL ++F G DW+ R IA G A+GL
Sbjct: 544 HHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGL 603
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLHE+C +I+HCDIKP+NILLDD F ++SDFGLAKL+ EQ+ T +RGT GY A
Sbjct: 604 AYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTT-MRGTRGYLA 662
Query: 653 PEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR-CYIGKNLDKL 711
PEW +I+ K DVYS+G++LLELI + + T+ + + ++ GK +D +
Sbjct: 663 PEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIV 722
Query: 712 AENDEEVKN-DL--KRVERLVMVALWCIQEDASLRP 744
D ++KN D+ +RV+R + ALWCIQED RP
Sbjct: 723 ---DGKMKNVDVTDERVQRAMKTALWCIQEDMQTRP 755
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 1.3e-77, Sum P(4) = 1.3e-77
Identities = 108/218 (49%), Positives = 146/218 (66%)
Query: 471 RSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
+ F ++ELE+AT F+ +G G FG+VYKG L ++ +A+KK+ G +EF TE+
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEI 560
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGI 588
++IG H NLV+L GFC G LLVYEYM++GSL LF P +W +R IA G
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
ARGL YLH C +IIHCD+KP+NILL D+F P+ISDFGL+KLL E++ T +RGT
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTT-MRGTR 679
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686
GY APEW A+I+ K DVYS+G++LLEL+ + + F
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSF 717
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 3.5e-71, Sum P(2) = 3.5e-71
Identities = 161/489 (32%), Positives = 241/489 (49%)
Query: 278 GACGYNSICAEINGEPKCLC-----PDNYSYLNQSDTSQGCKPNFPLPSCQDNGW-ETKY 331
G CG +C +G P C C P + + S+GC L SCQ N ET+
Sbjct: 284 GRCGPFGLCVR-SGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNL-SCQGNSSVETQG 341
Query: 332 NELVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIY-NGDYC--WKKKY 388
+ F N P Y+L + N + C Q C +C C A Y +G C W ++
Sbjct: 342 KDRDVFYHVSNIK-PPDSYEL--ASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQEL 398
Query: 389 ----PLSNGRRSTSVNRIALVKVPKVDVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIF 444
G + S+ R+A ++ K++ S V +I +L+ + +
Sbjct: 399 LDTVKFIGGGETLSL-RLAHSELTGRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQN 457
Query: 445 AISVAAYLFYHKKLLRSVSSPSATNVRSFTYKELEEATRGFRQI--LGRGAFGTVYKGVL 502
S+ + + S + + F +L+ AT F + LG+G FGTVYKG L
Sbjct: 458 GSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKL 517
Query: 503 ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562
D K +A+K+L QG +EF E+ +I + H+NL+RLLG C +G+ +LLVYEYM
Sbjct: 518 -QDGKE-IAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMV 575
Query: 563 NGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619
N SL F+F + + DW R I GIARGL+YLH + +++H D+K NILLD+
Sbjct: 576 NKSLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKM 635
Query: 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
P+ISDFGLA+L Q Q + + GT+GY +PE+ + + K D+YSFGVL+LE+I
Sbjct: 636 NPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIIT 695
Query: 680 CK--SSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVE--RLVMVALWC 735
K SS +G N L+ + + + L + D + + + VE R V + L C
Sbjct: 696 GKEISSFSYGKDNKN--LLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLC 753
Query: 736 IQEDASLRP 744
+Q A RP
Sbjct: 754 VQHQAIDRP 762
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 2.6e-69, Sum P(2) = 2.6e-69
Identities = 162/503 (32%), Positives = 242/503 (48%)
Query: 257 WRMEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLC-----PDNYSYLNQSDTSQ 311
W+ P + C DI G CG C I+ PKC C P + + + +
Sbjct: 264 WKSSYEGPANSC-----DI-YGVCGPFGFCV-ISDPPKCKCFKGFVPKSIEEWKRGNWTS 316
Query: 312 GCKPNFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDC 371
GC L CQ N N F + N P D+ + N V+ + C Q C +C
Sbjct: 317 GCARRTEL-HCQGNSTGKDANV---FHTVPNIKPP--DF-YEYANSVDAEGCYQSCLHNC 369
Query: 372 FCAAAIY-NGDYC--WKKKYPLSNGRRSTSVNRIALVKVP--KVDVSKLLEKKDQSTLVL 426
C A Y G C W K L + + ++ I +++ ++DV K ST+ L
Sbjct: 370 SCLAFAYIPGIGCLMWSKD--LMDTMQFSAGGEILSIRLAHSELDVHKRKMTIVASTVSL 427
Query: 427 VICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRSVSSPSATNVRSFTYKELEEATRGFR 486
+ ++LG + F + V +H + S + F ++ AT F
Sbjct: 428 TLFVILGFATFG----FWRNRVK----HHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFS 479
Query: 487 --QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG G FG+VYKG L D + +A+K+L +QG++EF E+ +I + H+NLVR+
Sbjct: 480 LSNKLGHGGFGSVYKGKL-QDGRE-IAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRV 537
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEECST 601
LG C EG +LL+YE+M N SL +F+FG + DW +R I GI RGL+YLH +
Sbjct: 538 LGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRL 597
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
++IH D+K NILLD+ P+ISDFGLA+L Q Q + GT+GY +PE+
Sbjct: 598 RVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVF 657
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
+ K D+YSFGVLLLE+I + F +AL+ +V+ C+ L + + +
Sbjct: 658 SEKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSH 717
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
V R V + L C+Q + RP
Sbjct: 718 PAEVGRCVQIGLLCVQHQPADRP 740
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
Identities = 219/749 (29%), Positives = 346/749 (46%)
Query: 24 SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGS-QVKLTNSGELVL 82
SP G + GF +N + IWF KI + +VW AN D P + + ++++G L+L
Sbjct: 37 SPGGFYELGFFSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLIL 96
Query: 83 YDPQGHELWQKPKD-GSKSSWATMQDDGNFVLLGGDS-NPIWESFKEPTDTLLP-GQILN 139
D + +W K S A + D GNFV++ S N +W+SF+ +T+LP ++
Sbjct: 97 LDGKQDVIWSTGKAFTSNKCHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMY 156
Query: 140 SPIN-----ITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNA 194
N +T+ ++ + S G F L+ + + V Y W ++
Sbjct: 157 DTSNGKKRVLTTWKSNSDPSPGEFS--LEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSG 214
Query: 195 DSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHPKYETACN 254
S + D A Y+ + T GT S Y R +Y+ + T P+ +
Sbjct: 215 ISGI--D-ASYV----SPFSVVQDTAAGTGSFS--YSTLR-NYNLSYVTLT-PEGKMKIL 263
Query: 255 F----TWRMEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLC-----PDNYSYLN 305
+ W++ +P++ C D+ G CG +C + PKC C P +
Sbjct: 264 WDDGNNWKLHLSLPENPC-----DL-YGRCGPYGLCVR-SDPPKCECLKGFVPKSDEEWG 316
Query: 306 QSDTSQGCKPNFPLPSCQ-DNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCE 364
+ + + GC L SCQ + +T+ + F Y TD D Q + +N + C
Sbjct: 317 KGNWTSGCVRRTKL-SCQAKSSMKTQGKDTDIF--YRMTDVKTPDLH-QFASFLNAEQCY 372
Query: 365 QLCREDCFCAAAIY-NGDYCWKKKYPLSNGRRSTSVNRIALVKVPKVDVSKLLEKKDQST 423
Q C +C C A Y +G C L++ + S +++ +++ +K
Sbjct: 373 QGCLGNCSCTAFAYISGIGCLVWNGELADTVQFLSSGEFLFIRLASSELAGSSRRK---- 428
Query: 424 LVLVICLLLGSSVFLNILLIFAISVAAYLFYHKKLLRS-VSSPSATNVRSFTYKELEEAT 482
+++ + S+FL IL+ AI + Y ++ + V F + AT
Sbjct: 429 --IIVGTTVSLSIFL-ILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNFFEMHTIRTAT 485
Query: 483 RGFRQI--LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN 540
F LG+G FG VYKG L D K + +K+L QG +EF E+++I + H+N
Sbjct: 486 NNFSPSNKLGQGGFGPVYKGKLV-DGKE-IGVKRLASSSGQGTEEFMNEITLISKLQHRN 543
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHE 597
LVRLLG+C +G+ +LL+YE+M N SL F+F DW +R I GIARGL+YLH
Sbjct: 544 LVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHR 603
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+ ++IH D+K NILLDD P+ISDFGLA++ Q Q + GT+GY +PE+
Sbjct: 604 DSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAW 663
Query: 658 KASITVKVDVYSFGVLLLELICCK--SSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715
+ K D+YSFGVL+LE+I K S ++G + W C G + L + D
Sbjct: 664 AGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWCETGGS--NLLDRD 721
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
V R V + L C+Q +A RP
Sbjct: 722 LTDTCQAFEVARCVQIGLLCVQHEAVDRP 750
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 1.3e-67, Sum P(2) = 1.3e-67
Identities = 113/277 (40%), Positives = 161/277 (58%)
Query: 473 FTYKELEEATRGF--RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
F+ + AT F LGRG FG VYKGVL + R +A+K+L QG EF+ E+
Sbjct: 517 FSLNAIAIATNDFCKENELGRGGFGPVYKGVL--EDGREIAVKRLSGKSGQGVDEFKNEI 574
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFG 587
+I + H+NLVRLLG C EG+ ++LVYEYM N SL FLF T+ DW R I G
Sbjct: 575 ILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEG 634
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
IARGL+YLH + +IIH D+K N+LLD P+ISDFG+A++ Q +A + GT
Sbjct: 635 IARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707
GY +PE+ + +VK DVYSFGVLLLE++ K + ++ +L+ + + Y
Sbjct: 695 YGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSE-HGSLIGYAWYLYTHGR 753
Query: 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
++L + V + R + VA+ C+Q+ A+ RP
Sbjct: 754 SEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERP 790
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 1.5e-67, P = 1.5e-67
Identities = 227/778 (29%), Positives = 355/778 (45%)
Query: 5 ANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDD 64
A I ES L K + S +G + GF +N + IWF I + +VW AN +
Sbjct: 24 AGITRESPLSIGKTLS---SSNGVYELGFFSFNNSQNQYVGIWFKGIIPRVVVWVANREK 80
Query: 65 PAP-RGSQVKLTNSGELVLYDPQGHELWQKPKD-GSKSSWATMQDDGNFVLLGGDSN-PI 121
P + + ++++G L+L++ +W + S S A + D+GN V++ +S +
Sbjct: 81 PVTDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSRAELTDNGNLVVIDNNSGRTL 140
Query: 122 WESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVY 181
WESF+ DT+LP L +N +TG R L + + S T Q+
Sbjct: 141 WESFEHFGDTMLPFSNL-----------MYNLATGEKRVLTSWKSHTDPSPGDFTVQITP 189
Query: 182 DV------------YWS---WNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSM 226
V YW W + + +++ + T R+
Sbjct: 190 QVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDTNGSGSFTYF-ERNF 248
Query: 227 QDFYIMARIDYDGVFRQYTHPKYETACNFTWRMEERIPQDICVAITGDIGSGACGYNSIC 286
+ YIM I +G + + H + W + P++ C DI G CG IC
Sbjct: 249 KLSYIM--ITSEGSLKIFQHNGMD------WELNFEAPENSC-----DI-YGFCGPFGIC 294
Query: 287 AEINGEPKCLC-----PDNYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKSYE 341
++ PKC C P + + + + GC + L CQ N T + F
Sbjct: 295 V-MSVPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTEL-HCQGN---TNGKTVNGFYHVA 349
Query: 342 NTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIY-NGDYC--WKKKY----PLSNGR 394
N P D+ + + V+ + C Q+C +C C A Y NG C W + S G
Sbjct: 350 NIKPP--DF-YEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSAGG 406
Query: 395 RSTSVNRIALVKVPKVDVSKLLEKKDQSTLVLVICLLLGSSVFLNILLIFAISVAAYLFY 454
S+ R+A ++ +K++ S L L + L + FL + +S
Sbjct: 407 EILSI-RLASSELGGNKRNKIIVASIVS-LSLFVILAFAAFCFLRYKVKHTVSAKISKIA 464
Query: 455 HKKLLRSVSSPS-ATNVRSFTYKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVA 511
K+ + P + ++ F ++ AT F LG+G FG+VYKG L D K +A
Sbjct: 465 SKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKL-QDGKE-IA 522
Query: 512 IKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571
+K+L QG++EF E+ +I + HKNLVR+LG C EG+ RLLVYE++ N SL +FLF
Sbjct: 523 VKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLF 582
Query: 572 GITRP---DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGL 628
+ DW +R I GIARGL YLH + ++IH D+K NILLD+ P+ISDFGL
Sbjct: 583 DSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGL 642
Query: 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT 688
A++ + Q + GT+GY APE+ + K D+YSFGV+LLE+I + F
Sbjct: 643 ARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSY 702
Query: 689 TNPEEALMDWVYR--CYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ L+ + + C G +D L ++ + + L+ VER V + L C+Q + RP
Sbjct: 703 GRQGKTLLAYAWESWCESG-GIDLLDKDVADSCHPLE-VERCVQIGLLCVQHQPADRP 758
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 1.6e-66, Sum P(2) = 1.6e-66
Identities = 117/296 (39%), Positives = 170/296 (57%)
Query: 460 RSVSSPSATNVRSFTYKELEE---ATRGFRQI--LGRGAFGTVYKGVLASDSKRFVAIKK 514
R +S + T+ E EE AT F LG+G FG VYKG L + +A+K+
Sbjct: 498 RHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE--MAVKR 555
Query: 515 LDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGIT 574
L K QG EF+ EV +I + H NLVRLL C + ++L+YEY+ N SL S LF +
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 575 RP---DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631
R +W R I GIARGL+YLH++ +IIH D+K NILLD Y TP+ISDFG+A++
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675
Query: 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP 691
++T+A + GT GY +PE+ ++K DV+SFGVLLLE+I K + F ++
Sbjct: 676 FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735
Query: 692 EEALMDWVYRCYI-GKNLDKLAENDEEVKNDLKRVE--RLVMVALWCIQEDASLRP 744
+ L+ V+R + GK L+ + + + ++ E R + + L C+QE A RP
Sbjct: 736 DLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRP 791
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4317 | 0.9503 | 0.8509 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00003760001 | SubName- Full=Chromosome chr13 scaffold_149, whole genome shotgun sequence; (808 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 745 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-26 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-24 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-22 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 71/193 (36%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLLGF 547
LG G FGTVY + + VAIK + K + E E+ ++ + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARD-KKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIHC 606
++ +H LV EY GSL L ++ ++I I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 607 DIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFRKASITVK 664
D+KP+NILLD D +++DFGL+KLL ++ I GT Y APE K + K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 665 VDVYSFGVLLLEL 677
D++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 77/196 (39%), Positives = 106/196 (54%), Gaps = 9/196 (4%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G+FGTVYK K VA+K L K + + ++ R E+ ++ + H N+VRL
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKI-VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQII 604
+ ++ DH LV EY G L +L ++ +IA I RGL YLH II
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS-ITV 663
H D+KP+NILLD+ +I+DFGLAK LL + T GT Y APE +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGP 178
Query: 664 KVDVYSFGVLLLELIC 679
KVDV+S GV+L EL+
Sbjct: 179 KVDVWSLGVILYELLT 194
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-49
Identities = 90/278 (32%), Positives = 127/278 (45%), Gaps = 49/278 (17%)
Query: 485 FRQILGRGAFGTVYKGVL---ASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG GAFG VYKG L + VA+K L D EQQ +EF E ++ + H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHP 61
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD---WNQRVQIAFGIARGLMYLH 596
N+V+LLG C E + ++V EYM G L +L RP + + A IARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
+ IH D+ +N L+ + +ISDFGL++ L + + G + + + APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESL 176
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716
++ T K DV+SFGVLL E+ T EE Y G ++
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIF----------TLGEEP--------YPGM-------SNA 211
Query: 717 EVKNDLKRVERL----------VMVALWCIQEDASLRP 744
EV LK+ RL + L C ED RP
Sbjct: 212 EVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 6e-49
Identities = 93/277 (33%), Positives = 127/277 (45%), Gaps = 48/277 (17%)
Query: 485 FRQILGRGAFGTVYKGVL---ASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG GAFG VYKG L K VA+K L D EQQ +EF E ++ + H
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHP 61
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGIARGLMYLHE 597
N+V+LLG C E + +V EYM G L S+L RP + + A IARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+ IH D+ +N L+ + +ISDFGL++ L + R G + + + APE +
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLK 176
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
+ T K DV+SFGVLL E+ T E+ Y G ++EE
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIF----------TLGEQP--------YPGM-------SNEE 211
Query: 718 VKNDLKRVERL----------VMVALWCIQEDASLRP 744
V LK RL + L C ED RP
Sbjct: 212 VLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 9e-49
Identities = 71/261 (27%), Positives = 115/261 (44%), Gaps = 25/261 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLL 545
+ LG G+FG VY + + VAIK + K + + ++E E+ ++ + H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARD-KKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIARGLMYLHEECSTQI 603
++ D LV EY G L L R + + I L YLH + I
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK---GI 118
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
+H D+KP+NILLD+ +++DFGLA+ L + + T + GT Y APE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 664 KVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723
VD++S GV+L EL+ K F + L + + + E K+ ++
Sbjct: 176 AVDIWSLGVILYELLTGKP--PFPGDDQLLELFKKIGKPKP-PFPPPEWDISPEAKDLIR 232
Query: 724 RVERLVMVALWCIQEDASLRP 744
+ + +D R
Sbjct: 233 K----------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 7e-47
Identities = 80/265 (30%), Positives = 126/265 (47%), Gaps = 23/265 (8%)
Query: 485 FRQILGRGAFGTVYKGVL---ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKN 540
+ LG GAFG VYKG L ++ VA+K L + ++ +EF E S++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
+VRLLG C +G+ +V EYM G L FL + +Q+A IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
S +H D+ +N L+ + +ISDFGL++ + + R G + + + APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 660 SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719
T K DV+SFGVLL E+ G +N E +++ + Y L + +E+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLELLEDGYR---LPRPENCPDELY 234
Query: 720 NDLKRVERLVMVALWCIQEDASLRP 744
+ + C D RP
Sbjct: 235 ELMLQ----------CWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 84/269 (31%), Positives = 126/269 (46%), Gaps = 30/269 (11%)
Query: 488 ILGRGAFGTVYKGVL--ASDSKRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNLVRL 544
LG GAFG VYKG L VA+K L + + E K+F E V+ + H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL---------FGITRPDWNQRVQIAFGIARGLMYL 595
LG C E + LV EYM G L +L + + A IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
S + +H D+ +N L+ + +ISDFGL++ + + +TG + + + APE
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 656 FRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715
+ T K DV+SFGVLL E I + + + EE +++++ + G L K
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWE-IFTLGATPYPGLSNEE-VLEYLRK---GYRLPKPEYCP 233
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
+E+ +M L C Q D RP
Sbjct: 234 DELYE--------LM--LSCWQLDPEDRP 252
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHK 539
TRG ++LGRG+FG+VY + D+ +A+K ++ E + E+ ++ H
Sbjct: 3 TRG--ELLGRGSFGSVYLALD-KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP 59
Query: 540 NLVRLLGFC--DEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQI-AFGIARGLMY 594
N+VR G +E + + EY+S GSL+S L FG ++ I GL Y
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP---VIRKYTRQILEGLAY 116
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
LH I+H DIK NIL+D +++DFG AK L +T +RGT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 655 WFRKASITVKVDVYSFGVLLLELICCK 681
R D++S G ++E+ K
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+G+G FG V G + VA+K L K + + F E SV+ H NLV+L
Sbjct: 10 LGATIGKGEFGDVMLGDYR---GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIARGLMYLHEECSTQ 602
LG +G+ +V EYM+ GSL +L R Q++ A + G+ YL E+
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+H D+ +N+L+ + ++SDFGLAK A Q Q + V + APE R+ +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQ---DSGKLPVKWTAPEALREKKFS 177
Query: 663 VKVDVYSFGVLLLEL 677
K DV+SFG+LL E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
+G+G FG VYK K VAIK + ++ +++ E+ ++ + H N+V+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKE-VAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQIIH 605
+ D +V E+ S GSL L + QIA+ + +GL YLH IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTL--TESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
DIK NILL ++ DFGL+ L + AR + GT + APE K
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTK---ARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 666 DVYSFGVLLLELI 678
D++S G+ +EL
Sbjct: 179 DIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
++GRGAFG VYKG L ++ FVAIK++ K++++ K E+ ++ H N+V+
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAF--GIARGLMYLHEECS 600
+G + D ++ EY NGSL + FG + + + + + +GL YLHE+
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+IH DIK NIL +++DFG+A L + GT + APE +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSG 175
Query: 661 ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD-KLAEND-EEV 718
+ D++S G ++EL+ + NP AL +R I ++ L E E+
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP--YYDLNPMAAL----FR--IVQDDHPPLPEGISPEL 227
Query: 719 KNDLKRVERLVMVALWCIQEDASLRP 744
K+ L + C Q+D +LRP
Sbjct: 228 KDFLMQ----------CFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 12/193 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQTHHKNLVRLLG- 546
LG+G+ G VYK + + A+KK+ +++ K+ E+ + +V+ G
Sbjct: 9 LGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLMYLHEECSTQII 604
F EG+ + V EYM GSLA L + V IA I +GL YLH + II
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTK--RHII 122
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H DIKP N+L++ +I+DFG++K+L E T GTV Y +PE + S +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 665 VDVYSFGVLLLEL 677
D++S G+ LLE
Sbjct: 181 ADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 77/274 (28%), Positives = 108/274 (39%), Gaps = 26/274 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQ-THHKNLV 542
+ LG G+FG VY ++ VA+K L K + KE F E+ ++ H N+V
Sbjct: 6 RKLGEGSFGEVYLAR----DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRV-QIAFGIARGLMYLHEEC 599
+L F + LV EY+ GSL L G P I I L YLH +
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 600 STQIIHCDIKPQNILLD-DYFTPRISDFGLAKLL----LAEQTQAARTGIRGTVGYFAPE 654
IIH DIKP+NILLD D ++ DFGLAKLL A + GT GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 655 WFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711
A + D++S G+ L EL+ + + I +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTPS 234
Query: 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745
+ N + + + +D R
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 72/206 (34%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
LG G FG V+ G +K VA+K L K + F E ++ + H LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTK--VAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPD--WNQRVQIAFGIARGLMYLHEECSTQIIHC 606
E + +V EYMS GSL FL Q V +A IA G+ YL IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVD 666
D+ +NIL+ + +I+DFGLA+ L+ + AR G + + + APE T+K D
Sbjct: 128 DLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 667 VYSFGVLLLELICCKSSVVFGTTNPE 692
V+SFG+LL E++ G TN E
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMTNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 52/288 (18%)
Query: 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRF---VAIKKL-DKVEQQGEKEFRTEVS 531
+ L+E ++LG GAFGTVYKGV + ++ VAIK L ++ + KE E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--IA 589
V+ H ++VRLLG C L+ + M G L ++ + + + + + IA
Sbjct: 62 VMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIA 119
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTP---RISDFGLAKLLLAEQTQAARTGIRG 646
+G+ YL E+ +++H D+ +N+L+ TP +I+DFGLAKLL ++ + G +
Sbjct: 120 KGMSYLEEK---RLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706
+ + A E T K DV+S+GV + EL+ FG + Y G
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELM------TFGA------------KPYEGI 215
Query: 707 NLDKLAENDEEVKNDLKRVERL----------VMVALWCIQEDASLRP 744
E+ + L++ ERL MV + C DA RP
Sbjct: 216 PA-------VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVRLL 545
+G+G+FG VY V + +K++D + EKE EV ++ + +H N+++
Sbjct: 8 IGKGSFGKVYL-VRRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFL-----FGITRPD---WNQRVQIAFGIARGLMYLHE 597
+E +V EY G L+ + G P+ + VQ+ L YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKYLHS 121
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+I+H DIKPQNI L ++ DFG++K +L+ A+T + GT Y +PE +
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 658 KASITVKVDVYSFGVLLLELICCK 681
K D++S G +L EL K
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 81/274 (29%), Positives = 127/274 (46%), Gaps = 39/274 (14%)
Query: 489 LGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQGEK-EFRTEVSVIGQTHHKNLVR 543
LG+G+FG VY+G+ + + VAIK +++ E+ EF E SV+ + + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-----------VQIAFGIARGL 592
LLG G L+V E M+ G L S+L RP+ +Q+A IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRS-RRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT--VGY 650
YL + +H D+ +N ++ + T +I DFG+ + + +T R G +G V +
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRW 187
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710
APE + T K DV+SFGV+L E+ G +N E V + I
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLKFVIDGGHLD 241
Query: 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
L EN + +L M W Q + +RP
Sbjct: 242 LPENCPDKLLEL-------MRMCW--QYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G GA G VYK + K VAIKK+ ++ +Q ++ E+ ++ H N+V
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKE-VAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECST 601
GD +V EYM GSL + N+ QIA+ + +GL YLH S
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQ-NFVRMNEP-QIAYVCREVLQGLEYLH---SQ 135
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+IH DIK NILL + +++DFG A L E+++ R + GT + APE ++
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDY 193
Query: 662 TVKVDVYSFGVLLLELI 678
KVD++S G++ +E+
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 487 QILGRGAFGTVYKGVLASDSKR--FVAIKKLDKVEQQGEK-EFRTEVSVIGQTHHKNLVR 543
+++G G FG V +G L K+ VAIK L ++ +F TE S++GQ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD----WNQRVQIAFGIARGLMYLHEEC 599
L G + +++ EYM NGSL FL D Q V + GIA G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL----AEQTQAARTGIRGTVGYFAPE- 654
+H D+ +NIL++ ++SDFGL++ L T+ + IR T APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 655 -WFRKASITVKVDVYSFGVLLLELI 678
+RK T DV+SFG+++ E++
Sbjct: 180 IAYRK--FTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 9/218 (4%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
E++ + + LG G FG V++G+ + + VA+K L K K+F E ++ +
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTL-KPGTMDPKDFLAEAQIMKKL 58
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIARGLMY 594
H L++L C + +V E M GSL +L G Q + +A +A G+ Y
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
L + IH D+ +N+L+ + +++DFGLA+++ E AR G + + + APE
Sbjct: 119 LEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPE 174
Query: 655 WFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
++K DV+SFG+LL E++ G TN E
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRF--VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG G FG+V KGV S + VA+K L + G+KEF E SV+ Q H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECSTQI 603
G C +G+ +LV E G L +L R + ++A +A G+ YL E
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYL-ESK--HF 116
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AARTGIRGTVGYFAPEWFRKASIT 662
+H D+ +N+LL + +ISDFG+++ L A A T R + ++APE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 663 VKVDVYSFGVLLLE 676
K DV+S+GV L E
Sbjct: 177 SKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 487 QILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNLVR 543
+++G+G FG VY G L K A+K L+++ E ++F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 544 LLGFC--DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ--IAFG--IARGLMYLHE 597
LLG C EG L+V YM +G L +F I N V+ I FG +A+G+ YL
Sbjct: 61 LLGICLPSEGS-PLVVLPYMKHGDLRNF---IRSETHNPTVKDLIGFGLQVAKGMEYL-- 114
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR--TGIRGTVGYFAPEW 655
S + +H D+ +N +LD+ FT +++DFGLA+ + ++ + TG + V + A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 656 FRKASITVKVDVYSFGVLLLELI 678
+ T K DV+SFGVLL EL+
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 36/89 (40%), Positives = 45/89 (50%), Gaps = 2/89 (2%)
Query: 53 EKTIVWSANGDDP-APRGSQVKLTNSGELVLYDPQGHELWQKPKDG-SKSSWATMQDDGN 110
+T+VW AN +P + L + G LVLYD G +W G A +QDDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 111 FVLLGGDSNPIWESFKEPTDTLLPGQILN 139
VL +W+SF PTDTLLPGQ
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDG 89
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 27/280 (9%)
Query: 471 RSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
+S T ++ + + ++ RG G YKG + +FV +K+++ V +E+
Sbjct: 681 KSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFV-VKEINDVNSIPS----SEI 734
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR 590
+ +G+ H N+V+L+G C L++EY+ +L+ L ++ W +R +IA GIA+
Sbjct: 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS---WERRRKIAIGIAK 791
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
L +LH CS ++ ++ P+ I++D P + L LL + + Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AY 844
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSS--VVFGTTNPEEALMDWVYRCYIGKNL 708
APE IT K D+Y FG++L+EL+ KS FG ++++W CY +L
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSDCHL 901
Query: 709 DKLAENDEEVKNDLKRVERLVM----VALWCIQEDASLRP 744
D D ++ D+ + ++ +AL C D + RP
Sbjct: 902 DMWI--DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/226 (32%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 489 LGRGAFGTVYKGVL----ASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVR 543
LG GAFG VY+G+ + VA+K L + +Q E +F E ++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--------VQIAFGIARGLMYL 595
L+G E R ++ E M+ G L SFL RP + + A +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPR---ISDFGLAKLLLAEQTQAARTGIRGT--VGY 650
E IH DI +N LL R I+DFG+A+ + + R G R + +
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIKW 187
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696
PE F T K DV+SFGVLL E+ G TN E
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 485 FRQILGRGAFGTVYKG---VLASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHK 539
F + LG G FG V L ++ VA+K L EQ +F E+ ++ H+
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH-RSDFEREIEILRTLDHE 66
Query: 540 NLVRLLGFCDEGDHR--LLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIARGLMYL 595
N+V+ G C++ R L+ EY+ +GSL +L R N + + + I +G+ YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYL 125
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL-LAEQTQAARTGIRGTVGYFAPE 654
+ + IH D+ +NIL++ +ISDFGLAK+L + + + ++APE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 655 WFRKASITVKVDVYSFGVLLLEL 677
R + + DV+SFGV L EL
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 66/197 (33%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG+G+FG V V D+ + A+K L K ++++ + TE +++ + +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 546 -GFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
F E + LV EY G L S L G + + A I L YLH
Sbjct: 60 YAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLHSL---G 113
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
II+ D+KP+NILLD +++DFGLAK L +E ++ GT Y APE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVLLGKGYG 171
Query: 663 VKVDVYSFGVLLLELIC 679
VD +S GVLL E++
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF----VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
F + LG GAFG VYKG L ++R VAIK L + E + ++EFR E ++ H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF---------------GITRPDW-NQRVQ 583
N+V LLG C + +++EY+++G L FL + + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
IA IA G+ YL S +H D+ +N L+ + T +ISDFGL++ + + ++
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
V + PE T + D++SFGV+L E+ +G +N E
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 15/194 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
LG G FG V++G L + R VAIK L + +++F+ EV + + HK+L+ L C
Sbjct: 14 LGSGYFGEVWEG-LWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPD-WNQRVQ----IAFGIARGLMYLHEECSTQI 603
G+ ++ E M GSL +FL P+ V +A +A G+ YL E+
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH D+ +NIL+ + +++DFGLA+L+ + ++ I + APE + +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFST 183
Query: 664 KVDVYSFGVLLLEL 677
K DV+SFG+LL E+
Sbjct: 184 KSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
E+E + LG G +G VY+GV S VA+K L K + +EF E +V+ +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTL-KEDTMEVEEFLKEAAVMKEI 59
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLMY 594
H NLV+LLG C ++ E+M+ G+L +L R + N V +A I+ + Y
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
L IH D+ +N L+ + +++DFGL++ L+ T A G + + + APE
Sbjct: 120 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE 175
Query: 655 WFRKASITVKVDVYSFGVLLLEL 677
++K DV++FGVLL E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 57/198 (28%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G FG VY V D+ +A+K ++ + + KE E+ V+ H NLV+ G
Sbjct: 8 IGGGTFGKVYTAV-NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHC 606
+ + EY S G+L L D + + GL YLH I+H
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHR 123
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG---YFAPEWFRKASITV 663
DIKP NI LD ++ DFG A L T ++ G Y APE
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAV-KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 664 K---VDVYSFGVLLLELI 678
D++S G ++LE+
Sbjct: 183 HGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 38/269 (14%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL-----DKVEQQGEKEFRTEVSVIGQTHHKNL 541
++LG G+FG+VY+G L D F A+K++ + Q+ K+ E++++ + H N+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAF---GIARGLMYLH 596
V+ LG E D+ + E + GSLA L +G I I GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP-----EPVIRLYTRQILLGLEYLH 119
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
+H DIK NIL+D +++DFG+AK ++ + +G+ + APE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYWMAPEVI 173
Query: 657 -RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715
++ + D++S G +LE+ + A+ IG++ + L
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEM--ATGKPPWSQLEGVAAVFK------IGRSKE-LPPIP 224
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ + ++ K C+Q D SLRP
Sbjct: 225 DHLSDEAKDFILK------CLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 73/210 (34%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHKNLVRLL 545
LG G FG V+ G +K VAIK L +QG F E +++ Q H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTK--VAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFL---FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
+ + ++ EYM NGSL FL GI N+ + +A IA G+ ++ +
Sbjct: 68 AVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLT-INKLIDMAAQIAEGMAFIERK---N 122
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH D++ NIL+ + +I+DFGLA+L+ + AR G + + + APE + T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFT 181
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+K DV+SFG+LL E++ G TNPE
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 72/211 (34%), Positives = 118/211 (55%), Gaps = 31/211 (14%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKK--LDKVEQQGEKEFRT-------EVSVIGQTHH 538
++G G+FG+VY G+ AS S +A+K+ L V + R+ E++++ + H
Sbjct: 7 LIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--FG-----ITRPDWNQRVQIAFGIARG 591
+N+V+ LG + DH + EY+ GS+A+ L +G + R Q I +G
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ-------ILKG 118
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL----LAEQTQAARTGIRGT 647
L YLH + IIH DIK NIL+D+ +ISDFG++K L L+ +T AR ++G+
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
V + APE ++ S T K D++S G L++E++
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 38/235 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS----DSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
++ LG GAFG V+ G + K VA+K L + K+F E ++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITR---PDWN---------------QR 581
N+V+ G C EGD ++V+EYM +G L FL R PD Q
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFL----RSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+QIA IA G++YL S +H D+ +N L+ +I DFG+++ + T R
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT--TDYYR 179
Query: 642 TGIRGT----VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
G G + + PE T + DV+SFGV+L E+ +G +N E
Sbjct: 180 VG--GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 22/205 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKR--FVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
+++G G FG V +G L KR FVAIK L E+Q ++F +E S++GQ H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNII 68
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFL------FGITRPDWNQRVQIAFGIARGLMYLH 596
L G + +++ E+M NG+L SFL F + Q V + GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-----QLVGMLRGIAAGMKYLS 123
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG---TVGYFAP 653
E +H D+ +NIL++ ++SDFGL++ L + + T G + + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 654 EWFRKASITVKVDVYSFGVLLLELI 678
E T DV+S+G+++ E++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F + LG G FG V+ G K VAIK + + E +F E V+ + H NLV+L
Sbjct: 8 FLKELGSGQFGVVHLGKWRG--KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLF---GITRPDWNQRVQIAFGIARGLMYLHEECST 601
G C + +V EYM+NG L ++L G +W + + + + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG-- 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
IH D+ +N L+ + ++SDFGLA+ +L +Q ++ G + V + PE F +
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRF 178
Query: 662 TVKVDVYSFGVLLLELICC 680
+ K DV+SFGVL+ E+
Sbjct: 179 SSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQ-THHKN 540
F +I+G G+F TV +K + AIK LDK ++++ K + E V+ + H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEY-AIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 541 LVRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
+++L F DE L V EY NG L ++ D A I L YLH
Sbjct: 64 IIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH-- 119
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL----LAEQTQAARTGIR--------- 645
S IIH D+KP+NILLD +I+DFG AK+L E + T I
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 646 -----GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
GT Y +PE + D+++ G ++ +++ K
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 37/273 (13%)
Query: 489 LGRGAFGTVY----KGVLASDSKRFVAIKKLDKVEQQGEK-EFRTEVSVIGQTHHKNLVR 543
LG+G+FG VY KGV+ + + VAIK +++ E+ EF E SV+ + + ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLF----------GITRPDWNQRVQIAFGIARGLM 593
LLG +G L++ E M+ G L S+L P + +Q+A IA G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG--TVGYF 651
YL+ + + +H D+ +N ++ + FT +I DFG+ + + +T R G +G V +
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 188
Query: 652 APEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711
+PE + T DV+SFGV+L E+ G +N E ++ +V G LDK
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVME---GGLLDK- 242
Query: 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+N ++ +L R+ C Q + +RP
Sbjct: 243 PDNCPDMLFELMRM---------CWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
Q +G G FG V+ G K VAIK + + E++F E V+ + H LV+L
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRK--VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECSTQ 602
G C E LV+E+M +G L+ +L R ++Q + + + G+ YL
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+IH D+ +N L+ + ++SDFG+ + +L +Q ++ TG + V + +PE F + +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYS 179
Query: 663 VKVDVYSFGVLLLEL 677
K DV+SFGVL+ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 28/208 (13%)
Query: 486 RQILGRGAFGTVYKGVLASDSKR--FVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNL 541
++++G G FG V++G+L ++ VAIK L E+Q ++F +E S++GQ H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHNI 68
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL------FGITRPDWNQRVQIAFGIARGLMYL 595
+RL G + +++ EYM NG+L +L F Q V + GIA G+ YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-----QLVGMLRGIAAGMKYL 123
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE-----QTQAARTGIRGTVGY 650
+ +H D+ +NIL++ ++SDFGL+++L + T + IR T
Sbjct: 124 SD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT--- 177
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELI 678
APE T DV+SFG+++ E++
Sbjct: 178 -APEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHKNLV 542
+++G GA VY + ++++ VAIK++D +E+ E R EV + Q +H N+V
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEK-VAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEEC 599
+ GD LV Y+S GSL + IA + +GL YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL--AEQTQAARTGIRGTVGYFAPEWF- 656
S IH DIK NILL + + +I+DFG++ L ++T+ R GT + APE
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 657 RKASITVKVDVYSFGVLLLELI 678
+ K D++SFG+ +EL
Sbjct: 180 QVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
E E G R +LG+G +G VY S R +AIK++ + + + + E+++
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVR-IAIKEIPERDSRYVQPLHEEIALHSYL 62
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLM 593
H+N+V+ LG E + E + GSL++ L P + I F I GL
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLH+ QI+H DIK N+L++ Y +ISDFG +K LA T GT+ Y A
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTET-FTGTLQYMA 177
Query: 653 PEWFRKA--SITVKVDVYSFGVLLLEL 677
PE K D++S G ++E+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG+G FG V + + A KKLDK +++GE+ E ++ + + +V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--IARGLMYLHEECSTQI 603
+ D LV M+ G L ++ + P + + I + I GL +LH+ +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
++ D+KP+N+LLDD+ RISD GLA L + R GT GY APE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDF 173
Query: 664 KVDVYSFGVLLLELICCKS 682
VD ++ G L E+I +S
Sbjct: 174 SVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G+G FG VYKGVL +++ VA+K + K F E ++ Q H N+V+L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE--VAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKL 57
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+G C + +V E + GSL +FL R + +Q++ A G+ YL +
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT----VGYFAPEWFRKA 659
IH D+ +N L+ + +ISDFG+++ E+ T G + + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 660 SITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
T + DV+S+G+LL E + G +N +
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKR--FVAIK--KLDKVEQQGEKEFRTEVSVI 533
++ + +++G G FG V G L KR VAIK K E+Q ++F +E S++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59
Query: 534 GQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL------FGITRPDWNQRVQIAFG 587
GQ H N++ L G + ++V EYM NGSL +FL F + Q V + G
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI-----QLVGMLRG 114
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL-----LAEQTQAART 642
IA G+ YL + +H D+ +NIL++ ++SDFGL+++L A T+ +
Sbjct: 115 IASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
IR T APE T DV+S+G+++ E++
Sbjct: 172 PIRWT----APEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 43/276 (15%)
Query: 489 LGRGAFGTVYKGV----LASDSKRFVAIKKLDKVEQQGEK-EFRTEVSVIGQTHHKNLVR 543
LG+G+FG VY+G + +++ VA+K +++ E+ EF E SV+ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD-----------WNQRVQIAFGIARGL 592
LLG +G L+V E M++G L S+L + RP+ + +Q+A IA G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG--TVGY 650
YL+ + + +H D+ +N ++ FT +I DFG+ + + +T R G +G V +
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRW 187
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE--EALMDWVYRCYIGKNL 708
APE + T D++SFGV+L E+ G +N + + +MD G L
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-------GGYL 240
Query: 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
D+ +N E DL R+ C Q + +RP
Sbjct: 241 DQ-PDNCPERVTDLMRM---------CWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-22
Identities = 33/106 (31%), Positives = 46/106 (43%), Gaps = 2/106 (1%)
Query: 24 SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83
S F GF + Q I + +T+VW AN D+P+ + L + G LV+Y
Sbjct: 12 SSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIY 70
Query: 84 DPQGHELWQKPKDGSKS-SWATMQDDGNFVLLGGDSNPIWESFKEP 128
D G +W + DDGN VL D N +W+SF P
Sbjct: 71 DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 65/194 (33%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F + LG G FG V G + VAIK + K E EF E V+ + H+ LV+L
Sbjct: 8 FLKELGTGQFGVVKYG--KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
G C + +V EYMSNG L ++L R +Q +++ + G+ YL S Q
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQF 121
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH D+ +N L+DD ++SDFGL++ +L ++ ++ G + V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFSS 180
Query: 664 KVDVYSFGVLLLEL 677
K DV++FGVL+ E+
Sbjct: 181 KSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 15/194 (7%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNLVRLLG 546
LG G++G+VYK + ++ + VAIK V + + +E E+S++ Q +V+ G
Sbjct: 10 KLGEGSYGSVYKA-IHKETGQVVAIKV---VPVEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQI 603
+ +V EY GS+ S + IT + +IA +GL YLH S +
Sbjct: 66 SYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEE-EIAAILYQTLKGLEYLH---SNKK 120
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH DIK NILL++ +++DFG++ L T A R + GT + APE ++
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 664 KVDVYSFGVLLLEL 677
K D++S G+ +E+
Sbjct: 179 KADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 489 LGRGAFGTVY----KGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG GAFG V+ +L K VA+K L + + ++F+ E ++ H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD----------------WNQRVQIAFGI 588
G C EG L+V+EYM +G L FL PD Q + IA I
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRS-HGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT- 647
A G++YL S +H D+ +N L+ +I DFG+++ + + T R G R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TDYYRVGGRTML 186
Query: 648 -VGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
+ + PE T + D++SFGV+L E+
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 76/218 (34%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
LG+G FG V+ G ++ VAIK L K + F E V+ + H+ LV+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTR--VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIARGLMYLHEECSTQIIHC 606
E + +V EYMS GSL FL G Q V +A IA G+ Y+ +H
Sbjct: 71 SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVD 666
D++ NIL+ + +++DFGLA+L+ + AR G + + + APE T+K D
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 667 VYSFGVLLLELICCKSSVVF-GTTNPEEALMDWVYRCY 703
V+SFG+LL EL K V + G N E ++D V R Y
Sbjct: 186 VWSFGILLTEL-TTKGRVPYPGMVNRE--VLDQVERGY 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 30/209 (14%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIG 534
L++ T G +I+G G FG V +G VA+K K D Q F E +V+
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYTGQK---VAVKNIKCDVTAQA----FLEETAVMT 54
Query: 535 QTHHKNLVRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIARG 591
+ HHKNLVRLLG G + +V E MS G+L +FL R + Q +Q + +A G
Sbjct: 55 KLHHKNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT---V 648
+ YL S +++H D+ +NIL+ + ++SDFGLA+ G+ + V
Sbjct: 113 MEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR--------VGSMGVDNSKLPV 161
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLEL 677
+ APE + + K DV+S+GVLL E+
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVS 531
Y+ LE +G+G+FGTV K SD K + K++D EKE +EV+
Sbjct: 2 YEVLET--------IGKGSFGTVRKVRRKSDGK-ILVWKEID-YGNMTEKEKQQLVSEVN 51
Query: 532 VIGQTHHKNLVRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRV------Q 583
++ + H N+VR D + L +V EY G LA + + + + +
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWR 109
Query: 584 IAFGIARGLMYLH--EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
I + L H + ++H D+KP NI LD ++ DFGLAK +L + A+
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAK 168
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
T + GT Y +PE S K D++S G L+ EL
Sbjct: 169 TYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKK----LDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG G G V K VL + + +A+K +++ Q K+ E+ ++ + + +V
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQ---KQILRELDILHKCNSPYIVGF 64
Query: 545 LG-FCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
G F + GD + + EYM GSL L R +IA + +GL YLHE+ +
Sbjct: 65 YGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HK 121
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IIH D+KP NIL++ ++ DFG++ L+ A+T + GT Y APE + +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGNDYS 177
Query: 663 VKVDVYSFGVLLLEL 677
VK D++S G+ L+EL
Sbjct: 178 VKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 472 SFTYKELEEATRGFRQILGRGAFGTVY----KGVLASDSKRFVAIKKLDKV-EQQGEKEF 526
+F L+E T LGRG FG V+ KG+ + V +K L K ++ + EF
Sbjct: 1 AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55
Query: 527 RTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN------- 579
R E+ + + HKN+VRLLG C E + ++ EY G L FL T+
Sbjct: 56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPL 114
Query: 580 ---QRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636
Q+V + IA G+ +L + + +H D+ +N L+ ++S L+K + +
Sbjct: 115 STKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
Query: 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
R + + + APE ++ + K DV+SFGVL+ E+
Sbjct: 172 YYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+++G+GAFG V V D+K+ A+K ++K VE+ + E ++ + +H L
Sbjct: 4 LLRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62
Query: 542 VRL-LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHE 597
V L F DE ++ LV + + G L + +++ Q+ F I L YLH
Sbjct: 63 VNLWYSFQDE-ENMYLVVDLLLGGDLR---YHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+ IIH DIKP NILLD+ I+DF +A + T GT GY APE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLC 172
Query: 658 KASITVKVDVYSFGVLLLELI 678
+ +V VD +S GV E +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECL 193
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 69/221 (31%), Positives = 110/221 (49%), Gaps = 19/221 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
LG G FG V+ G + +K VA+K L K + F E +++ H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNNSTK--VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ----IAFG--IARGLMYLHEECSTQ 602
+ + ++ EYM+ GSL FL + D +V I F IA G+ Y+ +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---N 123
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH D++ N+L+ + +I+DFGLA+++ + AR G + + + APE S T
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703
+K DV+SFG+LL E++ G +N + +M + R Y
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGY 221
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 76/219 (34%), Positives = 109/219 (49%), Gaps = 12/219 (5%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+ LG G FG V+ G ++K VA+K L K + F E ++ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK--VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLF-GITRP-DWNQRVQIAFGIARGLMYLHEECSTQII 604
E + +V EYMS GSL FL G R V +A +A G+ Y+ I
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H D++ NIL+ D +I+DFGLA+L+ + AR G + + + APE T+K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703
DV+SFG+LL EL+ K V + N E L + V R Y
Sbjct: 184 SDVWSFGILLTELV-TKGRVPYPGMNNREVL-EQVERGY 220
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 487 QILGRGAFGTVYKGVLASDSKR--FVAIKKLDKVEQ-QGEKE-----FRTEVSVIGQTHH 538
Q LG GAF + Y+ A D K +A+K++ V E+E R E+ ++ + +H
Sbjct: 6 QQLGTGAFSSCYQ---ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAF--GIARGLMY 594
+++R+LG E H L E+M+ GS++ L +G + + V I + + RGL Y
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSY 118
Query: 595 LHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKLLLAEQTQAA--RTGIRGTVGYF 651
LHE QIIH D+K N+L+D RI+DFG A L A+ T A + + GT+ +
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 652 APEWFRKASITVKVDVYSFGVLLLELICCK 681
APE R DV+S G +++E+ K
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF-VAIKKL-DKVEQQGEKEFRTEVSVIGQT-HHKNL 541
F+ ++G G FG V K + D R AIK++ + + ++F E+ V+ + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL-----------FGITRPDWN-----QRVQIA 585
+ LLG C+ + L EY +G+L FL F I + Q + A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+ARG+ YL ++ Q IH D+ +NIL+ + + +I+DFGL++ ++ +T R
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY-RCYI 704
V + A E + T DV+S+GVLL E++ + G T E +Y +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQ 238
Query: 705 GKNLDKLAENDEEVKNDLKRVER 727
G L+K D+EV + +++ R
Sbjct: 239 GYRLEKPLNCDDEVYDLMRQCWR 261
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 488 ILGRGAFGTV----YKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVS------VIGQTH 537
LG GAFG V G+ + VA+K L + EK+ VS +IG+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGK-- 74
Query: 538 HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----------FGITRPDWNQR----- 581
HKN++ LLG C + +V EY ++G+L FL RP
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
V A+ +ARG+ +L S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
T R V + APE T + DV+SFGVLL E+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 69/200 (34%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G+G+FG V+K V +D KR A+K++D K+ ++ +E E V+ + ++R
Sbjct: 8 IGKGSFGVVFKVVRKAD-KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 547 FCDEGDHRLLVYEYMSNGSLASFL---FGITRPD---WNQRVQIAFGIARGLMYLHEECS 600
+ +V EY NG L L G P+ W +QI G+A +LH S
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLH---S 119
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+I+H DIK N+ LD Y +I D G+AK LL++ T A T I GT Y +PE
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANT-IVGTPYYLSPELCEDKP 177
Query: 661 ITVKVDVYSFGVLLLELICC 680
K DV++ GV+L E CC
Sbjct: 178 YNEKSDVWALGVVLYE--CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 8e-21
Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 43/275 (15%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-------KVEQQGEKEFR---TEVSVIG-QTH 537
LG GAFG VYK ++ + +A+K+++ K +++ +K +EV++I Q
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 538 HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD--------WNQRVQIAFGIA 589
H N+VR E D +V + + L + WN VQ+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
L YLH+E +I+H D+ P NI+L + I+DFGLAK +Q ++ T + GT+
Sbjct: 126 --LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTIL 178
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709
Y PE + K DV++FG +L ++ C F +TN
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSLAT------------- 223
Query: 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
K+ E E + E + V C+ DA RP
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 8e-21
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 488 ILGRGAFGTVYKGVL-----ASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNL 541
LG GAFG VY+G VA+K L K Q +KEF E ++ +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL-------FGITRPDWNQRVQIAFGIARGLMY 594
V+LLG C + + ++ E M G L S+L FG + + I +A+G +Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 595 LHEECSTQIIHCDIKPQNILLD--DYFTPR---ISDFGLAKLLLAEQTQAARTGIRGTVG 649
L + IH D+ +N L+ Y R I DFGLA+ + V
Sbjct: 122 LEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ APE T + DV+SFGVL+ E++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 12/214 (5%)
Query: 479 EEATRGFRQILGRGAFGTVYK---GVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ 535
EE F Q LG+G FG+V L ++ VA+KKL + ++F E+ ++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 536 THHKNLVRLLGFCDEGDHR--LLVYEYMSNGSLASFLF-GITRPDWNQRVQIAFGIARGL 592
H N+V+ G C R LV EY+ GSL +L R D + + A I +G+
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL-LAEQTQAARTGIRGTVGYF 651
YL S + +H D+ +NIL++ +I DFGL K+L ++ R + ++
Sbjct: 122 EYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 652 APEWFRKASITVKVDVYSFGVLLLELI--CCKSS 683
APE ++ +V DV+SFGV+L EL KS
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
F +I G G+ G V +A+D + R VA+KK+D +QQ + EV ++ H N+V
Sbjct: 24 FVKI-GEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
+ GD +V E++ G+L + TR + Q + + + L +LH +
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+IH DIK +ILL ++SDFG + E + R + GT + APE +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYG 193
Query: 663 VKVDVYSFGVLLLELI 678
+VD++S G++++E++
Sbjct: 194 TEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 487 QILGRGAFGTVYKGVLASDSKR----FVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNL 541
+ LG G FG V K R VA+K L + E ++ +E +++ Q +H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLF-------GITRPDWNQR------------- 581
++L G C + LL+ EY GSL SFL D N+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 582 ----VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637
+ A+ I+RG+ YL E +++H D+ +N+L+ + +ISDFGL++ + E +
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
R+ R V + A E T + DV+SFGVLL E++
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 14/193 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLLGF 547
+G+G+FG VYKG+ + +K VAIK +D E + E E + E++V+ Q + R G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQII 604
+G ++ EY+ GS L +P + IA I +GL YLH E + I
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE---RKI 123
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H DIK N+LL + +++DFG+A L TQ R GT + APE ++++ K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 665 VDVYSFGVLLLEL 677
D++S G+ +EL
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF--VAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
+ILG G FG+V +G L+ D VA+K KLD +EF +E + + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 543 RLLGFCDEGDHR------LLVYEYMSNGSLASFLFGITRPDWNQR------VQIAFGIAR 590
+L+G C E +++ +M +G L SFL ++ ++ IA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE----QTQAARTGIRG 646
G+ YL + IH D+ +N +L + T ++DFGL+K + + Q + A+
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---- 177
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
V + A E T K DV++FGV + E+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 59/231 (25%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 489 LGRGAFGTVYK----GVLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+G+GAFG V++ G+L + VA+K L ++ + +F+ E +++ + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFL--------------------FGITRPDWN--QR 581
LLG C G L++EYM+ G L FL G+ + ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+ IA +A G+ YL E + +H D+ +N L+ + +I+DFGL++ + + A
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+ + PE T + DV+++GV+L E+ +G + E
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 5e-20
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 24 SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83
S + F GF + Q+ I + +T+VW AN D+P + L + G LVLY
Sbjct: 12 SGNSLFELGFFTLIMQN-DYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLY 69
Query: 84 DPQGHELWQKPKDGSKSSW-ATMQDDGNFVLLGGDSNPIWESF 125
D G +W G+ ++ + DDGN V+ D N +W+SF
Sbjct: 70 DGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF-VAIKKLDKVEQQGE-KEFRTEVSVIGQT-HHKNL 541
F ++G G FG V + ++ D + AIK L + + + ++F E+ V+ + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGI----TRPDW------------NQRVQIA 585
+ LLG C+ + + EY G+L FL T P + Q +Q A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+A G+ YL E+ Q IH D+ +N+L+ + +I+DFGL++ E+ +T R
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
V + A E + T K DV+SFGVLL E++ + G T E
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 85/278 (30%), Positives = 130/278 (46%), Gaps = 52/278 (18%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF---VAIKKLDKVEQQGEK---EFRTEVSVIGQTHHKN 540
++LG GAFGTVYKG+ + + VAIK L+ E G K EF E ++ H +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDEALIMASMDHPH 70
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV-QIAFGIARGLMYLHEEC 599
LVRLLG C +L V + M +G L ++ +Q + IA+G+MYL E
Sbjct: 71 LVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER- 128
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
+++H D+ +N+L+ +I+DFGLA+LL ++ + G + + + A E
Sbjct: 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 660 SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719
T + DV+S+GV + EL+ FG GK D + E+
Sbjct: 187 KFTHQSDVWSYGVTIWELM------TFG-----------------GKPYDGIPT--REIP 221
Query: 720 NDLKRVERL------------VMVALWCIQEDASLRPQ 745
+ L++ ERL VMV W I DA RP+
Sbjct: 222 DLLEKGERLPQPPICTIDVYMVMVKCWMI--DADSRPK 257
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 67/258 (25%), Positives = 117/258 (45%), Gaps = 36/258 (13%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
E+ + + LG G FG V+ +K VA+K + K + F E +V+
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTM-KPGSMSVEAFLAEANVMKTL 58
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI------AFGIAR 590
H LV+L + + ++ E+M+ GSL FL + D + + + IA
Sbjct: 59 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAE 113
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
G+ ++ + IH D++ NIL+ +I+DFGLA+++ + AR G + + +
Sbjct: 114 GMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKW 169
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE------------------ 692
APE S T+K DV+SFG+LL+E++ G +NPE
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 229
Query: 693 EALMDWVYRCYIGKNLDK 710
E L + + RC+ + ++
Sbjct: 230 EELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 485 FRQ--ILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHK 539
FRQ +LG+G FG V + + K + A KKL+K +++GE E ++ + + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--IARGLMYLHE 597
+V L + D LV M+ G L ++ + + + + + I GL LH+
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
E +I++ D+KP+NILLDD+ RISD GLA + QT R GTVGY APE +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVK 174
Query: 658 KASITVKVDVYSFGVLLLELICCKS 682
T D ++ G LL E+I +S
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 487 QILGRGAFGTVYKGV-LASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
Q +G G +G VYK +A+ VAIK + + + E+S++ + H N+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGE--LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR----GLMYLHEECST 601
G D +V EY GSL ++ +TR ++ QIA+ + R GL YLHE T
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL-QIAY-VCRETLKGLAYLHE---T 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF---RK 658
IH DIK NILL + +++DFG++ L A T A R GT + APE RK
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA--TIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 659 ASITVKVDVYSFGVLLLEL 677
K D+++ G+ +EL
Sbjct: 179 GGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 70/205 (34%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 485 FRQ--ILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHK 539
FR +LG+G FG V + + K + A KKL+K +++GE E ++ + + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN-QRVQI-AFGIARGLMYLHE 597
+V L + D LV M+ G L ++ + P ++ +R A I GL LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
E +I++ D+KP+NILLDDY RISD GLA + +T R GTVGY APE +
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVGYMAPEVVK 174
Query: 658 KASITVKVDVYSFGVLLLELICCKS 682
T D + G L+ E+I KS
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRF-VAIKKLDKVEQQGEK-EFRTEVSVIGQTHHKNLVRLLG 546
LG G FG V KGV K+ VAIK L ++ + E E ++ Q + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
C E + +LV E S G L FL G IT + V++ ++ G+ YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV---VELMHQVSMGMKYLEGK---N 115
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-QAARTGIRGTVGYFAPEWFRKASI 661
+H D+ +N+LL + +ISDFGL+K L A+ + AR+ + + ++APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 662 TVKVDVYSFGVLLLE 676
+ + DV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 51/150 (34%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNL 541
+ LG G +G VYK A D + VA+KK+ +++ + E T E+S++ + H N+
Sbjct: 5 EKLGEGTYGVVYK---ARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECS 600
V+LL LV+EY L +L P N I + + RGL Y H S
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
+I+H D+KPQNIL++ +++DFGLA+
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF-RTEVSVIGQTHHKNLVRLL 545
+ +G+G+FG VYK + + + VAIK +D E + E E + E+ + Q + +
Sbjct: 7 ECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQ 602
G +G ++ EY GS L +P IAF + GL YLHEE
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE---G 118
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH DIK NILL + +++DFG++ L T + R GT + APE +++
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 663 VKVDVYSFGVLLLELI 678
K D++S G+ +EL
Sbjct: 177 EKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 74/219 (33%), Positives = 114/219 (52%), Gaps = 36/219 (16%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV--EQQGEKEF--RT 528
Y+EL E +G GA+GTVYK A D + RFVA+KK+ +V ++G R
Sbjct: 1 YEELAE--------IGEGAYGTVYK---ARDLNTGRFVALKKV-RVPLSEEGIPLSTLR- 47
Query: 529 EVSVIGQT---HHKNLVRLLGFC-----DEGDHRLLVYEYMSNGSLASFLFGITRP--DW 578
E++++ Q H N+VRLL C D LV+E++ LA++L +P
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP 106
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
+ + RG+ +LH S +I+H D+KPQNIL+ +I+DFGLA++ +
Sbjct: 107 ETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFE 160
Query: 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
A T + T+ Y APE ++S VD++S G + EL
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 68/195 (34%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
LG+G FG V+ G +K VAIK L K + F E ++ + H LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTK--VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 549 DEGDHRLLVYEYMSNGSLASFLFG-----ITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
E + +V E+M GSL FL + P Q V +A IA G+ Y+
Sbjct: 71 SE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLP---QLVDMAAQIADGMAYIER---MNY 123
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH D++ NIL+ D +I+DFGLA+L+ + AR G + + + APE T+
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 664 KVDVYSFGVLLLELI 678
K DV+SFG+LL EL+
Sbjct: 183 KSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 461 SVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKL----- 515
S SS SA+ K L E R R +G GA GTVYK V+ + R A+K +
Sbjct: 56 SSSSSSASGSAPSAAKSLSELERVNR--IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHE 112
Query: 516 DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITR 575
D V +Q E+ ++ +H N+V+ D ++ E+M GSL G
Sbjct: 113 DTVRRQ----ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----GTHI 164
Query: 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
D +A I G+ YLH I+H DIKP N+L++ +I+DFG++++L
Sbjct: 165 ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--A 219
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKV----------DVYSFGVLLLE 676
QT GT+ Y +PE I + D++S GV +LE
Sbjct: 220 QTMDPCNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 11/194 (5%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRLLG 546
+G G +G VYK + VAIKK+ + E+ ++ + +H N+++LL
Sbjct: 7 IGEGTYGVVYKA-RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECSTQIIH 605
LV+E+M L + R ++ + + +GL + H S I+H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFRKASITVK 664
D+KP+N+L++ +++DFGLA+ + T T Y APE +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 665 VDVYSFGVLLLELI 678
VD++S G + EL+
Sbjct: 180 VDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 489 LGRGAFGTVYKGVLA--SDSKRFVAIKKLDKVEQQGE---KEFRTEVSVIGQTHHKNLVR 543
+ +GA+G V+ LA + AIK + K + + + TE ++ Q +V+
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 544 LLGFCDEGDHRL-LVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECS 600
L + +G L LV EY+ G LAS L G + + R+ IA I L YLH S
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIA-EIVLALEYLH---S 111
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT------QAARTGIRGTVGYFAPE 654
IIH D+KP NIL+D +++DFGL+K+ L + + I GT Y APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 655 WFRKASITVKVDVYSFGVLLLELIC 679
+ VD +S G +L E +
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F + LG G FG V+ G + K VAIK +++ E++F E V+ + H LV+L
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIK--VAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL---FGITRPDWNQRVQIAFGIARGLMYLHEECST 601
G C + +V E+M NG L ++L G D + + + G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLER---N 119
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
IH D+ +N L+ ++SDFG+ + +L ++ ++ +G + V + PE F +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKY 178
Query: 662 TVKVDVYSFGVLLLEL 677
+ K DV+SFGVL+ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 80/268 (29%), Positives = 118/268 (44%), Gaps = 45/268 (16%)
Query: 487 QILGRGAFGTV----YKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKN 540
Q +G+G FG V Y+G VA+K K D Q F E SV+ Q H N
Sbjct: 12 QTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA----FLAEASVMTQLRHSN 60
Query: 541 LVRLLGFCDEGDHRL-LVYEYMSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHE 597
LV+LLG E L +V EYM+ GSL +L G + + ++ + + + YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 119
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+ +H D+ +N+L+ + ++SDFGL K + Q + V + APE R
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALR 172
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTN-PEEALMDWVYRCYIGKNLDKLAENDE 716
+ + K DV+SFG+LL E+ FG P L D V R G +D
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
Query: 717 EVKNDLKRVERLVMVALWCIQEDASLRP 744
V + +K+ C DA+ RP
Sbjct: 227 VVYDVMKQ----------CWHLDAATRP 244
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
F + LG G+FG V V S ++ A+K L K V+ + + E ++ H L
Sbjct: 5 FIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 542 VRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC 599
V L G F D D L LV EY+ G L S L R A + L YLH
Sbjct: 64 VNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL- 120
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
I++ D+KP+N+LLD +I+DFG AK + +T + GT Y APE
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYT----LCGTPEYLAPEIILSK 173
Query: 660 SITVKVDVYSFGVLLLELIC 679
VD ++ G+L+ E++
Sbjct: 174 GYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVL---ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSV 532
EL + F + LG AFG +YKG L D + VAIK L D Q EF+ E S+
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 533 IGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF---------------GITRP- 576
+ + HH N+V LLG + +++EY++ G L FL G +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 577 -DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
D + IA IA G+ YL S +H D+ +NIL+ + +ISD GL++ + +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+ + + PE + D++SFGV+L E+ +G +N E
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 485 FRQILGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQT-HH 538
F + LG GAFG V + G+ SD+ VA+K L E+E +E+ ++ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGIARGLMYLH 596
+N+V LLG C G L++ EY G L +FL + ++ +A+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
S IH D+ +N+LL +I DFGLA+ ++ + + R V + APE
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 657 RKASITVKVDVYSFGVLLLEL 677
T + DV+S+G+LL E+
Sbjct: 216 FNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL---------DKVEQQGE-KEFRTEVSVIGQT 536
+++G+G +G VY L + +A+K++ Q+ K R+E+ +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
H N+V+ LGF ++ + EY+ GS+ S L R + + GL YLH
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
S I+H D+K N+L+D +ISDFG++K ++G+V + APE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 657 --RKASITVKVDVYSFGVLLLEL 677
+ KVD++S G ++LE+
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 485 FRQILGRGAFGTVY----KGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN 540
++ LG GAFG V+ + K VA+K L K+F E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG-------------ITRPDWNQRVQIAFG 587
+V+ G C EGD ++V+EYM +G L FL +Q + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
IA G++YL S +H D+ +N L+ + +I DFG+++ + + T R G
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS--TDYYRVGGHTM 183
Query: 648 --VGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
+ + PE T + DV+S GV+L E+
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNLVRLLGF 547
+G+G+FG V+KG+ + +++ VAIK +D E + E ++ + E++V+ Q + + G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEECSTQII 604
+ ++ EY+ GS L P D Q I I +GL YLH E + I
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKI 123
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H DIK N+LL ++ +++DFG+A L TQ R GT + APE ++++ K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 665 VDVYSFGVLLLEL 677
D++S G+ +EL
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 63/191 (32%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR-TEVSVIGQTHHKNLVRLLGF 547
+G+GA GTVY + + + VAIK+++ ++QQ +KE E+ V+ + H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQE-VAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCD 607
GD +V EY++ GSL + T D Q + + L +LH S Q+IH D
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 140
Query: 608 IKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDV 667
IK NILL + +++DFG + EQ++ R+ + GT + APE + + KVD+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 668 YSFGVLLLELI 678
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 14/193 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLLGF 547
+G+G+FG V+KG+ + +++ VAIK +D E + E E + E++V+ Q + + G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQII 604
+G ++ EY+ GS L R QIA I +GL YLH E + I
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE---KKI 123
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H DIK N+LL + +++DFG+A L TQ R GT + APE ++++ K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 665 VDVYSFGVLLLEL 677
D++S G+ +EL
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 19/235 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFV--AIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL- 545
LG G FG V + S ++ F +KK VE ++ +E ++ + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRVQIAFGIARGLMYLHEECSTQII 604
F D+ + ++ EY G L + L ++ R IA + YLH + II
Sbjct: 61 TFKDK-KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLH---NRGII 115
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
+ D+KP+N+LLD ++ DFG AK L + Q T GT Y APE
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFC-GTPEYVAPEIILNKGYDFS 172
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPE-----EALMDWVYRCYIGKNLDKLAEN 714
VD +S G+LL EL+ FG + + ++ + +DK A++
Sbjct: 173 VDYWSLGILLYELLT--GRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKD 225
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 485 FRQILGRGAFGTVY----KGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN 540
++ LG GAFG V+ + + K VA+K L K+F+ E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD-----------------WNQRVQ 583
+V+ G C +GD ++V+EYM +G L FL PD +Q +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA-HGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
IA IA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
+ + PE T + DV+SFGV+L E+
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 66/192 (34%), Positives = 98/192 (51%), Gaps = 8/192 (4%)
Query: 489 LGRGAFGTVYKGVLAS-DSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG G FGTV KG+ S++ VA+K K D + + E E +V+ Q + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
G C E + +LV E G L FL ++ ++ G+ YL E T +H
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVH 118
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLA-EQTQAARTGIRGTVGYFAPEWFRKASITVK 664
D+ +N+LL +ISDFGL+K L A E A+T + V ++APE + K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 665 VDVYSFGVLLLE 676
DV+SFGVL+ E
Sbjct: 179 SDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 31/205 (15%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKL-----DKVEQQGEKEFRTEVSVIGQTHHKNLV 542
LG GA G+V K ++ A+K + +++Q R E+ + +V
Sbjct: 8 RLGEGAGGSVTK-CRLKNTGMIFALKTITTDPNPDLQKQ---ILR-ELEINKSCKSPYIV 62
Query: 543 RLLG-FCDEGDHRL-LVYEYMSNGSLASFL------FGITRPDWNQRV--QIAFGIARGL 592
+ G F DE + + EY GSL S G ++V +IA + +GL
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI----GEKVLGKIAESVLKGL 118
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLH +IIH DIKP NILL ++ DFG++ L+ A T GT Y A
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFT-GTSFYMA 171
Query: 653 PEWFRKASITVKVDVYSFGVLLLEL 677
PE + ++ DV+S G+ LLE+
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLL 545
+++G G +G VYK + + VAIK +D +E + E+E + E +++ + ++H N+
Sbjct: 12 EVIGEGTYGKVYKARH-KKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFY 69
Query: 546 GF------CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV---QIAF---GIARGLM 593
G D LV E GS+ + G+ + +R+ IA+ RGL
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLA 127
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR-TGIRGTVGYFA 652
YLHE ++IH DIK QNILL ++ DFG++ L + T R T I GT + A
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFI-GTPYWMA 181
Query: 653 PEWF-----RKASITVKVDVYSFGVLLLEL 677
PE AS + DV+S G+ +EL
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 25/224 (11%)
Query: 488 ILGRGAFGTVYKGVLASDS-KRFVAIKKLDKVEQQGE-KEFRTEVSVIGQT-HHKNLVRL 544
++G G FG V K + D + AIK++ + + + ++F E+ V+ + HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGI----TRPDW------------NQRVQIAFGI 588
LG C+ + L EY +G+L FL T P + Q + A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
ARG+ YL ++ Q IH D+ +NIL+ + + +I+DFGL++ ++ +T R V
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+ A E + T DV+S+GVLL E++ + G T E
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 72/241 (29%), Positives = 113/241 (46%), Gaps = 26/241 (10%)
Query: 485 FRQ--ILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHK 539
FRQ +LG+G FG V + + K + A K+L+K +++GE E ++ + + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMY-ACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--IARGLMYLHE 597
+V L + D LV M+ G L ++ + P + + + + I GL LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
E ++ D+KP+NILLDDY RISD GLA + ++ R GTVGY APE
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLN 174
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
T+ D + G L+ E+I +S P + V R + +D+ EE
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQS--------PFRGRKEKVKR----EEVDRRVLETEE 222
Query: 718 V 718
V
Sbjct: 223 V 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 31/215 (14%)
Query: 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKK--LDKVEQ-QGEKEFRT---EVSVI 533
E T+G ++LG+GA+GTVY G+ ++ + +A+K+ LD EKE+ EV ++
Sbjct: 1 EWTKG--EVLGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 534 GQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAF----- 586
H N+V+ LG C + + + E++ GS++S L FG + F
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-------PLPEPVFCKYTK 109
Query: 587 GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI-- 644
I G+ YLH C ++H DIK N++L ++ DFG A+ L + +
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 645 --RGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
GT + APE ++ K D++S G + E+
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKR--FVAIKKL-DKVEQQGEKEFRTEVSVI 533
EL+ + +ILG G FG + +G L SKR VAI L + + F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 534 GQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF-----GI 588
GQ H N+VRL G G+ ++V EYMSNG+L SFL R Q V G+
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGL 116
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG-- 646
A G+ YL E +H + +L++ +IS F L ++++A T + G
Sbjct: 117 ASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS 170
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
V + APE + + DV+SFG+++ E++
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 58/281 (20%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF---VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLV 542
++LG GAFGTVYKG+ + ++ VAIK+L + + KE E V+ + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFL------FGITRPDWNQRVQIAFGIARGLMYLH 596
RLLG C +L + + M G L ++ G ++ N VQIA +G+ YL
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQIA----KGMNYLE 126
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
E +++H D+ +N+L+ +I+DFGLAKLL A++ + G + + + A E
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716
T + DV+S+GV + EL+ FG+ K D + +
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELM------TFGS-----------------KPYDGIPAS-- 218
Query: 717 EVKNDLKRVERL------------VMVALWCIQEDASLRPQ 745
E+ + L++ ERL +MV W I DA RP+
Sbjct: 219 EISSILEKGERLPQPPICTIDVYMIMVKCWMI--DADSRPK 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 56/279 (20%)
Query: 487 QILGRGAFGTVYKGVLASDS---KRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLV 542
++LG G FGTV+KG+ + K VAIK + D+ +Q +E + +G H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLF---GITRPD--WNQRVQIAFGIARGLMYLHE 597
RLLG C G LV + GSL + P N VQIA +G+ YL E
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA----KGMYYLEE 127
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
++H ++ +NILL +I+DFG+A LL + + + + + + A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
T + DV+S+GV + E +M + Y G E
Sbjct: 185 FGRYTHQSDVWSYGVTVWE------------------MMSYGAEPYAGMRP-------HE 219
Query: 718 VKNDLKRVERL------------VMVALWCIQEDASLRP 744
V + L++ ERL VMV W I E+ +RP
Sbjct: 220 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN--VRP 256
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHKNLVR 543
+++GRGAFG V+ ++ V IK++ VEQ + E + E V+ H N++
Sbjct: 6 RVVGRGAFGIVHL-CRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
E ++V EY G+LA ++ ++ + F + L+ LH + I
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF-FVQILLALHHVHTKLI 122
Query: 604 IHCDIKPQNILLDDYFTP-RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+H D+K QNILLD + +I DFG++K+L +++ + GT Y +PE
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 663 VKVDVYSFGVLLLELICCK 681
K D+++ G +L EL K
Sbjct: 180 QKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG+G FG V V ++ + A KKLDK ++ GEK E ++ + + +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+ H LV M+ G L ++ G + + + + I G+++LH S I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
++ D+KP+N+LLDD R+SD GLA L +T R GT GY APE ++ +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPEILKEEPYSY 173
Query: 664 KVDVYSFGVLLLELI 678
VD ++ G + E++
Sbjct: 174 PVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-18
Identities = 62/191 (32%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR-TEVSVIGQTHHKNLVRLLGF 547
+G+GA GTVY + + + VAI++++ ++QQ +KE E+ V+ + + N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQE-VAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCD 607
GD +V EY++ GSL + T D Q + + L +LH S Q+IH D
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 608 IKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDV 667
IK NILL + +++DFG + EQ++ R+ + GT + APE + + KVD+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 668 YSFGVLLLELI 678
+S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 487 QILGRGAFGTV--YKGVLASD-SKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLV 542
++LG G FG V Y A+D + VA+K L + QQ ++ E++++ +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 543 RLLGFCDEGDHR--LLVYEYMSNGSLASFLFGITRPDWN----QRVQIAFGIARGLMYLH 596
+ G C E + L+ EY+ GSL +L P Q + A I G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL-LAEQTQAARTGIRGTVGYFAPEW 655
S IH D+ +N+LLD+ +I DFGLAK + + R V ++A E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 656 FRKASITVKVDVYSFGVLLLELIC-CKSS 683
++ + DV+SFGV L EL+ C S
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVRLL 545
+G GA+G V K + VAIKK K + E +T EV V+ Q H+N+V L
Sbjct: 9 VGEGAYGVVLK-CRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 546 GFCDEGDHRLLVYEYMSNG---SLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
LV+EY+ L + G+ PD + + + + + Y H S
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVRS--YIWQLLQAIAYCH---SHN 120
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IIH DIKP+NIL+ + ++ DFG A+ L + + T Y A W+R +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLT------DYVATRWYRAPELL 173
Query: 663 VK-------VDVYSFGVLLLELI 678
V VDV++ G ++ EL+
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKL----DKVEQQGEKEFRT 528
FT ++L++ +GRGAFGTV K +L S +A+K++ D+ EQ K
Sbjct: 1 FTAEDLKDLGE-----IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQ---KRLLM 51
Query: 529 EVSVIGQTHH-KNLVRLLG--FCDEGDHRLLVYEYM--SNGSLASFLFGITRPDWNQRV- 582
++ V+ ++ +V+ G F EGD + E M S +++ + + + +
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALF-REGDC-WICMELMDISLDKFYKYVYEVLKSVIPEEIL 109
Query: 583 -QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+IA + L YL EE +IIH D+KP NILLD ++ DFG++ L A+
Sbjct: 110 GKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAK 164
Query: 642 TGIRGTVGYFAPEW---FRKASITVKVDVYSFGVLLLEL 677
T G Y APE + V+ DV+S G+ L E+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 7e-18
Identities = 62/191 (32%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR-TEVSVIGQTHHKNLVRLLGF 547
+G+GA GTVY + + + VAIK+++ ++QQ +KE E+ V+ + + N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQE-VAIKQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCD 607
GD +V EY++ GSL + T D Q + + L +LH S Q+IH D
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLH---SNQVIHRD 140
Query: 608 IKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDV 667
IK NILL + +++DFG + EQ++ R+ + GT + APE + + KVD+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 668 YSFGVLLLELI 678
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 16/196 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRLL- 545
LG+G++G+VYK SD++ F A+K++D + Q+ ++ E+ ++ +H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQ-FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFL---FGITRPDWNQRV-QIAFGIARGLMYLHEECST 601
F D G+ +V EY G L+ + + Q + +I + RGL LHE+
Sbjct: 67 AFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--- 122
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+I+H D+K NILL +I D G++K+L + A+T I GT Y APE ++
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVWKGRPY 178
Query: 662 TVKVDVYSFGVLLLEL 677
+ K D++S G LL E+
Sbjct: 179 SYKSDIWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL-GF 547
LG GAFG VYK ++ F A K + ++ ++F E+ ++ + H N+V L +
Sbjct: 13 LGDGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIHC 606
E +L+ E+ G+L S + + R Q + + L +LH ++IH
Sbjct: 72 FYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAP-----EWFRKASI 661
D+K NILL +++DFG++ + Q T I GT + AP E F+
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 662 TVKVDVYSFGVLLLEL 677
K D++S G+ L+EL
Sbjct: 186 DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNL 541
+G G +G VY+ + S VA+KK V E++ R E++++ H N+
Sbjct: 14 RIGEGTYGIVYRA-RDTTSGEIVALKK---VRMDNERDGIPISSLR-EITLLLNLRHPNI 68
Query: 542 VRLLGFC--DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEE 598
V L D LV EY LAS L + P +V+ + + RGL YLHE
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFR 657
IIH D+K N+LL D +I+DFGLA+ T T+ Y APE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLG 182
Query: 658 KASITVKVDVYSFGVLLLELI 678
+ T +D+++ G +L EL+
Sbjct: 183 CTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT----EVSVIGQTHHKNLVR 543
++G G++G V K ++ + VAIKK +E + +K + E+ ++ Q H+NLV
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 544 LLGFCDEGDHRLLVYEYMSN---GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
L+ LV+E++ + L + G+ D ++ + F I RG+ + H S
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL---DESRVRKYLFQILRGIEFCH---S 118
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
IIH DIKP+NIL+ ++ DFG A+ L A Y A W+R
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--------EVYTDYVATRWYRAPE 170
Query: 661 ITVK-------VDVYSFGVLLLELI 678
+ V VD+++ G L+ E++
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 76/269 (28%), Positives = 121/269 (44%), Gaps = 34/269 (12%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF---VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLV 542
++LG GAFGTVYKG+ D + VAIK L + + KE E V+ +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFL------FGITRPDWNQRVQIAFGIARGLMYLH 596
RLLG C +L V + M G L ++ G ++ N VQIA +G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIG-SQDLLNWCVQIA----KGMSYLE 126
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
E +++H D+ +N+L+ +I+DFGLA+LL ++T+ G + + + A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716
T + DV+S+GV + EL+ FG Y + + L E E
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELM------TFGAKP---------YDGIPAREIPDLLEKGE 228
Query: 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745
+ + M+ + C D+ RP+
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDSECRPR 257
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 40/227 (17%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+++GRGAFG V+ V D+ + A+K L K +++ R E ++ +
Sbjct: 5 VIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63
Query: 542 VRLL-GFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEE 598
V+L F DE +H LV EYM G L + L + + + F IA ++ L
Sbjct: 64 VKLYYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEETAR-----FYIAELVLALDSV 117
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAK----------LLLAEQTQAARTGIR--- 645
IH DIKP NIL+D +++DFGL K L R +
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 646 --------------GTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
GT Y APE R ++ D +S GV+L E++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHK 539
R +R +LG+G FG V + + K + A KKL+K +++GE E ++ + + +
Sbjct: 3 RHYR-VLGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--IARGLMYLHE 597
+V L + D LV M+ G L ++ + P ++++ I + + GL L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
E +I++ D+KP+NILLDD RISD GLA + +T R GTVGY APE
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVIN 174
Query: 658 KASITVKVDVYSFGVLLLELI 678
T D + G L+ E+I
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRT--EVSVIGQTH---HKN 540
+G GA+G V+K + RFVA+K+ V Q +E T EV+V+ H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 541 LVRLLGFC-----DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLM 593
+VRL C D LV+E++ L ++L + P + F + RGL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAP 653
+LH S +++H D+KPQNIL+ +++DFGLA++ Q A T + T+ Y AP
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 178
Query: 654 EWFRKASITVKVDVYSFGVLLLEL 677
E ++S VD++S G + E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 489 LGRGAFGTVYK-GVLASDSKRFVAIKK--LDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
+G GA G V+K + VA+KK L ++E + E+ + H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETG--ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECSTQII 604
G +LV EYM L+ L RP +V+ + +G+ Y+H I+
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFRKASITV 663
H D+KP N+L+ +I+DFGLA+ L +E+ + T Y APE +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 664 KVDVYSFGVLLLELI 678
VD+++ G + EL+
Sbjct: 181 GVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 7/190 (3%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
+G G+ G V K+ VA+KK+D +QQ + EV ++ HH+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQ-VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI 608
GD +V E++ G+L + TR + Q + + R L YLH + +IH DI
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDI 144
Query: 609 KPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVY 668
K +ILL ++SDFG + E + R + GT + APE + +VD++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 669 SFGVLLLELI 678
S G++++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVRLL 545
LG+G FG V + + K + A KKL+K + K + E ++ + H + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLY-ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITR--PDWNQRVQIAFG--IARGLMYLHEECST 601
LV M+ G L ++ + P + + + I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+II+ D+KP+N+LLD+ RISD GLA L Q++ G GT G+ APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAGTPGFMAPELLQGEEY 174
Query: 662 TVKVDVYSFGVLLLELICCK 681
VD ++ GV L E+I +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKE---FRTEVSVIGQTHHKNL 541
++LG+GAFG VY D+ R +A+K++ D + +KE E+ ++ H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 542 VRLLGFCDEGDHRLLVY-EYMSNGSLASFL--FG-----ITRPDWNQRVQIAFGIARGLM 593
V+ G C D L ++ EYM GS+ L +G +TR Q I G+
Sbjct: 67 VQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ-------ILEGVE 118
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR---GTVGY 650
YLH S I+H DIK NIL D ++ DFG +K L + TG++ GT +
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG--TGMKSVTGTPYW 173
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCK 681
+PE K DV+S G ++E++ K
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 7/190 (3%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
+G G+ G V + S S + VA+KK+D +QQ + EV ++ H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI 608
GD +V E++ G+L + TR + Q + + + L LH + +IH DI
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 609 KPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVY 668
K +ILL ++SDFG + E + R + GT + APE + +VD++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 669 SFGVLLLELI 678
S G++++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 56/190 (29%), Positives = 102/190 (53%), Gaps = 7/190 (3%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
+G+GA GTV+ + + + VAIK+++ +Q ++ E+ V+ + + N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQE-VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI 608
GD +V EY++ GSL + T D Q + + L +LH + Q+IH DI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 609 KPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVY 668
K N+LL + +++DFG + EQ++ R+ + GT + APE + + KVD++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 669 SFGVLLLELI 678
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-F-RT---EVSVIGQTHHKNLV 542
+G G +G VYK + VA+KK+ + EKE F T E+ ++ + H N+V
Sbjct: 6 QIGEGTYGQVYKA-RNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 543 RLLGF---CDEGDHRLLVYEYMS---NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
RL +G +V+EYM G L S T Q + GL YLH
Sbjct: 62 RLKEIVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLLEGLQYLH 117
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
S I+H DIK NIL+++ +++DFGLA+ + T T+ Y PE
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELL 173
Query: 657 RKASI-TVKVDVYSFGVLLLELI 678
A+ +VD++S G +L EL
Sbjct: 174 LGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 57/191 (29%), Positives = 96/191 (50%), Gaps = 8/191 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGF 547
+GRG FG V+ G L +D+ VA+K + + + +F E ++ Q H N+VRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNT-PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHC 606
C + +V E + G +FL R + +Q+ A G+ YL + IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHR 118
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT-VGYFAPEWFRKASITVKV 665
D+ +N L+ + +ISDFG+++ + A+ G++ V + APE + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 666 DVYSFGVLLLE 676
DV+SFG+LL E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 64/201 (31%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 489 LGRGAFGTVYKGV-LASDSKRF-VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG G+FG V +G S K VA+K L +F E +++ H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 546 GFCDEGDHRL-LVYEYMSNGSLASFL-------FGITRPDWNQRVQIAFGIARGLMYLHE 597
G H L +V E GSL L F I+ + VQIA G+ YL
Sbjct: 63 GVVL--THPLMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIANGMR----YLE- 114
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK-LLLAEQTQAARTGIRGTVGYFAPEWF 656
S + IH D+ +NILL +I DFGL + L E ++ + APE
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 657 RKASITVKVDVYSFGVLLLEL 677
R + + DV+ FGV L E+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
++LG+G FG V+KG L K VA+K + + Q+ + +F +E ++ Q H N+V+L+
Sbjct: 1 ELLGKGNFGEVFKGTL--KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPD---WNQRVQIAFGIARGLMYLHEECSTQ 602
G C + +V E + G SFL + D Q V+ A A G+ YL S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLE---SKN 113
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT-VGYFAPEWFRKASI 661
IH D+ +N L+ + +ISDFG+++ + + +G++ + + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 662 TVKVDVYSFGVLLLE 676
+ + DV+S+G+LL E
Sbjct: 172 SSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 30/224 (13%)
Query: 485 FRQILGRGAFGTVY----KGVLA---------SDSKRFVAIKKL-DKVEQQGEKEFRTEV 530
++ LG G FG V+ +G+ VA+K L V + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF------------GITRPDW 578
++ + + N++RLLG C D ++ EYM NG L FL I
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
+ +A IA G+ YL S +H D+ +N L+ +++T +I+DFG+++ L +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL-ICCK 681
+ + + A E T DV++FGV L E+ CK
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRLLG 546
+G GA+G V + + R VAIKKL + Q RT E+ ++ H+N++ LL
Sbjct: 23 VGSGAYGQVCS-AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 547 -FC-----DEGDHRLLVYEYMSNGSLASFLFGITR--PDWNQRVQ-IAFGIARGLMYLHE 597
F ++ LV M + L I + + +Q + + I RGL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH- 135
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WF 656
S IIH D+KP NI +++ +I DFGLA+ T TG T Y APE
Sbjct: 136 --SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIML 188
Query: 657 RKASITVKVDVYSFGVLLLELICCK 681
VD++S G ++ EL+ K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 487 QILGRGAFG--TVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNL 541
++LG+GAFG T+Y+ D V K+++ + + EKE R E+ ++ H N+
Sbjct: 6 RVLGKGAFGEATLYRR--TEDDS-LVVWKEVN-LTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 542 VRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA--FGIARGLMYLHEE 598
+ F D+ L+ EY + G+L + + + + + F I + Y+H+
Sbjct: 62 IAYYNHFMDDNT-LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
I+H DIK NI L ++ DFG++K+L +E A T + GT Y +PE +
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAETVV-GTPYYMSPELCQG 175
Query: 659 ASITVKVDVYSFGVLLLELICCKSSVVFGTTNP 691
K D+++ G +L EL+ K F TNP
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKR--TFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 29/205 (14%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVRLL 545
LG+G +G+VYK VL + +A+K++ ++E E +F E+ ++ + +V
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEI-RLELD-ESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 546 G-FCDEGDHRLLVY---EYMSNGSLASFLFG---ITRPDWNQRVQIAFGIARGLMYLHEE 598
G F EG VY EYM GSL G + +I + + +GL +L EE
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR- 657
IIH D+KP N+L++ ++ DFG++ L+A A+T I G Y APE +
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKTNI-GCQSYMAPERIKS 175
Query: 658 -----KASITVKVDVYSFGVLLLEL 677
+ TV+ DV+S G+ +LE+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 33/214 (15%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKL-----DKVEQQGEKEFRTEVSVIGQ-THHK 539
Q LG+GA+G V+K + +K VA+KK+ + + Q + FR E+ + + H
Sbjct: 12 LQKLGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQELGDHP 67
Query: 540 NLVRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQ---IAFGIARGLMY 594
N+V+LL E D + LV+EYM + L + R + + V I + + + L Y
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKALKY 122
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
+H S +IH D+KP NILL+ +++DFGLA+ L+E + + Y A
Sbjct: 123 IH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR-SLSELEENPENPV--LTDYVATR 176
Query: 655 WFRKASITVK-------VDVYSFGVLLLELICCK 681
W+R I + VD++S G +L E++ K
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 489 LGRGAFGTV----YKGVLASDSKRFVAIKKLDKVEQQGEK--EFRTEVSVIGQTHHKNLV 542
LG G FG V Y ++ VA+K L K E G + + E+ ++ +H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPE-GDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 543 RLLGFCDEGDHR--LLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
+ G C E L+ E++ +GSL +L + + Q+++ A I +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--- 126
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA-EQTQAARTGIRGTVGYFAPEWFRK 658
S Q +H D+ +N+L++ +I DFGL K + ++ + + V ++APE +
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 659 ASITVKVDVYSFGVLLLELIC-CKSS 683
+ + DV+SFGV L EL+ C S
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSE 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 16/193 (8%)
Query: 491 RGAFGTVY--KGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVI-GQTHHKNLVRLLGF 547
+GAFG+VY K D +KK D + + + E +++ Q + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 548 CDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
D+ LV EY++ G AS + G DW + Q + G+ LH+ IIH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---GIIH 120
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
DIKP+N+L+D +++DFGL++ L + GT Y APE
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKMS 174
Query: 666 DVYSFGVLLLELI 678
D +S G ++ E +
Sbjct: 175 DWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 77/236 (32%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT------ 528
YK +++ LG G FG+VY ++ VAIKK+ +K+F +
Sbjct: 1 YKVIKQ--------LGDGTFGSVYLAR-NKETGELVAIKKM-------KKKFYSWEECMN 44
Query: 529 --EV-SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA 585
EV S+ H N+V+L E D V+EYM L+ + + R
Sbjct: 45 LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGN-----LYQLMK----DRKGKP 95
Query: 586 F--GIARGLMYLHEECSTQII------------HCDIKPQNILLDDYFTPRISDFGLAKL 631
F + R ++Y QI+ H D+KP+N+L+ +I+DFGLA+
Sbjct: 96 FSESVIRSIIY-------QILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR- 147
Query: 632 LLAEQTQAARTGIR---------GTVGYFAPEWF-RKASITVKVDVYSFGVLLLEL 677
IR T Y APE R S + VD+++ G ++ EL
Sbjct: 148 -----------EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKL---DKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
+G+G F VYK + D R VA+KK+ + ++ + ++ E+ ++ Q H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDG-RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPD--------WNQRVQIAFGIARGLMYLHE 597
E + +V E G L+ + + W VQ+ L ++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMH- 123
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
S +I+H DIKP N+ + ++ D GL + + +T AA + + GT Y +PE
Sbjct: 124 --SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSPERIH 179
Query: 658 KASITVKVDVYSFGVLLLELICCKS 682
+ K D++S G LL E+ +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVS 531
E+ +T F + LG FG VYKG L + + VAIK L DK E +EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--------FGITRPDWNQR-- 581
+ + H N+V LLG + +++ Y S+ L FL G T D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 582 ------VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
V I IA G+ +L S ++H D+ +N+L+ D +ISD GL + + A
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
+ + +PE ++ D++S+GV+L E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 46/227 (20%)
Query: 485 FRQILGRGAFGTVY---------------KGVLASDSKRFVAIKKL-DKVEQQGEKEFRT 528
F + LG G FG V+ +D+ VA+K L ++F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 529 EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----------FGITRPD 577
EV ++ + N+ RLLG C ++ EYM NG L FL
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 578 WNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637
++ + +A IA G+ YL S +H D+ +N L+ +T +I+DFG+++ L +
Sbjct: 129 FSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS--- 182
Query: 638 QAARTGIRGTVGYFAP---EWFRKASI-----TVKVDVYSFGVLLLE 676
+ ++G AP W S+ T K DV++FGV L E
Sbjct: 183 -SDYYRVQGR----APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 78/258 (30%), Positives = 114/258 (44%), Gaps = 40/258 (15%)
Query: 489 LGRGAFGTVYKG-VLASDSKR-----FVAIKKLDKVEQQGEKEFRTEVS------VIGQT 536
LG G FG V L D + VA+K L + EK+ VS +IG+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGK- 79
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----------FGITR-PD----WNQ 580
HKN++ LLG C + ++ EY S G+L +L + I R PD +
Sbjct: 80 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 581 RVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
V + +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700
T R V + APE T + DV+SFGVL+ E+ S G P E L +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLK 253
Query: 701 RCYIGKNLDKLAENDEEV 718
G +DK A E+
Sbjct: 254 E---GHRMDKPANCTNEL 268
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 34/207 (16%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNLV 542
LG G + VYK ++ R VAIKK+ E++ K+ R E+ ++ + H N++
Sbjct: 8 LGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNII 65
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIA----------RGL 592
LL + LV+E+M + L + + I A RGL
Sbjct: 66 GLLDVFGHKSNINLVFEFME-----TDLEKVIK-----DKSIVLTPADIKSYMLMTLRGL 115
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLH S I+H D+KP N+L+ +++DFGLA+ + + + T Y A
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 653 PEWFRKASI-TVKVDVYSFGVLLLELI 678
PE A V VD++S G + EL+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G G+FG +Y SDS+ V IK++D K+ + ++ + EV ++ + H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--------------IAR 590
E +V EY G L +R+ G I+
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLM------------KRINRQRGVLFSEDQILSWFVQISL 112
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
GL ++H+ +I+H DIK QNI L + ++ DFG+A+ L + + A T + GT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCV-GTPY 167
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
Y +PE + K D++S G +L EL K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIG---QTHHKNLVR 543
+G GA+GTVYK S FVA+K + + T EV+++ H N+VR
Sbjct: 8 IGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 544 LLGFC-----DEGDHRLLVYEYMSNGSLASFLFGITRP--------DWNQRVQIAFGIAR 590
L+ C D LV+E++ L ++L + P D ++ R
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ------FLR 119
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
GL +LH C I+H D+KP+NIL+ +++DFGLA++ Q A T + T+ Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWY 173
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLEL 677
APE +++ VD++S G + E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 486 RQILGRGAFGTVY--KGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNL 541
++LG+G+FG V+ + + D+ + A+K L K + RT E ++ + +H +
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 542 VRL-LGFCDEGDHRLLVYEYMSNGSLASFL---FGITRPDWNQRVQIAFG-IARGLMYLH 596
V+L F EG L+ +++ G L + L T D V+ +A L +LH
Sbjct: 61 VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDHLH 115
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
S II+ D+KP+NILLD+ +++DFGL+K + + +A GTV Y APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAPEVV 170
Query: 657 RKASITVKVDVYSFGVLLLELI 678
+ T D +SFGVL+ E++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 487 QILGRGAFGTVYKGVLAS--DSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
+ +G G FG VY+GV S + K VA+K K EK F E ++ Q H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIV 70
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI---AFGIARGLMYLHEEC 599
+L+G E + +V E G L S+L + ++ ++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--- 124
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW--FR 657
S + +H DI +N+L+ ++ DFGL++ L E A G + + + APE FR
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIKWMAPESINFR 183
Query: 658 KASITVKVDVYSFGVLLLELI 678
+ T DV+ FGV + E++
Sbjct: 184 R--FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 45/238 (18%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSV 532
+K+LE+ LG G + TVYKG + VA+K LD E R E+S+
Sbjct: 2 FKQLEK--------LGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIR-EISL 51
Query: 533 IGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRP-DWNQRVQIAFGIA 589
+ + H+N+VRL + +LV+EYM L ++ G+ D N + +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
+G+ + HE +++H D+KPQN+L++ +++DFGLA+ GI V
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF----------GI--PVN 155
Query: 650 YFAPE----WFRKASI-------TVKVDVYSFGVLLLELICCKSSVVF-GTTNPEEAL 695
F+ E W+R + + +D++S G ++ E+I +F GT N ++ L
Sbjct: 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI--TGRPLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVI 533
Y+ LE ++GRGA+G VY+G + R VA+K ++ + + EV+++
Sbjct: 3 YQRLE--------LIGRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 534 GQTHH---KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR 590
Q N+ + G +G ++ EY GS+ + + + I+ I R
Sbjct: 54 SQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIR 108
Query: 591 ----GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
L Y+H +IH DIK NIL+ + ++ DFG+A LL Q + R+ G
Sbjct: 109 EVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVG 163
Query: 647 TVGYFAPEWFRKASI-TVKVDVYSFGVLLLELI 678
T + APE + K D++S G+ + E+
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 73/217 (33%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKEFR--- 527
F+ + E+ R+I G G+FG VY A D + VAIKK+ +Q ++++
Sbjct: 8 FSKDDPEKLFTDLREI-GHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDII 63
Query: 528 TEVSVIGQTHHKNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIA- 585
EV + Q H N + G C +H LV EY GS + L +P Q V+IA
Sbjct: 64 KEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKP--LQEVEIAA 119
Query: 586 --FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
G +GL YLH S + IH DIK NILL + T +++DFG A L+ +
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------ 170
Query: 644 IRGTVGYFAPE---WFRKASITVKVDVYSFGVLLLEL 677
GT + APE + KVDV+S G+ +EL
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 488 ILGRGAFGTV----YKGVLASDSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQT-HHK 539
+LG+G+FG V KG + A+K L K + Q + E TE V+ H
Sbjct: 2 VLGKGSFGKVLLAELKG-----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC 599
L +L D V EY++ G L + R D + A I GL +LHE
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER- 115
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR-----GTVGYFAPE 654
II+ D+K N+LLD +I+DFG+ K + G+ GT Y APE
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTSTFCGTPDYIAPE 166
Query: 655 WFRKASITVKVDVYSFGVLLLELICCKS 682
VD ++ GVLL E++ +S
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKL---DKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+G G FG V+ L D S+ + A+K + + + + E+ E V+ + H ++R
Sbjct: 9 VGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 544 LLGFCDEGDHRLL--VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
L F E D R L + EY+ G L S+L R + + A I L YLH S
Sbjct: 66 L--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SK 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART-GIRGTVGYFAPEWFRKAS 660
+I++ D+KP+NILLD +++DFG AK L RT + GT Y APE +
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAPEVIQSKG 174
Query: 661 ITVKVDVYSFGVLLLELI 678
VD ++ G+L+ E++
Sbjct: 175 HNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 487 QILGRGAFGTVY--KGVLASDSKRFVAIKKLDK---VEQQGEKEF-RTEVSVIGQTHHKN 540
++LG GA+G V+ + V DS + A+K L K V++ E RTE V+
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 541 LVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG-IARGLMYLHEE 598
+ L + + D +L L+ +Y++ G L + L R Q VQI G I L +LH+
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-EQEVQIYSGEIVLALEHLHK- 123
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR- 657
II+ DIK +NILLD ++DFGL+K ++ + A + GT+ Y AP+ R
Sbjct: 124 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRG 180
Query: 658 -KASITVKVDVYSFGVLLLELI 678
VD +S GVL+ EL+
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 510 VAIKKL--DKVEQQGE-KEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL-VYEYMSNGS 565
VAIK L D E++ + FR E ++ + +H N+V LL + L V+EY+ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 566 LASFLF--GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFT 620
L L G + ++ + L H + I+H D+KPQNI++
Sbjct: 66 LREVLAADGALPAG--ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPH 120
Query: 621 PRISDFGLAKLLL----AEQTQAARTG-IRGTVGYFAPEWFRKASITVKVDVYSFGVLLL 675
++ DFG+ LL A+ RT + GT Y APE R +T D+Y++G++ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 676 E 676
E
Sbjct: 181 E 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVR 543
+ +G GA+G V + K+ VAIKK+ V ++ R E+ ++ H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKK-VAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIA 68
Query: 544 LLGFC----DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG-IARGLMYLHEE 598
+ + +V + M + L + +P + ++ + RGL Y+H
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIH-- 124
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR--TGIRGTVGYFAPE-W 655
S +IH D+KP N+L+++ RI DFG+A+ L + T+ T T Y APE
Sbjct: 125 -SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 656 FRKASITVKVDVYSFGVLLLELI 678
T +D++S G + E++
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 487 QILGRGAFGTVY--KGVLASDSKRFVAIKKLDK---VEQQGEKEF-RTEVSVIGQTHHKN 540
++LG GA+G V+ + V D+ + A+K L K V++ E RTE V+
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 541 LVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG-IARGLMYLHEE 598
+ L + + D +L L+ +Y++ G L + L+ V++ I L +LH+
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT-ESEVRVYIAEIVLALDHLHQ- 123
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
II+ DIK +NILLD ++DFGL+K LAE+ + A + GT+ Y APE R
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRG 180
Query: 659 ASI--TVKVDVYSFGVLLLELI 678
S VD +S GVL EL+
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIG-QTHHKNLV 542
++LG+G+FG V L + F AIK L K +E + E V+ H L
Sbjct: 1 KVLGKGSFGKVMLAEL-KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 543 RLLGFC--DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
L FC +H V EY++ G L + R D + A I GL +LH
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---K 114
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
II+ D+K N+LLD +I+DFG+ K + + +A + GT Y APE +
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQK 172
Query: 661 ITVKVDVYSFGVLLLELICCKS 682
VD +SFGVLL E++ +S
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLV 542
F +++G+G++G V +D K++V IKKL+ ++ K E ++ Q H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 543 R--------------LLGFCDEGD--HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF 586
++GFC+ GD H+L G L P+ NQ V+
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKL----KEQKGKLL--------PE-NQVVEWFV 109
Query: 587 GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
IA L YLHE+ I+H D+K QN+ L ++ D G+A+ +L Q A T I G
Sbjct: 110 QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLI-G 164
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
T Y +PE F K DV++ G + E+ K
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 489 LGRGAFGTVYKGVLA---SDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+G G+FG K +L D K++V IK+++ K+ + +E R EV+V+ H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFL---FGITRP-----DWNQRVQIAFGIARGLMYL 595
+E + +V +Y G L + G+ P DW VQI L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHV 117
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H+ +I+H DIK QNI L T ++ DFG+A+ +L + ART I GT Y +PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCI-GTPYYLSPEI 172
Query: 656 FRKASITVKVDVYSFGVLLLELICCK 681
K D+++ G +L E+ K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 69/228 (30%), Positives = 117/228 (51%), Gaps = 19/228 (8%)
Query: 487 QILGRGAFGTVY--KGVLASDSKRFVAIKKLDK---VEQQGEKEF-RTEVSVIGQTHHKN 540
++LG GA+G V+ + V D+ + A+K L K V++ E RTE +V+
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 541 LVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQ-RVQIAFG-IARGLMYLHE 597
+ L + + + +L L+ +Y+S G + + L+ R ++++ V+ G I L +LH+
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHK 123
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART-GIRGTVGYFAPEWF 656
I++ DIK +NILLD ++DFGL+K L+E+ + RT GT+ Y APE
Sbjct: 124 ---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFCGTIEYMAPEII 178
Query: 657 RKASITVK-VDVYSFGVLLLELICCKSSVVF-GTTNPEEALMDWVYRC 702
R K VD +S G+L+ EL+ S G N + + + +C
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 485 FRQI--LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHK 539
F++I LG+G G V+ V + + A+K LDK E + TE ++ H
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA-FGIAR---GLMYL 595
L L + LV +Y G L L +P ++A F A L YL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT-------- 647
H I++ D+KP+NILL + +SDF L+K E ++ +G+
Sbjct: 120 HLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 648 ----------------VG---YFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT 688
VG Y APE VD ++ G+LL E++ +GT
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML-------YGT 229
Query: 689 T 689
T
Sbjct: 230 T 230
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
Q +G GAFG V A D + + VAIKK+ K ++ +R E+ ++ H+N+
Sbjct: 16 QPVGMGAFGLVCS---ARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENI 71
Query: 542 VRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEEC 599
+ L F + V E + L L +RP Q +Q + I RGL Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQILRGLKYVH--- 125
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR-TGIRGTVGYFAPE---- 654
S ++H D+KP NIL+++ +I DFGLA++ Q + TG T Y APE
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARI------QDPQMTGYVSTRYYRAPEIMLT 179
Query: 655 WFRKASITVKVDVYSFGVLLLELI 678
W + V+VD++S G + E++
Sbjct: 180 WQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLL 545
+++G G +G VYKG + + AIK +D E + E+E + E++++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYY 79
Query: 546 G-FCDEG-----DHRLLVYEYMSNGSLASFLFGIT----RPDWNQRVQIAFGIARGLMYL 595
G F + D LV E+ GS+ + + DW I I RGL +L
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHL 137
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H + ++IH DIK QN+LL + ++ DFG++ L ++T R GT + APE
Sbjct: 138 H---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEV 192
Query: 656 FR-----KASITVKVDVYSFGVLLLEL 677
A+ + D++S G+ +E+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 489 LGRGAFGTVYK----GVLAS--DSKRFVAIKKL-DKVEQQGEKEFRTEVS---VIGQTHH 538
LG G FG V + G+ S D VA+K L D + + +E+ +IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----------FGITRPDWNQ-----RV 582
KN++ LLG C + ++ EY + G+L FL F IT+ Q V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + +
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
R V + APE T + DV+SFG+L+ E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 489 LGRGAFGTVYKG-VLASDSKR-----FVAIKKL-DKVEQQGEKEFRTEVSVIGQT-HHKN 540
LG G FG V + D + VA+K L D + + +E+ ++ HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP----------------DWNQRVQI 584
++ LLG C + ++ EY S G+L +L P + V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
R V + APE T + DV+SFGVLL E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF-VAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+ LG G FG+V +G L D VA+K K+ + ++F +E + + H N++R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 544 LLGFCDEGDHR------LLVYEYMSNGSLASFLFGITRPDWNQR------VQIAFGIARG 591
L+G C + +++ +M +G L SFL D Q V+ IA G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL-AEQTQAARTGIRGTVGY 650
+ YL S IH D+ +N +L++ ++DFGL+K + + + R + V +
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA-KMPVKW 180
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
A E T K DV+SFGV + E+ + G N E
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 16/194 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHKNLVRLLG 546
LG G G+V K V + +A KK+ + + K+ E+ ++ + +V G
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 547 -FCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
F +E + + E+M GSL G + + IA + GL YL+ +I
Sbjct: 71 AFLNENN-ICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNV--HRI 125
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
+H DIKP NIL++ ++ DFG++ L+ A T + GT Y +PE + TV
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFV-GTSTYMSPERIQGGKYTV 181
Query: 664 KVDVYSFGVLLLEL 677
K DV+S G+ ++EL
Sbjct: 182 KSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSV-IGQTHHKNLV 542
+++G+G+FG V +D K F A+K L K ++++ +K E +V + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGK-FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITR----PDWNQRVQIAFGIARGLMYLHEE 598
L D V +Y++ G L F + R P+ R A IA L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLH-- 113
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR--GTVGYFAPEWF 656
S II+ D+KP+NILLD ++DFGL K E + ++T GT Y APE
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVL 168
Query: 657 RKASITVKVDVYSFGVLLLELI 678
RK VD + G +L E++
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 486 RQILGRGAFGTVYKGVLAS---DSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNL 541
+L G FG ++ G+L + V +K + D + E ++ H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 542 VRLLGFCDE-GDHRLLVYEYMSNGSLASFLFGITRPDWN--------QRVQIAFGIARGL 592
+ +L C E G+ ++Y YM+ G+L FL + N Q V +A IA G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
YLH +IH DI +N ++D+ +I+D L++ L V + A
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 653 PEWFRKASITVKVDVYSFGVLLLELI 678
E + DV+SFGVLL EL+
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 50/221 (22%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHK 539
+ +G GA+G V A D + VAIKK+ V ++ R E+ ++ H+
Sbjct: 4 LLKPIGSGAYGVV---CSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 540 NLVRLLGF-----CDEGDHRLLVYEYM---------SNGSLASFLFGITRPDWNQRVQ-I 584
N++ LL ++ + +V E M S L + +Q
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-----------DDHIQYF 108
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
+ I RGL YLH S +IH D+KP NIL++ +I DFGLA+ + ++ +
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK----- 160
Query: 645 RGTVGYFAPEWFRKASI-------TVKVDVYSFGVLLLELI 678
Y W+R + T +D++S G + EL+
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLL 545
+++G G +G VYKG + + AIK +D V E+E + E++++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKGRHVK-TGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 546 G-FCDEG-----DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLH 596
G F + D LV E+ GS+ L T+ + + IA+ I RGL +LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
+ ++IH DIK QN+LL + ++ DFG++ L ++T R GT + APE
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVI 183
Query: 657 R-----KASITVKVDVYSFGVLLLEL 677
A+ K D++S G+ +E+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 53/192 (27%), Positives = 96/192 (50%), Gaps = 11/192 (5%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G+ G V +A + S R VA+K +D +QQ + EV ++ H+N+V +
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHC 606
G+ ++ E++ G+L + TR + Q + + + L YLH S +IH
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHR 141
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVD 666
DIK +ILL ++SDFG + + + R + GT + APE + +VD
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 667 VYSFGVLLLELI 678
++S G++++E++
Sbjct: 200 IWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 489 LGRGAFGTVYKG-VLASDSKR-----FVAIKKLDKVEQQGEKEFRTEVS------VIGQT 536
LG G FG V + D ++ VA+K L EK+ +S +IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMMKMIGK- 82
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-----------------DWN 579
HKN++ LLG C + ++ EY S G+L +L RP +
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 580 QRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639
V A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
T R V + APE T + DV+SFGVLL E+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 71/205 (34%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL---- 544
+G+G FG VY+ V D++R A+K L K E +KE IG+ LVR
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEV---AHTIGE--RNILVRTLLDE 54
Query: 545 ------LGFCDEGDHRL-LVYEYMSNGSLASFLFGITR-PDWNQRVQIAFGIARGLMYLH 596
L F + D L LV +YMS G L L R + + IA + L +LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR-GTVGYFAPE- 654
+ I++ D+KP+NILLD + DFGL+K A T T GT Y APE
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 655 WFRKASITVKVDVYSFGVLLLELIC 679
+ T VD +S GVL+ E+ C
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 32/205 (15%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVR 543
+G G +G VYK A D + VA+KK+ ++E + E T E+S++ + +H N+VR
Sbjct: 7 IGEGTYGVVYK---ARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 544 LLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAF--GIARGLMYLHEECS 600
LL +++L LV+E++ + L ++ + + ++ + +G+ Y H S
Sbjct: 63 LLDVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---S 117
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG------TVGYFAPE 654
+++H D+KPQN+L+D +++DFGLA+ A +R T+ Y APE
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAPE 169
Query: 655 -WFRKASITVKVDVYSFGVLLLELI 678
+ VD++S G + E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVRLL 545
+GRG F VY+ D K VA+KK+ E K + E+ ++ Q +H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGIT--------RPDWNQRVQIAFGIARGLMYLHE 597
E + +V E G L+ + R W VQ+ + ++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMH- 123
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
S +++H DIKP N+ + ++ D GL + ++ T A + GT Y +PE
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLVGTPYYMSPERIH 179
Query: 658 KASITVKVDVYSFGVLLLELICCKS 682
+ K D++S G LL E+ +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 489 LGRGAFGTVYKGVL--ASDSKRF-------VAIKKLDKVEQQGEKEFRTEVSVIGQTHHK 539
LG+G F +YKGVL SD V +K L + F T S++ Q HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQ-RVQIAFGIARGLMYLHEE 598
+LV+L G C ++ ++V EY+ G L FL ++ +A +A L YL ++
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 599 CSTQIIHCDIKPQNILL-----DDYFTP--RISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
+++H ++ +NIL+ ++ + P ++SD G+ +L+ + + R + +
Sbjct: 121 ---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171
Query: 652 APEWFR--KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695
APE R +AS+T+ D +SFG LLE IC T + E
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKE 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF--VAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
++LG+G FG+V + L S+ F VA+K K D +EF E + + + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 543 RLLGFC--DEGDHRL----LVYEYMSNGSLASFLFG--ITRPDWNQRVQI----AFGIAR 590
+L+G RL ++ +M +G L +FL I + +Q IA
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
G+ YL S IH D+ +N +L++ T ++DFGL+K + + + V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
A E T DV++FGV + E++ + G N E
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 490 GRGAFGTVYKGV-LASDSKRFVAIKKL--DKVEQQG--EKEFRTEVSVIGQTHHKNLVRL 544
GRG +G VYK + AIKK DK + G + R E++++ + H+N+V L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVVSL 67
Query: 545 LG-FCDEGDHRL-LVYEYMSNGSLASF-LFGITRPDW---NQRVQIA--------FGIAR 590
+ F + D + L+++Y A L+ I + + +RV I + I
Sbjct: 68 VEVFLEHADKSVYLLFDY------AEHDLWQIIK--FHRQAKRVSIPPSMVKSLLWQILN 119
Query: 591 GLMYLHEECSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKLLLAE-QTQAARTGIR 645
G+ YLH S ++H D+KP NIL+ + +I D GLA+L A + A +
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 646 GTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELI 678
T+ Y APE A T +D+++ G + EL+
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL-GF 547
LG GAFG VYK ++ A K +D ++ +++ E+ ++ H N+V+LL F
Sbjct: 13 LGDGAFGKVYKA-QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG-IARGLMYLHEECSTQIIHC 606
E + +L+ E+ + G++ + + + RP ++++ L YLHE +IIH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127
Query: 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA--RTGIRGTVGYFAPEWF-----RKA 659
D+K NIL +++DFG++ A+ T+ R GT + APE +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 660 SITVKVDVYSFGVLLLEL 677
K DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF-VAIKKLDKVEQQGEKEFR-TEVSVIGQTHHKNLVRL 544
++LG+G+FG V L + + V + K D + Q + E TE ++ + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 545 LGFCDEGDHRLL-VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
L C + RL V E+++ G L + R D + A I LM+LH++ I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GI 117
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
I+ D+K N+LLD +++DFG+ K + + GT Y APE ++
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLYGP 175
Query: 664 KVDVYSFGVLLLELIC 679
VD ++ GVLL E++C
Sbjct: 176 SVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 8/148 (5%)
Query: 538 HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLH 596
H +++R+ G +V + + L ++L +RP +Q + I I GL YLH
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
+ +IIH D+K +NI ++D I D G A+ + A G+ GTV APE
Sbjct: 175 AQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVL 228
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSV 684
+ K D++S G++L E++ S++
Sbjct: 229 ARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 43/211 (20%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVR 543
+G G +G VYK A D + +A+KK+ ++EQ+ E T E+S++ + H N+VR
Sbjct: 10 IGEGTYGVVYK---ARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA----FGIARGLMYLHEEC 599
L LV+EY+ + L + + PD+ + ++ + I RG+ Y H
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 600 STQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE---- 654
S +++H D+KPQN+L+D +++DFGLA+ GI V F E
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF----------GI--PVRTFTHEVVTL 167
Query: 655 WFRKASI-------TVKVDVYSFGVLLLELI 678
W+R I + VD++S G + E++
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVS------VIGQTHHKNL 541
+LGRG FG V + + AIK L K + E + + H L
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELY-AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEEC 599
V L DH V EY + G L + I +++ V A + GL YLHE
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHEN- 120
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-QAARTGIR-GTVGYFAPEWFR 657
+I++ D+K N+LLD +I+DFGL K E RT GT + APE
Sbjct: 121 --KIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 658 KASITVKVDVYSFGVLLLELICCKS 682
+ S T VD + GVL+ E++ +S
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKL---DKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
+G G +GTV+K ++ VA+K++ D E R E+ ++ + HKN+VRL
Sbjct: 8 IGEGTYGTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLY 65
Query: 546 GFCDEGDHRL-LVYEYMSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQI 603
D +L LV+EY + L + D F + +GL + H +
Sbjct: 66 DVL-HSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAK 630
+H D+KPQN+L++ +++DFGLA+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLL 545
+ +G+G +G VYK D A+K LD + E E E +++ +H N+V+
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGS-LAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFY 85
Query: 546 GFCDEGDHRL-----LVYEYMSNGSLASFLFGITRPDWNQRVQ------IAFGIARGLMY 594
G + D + LV E + GS+ + G+ QR+ I +G GL +
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQH 143
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
LH + +IIH D+K NILL ++ DFG++ L + T+ R GT + APE
Sbjct: 144 LH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPE 198
Query: 655 WFR-----KASITVKVDVYSFGVLLLEL 677
S + DV+S G+ +EL
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/231 (26%), Positives = 92/231 (39%), Gaps = 46/231 (19%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRT 528
Y+ L + LG G FG VYK + R VA+KK+ EK+ R
Sbjct: 10 YEILGK--------LGEGTFGEVYKAR-QIKTGRVVALKKI---LMHNEKDGFPITALR- 56
Query: 529 EVSVIGQTHHKNLVRLLG-FCDEGD--HRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-- 583
E+ ++ + H N+V L+ + D R YM + L G+ N V+
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE---NPSVKLT 113
Query: 584 ------IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637
+ G+ YLHE I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 638 QAARTGIRGTVGYFA---PEWFRKASI-------TVKVDVYSFGVLLLELI 678
G GT Y W+R + T VD++ G + E+
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVRLL 545
+G G +G VYKG + + VA+KK+ ++E + E T E+S++ + H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKK-TGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA---FGIARGLMYLHEECSTQ 602
+ L++E++S L +L + + + + + I +G+++ H S +
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR 121
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG------TVGYFAPEWF 656
++H D+KPQN+L+D+ +++DFGLA+ A +R T+ Y APE
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR--------AFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 657 RKAS-ITVKVDVYSFGVLLLELI 678
+ + VD++S G + E+
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKE---FRTEVSVIGQTHHKNL 541
++LGRGAFG VY +D+ R +A+K++ D Q+ KE E+ ++ H +
Sbjct: 8 KLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 542 VRLLGFC--DEGDHRLLVY-EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
V+ G C D + +L ++ EYM GS+ L N + I +G+ YLH
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-- 123
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG---YFAPEW 655
S I+H DIK NIL D ++ DFG +K + + + TGI+ G + +PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGTPYWMSPEV 180
Query: 656 FRKASITVKVDVYSFGVLLLELICCK 681
K DV+S ++E++ K
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKR---------------FVAIKKL-DKVEQQGEKEFRT 528
F++ LG G FG V+ + + VA+K L + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 529 EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG---------------- 572
EV ++ + N++RLLG C + D ++ EYM NG L FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 573 ---ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
+ ++ + +A IA G+ YL S +H D+ +N L+ + T +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLE-LICCKS 682
+ L A + + + A E T DV++FGV L E L+ CK
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKE---FRTEVSVIGQTHHKNL 541
++LG+GAFG VY D+ R +A K++ D + KE E+ ++ H+ +
Sbjct: 8 KLLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 542 VRLLG-FCDEGDHRLLVY-EYMSNGSLASFL--FG-----ITRPDWNQRVQIAFGIARGL 592
V+ G D + L ++ EYM GS+ L +G +TR Q I G+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ-------ILEGM 119
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG--- 649
YLH S I+H DIK NIL D ++ DFG +K L + + TGIR G
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGIRSVTGTPY 174
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
+ +PE K DV+S G ++E++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 489 LGRGAFGTVYKG-VLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G FG V G SK V +K+L + F EV + +H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 547 FCDEGDHRLLVYEYMSNGSLASFL-------FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
C E LLV E+ G L ++L + + D QR +A +A GL++LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ-- 118
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW---- 655
IH D+ +N L + +I D+GLA E + + + APE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 656 ---FRKASITVKVDVYSFGVLLLEL 677
T K +++S GV + EL
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK--KLD-KVEQQGEKEFRTEVSVIGQTHHKNL 541
+++ILG G GTVYK ++R +A+K LD VE Q K+ +E+ ++ + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYI 61
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
+ G + + E+M GSL + I + IA + +GL YL S
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGR---IAVAVVKGLTYL---WSL 114
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+I+H D+KP N+L++ ++ DFG++ L+ A+T + GT Y APE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYV-GTNAYMAPERISGEQY 170
Query: 662 TVKVDVYSFGVLLLEL 677
+ DV+S G+ +EL
Sbjct: 171 GIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 64/232 (27%), Positives = 114/232 (49%), Gaps = 20/232 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHKNLVR 543
+++GRG++ V V ++R A+K + K +++ +TE V Q + +
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 544 LLGFCDEGDHRLL-VYEYMSNGSLASFLFGITR----PDWNQRVQIAFGIARGLMYLHEE 598
L C + + RL V EY++ G L +F + R P+ + R A I+ L YLHE
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLHER 115
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
II+ D+K N+LLD +++D+G+ K L + + GT Y APE R
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRG 170
Query: 659 ASITVKVDVYSFGVLLLELICCKS--SVVFGTTNPEEALMDWVYRCYIGKNL 708
VD ++ GVL+ E++ +S +V + NP++ D++++ + K +
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQTHH-KNLVRLLG 546
LGRGA+G V K + + +A+K++ V Q +K ++ + ++ V G
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 547 -FCDEGDHRLLVY---EYMSNGSLASF-----LFGITRPDWNQRVQIAFGIARGLMYLHE 597
EGD V+ E M SL F G+T P+ + +IA I + L YLH
Sbjct: 68 ALFREGD----VWICMEVMDT-SLDKFYKKVYDKGLTIPE-DILGKIAVSIVKALEYLHS 121
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF- 656
+ S +IH D+KP N+L++ ++ DFG++ L+ A+T G Y APE
Sbjct: 122 KLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERIN 176
Query: 657 ---RKASITVKVDVYSFGVLLLEL 677
+ VK DV+S G+ ++EL
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 489 LGRGAFGTVYK------GVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
LG GAFG VYK G LA A K ++ ++ +++ E+ ++ +H +V
Sbjct: 20 LGDGAFGKVYKAKNKETGALA-------AAKVIETKSEEELEDYMVEIEILATCNHPYIV 72
Query: 543 RLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECS 600
+LLG F +G +++ E+ G++ + + + R ++Q I + L YLH S
Sbjct: 73 KLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---S 128
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAP-----EW 655
+IIH D+K N+LL +++DFG++ + +T R GT + AP E
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV--KTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 656 FRKASITVKVDVYSFGVLLLEL 677
+ K D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK-------------VEQQ-----GEKEFRT 528
++LG+G+FG V L + F A+K L K VE++ E F T
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYF-AVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 529 EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGI 588
+ QT +H V E+++ G L + R D + A I
Sbjct: 60 HLYCTFQTK--------------EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI 105
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
GL +LH S II+ D+K N++LD +I+DFG+ K + +A + GT
Sbjct: 106 VCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTP 160
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE + T VD +SFGVLL E++ +S
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNL 541
+G G +G VYK D+ VA+KK V EKE R E+ ++ Q +H+N+
Sbjct: 14 QIGEGTYGQVYKAR-DKDTGELVALKK---VRLDNEKEGFPITAIR-EIKILRQLNHRNI 68
Query: 542 VRL----------LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARG 591
V L L F + LV+EYM + + G+ + + G
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
L Y H+ +H DIK NILL++ +++DFGLA+L +E+ T T+ Y
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE-SRPYTNKVITLWYR 184
Query: 652 APEWFR-KASITVKVDVYSFGVLLLEL 677
PE + +DV+S G +L EL
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 69/215 (32%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TE 529
F + EE G +I G G+FG VY S + VA+KK+ +Q ++++ E
Sbjct: 14 FYKDDPEEIFVGLHEI-GHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKE 71
Query: 530 VSVIGQTHHKNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIA--- 585
V + Q H N + G C +H LV EY GS + L +P Q V+IA
Sbjct: 72 VKFLQQLKHPNTIEYKG-CYLKEHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAIT 127
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
G +GL YLH +IH DIK NILL + +++DFG A +
Sbjct: 128 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFV 178
Query: 646 GTVGYFAPE---WFRKASITVKVDVYSFGVLLLEL 677
GT + APE + KVDV+S G+ +EL
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKE-FRTEVSVIGQT-HHKNLV 542
++LG+G+FG V+ L + +F AIK L K V + E E V+ H L
Sbjct: 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
L ++ V EY++ G L + + D + A I GL +LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKG 116
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKL-LLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
I++ D+K NILLD +I+DFG+ K +L + A GT Y APE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQKY 173
Query: 662 TVKVDVYSFGVLLLELICCKS 682
VD +SFGVLL E++ +S
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKL---DKVEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
+GRG F VY+ D VA+KK+ D ++ + + E+ ++ Q +H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGV-PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITR-----PD---WNQRVQIAFGIARGLMYLHE 597
E + +V E G L+ + + P+ W VQ+ L ++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH- 123
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
S +++H DIKP N+ + ++ D GL + + +T AA + + GT Y +PE
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHS-LVGTPYYMSPERIH 179
Query: 658 KASITVKVDVYSFGVLLLELICCKS 682
+ K D++S G LL E+ +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 12/192 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG--EKEFRTEVSVIGQTHHKNLVRLLG 546
LG G G V K + + +KL +E + + E+ V+ + + +V G
Sbjct: 13 LGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 547 -FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
F +G+ + + E+M GSL L R +++ + RGL YL E+ QI+H
Sbjct: 71 AFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMH 127
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
D+KP NIL++ ++ DFG++ L+ + GT Y +PE + +V+
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQS 183
Query: 666 DVYSFGVLLLEL 677
D++S G+ L+EL
Sbjct: 184 DIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE----FRTEVSVIGQTHHKNL 541
+ ++GRG FG V + V + A+K + K +E F E ++ ++ +
Sbjct: 6 KSLVGRGHFGEV-QVVREKATGDIYAMKVMKK-SVLLAQETVSFFEEERDILSISNSPWI 63
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
+L + D+ LV EY G L S L Q F +A ++ +H
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQ--FYLAELVLAIHSVHQM 121
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR---- 657
+H DIKP+N+L+D +++DFG A L A + ++ + GT Y APE
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNG 180
Query: 658 --KASITVKVDVYSFGVLLLELICCKSSVVFGTT 689
K + V+ D +S GV+ E+I +S GT+
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVI-GQTHHKNLV 542
+++G+G+FG V D K A+K L K + ++ +K E +V+ H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGK-CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITR----PDWNQRVQIAFGIARGLMYLHEE 598
L + V ++++ G L F + R P+ R A IA L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLH-- 113
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
S I++ D+KP+NILLD ++DFGL K +A+ T GT Y APE RK
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT--TTFCGTPEYLAPEVIRK 170
Query: 659 ASITVKVDVYSFGVLLLELI 678
VD + G +L E++
Sbjct: 171 QPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 489 LGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGE-KEFRTEVSVIGQTHHKNLVR 543
+G+G +G V+ LA D+ VA+K++ K + + E + TE ++ T + LV+
Sbjct: 9 VGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMY-----LH 596
LL + ++ L EY+ G + L G+ D F +A M+ LH
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMAE--MFEAVDALH 118
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
E IH D+KP+N L+D +++DFGL+K ++ G+ Y APE
Sbjct: 119 E---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVL 170
Query: 657 RKASITVKVDVYSFGVLLLELIC 679
R VD +S G +L E +C
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 39/235 (16%)
Query: 479 EEATRGFRQI---LGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKE-------- 525
+ + Q LG G +G V K A D + + VAIKK+ +E +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEK---AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 526 ----FRT--EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN 579
F T E+ ++ + H+N++ L+ EGD LV + M+ L + R +
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTES 119
Query: 580 QRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL------- 632
Q I I GL LH +H D+ P NI ++ +I+DFGLA+
Sbjct: 120 QVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 633 -LAEQTQAAR----TGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCK 681
L++ R T T+ Y APE A VD++S G + EL+ K
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 12/192 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHKNLVRLLG 546
LG G G V K VL S + +KL +E + + E+ V+ + + +V G
Sbjct: 9 LGAGNGGVVTK-VLHRPSG-LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 547 -FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
F +G+ + + E+M GSL L R N +I+ + RGL YL E+ +I+H
Sbjct: 67 AFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMH 123
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
D+KP NIL++ ++ DFG++ L+ A + + GT Y +PE + TV+
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFV-GTRSYMSPERLQGTHYTVQS 179
Query: 666 DVYSFGVLLLEL 677
D++S G+ L+E+
Sbjct: 180 DIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 60/227 (26%)
Query: 486 RQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEF--RT--EVSVIGQTHHK 539
+G GA+G V A+ + VAIKK+ E Q F RT E+ ++ + H+
Sbjct: 10 LSYIGEGAYGMV---CSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHE 63
Query: 540 NLVRLL------GFCD-----------EGD-HRLLVYEYMSNGSLASFLFGITRPDWNQR 581
N++ +L F E D ++L+ +++SN + FL+ I R
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR------ 117
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
GL Y+H S ++H D+KP N+LL+ +I DFGLA++ E
Sbjct: 118 ---------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT-- 163
Query: 642 TGIRGTVGYFAPEWFRKASI-------TVKVDVYSFGVLLLELICCK 681
Y A W+R I T +D++S G +L E++ +
Sbjct: 164 ---GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 46/227 (20%)
Query: 488 ILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGE---KEFRTEVSVIGQTHHKNLV 542
++G+G G VY LA D R VA+KK+ + + K F E + H +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV---------------QIAFG 587
+ C +GD Y+ +L S L + W + I
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR-- 645
I + Y+H S ++H D+KP NILL + I D+G A E+ +
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 646 --------------GTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
GT Y APE + D+Y+ GV+L +++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKE---FRTEVSVIGQTHHKNL 541
++LG+GAFG VY +D+ R +A+K++ D + KE E+ ++ H+ +
Sbjct: 8 KLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 542 VRLLGFCDEGDHRLL--VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC 599
V+ G + R L E+M GS+ L N + I G+ YLH
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH--- 123
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG---YFAPEWF 656
S I+H DIK NIL D ++ DFG +K L + + TG++ G + +PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 657 RKASITVKVDVYSFGVLLLELI 678
K D++S G ++E++
Sbjct: 182 SGEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 485 FRQILGRGAFGTVY----KGVLASDSKRF-----------VAIKKL-DKVEQQGEKEFRT 528
F++ LG G FG V+ +G+ K F VA+K L + + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 529 EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD----------- 577
E+ ++ + N++RLL C D ++ EYM NG L FL +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 578 WNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637
++ + +A IA G+ YL S +H D+ +N L+ +T +I+DFG+++ L +
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 638 QAARTGIRGTVGYFAPEWFRKASI-----TVKVDVYSFGVLLLE-LICCK 681
I+G W SI T DV++FGV L E L CK
Sbjct: 186 YR----IQGR-AVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 47/232 (20%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE----FRTEVSVIGQTHHKNLVR 543
++GRGAFG V + V D+ A+KKL K E EKE R E ++ + + +V+
Sbjct: 8 VIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVK 65
Query: 544 LL-GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
L F DE ++ L+ EY+ G + + L + D + F IA ++ +
Sbjct: 66 LYYSFQDE-NYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAK---------------------LLLAEQTQAAR 641
IH DIKP N+LLD ++SDFGL L +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 642 TG---------------IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
GT Y APE F + + D +S GV++ E++
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVI-GQTHHKNLVRLL 545
+ +G+G +G V+K VL + A+K LD + E E E +++ + H N+V+
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFY 81
Query: 546 GF-----CDEGDHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEEC 599
G GD LV E + GS+ + G + R + + IA+ + LM L
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR-- 657
+ IH D+K NILL ++ DFG++ L + T+ R GT + APE
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACE 199
Query: 658 ---KASITVKVDVYSFGVLLLEL 677
++ + DV+S G+ +EL
Sbjct: 200 QQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 484 GFRQILGRGAFGTVYKGVL-ASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNL 541
F +LG+G+FG V +D + I K D V Q + E E V+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 542 VRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
+ L C + RL V EY++ G L + + + Q V A I+ GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR-- 120
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
II+ D+K N++LD +I+DFG+ K + + RT GT Y APE
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRT-FCGTPDYIAPEIIAYQP 177
Query: 661 ITVKVDVYSFGVLLLELI 678
VD +++GVLL E++
Sbjct: 178 YGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVI-GQTHHKNLV 542
+++G+G+FG V ++ K F A+K L K ++++ EK +E +V+ H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEK-FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIARGLMYLHEECST 601
L D V +Y++ G L L R R + A IA L YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
I++ D+KP+NILLD ++DFGL K + + + GT Y APE K
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 662 TVKVDVYSFGVLLLELI 678
VD + G +L E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 486 RQILGRGAFGTVY--KGVLASDSKRFVAIKKLDKV----EQQGEKEFRTEVSVIGQTHHK 539
++LG+G +G V+ + V +D+ + A+K L K Q+ + E +++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHE 597
+V L+ G L+ EY+S G L L GI D F ++ + L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED-----TACFYLSEISLALEH 115
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
II+ D+KP+NILLD +++DFGL K + E T GT+ Y APE
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILM 173
Query: 658 KASITVKVDVYSFGVLLLELI 678
++ VD +S G L+ +++
Sbjct: 174 RSGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLV 542
+ LG G+FG V + + AIK L K E K+ + E S++ + H +V
Sbjct: 23 GETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 543 RLL-GFCDEGDHRLLVYEYMSNGSLASFLFGITR-PD-----WNQRVQIAFGIARGLMYL 595
++ F DE + + E++ G L + L R P+ ++ + +AF YL
Sbjct: 82 NMMCSFQDE-NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------YL 134
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H S II+ D+KP+N+LLD+ +++DFG AK + ++T + GT Y APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFT----LCGTPEYLAPEV 186
Query: 656 FRKASITVKVDVYSFGVLLLELI 678
+ VD ++ GVLL E I
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEK---EFRTEVSVIGQTHHKNL 541
I+GRG FG VY G +D+ + A+K LDK +QGE R +S++ +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
V + D + + M+ G L L + A I GL ++H
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+++ D+KP NILLD++ RISD GLA ++ A+ GT GY APE +K +
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTA 172
Query: 662 -TVKVDVYSFGVLLLELI 678
D +S G +L +L+
Sbjct: 173 YDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 489 LGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVR 543
+G G +G VYK A + VA+KK+ +++ + E T E+S++ + +H N+V+
Sbjct: 8 IGEGTYGVVYK---ARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA---FGIARGLMYLHEECS 600
LL + LV+E++ + L F+ + I F + +GL + H S
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH---S 118
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+++H D+KPQN+L++ +++DFGLA+ A +R W+R
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAPE 170
Query: 661 I-------TVKVDVYSFGVLLLELI 678
I + VD++S G + E++
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 36/225 (16%)
Query: 489 LGRGAFGTVYKGVL--ASDSKRF----VAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
LG+G F ++KG+ D V +K LDK + + F S++ Q HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFL---FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
G C GD ++V EY+ GSL ++L + W ++++A +A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 600 STQIIHCDIKPQNILL-----DDYFTP---RISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
+ H ++ +N+LL P ++SD G++ +L ++ R + +
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER------IPWV 171
Query: 652 APEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695
PE ++++ D +SFG L E I G P AL
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWE-IFS------GGDKPLSAL 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 52/263 (19%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
LG G+ G V+ V SD + VA+KK+ + Q K E+ +I + H N+V++
Sbjct: 13 LGCGSNGLVFSAV-DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 549 DEGDHRL--------------LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMY 594
L +V EYM LA+ L + + R+ + + RGL Y
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 595 LHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA- 652
+H S ++H D+KP N+ ++ + +I DFGLA+++ + GY +
Sbjct: 130 IH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK---------GYLSE 177
Query: 653 ---PEWFRKASI-------TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC 702
+W+R + T +D+++ G + E++ K +F + E M +
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP--LFAGAHELE-QMQLI--- 231
Query: 703 YIGKNLDKLAENDEEVKNDLKRV 725
L+ + EE +N+L V
Sbjct: 232 -----LESVPVVREEDRNELLNV 249
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 17/205 (8%)
Query: 487 QILGRGAFGTVYKGVLASD-SKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G G FG V G + S + V +K+L Q + +F E H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFG-----ITRPDWNQRVQIAFGIARGLMYLHEEC 599
LG C E LLV E+ G L +L + PD ++A IA GL++LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK- 658
IH D+ +N LL T +I D+GL+ E + + + APE +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 659 ------ASITVKVDVYSFGVLLLEL 677
T + +V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---GEKEFRTEV 530
T E+ + R +Q+ G GA+GTV + + VAIKKL + Q ++ +R E+
Sbjct: 9 TIWEVPDRYRDLKQV-GSGAYGTVCSALDRRTGAK-VAIKKLYRPFQSELFAKRAYR-EL 65
Query: 531 SVIGQTHHKNLVRLLGF------CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ- 583
++ H+N++ LL D LV +M G+ L + R+Q
Sbjct: 66 RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS-EDRIQF 122
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
+ + + +GL Y+H + IIH D+KP N+ +++ +I DFGLA+ QT + TG
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174
Query: 644 IRGTVGYFAPE----WFRKASITVKVDVYSFGVLLLELICCK 681
T Y APE W T VD++S G ++ E++ K
Sbjct: 175 YVVTRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQT-HHKNLV 542
+++G+G+FG V SD F A+K L K ++++ + E +V+ + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGS-FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEEC 599
L + V +Y++ G L F + R + F +A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLH--- 113
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
S II+ D+KP+NILLD ++DFGL K + + + GT Y APE RK
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST--FCGTPEYLAPEVLRKE 171
Query: 660 SITVKVDVYSFGVLLLELI 678
VD + G +L E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRLLG 546
LG G++ TVYKG+ + + + VA+K + ++G F E S++ H N+V L
Sbjct: 13 LGEGSYATVYKGI-SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRP----DWNQRVQIAFGIARGLMYLHEECSTQ 602
+ V+EYM LA ++ I P +N R+ F + RGL Y+H +
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYM--IQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---H 123
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKL-LLAEQTQAARTGIRGTVGYFAPEWFRKAS- 660
I+H D+KPQN+L+ +++DFGLA+ + QT ++ T+ Y P+ A+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV---VTLWYRPPDVLLGATD 180
Query: 661 ITVKVDVYSFGVLLLELICCKSSVVF-GTTN-PEEALMDW 698
+ +D++ G + +E++ + F G ++ E+ W
Sbjct: 181 YSSALDIWGAGCIFIEML--QGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 7e-11
Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 37/202 (18%)
Query: 492 GAFGTVYKGVL--ASDSKRFVAIKKLDKVEQQGEKEFRT-EVSVIGQTH-----HKNLVR 543
G FG V VL K FV +K+ K K F E V H + N ++
Sbjct: 27 GKFGKVS--VLKHKPTQKLFV--QKIIK-----AKNFNAIEPMV----HQLMKDNPNFIK 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
L +L+ +Y+ +G L L + + +I + L LH I
Sbjct: 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNI 130
Query: 604 IHCDIKPQNILLDDYFTPR----ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
IH DIK +N+L Y + + D+GL K++ GT+ YF+PE +
Sbjct: 131 IHNDIKLENVL---YDRAKDRIYLCDYGLCKIIGTPSCY------DGTLDYFSPEKIKGH 181
Query: 660 SITVKVDVYSFGVLLLELICCK 681
+ V D ++ GVL EL+ K
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 71/234 (30%), Positives = 104/234 (44%), Gaps = 49/234 (20%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---GEKEFRTEVSVIGQTHHKNLV 542
R I G GAFG V+ D KR VA+KK+ V Q ++ FR E+ ++ H N++
Sbjct: 6 RPI-GYGAFGVVWSVTDPRDGKR-VALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVL 62
Query: 543 RLL-----GFCDEGDHRLLVYEYM---------SNGSLAS-----FLFGITRPDWNQRVQ 583
L D + +V E M S L+S FL+ I
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL--------- 113
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR-T 642
RGL YLH S I+H DIKP N+L++ +I DFGLA+ + E ++ T
Sbjct: 114 ------RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPDESKHMT 162
Query: 643 GIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695
T Y APE + T VD++S G + EL+ + ++F +P + L
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR--ILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 44/211 (20%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLL 545
+G GA+G+V R VA+KKL + Q ++ +R E+ ++ H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-----------IAFGIARGLMY 594
E ++ L + L G D N V+ + + I RGL Y
Sbjct: 83 DVFTPARS----LEEFNDVYLVTHLMG---ADLNNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
+H S IIH D+KP N+ +++ +I DFGLA+ E T GY A
Sbjct: 136 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATR 181
Query: 655 WFRKASI-------TVKVDVYSFGVLLLELI 678
W+R I VD++S G ++ EL+
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 21/162 (12%)
Query: 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVS 531
+Y++LE+ LG G++ TVYKG + K VA+K + E++G F E S
Sbjct: 6 SYEKLEK--------LGEGSYATVYKGKSKVNGK-LVALKVIRLQEEEG-TPFTAIREAS 55
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF---GITRPDWNQRVQIAFGI 588
++ H N+V L + LV+EY+ L ++ G P+ N ++ F +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKL-FLFQL 112
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
RGL Y+H+ I+H D+KPQN+L+ D +++DFGLA+
Sbjct: 113 LRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHKNLVR 543
+++GRGAFG V V ++ + A+K L+K E E FR E V+ + +
Sbjct: 7 KVIGRGAFGEVAV-VKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITN 65
Query: 544 L-LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECS 600
L F DE ++ LV +Y G L + L F P+ R F +A ++ +
Sbjct: 66 LHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQ 120
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR--- 657
+H DIKP N+LLD R++DFG LLA+ T + + GT Y +PE +
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAME 179
Query: 658 --KASITVKVDVYSFGVLLLELICCKSSVVFGTT 689
K + D +S GV + E++ +G T
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEML-------YGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 486 RQILGRGAFGTVYKGVLASDSK-----RFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHH 538
+Q LG+G+FGTVY L D K R +K++ E + + E ++ + H
Sbjct: 5 QQRLGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----FGITRPDWNQRVQIAFGIARGLM 593
+V+ E D ++ EY L L G T + NQ + + G+
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCEWFIQLLLGVH 120
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAP 653
Y+H+ +I+H D+K +NI L + +I DFG+++LL+ A T GT Y +P
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTFTGTPYYMSP 174
Query: 654 EWFRKASITVKVDVYSFGVLLLELIC 679
E + K D++S G +L E+ C
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 44/214 (20%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL--- 544
I+G G+FG VY+ + S++ VAIKK+ + Q +E + ++ +H N++ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEK-VAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDY 127
Query: 545 ------------------LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF 586
+ F + H+ + + +N +L FL + ++
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL----------YSY 177
Query: 587 GIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+ R L Y+H S I H D+KPQN+L+D + T ++ DFG AK LLA Q + R
Sbjct: 178 QLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 646 GTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELI 678
Y APE A+ T +D++S G ++ E+I
Sbjct: 235 ---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHKNLVRLLG 546
LG G + TV+KG + ++ VA+K++ ++G R EVS++ H N+V L
Sbjct: 13 LGEGTYATVFKG-RSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIARGLMYLHEECSTQIIH 605
LV+EY+ + L +L V+I F + RGL Y H+ +I+H
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILH 126
Query: 606 CDIKPQNILLDDYFTPRISDFGLAK 630
D+KPQN+L+++ +++DFGLA+
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHH-KNLVRLLG 546
+G G G VYK +A+K++ + + E K ++ V+ ++H +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGH-VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 547 -FCDEGDHRLLVYEYMS----------NGSLASFLFGITRPDWNQRVQIAFGIARGLMYL 595
F + D + + E MS G + + G ++ I + L YL
Sbjct: 82 YFITDSDVFICM-ELMSTCLDKLLKRIQGPIPEDILG----------KMTVAIVKALHYL 130
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
E+ +IH D+KP NILLD ++ DFG++ L+ + A+T G Y APE
Sbjct: 131 KEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPER 185
Query: 656 F----RKASITVKVDVYSFGVLLLEL 677
++ DV+S G+ L+EL
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASD--SKRFVAIK--KLDKVEQQGEKE-FRTEVSVIGQTHHK 539
F +LG+G+FG V +LA + AIK K D + Q + E E V+
Sbjct: 4 FLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 540 NLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
+ L C + RL V EY++ G L + + + V A IA GL +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
S II+ D+K N++LD +I+DFG+ K + RT GT Y APE
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRT-FCGTPDYIAPEIIAY 175
Query: 659 ASITVKVDVYSFGVLLLELI 678
VD ++FGVLL E++
Sbjct: 176 QPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT----EVSVIGQTHHKNLVRL 544
+G G++G V+K ++ + VAIKK VE + + + E+ ++ Q H NLV L
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQII 604
+ LV+EY + L + +I + + + + H I
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCI 122
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV- 663
H D+KP+NIL+ ++ DFG A++L G T Y A W+R + V
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARIL-------TGPGDDYT-DYVATRWYRAPELLVG 174
Query: 664 ------KVDVYSFGVLLLELIC 679
VDV++ G + EL+
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 66/201 (32%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 489 LGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVR 543
+G G+FG VY A D + VAIKK+ +Q ++++ EV + + H N +
Sbjct: 33 IGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 544 LLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIA---FGIARGLMYLHEEC 599
G C +H LV EY GS + L +P Q V+IA G +GL YLH
Sbjct: 90 YKG-CYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLH--- 142
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE---WF 656
S +IH DIK NILL + +++DFG A + + GT + APE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEVILAM 196
Query: 657 RKASITVKVDVYSFGVLLLEL 677
+ KVDV+S G+ +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHKNLVR 543
+++GRGAFG V + V S++ A+K L K E + F E ++ + +V+
Sbjct: 49 KVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD-WNQRVQIAFGIARGLMYLHEECSTQ 602
L + + +V EYM G L + + P+ W + F A ++ L S
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVLALDAIHSMG 162
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR-GTVGYFAPEWFRKAS- 660
+IH D+KP N+LLD + +++DFG + ++T R GT Y +PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 661 ---ITVKVDVYSFGVLLLELI 678
+ D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 51/165 (30%), Positives = 84/165 (50%), Gaps = 27/165 (16%)
Query: 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDKVEQQGEKEFRT-- 528
TYK+L++ LG G++ TVYKG SK + VA+K++ ++E + F
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGR----SKLTGQLVALKEI-RLEHEEGAPFTAIR 52
Query: 529 EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF---GITRPDWNQRVQIA 585
E S++ H N+V L LV+EY+ L ++ G N R+
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL-FL 109
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
F + RGL Y H+ +++H D+KPQN+L+ + +++DFGLA+
Sbjct: 110 FQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVR 543
+G G+FG VY A D + VAIKK+ +Q ++++ EV + + H N ++
Sbjct: 23 IGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 544 LLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIA---FGIARGLMYLHEEC 599
G C +H LV EY GS + L +P Q V+IA G +GL YLH
Sbjct: 80 YRG-CYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH--- 132
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE---WF 656
S +IH D+K NILL + ++ DFG A ++ A GT + APE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAM 186
Query: 657 RKASITVKVDVYSFGVLLLEL 677
+ KVDV+S G+ +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 71/276 (25%), Positives = 107/276 (38%), Gaps = 72/276 (26%)
Query: 487 QILGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSV-IGQTHHKN 540
++LG GAFG V + G+ S VA+K L + E K +E+ + I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 541 LVRLLGFCDEGDHRLLV------YEYMSN------------------------------- 563
+V LLG C + + L+V Y +SN
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 564 ------GSLASFLFGITRPDWNQRVQ--------------------IAFGIARGLMYLHE 597
AS LF +P + +F +ARG+ +L
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL-- 190
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
S + IH D+ +NILL + +I DFGLA+ + + + R + + APE
Sbjct: 191 -ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693
T + DV+SFGVLL E+ +S G EE
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/200 (31%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 485 FRQILGRGAFGTVY----KGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHK 539
F +LG+G+FG V KG +D + I K D V Q + E E V+ +
Sbjct: 4 FLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 540 NLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
+ L C + RL V EY++ G L + + R V A IA GL +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
S II+ D+K N++LD +I+DFG+ K + + GT Y APE
Sbjct: 119 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDYIAPEIIAY 175
Query: 659 ASITVKVDVYSFGVLLLELI 678
VD ++FGVLL E++
Sbjct: 176 QPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVR 543
++LG+G FG V V S ++ A+K L K + + TE V+ T H L
Sbjct: 1 KLLGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECS 600
L D V EY++ G L F ++R + F I L YLH S
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLH---S 113
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+I++ D+K +N++LD +I+DFGL K + + A GT Y APE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDND 171
Query: 661 ITVKVDVYSFGVLLLELIC 679
VD + GV++ E++C
Sbjct: 172 YGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKEFRT--E 529
T E+ E + + G GA+G+V A D++ + VA+KKL + Q RT E
Sbjct: 9 TVWEVPERYQNLTPV-GSGAYGSVCS---AYDTRLRQKVAVKKLSRPFQSLIHARRTYRE 64
Query: 530 VSVIGQTHHKNLVRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPD--WNQRVQ-IA 585
+ ++ H+N++ LL F Y+ + + L I + ++ VQ +
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+ + RGL Y+H S IIH D+KP N+ +++ RI DFGLA+ E T
Sbjct: 125 YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-------- 173
Query: 646 GTVGYFAPEWFRKASITVK-------VDVYSFGVLLLELICCKSSVVF 686
GY A W+R I + VD++S G ++ EL+ K +F
Sbjct: 174 ---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL--KGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEK---EFRTEVSVIGQTHHKNL 541
I+GRG FG VY G +D+ + A+K LDK +QGE R +S++ +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
V + D + + M+ G L L + A I GL ++H
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF-- 117
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-S 660
+++ D+KP NILLD++ RISD GLA ++ A+ GT GY APE +K +
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVA 172
Query: 661 ITVKVDVYSFGVLLLELI 678
D +S G +L +L+
Sbjct: 173 YDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
Q +G G +G VYK + + AIK + + + E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVN-TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR----GLMYLHEECSTQ 602
D + E+ GSL ++ +T P QIA+ ++R GL YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAY-VSRETLQGLYYLHSKGK-- 127
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF---RKA 659
+H DIK NILL D +++DFG++ + A T A R GT + APE RK
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 660 SITVKVDVYSFGVLLLEL 677
D+++ G+ +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 485 FRQI--LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHK 539
F I +GRGAFG V + V SK+ A+K L K E + F E ++ + +
Sbjct: 45 FDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 540 NLVRL-LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHE 597
+V+L F D+ + +V EYM G L + + P W + F A ++ L
Sbjct: 104 WIVQLHYAFQDD-KYLYMVMEYMPGGDLVNLMSNYDIPEKWAR-----FYTAEVVLALDA 157
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
S IH D+KP N+LLD +++DFG + A T + GT Y +PE +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLK 216
Query: 658 KASITV----KVDVYSFGVLLLELI 678
+ D +S GV L E++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 18/228 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHKNLVR 543
+++GRG++ V V + + A+K + K +++ +TE V Q +
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 544 LLGFCDEGDHRL-LVYEYMSNGSLASFLFGITR----PDWNQRVQIAFGIARGLMYLHEE 598
L C + RL LV EY++ G L +F + R P+ + R A I L +LHE
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAA-EICIALNFLHER 115
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
II+ D+K N+LLD +++D+G+ K L + GT Y APE R
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGTPNYIAPEILRG 170
Query: 659 ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706
VD ++ GVL+ E++ +S T NP+ D++++ + K
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF-RTEVSVIGQTHHKNLVRLL 545
Q +G G +G VYK + +A K+ K+E + + E+ ++ + H N+V
Sbjct: 15 QRVGSGTYGDVYKARNLHTGE--LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQ 602
G + + EY GSL ++ +T P +QIA+ +GL YLH S
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAYLH---SKG 126
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF---RKA 659
+H DIK NILL D +++DFG+A + A T A R GT + APE +
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 660 SITVKVDVYSFGVLLLEL 677
D+++ G+ +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 67/240 (27%), Positives = 115/240 (47%), Gaps = 40/240 (16%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQ-THHKNLV 542
+++GRG++ V L ++R A+K + K +++ +TE V ++H LV
Sbjct: 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 543 RLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITR----PDWNQRVQIAFGIARGLMYLHE 597
L C + + RL V E++S G L +F + R P+ + R A I+ L +LHE
Sbjct: 60 GLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNFLHE 114
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR---------GTV 648
II+ D+K N+LLD +++D+G+ K GIR GT
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-----------EGIRPGDTTSTFCGTP 160
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKS--SVVFGTTNPEEALMDWVYRCYIGK 706
Y APE R VD ++ GVL+ E++ +S +V + NP++ D++++ + K
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/199 (30%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVR 543
++LG+G FG V V + R+ A+K L K + E TE V+ T H L
Sbjct: 1 KLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECS 600
L D V EY + G L F ++R + F I L YLH S
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH---S 113
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+++ DIK +N++LD +I+DFGL K +++ A GT Y APE
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDND 171
Query: 661 ITVKVDVYSFGVLLLELIC 679
VD + GV++ E++C
Sbjct: 172 YGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 37/211 (17%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---GEKEFRTEVSVIGQTHHKNLVRLL 545
+G GA+G+V + + VAIKKL + Q ++ +R E++++ H+N++ LL
Sbjct: 23 VGSGAYGSVCSAI-DKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 546 GF------CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEE 598
DE LV YM + G + +VQ + + + GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSE--DKVQYLVYQMLCGLKYIH-- 134
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
S IIH D+KP N+ +++ +I DFGLA+ AE T GY W+R
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----------GYVVTRWYRA 182
Query: 659 ASI-------TVKVDVYSFGVLLLELICCKS 682
+ VD++S G ++ E++ K+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVS 531
TY +LE+ LG G + TV+KG + ++ VA+K++ ++G R EVS
Sbjct: 7 TYIKLEK--------LGEGTYATVFKG-RSKLTENLVALKEIRLEHEEGAPCTAIR-EVS 56
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIAR 590
++ H N+V L LV+EY+ + L ++ V+I + I R
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
GL Y H +++H D+KPQN+L+++ +++DFGLA+ + + T+ Y
Sbjct: 116 GLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWY 170
Query: 651 FAPEWFRKAS-ITVKVDVYSFGVLLLEL 677
P+ +S + ++D++ G + E+
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 7/192 (3%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRLL 545
++G GA+G V K ++K VAIKK E+ E + T E+ ++ +N+V L
Sbjct: 8 VVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
LV+EY+ L + + + + + + H+ I+H
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVH 123
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
DIKP+N+L+ ++ DFG A+ L+E + A T T Y +PE A V
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 666 DVYSFGVLLLEL 677
D++S G +L EL
Sbjct: 183 DMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVR 543
++LG+G FG V V + ++ A+K L K + + TE V+ T H L
Sbjct: 1 KLLGKGTFGKVIL-VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECS 600
L D V EY + G L F ++R + F I L YLH S
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLH---S 113
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR-GTVGYFAPEWFRKA 659
+++ D+K +N++LD +I+DFGL K + A GT Y APE
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 660 SITVKVDVYSFGVLLLELIC 679
VD + GV++ E++C
Sbjct: 171 DYGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 45/213 (21%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRLLG 546
+GRGA+G V S++ VAIKK+ RT E+ ++ H+N++ +
Sbjct: 13 IGRGAYGIVCSAK-NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 547 FCDEGDHR------LLVYEYM---------SNGSLAS-----FLFGITRPDWNQRVQIAF 586
HR +VYE M S+ +L+ FL+ + R
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR----------- 119
Query: 587 GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
GL Y+H S ++H D+KP N+LL+ +I DFGLA+ + T
Sbjct: 120 ----GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV 170
Query: 647 TVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELI 678
T Y APE S T +DV+S G + EL+
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 9/145 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHKNLVRLLG 546
LG G + TVYKG + + VA+K++ ++G R EVS++ H N+V L
Sbjct: 14 LGEGTYATVYKG-RSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIARGLMYLHEECSTQIIH 605
LV+EY+ + L +L V++ F + RGL Y H +++H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLH 127
Query: 606 CDIKPQNILLDDYFTPRISDFGLAK 630
D+KPQN+L+++ +++DFGLA+
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 12/192 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG--EKEFRTEVSVIGQTHHKNLVRLLG 546
LG G G V+K ++ + +KL +E + + E+ V+ + + +V G
Sbjct: 13 LGAGNGGVVFK--VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 547 -FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
F +G+ + + E+M GSL L R +++ + +GL YL E+ +I+H
Sbjct: 71 AFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 127
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
D+KP NIL++ ++ DFG++ L+ + GT Y +PE + +V+
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQS 183
Query: 666 DVYSFGVLLLEL 677
D++S G+ L+E+
Sbjct: 184 DIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 28/226 (12%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK----VEQQGEKEFRTEVSVIGQTHHKNLV 542
+++ GA+G VY V ++++ A+KK++K + Q ++ F E ++ + +V
Sbjct: 7 KLISNGAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVV 64
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECST 601
+ + H +V EY+ G A+ L I P R+ A + L YLH +
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH---NY 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-------------IRGTV 648
I+H D+KP N+L+ +++DFGL+K+ L T G + GT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLE-LICCKSSVVFGTTNPEE 693
Y APE + VD ++ G++L E L+ C FG T PEE
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP--FFGDT-PEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 487 QILGRGAFGTVYKGVL-ASDSKRFVAIKKLDKVEQQGEKEFR-TEVSVIG-QTHHKNLVR 543
++LG+G+FG V L +D + + K D + Q + + TE ++ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEECS 600
L D V EY++ G L +F I R D + A + LM+LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+I+ D+K NILLD +++DFG+ K + T GT Y APE ++
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQELE 172
Query: 661 ITVKVDVYSFGVLLLELI 678
VD ++ GVL+ E++
Sbjct: 173 YGPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVRLL 545
+G+G+FG V + V D++R A+K + K E E +V+ Q + +V L
Sbjct: 1 IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL- 58
Query: 546 GFCDEGDHRL-LVYEYMSNGSLASFL-----FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
F + +L LV +++ G L L F ++R F A L L
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA--------RFYTAELLCALENLH 110
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
+I+ D+KP+NILLD + DFGL KL + + + GT Y APE
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLAPELLLGH 168
Query: 660 SITVKVDVYSFGVLLLELI 678
T VD ++ GVLL E++
Sbjct: 169 GYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-09
Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 11/90 (12%)
Query: 321 SCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYNG 380
+C +G + +L D K L D I ++ + C + C +C C A YN
Sbjct: 4 NCGGDGSTDGFLKLPDVK--------LPDNASAI-TAISLEECREACLSNCSCTAYAYNN 54
Query: 381 D--YCWKKKYPLSNGRRSTSVNRIALVKVP 408
C L+N R +S +++
Sbjct: 55 GSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHKNLVR 543
+++GRGAFG V V ++R A+K L+K E E FR E +V+ + +
Sbjct: 7 KVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITT 65
Query: 544 L-LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECS 600
L F DE ++ LV +Y G L + L F P+ R F IA ++ +H
Sbjct: 66 LHYAFQDE-NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQ 120
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+H DIKP N+LLD R++DFG + + T + + GT Y +PE +
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAME 179
Query: 661 ITV-----KVDVYSFGVLLLELI 678
+ + D +S GV + E++
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---FRTEVSVIGQTHHKNLVR 543
+++GRGAFG V L + K F A+K L+K E E FR E V+ ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVF-AMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECST 601
L + ++ LV +Y G L + L F P+ R F +A ++ +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQL 121
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR---- 657
+H DIKP NIL+D R++DFG L+ + T + + GT Y +PE +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 658 -KASITVKVDVYSFGVLLLELI 678
K + D +S GV + E++
Sbjct: 181 GKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVR 543
++LG+G FG V V + R+ A+K L K V + TE V+ + H L
Sbjct: 1 KLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECS 600
L D V EY + G L F ++R + F I L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+++ D+K +N++LD +I+DFGL K + + A GT Y APE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDND 172
Query: 661 ITVKVDVYSFGVLLLELIC 679
VD + GV++ E++C
Sbjct: 173 YGRAVDWWGLGVVMYEMMC 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 66/221 (29%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 489 LGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVR 543
+G GA G V A D+ + VAIKKL + Q ++ +R E+ ++ +HKN++
Sbjct: 24 IGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 544 LLG-FC-----DEGDHRLLVYEYMSNGSLASFLFGITRPDWN--QRVQIAFGIAR----- 590
LL F +E LV E M D N Q +Q+ R
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELM---------------DANLCQVIQMDLDHERMSYLL 124
Query: 591 -----GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
G+ +LH S IIH D+KP NI++ T +I DFGLA+ T T
Sbjct: 125 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYV 178
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686
T Y APE VD++S G ++ E+I +V+F
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR--GTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 34/90 (37%), Positives = 48/90 (53%)
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
L+ +H S +IH DIK NILL ++ DFG +K+ A + GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 652 APEWFRKASITVKVDVYSFGVLLLELICCK 681
APE +R+ + K D++S GVLL EL+ K
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 3/93 (3%)
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
+F +ARG+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
R + + APE T + DV+SFGVLL E+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 491 RGAFGTVYKGVLASDSKRFV--AIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
RGAFG VY G ++SK + +KK D + + + + E + + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI 608
++ LV EY+ G + S L D V+ +A L YLH IIH D+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDL 130
Query: 609 KPQNILLDDYFTPRISDFGLAKLLL 633
KP N+L+ + +++DFGL+K+ L
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 45/251 (17%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIK---KLDKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+++GRGAFG V + V D+ A+K K D +E++ R E ++ + +V+
Sbjct: 7 KVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+ + + L+ E++ G + + L + D F IA ++ +
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAK-LLLAEQTQAART-------------------- 642
IH DIKP N+LLD ++SDFGL L A +T+ R
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 643 ------------GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN 690
GT Y APE F + D +S GV++ E++ F +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP--FCSET 240
Query: 691 PEEA---LMDW 698
P+E +M+W
Sbjct: 241 PQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 63/251 (25%), Positives = 105/251 (41%), Gaps = 45/251 (17%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIK---KLDKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+++GRGAFG V + V D+ A+K K D +E++ R E ++ + +V+
Sbjct: 7 KVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+ + + L+ E++ G + + L + D + F IA ++ +
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAK-LLLAEQTQ----------------------AA 640
IH DIKP N+LLD ++SDFGL L A +T+ A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 641 RTGIR----------GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN 690
T R GT Y APE F + D +S GV++ E++ F +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP--FCSET 240
Query: 691 PEEA---LMDW 698
P+E +M+W
Sbjct: 241 PQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 3/109 (2%)
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
+F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693
R + + APE T++ DV+SFGVLL E+ +S G EE
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
F + LG G+FG V ++ VAIK+ +K ++Q+ +E ++ +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
V L G + + LV E++ G +FL R + A I YL S
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SL 150
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART-GIRGTVGYFAPEWFRKAS 660
I++ D+KP+N+LLD +++DFG AK++ RT + GT Y APE
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEYIAPEILLNVG 204
Query: 661 ITVKVDVYSFGVLLLELI 678
D ++ G+ + E++
Sbjct: 205 HGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 42/193 (21%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKN 540
+G+G FG V+K +K+ VA+KK V + EKE R E+ ++ H+N
Sbjct: 18 AKIGQGTFGEVFK-ARHKKTKQIVALKK---VLMENEKEGFPITALR-EIKILQLLKHEN 72
Query: 541 LVRLLGFC---------DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG-IAR 590
+V L+ C +G LV+E+ + LA L N+ V+ I +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSF-YLVFEFCEH-DLAGLLS-------NKNVKFTLSEIKK 123
Query: 591 -------GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK-LLLAEQTQAAR- 641
GL Y+H +I+H D+K NIL+ +++DFGLA+ L++ ++ R
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 642 TGIRGTVGYFAPE 654
T T+ Y PE
Sbjct: 181 TNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 21/190 (11%)
Query: 510 VAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGF------CDEGDHRLLVYEY 560
VA+KKL + Q ++ +R E+ ++ +HKN++ LL +E LV E
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620
M + +L + D + + + + G+ +LH S IIH D+KP NI++ T
Sbjct: 108 M-DANLCQVIH--MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 161
Query: 621 PRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICC 680
+I DFGLA+ T T T Y APE VD++S G ++ EL+
Sbjct: 162 LKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV-- 216
Query: 681 KSSVVFGTTN 690
K SV+F T+
Sbjct: 217 KGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 489 LGRGAFGTV--YKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH---HKNLVR 543
LG+GA+G V + S+ + VAIKK+ V + R + H HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 544 L--LGFCDEGDHR-LLVYEYMSNGSLASFLFGITRPDWNQRVQIA------FGIARGLMY 594
L + G+ L +YE + L I R Q + A + I GL Y
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQ----IIRSG--QPLTDAHFQSFIYQILCGLKY 120
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA--EQTQAARTGIRGTVGYFA 652
+H S ++H D+KP N+L++ +I DFGLA+ + T T Y A
Sbjct: 121 IH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 653 PE-WFRKASITVKVDVYSFGVLLLELI 678
PE S T +DV+S G +L EL+
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 489 LGRGAFGTVYKGVL----------ASDSKRF-VAIKKLDKVEQQGEKEFRTEVSVIGQTH 537
LGRG +Y G+L S K V +K LD + F S++ Q
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 538 HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMY 594
HK++V L G C ++V E++ G L F+ + W + ++A +A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 595 LHEECSTQIIHCDIKPQNILL-----DDYFTP--RISDFGLAKLLLAEQTQAARTGIRGT 647
L ++ ++H ++ +NILL D P ++SD G+ +L+ Q R
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------ 171
Query: 648 VGYFAPEWFR-KASITVKVDVYSFGVLLLELIC 679
+ + APE ++++ D +SFG L E IC
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWE-IC 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 42/225 (18%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKK-LDKVEQQG--EKEFRTE 529
Y++LE +G G +G VYK A D + + VA+KK +++++G R E
Sbjct: 3 YEKLE--------KIGEGTYGKVYK---ARDKNTGKLVALKKTRLEMDEEGIPPTALR-E 50
Query: 530 VSVIGQTHHKN-LVRLLGF----CDEGDHRL-LVYEYMSNGSLASFLF----GITRPDWN 579
+S++ +VRLL G L LV+EY+ + L F+ G RP
Sbjct: 51 ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPA 109
Query: 580 QRVQ-IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP-RISDFGLAKLL---LA 634
+ ++ + + +G+ + H ++H D+KPQN+L+D +I+D GL + +
Sbjct: 110 KTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166
Query: 635 EQTQAARTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELI 678
T T+ Y APE ++ + VD++S G + E+
Sbjct: 167 SYTHEIV-----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 22/220 (10%)
Query: 475 YKELEEATRGFR---------QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGE 523
YK+ R R +++GRGAFG V + V +++ A+K L K E ++ +
Sbjct: 28 YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSD 86
Query: 524 KEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRV 582
F E I + V L + + D L +V EYM G L + + P+ R
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR- 145
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642
F A ++ L S IH D+KP N+LLD +++DFG + E T
Sbjct: 146 ---FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 643 GIRGTVGYFAPEWFRKAS----ITVKVDVYSFGVLLLELI 678
+ GT Y +PE + + D +S GV L E++
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
++ + +A+G+ +L S IH D+ +N+LL D +I DFGLA+ ++ + +
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
R V + APE TV+ DV+S+G+LL E+
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 489 LGRGAFGTV---YKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLV 542
+G GA G V Y +L +R VAIKKL + Q ++ +R E+ ++ +HKN++
Sbjct: 32 IGSGAQGIVCAAYDAIL----ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 543 RLLGF------CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
LL +E +V E M + +L + D + + + + G+ +LH
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
S IIH D+KP NI++ T +I DFGLA+ T T T Y APE
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 657 RKASITVKVDVYSFGVLLLELICCK 681
VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 485 FRQILGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQT-HH 538
F + LG GAFG V + G+ SD+ VA+K L E+E +E+ V+ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL 570
N+V LLG C G L++ EY G L +FL
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 25/224 (11%)
Query: 464 SPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE 523
P + N R Y ++GR + SD K V K + +++
Sbjct: 58 VPESNNPREHMYV--------LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQA 109
Query: 524 KEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ 583
R+E+ + H +V+ D LL+ EY S G L + QR++
Sbjct: 110 AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--------KQRLK 161
Query: 584 IAFGIAR---GLMY------LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634
GL++ L E S +++H D+K NI L ++ DFG +K
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ + GT Y APE + + + K D++S GV+L EL+
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 26/202 (12%)
Query: 489 LGRGAFGTV---YKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLV 542
+G GA G V Y VL R VAIKKL + Q ++ +R E+ ++ +HKN++
Sbjct: 25 IGSGAQGIVCAAYDAVL----DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 79
Query: 543 RLLGF------CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
LL +E LV E M + +L + D + + + + G+ +LH
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 136
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
S IIH D+KP NI++ T +I DFGLA+ T T T Y APE
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 657 RKASITVKVDVYSFGVLLLELI 678
VD++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 49/211 (23%)
Query: 492 GAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGE----KEFRTEVSVIGQTHHKNLVRL- 544
G +G VY+ A D K VA+KKL K+E++ E R E++++ + H N+V +
Sbjct: 16 GTYGVVYR---ARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQHPNIVTVK 70
Query: 545 ---LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIA----------RG 591
+G D +V EY+ + L S + + +P F + G
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQP---------FLQSEVKCLMLQLLSG 118
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL---LAEQTQAARTGIRGTV 648
+ +LH+ I+H D+K N+LL++ +I DFGLA+ L TQ + T+
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ-----LVVTL 170
Query: 649 GYFAPEWFRKASI-TVKVDVYSFGVLLLELI 678
Y APE A + +D++S G + EL+
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 485 FRQILGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQT-HH 538
F + LG GAFG V + G+ D+ VA+K L E+E +E+ ++ H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL 570
KN+V LLG C G L++ EY G L +FL
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 7/158 (4%)
Query: 528 TEVSVIGQTHHKNLVRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF 586
TE ++ +H ++++L G F L++ Y ++ L +L + I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILAIER 189
Query: 587 GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
+ R + YLHE +IIH DIK +NI ++ + DFG A + G G
Sbjct: 190 SVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSV 684
T+ APE + VD++S G++L E+ C S+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 29/203 (14%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEK--EFRTEVSVIGQ-THHKNLVRLL 545
+G G F V K K + AIK + K + E+ R E+ + + + H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGK-YYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64
Query: 546 GFC-DEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECSTQ 602
D RL LV+E M + +L + G RP +RV+ + + + L ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK---- 658
I H DIKP+NIL+ D +++DFG + + ++ Y + W+R
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---------YISTRWYRAPECL 170
Query: 659 ---ASITVKVDVYSFGVLLLELI 678
K+D+++ G + E++
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
++ +A+G+ +L S IH D+ +NILL +I DFGLA+ + + +
Sbjct: 220 SYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSS 683
R V + APE T + DV+S+G+LL E+ SS
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS 315
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 510 VAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASF 569
V +K LD + F S++ Q H +L + G C G ++V E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 570 LF---GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNIL-----LDDYFTP 621
L G W ++ +A +A L YL ++ ++H ++ +NIL L + +P
Sbjct: 107 LRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSP 161
Query: 622 --RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELI 678
++SD G++ L+ + + R + + APE S++ D +SFG LLE I
Sbjct: 162 FIKLSDPGVSFTALSREERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLLE-I 214
Query: 679 CCKSSVVFGTTNPEE 693
C V P E
Sbjct: 215 CFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 15/201 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+++G G+FG + +++ + ++ R E ++ + H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 547 FCDEGDHRLLVYEYMSNGSLASFL---FGITRPD---WNQRVQIAFGIARGLMYLHEECS 600
+ H +V EY G L + G P+ VQ+ G+ ++HE+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----HIHEK-- 119
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+++H DIK +NI L ++ DFG A+ LL A T + GT Y PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 661 ITVKVDVYSFGVLLLELICCK 681
K D++S G +L EL K
Sbjct: 177 YNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 54/237 (22%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLL 545
+G GAFG V V D+ A+K L K + + + E ++ + ++ +V+L
Sbjct: 9 IGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+ D+ V +Y+ G + S L GI D R IA + + +H+
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIA-ELTCAIESVHK---MGF 122
Query: 604 IHCDIKPQNILLDDYFTPRISDFGL----------------------------------- 628
IH DIKP NIL+D +++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 629 AKLLLAEQTQAARTGIR-------GTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+L E+ + R R GT Y APE + T D +S GV+L E++
Sbjct: 183 CRLKPLER-RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 35/113 (30%), Positives = 50/113 (44%), Gaps = 4/113 (3%)
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
Q + I + L YLH IIH D+K +NI LD+ + DFG A L A
Sbjct: 185 EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP 691
G GT+ +PE K D++S G++L E+ K+ +FG
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS-VKNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 14/124 (11%)
Query: 581 RVQIAFGIARGLM----YLHEECSTQIIHCDIKPQNILLDDYFTPR---ISDFGLAKLLL 633
Q+ +AR L+ Y+H E IIH DIK +N+L++ P + DFG A
Sbjct: 259 LAQVT-AVARQLLSAIDYIHGE---GIIHRDIKTENVLVN---GPEDICLGDFGAACFAR 311
Query: 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693
+ GI GTV APE T VD++S G+++ E +S+ + E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371
Query: 694 ALMD 697
D
Sbjct: 372 RPYD 375
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 67/262 (25%), Positives = 98/262 (37%), Gaps = 62/262 (23%)
Query: 487 QILGRGAFGTVYKGVLA--SDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNL 541
+ LG GAFG V LA D+K A+K L K + + + E ++ + ++ +
Sbjct: 7 KTLGIGAFGEV---CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWV 63
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
VRL + D+ V +Y+ G + S L GI D + F IA +
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLAR-----FYIAELTCAVESVH 118
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGL------------------------------- 628
IH DIKP NIL+D +++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 629 -------AKLLLAEQTQAARTGIR-------GTVGYFAPEWFRKASITVKVDVYSFGVLL 674
L + +AAR R GT Y APE + T D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 675 LELICCKSSVVFGTTNPEEALM 696
E++ + F P E M
Sbjct: 239 YEMLVGQPP--FLAQTPLETQM 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ-TQAARTGI 644
+ + R L Y+H + + H D+KP+NIL + +I DFGLA++ + T T
Sbjct: 110 YQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 645 RGTVGYFAPE----WFRKASITVKVDVYSFGVLLLELICCK 681
T Y APE +F K T +D++S G + E++ K
Sbjct: 167 VATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 489 LGRGAFGTVYKGVL--ASDSKRFVAIKKLDKVEQQG-EKEFRTEVSVIGQTHHKNLVRLL 545
+GRG +G VYK D + + L ++E G E++++ + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYA----LKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 546 G-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMY-----LHEE 598
F D ++ L+++Y + F + VQ+ G+ + L+Y +H
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 599 CSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKLLLAE-QTQAARTGIRGTVGYFAP 653
+ ++H D+KP NIL+ + +I+D G A+L + + A + T Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 654 EWFRKAS-ITVKVDVYSFGVLLLELI 678
E A T +D+++ G + EL+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
+ + +ARG+ +L S +H D+ +N+LL +I DFGLA+ ++ +
Sbjct: 237 LDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293
Query: 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
++ V + APE T DV+S+G+LL E+
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 56/248 (22%), Positives = 94/248 (37%), Gaps = 66/248 (26%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHKNLVR 543
+++G+GAFG V + V D+ + A+K L K E + + + E V+ ++ +V
Sbjct: 7 KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLF-------GITRPDWNQRVQIAFGIARGLMYLH 596
L + + L+ E++ G L + L +TR F +A ++ +
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR----------FYMAECVLAIE 115
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLA-------------KLLLAEQTQAARTG 643
IH DIKP NIL+D ++SDFGL+ KLL + +
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 644 IRG-----------------------------TVG---YFAPEWFRKASITVKVDVYSFG 671
TVG Y APE F + + D +S G
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235
Query: 672 VLLLELIC 679
++ E +
Sbjct: 236 AIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 53/259 (20%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIG 534
E EA RG + +G +R +A K K + + E+ +G
Sbjct: 172 STEEAEARRGVN---------STNQGK--PKCERLIA--KRVKAGSRAAIQLENEILALG 218
Query: 535 QTHHKNLVRLLGFCDEGDHRLLV--------YEYMSNGSLASFLFGITRPDWNQR--VQI 584
+ +H+N++++ + ++ Y +M + + DW R ++
Sbjct: 219 RLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----------DWKDRPLLKQ 268
Query: 585 AFGIARGLM----YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
I + L+ Y+H ++IH DIK +NI L+ + DFG A E+ + A
Sbjct: 269 TRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF--EKEREA 323
Query: 641 RT-GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK-SSVVFGTTNPEEALMDW 698
G GTV +PE D++S G++LL+++ + G P + L+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL-- 381
Query: 699 VYRCYIGKNLDKLAENDEE 717
K +D L+ DEE
Sbjct: 382 -------KIIDSLSVCDEE 393
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
V ++ +A G+ +L S +H D+ +N+L+ + +I DFGLA+ ++ + ++
Sbjct: 242 VGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK 298
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR 701
+ + APE T DV+SFG+LL E+ + GT PE + + Y
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF-----TLGGTPYPELPMNEQFYN 353
Query: 702 CYI-GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
G + K A +E+ +++ C +E +RP
Sbjct: 354 AIKRGYRMAKPAHASDEIYEIMQK----------CWEEKFEIRP 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 485 FRQILGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSV-IGQTHH 538
+ LGRGAFG V + G+ S S R VA+K L + E K TE+ + I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 539 KNLVRLLGFCDEGDHRLLV-YEYMSNGSLASFL 570
N+V LLG C + L+V EY G+L+++L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 5e-05
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G FG V+ V ++ F K + ++++ + + EV+V+ + HKN+VR +
Sbjct: 21 IGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 547 -FCDEGDHRL-LVYEYMSNGSLASF------LFGITRPDWNQRVQIAFGIARGLMYLHE- 597
F ++ + +L ++ E+ G L+ +FG + + + V I + L Y H
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG--KIEEHAIVDITRQLLHALAYCHNL 137
Query: 598 ---ECSTQIIHCDIKPQNILLDDYF-----------------TPRISDFGLAKLLLAEQT 637
+++H D+KPQNI L +I DFGL+K + E
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197
Query: 638 QAARTGIRGTVGYFAPEWF--RKASITVKVDVYSFGVLLLELICCKSSVVFGTTN 690
A + + GT Y++PE S K D+++ G ++ EL C F N
Sbjct: 198 --AHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL--CSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 487 QILGRGAFGTVYKGVLASDS----------KRFVAIKKLDKVEQQGEKEFRTEVSVIGQT 536
Q +G G FG V + +D+ K + K+ ++ QQG+ +
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ------- 53
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------VQIAFGIA 589
H N+++ LG C E LLV+EY G L S+L ++ W++R ++A IA
Sbjct: 54 -HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIA 109
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
G+ ++H+ +H D+ +N L T ++ D+G+ E +
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 650 YFAPEW---FRKASITVK----VDVYSFGVLLLELICC 680
+ APE F IT + +V++ GV L EL
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFEN 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 46/169 (27%), Positives = 64/169 (37%), Gaps = 33/169 (19%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGF- 547
LG GAFG VYK L + + L K + G E V + + GF
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFL 199
Query: 548 ----CDEGDHRLLVYEYMSNGSLA-------------SFLF--------GITRPDWNQRV 582
+ D LV+ Y +LA +L G+ R N+ +
Sbjct: 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERE--NKII 257
Query: 583 QIAFG-IARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLA 629
Q I L LH ST I+H D+KPQNI+ + + +I D G A
Sbjct: 258 QTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 489 LGRGAFGTVYKGVL--ASDSKRFVAIKKLDKVEQQG-EKEFRTEVSVIGQTHHKNLVRLL 545
+GRG +G VYK D K + L ++E G E++++ + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYA----LKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 546 G-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMY-----LHEE 598
F D ++ L+++Y + F + +Q+ + + L+Y +H
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 599 CSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKLLLAE-QTQAARTGIRGTVGYFAP 653
+ ++H D+KP NIL+ + +I+D G A+L + + A + T Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 654 EWFRKAS-ITVKVDVYSFGVLLLELI 678
E A T +D+++ G + EL+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 58/243 (23%)
Query: 487 QILGRGAFGTVYKGVLAS--DSKRFVAIKKL---DKVEQQGEKEFRTEVSVIGQTHHKNL 541
+ LG GAFG V LA D+ A+K L D + + + E ++ + ++ +
Sbjct: 7 KTLGIGAFGEV---CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWV 63
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
V+L + D+ V +Y+ G + S L R + V F IA + +
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLA-------------------------------- 629
IH DIKP NIL+D +++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 630 -------KLLLAEQTQAARTGIR-------GTVGYFAPEWFRKASITVKVDVYSFGVLLL 675
+L EQ +A + R GT Y APE + T D +S GV+L
Sbjct: 181 SNCRCGDRLKTLEQ-RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 676 ELI 678
E++
Sbjct: 240 EML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 489 LGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTH-HKNLV 542
LG GAFG V + G+ S S VA+K L + EK+ +E+ ++ H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFL 570
LLG C +G ++ EY G L +L
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 489 LGRGAFGTVYK----GVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSV-IGQTHHKNLV 542
LGRGAFG V + G+ + + R VA+K L + E + +E+ + I HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 543 RLLGFCDE-GDHRLLVYEYMSNGSLASFL 570
LLG C + G +++ E+ G+L+++L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKR----FVAIKKLDKVEQQGEKE-FRTEVSVIGQTH---H 538
+ILG GAFG V +G S+ VA+K L + EK+ +E+ ++ TH H
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIM--THLGPH 100
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL 570
N+V LLG C + ++ EY G L ++L
Sbjct: 101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 50/185 (27%), Positives = 73/185 (39%), Gaps = 28/185 (15%)
Query: 510 VAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASF 569
V I L+ ++ K + EV + H N++ G ++ +M+ GS S
Sbjct: 30 VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89
Query: 570 LFGITRPDWNQRV--QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627
L ++ + I FG RGL YLH+ IH +IK +IL IS G
Sbjct: 90 LKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHIL--------ISGDG 138
Query: 628 LAKLL-LAEQTQAARTGIRGTVGY------------FAPEWFRK--ASITVKVDVYSFGV 672
L L L+ R G + V Y +PE R+ VK D+YS G+
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 673 LLLEL 677
EL
Sbjct: 199 TACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 40/219 (18%)
Query: 487 QILGRGAFGTVYKGVLASD---SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+++G G FG VY+ ASD + + VA K+E + E V + + +
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVA-----KIENLENETIVMETLVYNNIYDIDKIA 72
Query: 544 LLGFCDEGDH-------------------RLLVYE--YMSNGSLASFLFGITRPDWNQRV 582
L DH R ++ E + + + +
Sbjct: 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN-- 130
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL-----AEQT 637
I + L Y+HE I H DIKP+NI++D I D+G+A + E +
Sbjct: 131 -IMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLE 676
+ + RGT+ Y + A +T + D+ S G +L+
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.68 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.87 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.82 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.3 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.01 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.62 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.35 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.92 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.78 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.41 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=412.53 Aligned_cols=272 Identities=46% Similarity=0.781 Sum_probs=240.9
Q ss_pred CcCccCHHHHHHHHhcch--hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEE
Q 040134 469 NVRSFTYKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546 (745)
Q Consensus 469 ~~~~~~~~~l~~~~~~~~--~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 546 (745)
..+.|++.+|.+||.+|. .+||+|+||.||+|.+.++ +.||||++........++|.+|++++.+++||||++++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~--~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG--TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC--CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 577899999999999998 5899999999999999764 679999887644331566999999999999999999999
Q ss_pred EEecCC-eEEEEEEecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEE
Q 040134 547 FCDEGD-HRLLVYEYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI 623 (745)
Q Consensus 547 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 623 (745)
||.+.+ +.+||||||++|+|.++|+... .++|..+++|+.++|+||+|||+.+...||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999999 5999999999999999998775 8899999999999999999999987778999999999999999999999
Q ss_pred eeccCcccccc-cccccccccc-cccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 040134 624 SDFGLAKLLLA-EQTQAARTGI-RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR 701 (745)
Q Consensus 624 ~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~ 701 (745)
+|||+|+.... ... .... .||.+|+|||++..+..+.|+||||||++|+||+||+.+.+......+..+.+|++.
T Consensus 219 sDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred cCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999976543 221 1112 799999999999999999999999999999999999999887665555668999999
Q ss_pred HhhcCccccccccccc-ccccH-HHHHHHHHHHHhccccCcCCCCC
Q 040134 702 CYIGKNLDKLAENDEE-VKNDL-KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 702 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+..+.+.+++|+.+. ..... +++.++.+++.+|++.+|++||+
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~ 341 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPT 341 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcC
Confidence 9999999999999976 44443 78999999999999999999996
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.97 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=208.1
Q ss_pred ccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEec
Q 040134 472 SFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE 550 (745)
Q Consensus 472 ~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 550 (745)
..+..+|+. ...||+|..|+||+++++. +++.+|+|.+.. .++...+++.+|++++++.+||+||+++|.|..
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKP-TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcC-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 345555553 4679999999999999876 568899999943 345566899999999999999999999999999
Q ss_pred CC-eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 551 GD-HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 551 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
.. ...++||||++|+|++++...+++++....+|+.++++||.|||+. .+||||||||+|||++..|.+||+|||.+
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccccc
Confidence 88 5999999999999999999889999999999999999999999963 59999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
+.+... .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....... ....+. ...+..+...
T Consensus 227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~L-l~~Iv~~ppP 300 (364)
T KOG0581|consen 227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFEL-LCAIVDEPPP 300 (364)
T ss_pred HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHH-HHHHhcCCCC
Confidence 887544 2456789999999999999999999999999999999999999997652211 111111 1222222222
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+... ....++..++..||++||.+|||
T Consensus 301 ~lP~~--------~fS~ef~~FV~~CL~Kdp~~R~s 328 (364)
T KOG0581|consen 301 RLPEG--------EFSPEFRSFVSCCLRKDPSERPS 328 (364)
T ss_pred CCCcc--------cCCHHHHHHHHHHhcCCcccCCC
Confidence 22111 34567999999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=351.25 Aligned_cols=198 Identities=30% Similarity=0.462 Sum_probs=179.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+|++||+|+++... ..||||.+.+. .....+.+..|+.+|+.++|||||++++++..++.++|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~-~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSG-TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCC-ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 445667999999999999998865 78999999764 555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC------CceEEeeccCcccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY------FTPRISDFGLAKLLLA 634 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~------~~~kl~Dfg~a~~~~~ 634 (745)
|.+|+|.+||+..+.+++..+..++.||+.||++||+. +||||||||+||||... -.+||+|||+|+.+..
T Consensus 91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999999999999999999999999999999999965 99999999999999754 5689999999999864
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
... ....+|++-|||||+++...|+.|+|+||+|+|||++++|+.||...
T Consensus 168 ~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 168 GSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 433 45678999999999999999999999999999999999999999643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=360.16 Aligned_cols=239 Identities=35% Similarity=0.529 Sum_probs=196.2
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC--HHHHHHHHHHHhccCCCCceeEEEEEecCC-eEEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG--EKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-HRLLVYEYM 561 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~ 561 (745)
+.+.||+|+||+||+|.+... ..||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+||||+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 456699999999999999753 239999997533222 569999999999999999999999999988 799999999
Q ss_pred CCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEECCCC-ceEEeeccCccccccccc
Q 040134 562 SNGSLASFLFG--ITRPDWNQRVQIAFGIARGLMYLHEECSTQ-IIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 562 ~~gsL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 637 (745)
++|+|.++++. ...+++..+++++.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999988 57899999999999999999999965 6 99999999999999997 99999999998765432
Q ss_pred ccccccccccccccchhccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFR--KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
...+...||+.|||||++. ...++.|+||||||++||||+||+.||..... ...+......+....+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p--- 268 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIP--- 268 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCC---
Confidence 2234468999999999999 66999999999999999999999999964332 12222222222222211
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+..++.+||+.||+.||+
T Consensus 269 ------~~~~~~l~~l~~~CW~~dp~~RP~ 292 (362)
T KOG0192|consen 269 ------KECPPHLSSLMERCWLVDPSRRPS 292 (362)
T ss_pred ------ccCCHHHHHHHHHhCCCCCCcCCC
Confidence 114566889999999999999997
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.34 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=202.9
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-------ccCHHHHHHHHHHHhccCCCCceeEEEEEecC
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG 551 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 551 (745)
....|-+.+.||+|+||.|-+|..+. +++.||||++.+.. ......+.+|+++|++|+|||||++++++...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 44556678999999999999998766 56779999996421 11234567999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CceEEeeccC
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGL 628 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~ 628 (745)
+..||||||++||.|.+.+-.++.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999999999999999999999999999999965 99999999999999765 7899999999
Q ss_pred cccccccccccccccccccccccchhccccCCC---CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI---TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 629 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
|+..+... .....+||+.|.|||++..+.. ..+.|+||+||+||-+++|.+||.....++ .+.+ .+..
T Consensus 326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~ 396 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILK 396 (475)
T ss_pred hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhc
Confidence 99876333 2567899999999999987653 347899999999999999999997554432 1222 2223
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
|..... ...+.+..++..++|.+||+.||++|||
T Consensus 397 G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s 430 (475)
T KOG0615|consen 397 GRYAFG------PLQWDRISEEALDLINWMLVVDPENRPS 430 (475)
T ss_pred Cccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcC
Confidence 322221 1124455678899999999999999997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.34 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=203.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+|...+.||+|+|+.+|+++... .++.||+|++.+ ......+.+.+|+++.+.|+|||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 456677899999999999999744 456799999965 3445567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
.|.|+.++|.++++..+.+++.+++.+++||+.||.|||+. +|+|||||..|++++++.++||+|||+|..+..+..
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999999889999999999999999999999954 999999999999999999999999999998865433
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. ....+||+.|.|||++.....+..+||||+|||||.||+|++||....- .-.++.+...+....
T Consensus 174 r--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------kety~~Ik~~~Y~~P------ 238 (592)
T KOG0575|consen 174 R--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------KETYNKIKLNEYSMP------ 238 (592)
T ss_pred c--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------HHHHHHHHhcCcccc------
Confidence 2 4567999999999999999999999999999999999999999963211 112232222211111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+||..+|++||.+|||
T Consensus 239 ----~~ls~~A~dLI~~lL~~~P~~Rps 262 (592)
T KOG0575|consen 239 ----SHLSAEAKDLIRKLLRPNPSERPS 262 (592)
T ss_pred ----cccCHHHHHHHHHHhcCCcccCCC
Confidence 122345678999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=329.78 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=204.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcc--cccccCHHHHHHHHHHHhccCCCCceeEEE-EEecCCe-EE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRLLG-FCDEGDH-RL 555 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~ 555 (745)
.+.+.+.++||+|.||.||++.... +++.||.|.+. ..+....+++..|+.+|++|+|||||++++ -+.+.+. ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~-~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL-DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc-CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3456678899999999999998766 45779999885 345556678999999999999999999998 4555555 89
Q ss_pred EEEEecCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 556 LVYEYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGLMYLHEECS-TQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
||||++..|+|...++ ..+.++++.+++++.|++.||..+|.... .-|+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999985 34678999999999999999999996321 239999999999999999999999999999
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
.+...... ....+|||.||+||.+.+.+|+.|+||||+||++|||+.-++||... .+. ...+.+..++...
T Consensus 177 ~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 177 FLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPP 247 (375)
T ss_pred HhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCC
Confidence 88665443 45678999999999999999999999999999999999999999643 121 1234444454443
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+. +......+.+||..|+..||+.||+
T Consensus 248 ~p--------~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 248 LP--------DEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred Cc--------HHHhhhHHHHHHHHHccCCcccCCC
Confidence 32 2445678999999999999999995
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=356.13 Aligned_cols=247 Identities=30% Similarity=0.446 Sum_probs=202.2
Q ss_pred HHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 477 ~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
++......+.+.||+|-||.||.|.++...+ ||+|.++.. ....+.|.+|++++++|+|+|||+++++|..+..++|
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~--vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTK--VAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCc--ccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 4445555678899999999999999986544 999999764 3445789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 557 VYEYMSNGSLASFLFG--ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
|||||+.|+|.++|.. ...++..+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||+|+.+.+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999986 4678899999999999999999995 5999999999999999999999999999996655
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
+.... .....-+..|.|||.+....++.|||||||||+||||+|-....+.+... .+.+ +.+..
T Consensus 356 ~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----~ev~-~~le~--------- 419 (468)
T KOG0197|consen 356 DEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----EEVL-ELLER--------- 419 (468)
T ss_pred Cceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----HHHH-HHHhc---------
Confidence 55433 44445678999999999999999999999999999999854443322221 1212 22222
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+...+..++..+.+||..||+.+|++|||
T Consensus 420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred cCcCCCCCCCCHHHHHHHHHHhhCCcccCCC
Confidence 2222234446678999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=330.26 Aligned_cols=241 Identities=26% Similarity=0.347 Sum_probs=199.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
..++.++||+|+||+||.++-. ++++.+|+|++++. .....+...+|..+|.+++||.||+++-.|++..++|+|+
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred heeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 3456789999999999999977 57789999999753 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+.||.|..+|.++..+++..+.-++..|+.||.|||+. |||||||||+|||||++|+++|+|||+++.......
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~- 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD- 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence 9999999999999999999999999999999999999955 999999999999999999999999999986433322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+||+.|||||++.+..++.++|.||||+++|||++|.+||...... . +.+.+..+.+...
T Consensus 181 -~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~-~~~~I~~~k~~~~------- 245 (357)
T KOG0598|consen 181 -ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------K-MYDKILKGKLPLP------- 245 (357)
T ss_pred -ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------H-HHHHHhcCcCCCC-------
Confidence 244579999999999999999999999999999999999999999744321 1 2222222221110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
+.-...+..+++...|+.||++|-
T Consensus 246 --p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 --PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CccCCHHHHHHHHHHhccCHHHhc
Confidence 001123467788899999999983
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.94 Aligned_cols=250 Identities=30% Similarity=0.514 Sum_probs=205.6
Q ss_pred HHHHHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecC
Q 040134 477 ELEEATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEG 551 (745)
Q Consensus 477 ~l~~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 551 (745)
++......+.+.||+|+||+||+|+... .....||||.+++.... ..++|++|++++..|+|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 3444445577899999999999998743 34678999999875554 778999999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCC----------C----CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 552 DHRLLVYEYMSNGSLASFLFGI----------T----RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~----------~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
+..+||+|||..|+|.+||... . +++..+.+.|+.|||.||+||.+ +.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 9999999999999999999632 1 26788999999999999999995 49999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALM 696 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~ 696 (745)
+..|||+|||+++.+.............-+.+|||||.+..+++|.+||||||||+|||+++ |+.|++ +..+ +
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-glSn-~---- 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-GLSN-Q---- 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc-ccch-H----
Confidence 99999999999998876665544444456789999999999999999999999999999997 445543 3322 1
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+.+..+.+ .+....++.++..||..||+.+|++|||
T Consensus 713 -EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 713 -EVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred -HHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCC
Confidence 12344444443 1233455678999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.63 Aligned_cols=243 Identities=28% Similarity=0.337 Sum_probs=201.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.|.+.||+|+|++|++++... +++.+|||++.+ ..+...+.+..|-+.|.+| .||.|++|+-.|+++..+|+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~-t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKA-TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hcchhheeccccceeEEEeeecC-CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34578999999999999999876 567899999965 2344556788899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
+||+++|+|.++|++.+.+++...+.++.+|+.||+||| +.|||||||||+|||||+++++||+|||.|+.+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999 55999999999999999999999999999998865432
Q ss_pred c---------cc--cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 638 Q---------AA--RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 638 ~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
. .. ...++||..|.+||++.+...++.+|||+||||||+|+.|.+||.... +...+ +.+..
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliF-----qkI~~- 301 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIF-----QKIQA- 301 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHH-----HHHHH-
Confidence 2 11 245889999999999999999999999999999999999999996432 11111 11111
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
-+... .....+.+.+|+.+.|..||.+|+|
T Consensus 302 -------l~y~f--p~~fp~~a~dLv~KLLv~dp~~Rlt 331 (604)
T KOG0592|consen 302 -------LDYEF--PEGFPEDARDLIKKLLVRDPSDRLT 331 (604)
T ss_pred -------hcccC--CCCCCHHHHHHHHHHHccCcccccc
Confidence 11111 1112245778899999999999987
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=316.67 Aligned_cols=256 Identities=23% Similarity=0.251 Sum_probs=201.1
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+-..++|+|+||.||+++.+. +++.||||++.... +...+.-.+|+++|++++|+|+|.++.+|......+||+||+
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~-TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKD-TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred hhhhccccCcceEEEEeccCC-cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 334579999999999999766 67899999986432 333466789999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+..-|.++-+....++.+.+.+++.|++.|+.|+|. .++|||||||+||||+.++.+||+|||+|+.+... ....
T Consensus 84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~Y 158 (396)
T KOG0593|consen 84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNY 158 (396)
T ss_pred chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchh
Confidence 886676665555778899999999999999999995 49999999999999999999999999999988642 2225
Q ss_pred ccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH--------H-hhcCccccc
Q 040134 642 TGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR--------C-YIGKNLDKL 711 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~--------~-~~~~~~~~~ 711 (745)
+..+.|..|.|||++.+ ..|....||||+||++.||++|.+.|+..++-+...+...... . .....+..+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 66788999999999977 7899999999999999999999999875554333322221111 1 111222223
Q ss_pred cccccccccc-----HHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKND-----LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.-+......+ +....-+++++..||+.||++|+|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s 277 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS 277 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc
Confidence 2233322222 223456889999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.12 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=205.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..|++.++||.|..++||+|+....+ +.||||++.-.. ....+.+++|+..+..++||||++++..|..+..+++||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~-e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTN-EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccC-CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 45778899999999999999987754 789999986422 2336899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||.+|++.++++.. ..+++..+..|++++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999754 5588999999999999999999965 999999999999999999999999999877655432
Q ss_pred cc-cc-ccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 638 QA-AR-TGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 638 ~~-~~-~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.. .. ....|++.|||||++.. ..|+.|+||||||++..||.+|..||....+ ... ....+ ++....+.-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkv----Ll~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKV----LLLTL-QNDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHH----HHHHh-cCCCCCccc
Confidence 21 11 55789999999999654 4799999999999999999999999853322 111 11222 233332222
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+......+.+++..||+.||++|||
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt 286 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPT 286 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCC
Confidence 22333334455568899999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=351.13 Aligned_cols=258 Identities=30% Similarity=0.465 Sum_probs=213.3
Q ss_pred CCcCccCHHHHHHHHhcc-----------hhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHH
Q 040134 468 TNVRSFTYKELEEATRGF-----------RQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVI 533 (745)
Q Consensus 468 ~~~~~~~~~~l~~~~~~~-----------~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l 533 (745)
..+..++|++-.++..+| .++||.|.||.|++|+++... ...||||.++.. .+....+|+.|+.|+
T Consensus 605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM 684 (996)
T KOG0196|consen 605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM 684 (996)
T ss_pred eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence 345678888766666655 458999999999999997543 568999999864 345567899999999
Q ss_pred hccCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 040134 534 GQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQN 612 (745)
Q Consensus 534 ~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~N 612 (745)
.+++||||++|.|+.......+||.|||++|+|+.||+.+ +.+.+.++.-++++|+.||+||.+ +++|||||.++|
T Consensus 685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARN 761 (996)
T KOG0196|consen 685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARN 761 (996)
T ss_pred ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhh
Confidence 9999999999999999999999999999999999999866 678999999999999999999994 599999999999
Q ss_pred EEECCCCceEEeeccCccccccccccccccc--ccccccccchhccccCCCCccchhHHHHHHHHHHH-hCCCCCCCCCC
Q 040134 613 ILLDDYFTPRISDFGLAKLLLAEQTQAARTG--IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI-CCKSSVVFGTT 689 (745)
Q Consensus 613 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ell-tg~~p~~~~~~ 689 (745)
||++.+..+|++|||+++.+.++.... .+. -.-+.+|.|||.+...+++.++||||||++|||++ .|.+|+-..+.
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred eeeccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 999999999999999999876655222 222 23357899999999999999999999999999976 47788643322
Q ss_pred CchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 690 NPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ++...++...+.+..++++..|.+||++|||+|-.+||+
T Consensus 841 Q----------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~ 880 (996)
T KOG0196|consen 841 Q----------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPK 880 (996)
T ss_pred H----------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCC
Confidence 1 111222334455556778888999999999999999995
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.20 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=199.9
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc----cc-cCHHHHHHHHHHHhccC-CCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV----EQ-QGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||+|+.|..... ++.||+|.+... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t-~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLT-GEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccC-CCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34566788999999999999988764 477999977542 12 34567778999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CceEEeeccCcccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKLL 632 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~a~~~ 632 (745)
.++||||+.+|.|.+++...+++.+.++.+++.|++.|++|||. .||+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999998999999999999999999999995 499999999999999999 99999999999987
Q ss_pred cccccccccccccccccccchhccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKAS-IT-VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
. .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||..... .. +.+.+..+.+.-
T Consensus 172 ~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~-----l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 172 P--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PN-----LYRKIRKGEFKI 242 (370)
T ss_pred C--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HH-----HHHHHhcCCccC
Confidence 4 1222356678999999999999987 86 789999999999999999999975211 11 112222222221
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.... ...+..++.+||+.||.+|+|
T Consensus 243 --------p~~~~-S~~~~~Li~~mL~~~P~~R~t 268 (370)
T KOG0583|consen 243 --------PSYLL-SPEARSLIEKMLVPDPSTRIT 268 (370)
T ss_pred --------CCCcC-CHHHHHHHHHHcCCCcccCCC
Confidence 11111 456889999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=300.94 Aligned_cols=233 Identities=27% Similarity=0.329 Sum_probs=196.6
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.||.|+||.|..++.+.. +..+|+|++++..- ...+...+|..+|+.+.||.++++.+.+.+.+.++|||||+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~-g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHS-GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred heeeeccCccceEEEEEEccC-CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 567899999999999998874 78899999976332 23455778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++|.|..++++.+++++..++.++.||+.||+||| +.+|++|||||+|||||.+|.+||+|||.|+..... .
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T 198 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----T 198 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----E
Confidence 99999999999999999999999999999999999 559999999999999999999999999999986433 4
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
...+||+.|+|||++..+++..++|.|||||++|||+.|.+||..... ..+++.+.++.+.-..
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~fP~--------- 262 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVKFPS--------- 262 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCcccCCc---------
Confidence 567899999999999999999999999999999999999999975433 2244555444433211
Q ss_pred HHHHHHHHHHHHhccccCcCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLR 743 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~R 743 (745)
-....+.+|+...||.|-.+|
T Consensus 263 -~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 -YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -ccCHHHHHHHHHHHhhhhHhh
Confidence 112345667777777777666
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=320.84 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=193.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC--eEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD--HRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~ 560 (745)
....+.||+|+||.||++..... ++..|||.+...+....+.+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~-g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKT-GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhccccCccceEEEEEEecCC-CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 33567899999999999998653 5679999987543333677999999999999999999999854444 68999999
Q ss_pred cCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCcccccccc-c
Q 040134 561 MSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQ-T 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~-~ 637 (745)
+++|+|.+++...+ .+++..+.++..||++||+|||+ +|||||||||+|||++. ++.+||+|||++....... .
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999998776 79999999999999999999995 59999999999999999 7999999999998876411 1
Q ss_pred ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
........||+.|||||++... ...+++|||||||++.||+||+.|+..- . ....++.....+.....+
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~----~~~~~~~~ig~~~~~P~i----- 244 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F----EEAEALLLIGREDSLPEI----- 244 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c----chHHHHHHHhccCCCCCC-----
Confidence 1223457899999999999853 3345999999999999999999998642 1 111222222222222211
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+++..|++.||++|||
T Consensus 245 ----p~~ls~~a~~Fl~~C~~~~p~~Rpt 269 (313)
T KOG0198|consen 245 ----PDSLSDEAKDFLRKCFKRDPEKRPT 269 (313)
T ss_pred ----CcccCHHHHHHHHHHhhcCcccCcC
Confidence 1113445778999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.55 Aligned_cols=239 Identities=29% Similarity=0.433 Sum_probs=201.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+||.||||+-+. +.+.||+|.+.+. .....+.+.+|++++++++||||+.+++.|+...++++|.||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~-t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKY-TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeeccccc-ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 4456789999999999999665 6688999999753 333456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+.+ +|..+|...+.++++.+..++.+++.||.||| +.+|+|||+||+|||++..+.+|++|||+|+.+..... .
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--v 156 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--V 156 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCce--e
Confidence 987 99999999999999999999999999999999 45999999999999999999999999999998765433 3
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.+.+.||+-|||||++.+.+|+..+|+||+|||+||+++|++||... .+...+ +.+....+..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv-~~I~~d~v~~---------- 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLV-KSILKDPVKP---------- 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHH-HHHhcCCCCC----------
Confidence 56789999999999999999999999999999999999999999632 122222 2222222221
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+....+..++...|++||..|-|
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~Rlt 244 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLT 244 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhccc
Confidence 1134556888999999999999965
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.16 Aligned_cols=257 Identities=22% Similarity=0.263 Sum_probs=197.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhccC-CCCceeEEEEEecCC-eEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGD-HRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~l 556 (745)
...|...++||.|.||.||+|+-.. .+..||||++++.-. ..+..-.+|+..|++|+ ||||+++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~-~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKE-TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecC-CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3456778899999999999999766 456799999975322 22233468999999998 999999999998888 9999
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|||||+ .+|.++++.+ +.+++..+..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+.+...
T Consensus 88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 999995 5999999866 5689999999999999999999965 9999999999999999999999999999988654
Q ss_pred ccccccccccccccccchhccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH-----HHh------
Q 040134 636 QTQAARTGIRGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY-----RCY------ 703 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~-----~~~------ 703 (745)
.. .+..+.|..|+|||++. ..-|+.+.||||+|||++|+.+-++.|+....-++..-.-.+. +.+
T Consensus 164 pP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 164 PP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 43 66778899999999875 5678999999999999999999999886443222111100000 000
Q ss_pred ---hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 ---IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..-.+.......+..- -.....++++++.+|++.||.+|||
T Consensus 241 a~~mnf~~P~~~~~~l~~L-~p~~s~~~~~li~~ll~WDP~kRpT 284 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDL-LPNASSEAASLIERLLAWDPDKRPT 284 (538)
T ss_pred HHHhccCCCcCCCCChHHh-CcccCHHHHHHHHHHhcCCCccCcc
Confidence 0001111111111100 1125678899999999999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.23 Aligned_cols=254 Identities=24% Similarity=0.298 Sum_probs=195.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 558 (745)
++-.++||+|.||.||+++... +++.||+|+++.. .+....-..+|+.+|++|+||||+++.+...+. ..+|||+
T Consensus 119 feki~kIGeGTyg~VYkAr~~~-tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLE-TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHhcCcchhheeEeeecc-cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3445689999999999999766 5678999998653 344456778999999999999999999998776 6899999
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+. +|.-++... -.+++.++..++.||+.||+|+|. .||+|||||.+|||||++|.+||+|||+|+.+.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99976 788877653 578999999999999999999995 5999999999999999999999999999998766554
Q ss_pred ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH--------hhcCcc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC--------YIGKNL 708 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~--------~~~~~~ 708 (745)
.. .+..+-|+.|.|||++.+. .|+.+.|+||.||||.||++|++.++....-++ + ..+.+. +....+
T Consensus 274 ~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l-~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 274 AP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--L-HKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred cc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--H-HHHHHHhCCCChhccccccC
Confidence 43 5667789999999999874 799999999999999999999998864432222 1 112111 111111
Q ss_pred c--ccccccccccccH-----HHHHHHHHHHHhccccCcCCCCC
Q 040134 709 D--KLAENDEEVKNDL-----KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~--~~~~~~~~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ..+.+...-+... ......++|+..+|..||.+|.|
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence 1 1111111100011 11345778999999999999976
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=326.75 Aligned_cols=238 Identities=32% Similarity=0.424 Sum_probs=201.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
++||+|+.|.||.+.... .++.||||++........+.+.+|+.+++..+|+|||++++.+...+.+++||||+++|+|
T Consensus 279 ~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKIS-TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeeeecc-CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 579999999999998766 4567999999877777778899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccc
Q 040134 567 ASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646 (745)
Q Consensus 567 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 646 (745)
.+.+.. ..+++.++..|.++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... .+...+|
T Consensus 358 TDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVG 431 (550)
T KOG0578|consen 358 TDVVTK-TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVG 431 (550)
T ss_pred hhhhhc-ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccC
Confidence 999854 4589999999999999999999954 999999999999999999999999999998876654 2566789
Q ss_pred cccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHH
Q 040134 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVE 726 (745)
Q Consensus 647 t~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (745)
|+.|||||++..+.|.+|.||||||++++||+-|++||....... . ++.....+. +..+.......
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--A----lyLIa~ng~--------P~lk~~~klS~ 497 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--A----LYLIATNGT--------PKLKNPEKLSP 497 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--H----HHHHhhcCC--------CCcCCccccCH
Confidence 999999999999999999999999999999999999986533211 1 111112221 22222334456
Q ss_pred HHHHHHHhccccCcCCCCC
Q 040134 727 RLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 727 ~l~~li~~Cl~~dp~~RPT 745 (745)
.|.++..+||+.|+++|||
T Consensus 498 ~~kdFL~~cL~~dv~~Ras 516 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRAS 516 (550)
T ss_pred HHHHHHHHHhhcchhcCCC
Confidence 7889999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=317.14 Aligned_cols=240 Identities=22% Similarity=0.287 Sum_probs=193.0
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+..+||+|+||.||.++-+. +++.+|+|++++.. ....+-++.|-.+|...++|.||+++-.|++.+.+||||||+
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~-Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKD-TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hheeeccccceeEEEEEEcc-CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 44689999999999998665 67899999997643 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc------
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE------ 635 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~------ 635 (745)
+||++..+|.....+++..+..++.+++.||+.||+. |||||||||+|+|||..|++||+|||++.-+...
T Consensus 224 PGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 224 PGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred CCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 9999999999999999999999999999999999965 9999999999999999999999999998543210
Q ss_pred ----------------cccc----c-------------------cccccccccccchhccccCCCCccchhHHHHHHHHH
Q 040134 636 ----------------QTQA----A-------------------RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLE 676 (745)
Q Consensus 636 ----------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~e 676 (745)
.... . ....+|||.|||||++.++.++..+|.||||||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 0000 0 012479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCchhhHHHHHHHHhhcCc--ccccccccccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 677 LICCKSSVVFGTTNPEEALMDWVYRCYIGKN--LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 677 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
||.|.+||...... +.. +.+.... +.... ......+..++|.+|+- ||+.|-
T Consensus 381 mLvGyPPF~s~tp~--~T~-----rkI~nwr~~l~fP~--------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQ--ETY-----RKIVNWRETLKFPE--------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHhCCCCCCCCCHH--HHH-----HHHHHHhhhccCCC--------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999644432 222 2221111 11111 11122567788889888 998883
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=313.54 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=194.4
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhc--cCCCCceeEEEEEecCC----eEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ--THHKNLVRLLGFCDEGD----HRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv 557 (745)
++.++||+|.||.||+|.+.. +.||||++.. +..+.|++|-++... ++|+||+++++.-.... .++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~---~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN---RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhccC---ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 356889999999999999964 6799999964 445678888888765 58999999999887665 88999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhc------CCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE------CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+||.+.|+|.++|.. ..++|.+..+|+..+++||+|||+. ++++|+|||||.+||||.+|+++.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999999965 5679999999999999999999985 356799999999999999999999999999999
Q ss_pred ccccccccccccccccccccchhccccC-CCC-----ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhH----------
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKA-SIT-----VKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL---------- 695 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l---------- 695 (745)
+............+||.+|||||++.+. .+. .+.||||+|.|||||++...-++.+...+.+..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 8877666656678999999999999764 222 469999999999999987665542222111111
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.++.....+.....+..... ....+.-+++.+..||..||+.|-|
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhh
Confidence 1122222222222221111111 1144677999999999999999965
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=327.55 Aligned_cols=243 Identities=29% Similarity=0.459 Sum_probs=192.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.||+|.||+||+|.+..+ ||||++.. ...+..++|++|+..+++-+|.||+-+.|+|..+.. .||..+
T Consensus 394 v~l~~rIGsGsFGtV~Rg~whGd----VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWHGD----VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred hhccceeccccccceeecccccc----eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 34667899999999999999753 99999964 344567899999999999999999999999999887 999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++-+|..+|+-. ..++....+.|+.||++|+.|||.+ +|||+|||..||++.+++.|||+|||++..-..-....
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999999855 6788899999999999999999954 99999999999999999999999999987543322222
Q ss_pred ccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
......|...|||||+++. .+|+..+||||||+|+|||+||..|+.... .+..+ -.+-+.+. ..++...
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIi-fmVGrG~l---~pd~s~~-- 617 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQII-FMVGRGYL---MPDLSKI-- 617 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheE-EEeccccc---Cccchhh--
Confidence 2334567889999999964 479999999999999999999999986221 11111 00101110 1111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+|+..||..++++||+
T Consensus 618 ----~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 618 ----RSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred ----hccCHHHHHHHHHHHHhcCcccCcc
Confidence 2234456888999999999999996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.33 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=190.1
Q ss_pred HHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC-Ce
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG-DH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~ 553 (745)
..+.+.++||+|+||.||+|... ...++.||||+++... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 45667889999999999999753 2234679999986432 23346789999999999 899999999988764 46
Q ss_pred EEEEEEecCCCCHHHHhcCC------------------------------------------------------------
Q 040134 554 RLLVYEYMSNGSLASFLFGI------------------------------------------------------------ 573 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 573 (745)
.++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 88999999999999998642
Q ss_pred --CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccccccccc
Q 040134 574 --TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651 (745)
Q Consensus 574 --~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 651 (745)
..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2366778899999999999999964 99999999999999999999999999998764332222122334567899
Q ss_pred chhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHH
Q 040134 652 APEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVM 730 (745)
Q Consensus 652 aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 730 (745)
|||.+.+..++.++||||||++||||++ |..||...... ..+ ......+..... .......+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~----~~~~~~~~~~~~---------~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEF----CQRLKDGTRMRA---------PENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHH----HHHHhcCCCCCC---------CCCCCHHHHH
Confidence 9999999999999999999999999997 99998643322 111 112222211111 1112346889
Q ss_pred HHHhccccCcCCCCC
Q 040134 731 VALWCIQEDASLRPQ 745 (745)
Q Consensus 731 li~~Cl~~dp~~RPT 745 (745)
++.+||+.||++|||
T Consensus 309 li~~cl~~dp~~RPs 323 (338)
T cd05102 309 IMLACWQGDPKERPT 323 (338)
T ss_pred HHHHHccCChhhCcC
Confidence 999999999999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.68 Aligned_cols=242 Identities=28% Similarity=0.432 Sum_probs=200.6
Q ss_pred CCcCccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEE
Q 040134 468 TNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGF 547 (745)
Q Consensus 468 ~~~~~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 547 (745)
..+..+.+++|.+- +-||.|+.|.||+|++.. +.||||+++... ..+++.|++|+||||+.+.|+
T Consensus 116 ~e~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~n---etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISEL-----EWLGSGAQGAVFLGRLHN---ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhh-----hhhccCcccceeeeeccC---ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeee
Confidence 44566777777643 459999999999999964 459999986422 357888999999999999999
Q ss_pred EecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 548 CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 548 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
|.....++||||||..|.|.++|+....+.......+.++||.||.|||.+ .|||||||.-||||..+..+||+|||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999999999999999999999999999999999965 99999999999999999999999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
-++...+... ...+.||..|||||++++.+.+.|.|||||||||||||||..|+..-... ..+|. +-
T Consensus 258 TS~e~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwG-VG--- 324 (904)
T KOG4721|consen 258 TSKELSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWG-VG--- 324 (904)
T ss_pred chHhhhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEe-cc---
Confidence 9988755432 44578999999999999999999999999999999999999998532221 11111 11
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.....-.+++-+.-|+++||+..|.+|||
T Consensus 325 -----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPS 357 (904)
T KOG4721|consen 325 -----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPS 357 (904)
T ss_pred -----CCcccccCcccCchHHHHHHHHHHhcCCCCCcc
Confidence 111222223445667888999999999999997
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=312.38 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=193.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--------------cCHHHHHHHHHHHhccCCCCceeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--------------QGEKEFRTEVSVIGQTHHKNLVRLLG 546 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 546 (745)
..|.+.+.||+|.||.|-+|+... .++.||||++.+... ...+.+.+|+.++++++|||||+|+.
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~-~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEV-DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hheehhhhhcCCccceEEEEeecC-CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 346677899999999999998765 567899999854211 12358899999999999999999999
Q ss_pred EEec--CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 547 FCDE--GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 547 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
+..+ .+.+|||+||+..|.+...-.....+.+.++++++++++.||+|||.+ |||||||||+|+||+++|++||+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence 9876 458999999999888766543333488999999999999999999955 99999999999999999999999
Q ss_pred eccCccccccc---ccccccccccccccccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHH
Q 040134 625 DFGLAKLLLAE---QTQAARTGIRGTVGYFAPEWFRKAS----ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD 697 (745)
Q Consensus 625 Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~ 697 (745)
|||.+...... ..........||+.|+|||...+.. .+.+.||||+||+||-|+.|+.||.....
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-------- 324 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-------- 324 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--------
Confidence 99999866222 1222234478999999999987632 35789999999999999999999953211
Q ss_pred HHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 698 WVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .++++...+..+...+..+++.+|++++|++||+.|-|
T Consensus 325 --~~l-----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 325 --LEL-----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred --HHH-----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee
Confidence 111 22333334444445566778999999999999999964
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=316.94 Aligned_cols=239 Identities=27% Similarity=0.376 Sum_probs=200.6
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
-.+.||+|+||.||+|.... .++.||+|++.-. .....++++.|+.+|..++++||.++++.+..+..++++|||+.+
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~-t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNK-TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred cchhccccccceeeeeeecc-ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 34789999999999999876 5678999999753 344567899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
|++.+.+.....+++..+.-++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++..+...... ...
T Consensus 96 Gsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~t 170 (467)
T KOG0201|consen 96 GSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKT 170 (467)
T ss_pred cchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--ccc
Confidence 99999998888779999999999999999999955 9999999999999999999999999999887654433 366
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
.+||+-|||||+++...|+.|+||||||++.+||++|.+|+....+..... .+.+-..+.+. ..
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L~----~~ 234 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRLD----GD 234 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCccc----cc
Confidence 889999999999998899999999999999999999999986443311110 01111112222 13
Q ss_pred HHHHHHHHHHhccccCcCCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++..||+.||+.|||
T Consensus 235 ~S~~~kEFV~~CL~k~P~~Rps 256 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPS 256 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcC
Confidence 4456889999999999999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.11 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=192.3
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC---------------CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS---------------DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~---------------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l 544 (745)
..+.+.++||+|+||.||++.+.. +....||+|.+... .......+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 446678899999999999998643 23457999998653 23345679999999999999999999
Q ss_pred EEEEecCCeEEEEEEecCCCCHHHHhcCC-------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeee
Q 040134 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGI-------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 605 (745)
++++.+.+..++||||+++++|.+++... ..+++..+++++.||+.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999998543 1356778899999999999999965 9999
Q ss_pred CCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 606 ~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
|||||+|||+++++.+||+|||+++.+.............++..|+|||.+....++.++||||||+++|||+++..+.+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986643332222223445788999999988889999999999999999998654444
Q ss_pred CCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 686 FGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 686 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+........+ ..+......... ..... ........+.+++.+||+.||++|||
T Consensus 242 ~~~~~~~~~~-~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 242 YGELTDEQVI-ENAGEFFRDQGR-QVYLF-----RPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred CCcCCHHHHH-HHHHHHhhhccc-ccccc-----CCCCCCHHHHHHHHHHccCCchhCcC
Confidence 4333322222 222221111110 00000 01122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=347.01 Aligned_cols=245 Identities=31% Similarity=0.493 Sum_probs=198.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcE----EEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKR----FVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
-.+.+.||+|+||.||+|......+. .||||.+++. +.+...+|.+|..+++.++||||++++|+|.+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 34567899999999999998765443 4999999763 556678999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 558 YEYMSNGSLASFLFGI-------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
+|||++|+|..||++. ..+...+.+.++.|||+|+.|||+. ++|||||..+|+||++...+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999865 3478899999999999999999954 99999999999999999999999999999
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
.+.............-+.+|||||.+++..++.|+|||||||+|||++|...+.+....+ .+.+ . ....+++++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~-~---~~~~ggRL~- 924 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVL-L---DVLEGGRLD- 924 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHH-H---HHHhCCccC-
Confidence 665544332222223467899999999999999999999999999999976554433322 2211 1 122233222
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+.+.+||..||+.+|++||+
T Consensus 925 ---------~P~~CP~~ly~lM~~CW~~~pe~RP~ 950 (1025)
T KOG1095|consen 925 ---------PPSYCPEKLYQLMLQCWKHDPEDRPS 950 (1025)
T ss_pred ---------CCCCCChHHHHHHHHHccCChhhCcc
Confidence 23456678999999999999999997
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=304.07 Aligned_cols=242 Identities=23% Similarity=0.332 Sum_probs=204.2
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
.+-.|+|.+.||+|.||+|-++.... .++.||||.+++. +++..-.+++|++++..|+||||+.++.+|+..+.+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~-sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHK-SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhcc-CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 45668889999999999999988654 5678999999763 3444556889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||..+|.|.+|+...+.+++.++.++++||..|+.|+|++ +++|||||.+|||+|+++++||+|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999999999999999999999999999999965 9999999999999999999999999999887654
Q ss_pred ccccccccccccccccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASIT-VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.. ...++|++-|.+||++.+.+|. +..|-||||++||.|+.|..||+..+- ..+.+.+..|...+..
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaYrEP~-- 274 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAYREPE-- 274 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccccCCC--
Confidence 43 5668899999999999999884 889999999999999999999963221 1122333334433322
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......-||.|||-.+|++|.|
T Consensus 275 ---------~PSdA~gLIRwmLmVNP~RRAT 296 (668)
T KOG0611|consen 275 ---------TPSDASGLIRWMLMVNPERRAT 296 (668)
T ss_pred ---------CCchHHHHHHHHHhcCcccchh
Confidence 2233567999999999999976
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.01 Aligned_cols=238 Identities=25% Similarity=0.302 Sum_probs=195.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||+++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677899999999999999865 45679999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999999998888889999999999999999999965 99999999999999999999999999998654322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .. ..+.+..+.+.. +
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~----~~~~i~~~~~~~---p---- 235 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FR----IYEKILAGRLKF---P---- 235 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HH----HHHHHhcCCcCC---C----
Confidence 234689999999999999999999999999999999999999853221 11 112222222111 0
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....++.+++.+||+.||++|||
T Consensus 236 ---~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 236 ---NWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHcCC
Confidence 011245788999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.76 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=199.7
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+..-.|.++||+|-||.|.++.... ...||||+++.... ....+|.+|+++|.+++||||++++|+|..++.+++|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC--ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3344467899999999999998865 46699999986544 34589999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGITR--PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||++|+|.+++..+.. ...+...+|+.||+.||+||. +.++|||||.++|+|++.++++||+|||+++.+....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999987733 355667889999999999999 5699999999999999999999999999999877666
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhC--CCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICC--KSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg--~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
........+-+++|||||.+..++++.++|||+||++|||+++- ..|+. ...++ ...+-.-..+..+.. ..+..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~--~lt~e-~vven~~~~~~~~~~-~~~l~ 767 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS--QLTDE-QVVENAGEFFRDQGR-QVVLS 767 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh--hhhHH-HHHHhhhhhcCCCCc-ceecc
Confidence 55545556678999999999999999999999999999998654 45543 22221 122212122211111 11111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...-+...+.+++.+||..|.++|||
T Consensus 768 -----~P~~cp~~lyelml~Cw~~es~~RPs 793 (807)
T KOG1094|consen 768 -----RPPACPQGLYELMLRCWRRESEQRPS 793 (807)
T ss_pred -----CCCcCcHHHHHHHHHHhchhhhcCCC
Confidence 12334567889999999999999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=285.87 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=193.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.-.+.||+|.||.||+|+... +++.||||+++.... .......+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~-t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTE-TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecC-CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 3445789999999999999876 566799999975322 2245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++. +|+..++.. ..+...++..++.++++||+|||.. .|+||||||.|+||+++|.+||+|||+|+.+......
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~- 157 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI- 157 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence 975 999999876 5678999999999999999999954 9999999999999999999999999999988655433
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc------ccc
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD------KLA 712 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~~ 712 (745)
.+..+-|.-|.|||++.+ +.|+...||||.|||+.||+-|.+-|+..++-++ + ..+.+.+..-..+ .+.
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L-~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--L-SKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--H-HHHHHHcCCCCcccCccccccc
Confidence 233467899999999877 5799999999999999999987765543222121 1 1122221111000 000
Q ss_pred c-------cc-ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 E-------ND-EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~-------~~-~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
| +. .....-.......++++..|+..||.+|.|
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit 274 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT 274 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc
Confidence 0 00 000011223456789999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.10 Aligned_cols=237 Identities=24% Similarity=0.298 Sum_probs=193.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4567889999999999999765 35679999986422 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 999999999998888899999999999999999999954 9999999999999999999999999999865432
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+ .+.+..+....
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~----~~~i~~~~~~~--------- 217 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGI----YEKILAGKLEF--------- 217 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHHhCCcCC---------
Confidence 2234689999999999998999999999999999999999999854321 111 11122221110
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||.+||+
T Consensus 218 -~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 218 -PRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHccC
Confidence 0111345789999999999999994
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.80 Aligned_cols=243 Identities=28% Similarity=0.346 Sum_probs=192.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+...+.||+|+||.||++.... +++.||+|.+.... ......+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec-CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3456789999999999999865 45679999986422 2234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999887543 4678999999999999999999954 999999999999999999999999999986533221
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ..+..........
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~-------- 223 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQEE-------- 223 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccccc--------
Confidence 23346899999999999999999999999999999999999999654332111 1111111111100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+....+.+|+.+||+.||++|||
T Consensus 224 --~~~~~s~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05631 224 --YSEKFSEDAKSICRMLLTKNPKERLG 249 (285)
T ss_pred --CCccCCHHHHHHHHHHhhcCHHHhcC
Confidence 11122346788999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=320.62 Aligned_cols=235 Identities=24% Similarity=0.294 Sum_probs=190.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
++||+|+||.||+++... +++.||+|+++... ......+.+|++++++++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 368999999999998765 45679999986532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 154 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence 99999998888899999999999999999999954 999999999999999999999999999875322211 1234
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.. ....+.... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~----~~~~~~~~~----------p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE----LILMEEIRF----------PRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHH----HHHcCCCCC----------CCC
Confidence 5689999999999999999999999999999999999999853221 11111 111111110 111
Q ss_pred HHHHHHHHHHhccccCcCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RP 744 (745)
....+.+++.+||+.||++||
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcC
Confidence 234578899999999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=317.63 Aligned_cols=234 Identities=25% Similarity=0.300 Sum_probs=190.4
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||+|+||.||+++... +++.||+|+++.. .......+.+|+.++++++||||+++++.+.+.+..++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 7999999999999765 4567999998642 23344677889999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 645 (745)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 154 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC 154 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence 999998888899999999999999999999965 999999999999999999999999999875432221 123456
Q ss_pred ccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHH
Q 040134 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRV 725 (745)
Q Consensus 646 gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (745)
|++.|+|||.+.+..++.++|||||||++|||++|+.||..... . .. .+....+.... .....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--~----~~-~~~~~~~~~~~----------~~~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--N----EM-YRKILQEPLRF----------PDGFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--H----HH-HHHHHcCCCCC----------CCcCC
Confidence 89999999999999999999999999999999999999863221 1 11 11111111110 11123
Q ss_pred HHHHHHHHhccccCcCCCCC
Q 040134 726 ERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 726 ~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+++.+||+.||++|||
T Consensus 218 ~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCC
Confidence 45788999999999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.06 Aligned_cols=241 Identities=22% Similarity=0.274 Sum_probs=197.2
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
....+.+.+.||+|+||.||+|.........||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3345677889999999999999987655578999998642 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999998888899999999999999999999955 9999999999999999999999999999865322
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .. ..+.+..+.... .
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~----~~~~i~~~~~~~--p-- 248 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LL----IYQKILEGIIYF--P-- 248 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HH----HHHHHhcCCCCC--C--
Confidence 2235689999999999988899999999999999999999999963321 11 122222222110 0
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
......+.+++.+||+.||++|+
T Consensus 249 ------~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 249 ------KFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred ------CCCCHHHHHHHHHHcccCHHHcC
Confidence 01123467899999999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.04 Aligned_cols=239 Identities=24% Similarity=0.292 Sum_probs=199.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.+.||.|+.|.|-.|+... +++.+|||++.+. .......+.+|+.+|+.+.|||++++++++++..++|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~-TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAE-TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhccc-ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4567889999999999999876 5678999999653 22334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|-|.+++...+++.+.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-..+ .
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---k 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---K 166 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC---c
Confidence 999999999999999999999999999999999999954 9999999999999999999999999999864333 3
Q ss_pred ccccccccccccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASIT-VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+|++.|+|||++.+.+|. .++||||+|||||.||||+.||+.. .+.. +...+..|.++-.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~-LLlKV~~G~f~MP------- 232 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRV-LLLKVQRGVFEMP------- 232 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHH-HHHHHHcCcccCC-------
Confidence 35667899999999999999985 7899999999999999999999721 1111 2223333433322
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
-....+..+|+.+|+..||+.|-|
T Consensus 233 ---s~Is~eaQdLLr~ml~VDp~~RiT 256 (786)
T KOG0588|consen 233 ---SNISSEAQDLLRRMLDVDPSTRIT 256 (786)
T ss_pred ---CcCCHHHHHHHHHHhccCcccccc
Confidence 122345778999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.72 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=194.3
Q ss_pred cCccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC---HHHHHHHHHHHhccCCCCceeEEE
Q 040134 470 VRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG---EKEFRTEVSVIGQTHHKNLVRLLG 546 (745)
Q Consensus 470 ~~~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~ 546 (745)
++.++.++++..+ ...|++|+++.||+|.+. ++.||||.++...... .+.+.+|+.++.+++||||+++++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIFN---NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEEC---CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 4445555553221 146999999999999983 5679999997643333 467889999999999999999999
Q ss_pred EEec----CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceE
Q 040134 547 FCDE----GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPR 622 (745)
Q Consensus 547 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~k 622 (745)
++.+ ....++||||+++|+|.+++.....+++....+++.|++.||.|||+. .+++||||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEE
Confidence 9876 457899999999999999998888899999999999999999999952 3788999999999999999999
Q ss_pred EeeccCcccccccccccccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 040134 623 ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700 (745)
Q Consensus 623 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~ 700 (745)
|+|||+++.+.... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+ +.
T Consensus 164 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~~-~~---- 231 (283)
T PHA02988 164 IICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKE-IY---- 231 (283)
T ss_pred EcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--HHH-HH----
Confidence 99999988653321 22357889999999976 689999999999999999999999986332 111 11
Q ss_pred HHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..+...... +......+.+++.+||+.||++|||
T Consensus 232 ~~i~~~~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rps 268 (283)
T PHA02988 232 DLIINKNNSLKL--------PLDCPLEIKCIVEACTSHDSIKRPN 268 (283)
T ss_pred HHHHhcCCCCCC--------CCcCcHHHHHHHHHHhcCCcccCcC
Confidence 111111111111 1123456889999999999999997
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=318.23 Aligned_cols=200 Identities=26% Similarity=0.337 Sum_probs=174.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..+++.+.||+|+||.||+++... .+..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECC-CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345667889999999999999765 4567999988643 22345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999999998878889999999999999999999963 369999999999999999999999999987653322
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23346899999999999989999999999999999999999998543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=287.19 Aligned_cols=250 Identities=27% Similarity=0.304 Sum_probs=199.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 554 (745)
..+|.+.+.+|+|||+-||.++.-. +++.+|+|++.-...+..+..++|++..++++||||++++++...+ ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s-~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLS-TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccC-cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4567788999999999999998554 4567999999766667788899999999999999999999877443 358
Q ss_pred EEEEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 555 LLVYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
|++++|...|+|.+.+... ..+++.++++|+.+|.+||++||+. ...++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998643 4689999999999999999999976 4469999999999999999999999999987
Q ss_pred cccccccc-------cccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 040134 631 LLLAEQTQ-------AARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700 (745)
Q Consensus 631 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~ 700 (745)
...-.... ........|..|.|||++. +..++.++|||||||+||+|+.|..||.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 64321110 0112345789999999985 44678999999999999999999999953211
Q ss_pred HHhhcCccccccc-ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYIGKNLDKLAE-NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.++.+...+. .....+.+....+.+.+++.+|+|.||.+|||
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~ 289 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT 289 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC
Confidence 2232322222 23333344447788999999999999999997
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.67 Aligned_cols=243 Identities=23% Similarity=0.331 Sum_probs=194.2
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||.||++.... .++.||+|+++.. .....+.+..|..++.++ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 368999999999999765 4567999999753 223345688899999888 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 999999998778899999999999999999999965 99999999999999999999999999987532211 1123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc--hhhHHHHHHHHhhcCcccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP--EEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .....++..+....+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI---------- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----------
Confidence 4568999999999999999999999999999999999999996433221 2222233333333332211
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||.+|||
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCC
Confidence 0112345788999999999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.63 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=192.9
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||++.... .++.+|+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 368999999999999765 4567999998753 223345677888888776 89999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 999999998878899999999999999999999965 999999999999999999999999999875322111 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC--chhhHHHHHHHHhhcCcccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN--PEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .......++.+....+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---------- 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---------- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC----------
Confidence 456899999999999999999999999999999999999999642221 11122223333332222210
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCC
Confidence 1112345778999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=309.79 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=194.7
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
++...+.+.+.||+|+||.||+|.+.. ..+..||+|.++... ......+.+|+..+++++||||+++++++...+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 345567788999999999999998753 345689999987542 23346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 555 LLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999764 5689999999999999999999965 99999999999999999999999999876542
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .. + .+....+....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~-~----~~~~~~~~~~~-- 228 (266)
T cd05064 159 SEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QD-V----IKAVEDGFRLP-- 228 (266)
T ss_pred ccchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HH-H----HHHHHCCCCCC--
Confidence 221111 112335678999999999999999999999999999775 9988853321 11 1 11111211111
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++..||+.+|++|||
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~ 254 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPR 254 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCC
Confidence 01123456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.21 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=196.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.+.||+|++|.||++......++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 66788999999999999987765466788888755444445678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 563 NGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 563 ~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988753 34678889999999999999999954 9999999999999999999999999999876543322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . +.. .....+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~----~~~-~~~~~~~~~~~------- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--R----EIM-QQVLYGKYDPF------- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--H----HHH-HHHHhCCCCCC-------
Confidence 223445689999999999999999999999999999999999999853221 1 111 11111221111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps 316 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPT 316 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcC
Confidence 0112345889999999999999997
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.16 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=195.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+|+... .++.||+|+++... ....+.+.+|++++..++||||+++++++.+.+..++|||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4567889999999999999865 35679999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999998888899999999999999999999965 999999999999999999999999999976543
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.. ..+... ...+...... .
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~-~~i~~~--~~~~~~~~~~----~ 224 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NETW-ENLKYW--KETLQRPVYD----D 224 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--HHHH-HHHHhc--cccccCCCCC----c
Confidence 13345689999999999999999999999999999999999999864322 1111 111110 0011110000 0
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s 250 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGS 250 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCC
Confidence 01123456788999999999999996
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.65 Aligned_cols=235 Identities=25% Similarity=0.302 Sum_probs=190.3
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
++||+|+||.||++.... .++.||+|++... .......+.+|+++++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999998765 4567999998653 223446788899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
++|..++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 154 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT 154 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence 99999998888899999999999999999999954 999999999999999999999999999875422211 1233
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... . .+. +........ . ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~-~~~----~~~~~~~~~------~----p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E-KLF----ELILMEDIK------F----PRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--H-HHH----HHhccCCcc------C----CCC
Confidence 5689999999999988999999999999999999999999864321 1 111 111111111 0 111
Q ss_pred HHHHHHHHHHhccccCcCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RP 744 (745)
....+.+++.+||+.||++||
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcC
Confidence 234578899999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.97 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=175.2
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
....+++.+.||+|+||.||++.... .++.+|+|.+... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECC-CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34566778899999999999998865 4566899987643 233346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|.+++.....+++..+..++.|++.||.|||+. .+|+|+||||+||++++++.+||+|||++..+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999999998878889999999999999999999953 379999999999999999999999999987653321
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 23346889999999999888999999999999999999999998644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.97 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=191.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||++... .+.+..||||+++.. .....+.+.+|+.++..+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 345667899999999999999742 334567999998643 233456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCC------------------------------------------------------------
Q 040134 554 RLLVYEYMSNGSLASFLFGI------------------------------------------------------------ 573 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 573 (745)
.++||||+++|+|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999988542
Q ss_pred ---------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 574 ---------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 574 ---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1367788899999999999999954 9999999999999999999999999999876443322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+...+ ..+.... .+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~----~~~~~~~--~~--- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMI----KEGYRML--SP--- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHH----HhCccCC--CC---
Confidence 11222345678999999999999999999999999999998 7777743221 11222221 1111100 00
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....++.+|+.+||+.||++|||
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs 363 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPT 363 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcC
Confidence 011346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.25 Aligned_cols=235 Identities=25% Similarity=0.306 Sum_probs=189.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||+|+||.||++.... +++.||+|+++.. .......+.+|+++++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 368999999999998765 4567999998653 223345677899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
++|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........ ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 99999998878899999999999999999999954 999999999999999999999999999875322211 1233
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .. ... ........ . ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~-~~~----~~~~~~~~------~----p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ER-LFE----LILMEEIR------F----PRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HH-HHH----HHhcCCCC------C----CCC
Confidence 5689999999999988999999999999999999999999853322 11 111 11111111 0 011
Q ss_pred HHHHHHHHHHhccccCcCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RP 744 (745)
....+.+++.+||+.||++||
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhC
Confidence 234578899999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.83 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=193.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||++.... .++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 369999999999999766 45679999997532 23345688899999888 69999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 999999998778899999999999999999999965 999999999999999999999999999875322111 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.....+.+.+......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----------PR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC----------CC
Confidence 45689999999999999999999999999999999999999965433322222233333332222111 01
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCC
Confidence 11245778999999999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=312.29 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=171.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|+||.||+++... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred ceEEEEecccCCEEEEEEEECC-CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4567889999999999999865 4567999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++.+..+......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...... .
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 157 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-N 157 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-c
Confidence 99987776665556789999999999999999999954 9999999999999999999999999999876432221 1
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 23356899999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.96 Aligned_cols=238 Identities=26% Similarity=0.370 Sum_probs=195.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
..|..+||+|.||+|+++.++.. ++.+|||.+++. ..+..+..+.|.+++... +||.++.++..|++.+++|+||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~-~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGT-NEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCC-CcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 45678999999999999999875 568999999863 455667888899998887 5999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+.||++.. +.....+++..+..++..|+.||+|||++ +||+||||.+|||||.+|.+||+|||+++..-.. .
T Consensus 449 ey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g 522 (694)
T KOG0694|consen 449 EYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--G 522 (694)
T ss_pred EecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC--C
Confidence 9999999433 33457899999999999999999999965 9999999999999999999999999999864322 2
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....++||+.|||||++.+..|+.+.|.|||||+|||||.|..||...+ ++.+.+-+ ...++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~FdsI----~~d~~---------- 585 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEVFDSI----VNDEV---------- 585 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH----hcCCC----------
Confidence 23567899999999999999999999999999999999999999996332 22222222 11111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.+..-...+.+.|+.++|..+|++|-
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRL 611 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRL 611 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCccccc
Confidence 11223345688999999999999984
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.12 Aligned_cols=242 Identities=31% Similarity=0.503 Sum_probs=186.5
Q ss_pred chhhcCcceeEEEEEEEee---CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 485 FRQILGRGAFGTVYKGVLA---SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.||.|.||.||+|.+. ...+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999998 234578999999653 233468999999999999999999999999988889999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++|+|.++|... ..+++..+..|+.||++||+|||+. +++|++|+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 6789999999999999999999965 9999999999999999999999999999876322222
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
...........|+|||.+....++.++||||||+++|||++ |+.|+... .. ..+.. .+.++.....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~-~~~~~----~~~~~~~~~~------ 226 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DN-EEIIE----KLKQGQRLPI------ 226 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CH-HHHHH----HHHTTEETTS------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--cc-ccccc----ccccccccee------
Confidence 22333456789999999999889999999999999999999 66776432 11 11111 1122211111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++..||+.||++|||
T Consensus 227 ---~~~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 227 ---PDNCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp ---BTTSBHHHHHHHHHHT-SSGGGS--
T ss_pred ---ccchhHHHHHHHHHHcCCChhhCcC
Confidence 1112345889999999999999997
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=323.08 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=190.8
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||+++... ...+.||+|+++... ......+.+|+++++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4456678999999999999998532 233579999996532 23346788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCC------------------------------------------------------------
Q 040134 554 RLLVYEYMSNGSLASFLFGI------------------------------------------------------------ 573 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 573 (745)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999988532
Q ss_pred ----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 574 ----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 574 ----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
.++++.++++++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1356778899999999999999954 999999999999999999999999999976543322211222
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ....+ ... ..+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~----~~~~~-~~~-~~~~------- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYK----MVKRG-YQM-SRPD------- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHH----HHHcc-cCc-cCCC-------
Confidence 345678999999988899999999999999999997 99998643221 11111 11111 000 0000
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs 361 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPT 361 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcC
Confidence 11346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.59 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=190.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||.||+++... +++.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 368999999999999765 4567999998642 233445677888888876 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS 154 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence 999999998888899999999999999999999955 999999999999999999999999999875422211 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+ .+.+..+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~----~~~i~~~~~~~----------~~ 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDL----FEAILNDEVVY----------PT 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHH----HHHHhcCCCCC----------CC
Confidence 45689999999999988999999999999999999999999863321 111 12222221110 01
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCC
Confidence 12345788999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.94 Aligned_cols=236 Identities=25% Similarity=0.332 Sum_probs=189.8
Q ss_pred hhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc----ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 487 QILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.||+|+||.||+++... ..++.||+|.++... ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 579999999999998643 346789999986421 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--V 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--c
Confidence 99999999998888888999999999999999999954 999999999999999999999999999875432221 1
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. . ...+..+....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--~~-~----~~~~~~~~~~~---------- 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--KK-T----IDKILKGKLNL---------- 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--HH-H----HHHHHcCCCCC----------
Confidence 2335689999999999988899999999999999999999999864321 11 1 11111121110
Q ss_pred cHHHHHHHHHHHHhccccCcCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......+.+++.+||+.||++||
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~ 243 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRL 243 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcC
Confidence 011234578999999999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.43 Aligned_cols=193 Identities=24% Similarity=0.336 Sum_probs=167.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||.||++.... .++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~-~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNK-TCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECC-CCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46677899999999999998765 45679999753 245688999999999999999999999999999999998
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
. ++|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~ 240 (391)
T PHA03212 166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKY 240 (391)
T ss_pred C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccc
Confidence 5 68999988777889999999999999999999964 999999999999999999999999999975432221 112
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 345789999999999988999999999999999999999988753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.50 Aligned_cols=236 Identities=28% Similarity=0.360 Sum_probs=187.4
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||.||+|+... .++.||+|.++.. .....+.+..|..++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 368999999999999865 4567999998643 223344556677777654 89999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 999999998888899999999999999999999964 99999999999999999999999999997643222 1133
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ +. ..+...... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~-~~----~~i~~~~~~--~--------~~ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DE-LF----DSILNDRPH--F--------PR 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HH-HH----HHHHcCCCC--C--------CC
Confidence 45689999999999988999999999999999999999999863221 11 11 111111100 0 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~ 240 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLG 240 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCC
Confidence 12345778999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.92 Aligned_cols=241 Identities=29% Similarity=0.378 Sum_probs=192.7
Q ss_pred chhhcCcceeEEEEEEEeeCCCc---EEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 485 FRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.++||+|+||.||+|++..... ..||||..+. ......++|.+|++++++++||||++++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 45889999999999999976543 2389999874 34566789999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|++.||+|.++|.+.+ .++..++++++.+.|.||+|||. ++++||||..+|+|+..++.+||+|||+++.-..-..
T Consensus 241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 9999999999998876 59999999999999999999995 4999999999999999999999999999876431111
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. .....-+.+|+|||.+....++.++|||||||++||+++ |..|+..... . .+..++ ...+.....
T Consensus 318 ~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~-~v~~kI---~~~~~r~~~----- 384 (474)
T KOG0194|consen 318 K--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--Y-EVKAKI---VKNGYRMPI----- 384 (474)
T ss_pred c--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--H-HHHHHH---HhcCccCCC-----
Confidence 1 112245789999999999999999999999999999998 6776642221 1 111111 111111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+...+..+..++.+|++.||++|||
T Consensus 385 ----~~~~p~~~~~~~~~c~~~~p~~R~t 409 (474)
T KOG0194|consen 385 ----PSKTPKELAKVMKQCWKKDPEDRPT 409 (474)
T ss_pred ----CCCCHHHHHHHHHHhccCChhhccC
Confidence 1123455778888999999999997
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.47 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=167.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
|.+.++||+|+||.||+|+... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECC-CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 5667899999999999998765 45679999986432 233457789999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~ 159 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T 159 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence 75 899888654 4578899999999999999999954 999999999999999999999999999876432221 1
Q ss_pred cccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233467899999998865 56899999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=313.03 Aligned_cols=246 Identities=25% Similarity=0.288 Sum_probs=193.1
Q ss_pred hcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc----ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 555 (745)
+.+.+.||+|+||.||+++... ..++.||+|++.... ....+.+.+|+.+++++ +|+||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 4567889999999999988643 346789999986421 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998888899999999999999999999965 9999999999999999999999999999865333
Q ss_pred ccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......... ..+.........
T Consensus 159 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~~------ 228 (332)
T cd05614 159 EKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKCDP------ 228 (332)
T ss_pred CCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcCCC------
Confidence 2211 2345689999999999765 4789999999999999999999999644322111 111111111111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. .......+.+++.+||+.||++|||
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~dp~~R~~ 255 (332)
T cd05614 229 PF----PSFIGPEAQDLLHKLLRKDPKKRLG 255 (332)
T ss_pred CC----CCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 00 0112345778999999999999994
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=278.72 Aligned_cols=237 Identities=27% Similarity=0.361 Sum_probs=196.8
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
++.+.||+|.||.||.|+.+. +.-.||+|++.+. ......++.+|+++...|+||||++++++|.+....||++||
T Consensus 25 eigr~LgkgkFG~vYlarekk-s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKK-SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred cccccccCCccccEeEeeecc-CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 467889999999999999876 4567999998652 334457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
.+.|.|...|. ...++++.....++.|+|.||.|+|. .+++||||||+|+|++..+.+||+|||.+..-. .
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~ 176 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 176 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC----C
Confidence 99999999998 55789999999999999999999994 599999999999999999999999999987543 2
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......+||..|.|||...+...+...|+|++|++.||++.|.+||.... .. .. ++.+.+-++.. +
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~-et----YkrI~k~~~~~---p---- 242 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HS-ET----YKRIRKVDLKF---P---- 242 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hH-HH----HHHHHHccccC---C----
Confidence 22556789999999999999999999999999999999999999996433 11 11 22222111111 1
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........++|.+|+..+|.+|.+
T Consensus 243 ---~~is~~a~dlI~~ll~~~p~~r~~ 266 (281)
T KOG0580|consen 243 ---STISGGAADLISRLLVKNPIERLA 266 (281)
T ss_pred ---cccChhHHHHHHHHhccCcccccc
Confidence 112345778999999999999964
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.66 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=195.8
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
+...+.+.+.||+|+||.||++.... .....+|+|.+........+.+.+|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 34456678899999999999998532 34567899998765555567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC-------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCce
Q 040134 555 LLVYEYMSNGSLASFLFGIT-------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP 621 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~ 621 (745)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 478999999999999999999965 99999999999999999999
Q ss_pred EEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 040134 622 RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVY 700 (745)
Q Consensus 622 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~ 700 (745)
||+|||++..+.............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .. . .
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~-~----~ 232 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE-V----I 232 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH-H----H
Confidence 9999999986643322221223345778999999998889999999999999999998 8888743221 11 1 1
Q ss_pred HHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+...... ......+.+++.+||+.||.+|||
T Consensus 233 ~~i~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt 268 (288)
T cd05093 233 ECITQGRVLQRP---------RTCPKEVYDLMLGCWQREPHMRLN 268 (288)
T ss_pred HHHHcCCcCCCC---------CCCCHHHHHHHHHHccCChhhCCC
Confidence 222222211110 012345899999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=309.06 Aligned_cols=236 Identities=26% Similarity=0.327 Sum_probs=188.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||.||+++... .++.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 369999999999999865 45679999986532 23345667788887754 89999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 999999998878889999999999999999999954 99999999999999999999999999987432111 1133
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+...+ ...... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~----~~~~~~------~~~---- 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESI----RVDTPH------YPR---- 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCCC------CCC----
Confidence 4568999999999999999999999999999999999999985332 11121111 111100 000
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~ 240 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLG 240 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCC
Confidence 12345778999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.54 Aligned_cols=235 Identities=24% Similarity=0.331 Sum_probs=189.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||.||+|+... .++.||+|+++.. .....+.+..|.+++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 368999999999999765 4567999998653 233345677888888866 89999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ ...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 999999998888899999999999999999999965 999999999999999999999999999875432221 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. .+.. .+..+.... + .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~-~~~~----~i~~~~~~~---p-------~ 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--ED-DLFE----SILHDDVLY---P-------V 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--HH-HHHH----HHHcCCCCC---C-------C
Confidence 4568999999999999899999999999999999999999986332 11 1111 111111110 0 0
Q ss_pred HHHHHHHHHHHhccccCcCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.....+.+++..||+.||++||
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcC
Confidence 1124578899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.25 Aligned_cols=236 Identities=24% Similarity=0.300 Sum_probs=189.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||+|+||.||++.... .++.||+|.++... ......+.+|+++++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999998765 45689999986532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
++|..++.....+++..+..++.||+.||+|||+. .+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 99999998888899999999999999999999951 4999999999999999999999999999875322211 1233
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||..... +.... ......... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~----~i~~~~~~~----------p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE----LILMEEIRF----------PRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHH----HHhcCCCCC----------CCC
Confidence 5689999999999999999999999999999999999999854321 11111 111111110 011
Q ss_pred HHHHHHHHHHhccccCcCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RP 744 (745)
....+.+++.+||+.||++||
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhC
Confidence 234578899999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.34 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=199.5
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEE-ec------CCeEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFC-DE------GDHRL 555 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~-~~------~~~~~ 555 (745)
.+.++|.+|||+.||.+.+...+ ..+|+|++-..++...+.+++|++++++|+ |+|||.+++.. .. .-+++
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~-~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGG-KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCC-ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 45678999999999999987654 569999987778888899999999999996 99999999932 11 23678
Q ss_pred EEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 556 LVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
|.||||++|.|-+++... ..+++.++++|+.++++|+++||.. ...|||||||.+||||..++..||||||.+....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999743 5699999999999999999999976 7789999999999999999999999999986543
Q ss_pred ccccccc-------cccccccccccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh
Q 040134 634 AEQTQAA-------RTGIRGTVGYFAPEWF---RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 634 ~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
....... .-.-.-|+.|+|||.+ .+.++++|+|||||||+||-|+....||.....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------- 263 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------- 263 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------------
Confidence 2221000 0112458999999977 577899999999999999999999999964422
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+++.....+....+..+|..||..||++||.+||+
T Consensus 264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPn 300 (738)
T KOG1989|consen 264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPN 300 (738)
T ss_pred -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCC
Confidence 2344555555556788899999999999999999995
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.88 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=191.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCC-CCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHH-KNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.+.+.||+|+||.||+|+... .++.||+|++... .....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4567889999999999999765 4567999998643 23345677889999999965 56888999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 9999999999998888889999999999999999999965 999999999999999999999999999865321111
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......|++.|+|||.+.+..++.++||||||+++|||+||+.||..... ..+.. .+.......
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~----~i~~~~~~~-------- 220 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQ----SIMEHNVSY-------- 220 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHcCCCCC--------
Confidence 12345689999999999999999999999999999999999999863321 11111 111111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||.+||+
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~R~~ 245 (324)
T cd05587 221 --PKSLSKEAVSICKGLLTKHPAKRLG 245 (324)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 0112345788999999999999985
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.12 Aligned_cols=240 Identities=25% Similarity=0.321 Sum_probs=191.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.+.+.||+|+||.||+++... .++.||+|.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3467889999999999998765 45679999986532 22334567788888777 6899999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 9999999999998888899999999999999999999965 999999999999999999999999999875432211
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.. .+.......
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~----~i~~~~~~~-------- 220 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ----SIMEHNVAY-------- 220 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCCCCC--------
Confidence 12345689999999999999999999999999999999999999864321 11211 111111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 221 --p~~~s~~~~~li~~~l~~~p~~R~~ 245 (323)
T cd05616 221 --PKSMSKEAVAICKGLMTKHPGKRLG 245 (323)
T ss_pred --CCcCCHHHHHHHHHHcccCHHhcCC
Confidence 1112345788999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=310.92 Aligned_cols=236 Identities=27% Similarity=0.340 Sum_probs=186.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHH-HHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVS-VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||+||+++... +++.||+|++.... ....+.+..|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 368999999999999765 45679999986432 122334455544 4678899999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++....... ....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 999999998888899999999999999999999965 99999999999999999999999999987532221 1133
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . .+ .+....+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~-~~----~~~i~~~~~~~----------~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--A-EM----YDNILNKPLRL----------KP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--H-HH----HHHHHcCCCCC----------CC
Confidence 45689999999999999999999999999999999999999863321 1 11 11111111110 01
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~ 240 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLG 240 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCC
Confidence 12345789999999999999996
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.57 Aligned_cols=236 Identities=26% Similarity=0.338 Sum_probs=189.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||++.... +++.||+|+++.. .......+..|.++++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 368999999999999865 4567999998753 233445677888998888 79999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 999999998888899999999999999999999954 999999999999999999999999999865322111 122
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+. .....+.... ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~----~~i~~~~~~~----------~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELF----QSILEDEVRY----------PR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHH----HHHHcCCCCC----------CC
Confidence 3468999999999999999999999999999999999999985332 11111 1111111110 01
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s 240 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLG 240 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCC
Confidence 12346789999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=305.30 Aligned_cols=245 Identities=29% Similarity=0.465 Sum_probs=193.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCC----cEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDS----KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
.+.+.+.||+|+||.||+|...... .+.|++|.+.... ......+.+|++++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4557789999999999999875432 2569999986432 2334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 040134 557 VYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~ 620 (745)
+|||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 99999999999998654 3467788999999999999999965 9999999999999999999
Q ss_pred eEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 040134 621 PRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWV 699 (745)
Q Consensus 621 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~ 699 (745)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~--- 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVI--- 236 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH---
Confidence 99999999986543332222233456788999999988899999999999999999998 9888853322 1111
Q ss_pred HHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 700 YRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.+..+..... ......++.+|+.+||+.||++|||
T Consensus 237 -~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~ 272 (283)
T cd05048 237 -EMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPR 272 (283)
T ss_pred -HHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcC
Confidence 12222221111 1223467889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.15 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=186.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhcc---CCCCceeEEEEEe-----cCC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQT---HHKNLVRLLGFCD-----EGD 552 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~~ 552 (745)
|.+.+.||+|+||.||+++....+++.||+|.++... ......+.+|+.+++++ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 5567889999999999999865556789999886422 22234566777777665 6999999999885 345
Q ss_pred eEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 553 HRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
..++||||++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 5899988653 4578899999999999999999965 99999999999999999999999999997
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc---Cc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG---KN 707 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 707 (745)
...... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.+.. +.+.... ..
T Consensus 159 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~-i~~~~~~~~~~~ 232 (290)
T cd07862 159 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGK-ILDVIGLPGEED 232 (290)
T ss_pred eccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHH-HHHHhCCCChhh
Confidence 654331 13345689999999999888999999999999999999999999864332 122211 1111100 00
Q ss_pred c-------cccccccccc---cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 L-------DKLAENDEEV---KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~-------~~~~~~~~~~---~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......... .........+.+++.+||+.||++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 280 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC
Confidence 0 0000000000 000112345779999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.61 Aligned_cols=236 Identities=27% Similarity=0.327 Sum_probs=187.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||+|.... .++.||+|.++... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 368999999999999765 45679999986532 23345566788888764 99999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 999999998777889999999999999999999965 999999999999999999999999999875322111 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+... +...... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~----i~~~~~~--~--------~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS----IRMDNPC--Y--------PR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCCCC--C--------Cc
Confidence 45689999999999998999999999999999999999999854321 111111 1111110 0 01
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~ 240 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLG 240 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCC
Confidence 12245788999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.82 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=187.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHH---hccCCCCceeEEEEEecCCeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVI---GQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.||+|+||.||++.... .++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred eEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999998765 45679999986432 22345566676655 566899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988854 5689999999999999999999964 999999999999999999999999999875322211
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.+ ..+..+....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~~~~-----~~i~~~~~~~------- 220 (324)
T cd05589 157 --RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--EEVF-----DSIVNDEVRY------- 220 (324)
T ss_pred --cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--HHHH-----HHHHhCCCCC-------
Confidence 12345689999999999999999999999999999999999999853321 1111 1111111110
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 221 ---p~~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 221 ---PRFLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 0112345788999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=317.29 Aligned_cols=246 Identities=23% Similarity=0.362 Sum_probs=190.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 555 (745)
.+.+.++||+|+||.||+|+... .....||||+++... ....+.+.+|+++++++. ||||+++++++.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 44567899999999999998632 223469999996432 233467899999999995 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC--------------------------------------------------------------
Q 040134 556 LVYEYMSNGSLASFLFGI-------------------------------------------------------------- 573 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-------------------------------------------------------------- 573 (745)
+||||+++|+|.++|...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999987532
Q ss_pred ----------------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 574 ----------------------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 574 ----------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
..+++.++..++.||+.||+|||+. +|+|+||||+||++++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 1356777889999999999999954 999999999999999999
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDW 698 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~ 698 (745)
.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~--- 349 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF--- 349 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH---
Confidence 999999999987643332222233456788999999988889999999999999999997 88887543221 111
Q ss_pred HHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.... ........+.+++.+||+.||++|||
T Consensus 350 -~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 350 -YNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred -HHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcC
Confidence 11111111100 01123456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.47 Aligned_cols=237 Identities=24% Similarity=0.295 Sum_probs=190.7
Q ss_pred hhcCcceeEEEEEEEee--CCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLA--SDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||+++.. ...++.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 46999999999998763 2356789999986532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--cee
Confidence 999999998778899999999999999999999955 999999999999999999999999999876533211 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ........ ..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~----i~~~~~~~----------p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTM----ILKAKLGM----------PQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHH----HHcCCCCC----------CC
Confidence 35689999999999988899999999999999999999999863321 111111 11111110 01
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~ 242 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLG 242 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCC
Confidence 12345778999999999999996
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=347.68 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=200.2
Q ss_pred cCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC
Q 040134 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD 552 (745)
Q Consensus 473 ~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 552 (745)
++++++... ....++||+|+||.||+|+... .++.||||+++..... ..+|++.+++++||||+++++++.+.+
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECC-CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 344444332 2345689999999999999755 3567999998643322 234688899999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 553 HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
..++||||+++|+|.++++ .++|..+.+++.|+++||+|||..+..+|+||||||+||+++.++.+++. |+.+...
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999999999999995 47899999999999999999997767799999999999999999888876 6655432
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
.. .....++..|+|||.+.+..++.++|||||||++|||+||+.|+..... ....+.+|.............+
T Consensus 833 ~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 833 CT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred cc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhhee
Confidence 21 1223578999999999999999999999999999999999999854332 2334556665544444444444
Q ss_pred ccccc--ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEE--VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~--~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
++... .....++..++.+++.+||+.||++|||
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt 940 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC
Confidence 44432 2234567778999999999999999997
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.35 Aligned_cols=240 Identities=25% Similarity=0.328 Sum_probs=191.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+++.+.||+|+||+||++.... +++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4567889999999999998765 4567999998643 2233456778888888885 678889999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 9999999999998888899999999999999999999965 999999999999999999999999999875432221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.. .+.......
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~----~i~~~~~~~-------- 220 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQ----SIMEHNVSY-------- 220 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCCCCC--------
Confidence 12335689999999999988999999999999999999999999854321 11111 111111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||.+|++
T Consensus 221 --p~~~~~~~~~li~~~l~~~p~~R~~ 245 (323)
T cd05615 221 --PKSLSKEAVSICKGLMTKHPSKRLG 245 (323)
T ss_pred --CccCCHHHHHHHHHHcccCHhhCCC
Confidence 0112345788999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=305.19 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=195.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.+.+.||+|+||.||+++... .....+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 345567889999999999998543 2345689999876555556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 040134 557 VYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~ 620 (745)
||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 99999999999998643 2368889999999999999999955 9999999999999999999
Q ss_pred eEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 040134 621 PRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWV 699 (745)
Q Consensus 621 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~ 699 (745)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+ ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~-~~--- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TE-VI--- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH-HH---
Confidence 99999999976544332222233456788999999998899999999999999999999 8888753322 11 11
Q ss_pred HHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 700 YRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+....+..... .......+.+++.+||+.||++|||
T Consensus 236 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt 271 (291)
T cd05094 236 -ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLN 271 (291)
T ss_pred -HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcC
Confidence 11222222111 1112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.71 Aligned_cols=238 Identities=26% Similarity=0.348 Sum_probs=188.2
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||+|+||+||++.... +++.+|+|.+.... ....+.+..|++++++++|+||+++.+++......++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRA-TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEcc-CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999998765 45679999986422 2233567889999999999999999999999999999999999999
Q ss_pred HHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 566 LASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 566 L~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..+...... .
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~ 154 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T 154 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence 9988743 35688999999999999999999965 9999999999999999999999999999765433221 2
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .. .......... ...
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~----------~~~ 221 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE-LKQRILNDSV----------TYP 221 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HH-HHHhhcccCC----------CCc
Confidence 3356899999999999999999999999999999999999998654322111 01 1111111110 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++||+
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~ 245 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLG 245 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcC
Confidence 123456889999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.74 Aligned_cols=236 Identities=25% Similarity=0.318 Sum_probs=186.5
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHH-HHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVS-VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||.||+++... +++.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 369999999999999765 45679999986422 222344555554 5788899999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|...+.....+.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 999999998778889999999999999999999954 99999999999999999999999999987532221 1123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+ .+....+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~----~~~i~~~~~~~----------~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQM----YDNILHKPLQL----------PG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHH----HHHHhcCCCCC----------CC
Confidence 45689999999999988999999999999999999999999864321 111 11111111110 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||.+||+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~ 240 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLG 240 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCC
Confidence 12345889999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.68 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=195.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
...+.+.+.||+|+||.||+|.... ...+.||+|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4456778899999999999998743 23467999998754333 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 040134 555 LLVYEYMSNGSLASFLFGI--------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~ 620 (745)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999998643 2367888999999999999999954 9999999999999999999
Q ss_pred eEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 040134 621 PRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWV 699 (745)
Q Consensus 621 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~ 699 (745)
+||+|||++..+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ......+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH
Confidence 99999999976543322111223345788999999999999999999999999999998 9998753322 1121211
Q ss_pred HHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 700 YRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+...... ......+.+++.+||+.||++|||
T Consensus 238 ----~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~ 270 (280)
T cd05049 238 ----TQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRIN 270 (280)
T ss_pred ----HcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCC
Confidence 122221111 112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.18 Aligned_cols=198 Identities=25% Similarity=0.367 Sum_probs=166.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|+... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKV-NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECC-CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 35677899999999999999865 456799999864322 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 96 5777777544 5688899999999999999999955 999999999999999999999999999875432221
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1233467899999999865 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.90 Aligned_cols=246 Identities=26% Similarity=0.314 Sum_probs=185.3
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-----eEEEEEEe
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-----HRLLVYEY 560 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~ 560 (745)
.+++|.|+||.||+|++... ++.||||+.-.... .--+|+++|++++|||||+++-+|.... ...+||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~-~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRET-EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcCC-CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 46899999999999999875 67799999743222 2246999999999999999998885432 33489999
Q ss_pred cCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CceEEeeccCccccccc
Q 040134 561 MSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKLLLAE 635 (745)
Q Consensus 561 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~a~~~~~~ 635 (745)
|+. +|.++++. ..+++...+.-+..||.+||+|||+ .+|+||||||+|+|+|.+ |.+||+|||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 976 89888874 5778888999999999999999995 599999999999999976 99999999999988655
Q ss_pred ccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH-------Hh----
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR-------CY---- 703 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~-------~~---- 703 (745)
... .....|.-|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|...+. ...+...+.- .+
T Consensus 180 epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 180 EPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhhcC
Confidence 542 34557889999999877 5799999999999999999999999865333 2333332211 01
Q ss_pred ---hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 ---IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.....+.......-.......+.++++.++|+.+|.+|.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~ 299 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS 299 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC
Confidence 011111111111100012223456889999999999999975
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.25 Aligned_cols=236 Identities=26% Similarity=0.316 Sum_probs=186.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHH-HHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVS-VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++||+|+||+||+++... +++.+|+|++... .......+..|.. +++.++||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 368999999999998765 4567999998643 1223345555554 4677899999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 999999998888899999999999999999999954 999999999999999999999999999875322111 123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ + .+....+... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~-~----~~~~~~~~~~--~~--------~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--AE-M----YDNILHKPLV--LR--------P 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--HH-H----HHHHHcCCcc--CC--------C
Confidence 45689999999999999999999999999999999999999864321 11 1 1111111111 01 1
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+|++.||.+||+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~ 240 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLG 240 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCC
Confidence 12345778999999999999996
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=304.19 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=191.3
Q ss_pred HHhcchhhcCcceeEEEEEEEee---CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA---SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...++.+.||+|+||.||+|... ....+.|++|.+... .......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 34567789999999999999863 223467999998642 23334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC-----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 557 VYEYMSNGSLASFLFGI-----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
+|||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999998522 2367888899999999999999965 999999999999999999
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDW 698 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~ 698 (745)
.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHH-
Confidence 999999999987644332222233445678999999988889999999999999999998 887874321 111111
Q ss_pred HHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+..... ......++.+++.+|++.||++|||
T Consensus 238 ---~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (283)
T cd05090 238 ---MVRKRQLLPC---------SEDCPPRMYSLMTECWQEGPSRRPR 272 (283)
T ss_pred ---HHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcC
Confidence 1111111110 1112346888999999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.49 Aligned_cols=200 Identities=23% Similarity=0.377 Sum_probs=167.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 555 (745)
|.+.++||+|+||.||+|+... +++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECC-CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4567899999999999999765 4567999998642 223345788999999999999999999988543 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||+. ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999998878899999999999999999999965 9999999999999999999999999999865332
Q ss_pred ccc-cccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 636 QTQ-AARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 211 11234568999999999865 67899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.32 Aligned_cols=236 Identities=27% Similarity=0.343 Sum_probs=185.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHH-HHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEV-SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||+++... +++.||+|++.... ......+..|. .+++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 368999999999999765 45679999986422 12223444444 45677899999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+.+..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 999999998878888899999999999999999954 999999999999999999999999999875432211 133
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ ....+ ..+... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~-~~~~i----~~~~~~--~--------~~ 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AE-MYDNI----LNKPLQ--L--------KP 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HH-HHHHH----HhCCcC--C--------CC
Confidence 45689999999999999999999999999999999999999863221 11 11111 111111 0 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||.+||+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~ 240 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLG 240 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCC
Confidence 12345788999999999999996
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=282.42 Aligned_cols=245 Identities=23% Similarity=0.307 Sum_probs=197.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcc--cccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
..+.+.++||+|.|+.|++..... +++..|+|++. +......+++.+|+++-+.|+||||+++++...+....|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~-tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhcc-chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456678899999999999987654 45557777763 334457789999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCceEEeeccCccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+|+|+.|..-|-...-.++..+-..+.||+++|.|+|.. +|||||+||.|+++. ..--+||+|||+|..+...
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999999987766556678888999999999999999954 999999999999994 3457999999999988732
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
. ......||++|||||+++..+++..+|||+.|+|||-|+.|..||...+. . .+++.+..+..+-.
T Consensus 167 ~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~----rlye~I~~g~yd~~---- 232 (355)
T KOG0033|consen 167 E---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---H----RLYEQIKAGAYDYP---- 232 (355)
T ss_pred c---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---H----HHHHHHhccccCCC----
Confidence 2 24557899999999999999999999999999999999999999964322 2 23334444433321
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.++.....+...+++.+||..||.+|-|
T Consensus 233 --~~~w~~is~~Ak~LvrrML~~dP~kRIt 260 (355)
T KOG0033|consen 233 --SPEWDTVTPEAKSLIRRMLTVNPKKRIT 260 (355)
T ss_pred --CcccCcCCHHHHHHHHHHhccChhhhcc
Confidence 1112223455778999999999999976
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=287.80 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=190.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCC-ceeEEEEEecCC------e
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKN-LVRLLGFCDEGD------H 553 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~ 553 (745)
+...++||+|+||+||+|+.... ++.||+|+++-... .......+|+.++++++|+| |+++++++...+ .
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~-g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRT-GKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecC-CCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 33446799999999999998774 57899999975333 23456689999999999999 999999998877 8
Q ss_pred EEEEEEecCCCCHHHHhcCCC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 554 RLLVYEYMSNGSLASFLFGIT----RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
.++|+||++. +|..++.... .++...+..++.||+.||+|||++ +|+||||||+||||++.|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999954 8999987654 466778999999999999999954 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc---
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG--- 705 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--- 705 (745)
+...-... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++..|+.... .+.+.. +.+.+..
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~-If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFR-IFRLLGTPNE 242 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHH-HHHHcCCCCc
Confidence 96542221 24556789999999999876 799999999999999999998888865443 222212 2222111
Q ss_pred Ccccccc---cc-----ccc-ccccH----HHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLA---EN-----DEE-VKNDL----KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~---~~-----~~~-~~~~~----~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+. +- ... ..... .......+++.+||+.+|.+|.|
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S 295 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS 295 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC
Confidence 0000000 00 000 00000 11146789999999999999976
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.57 Aligned_cols=201 Identities=24% Similarity=0.338 Sum_probs=171.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||+||+|+... .++.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 3456789999999999998765 45679999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc--
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-- 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 637 (745)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999998888889999999999999999999954 999999999999999999999999999764321000
Q ss_pred -------------------------------------------ccccccccccccccchhccccCCCCccchhHHHHHHH
Q 040134 638 -------------------------------------------QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLL 674 (745)
Q Consensus 638 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl 674 (745)
........||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0001234689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 040134 675 LELICCKSSVVFG 687 (745)
Q Consensus 675 ~elltg~~p~~~~ 687 (745)
|||++|+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (381)
T cd05626 239 FEMLVGQPPFLAP 251 (381)
T ss_pred HHHHhCCCCCcCC
Confidence 9999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.53 Aligned_cols=239 Identities=25% Similarity=0.346 Sum_probs=186.3
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
+.||+|+||.||+|+.... ++.+|+|.+... ..+....+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRAD-NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecC-CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999998653 567999987542 23345679999999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccc
Q 040134 566 LASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644 (745)
Q Consensus 566 L~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 644 (745)
|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...............
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999654 4678999999999999999999954 9999999999999999999999999998765432111111112
Q ss_pred cccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 645 ~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+..... .... .......... ....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~----~~~~~~~~~~---------~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTR----EAIEQGVRLP---------CPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHH----HHHHcCCCCC---------Cccc
Confidence 23457999999988889999999999999999998 7777743221 1111 1111111000 0112
Q ss_pred HHHHHHHHHHhccccCcCCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++.+|++.+|++|||
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps 242 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPS 242 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcC
Confidence 2456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.55 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=191.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+++... .++.||||++.... ......+.+|++++..++||||+++++.+.+++..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 4566889999999999999865 45679999986532 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998888899999999999999999999965 99999999999999999999999999987643221100
Q ss_pred ------------------------------------ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 040134 640 ------------------------------------ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSS 683 (745)
Q Consensus 640 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p 683 (745)
......||+.|+|||++....++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 01124589999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 684 VVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 684 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
|..... .+.. .. +........... .......+.+++.+|+. +|.+||+
T Consensus 239 f~~~~~--~~~~----~~-i~~~~~~~~~~~------~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 239 FCSDNP--QETY----RK-IINWKETLQFPD------EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCH--HHHH----HH-HHcCCCccCCCC------CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 864321 1111 11 111110000000 11123456778888986 8999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.40 Aligned_cols=243 Identities=26% Similarity=0.331 Sum_probs=195.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||+||+++... +++.||+|+++... ......+.+|++++..++|+||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4567889999999999999865 45679999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc---
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ--- 636 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 636 (745)
|+++++|.+++.....+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999887889999999999999999999996 499999999999999999999999999998764432
Q ss_pred ------------------------cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch
Q 040134 637 ------------------------TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692 (745)
Q Consensus 637 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~ 692 (745)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--~ 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL--Q 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH--H
Confidence 00112335689999999999999999999999999999999999999864331 1
Q ss_pred hhHHHHHHHHhhc--CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIG--KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ...+.. ...... ........+.+++.+|++ ||.+||+
T Consensus 237 ~~-----~~~i~~~~~~~~~p--------~~~~~~~~~~~li~~ll~-dp~~R~~ 277 (350)
T cd05573 237 ET-----YNKIINWKESLRFP--------PDPPVSPEAIDLICRLLC-DPEDRLG 277 (350)
T ss_pred HH-----HHHHhccCCcccCC--------CCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence 11 111111 111100 011124567889999998 9999996
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.92 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=191.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCC-------------CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASD-------------SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLL 545 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~-------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~ 545 (745)
...+++.+.||+|+||.||++..... ....||+|.++.. .......+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 44567888999999999999876431 2345899998653 233456789999999999999999999
Q ss_pred EEEecCCeEEEEEEecCCCCHHHHhcCC------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 546 GFCDEGDHRLLVYEYMSNGSLASFLFGI------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 546 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
+++...+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 9999999999999999999999998543 1357888999999999999999954 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
++++++.+||+|||++................++..|+|||.+....++.++||||||+++|||+++..+.++.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999997654332222122334567899999998888999999999999999999854433333322222
Q ss_pred hHHHHHHHHhhc-CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIG-KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.. +.+.... +....... .......+.+++.+|++.||++|||
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs 285 (295)
T cd05097 241 VIEN-TGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPT 285 (295)
T ss_pred HHHH-HHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcC
Confidence 2211 1111111 01000000 1112357899999999999999997
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.88 Aligned_cols=243 Identities=30% Similarity=0.370 Sum_probs=192.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
++..++||+|+||+||++.... +++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcC-CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4566789999999999998755 45789999986422 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888643 4588999999999999999999954 999999999999999999999999999876533221
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....|+..|+|||.+.+..++.++||||+|+++|||++|+.||....... ....+...+.....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~--------- 222 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQE--------- 222 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhccc---------
Confidence 223468899999999998899999999999999999999999986432211 11111111111110
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++..||+.||++|||
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 223 -EYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred -ccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 011123456789999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.96 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=193.2
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
....+.+.+.||+|++|.||+|.... .+.||+|.++... ...+++.+|++++++++|+||+++++++...+..+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN--TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC--CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34556778999999999999998654 3569999986532 34577999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999997653 689999999999999999999965 99999999999999999999999999998765322
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... .. .+.. ...... ...
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~-~~~~----~~~~~~-~~~---- 224 (261)
T cd05068 158 YEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NA-EVLQ----QVDQGY-RMP---- 224 (261)
T ss_pred ccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HH-HHHH----HHHcCC-CCC----
Confidence 111 122233468999999988899999999999999999999 888874221 11 1111 111111 000
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+|++.+|++|||
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~P~~Rp~ 250 (261)
T cd05068 225 ----CPPGCPKELYDIMLDCWKEDPDDRPT 250 (261)
T ss_pred ----CCCcCCHHHHHHHHHHhhcCcccCCC
Confidence 01122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=309.61 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=190.7
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCC---cEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDS---KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
....+...+.||+|+||.||+|++.... ...||+|.++... ....+++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3445667788999999999999875432 2348999986432 33456889999999999999999999999765 56
Q ss_pred EEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 555 LLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
++++||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 7999999999999999764 4678899999999999999999965 99999999999999999999999999998765
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
.............+..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...+. .....+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~----~~~~~~~~~~-~ 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEIS----SILEKGERLP-Q 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HHHhCCCCCC-C
Confidence 4332221222334678999999999999999999999999999998 888875321 11111 1111111110 0
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 233 --------~~~~~~~~~~li~~cl~~~p~~Rps 257 (316)
T cd05108 233 --------PPICTIDVYMIMVKCWMIDADSRPK 257 (316)
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCcC
Confidence 0112245788999999999999997
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.96 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=190.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
...+.+.+.||+|++|.||+|.... ..++.||+|.+.... .....++.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 3456778899999999999998642 234679999985422 23345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 555 LLVYEYMSNGSLASFLFGI----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998642 2346778899999999999999964 99999999999999999999999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||++..+.............++..|+|||.+.+..++.++||||||+++|||++ |..||.... .. .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--~~-~~~~----~~ 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--NE-QVLR----FV 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HH-HHHH----HH
Confidence 9999876543322211222345678999999998899999999999999999999 677774321 11 1111 11
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+...... ......+.+++.+||+.||++|||
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps 267 (277)
T cd05062 235 MEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPS 267 (277)
T ss_pred HcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcC
Confidence 122111111 112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.65 Aligned_cols=246 Identities=29% Similarity=0.420 Sum_probs=193.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+|..... ....|++|.++... ......+.+|+.++++++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 3456778999999999999998643 34579999986532 33346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999998764 4689999999999999999999954 99999999999999999999999999998775222
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.........++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+...+ ..+....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~----- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRLP----- 228 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCCC-----
Confidence 2111222345678999999998899999999999999999998 8888743221 1111111 1111100
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+|++.+|++|||
T Consensus 229 ----~~~~~~~~l~~li~~cl~~~p~~Rp~ 254 (266)
T cd05033 229 ----PPMDCPSALYQLMLDCWQKDRNERPT 254 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 01122456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.13 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=192.0
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|++|.||+|.... .++.|++|.+... ....+++.+|++++++++|+||+++++++...+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec-CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345677889999999999999875 3567999998643 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999998654 4578899999999999999999954 9999999999999999999999999999876433221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. ......+..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+. +...... .. .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~----~~~~~~~-~~----~-- 225 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVY----ELLEKGY-RM----E-- 225 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCC-CC----C--
Confidence 1 112234568999999998999999999999999999998 8888753221 1111 1111110 00 0
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 226 --~~~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 226 --RPEGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCCC
Confidence 01112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=292.56 Aligned_cols=198 Identities=29% Similarity=0.392 Sum_probs=172.2
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEec-----CCeEEEEE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-----GDHRLLVY 558 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~ 558 (745)
.+.||+|+||.|..+..... ++.||||++.. ...-..+...+|+.+|+.++|+||+.+.+++.. -+.+|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t-~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRT-GEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCC-CCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 46799999999999998774 47799999863 334445778899999999999999999998855 45789999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+| ..+|...++..+.++...+..++.||++||+|+| +.+++||||||+|++++.+..+||+|||+|+........
T Consensus 106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999 5599999998888999999999999999999999 569999999999999999999999999999988654333
Q ss_pred cccccccccccccchhccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 639 AARTGIRGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
...+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++.|+...
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 3356778899999999875 4689999999999999999999999997654
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.17 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=192.3
Q ss_pred HhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...+.++||+|+||.||++... ...+..+++|.+..........+.+|++++++++|+||+++++++......+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 3456789999999999999753 234567999998766666667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC---------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceE
Q 040134 558 YEYMSNGSLASFLFGIT---------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPR 622 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~k 622 (745)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence 99999999999986542 478899999999999999999955 999999999999999999999
Q ss_pred EeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHH
Q 040134 623 ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYR 701 (745)
Q Consensus 623 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 701 (745)
|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .. .. .
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~-~~----~ 235 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TE-AI----E 235 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HH-HH----H
Confidence 999999876543222111222345678999999998899999999999999999998 8888743221 11 11 1
Q ss_pred HhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 702 CYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.... . .......+.+++.+||+.||++|||
T Consensus 236 ~~~~~~~~~--~-------~~~~~~~~~~li~~cl~~~P~~Rp~ 270 (280)
T cd05092 236 CITQGRELE--R-------PRTCPPEVYAIMQGCWQREPQQRMV 270 (280)
T ss_pred HHHcCccCC--C-------CCCCCHHHHHHHHHHccCChhhCCC
Confidence 111111110 0 0112345789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.19 Aligned_cols=242 Identities=26% Similarity=0.283 Sum_probs=196.7
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
++.+.||.|.-|+||++.+... ....|+|++.+.. .......+.|.+||+.++||.++.++..++.++..+++|||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t-~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGT-NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCC-CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3567899999999999998764 4789999997633 34455677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc----
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA---- 634 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~---- 634 (745)
|+||+|..+++++ +.+++..+..++..++.||+||| ..|||.|||||+||||.++|++-|+||.++.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999998765 67899999999999999999999 45999999999999999999999999998754310
Q ss_pred -----------------------------c-c--------------------cccccccccccccccchhccccCCCCcc
Q 040134 635 -----------------------------E-Q--------------------TQAARTGIRGTVGYFAPEWFRKASITVK 664 (745)
Q Consensus 635 -----------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 664 (745)
. . ........+||..|.|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 0011123679999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 665 ~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.|.|+|||+||||+.|..||.... .++.+...+. ..+.....++....+.+||...|.+||++|-
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~-------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVG-------------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhc-------------CCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999996443 3344433222 2222222334456788999999999999983
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.11 Aligned_cols=238 Identities=24% Similarity=0.378 Sum_probs=183.9
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.+.||+|+||.||+++... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRP-TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhccCCCCeEEEEEEECC-CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 45789999999999998765 35679999985432 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
++|... ....+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..+..... ....
T Consensus 157 ~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 227 (353)
T PLN00034 157 GSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNS 227 (353)
T ss_pred Cccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccc
Confidence 998654 3446778889999999999999965 999999999999999999999999999987643221 1233
Q ss_pred ccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 644 IRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
..|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+ +...... ....
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~-~~~~-------- 295 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICMS-QPPE-------- 295 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhcc-CCCC--------
Confidence 568999999998743 2345689999999999999999999974332221111 1111111 0000
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 296 -~~~~~~~~l~~li~~~l~~~P~~Rpt 321 (353)
T PLN00034 296 -APATASREFRHFISCCLQREPAKRWS 321 (353)
T ss_pred -CCCccCHHHHHHHHHHccCChhhCcC
Confidence 01122356889999999999999997
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.85 Aligned_cols=200 Identities=25% Similarity=0.354 Sum_probs=170.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||.||+++... .++.||+|++.... ......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 3456789999999999999765 45679999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc--
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-- 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 637 (745)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998877889999999999999999999965 999999999999999999999999999753311000
Q ss_pred -------------------------------------------ccccccccccccccchhccccCCCCccchhHHHHHHH
Q 040134 638 -------------------------------------------QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLL 674 (745)
Q Consensus 638 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl 674 (745)
........||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001224689999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 040134 675 LELICCKSSVVF 686 (745)
Q Consensus 675 ~elltg~~p~~~ 686 (745)
|||++|+.||..
T Consensus 239 ~elltG~~Pf~~ 250 (382)
T cd05625 239 YEMLVGQPPFLA 250 (382)
T ss_pred HHHHhCCCCCCC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=294.88 Aligned_cols=238 Identities=25% Similarity=0.354 Sum_probs=186.8
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||+|+||.||+++... .++.+|+|.+.... ....+.+..|++++++++||||+++++.+..+...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEcc-CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 7999999999998765 45679999986421 2223456679999999999999999999999999999999999999
Q ss_pred HHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 566 LASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 566 L~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..+..... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 99888544 3578888999999999999999965 999999999999999999999999999876643221 223
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..++..|+|||.+.+..++.++|||||||++|||++|+.||........ ... +.+.......... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~---------~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEE-LKRRTLEDEVKFE---------HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHH-HHHHhhccccccc---------ccc
Confidence 4688999999999988899999999999999999999999864322111 111 1111111111110 001
Q ss_pred HHHHHHHHHHhccccCcCCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++..||+.||++|||
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~ 243 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLG 243 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCC
Confidence 2345789999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=311.82 Aligned_cols=202 Identities=22% Similarity=0.280 Sum_probs=173.1
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeC-CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
+....+.+.+.||+|+||.||++.... ..++.|++|.+... +...+|++++++++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 334457788999999999999997643 24567999987542 345689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+||++. ++|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++..+....
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999985 68888887778899999999999999999999965 99999999999999999999999999998765443
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
.........||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 3322334678999999999999999999999999999999999999986543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=278.95 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=198.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-----cc---cCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-----EQ---QGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD 552 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 552 (745)
.+.-+++||+|..+.|-+...+.+++ ..|+|++... .+ .-.++-..|+.+|+++ -||+|+++.++++.+.
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~-e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGK-EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhccccc-ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 34456789999999999988877554 4677776421 11 1234567899999998 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 553 HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
..++|+|.|+.|.|.++|...-.+++++..+|++|+.+|++|||.. +||||||||+|||++++.++||+|||++..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999989999999999999999999999965 9999999999999999999999999999987
Q ss_pred cccccccccccccccccccchhccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFR------KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
..... ....+||++|+|||.++ ...|+...|+||+|+|||.|+.|.+||.... .-.+.+.+.+|
T Consensus 174 ~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeG 243 (411)
T KOG0599|consen 174 EPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEG 243 (411)
T ss_pred CCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhc
Confidence 65443 55678999999999985 2468889999999999999999999995321 11234555555
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+- ..+...+......++|.+|||.||.+|-|
T Consensus 244 kyqF------~speWadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 244 KYQF------RSPEWADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred cccc------CCcchhhccccHHHHHHHHHeeCchhccc
Confidence 4443 22234455667889999999999999975
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=291.84 Aligned_cols=241 Identities=26% Similarity=0.401 Sum_probs=190.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||++.... +..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~--~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRA--QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HcEEeeEecCCcCceEEEEEecc--CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 35567889999999999998764 345899987642 334568899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS- 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence 999999998754 4678999999999999999999965 99999999999999999999999999987654322211
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... . ..... +..+.. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~-~~~~~----i~~~~~--~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--Y-EVVEM----ISRGFR--LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--H-HHHHH----HHCCCC--CCCCC----
Confidence 122335678999999988889999999999999999999 8888753321 1 11111 111111 11111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.+|++|||
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps 247 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPT 247 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcC
Confidence 11346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.00 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|+||.||+|+... +++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLH-TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECC-CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 346677899999999999999765 4567999998755445556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++..+..... .
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 99999999998777889999999999999999999954 999999999999999999999999999987643221 1
Q ss_pred cccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ .. ........ .+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-----~~~~~~~~---~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-----LMSKSNFQ---PPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-----eeecCCCC---CCCCc
Confidence 23345788999999884 34578899999999999999999999853322111 00 00000000 01111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcC
Confidence 01122356889999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.06 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=189.4
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
.+.++||+|++|.||+++... .++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEcC-CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456789999999999998765 4567999998543 23345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|..+ ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 83 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~ 151 (279)
T cd06619 83 GGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AK 151 (279)
T ss_pred CCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----cc
Confidence 9999765 3467888899999999999999965 99999999999999999999999999997654322 23
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||................+.........+. ..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 223 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--------VG 223 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC--------CC
Confidence 3568899999999998899999999999999999999999986433221111111111111111111110 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....++.+++.+|++.||++|||
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~ 246 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPA 246 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCC
Confidence 12345789999999999999997
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.93 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=199.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe-EEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH-RLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~ 558 (745)
.|.+.++||+|+||.++..+.+.+. +.+|+|.+.. ......+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~-~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDD-KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCC-ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4566789999999999998887654 4688888753 334444577899999999999999999999998888 99999
Q ss_pred EecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+|++||+|.+.|...+ .++++.+..++.|++.|+.|||+. +|+|||||+.||+++.+..+||.|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999997654 578899999999999999999955 99999999999999999999999999999987665
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.. .....||+.||.||++.+.+|..|+|||||||++|||++-+++|..... ..+ +.+. ..+. ..+
T Consensus 161 ~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~L---i~ki-~~~~----~~P-- 225 (426)
T KOG0589|consen 161 SL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SEL---ILKI-NRGL----YSP-- 225 (426)
T ss_pred hh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHH---HHHH-hhcc----CCC--
Confidence 22 4457899999999999999999999999999999999999999864322 111 1111 1111 111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+..++..||+.+|+.|||
T Consensus 226 ---lp~~ys~el~~lv~~~l~~~P~~RPs 251 (426)
T KOG0589|consen 226 ---LPSMYSSELRSLVKSMLRKNPEHRPS 251 (426)
T ss_pred ---CCccccHHHHHHHHHHhhcCCccCCC
Confidence 12234567889999999999999997
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.44 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=191.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCC----CcEEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..+.+.+.||+|+||.||+|..... ..+.||+|+++.... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4566788999999999999987532 356799999975332 23467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 556 LVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
+++||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999998521 2467788899999999999999954 999999999999999999
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDW 698 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~ 698 (745)
.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..|+..... ..+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~--- 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDV--- 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHH---
Confidence 999999999887643332221223445778999999988889999999999999999998 7677643211 111
Q ss_pred HHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+..+..... .......+.+++..||+.+|++|||
T Consensus 236 -~~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~ 272 (283)
T cd05091 236 -IEMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPR 272 (283)
T ss_pred -HHHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCC
Confidence 122222222111 1123455889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.37 Aligned_cols=244 Identities=24% Similarity=0.279 Sum_probs=192.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+++... .++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4567889999999999998765 45679999987532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+......
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999776 6789999999999999999999955 9999999999999999999999999999876443322
Q ss_pred cccccccccccccchhccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 639 AARTGIRGTVGYFAPEWFR------KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
......|++.|+|||.+. ...++.++||||||+++|||++|+.||..... ...+ ...........
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~----~~i~~~~~~~~-- 229 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--AKTY----NNIMNFQRFLK-- 229 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--HHHH----HHHHcCCCccC--
Confidence 123346899999999986 45678999999999999999999999864322 1111 11111111000
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..........+.+++..|++ +|++|||
T Consensus 230 -----~~~~~~~~~~~~~li~~ll~-~p~~R~t 256 (330)
T cd05601 230 -----FPEDPKVSSDFLDLIQSLLC-GQKERLG 256 (330)
T ss_pred -----CCCCCCCCHHHHHHHHHHcc-ChhhCCC
Confidence 00111223457788999998 9999997
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=319.71 Aligned_cols=245 Identities=23% Similarity=0.278 Sum_probs=192.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------ 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 552 (745)
..|.+.++||+|+||+||+++... +++.||||++... .......+.+|+..+..++|+||++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVS-DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcC-CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 356778899999999999998765 4567999998642 3344567889999999999999999988775432
Q ss_pred --eEEEEEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeec
Q 040134 553 --HRLLVYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDF 626 (745)
Q Consensus 553 --~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 626 (745)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence 367999999999999998643 4678899999999999999999954 9999999999999999999999999
Q ss_pred cCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 627 GLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 627 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
|+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... .....+
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~-~~~~~~ 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVM-HKTLAG 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHhcC
Confidence 999876543322223446789999999999999999999999999999999999999853211 1111 111222
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+ .......+.+++.+||+.||++|||
T Consensus 261 ~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs 290 (496)
T PTZ00283 261 RYDPL---------PPSISPEMQEIVTALLSSDPKRRPS 290 (496)
T ss_pred CCCCC---------CCCCCHHHHHHHHHHcccChhhCcC
Confidence 22111 1112346889999999999999997
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.08 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=190.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEec-CCe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE-GDH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-~~~ 553 (745)
..+++.++||+|+||.||+|+... ...+.||+|+++... ....+.+..|+.++.++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 356778999999999999997533 234679999986432 22345678899999999 89999999998864 457
Q ss_pred EEEEEEecCCCCHHHHhcCC------------------------------------------------------------
Q 040134 554 RLLVYEYMSNGSLASFLFGI------------------------------------------------------------ 573 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 573 (745)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999988532
Q ss_pred -CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccc
Q 040134 574 -TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652 (745)
Q Consensus 574 -~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 652 (745)
..+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2568888999999999999999954 999999999999999999999999999987644332222233456778999
Q ss_pred hhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHH
Q 040134 653 PEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMV 731 (745)
Q Consensus 653 PE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 731 (745)
||.+.+..++.++|||||||++|||++ |..||...... +.+.. ....+..... .......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~----~~~~~~~~~~---------~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCR----RLKEGTRMRA---------PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHH----HHhccCCCCC---------CccCCHHHHHH
Confidence 999999999999999999999999998 98888542221 11111 1111111110 11223568899
Q ss_pred HHhccccCcCCCCC
Q 040134 732 ALWCIQEDASLRPQ 745 (745)
Q Consensus 732 i~~Cl~~dp~~RPT 745 (745)
+.+||+.+|++|||
T Consensus 309 ~~~cl~~~p~~RPs 322 (337)
T cd05054 309 MLDCWHNNPEDRPT 322 (337)
T ss_pred HHHHccCChhhCcC
Confidence 99999999999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.64 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=195.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.++||.|++|.||+|.... ++.+++|.+..........+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 346677899999999999999876 456999999776555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.+||+|||.+..+......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999754 4578999999999999999999965 9999999999999999999999999999876433221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....++..|+|||.+....++.++||||||+++|+|++ |+.|+.... ..+ ....+. .+...
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~-~~~~~~----~~~~~-------- 223 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHE-VYDQIT----AGYRM-------- 223 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHH-HHHHHH----hCCcC--------
Confidence 123345678999999988889999999999999999998 788875322 111 111111 11100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++|||
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 011223456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=280.16 Aligned_cols=196 Identities=26% Similarity=0.363 Sum_probs=167.8
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cC-HHHHHHHHHHHhccCCCCceeEEEEEe--cCCeEEEEEEec
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QG-EKEFRTEVSVIGQTHHKNLVRLLGFCD--EGDHRLLVYEYM 561 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e~~ 561 (745)
...|++|.||.||+|+++. +++.||+|+++...+ .+ --.-.+|+.+|.+++|||||.+-.+.. +-+.+||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~-t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKK-TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HhhcccCcceeEEEeccCC-cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 4579999999999999876 567899999975321 11 235678999999999999999988774 445799999999
Q ss_pred CCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+. +|..++...+ ++...++..++.|+++||+|||. ..|+||||||+|+|+...|.+||+|||+|+.+.... ..
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~ 233 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--KP 233 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc--cc
Confidence 76 8999987764 78899999999999999999995 499999999999999999999999999999886553 23
Q ss_pred cccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
.+..+-|..|.|||++.+. .|+.+.|+||+|||+.||+++++.|+..+
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 5667889999999998774 68999999999999999999998886444
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.48 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=193.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC---------------cEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS---------------KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l 544 (745)
..+.+.+.||+|+||.||++...... ...||+|.+.... ....+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 34567889999999999999875422 2458999986432 3345688999999999999999999
Q ss_pred EEEEecCCeEEEEEEecCCCCHHHHhcCCC-----------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGIT-----------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
++++..++..++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999997654 688999999999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCc
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC--CKSSVVFGTTNP 691 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt--g~~p~~~~~~~~ 691 (745)
++++++.++|+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ +..|+. ....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~--~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE--HLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC--CcCh
Confidence 999999999999999886543332222233456778999999988889999999999999999998 445543 2222
Q ss_pred hhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 692 EEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ...+.............. .......++.+++.+||+.||++|||
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt 286 (296)
T cd05051 240 QQV-IENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPT 286 (296)
T ss_pred HHH-HHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCC
Confidence 221 122222111111111111 11122356899999999999999997
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.25 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=189.7
Q ss_pred cchhhcCcceeEEEEEEEee---CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLA---SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 557 (745)
.+.+.||+|+||+||++... ...++.||+|.++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 56788999999999887642 2345679999986532 23456788999999999999999999988653 468899
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|.+++.. ..+++.+++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..+.....
T Consensus 87 ~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999865 3589999999999999999999965 999999999999999999999999999987643322
Q ss_pred cc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.. ......++..|+|||.+.+..++.++||||||+++|||++|..|+........+.+ ...........+..+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhhhcCC
Confidence 11 11223356679999999888899999999999999999999999754332111100 00000000000111111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...........+.+++.+||++||++|||
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps 270 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPT 270 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCC
Confidence 11111223457889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.13 Aligned_cols=200 Identities=24% Similarity=0.327 Sum_probs=172.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||+||++.... .++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++|||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKD-TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 3466789999999999998765 45689999986532 2334578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ- 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 638 (745)
|+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999998888899999999999999999999954 9999999999999999999999999998765321100
Q ss_pred --------------------------------cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 --------------------------------AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.99 Aligned_cols=238 Identities=27% Similarity=0.393 Sum_probs=186.9
Q ss_pred hcCcceeEEEEEEEee-CCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCC
Q 040134 488 ILGRGAFGTVYKGVLA-SDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 564 (745)
.||+|+||.||+|.+. ...++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999764 3345779999986432 234567899999999999999999999885 45678999999999
Q ss_pred CHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-cccc
Q 040134 565 SLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTG 643 (745)
Q Consensus 565 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 643 (745)
+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777889999999999999999999965 99999999999999999999999999998764433211 1122
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+... +..+..... ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----i~~~~~~~~---------~~ 221 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQM----IESGERMEC---------PQ 221 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCCC---------CC
Confidence 234578999999988889999999999999999998 8888853321 112121 112111111 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~ 244 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPG 244 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcC
Confidence 22356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.90 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=191.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+++... .++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456677899999999999998765 4567999998642 223345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..+.....
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999998653 578888999999999999999954 999999999999999999999999999987643322
Q ss_pred ccccccccccccccchhccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKA----SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.. .....|++.|+|||.+... .++.++|||||||++|||++|+.||..... .. . ...+...... +
T Consensus 198 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~-~----~~~i~~~~~~-~-- 266 (370)
T cd05596 198 VR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VG-T----YSKIMDHKNS-L-- 266 (370)
T ss_pred cc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--HH-H----HHHHHcCCCc-C--
Confidence 11 2345689999999998653 478999999999999999999999864322 11 1 1111111100 0
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCC--CCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASL--RPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--RPT 745 (745)
..+........+.+++.+||+.+|++ |||
T Consensus 267 ---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s 297 (370)
T cd05596 267 ---TFPDDIEISKQAKDLICAFLTDREVRLGRNG 297 (370)
T ss_pred ---CCCCcCCCCHHHHHHHHHHccChhhccCCCC
Confidence 01111123456788999999999987 886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.61 Aligned_cols=201 Identities=23% Similarity=0.350 Sum_probs=171.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+++... .++.||+|++.... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 4567889999999999999765 46789999986422 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc---
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ--- 636 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~--- 636 (745)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998888889999999999999999999965 99999999999999999999999999975331000
Q ss_pred --------------------------------------cccccccccccccccchhccccCCCCccchhHHHHHHHHHHH
Q 040134 637 --------------------------------------TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678 (745)
Q Consensus 637 --------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ell 678 (745)
.........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000011346899999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 040134 679 CCKSSVVFG 687 (745)
Q Consensus 679 tg~~p~~~~ 687 (745)
+|+.||...
T Consensus 239 ~G~~Pf~~~ 247 (376)
T cd05598 239 VGQPPFLAD 247 (376)
T ss_pred hCCCCCCCC
Confidence 999999644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=294.92 Aligned_cols=241 Identities=29% Similarity=0.404 Sum_probs=190.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|++|.||++.... ...+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC--CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45677889999999999998754 235999988643 234567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee-
Confidence 999999999764 4689999999999999999999965 99999999999999999999999999987654332211
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..... ....+.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~-------- 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVE----KVSQGLRLYR-------- 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHhcCCCCCC--------
Confidence 122345678999999988889999999999999999998 8888753221 11111 1111111110
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rp~ 247 (256)
T cd05113 223 -PHLASEKVYAIMYSCWHEKAEERPT 247 (256)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCC
Confidence 0012356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.28 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=194.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCH--HHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE--KEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|++.+.||+|+||+||+++.... ++.+|+|.+........ ....+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKN-GQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTT-TEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCC-CeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 45678999999999999998764 56799999975433322 2345699999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++..+..++.||++||++||+. +|+|+||||+||++++++.++|+|||.+...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~ 154 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN 154 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence 99999999998778889999999999999999999975 9999999999999999999999999999764111 112
Q ss_pred cccccccccccchhccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~-~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+. +...+.++||||||+++|+|++|..|+........... ..+.... .......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~-~~~~~~~------ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKR-PLPSSSQ------ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHT-HHHHHTT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccc-ccccccc------
Confidence 34456889999999998 78899999999999999999999999864411111111 1111110 0000000
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~ 250 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPS 250 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcC
Confidence 00011267899999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.23 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=187.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+++.+.||+|+||.||+|+....+. ..+++|.+.... .....++..|+..+++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 34456789999999999999754332 247888875432 2234677888889999999999999998864 557889
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+||+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999754 5689999999999999999999965 99999999999999999999999999998764433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.........++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+.+. +..+.... .+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~--~~~ 234 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDL----LEKGERLA--QPQ 234 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCcCC--CCC
Confidence 2222333456788999999988889999999999999999998 8888753321 111111 11221111 111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+|++.||++|||
T Consensus 235 -------~~~~~~~~li~~c~~~~p~~Rps 257 (279)
T cd05111 235 -------ICTIDVYMVMVKCWMIDENVRPT 257 (279)
T ss_pred -------CCCHHHHHHHHHHcCCCcccCcC
Confidence 11235678999999999999997
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=307.68 Aligned_cols=238 Identities=26% Similarity=0.371 Sum_probs=196.8
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCHH
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLA 567 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 567 (745)
+||+|.||+||-|++.. +...+|||.+...+....+-+.+|+.+.++|+|.|||+++|.+.++..+-+.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~-tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD-TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeecccc-ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 79999999999999876 45679999998777777788999999999999999999999999999999999999999999
Q ss_pred HHhcCC-CCC--ChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEEeeccCccccccccccccccc
Q 040134 568 SFLFGI-TRP--DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 568 ~~l~~~-~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
++|... +++ ++..+-.+.+||++||.|||+. .|||||||-+||||+ -.|.+||+|||-++.+..-. .....
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence 999866 566 7888899999999999999976 999999999999996 46899999999998874332 33556
Q ss_pred ccccccccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 644 IRGTVGYFAPEWFRKA--SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~--~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
+-||..|||||++..+ .|..++|||||||++.||.||++||..-.......+ .-|. ....+ +..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGm----yKvHP--~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGM----YKVHP--PIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcc----eecCC--CCc
Confidence 7899999999999654 688999999999999999999999965443222111 0111 11111 123
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+...+...++++|+.+||.+||+
T Consensus 802 eelsaeak~FilrcFepd~~~R~s 825 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPS 825 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCcc
Confidence 455677889999999999999996
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=311.06 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=170.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||++.... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 4466889999999999998765 4567999998542 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ- 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 638 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998888889999999999999999999954 9999999999999999999999999998643211000
Q ss_pred -----------c---------------------------------ccccccccccccchhccccCCCCccchhHHHHHHH
Q 040134 639 -----------A---------------------------------ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLL 674 (745)
Q Consensus 639 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl 674 (745)
. ......||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 040134 675 LELICCKSSVVF 686 (745)
Q Consensus 675 ~elltg~~p~~~ 686 (745)
|||++|..||..
T Consensus 239 ~elltG~~Pf~~ 250 (377)
T cd05629 239 FECLIGWPPFCS 250 (377)
T ss_pred hhhhcCCCCCCC
Confidence 999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.92 Aligned_cols=198 Identities=27% Similarity=0.364 Sum_probs=167.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-----eEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-----HRLL 556 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~l 556 (745)
.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPR-DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred cccceeeeCCCEEEEEEEECC-CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 356789999999999998754 4567999998642 2233467889999999999999999999998776 7899
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|+||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 v~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 999996 58888887778899999999999999999999954 99999999999999999999999999998654332
Q ss_pred cccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 158 SKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 211 2334578899999998774 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=295.10 Aligned_cols=243 Identities=27% Similarity=0.410 Sum_probs=191.9
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
...+.+.++||+|++|.||+|.... +..||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN--STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC--CceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3455677899999999999998654 345999987643 2345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999998653 5678889999999999999999964 999999999999999999999999999987644322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.. .....++..|+|||.+....++.++||||||+++|+|++ |+.||..... ......+ ..+.... .
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~~----~- 225 (261)
T cd05072 159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSAL----QRGYRMP----R- 225 (261)
T ss_pred ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCCC----C-
Confidence 11 223345678999999988889999999999999999998 8888753221 1111111 1111100 0
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~ 250 (261)
T cd05072 226 ----MENCPDELYDIMKTCWKEKAEERPT 250 (261)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcC
Confidence 0112345889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.75 Aligned_cols=242 Identities=29% Similarity=0.359 Sum_probs=190.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+...++||+|+||.||++.... .++.||+|.+.... ....+.+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcC-CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3456789999999999999876 45679999886432 2223567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++... ..+++.++..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999988543 4588899999999999999999954 999999999999999999999999999876533221
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch-hhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE-EALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ......... . ... .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~----~~~-----~ 224 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-V----QEE-----Y 224 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-h----hhh-----c
Confidence 2234689999999999998999999999999999999999999964332211 111111000 0 000 0
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++..||+.||++|||
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 225 ----SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred ----CccCCHHHHHHHHHHhhcCHHHccC
Confidence 0112345788999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.57 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=194.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||++.... .++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVN-TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcC-CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45677899999999999998765 45679999987554444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.....+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+..... ..
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~ 163 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KR 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--cc
Confidence 9999999998888899999999999999999999965 999999999999999999999999999876543221 12
Q ss_pred ccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
....|+..|+|||.+. ...++.++||||||+++|||++|+.|+...... ..+... ....... +...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~~~~~-----~~~~~~~---~~~~- 232 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALFLM-----TKSNFQP---PKLK- 232 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hhHHhh-----hccCCCC---Cccc-
Confidence 3456889999999874 456889999999999999999999998543221 111110 0111110 0000
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 233 -DKMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred -ccCCCCHHHHHHHHHHccCCchhCcC
Confidence 01112345788999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=295.13 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=188.3
Q ss_pred cchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe------
Q 040134 484 GFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH------ 553 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 553 (745)
.+.+.||+|+||.||+|....+. .+.||+|+++.. .......+.+|++.++.++||||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45678999999999999986533 467999998642 22334678999999999999999999998866554
Q ss_pred EEEEEEecCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 554 RLLVYEYMSNGSLASFLFGI------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
.++++||+++++|..++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998432 3578889999999999999999965 99999999999999999999999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
+++................+..|+|||.+....++.++||||||+++|||++ |..|+..... ..+.+ ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYD----YLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcC
Confidence 9987644332211222334678999999988889999999999999999999 7777743221 11111 11222
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..... .......+.+++.+||+.||++|||
T Consensus 232 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~ 261 (273)
T cd05035 232 NRLKQ---------PEDCLDELYDLMYSCWRADPKDRPT 261 (273)
T ss_pred CCCCC---------CcCCCHHHHHHHHHHcCCChhhCcC
Confidence 11111 1123456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.11 Aligned_cols=198 Identities=26% Similarity=0.346 Sum_probs=171.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||+|+||.||++.... +++.+++|.+... ......++.+|++++++++||||+++++.+.+++..++||||+
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcC-CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 4566789999999999998765 4567888987643 2233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.....+++..+..++.|+++||.|||+. .+++|+||||+||++++++.+||+|||++..+.... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~ 155 (308)
T cd06615 82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 155 (308)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----c
Confidence 9999999998888889999999999999999999952 489999999999999999999999999987653321 2
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 2346789999999998888999999999999999999999998543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.87 Aligned_cols=200 Identities=24% Similarity=0.337 Sum_probs=170.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+++... +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.+++..++|
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKS-SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 446677899999999999999865 4567999998642 222345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..+.....
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999998654 578889999999999999999954 999999999999999999999999999987643222
Q ss_pred ccccccccccccccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 638 QAARTGIRGTVGYFAPEWFRKAS----ITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. ......||+.|+|||++.... ++.++|||||||++|||++|+.||..
T Consensus 198 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 198 V-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred e-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 1 123456899999999997543 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.44 Aligned_cols=241 Identities=28% Similarity=0.378 Sum_probs=194.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||++..... ++.|++|.+.. ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKAD-KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCC-CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 34667899999999999998654 56799998753 2344567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 5678899999999999999999964 9999999999999999999999999998876543221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+..++.++||||||++++||++|+.||.... . ... .+....+....+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~-~~~----~~~~~~~~~~~~~------ 222 (256)
T cd08529 158 --ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--Q-GAL----ILKIIRGVFPPVS------ 222 (256)
T ss_pred --hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--H-HHH----HHHHHcCCCCCCc------
Confidence 223457889999999999899999999999999999999999985332 1 111 1111222221111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.+|++|||
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (256)
T cd08529 223 ---QMYSQQLAQLIDQCLTKDYRQRPD 246 (256)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcC
Confidence 123356889999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=307.85 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=172.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.+.||+|+||.||++.... .++.||+|+++.. .......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKD-TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 3456789999999999999765 4567999998642 23345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ- 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 638 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998888899999999999999999999954 9999999999999999999999999998754321100
Q ss_pred --------------------------------cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 --------------------------------AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999999999999999999999999999999999864
Q ss_pred C
Q 040134 687 G 687 (745)
Q Consensus 687 ~ 687 (745)
.
T Consensus 239 ~ 239 (360)
T cd05627 239 E 239 (360)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.36 Aligned_cols=245 Identities=27% Similarity=0.301 Sum_probs=203.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc---CHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---GEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 555 (745)
...|.+.+.||+|.||.||+++.+.. ++.+|+|.+.+.... ....+.+|+.+|+++. ||||+.+++.+++.+..+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~t-g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKST-GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCC-CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45577789999999999999998764 677999999764332 3468999999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC----CCceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD----YFTPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~Dfg~a~~ 631 (745)
+|||++.+|.|.+.+... .+++..+..++.|++.+++|||. .||+||||||+|+|+.. ++.+|++|||++..
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999766 48999999999999999999995 59999999999999953 35799999999998
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
... .......+||+.|+|||++....++..+||||+|+++|.|++|.+||........ . ..+..+..
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~-----~~i~~~~~--- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--F-----LAILRGDF--- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--H-----HHHHcCCC---
Confidence 765 2236678999999999999999999999999999999999999999975443211 1 12223333
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+......+.+.+++..|+..||.+|+|
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~t 286 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLT 286 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCC
Confidence 1122223344667889999999999999987
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.88 Aligned_cols=242 Identities=28% Similarity=0.356 Sum_probs=190.5
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
...+.||+|+||+||++.... +++.+|+|.+.... ......+.+|++++++++|+||+++++.+..++..+++|||
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRA-TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEECC-CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 345789999999999998865 45679999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999888643 4689999999999999999999954 999999999999999999999999999876532221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....|+..|+|||.+.+..++.++|+||||+++|||++|..||...... ... ..+..........
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--~~~-~~~~~~~~~~~~~--------- 223 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--VKR-EEVDRRVLETEEV--------- 223 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHHhhhccccc---------
Confidence 22346899999999998889999999999999999999999998643221 111 1111111111100
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++..|++.||++|||
T Consensus 224 -~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05632 224 -YSAKFSEEAKSICKMLLTKDPKQRLG 249 (285)
T ss_pred -cCccCCHHHHHHHHHHccCCHhHcCC
Confidence 01112345778999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.95 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=193.8
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
....+.+.+.||+|+||.||+|.... .....|++|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34456677899999999999998753 234679999986432 2334578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEE
Q 040134 554 RLLVYEYMSNGSLASFLFGI----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI 623 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 623 (745)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999998643 2367888999999999999999954 9999999999999999999999
Q ss_pred eeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 040134 624 SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |+.|+..... ..+...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~--- 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV--- 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH---
Confidence 99999986644332222233446788999999988889999999999999999998 8888753221 1121211
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+...... ......+.+++.+||+.+|++|||
T Consensus 235 -~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt 267 (277)
T cd05032 235 -IDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPT 267 (277)
T ss_pred -hcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCC
Confidence 111111111 112456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.51 Aligned_cols=245 Identities=29% Similarity=0.396 Sum_probs=189.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCC----CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
.+.+.+.||+|++|.||+|..... ....|++|.+.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 355678899999999999998651 35679999886432 3334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---ceEEeec
Q 040134 557 VYEYMSNGSLASFLFGIT-------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---TPRISDF 626 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Df 626 (745)
||||+++++|.+++.... .+++..+++++.||+.||+|||+. +++|+||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999986542 478899999999999999999965 999999999999998654 6999999
Q ss_pred cCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 627 GLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 627 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
|+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+... ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~----~~~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEF----VTG 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHc
Confidence 99987633222111112233568999999998899999999999999999997 8888753222 111111 111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..... ........+.+++.+|++.+|++|||
T Consensus 237 ~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps 267 (277)
T cd05036 237 GGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPN 267 (277)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 11000 01122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.70 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=189.2
Q ss_pred HHhcchhhcCcceeEEEEEEEee---------------CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA---------------SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~---------------~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l 544 (745)
..+.+.+.||+|+||.||++... ......||+|.+... .......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34667889999999999998532 223456899998653 33345689999999999999999999
Q ss_pred EEEEecCCeEEEEEEecCCCCHHHHhcCCC-----------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGIT-----------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
++++...+..++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999986542 355678999999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCc
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC--CKSSVVFGTTNP 691 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt--g~~p~~~~~~~~ 691 (745)
++++++.++|+|||++..+.............++..|+|||......++.++||||||+++|||++ |..|+.. ...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~--~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ--LSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc--cCh
Confidence 999999999999999986643322111222334678999999888889999999999999999998 5555532 222
Q ss_pred hhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 692 EEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.... ..+....... ....+. .......+.+++.+||+.||++|||
T Consensus 240 ~~~~~~-~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~ 286 (296)
T cd05095 240 EQVIEN-TGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPS 286 (296)
T ss_pred HHHHHH-HHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCC
Confidence 221111 1111111100 000010 1112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=296.87 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=189.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
....+.++||+|+||.||+|.....+. ..||+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 445567899999999999998754332 25899998643 333456788999999999999999999998754 5779
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
++||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999764 5689999999999999999999955 9999999999999999999999999999876433
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
..........++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+..++ ..+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~~~~--- 232 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLL----EKGERLPQ--- 232 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----HCCCcCCC---
Confidence 32211222334678999999988899999999999999999998 888874322 12222221 11111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 233 ------~~~~~~~~~~li~~~l~~dp~~Rp~ 257 (279)
T cd05109 233 ------PPICTIDVYMIMVKCWMIDSECRPR 257 (279)
T ss_pred ------CccCCHHHHHHHHHHcCCChhhCcC
Confidence 1122346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.93 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=192.8
Q ss_pred HHHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||++... ......||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 345667889999999999999752 2234579999986532 23346789999999999 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 554 RLLVYEYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
.+++|||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 378999999999999999999965 999999999999999999999999999986
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...+.. ....+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~~ 264 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYK----LIKEGYRMA 264 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHH----HHHcCCcCC
Confidence 643322111222345778999999998889999999999999999998 8888753322 111111 111111000
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......+.+++.+|++.+|++|||
T Consensus 265 -----~----~~~~~~~~~~li~~cl~~~p~~Rpt 290 (302)
T cd05055 265 -----Q----PEHAPAEIYDIMKTCWDADPLKRPT 290 (302)
T ss_pred -----C----CCCCCHHHHHHHHHHcCCCchhCcC
Confidence 0 0111346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.30 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=192.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-----ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
+...+.||+|++|.||++.... .++.+++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~-~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred ccccceecCCCceEEEEEEEcC-CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 4456889999999999998754 45679999875422 12235788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
+||+++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++..+.....
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998778889999999999999999999965 999999999999999999999999999876543221
Q ss_pred ccc-cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAA-RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .... ...........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~----~~~~~~~~~~~------ 227 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAI----FKIATQPTNPQ------ 227 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHH----HHHhccCCCCC------
Confidence 110 1234577899999999998899999999999999999999999853211 1111 11111111110
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rpt 253 (263)
T cd06625 228 ---LPSHVSPDARNFLRRTFVENAKKRPS 253 (263)
T ss_pred ---CCccCCHHHHHHHHHHhhcCcccCCC
Confidence 11122345788999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.07 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=189.7
Q ss_pred HhcchhhcCcceeEEEEEEEee---CCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLA---SDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l 556 (745)
.+.+.+.||+|+||.||++... ...++.|++|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3456788999999999999853 33466799999876655566789999999999999999999998754 346889
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+...
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999754 4689999999999999999999965 9999999999999999999999999999876433
Q ss_pred cccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch---------hhHHHHHHHHhhc
Q 040134 636 QTQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE---------EALMDWVYRCYIG 705 (745)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~---------~~l~~~~~~~~~~ 705 (745)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..++........ ........+....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 2211 01112234569999999888899999999999999999998776532211000 0000001111111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+ ............+.+++.+||+.+|++|||
T Consensus 242 ~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 272 (284)
T cd05081 242 N---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272 (284)
T ss_pred C---------CcCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 1 000111122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.33 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=192.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|++|.||++.... .....+|+|.+... .......+.+|++++.++ +|+||+++++++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3445677899999999999998753 23467999998643 223345688999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcC----------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 554 RLLVYEYMSNGSLASFLFG----------------ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
.+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 9999999999999999853 24578889999999999999999965 9999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALM 696 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~ 696 (745)
++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EEL- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHH-
Confidence 99999999999987654332221222345678999999988899999999999999999997 8888753221 111
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+....+.... ........+.+++.+|++.||++|||
T Consensus 244 ---~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps 280 (293)
T cd05053 244 ---FKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPT 280 (293)
T ss_pred ---HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcC
Confidence 11111111110 11122456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=291.40 Aligned_cols=241 Identities=28% Similarity=0.397 Sum_probs=189.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
...+.+.||+|++|.||++.... +..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~--~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG--KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC--CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 34577899999999999998753 3468999886422 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 999999998754 4678999999999999999999965 99999999999999999999999999987654322111
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+ .. .....+....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~-~~----~~~~~~~~~~--------- 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SE-VV----ESVSAGYRLY--------- 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HH-HH----HHHHcCCcCC---------
Confidence 112234567999999998899999999999999999999 7888753221 11 11 1111111000
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt 247 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPA 247 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 01113456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=288.33 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=191.4
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhc--cCCCCceeEEEEEecCC----eEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ--THHKNLVRLLGFCDEGD----HRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv 557 (745)
.+.+.||+|.||.||+|.++. +.||||++... .++...+|.++.+. |+|+||+.+++.-..++ .++||
T Consensus 214 ~L~e~IGkGRyGEVwrG~wrG---e~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWRG---EDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred EEEEEecCccccceeeccccC---CceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 356789999999999999975 45999999643 35667788888774 59999999998775544 68999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE-----CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
.+|.+.|||.+||.. ..++....++++..+|.||++||.+ -++.|.|||||..|||+..++.+.|+|+|+|...
T Consensus 288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 999999999999976 7789999999999999999999975 2467999999999999999999999999999887
Q ss_pred cccc--cccccccccccccccchhccccC----CC--CccchhHHHHHHHHHHHhC----------CCCCCCCCCCchhh
Q 040134 633 LAEQ--TQAARTGIRGTVGYFAPEWFRKA----SI--TVKVDVYSFGVLLLELICC----------KSSVVFGTTNPEEA 694 (745)
Q Consensus 633 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~--s~~~DvwslG~vl~elltg----------~~p~~~~~~~~~~~ 694 (745)
.... ........+||.+|||||++... .+ -..+||||||.|+||++.. +.||+.-.+.+.
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-- 444 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-- 444 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC--
Confidence 6543 23334556899999999999543 12 2469999999999999753 344443222211
Q ss_pred HHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 695 LMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 695 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
-.+.+.+.+-...+...++.+.. +.+.+..+.++|..||..+|..|-|
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred CHHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhH
Confidence 11222333333334444433333 5577888999999999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=324.22 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=189.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||.||+|.... .++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~-tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPV-CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECC-CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4567899999999999998765 45679999986422 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccC
Q 040134 560 YMSNGSLASFLFGI-----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGL 628 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 628 (745)
|+++++|.+++... ...++..+++++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998531 2345667889999999999999965 999999999999999999999999999
Q ss_pred cccccccccc----------------cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch
Q 040134 629 AKLLLAEQTQ----------------AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692 (745)
Q Consensus 629 a~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~ 692 (745)
++........ .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-- 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-- 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--
Confidence 9876211100 0012246899999999999999999999999999999999999998642211
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. . ..... ....... ....+....+.+++.+|++.||++||+
T Consensus 238 k-i---~~~~~----i~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 238 K-I---SYRDV----ILSPIEV----APYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred h-h---hhhhh----ccChhhc----cccccCCHHHHHHHHHHccCChhhCcC
Confidence 0 0 11110 0000000 001122345788999999999999985
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=308.55 Aligned_cols=193 Identities=24% Similarity=0.280 Sum_probs=165.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||++..... ++.||||... ...+.+|++++++++|+||+++++++..+...++|||++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~-~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDY-PQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCC-CCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 355678899999999999998764 5679999642 234578999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
. ++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+........
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 6888887654 5689999999999999999999954 999999999999999999999999999987643322222
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
.....||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 234568999999999999999999999999999999999887664
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=295.73 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=194.0
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCC---CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCe
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASD---SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDH 553 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 553 (745)
....+.+.++||+|+||.||+|..... ..+.|++|.+... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 445667889999999999999998752 2577999988643 23335678899999999999999999998766 567
Q ss_pred EEEEEEecCCCCHHHHhcCC--------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 554 RLLVYEYMSNGSLASFLFGI--------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
.++++||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653 3478899999999999999999965 999999999999999999999999
Q ss_pred ccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 626 FGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 626 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ..+..++.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH----
Confidence 999987644332222223345778999999988889999999999999999999 8988853211 11212111
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+... .........+.+++.+||+.||++|||
T Consensus 234 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps 265 (280)
T cd05043 234 DGYRL---------AQPINCPDELFAVMACCWALDPEERPS 265 (280)
T ss_pred cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCC
Confidence 11100 001112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.63 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=184.7
Q ss_pred hcCcceeEEEEEEEeeCC-CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 488 ILGRGAFGTVYKGVLASD-SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.||+|+||.||+|++... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 389999999999987532 34569999986543 233467899999999999999999999885 457899999999999
Q ss_pred HHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-cccc
Q 040134 566 LASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTG 643 (745)
Q Consensus 566 L~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 643 (745)
|.+++.. ...+++..+++++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+....... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999875 35689999999999999999999965 99999999999999999999999999998654332211 1122
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..++..|+|||.+....++.++||||||+++|||++ |..||..... .... ..+..+.... .+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~~---------~~~ 221 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVM----SFIEQGKRLD---------CPA 221 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHH----HHHHCCCCCC---------CCC
Confidence 233578999999988889999999999999999996 8888853322 1111 1111111111 111
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~ 244 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPN 244 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcC
Confidence 22456888999999999999997
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=297.06 Aligned_cols=243 Identities=28% Similarity=0.405 Sum_probs=188.4
Q ss_pred cchhhcCcceeEEEEEEEeeCC----CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.||+|+||.||+|..... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 4567899999999999986431 22468888886432 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 040134 559 EYMSNGSLASFLFGI------------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNIL 614 (745)
Q Consensus 559 e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIl 614 (745)
||+.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 999999999997532 2467888999999999999999955 9999999999999
Q ss_pred ECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 040134 615 LDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEE 693 (745)
Q Consensus 615 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~ 693 (745)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~ 236 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---PE 236 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---HH
Confidence 99999999999999986543332211223345678999999988889999999999999999998 888874221 11
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+...+. .. .... . .......+.+++.+|++++|++|||
T Consensus 237 ~~~~~~~----~~-~~~~----~----~~~~~~~~~~~i~~cl~~~P~~Rp~ 275 (290)
T cd05045 237 RLFNLLK----TG-YRME----R----PENCSEEMYNLMLTCWKQEPDKRPT 275 (290)
T ss_pred HHHHHHh----CC-CCCC----C----CCCCCHHHHHHHHHHccCCcccCCC
Confidence 2222111 11 1000 0 1112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.14 Aligned_cols=243 Identities=27% Similarity=0.362 Sum_probs=193.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|++|.||+|+... .++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECC-CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 34556789999999999998654 45679999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.. ..+++.++..++.|++.||+|||.. +|+|+||||+||+++.++.+||+|||++......... .
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~ 173 (296)
T cd06654 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 173 (296)
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--c
Confidence 99999999854 4578899999999999999999954 9999999999999999999999999998765432211 2
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.. ....+ ...+ ...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~----~~~~~-~~~~-------~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL----IATNG-TPEL-------QNP 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH----HhcCC-CCCC-------CCc
Confidence 2345788999999998888999999999999999999999998643321 11111 11111 1010 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt 263 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGS 263 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcC
Confidence 123355888999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.81 Aligned_cols=200 Identities=24% Similarity=0.388 Sum_probs=166.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|+... .++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecC-CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 35567889999999999998765 45679999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 975 888877654 4578899999999999999999965 9999999999999999999999999998764332211
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223457889999998865 468899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.55 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=190.9
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccccc-cCHHHHHHHHHHHhccC-CCCceeEEEEEecC
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEG 551 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 551 (745)
+......+.+.||+|+||.||+|++.. ..++.||+|+++.... ...+.+.+|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 334445567899999999999998643 2346799999975322 22457889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC---------------------------------------------------------
Q 040134 552 DHRLLVYEYMSNGSLASFLFGIT--------------------------------------------------------- 574 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 574 (745)
...++||||+++|+|.++++..+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999985421
Q ss_pred -----------------------------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 575 -----------------------------------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 575 -----------------------------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
.+++..++.++.||+.||+|||+ .+++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence 24566778899999999999995 4999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPE 692 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~ 692 (745)
|+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~ 348 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--N 348 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--h
Confidence 999999999999999986543222111223346788999999988889999999999999999998 7888753221 1
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.+. ..+..+.... . .......+.+++..||+.+|.+|||
T Consensus 349 ~~~~----~~~~~~~~~~--~-------p~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 349 EQFY----NAIKRGYRMA--K-------PAHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred HHHH----HHHHcCCCCC--C-------CCCCCHHHHHHHHHHcCCChhHCcC
Confidence 1111 1111111000 0 1112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=289.89 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=192.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+|+.... ++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++++|
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLD-RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCC-CCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 45678899999999999997653 467999987532 23334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 560 YMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 560 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988752 34578889999999999999999965 9999999999999999999999999998876433
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+........ .+. ...........
T Consensus 160 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~---- 228 (267)
T cd08228 160 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----SLC-QKIEQCDYPPL---- 228 (267)
T ss_pred hHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----HHH-HHHhcCCCCCC----
Confidence 221 2234678899999999888899999999999999999999999854332211 111 11111111111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~ 254 (267)
T cd08228 229 ----PTEHYSEKLRELVSMCIYPDPDQRPD 254 (267)
T ss_pred ----ChhhcCHHHHHHHHHHCCCCcccCcC
Confidence 01123456889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.55 Aligned_cols=239 Identities=29% Similarity=0.424 Sum_probs=188.0
Q ss_pred hhcCcceeEEEEEEEeeCCC--cEEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
++||+|+||.||+|+....+ ...+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875543 36799999875433 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-ccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ART 642 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~ 642 (745)
++|.+++.....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.+....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999965 99999999999999999999999999998764433211 111
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
...++..|+|||.+....++.++||||||+++|||++ |..||..... ..+...+. ...... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~---------~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLP---------RP 220 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCC---------CC
Confidence 2234568999999988899999999999999999998 8888753321 12222221 111100 01
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+|++.+|++|||
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~ 244 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPT 244 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcC
Confidence 112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=293.82 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=192.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+++.+.||+|+||.||+|...... ...||+|.++.. .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34667889999999999999986543 346999998653 333456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999998754 5678999999999999999999965 99999999999999999999999999987654332
Q ss_pred cccccccc---cccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 637 TQAARTGI---RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 637 ~~~~~~~~---~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
........ ..+..|+|||.+....++.++||||||+++|||++ |..||..... ......+... ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~---~~~~--- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQD---YRLP--- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcC---CcCC---
Confidence 21111111 12457999999998899999999999999999886 8888753221 1121222110 0000
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+....+.+++.+||+.+|++|||
T Consensus 232 -------~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (269)
T cd05065 232 -------PPMDCPTALHQLMLDCWQKDRNARPK 257 (269)
T ss_pred -------CcccCCHHHHHHHHHHcCCChhhCcC
Confidence 01122345789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=291.81 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=197.8
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
...+++.+.||+|++|+||++.... .++.||+|++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC-CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3456677899999999999998765 3567899987543 2344578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++...+.+++..+..++.+++.||.|||+. .+++|+||+|+||++++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999999998777889999999999999999999962 489999999999999999999999999987543221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc-----hhhHHHHHHHHhhcCccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP-----EEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+.++..... ......+
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-- 233 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRL-- 233 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCC--
Confidence 223468899999999988889999999999999999999999987543321 111112221111 1111110
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+....+.+++.+|++.||++|||
T Consensus 234 ------~~~~~~~~~~~li~~~l~~dp~~Rpt 259 (284)
T cd06620 234 ------PSSDFPEDLRDFVDACLLKDPTERPT 259 (284)
T ss_pred ------CchhcCHHHHHHHHHHhcCCcccCcC
Confidence 01123356888999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.39 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=189.4
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
...+.+.+.||+|+||.||+|.... .....||+|.+.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3456778899999999999997642 234579999886432 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 555 LLVYEYMSNGSLASFLFGI----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
++||||+++++|.+++... ..+.+..+..++.|++.||.|||+. +|+||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999642 2345677889999999999999955 99999999999999999999999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ..+ ... ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--~~~-~~~----~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--NEQ-VLK----FV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--HHH-HHH----HH
Confidence 9999886543332221222345678999999988889999999999999999998 677764321 111 111 11
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..... .......+.+++.+||+.||++|||
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps 267 (288)
T cd05061 235 MDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPT 267 (288)
T ss_pred HcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcC
Confidence 11111110 0112356899999999999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.23 Aligned_cols=235 Identities=27% Similarity=0.314 Sum_probs=183.1
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhcc---CCCCceeEEEEEecCCeEEEEEEecC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQT---HHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
||+|+||+||+++... .++.||+|++..... .....+..|..++.+. +||||+++++.+.+.+..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 7999999999998765 456799999864221 2223445566666655 69999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 999999998888899999999999999999999965 999999999999999999999999999875432221 123
Q ss_pred cccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
...|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... .+ ..+.+..+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~-----~~~~i~~~~~~~-~~-------- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQ-----MYRNIAFGKVRF-PK-------- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--HH-----HHHHHHcCCCCC-CC--------
Confidence 45689999999998754 579999999999999999999999854321 11 111222121111 00
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++||+
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~ 242 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLG 242 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCC
Confidence 012345778999999999999984
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=286.97 Aligned_cols=240 Identities=32% Similarity=0.475 Sum_probs=193.8
Q ss_pred hhcCcceeEEEEEEEeeCC--CcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||+|+||.||++..... .+..|++|.+...... ..+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999998752 2567999998754333 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 564 GSLASFLFGI---------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 564 gsL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++|.+++... ..+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 678999999999999999999995 4999999999999999999999999999988755
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
...........++..|+|||.+....++.++||||||+++|||++ |..||..... ..+ .+....+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEV----LEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCCC---
Confidence 432222334557889999999988889999999999999999999 5888754421 111 12221111111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcC
Confidence 01122456889999999999999997
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.88 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=190.2
Q ss_pred hhcCcceeEEEEEEEeeCCCc--EEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||+|++|.||+|.+....+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865333 3699999976544 556789999999999999999999999988 899999999999
Q ss_pred CCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-c
Q 040134 564 GSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-A 640 (745)
Q Consensus 564 gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~ 640 (745)
++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997653 678999999999999999999954 99999999999999999999999999998765432211 1
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+..... .+ ....+.. .. ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~-~~~~~~~---~~--~~~~------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQ-ILKKIDK---EG--ERLE------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HH-HHHHHHh---cC--CcCC-------
Confidence 123456788999999988899999999999999999998 9999853221 11 1111111 11 0000
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+|++.+|++|||
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps 247 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPT 247 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCC
Confidence 01122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.84 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=185.6
Q ss_pred chhhcCcceeEEEEEEEeeCCCc-EEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------CeEE
Q 040134 485 FRQILGRGAFGTVYKGVLASDSK-RFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DHRL 555 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~-~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 555 (745)
+.++||+|+||.||+|....... ..||+|.++.. .....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56789999999999999865433 35899988642 233456788999999999999999999987432 2568
Q ss_pred EEEEecCCCCHHHHhcC------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 556 LVYEYMSNGSLASFLFG------ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
++|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 23478899999999999999999965 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNL 708 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 708 (745)
+.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... . ..+ ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~-~~~----~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--N-SEI----YDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--H-HHH----HHHHHcCCC
Confidence 87644322111222345678999999998899999999999999999999 778875321 1 111 122222211
Q ss_pred cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .......+.+++.+||+.||++|||
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcC
Confidence 110 1122345889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=288.46 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=191.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+++.+.||+|+||.||++.... .+..+++|.+........+.+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC-CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 4566789999999999999765 456789999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RR 160 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--cc
Confidence 9999998764 45689999999999999999999965 999999999999999999999999999876533221 12
Q ss_pred ccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 642 TGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
....++..|+|||.+. +..++.++||||||+++|||++|+.||.... ....... .. ......+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~----~~-~~~~~~~~~--- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLK----IA-KSEPPTLAQ--- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHH----Hh-hcCCCCCCC---
Confidence 3346889999999984 4457889999999999999999999975322 1111111 11 111111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rp~ 255 (282)
T cd06643 231 ----PSRWSSEFKDFLKKCLEKNVDARWT 255 (282)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcC
Confidence 1112346889999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=288.11 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=197.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||.|++|.||++..... ++.+++|.+........+.+.+|++++++++||||+++++.+......+++|||+
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIAT-GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCC-CCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 355678899999999999998653 4569999987655556788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+..+..... .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999999998776 7789999999999999999999965 999999999999999999999999999876543221 1
Q ss_pred cccccccccccchhccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKA---SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~---~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....++..|+|||.+... .++.++||||||+++|||++|+.|+...... ..... ........ ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~-----~~~~~~~~-----~~ 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFL-----ISKSNFPP-----PK 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-----HHhccCCC-----cc
Confidence 2334678899999999776 8899999999999999999999998643321 11111 11111110 00
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..........+.+++.+||+.+|.+|||
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt 253 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPT 253 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCC
Confidence 1112234567899999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.55 Aligned_cols=241 Identities=30% Similarity=0.414 Sum_probs=188.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.++||+|++|.||+|+.... ..||+|+++.. ....+.+.+|++++++++|+||+++++++.+ ...++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~--~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC--ceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 4577889999999999999987643 34999998752 2345678999999999999999999998754 567899999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999753 4578899999999999999999954 9999999999999999999999999999766433221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .. . ......+...
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~-~----~~~~~~~~~~-------- 222 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE-V----LDQVERGYRM-------- 222 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HH-H----HHHHhcCCCC--------
Confidence 1 222345678999999988889999999999999999999 7777643221 11 1 1111111100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+....+.+++.+|++.||++|||
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~ 249 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPT 249 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCC
Confidence 111233456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=300.15 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=187.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC-cEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS-KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+|...... ...+++|.++.. .....+.+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34567889999999999999976533 245788877542 233456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCce
Q 040134 558 YEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP 621 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~ 621 (745)
|||+++++|.+++... ..+++.+++.++.||+.||+|||+. +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 9999999999998643 2467889999999999999999954 99999999999999999999
Q ss_pred EEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 040134 622 RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVY 700 (745)
Q Consensus 622 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~ 700 (745)
||+|||++........ ......+..|+|||.+....++.++||||||+++|||+| |..||..... .....
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~--- 234 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE--- 234 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHH---
Confidence 9999999864321111 111234567999999988889999999999999999998 8988853221 11111
Q ss_pred HHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.... ........+.+++.+||+.+|++|||
T Consensus 235 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~ 269 (303)
T cd05088 235 -KLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPS 269 (303)
T ss_pred -HHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 111110000 01112345789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.91 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=195.8
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEE--ccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe--EEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKK--LDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH--RLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~--~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lv 557 (745)
+|.++||+|+|-+||+|.+.. .+..||=-. +++ ..+...+.|..|+++|+.|+||||++++..+.+... .-+|
T Consensus 43 k~~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccc-cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 356789999999999999854 444465222 222 234445889999999999999999999999877654 7789
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 636 (745)
+|.+..|+|..|+++.++++.+.+..|++||++||.|||.+ .++|||||||.+||+|+. .|.+||+|+|+|..+....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999999999999999999999999999999998 889999999999999975 5899999999999875544
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....|||.|||||... ..|+...||||||++++||+|+..|+.--.. ...+++.+..|.....+..-.
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhccC
Confidence 23368999999999996 8899999999999999999999999852221 345666666665444332211
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
-.++.++|..||.. .++|||
T Consensus 270 --------dPevr~fIekCl~~-~~~R~s 289 (632)
T KOG0584|consen 270 --------DPEVREFIEKCLAT-KSERLS 289 (632)
T ss_pred --------CHHHHHHHHHHhcC-chhccC
Confidence 13477899999999 899997
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.22 Aligned_cols=246 Identities=27% Similarity=0.440 Sum_probs=191.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+...+.||+|++|.||+|+..... ...+++|.++.. .....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 34556788999999999999986433 247999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999754 5688999999999999999999965 99999999999999999999999999987664322
Q ss_pred ccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... .......+..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.. .+..+... +
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~----~i~~~~~~----~ 230 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMK----AINDGFRL----P 230 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHH----HHhcCCCC----C
Confidence 111 1111223457999999988889999999999999999997 9999853321 11111 11111100 0
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+|++.+|++||+
T Consensus 231 -----~~~~~~~~~~~li~~c~~~~p~~Rp~ 256 (268)
T cd05063 231 -----APMDCPSAVYQLMLQCWQQDRARRPR 256 (268)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 01122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=288.83 Aligned_cols=232 Identities=24% Similarity=0.357 Sum_probs=180.9
Q ss_pred hhcCcceeEEEEEEEeeCC-----------CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 487 QILGRGAFGTVYKGVLASD-----------SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
+.||+|+||.||+|+.... ....|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986432 12358899887655555568889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-------eEEeecc
Q 040134 556 LVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT-------PRISDFG 627 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~-------~kl~Dfg 627 (745)
+||||+++++|..++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998754 5689999999999999999999954 9999999999999986654 8999999
Q ss_pred Ccccccccccccccccccccccccchhccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELI-CCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwslG~vl~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|..|+......+. .+. ..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~-~~ 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERF-YE 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHH-Hh
Confidence 98755322 2234678899999886 467899999999999999998 57777643221110 011 11
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+... .. ......+.+++.+||+.||++|||
T Consensus 224 ~~~~-~~---------~~~~~~~~~li~~cl~~dp~~Rp~ 253 (262)
T cd05077 224 GQCM-LV---------TPSCKELADLMTHCMNYDPNQRPF 253 (262)
T ss_pred cCcc-CC---------CCChHHHHHHHHHHcCCChhhCcC
Confidence 1111 00 011345789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.54 Aligned_cols=241 Identities=29% Similarity=0.410 Sum_probs=188.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|++|.||++.... +..+|+|.+.... ...+.+.+|+.++++++|+||+++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG--NTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC--CceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 346678899999999999998754 3458999986533 24567999999999999999999999885 4568899999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999998753 4578999999999999999999965 9999999999999999999999999999876433211
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+....++.++||||||+++|||++ |..||..... .+ .... +..+...
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~-~~~~----~~~~~~~-------- 222 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--RE-VLEQ----VERGYRM-------- 222 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HH-HHHH----HHcCCCC--------
Confidence 1 122335678999999988889999999999999999999 7888753221 11 1111 1111100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+|++.+|++|||
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt 249 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPT 249 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcC
Confidence 011122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=290.18 Aligned_cols=239 Identities=22% Similarity=0.334 Sum_probs=197.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|.|..|-+++.-- +++.||||++++.. ......+..|++.++.++|||||++|.+......+|||+|.
T Consensus 20 YDLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhc-ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 5567889999999998887644 45679999997643 33345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-CCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL-DDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
-.+|+|.+||.++ ..+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+ ..-|-+||+|||++..+.+...
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 9999999999766 6789999999999999999999965 89999999999876 6678999999999987755443
Q ss_pred cccccccccccccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASIT-VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.+..+|+..|-|||++.+..|+ ++.||||||||||.|++|+.||+.....+ .+ ..++|-...
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--TL-------------TmImDCKYt 237 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--TL-------------TMIMDCKYT 237 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--hh-------------hhhhccccc
Confidence 5667899999999999998886 77999999999999999999997544332 22 222222221
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .-....++.+||..||+.||++|.|
T Consensus 238 v--PshvS~eCrdLI~sMLvRdPkkRAs 263 (864)
T KOG4717|consen 238 V--PSHVSKECRDLIQSMLVRDPKKRAS 263 (864)
T ss_pred C--chhhhHHHHHHHHHHHhcCchhhcc
Confidence 1 2234567889999999999999975
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.12 Aligned_cols=241 Identities=29% Similarity=0.429 Sum_probs=186.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCc-EEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSK-RFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~-~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||.||+|....... ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567899999999999998865432 34788887642 233456789999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEE
Q 040134 560 YMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI 623 (745)
Q Consensus 560 ~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 623 (745)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 99999999999643 2467889999999999999999965 9999999999999999999999
Q ss_pred eeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 040134 624 SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
+|||++........ ......+..|+|||.+....++.++||||||+++|||++ |..||..... .. + .+.
T Consensus 161 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--~~-~----~~~ 230 (297)
T cd05089 161 ADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--AE-L----YEK 230 (297)
T ss_pred CCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HH-H----HHH
Confidence 99999864321111 111223567999999988889999999999999999997 9888853322 11 1 111
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.... ........+.+++.+||+.+|.+|||
T Consensus 231 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~ 264 (297)
T cd05089 231 LPQGYRME---------KPRNCDDEVYELMRQCWRDRPYERPP 264 (297)
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 11111000 01112345789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.77 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=170.7
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...+.+.+.||+|+||.||+++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+++..++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECC-CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3556677899999999999999765 4567999998642 22234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999999998653 578888999999999999999954 99999999999999999999999999998764332
Q ss_pred cccccccccccccccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKAS----ITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
... .....||+.|+|||++.... ++.++|||||||++|||++|+.||..
T Consensus 197 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 197 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred ccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 211 23456899999999987543 78999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.34 Aligned_cols=231 Identities=24% Similarity=0.356 Sum_probs=179.5
Q ss_pred hcCcceeEEEEEEEeeC-----------------------CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeE
Q 040134 488 ILGRGAFGTVYKGVLAS-----------------------DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~-----------------------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 544 (745)
.||+|+||.||+|.+.. .....|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998632 1124588999876544455678899999999999999999
Q ss_pred EEEEecCCeEEEEEEecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----
Q 040134 545 LGFCDEGDHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---- 619 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---- 619 (745)
++++.+....++||||+++++|..++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 46688999999999999999999954 999999999999997543
Q ss_pred ---ceEEeeccCcccccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCchhh
Q 040134 620 ---TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELI-CCKSSVVFGTTNPEEA 694 (745)
Q Consensus 620 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~ell-tg~~p~~~~~~~~~~~ 694 (745)
.+||+|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 4899999987643221 12346788999998865 56899999999999999994 6888875432211
Q ss_pred HHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 695 LMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 695 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....... ...... .....+.+++.+||+.+|++|||
T Consensus 230 ~~~~~~~---~~~~~~------------~~~~~~~~li~~cl~~~p~~Rps 265 (274)
T cd05076 230 KERFYEK---KHRLPE------------PSCKELATLISQCLTYEPTQRPS 265 (274)
T ss_pred HHHHHHh---ccCCCC------------CCChHHHHHHHHHcccChhhCcC
Confidence 1111110 000000 01235788999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.38 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=190.8
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCC------CcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEec
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASD------SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE 550 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 550 (745)
....+.+.+.||+|+||.||++..... ....+|+|.++.. .......+.+|+++++++ +|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 345677889999999999999986431 1246999998753 233346788899999999 79999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 040134 551 GDHRLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNIL 614 (745)
Q Consensus 551 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIl 614 (745)
.+..++||||+++++|.+++... ..+++.++++++.|++.||+|||+. +++|+||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 99999999999999999999653 2467889999999999999999964 9999999999999
Q ss_pred ECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 040134 615 LDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEE 693 (745)
Q Consensus 615 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~ 693 (745)
++.++.+||+|||.+..+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+... +..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~---~~~ 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVE 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC---CHH
Confidence 99999999999999876543221111222234568999999988889999999999999999998 77777422 111
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.. ....+.... ........+.+++.+|++.+|++|||
T Consensus 250 ~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps 288 (307)
T cd05098 250 ELFK----LLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPT 288 (307)
T ss_pred HHHH----HHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcC
Confidence 1111 111111111 01122356888999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.22 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=192.4
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeC------CCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEe
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLAS------DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCD 549 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 549 (745)
+....+.+.+.||+|+||.||+++... .....||+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 445566778899999999999997521 22357999998643 233456789999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 550 EGDHRLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 550 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
.....++||||+++++|.+++... ..+++.+++.++.||++||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999998653 2356778899999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPE 692 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~ 692 (745)
++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~ 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---V 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---H
Confidence 999999999999999987644332222223345678999999988889999999999999999998 677764221 1
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+ .+....+.... ........+.+++.+||+.+|++|||
T Consensus 246 ~~~----~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps 285 (304)
T cd05101 246 EEL----FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPT 285 (304)
T ss_pred HHH----HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCC
Confidence 111 11111111110 01123456888999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=289.27 Aligned_cols=242 Identities=29% Similarity=0.415 Sum_probs=192.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc---------CHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---------GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
.+...||+|++|.||+|.... .++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred cccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456789999999999998765 3567999987543221 125688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++|+||+++++|.+++.....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999998878889999999999999999999954 999999999999999999999999999987753
Q ss_pred ccccc----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 635 EQTQA----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 635 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .... .. ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~----~~-~~~~~~~~ 231 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAI----FK-IGENASPE 231 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHH----HH-HhccCCCc
Confidence 22111 11234578899999999888899999999999999999999999864321 1111 11 11110111
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......+.+++.+||+.||++|||
T Consensus 232 -----~----~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06628 232 -----I----PSNISSEAIDFLEKTFEIDHNKRPT 257 (267)
T ss_pred -----C----CcccCHHHHHHHHHHccCCchhCcC
Confidence 1 1122356788999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=286.52 Aligned_cols=243 Identities=27% Similarity=0.390 Sum_probs=181.9
Q ss_pred hcCcceeEEEEEEEeeCC-CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 488 ILGRGAFGTVYKGVLASD-SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.||+|+||.||+|....+ ....+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 589999999999986532 34569999886533 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 566 LASFLFGI-----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 566 L~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
|.+++... ...++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99998643 2346677889999999999999965 999999999999999999999999999876443322222
Q ss_pred cccccccccccchhccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKA-------SITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-------~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
.....++..|+|||.+... .++.++||||||+++|||++ |+.||...... +.. ... ..+....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~-~~~----~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVL-TYT----VREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHH-HHH----hhcccCCCC
Confidence 2334567889999998642 35789999999999999996 99898543221 111 111 111111111
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.... ...+.+.+++..|+ .+|++|||
T Consensus 232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt 259 (269)
T cd05087 232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPS 259 (269)
T ss_pred CCccCC----CCChHHHHHHHHHh-cCcccCCC
Confidence 221111 12234777889998 58999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.74 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=202.7
Q ss_pred HHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 476 ~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
-|+++...-+.++||-|.||.||.|+++... ..||||.++. +....++|+.|+.+++.++|||+|+++|+|..+..+|
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkys-lTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccc-eeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3455555556789999999999999998754 5699999975 4456789999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 556 LVYEYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
||.|||.+|+|.+||+... .++..-.+.++.||+.||+||... ++|||||..+|.|+.++..+|++|||+++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999998653 356667789999999999999955 99999999999999999999999999999987
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
.+.... .....-.+.|.|||-+....++.|+|||+|||+|||+.| |-.|++ +-. ...++.++.++
T Consensus 417 gDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-Gid------lSqVY~LLEkg------ 482 (1157)
T KOG4278|consen 417 GDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-GID------LSQVYGLLEKG------ 482 (1157)
T ss_pred CCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-Ccc------HHHHHHHHhcc------
Confidence 665433 334455789999999999999999999999999999987 445543 211 12334443332
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+....+...+.+||+.||+.+|.+||+
T Consensus 483 ---yRM~~PeGCPpkVYeLMraCW~WsPsDRPs 512 (1157)
T KOG4278|consen 483 ---YRMDGPEGCPPKVYELMRACWNWSPSDRPS 512 (1157)
T ss_pred ---ccccCCCCCCHHHHHHHHHHhcCCcccCcc
Confidence 222223445678999999999999999996
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=292.80 Aligned_cols=244 Identities=22% Similarity=0.303 Sum_probs=192.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+++.+.||+|+||.||+|.... .++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECC-CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46677889999999999998765 45679999987665566678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|..++.+ ...+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-- 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc--
Confidence 99999988754 35689999999999999999999954 9999999999999999999999999998754322111
Q ss_pred cccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... .... ... .......+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~----~~~-~~~~~~~~~--- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVL----LKI-AKSEPPTLS--- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHH----HHH-hcCCCccCC---
Confidence 23345788999999984 34578899999999999999999999854321 1111 111 111111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 237 ----~~~~~~~~~~~li~~~l~~~p~~Rp~ 262 (292)
T cd06644 237 ----QPSKWSMEFRDFLKTALDKHPETRPS 262 (292)
T ss_pred ----CCcccCHHHHHHHHHHhcCCcccCcC
Confidence 11122345788999999999999997
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.23 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=184.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhcc---CCCCceeEEEEEec-----CC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQT---HHKNLVRLLGFCDE-----GD 552 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 552 (745)
|.+.+.||+|+||.||++.... +++.||+|.++... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4566889999999999999865 46789999986422 22234566777777665 79999999998864 34
Q ss_pred eEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 553 HRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
..++||||+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 68999999975 888888654 3478999999999999999999955 99999999999999999999999999998
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc---Cc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG---KN 707 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 707 (745)
.+..... .....++..|+|||.+.+..++.++|||||||++|||++|++||..... ...+.. +...... ..
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGK-IFDLIGLPPEDD 230 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHH-HHHHhCCCChhh
Confidence 7643221 2334678999999999888999999999999999999999999854322 111111 1111000 00
Q ss_pred ccc-------cccccc---cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDK-------LAENDE---EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~-------~~~~~~---~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ...+.. ......+..+.+.+++.+||+.||++|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 000 000000 00001122356789999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.85 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=180.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecC--------Ce
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--------DH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~ 553 (745)
.+.+.++||+|+||.||+|+... .++.||||++... .....+|+.+++.++||||+++++++... ..
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 35677899999999999999765 4567999987532 12345799999999999999999876432 24
Q ss_pred EEEEEEecCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccC
Q 040134 554 RLLVYEYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGL 628 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~ 628 (745)
.++||||+++ +|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 6789999975 6766653 346788999999999999999999954 999999999999998664 799999999
Q ss_pred cccccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC-
Q 040134 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK- 706 (745)
Q Consensus 629 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~- 706 (745)
++.+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|.+||..... .+.+...+ +.+...
T Consensus 218 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~-~~~~~p~ 291 (440)
T PTZ00036 218 AKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRII-QVLGTPT 291 (440)
T ss_pred chhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH-HHhCCCC
Confidence 987643222 223467899999999865 4689999999999999999999999854322 12222211 111000
Q ss_pred ---------ccccccccc-----ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 ---------NLDKLAEND-----EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ---------~~~~~~~~~-----~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+..+. ...........++.+++.+||+.||.+|||
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t 344 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 000000000 000000112356889999999999999997
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=295.52 Aligned_cols=198 Identities=17% Similarity=0.216 Sum_probs=164.2
Q ss_pred chhhcCcc--eeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 485 FRQILGRG--AFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 485 ~~~~Ig~G--~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.++||+| ++++||++.... +++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecc-cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999998875 46779999986432 23345778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999998653 4588999999999999999999954 9999999999999999999999999875543221110
Q ss_pred c-----ccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 A-----ARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 ~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112346778999999976 4688999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=288.45 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=192.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|++|.||++..... ++.++||.+... ......++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLD-GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCC-CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 45678899999999999997653 467999987542 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 560 YMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 560 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+++++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 35578999999999999999999965 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+. . ... ...........
T Consensus 160 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~---~~~-~~~~~~~~~~~---- 228 (267)
T cd08229 160 TTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y---SLC-KKIEQCDYPPL---- 228 (267)
T ss_pred Ccc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-H---HHh-hhhhcCCCCCC----
Confidence 221 223467889999999988889999999999999999999999985332211 1 111 11111111100
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt 254 (267)
T cd08229 229 ----PSDHYSEELRQLVNMCINPDPEKRPD 254 (267)
T ss_pred ----CcccccHHHHHHHHHhcCCCcccCCC
Confidence 01123456889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.95 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=189.0
Q ss_pred HHhcchhhcCcceeEEEEEEEee------CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA------SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~------~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 552 (745)
..+.+.+.||+|+||.||++... ......+|+|.++.. .......+.+|+++++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 44567789999999999999753 123456899998743 233356788999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 553 HRLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
..+++|||+++++|.+++... ..+++.++.+++.|++.||.|||+. +++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999999999998643 3467888999999999999999965 999999999999999
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEAL 695 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l 695 (745)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence 999999999999987643222111122234567999999988889999999999999999999 787774221 1112
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ....+..... .......+.+++.+||+.||++|||
T Consensus 246 ~~----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps 282 (314)
T cd05099 246 FK----LLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPT 282 (314)
T ss_pred HH----HHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcC
Confidence 12 1111111110 1112346778999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.08 Aligned_cols=241 Identities=31% Similarity=0.443 Sum_probs=200.8
Q ss_pred chhhcCcceeEEEEEEEeeCCC---cEEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 485 FRQILGRGAFGTVYKGVLASDS---KRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
-.++||+|+||+||+|.+-... +.+||||++.. ...+..+++.+|+-++.+++|||++|++++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 3468999999999999985443 34799999865 44556789999999999999999999999998876 8899999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++.|+|.++++.+ ..+..+..+.|..|||+||.|||++ .+|||||..+|||+.+-..+||.|||+++.+..+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999865 6688899999999999999999976 99999999999999999999999999999987776655
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......-.+.|||-|.+....++.++|||||||++||++| |..|+..... .++.+++....+.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------------~eI~dlle~geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------------EEIPDLLEKGERL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------HHhhHHHhccccC
Confidence 5555566789999999999999999999999999999987 5566532211 1222333333344
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
++.+-...++..++.+||..|++.||+
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~ 946 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPT 946 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCcc
Confidence 555666778999999999999999996
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.19 Aligned_cols=237 Identities=28% Similarity=0.424 Sum_probs=183.5
Q ss_pred hhcCcceeEEEEEEEeeCCCc-EEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSK-RFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~-~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
++||+|+||.||+|.+..... ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999865433 35788888643 234456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 564 GSLASFLFGIT----------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 564 gsL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
++|.+++.... .+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 367889999999999999999964 99999999999999999999999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
++........ ......+..|+|||.+....++.++||||||+++|||++ |..||..... . .+. +....+
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~-~~~----~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--A-ELY----EKLPQG 227 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--H-HHH----HHHhCC
Confidence 9863221111 111233567999999988889999999999999999997 8888843221 1 111 111111
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... ........+.+++.+|++.||.+|||
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps 257 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPS 257 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCC
Confidence 1000 01112345889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=288.57 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=179.4
Q ss_pred hhcCcceeEEEEEEEeeCC-CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCC
Q 040134 487 QILGRGAFGTVYKGVLASD-SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 564 (745)
+.||+|+||.||+|..... ....+++|.+.... ......+.+|++.++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3589999999999976433 34568888875432 233457889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCC-----CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 565 SLASFLFGIT-----RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 565 sL~~~l~~~~-----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+|.+++.... ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999996542 235677889999999999999965 99999999999999999999999999987543322211
Q ss_pred ccccccccccccchhcccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRK-------ASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
......++..|+|||.+.. ..++.++||||||+++|||++ |..|+.... +.+.+. ....... ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~----~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--DEQVLK----QVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHH----HHhhccC-ccC
Confidence 1222345678999998743 356789999999999999999 667764321 112111 1111111 111
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.. .......+.+++..|+ .||++|||
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt 259 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPT 259 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccC
Confidence 11111 1122345667888888 49999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.11 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=195.0
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcc--cccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 555 (745)
....|++.++||+||.+.||++...+ .+.+|+|++. ..+.+...-|.+|+..|.+| .|.+|+++++|-..++.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~--~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD--KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC--CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34456667899999999999987543 3457777764 34556678899999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCC-ChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
|||||- ..+|..+|.+.... ..-.+..+..||+.++.++|++ ||||.||||.|+|+.. |.+||+|||+|..+..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999987 56999999876443 3247888999999999999987 9999999999999976 4899999999999988
Q ss_pred cccccccccccccccccchhccccC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKA-----------SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
+.........+||+.||+||.+... +.+.++||||||||||+|+.|+.||.. +.....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~a--- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIA--- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHH---
Confidence 8777777788999999999998532 366899999999999999999999841 111111
Q ss_pred hcCccccccccccccccc-HHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKND-LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+..+.++....++. .....++++|++.||+.||++|||
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~s 620 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWS 620 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCC
Confidence 233344443322221 111223999999999999999997
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.91 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=192.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEee---CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--Ce
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLA---SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 553 (745)
...+.+.+.||+|+||.||+++.. ...++.||+|.++... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 344566778999999999999853 2346779999986432 33456799999999999999999999998775 57
Q ss_pred EEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 554 RLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 89999999999999998654 4579999999999999999999965 9999999999999999999999999999876
Q ss_pred cccccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC---------chhhHHHHHHHH
Q 040134 633 LAEQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN---------PEEALMDWVYRC 702 (745)
Q Consensus 633 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~---------~~~~l~~~~~~~ 702 (745)
...... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... ........ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-VRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-HHH
Confidence 443221 1122345677899999998888999999999999999999987664321110 00111111 111
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.... ........+.+++.+||+.||++|||
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt 272 (284)
T cd05079 239 LEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTT 272 (284)
T ss_pred HHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcC
Confidence 11111110 01123457899999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=285.09 Aligned_cols=242 Identities=25% Similarity=0.345 Sum_probs=194.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|++|.||+++... .++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 35567889999999999999875 346799999865332 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+..... .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 99999999865 35679999999999999999999965 999999999999999999999999999887643321 1
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ . ........ .....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~-----~~~~~~~~-------~~~~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--I-----FMIPNKPP-------PTLSD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--h-----hhhccCCC-------CCCCc
Confidence 2234478899999999988999999999999999999999999864322110 0 00000000 00111
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.||++|||
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps 246 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPS 246 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcC
Confidence 1223356889999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=288.25 Aligned_cols=244 Identities=30% Similarity=0.437 Sum_probs=191.1
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
+....+++.++||+|+||.||+|.... ++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~--~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG--HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC--CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 345677888999999999999998654 4569999986533 34568899999999999999999999874 4578999
Q ss_pred EEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 558 YEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998653 467889999999999999999995 49999999999999999999999999999776432
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....++..|+|||.+....++.++||||||+++|||++ |+.||..... .. +.. .+..+.....
T Consensus 156 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~-~~~----~~~~~~~~~~--- 224 (260)
T cd05067 156 EYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PE-VIQ----NLERGYRMPR--- 224 (260)
T ss_pred Cccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HH-HHH----HHHcCCCCCC---
Confidence 2211 223345678999999988889999999999999999999 8988853321 11 111 1111111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+++.+|++.+|++|||
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05067 225 ------PDNCPEELYELMRLCWKEKPEERPT 249 (260)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCC
Confidence 1112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=296.49 Aligned_cols=199 Identities=26% Similarity=0.346 Sum_probs=169.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+++... .++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 4567889999999999999865 3567999998642 22334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999975 45788999999999999999999965 9999999999999999999999999998765433221
Q ss_pred cccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 AARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .....|++.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 159 Q-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred c-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 1 223468999999999863 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.76 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=204.1
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCC---CcEEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASD---SKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~---~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
.++.-.+.++||.|-||.||+|++... ..-.||||..+. ...+..+.|..|..++++++||||++++|+|.+ +..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 333444567899999999999998543 345799999876 566678899999999999999999999999976 568
Q ss_pred EEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 555 LLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
++|||.++.|.|.+||... ..++......++.||..||+||| +.++|||||..+|||+.....+||+|||+++.+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999999865 56888899999999999999999 5699999999999999999999999999999987
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
++.... .+...-+..|||||.+.-..++.++|||.|||++||++. |..||..-.. .++..-+
T Consensus 543 d~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~~i 605 (974)
T KOG4257|consen 543 DDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIGHI 605 (974)
T ss_pred ccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEEEe
Confidence 766544 234456788999999999999999999999999999864 7788753322 1222223
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+...+.+....++..|..++.+||..||.+||+
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPr 638 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPR 638 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCc
Confidence 333444556677888999999999999999995
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.38 Aligned_cols=195 Identities=23% Similarity=0.362 Sum_probs=158.8
Q ss_pred hhcCcceeEEEEEEEeeC-CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~ 563 (745)
.+||+|+||.||+|+... ...+.+|+|.+... .....+.+|++++++++||||+++++++.. ....+++|||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 579999999999998753 34567999998642 234567889999999999999999998854 4578899999864
Q ss_pred CCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCceEEeeccCcc
Q 040134 564 GSLASFLFGI---------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL----DDYFTPRISDFGLAK 630 (745)
Q Consensus 564 gsL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~a~ 630 (745)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 787776422 2478888999999999999999955 99999999999999 456789999999998
Q ss_pred cccccccc-cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 631 LLLAEQTQ-AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 631 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.+...... .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76443221 11234568999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.08 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=166.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||++.... +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcC-CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 35567889999999999998765 45679999986432 33345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 97 5898888654 567889999999999999999995 49999999999999999999999999998764322211
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 223356889999998865 45788999999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=300.53 Aligned_cols=197 Identities=27% Similarity=0.315 Sum_probs=164.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------ 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 552 (745)
..|.+.+.||+|+||.||++.... .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcC-CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 346667899999999999998765 4567999998642 2334567889999999999999999999986443
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 553 HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999975 5666653 3478888999999999999999965 9999999999999999999999999999764
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 174 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 33221 23356889999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=292.06 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=193.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.+.||.|++|.||+++... .++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVA-TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcC-CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 4456789999999999998655 456799999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+...... ..
T Consensus 100 ~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~ 173 (296)
T cd06655 100 GGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RS 173 (296)
T ss_pred CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CC
Confidence 9999998864 4589999999999999999999955 9999999999999999999999999998765433221 22
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .+.. + . ......+.. ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~~-~---~-~~~~~~~~~-------~~ 239 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYL-I---A-TNGTPELQN-------PE 239 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-H---H-hcCCcccCC-------cc
Confidence 3457889999999998889999999999999999999999985433211 1111 1 0 011111100 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt 262 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGS 262 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCC
Confidence 12345778999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=287.78 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=187.8
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
...||+|+||.||+|+... +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~-~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLS-TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred eEEEecCCceEEEEeEecC-CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 3579999999999998765 456799999876555566789999999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCC--ChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCccccccccccccc
Q 040134 566 LASFLFGI-TRP--DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 566 L~~~l~~~-~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
|.+++... ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++..+..... ..
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~ 166 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT 166 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence 99999754 444 7788899999999999999954 9999999999999976 67999999999876543221 12
Q ss_pred ccccccccccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKA--SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~--~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
....++..|+|||.+... .++.++||||||+++|+|++|+.|+......... . +..... .....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~--~~~~~~--~~~~~--------- 232 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-M--FKVGMF--KIHPE--------- 232 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-H--hhhhhh--ccCCC---------
Confidence 234578899999998654 3789999999999999999999998543221111 0 000000 00000
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt 258 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRAS 258 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCC
Confidence 11122355788999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.16 Aligned_cols=241 Identities=27% Similarity=0.381 Sum_probs=191.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+...+.||+|++|.||+|.... .++.||+|.+.... ....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC-CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34456789999999999998765 45679999986432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+......
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-- 157 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh--
Confidence 999999998854 5678899999999999999999954 9999999999999999999999999998766433211
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ..+...... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~-----~~~~~~~~~-----~~---- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVL-----FLIPKNSPP-----TL---- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHH-----hhhhcCCCC-----CC----
Confidence 22245788999999999888999999999999999999999997532211 111 111111111 11
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPT 246 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcC
Confidence 1123456889999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=290.10 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=190.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..+.+.+.||+|+||.||++.... .....||+|.+.... ....+++.+|+.++++++||||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 345667889999999999998642 245679999986532 334567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC----------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 556 LVYEYMSNGSLASFLFGI----------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
+|+||+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 999999999999998642 2356778899999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPE 692 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~ 692 (745)
++++++.++|+|||++..+..............+..|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--~ 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--E 239 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999999999876543322111222334678999999988899999999999999999997 7777642211 1
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+ . ...+..+..... ......++.+++.+||+.||++|||
T Consensus 240 ~-~----~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt 278 (288)
T cd05050 240 E-V----IYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPS 278 (288)
T ss_pred H-H----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCC
Confidence 1 1 112222221110 0112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=291.09 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=193.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|++|.||+++... .++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 345567889999999999998754 4567999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.+ ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 999999999854 4578899999999999999999964 9999999999999999999999999998765433221
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ +. .....+ ... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~-~~~-------~~~ 237 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNG-TPE-------LQN 237 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCC-CCC-------CCC
Confidence 2234578899999999988899999999999999999999999854322110 00 000000 000 001
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps 262 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGS 262 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcC
Confidence 1122345778999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.40 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=187.4
Q ss_pred HHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEec-CCe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE-GDH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-~~~ 553 (745)
..+.+.+.||+|+||.||+|... ...++.||||+++... ......+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 45678899999999999999753 2345789999986532 23346788999999999 78999999998865 456
Q ss_pred EEEEEEecCCCCHHHHhcCC------------------------------------------------------------
Q 040134 554 RLLVYEYMSNGSLASFLFGI------------------------------------------------------------ 573 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 573 (745)
.+++|||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999998532
Q ss_pred -------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccc
Q 040134 574 -------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646 (745)
Q Consensus 574 -------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 646 (745)
..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||++..+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1256777889999999999999964 999999999999999999999999999987543322111222345
Q ss_pred cccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHH
Q 040134 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRV 725 (745)
Q Consensus 647 t~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (745)
+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+ ......+..... +. ...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~~--~~-------~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRMRA--PD-------YTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCCCC--CC-------CCC
Confidence 678999999988899999999999999999997 88887543221 111 111111111111 00 012
Q ss_pred HHHHHHHHhccccCcCCCCC
Q 040134 726 ERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 726 ~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+++.+||+.||++|||
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps 328 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPT 328 (343)
T ss_pred HHHHHHHHHHccCChhhCcC
Confidence 35789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=286.40 Aligned_cols=241 Identities=30% Similarity=0.407 Sum_probs=187.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|++|.||++..... ..+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT--TKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC--ceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4467788999999999999987653 34899987643 234567899999999999999999999875 4568899999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999754 3478899999999999999999965 9999999999999999999999999999765433221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... +.+ ....+ ..+....
T Consensus 159 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~-~~~~~----~~~~~~~------- 223 (260)
T cd05069 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NRE-VLEQV----ERGYRMP------- 223 (260)
T ss_pred c-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHH-HHHHH----HcCCCCC-------
Confidence 1 222345678999999988889999999999999999999 888875322 111 11111 1111000
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rp~ 249 (260)
T cd05069 224 --CPQGCPESLHELMKLCWKKDPDERPT 249 (260)
T ss_pred --CCcccCHHHHHHHHHHccCCcccCcC
Confidence 01123456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=289.53 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=192.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+|.....+ ...+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667889999999999999875332 3478999986432 23356889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999765 4678999999999999999999965 99999999999999999999999999998764432
Q ss_pred ccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... ......++..|+|||.+.+..++.++||||||+++||+++ |..||...... + ....+ .++. .. +
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~-~~~~~----~~~~-~~---~ 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--D-VIKAI----EEGY-RL---P 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--H-HHHHH----hCCC-cC---C
Confidence 211 1111223568999999998889999999999999999886 99988533221 1 11111 1111 00 0
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+|++.+|++|||
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~ 255 (267)
T cd05066 230 -----APMDCPAALHQLMLDCWQKDRNERPK 255 (267)
T ss_pred -----CCCCCCHHHHHHHHHHcccCchhCCC
Confidence 01122356789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=287.13 Aligned_cols=244 Identities=31% Similarity=0.456 Sum_probs=192.7
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
....+.+.+.||+|++|.||++.... .+.|++|.+... ....+++.+|+.++++++|+||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~--~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG--TTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC--CceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 34456678899999999999998754 356999998743 334578999999999999999999999999989999999
Q ss_pred EecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999764 3688999999999999999999965 99999999999999999999999999988764322
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ....+ .. ...+. ....
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~-~~----~~~~~-~~~~--- 225 (261)
T cd05034 158 YTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVL-EQ----VERGY-RMPR--- 225 (261)
T ss_pred hhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHH-HH----HHcCC-CCCC---
Confidence 111 122334578999999998889999999999999999998 888874321 11111 11 11110 0000
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rp~ 250 (261)
T cd05034 226 -----PPNCPEELYDLMLQCWDKDPEERPT 250 (261)
T ss_pred -----CCCCCHHHHHHHHHHcccCcccCCC
Confidence 0111356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=319.12 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=190.4
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCe
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDH 553 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 553 (745)
.....|.+.+.||+|+||+||++.... .++.||+|.+... .......+..|+.++++++||||+++++++.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~-tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKR-TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC-CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 333456778899999999999999865 4678999988642 23345678999999999999999999998854 457
Q ss_pred EEEEEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcC----CCCeeeCCCCCCCEEECC--------
Q 040134 554 RLLVYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEEC----STQIIHCDIKPQNILLDD-------- 617 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~dikp~NIll~~-------- 617 (745)
++|||||+++++|.++|... ..+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998642 56899999999999999999999641 146999999999999964
Q ss_pred ---------CCceEEeeccCcccccccccccccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 618 ---------YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 618 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999987643322 234568999999999854 4588999999999999999999999864
Q ss_pred CCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 687 GTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 687 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ...+ ...+..+....+ ......+.+|+..||+.+|.+|||
T Consensus 246 ~~~--~~ql----i~~lk~~p~lpi----------~~~S~eL~dLI~~~L~~dPeeRPS 288 (1021)
T PTZ00266 246 ANN--FSQL----ISELKRGPDLPI----------KGKSKELNILIKNLLNLSAKERPS 288 (1021)
T ss_pred CCc--HHHH----HHHHhcCCCCCc----------CCCCHHHHHHHHHHhcCChhHCcC
Confidence 322 1111 111111110000 012345889999999999999997
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=287.67 Aligned_cols=237 Identities=28% Similarity=0.400 Sum_probs=191.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|++|.||++... ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 34567789999999999999874 45699999976433 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999997654 689999999999999999999965 999999999999999999999999999987632221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
....+..|+|||.+....++.++||||||+++|||++ |..||.... ...+.. ....+.....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~----~~~~~~~~~~------ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVP----HVEKGYRMEA------ 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH----HHhcCCCCCC------
Confidence 2234568999999988889999999999999999997 888875321 111211 1111111100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~ 245 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPT 245 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcC
Confidence 1112356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=284.53 Aligned_cols=237 Identities=26% Similarity=0.362 Sum_probs=185.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
++||+|+||.||+|.... ++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD--KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecC--CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 368999999999998653 4569999986533 2234578899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccc
Q 040134 566 LASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644 (745)
Q Consensus 566 L~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 644 (745)
|.+++... ..+++..+..++.|++.+|.|||+. +++|+||||+||++++++.+||+|||++.......... ....
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 99998654 4578999999999999999999954 99999999999999999999999999987543322111 1122
Q ss_pred cccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 645 ~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
.++..|+|||.+....++.++||||||+++|||++ |..||..... .. . ......+.... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--~~-~----~~~~~~~~~~~---------~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQ-A----REQVEKGYRMS---------CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--HH-H----HHHHHcCCCCC---------CCCC
Confidence 34567999999988889999999999999999998 8888853321 11 1 11111111110 0112
Q ss_pred HHHHHHHHHHhccccCcCCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++.+|++.+|++|||
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCC
Confidence 2456889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=289.43 Aligned_cols=255 Identities=23% Similarity=0.285 Sum_probs=193.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+++.+.||+|++|.||+++... .++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred eeeeeeecccCCeEEEEEEECC-CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4566789999999999999865 35679999886432 22346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++.|..++.....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..+......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 156 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-- 156 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc--
Confidence 99999998887777889999999999999999999964 9999999999999999999999999999876443211
Q ss_pred cccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH----------hhcCc-c
Q 040134 641 RTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC----------YIGKN-L 708 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~----------~~~~~-~ 708 (745)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +.+....... +.... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV--DQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhccccccc
Confidence 223456788999999876 55789999999999999999999998643322 1111111000 00000 0
Q ss_pred cccccccccccccH-----HHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDL-----KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..+........ .....+.+++.+||+.||++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 276 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC
Confidence 00011111111111 12356889999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=284.95 Aligned_cols=238 Identities=26% Similarity=0.388 Sum_probs=186.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
++||+|++|.||++.... ++.|++|.++..... ..+.+.+|++++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999765 567999998654333 45689999999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccc
Q 040134 566 LASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644 (745)
Q Consensus 566 L~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 644 (745)
|.+++... ..+++..+..++.+++.||+|||+. +++||||+|+||+++.++.+||+|||++...............
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99998653 5678899999999999999999955 9999999999999999999999999999865432221111122
Q ss_pred cccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 645 ~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..+..|+|||.+.+..++.++||||||+++|||+| |..|+...... .... ...... .+. ....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~----~~~~~~--~~~-------~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRE----RIESGY--RMP-------APQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHH----HHhcCC--CCC-------CCcc
Confidence 34567999999988889999999999999999999 77776433211 1111 111110 000 0112
Q ss_pred HHHHHHHHHHhccccCcCCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++.+|++.+|++|||
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~ 241 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPS 241 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcC
Confidence 2346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=298.41 Aligned_cols=190 Identities=26% Similarity=0.356 Sum_probs=161.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||+|+... .++.||+|..... ....|+.++++++|+||+++++++.+....++|+|++
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPG-QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECC-CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 46677899999999999999765 4567999975432 2356999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 212 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--- 212 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---
Confidence 5 578887754 46789999999999999999999965 999999999999999999999999999875322211
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
.....|+..|+|||.+.+..++.++|||||||++|||+++..++.
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 233568999999999999999999999999999999998766653
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.87 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=193.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeC---CCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS---DSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 555 (745)
.+.+.+.||+|+||.||++++.. ..++.+|+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 44566889999999999998753 34678999998754332 46789999999999999999999999877 66889
Q ss_pred EEEEecCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997654 689999999999999999999954 999999999999999999999999999987653
Q ss_pred cccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh--------hHHHHHHHHhhc
Q 040134 635 EQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE--------ALMDWVYRCYIG 705 (745)
Q Consensus 635 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~--------~l~~~~~~~~~~ 705 (745)
.... .......++..|+|||.+....++.++||||||++++||++|+.|+......... .......+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2221 1111233456799999998888999999999999999999999987543221100 001111111111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+. ..........++.+++.+||+.+|++|||
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 272 (284)
T cd05038 242 GE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPS 272 (284)
T ss_pred CC---------cCCCCccCCHHHHHHHHHHhccChhhCCC
Confidence 11 00111122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.78 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=193.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||.|++|.||++.... +++.+|+|.++.......+.+.+|++++++++|+||+++++.+......++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 35677889999999999999865 45679999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-- 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc--
Confidence 999999998764 5689999999999999999999965 9999999999999999999999999998765332211
Q ss_pred cccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||..... ...+ .. ...+....+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~~----~~-~~~~~~~~~~--- 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRVL----LK-ILKSEPPTLD--- 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHHH----HH-HhcCCCCCcC---
Confidence 23345788999999874 34577899999999999999999999853321 1111 11 1111111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++..||+.+|++|||
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps 255 (280)
T cd06611 230 ----QPSKWSSSFNDFLKSCLVKDPDDRPT 255 (280)
T ss_pred ----CcccCCHHHHHHHHHHhccChhhCcC
Confidence 01112345788999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=286.00 Aligned_cols=241 Identities=21% Similarity=0.291 Sum_probs=192.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||+|+||.||++..... ++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNS-DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCC-CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 45678899999999999987654 566899987532 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 999999988643 4578899999999999999999965 9999999999999999999999999998765432211
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... . ... .....+....+.
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~----~~~-~~~~~~~~~~~~------- 221 (255)
T cd08219 157 -ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--K----NLI-LKVCQGSYKPLP------- 221 (255)
T ss_pred -cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--H----HHH-HHHhcCCCCCCC-------
Confidence 2235678899999999888899999999999999999999999853221 1 111 111122222111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 222 --~~~~~~~~~li~~~l~~~P~~Rp~ 245 (255)
T cd08219 222 --SHYSYELRSLIKQMFKRNPRSRPS 245 (255)
T ss_pred --cccCHHHHHHHHHHHhCCcccCCC
Confidence 112345788999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.01 Aligned_cols=236 Identities=26% Similarity=0.307 Sum_probs=193.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|++|.||++.... .++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 4567889999999999999865 45679999986422 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998888899999999999999999999964 9999999999999999999999999998876433
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... .. ..+....+....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~-----~~~~~~~~~~~~--------- 217 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQ-----IYEKILEGKVRF--------- 217 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH-----HHHHHhcCCccC---------
Confidence 2234578899999999888889999999999999999999999854331 11 111111111110
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......+.+++.+||+.||.+||
T Consensus 218 -~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 218 -PSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred -CccCCHHHHHHHHHHccCCHHHcc
Confidence 011135678999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=282.64 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=194.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|++|.||+|.... +++.|++|.++. ......+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcC-CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 35677899999999999999874 456799998753 22333568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 559 EYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 559 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
||+++++|.+++.. ...+++.++..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 24578899999999999999999965 999999999999999999999999999876543
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... +.+.. +....+......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEKCDYPPLP-- 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHH-hhhhcCCCCCCC--
Confidence 2211 22345788999999998888999999999999999999999998543322 11111 111111111111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~ 254 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPD 254 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCC
Confidence 1123456889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=284.60 Aligned_cols=240 Identities=27% Similarity=0.373 Sum_probs=192.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+...+.||.|+||.||+|.... .++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEcc-CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4455789999999999998765 35679999886432 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..+...... .
T Consensus 85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~ 158 (277)
T cd06640 85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--R 158 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--c
Confidence 99999999865 5678889999999999999999954 9999999999999999999999999999776433211 2
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....++..|+|||.+.+..++.++|+||||+++|||++|..|+...... ... ........ ....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~-----~~~~~~~~---------~~~~ 222 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVL-----FLIPKNNP---------PTLT 222 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHh-----hhhhcCCC---------CCCc
Confidence 2345788899999998888999999999999999999999998533221 100 00111111 1112
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.+|++|||
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPT 246 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcC
Confidence 234567889999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=298.14 Aligned_cols=193 Identities=28% Similarity=0.393 Sum_probs=165.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-C-----CCceeEEEEEecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-H-----KNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~ 555 (745)
+|.+.++||+|.||+|-++.... +++.||||+++.. ..-..+-..|+.+|..|+ | -|+|+++++|...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~-T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK-TGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecC-CCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 56678999999999999998765 5678999999763 334456678999999996 4 48999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY--FTPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~--~~~kl~Dfg~a~~ 631 (745)
||+|.+. .+|.++|+.. ..++...++.++.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.+..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999995 5999999866 5678999999999999999999965 99999999999999644 4799999999987
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
...... ...-+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 533221 3456778999999999999999999999999999999976664
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=297.77 Aligned_cols=250 Identities=28% Similarity=0.377 Sum_probs=192.0
Q ss_pred HHHHHHhcchhhcCcceeEEEEEEEeeCC------CcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEE
Q 040134 477 ELEEATRGFRQILGRGAFGTVYKGVLASD------SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFC 548 (745)
Q Consensus 477 ~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 548 (745)
++....+.+.+.||+|+||.||++..... ....||+|.++.. .....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 34455677889999999999999975321 2236899988643 233456889999999999 899999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 040134 549 DEGDHRLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQN 612 (745)
Q Consensus 549 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~N 612 (745)
......++++||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999998643 2367788899999999999999964 99999999999
Q ss_pred EEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040134 613 ILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNP 691 (745)
Q Consensus 613 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~ 691 (745)
|++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999986643322211222334567999999999999999999999999999998 777774321
Q ss_pred hhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 692 EEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+. ..+..+..... .......+.+++.+|++.+|++|||
T Consensus 242 ~~~~~----~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps 282 (334)
T cd05100 242 VEELF----KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPT 282 (334)
T ss_pred HHHHH----HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcC
Confidence 11111 11111111110 1122346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=289.38 Aligned_cols=246 Identities=30% Similarity=0.386 Sum_probs=191.5
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCC---cEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDS---KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
...+.+.+.||+|+||.||+|.....+ ...+++|.+.... .....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 345567789999999999999875433 2468999886543 3345678899999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+|+||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999764 4689999999999999999999964 999999999999999999999999999987653
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
...........++..|+|||.+....++.++||||||+++||+++ |+.|+..... +.+.. .+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~-- 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPD----LLEKGERLPQ-- 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH----HHhCCCCCCC--
Confidence 332221222234568999999988889999999999999999998 9998853321 11111 1111111100
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||..||++|||
T Consensus 233 -------~~~~~~~~~~~~~~~l~~~p~~Rp~ 257 (279)
T cd05057 233 -------PPICTIDVYMVLVKCWMIDAESRPT 257 (279)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCCC
Confidence 0011235788999999999999997
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=277.68 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=202.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
...+.++||+|+||.||++..+. .++.||||.+.. ....+++..|+.++++.+.|++|+++|.+.....+++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~E-sG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRE-SGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhc-cCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34456789999999999999876 567899999864 445789999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
..|++.+.++.. +++.++++..+++..++||+|||.- .-+|||||..|||++.+|.+||+|||.|..+.+... .
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K 185 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K 185 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence 999999998754 7899999999999999999999964 779999999999999999999999999987754332 2
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....||+-|||||++..-.|+.++||||||+...||.-|++|+..-.+-. ..+.-...+.+..+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------AIFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------AIFMIPTKPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------------eeEeccCCCCCCCCC
Confidence 455789999999999999999999999999999999999999985322210 011111223333344
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+-..++.+++..||-+.|++|.|
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~T 276 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKT 276 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHH
Confidence 5556678999999999999999965
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=287.89 Aligned_cols=239 Identities=28% Similarity=0.446 Sum_probs=186.2
Q ss_pred hcCcceeEEEEEEEeeC-----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 488 ILGRGAFGTVYKGVLAS-----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.||+|+||.||+|+... ..++.+++|.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998753 223578999886432 234568899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-----ceEEeeccCc
Q 040134 562 SNGSLASFLFGI-------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-----TPRISDFGLA 629 (745)
Q Consensus 562 ~~gsL~~~l~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-----~~kl~Dfg~a 629 (745)
++++|.+++... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998642 3367889999999999999999954 999999999999999877 8999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNL 708 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 708 (745)
..+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... . .....+ ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~-~~~~~~----~~~~~ 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--Q-EVLQHV----TAGGR 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--H-HHHHHH----hcCCc
Confidence 76543322211222345678999999998899999999999999999998 8988853221 1 111111 11110
Q ss_pred cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .........+.+++.+||+.+|++|||
T Consensus 232 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~ 259 (269)
T cd05044 232 L---------QKPENCPDKIYQLMTNCWAQDPSERPT 259 (269)
T ss_pred c---------CCcccchHHHHHHHHHHcCCCcccCCC
Confidence 0 011123456889999999999999997
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=287.04 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=188.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC------CeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG------DHR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~~ 554 (745)
.+.+.+.||+|+||.||+|.... .++.||+|.+... ......+..|+.++.++ +|+||+++++++... ...
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcC-CCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 35566789999999999998865 4577999998643 34456788999999998 799999999998653 468
Q ss_pred EEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 555 LLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999998753 4578999999999999999999965 9999999999999999999999999998765
Q ss_pred cccccccccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
..... ......|+..|+|||.+. +..++.++||||||+++|||++|+.||........ . .......
T Consensus 162 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--~-----~~~~~~~ 232 (272)
T cd06637 162 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L-----FLIPRNP 232 (272)
T ss_pred ccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH--H-----HHHhcCC
Confidence 33221 133456889999999986 34578899999999999999999999853221110 0 0011111
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+. .......+.+++.+||+.||.+|||
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCC
Confidence 11111 1112345789999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=284.15 Aligned_cols=230 Identities=29% Similarity=0.478 Sum_probs=181.2
Q ss_pred hhcCcceeEEEEEEEeeCCC---------cEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 487 QILGRGAFGTVYKGVLASDS---------KRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
+.||+|+||.||+|...... ...|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999987543 135778877643333 6789999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-------ceEEeeccCc
Q 040134 558 YEYMSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-------TPRISDFGLA 629 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-------~~kl~Dfg~a 629 (745)
|||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998665 789999999999999999999954 999999999999999887 7999999999
Q ss_pred ccccccccccccccccccccccchhccccC--CCCccchhHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKA--SITVKVDVYSFGVLLLELICC-KSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
..... .....++..|+|||.+... .++.++||||||+++|||++| ..|+......... . .+...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~----~~~~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---R----FYQDQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---H----HHhcC
Confidence 86543 1123456789999999776 789999999999999999995 5655433211111 1 01010
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. . .. .....+.+++.+||+.+|++|||
T Consensus 223 ~~--~-----~~----~~~~~~~~li~~~l~~~p~~Rpt 250 (259)
T cd05037 223 HR--L-----PM----PDCAELANLINQCWTYDPTKRPS 250 (259)
T ss_pred CC--C-----CC----CCchHHHHHHHHHhccChhhCCC
Confidence 00 0 00 00156889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=288.91 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=191.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCC----CcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
.+...+.||+|+||.||+++.... ..+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 344567899999999999997432 3467999988654333 45689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC---------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 557 VYEYMSNGSLASFLFGIT---------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~---------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999997654 688999999999999999999955 99999999999999999999999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
++......... ......++..|+|||.+.+...+.++||||||+++|+|++ |..||..... .. .. .....+
T Consensus 163 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~-~~----~~~~~~ 234 (275)
T cd05046 163 LSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EE-VL----NRLQAG 234 (275)
T ss_pred cccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HH-HH----HHHHcC
Confidence 98754322211 1223345778999999988888999999999999999998 6777642211 11 11 111112
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... .......+.+++.+||+.+|++|||
T Consensus 235 ~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~ 265 (275)
T cd05046 235 KLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPS 265 (275)
T ss_pred CcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCC
Confidence 221111 1112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=286.17 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=196.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||+|++|.||++.... .++.+++|.+.... ....+++.+|++++++++||||+++++.+...+..++++||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcC-CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 3456789999999999999865 45679999886532 345567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+..+......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 999999999766 778899999999999999999995 159999999999999999999999999998765432221
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....+.+... .......+.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~-------- 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYI-VNEPPPRLP-------- 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHH-hcCCCCCCC--------
Confidence 1567889999999998899999999999999999999999986543221 1122222221 111111110
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt 250 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPS 250 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcC
Confidence 0113456889999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=285.77 Aligned_cols=243 Identities=25% Similarity=0.409 Sum_probs=189.7
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
....+.+.+.||+|+||.||++..... ..+++|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~--~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKH--TKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCC--ccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 345567788999999999999986543 34899988643 2335678999999999999999999999887 7789999
Q ss_pred EecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999753 4568888999999999999999965 99999999999999999999999999997654322
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....++..|+|||.+....++.++|+||||+++|+|++ |+.||..... ..+.. .+..+.....
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~~~~---- 224 (260)
T cd05073 157 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIR----ALERGYRMPR---- 224 (260)
T ss_pred ccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHhCCCCCCC----
Confidence 211 222345678999999988889999999999999999999 8888753221 11111 1111111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 225 -----~~~~~~~~~~~i~~~l~~~p~~Rp~ 249 (260)
T cd05073 225 -----PENCPEELYNIMMRCWKNRPEERPT 249 (260)
T ss_pred -----cccCCHHHHHHHHHHcccCcccCcC
Confidence 1122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=295.59 Aligned_cols=199 Identities=25% Similarity=0.331 Sum_probs=170.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+++... .++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..++|||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4567889999999999998765 4567999998642 22234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999976 46788999999999999999999954 9999999999999999999999999999776433221
Q ss_pred cccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 AARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .....|++.|+|||.+.+ ..++.++||||||++||||++|+.||..
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 159 Q-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred e-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 1 223568999999999865 4678899999999999999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.83 Aligned_cols=241 Identities=26% Similarity=0.365 Sum_probs=193.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||.|++|.||+|+... +++.|++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECC-CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4566789999999999999765 45679999986432 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR 155 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence 999999999765 789999999999999999999954 999999999999999999999999999987654321 12
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....++..|+|||.+.+..++.++||||||+++|+|+||+.||..... ... . ..........+..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~----~-~~~~~~~~~~~~~-------- 220 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRV----L-FLIPKNNPPSLEG-------- 220 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHH----H-HHhhhcCCCCCcc--------
Confidence 334678899999999988899999999999999999999999853321 111 1 1111111111110
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.+|++|||
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt 244 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPS 244 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcC
Confidence 002345788999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.67 Aligned_cols=241 Identities=28% Similarity=0.490 Sum_probs=181.8
Q ss_pred hhcCcceeEEEEEEEeeC--CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEe-cCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD-EGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~ 562 (745)
+.||+|+||.||+|.... .....||+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998743 23467999998542 2334567889999999999999999999875 4556889999999
Q ss_pred CCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc--c
Q 040134 563 NGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ--A 639 (745)
Q Consensus 563 ~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~ 639 (745)
+++|.+++... ..+.+..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.+...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999754 4467788899999999999999965 9999999999999999999999999999765432211 1
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
......++..|+|||.+....++.++||||||+++|||++|..|+.... . ...+... ...+.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~-~~~~~~~----~~~~~~~~--~------ 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-D-SFDITVY----LLQGRRLL--Q------ 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-C-HHHHHHH----HhcCCCCC--C------
Confidence 1123345678999999988899999999999999999999655432221 1 1111111 11111110 0
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+..+.+++..||+.+|++|||
T Consensus 224 -~~~~~~~~~~li~~cl~~~p~~Rp~ 248 (262)
T cd05058 224 -PEYCPDPLYEVMLSCWHPKPEMRPT 248 (262)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCCC
Confidence 0112346889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.95 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=191.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||++.... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECC-CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4566789999999999998765 45679999886532 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc--
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-- 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 637 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999998878889999999999999999999965 999999999999999999999999999864211000
Q ss_pred -----------ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 638 -----------QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 638 -----------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
........++..|+|||.+....++.++||||||+++|||++|..||.... ..+.+ .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--~~~~~-----~~~~~~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELF-----GQVISD 231 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHH-----HHHHhc
Confidence 001122457889999999988889999999999999999999999985321 11111 111111
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........ ......+.+++.+||+.||++|||
T Consensus 232 ~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~ 263 (305)
T cd05609 232 DIEWPEGD-------EALPADAQDLISRLLRQNPLERLG 263 (305)
T ss_pred ccCCCCcc-------ccCCHHHHHHHHHHhccChhhccC
Confidence 11111100 012345789999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.37 Aligned_cols=197 Identities=28% Similarity=0.314 Sum_probs=164.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------C
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------D 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 552 (745)
..+.+.+.||+|+||.||++.... .++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECC-CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 346667899999999999998765 4567999998642 233446788999999999999999999987543 3
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 553 HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999975 6777764 3477888999999999999999954 9999999999999999999999999999865
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
..... .....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 43221 23356899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.18 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=190.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+++.+.||+|+||.||++.... .++.||+|.+... .......+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRP-TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcC-CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4567899999999999998865 4567999988642 2333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++++|..++... ..+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999998763 3689999999999999999999952 489999999999999999999999999987653222
Q ss_pred cccccccccccccchhccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKA------SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+ .....+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~-~~~~~~~~~~-- 229 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQL-SAIVDGDPPT-- 229 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHH-HHHhhcCCCC--
Confidence 2234577899999998554 3578999999999999999999998643221 111111 1111111111
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~ 255 (286)
T cd06622 230 -------LPSGYSDDAQDFVAKCLNKIPNRRPT 255 (286)
T ss_pred -------CCcccCHHHHHHHHHHcccCcccCCC
Confidence 11123456789999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.08 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=190.7
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc----------cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ----------QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
..+.||+|++|.||+|.... .++.||+|.++.... ...+.+.+|+.++++++|+||+++++++...+..
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred ecceecccCceEEEEEeecC-CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 45789999999999998765 356799998753111 1124678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999998878889999999999999999999964 999999999999999999999999999976543
Q ss_pred cccccccccccccccccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKAS--ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
...........++..|+|||.+.... ++.++|+||||+++|||++|..|+..... ...+ .+.. .......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~----~~~~-~~~~~~~~ 233 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IAAM----FKLG-NKRSAPPI 233 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--HHHH----HHhh-ccccCCcC
Confidence 22222233456788999999987654 78999999999999999999999852211 1111 1111 11111111
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. .........+.+++.+|++.+|++|||
T Consensus 234 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 234 PP----DVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred Cc----cccccCCHHHHHHHHHHhcCChhhCCC
Confidence 11 111223467888999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.38 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=193.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc------ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...+.||+|++|.||++.... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~-~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred cccceecCcCceEEEEEEEcC-CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 345789999999999998754 45679999886422 11346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 636 (745)
+||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||.+..+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998778889999999999999999999955 999999999999998775 69999999988765432
Q ss_pred ccc--ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQA--ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... ......++..|+|||.+.+..++.++||||+|+++++|++|+.||......... ..+.+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~----- 230 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATTAP----- 230 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCCCC-----
Confidence 111 112345788999999998888999999999999999999999998543322111 1111111111100
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+|++.+|++|||
T Consensus 231 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~ 257 (268)
T cd06630 231 ----SIPEHLSPGLRDVTLRCLELQPEDRPP 257 (268)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCcC
Confidence 111223456889999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.53 Aligned_cols=197 Identities=26% Similarity=0.391 Sum_probs=165.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||+|+... .++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKK-TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECC-CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3456789999999999999765 3567999998643 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
++ ++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 5888887543 4578999999999999999999954 999999999999999999999999999876533221
Q ss_pred ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 638 QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12233568899999988654 578999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=280.50 Aligned_cols=241 Identities=32% Similarity=0.489 Sum_probs=192.4
Q ss_pred chhhcCcceeEEEEEEEeeCCC---cEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 485 FRQILGRGAFGTVYKGVLASDS---KRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.||.|+||.||+++..... ...||+|.+...... ..+.+..|++.++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 5678999999999999987633 477999999654332 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGITR--PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++..... +++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976544 89999999999999999999954 9999999999999999999999999999876544222
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+....++.++||||||+++++|++ |..|+... ....+.. ....+.....
T Consensus 160 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~----~~~~~~~~~~------ 225 (258)
T smart00219 160 K-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLE----YLKKGYRLPK------ 225 (258)
T ss_pred c-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHH----HHhcCCCCCC------
Confidence 1 112336789999999988889999999999999999998 66766431 1111111 1111111111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+++.+|++.||++|||
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt 250 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPT 250 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcC
Confidence 0113456888999999999999997
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.55 Aligned_cols=195 Identities=23% Similarity=0.360 Sum_probs=158.2
Q ss_pred hhcCcceeEEEEEEEeeC-CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEe--cCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD--EGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e~~~~ 563 (745)
.+||+|+||.||+|+... ...+.||+|.+... .....+.+|++++++++||||+++++++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998754 24567999988643 23356788999999999999999999884 45678999999875
Q ss_pred CCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCceEEeeccCcc
Q 040134 564 GSLASFLFGI---------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL----DDYFTPRISDFGLAK 630 (745)
Q Consensus 564 gsL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~a~ 630 (745)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 2467888999999999999999954 99999999999999 566799999999998
Q ss_pred cccccccc-cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 631 LLLAEQTQ-AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 631 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.+...... .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76443221 11234568899999999876 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=286.71 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=190.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...+.+.+.||+|++|.||+|..... ....|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34456778999999999999987543 23468999886543 3445689999999999999999999998875 45789
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999764 4579999999999999999999954 9999999999999999999999999998866443
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....++..|+|||.+....++.++||||||+++|||++ |..||..... .+.+ .. ...+.....
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~-~~----~~~~~~~~~--- 229 (270)
T cd05056 161 SYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVI-GR----IENGERLPM--- 229 (270)
T ss_pred ccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHH-HH----HHcCCcCCC---
Confidence 2211 222334568999999988889999999999999999986 9999854322 1111 11 111111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|+..+|++|||
T Consensus 230 ------~~~~~~~~~~li~~~l~~~P~~Rpt 254 (270)
T cd05056 230 ------PPNCPPTLYSLMTKCWAYDPSKRPR 254 (270)
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 1122346888999999999999997
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.01 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=196.0
Q ss_pred chhhcCcceeEEEEEEEeeCCC--cEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.++||+|.||.|++|.+.... ...||||.++..... ...+|++|+.++.+|+|+|++++||+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 5688999999999999987544 357999999764443 56899999999999999999999999988 7889999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+.|+|.+.|++. ..+-......++.|||.||.||.. +++|||||..+|+|+-....+||+|||+.+.+.......
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999873 446677888999999999999994 599999999999999999999999999999887655433
Q ss_pred ccc-cccccccccchhccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 640 ART-GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICC-KSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 640 ~~~-~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
... ...-...|.|||.++...++.++|||+|||+||||+|+ +.|+..-.. ..+.+ .+|....
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL~---------~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQILK---------NIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHHH---------hcccccc
Confidence 222 23346789999999999999999999999999999985 455532111 11111 2222333
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..-...+.++++++++.||.++|++|||
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRpt 361 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPT 361 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCcccccc
Confidence 3334567889999999999999999997
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.67 Aligned_cols=236 Identities=27% Similarity=0.365 Sum_probs=185.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEE-ecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC-DEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e 559 (745)
..+.+.+.||+|++|.||++... ++.|++|.++.. ...+.+.+|+.++++++|+|++++++++ .+.+..++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 35667789999999999999764 345899988642 3356789999999999999999999976 45567899999
Q ss_pred ecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999987543 478899999999999999999954 99999999999999999999999999987643322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+... +..+.....
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~----- 220 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMDA----- 220 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCCC-----
Confidence 12234568999999988889999999999999999997 8888753211 111111 111111110
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 221 ----~~~~~~~~~~li~~~l~~~p~~Rpt 245 (256)
T cd05082 221 ----PDGCPPVVYDVMKQCWHLDAATRPS 245 (256)
T ss_pred ----CCCCCHHHHHHHHHHhcCChhhCcC
Confidence 1122356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=287.05 Aligned_cols=233 Identities=24% Similarity=0.398 Sum_probs=180.1
Q ss_pred hhcCcceeEEEEEEEeeCCC------cEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 487 QILGRGAFGTVYKGVLASDS------KRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.||+|+||.||+|...... ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999875322 234888887655445557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------eEEeeccCccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT--------PRISDFGLAKL 631 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~--------~kl~Dfg~a~~ 631 (745)
+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999765 4578999999999999999999965 9999999999999987664 69999998865
Q ss_pred ccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|..++..... ... ... .. .... .
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~-~~~----~~-~~~~-~ 223 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQK-KLQ----FY-EDRH-Q 223 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHH-HHH----HH-Hccc-c
Confidence 432 122457789999999976 4578999999999999999999644322111 111 000 00 1100 0
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ......+.+++.+||+.||++|||
T Consensus 224 -----~~----~~~~~~~~~li~~~l~~~p~~Rps 249 (258)
T cd05078 224 -----LP----APKWTELANLINQCMDYEPDFRPS 249 (258)
T ss_pred -----CC----CCCcHHHHHHHHHHhccChhhCCC
Confidence 00 011245889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.84 Aligned_cols=242 Identities=26% Similarity=0.308 Sum_probs=196.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||.|+||.||++.... .++.|++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEcc-CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4567889999999999999765 45669999986432 2346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 999999999998777889999999999999999999965 999999999999999999999999999887644321
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+....++.++|+||||+++|+|++|..|+..........+ ....... ...
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~--~~~-------- 220 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQETA--DVL-------- 220 (258)
T ss_pred -ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhccc--ccc--------
Confidence 2334578899999999888899999999999999999999999875543211111 1111110 000
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||.+|||
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCC
Confidence 11112366889999999999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=299.41 Aligned_cols=195 Identities=29% Similarity=0.330 Sum_probs=163.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------Ce
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 553 (745)
.+.+.+.||+|+||.||++.... .++.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecC-CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45567889999999999998754 4567999998643 223346778899999999999999999988543 35
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 ~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred eEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 7999999975 6666664 3478888999999999999999955 99999999999999999999999999998654
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 171 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred Cccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 2335689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=284.00 Aligned_cols=240 Identities=28% Similarity=0.418 Sum_probs=192.3
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-----ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
...+.||+|++|.||+|.... .++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......++++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred cccceeeecCCceEEEEEEcC-CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455789999999999999864 35679999885432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999998777789999999999999999999965 99999999999999999999999999987754332
Q ss_pred cccccccccccccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..... ...........+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~----~~~~~~~~~~~~------ 223 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAV----FKIGRSKELPPI------ 223 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHH----HHHHhcccCCCc------
Confidence 123456788999999987766 8999999999999999999999985432 11111 111110111111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 224 ---~~~~~~~~~~li~~~l~~~p~~Rp~ 248 (258)
T cd06632 224 ---PDHLSDEAKDFILKCLQRDPSLRPT 248 (258)
T ss_pred ---CCCcCHHHHHHHHHHhhcCcccCcC
Confidence 1112355788999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.24 Aligned_cols=199 Identities=26% Similarity=0.352 Sum_probs=169.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||.||+++... .++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4567889999999999999865 4567999998542 22234458889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999976 36788999999999999999999954 9999999999999999999999999998765432221
Q ss_pred cccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 AARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 123356899999999986 34678999999999999999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=279.42 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=191.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 559 (745)
|.+.+.||+|++|.||++....+ ++.|++|.+... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTD-GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCC-CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 45778999999999999998654 567999998542 23345678899999999999999999998764 446789999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++... ..+++.++..++.|++.||++||+. +++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998753 4578999999999999999999954 999999999999999999999999999876643221
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......+++.|+|||.+.+..++.++||||||+++++|++|+.||..... . ..... ...+....+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~----~~~~~-~~~~~~~~~------ 222 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--N----SLVYR-IIEGKLPPM------ 222 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--H----HHHHH-HHhcCCCCC------
Confidence 12345678899999999999999999999999999999999999853221 1 11111 122222111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.||++|||
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rp~ 247 (257)
T cd08223 223 ---PKDYSPELGELIATMLSKRPEKRPS 247 (257)
T ss_pred ---ccccCHHHHHHHHHHhccCcccCCC
Confidence 1123356889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.71 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=190.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
..||+|+||.||++.... .++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcC-CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 469999999999998764 4567999998654455567788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccc
Q 040134 567 ASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646 (745)
Q Consensus 567 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 646 (745)
.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..+...... .....+
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~ 179 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVG 179 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceec
Confidence 998754 5678999999999999999999954 9999999999999999999999999998765432211 233568
Q ss_pred cccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHH
Q 040134 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVE 726 (745)
Q Consensus 647 t~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (745)
+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+ .. +......... .......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~-~~----~~~~~~~~~~-------~~~~~~~ 245 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAM-KR----LRDSPPPKLK-------NAHKISP 245 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH-HH----HhccCCCCcc-------ccCCCCH
Confidence 8999999999888899999999999999999999999864322 1111 11 1111111000 0111234
Q ss_pred HHHHHHHhccccCcCCCCC
Q 040134 727 RLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 727 ~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+++.+||+.+|++|||
T Consensus 246 ~l~~~i~~~l~~~P~~Rps 264 (297)
T cd06659 246 VLRDFLERMLTREPQERAT 264 (297)
T ss_pred HHHHHHHHHhcCCcccCcC
Confidence 5788999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=281.36 Aligned_cols=237 Identities=24% Similarity=0.270 Sum_probs=191.5
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||.|++|.||+++... .++.+++|.+.... ....+.+.+|+.++++++||||+++++.+.++...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6899999999999865 45679999986422 2345679999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 645 (745)
|.+++.+...+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 999998877889999999999999999999964 99999999999999999999999999998764432 122345
Q ss_pred ccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHH
Q 040134 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRV 725 (745)
Q Consensus 646 gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (745)
++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+..... +....+.... .......
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-----NDILKGNGKL--------EFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH-----HHHhccCCCC--------CCCcccC
Confidence 78899999999888899999999999999999999999865443221111 1111100000 0011114
Q ss_pred HHHHHHHHhccccCcCCCCC
Q 040134 726 ERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 726 ~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+++.+||+.+|++|||
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHHHHccCChhhCcC
Confidence 56899999999999999997
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=279.85 Aligned_cols=243 Identities=27% Similarity=0.399 Sum_probs=190.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc----------cccCHHHHHHHHHHHhc-cCCCCceeEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV----------EQQGEKEFRTEVSVIGQ-THHKNLVRLLGFCDEG 551 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~ 551 (745)
+.+.+.||+|+||.||++......++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 345678999999999999987755678999987531 12223557788888865 7999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 552 DHRLLVYEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988742 35678899999999999999999952 489999999999999999999999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ... . ....+..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~---~-~~~~~~~ 229 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSL---A-TKIVEAV 229 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHH---H-HHHhhcc
Confidence 998754432 23345688899999999988899999999999999999999999853221 111 1 1111111
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.. ......+.+++.+||+.||++|||
T Consensus 230 ~~~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~ 259 (269)
T cd08528 230 YEPLPE--------GMYSEDVTDVITSCLTPDAEARPD 259 (269)
T ss_pred CCcCCc--------ccCCHHHHHHHHHHCCCCCccCCC
Confidence 111110 012346889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=283.05 Aligned_cols=200 Identities=26% Similarity=0.351 Sum_probs=167.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-----ccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 555 (745)
+...+.||+|++|.||++.... .++.|++|++.... ....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred ccccceecCCCCEEEEEEEEcC-CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 3456789999999999998765 35679999875321 1233568899999999999999999998865 46788
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+++||+++++|.+++.....+++...+.++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++..+...
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999998777789999999999999999999954 9999999999999999999999999998765432
Q ss_pred cc-ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 636 QT-QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 636 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 11 1112234578899999999988899999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=278.56 Aligned_cols=241 Identities=22% Similarity=0.333 Sum_probs=193.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.++||.|+||.||.++... .++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcC-CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4567889999999999988765 4566999987542 344557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999764 4578999999999999999999954 999999999999999999999999999986644332
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... . +..... ..+.....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~----~~~~~~-~~~~~~~~------- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--L----NLVVKI-VQGNYTPV------- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--H----HHHHHH-HcCCCCCC-------
Confidence 12334678999999999888889999999999999999999999853221 1 111111 12222111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~R~s 246 (256)
T cd08221 222 --VSVYSSELISLVHSLLQQDPEKRPT 246 (256)
T ss_pred --ccccCHHHHHHHHHHcccCcccCCC
Confidence 1122356889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.86 Aligned_cols=197 Identities=23% Similarity=0.325 Sum_probs=160.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC------CCCceeEEEEEecC-Ce
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH------HKNLVRLLGFCDEG-DH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~-~~ 553 (745)
..+.+.++||+|+||+||++.... .++.||||+++... ...+.+..|+.+++.++ |.+++++++++... .+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcC-CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 346677899999999999998765 45789999986422 22345566777766664 45688999988764 57
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC--------------
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-------------- 619 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-------------- 619 (745)
.++|||++ +++|.+++.....+++..+..|+.||+.||+|||.+ .+||||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 88999987 678999988778899999999999999999999952 4999999999999998765
Q ss_pred --ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 620 --TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 620 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 284 ~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred CceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998754321 133467899999999999999999999999999999999999999643
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=282.07 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=194.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|++|.||++.... .++.|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECC-CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4566889999999999998765 356799999865433 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999998877789999999999999999999965 999999999999999999999999999987654332211
Q ss_pred --cccccccccccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 641 --RTGIRGTVGYFAPEWFRKAS---ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 641 --~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....++..|+|||.+.... .+.++||||||++++||++|+.||...... ... .... ..+....+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~---~~~~-~~~~~~~~---- 227 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQI---MFHV-GAGHKPPI---- 227 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHH---HHHH-hcCCCCCC----
Confidence 11345788999999998765 889999999999999999999998533211 111 1111 11111111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+........+.+++.+||+.+|++|||
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~p~~R~~ 254 (264)
T cd06626 228 ---PDSLQLSPEGKDFLDRCLESDPKKRPT 254 (264)
T ss_pred ---CcccccCHHHHHHHHHHccCCcccCCC
Confidence 111112345778999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=279.48 Aligned_cols=243 Identities=25% Similarity=0.336 Sum_probs=178.1
Q ss_pred hcCcceeEEEEEEEeeCCC-cEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 488 ILGRGAFGTVYKGVLASDS-KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.||+|+||.||++...... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999764432 3456677765432 3345789999999999999999999999999999999999999999
Q ss_pred HHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 566 LASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 566 L~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
|.+++... ...++..+..++.||+.||+|||+. +++|+||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999753 3345667789999999999999965 9999999999999999999999999998643222111112
Q ss_pred ccccccccccchhcccc-------CCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 642 TGIRGTVGYFAPEWFRK-------ASITVKVDVYSFGVLLLELICC-KSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+... .+.+.+.. ...+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~-----~~~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SDREVLNH-----VIKDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHH-----HHhhcccccCC
Confidence 33457889999998743 2457899999999999999975 4455321 12111111 11122222222
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+..... ...++.+++..|+ .+|++|||
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~ 258 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRAT 258 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCC
Confidence 222211 2345777888899 57999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.88 Aligned_cols=244 Identities=25% Similarity=0.266 Sum_probs=192.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.+.||+|++|.||++.... .++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+.+....++|||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4456789999999999998865 456799999865322 244678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+.+++|.+++... ..+++..+..++.|++.||+|||.. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998754 5688999999999999999999954 999999999999999999999999999876432211
Q ss_pred c---------------------------cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 040134 638 Q---------------------------AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN 690 (745)
Q Consensus 638 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~ 690 (745)
. .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~- 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR- 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-
Confidence 0 001123578899999999988899999999999999999999999853322
Q ss_pred chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 691 PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.. ....... ..........+.+++.+||+.||++|||
T Consensus 238 -~~~~~~-----~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 238 -DETFSN-----ILKKEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred -HHHHHH-----HhcCCcc--------CCCccccCHHHHHHHHHHccCCHhHCCC
Confidence 111111 1111111 0111113467899999999999999997
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=291.70 Aligned_cols=243 Identities=29% Similarity=0.417 Sum_probs=186.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
++..+.||+|+||.||+|....... ..||+|.+..... ....++.+|+.++++++||||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 3456789999999999998765433 3578888864322 2234788999999999999999999998764 467899
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.+.....
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999998765 3578899999999999999999965 999999999999999999999999999987643332
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
........++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ......++ ..+.....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~~~~----- 232 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLL----EKGERLPQ----- 232 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HCCCCCCC-----
Confidence 221223345678999999988899999999999999999997 888874321 11122221 11111100
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++..|+..+|++|||
T Consensus 233 ----~~~~~~~~~~li~~c~~~~p~~Rp~ 257 (303)
T cd05110 233 ----PPICTIDVYMVMVKCWMIDADSRPK 257 (303)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 0112345788999999999999997
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=280.02 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=190.3
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc------ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred cccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 35678999999999999764 35679999875321 12235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
+||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998777889999999999999999999965 999999999999999999999999999876532111
Q ss_pred ----ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 638 ----QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 638 ----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ............+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~---~~~~~~~~~~~~~-- 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAM---FYIGAHRGLMPRL-- 230 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHH---HHhhhccCCCCCC--
Confidence 11122345788999999999888999999999999999999999998532211 111 0000000111111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 231 -------~~~~~~~~~~~i~~~l~~~p~~Rp~ 255 (265)
T cd06631 231 -------PDSFSAAAIDFVTSCLTRDQHERPS 255 (265)
T ss_pred -------CCCCCHHHHHHHHHHhcCCcccCCC
Confidence 1122356789999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=283.48 Aligned_cols=236 Identities=27% Similarity=0.289 Sum_probs=181.9
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHh---ccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIG---QTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+||+|+||.||++.... .++.+|+|.+.... ......+.+|..+++ ..+||||+.+++.+...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECC-CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 48999999999998765 45689999885422 112233444544433 347999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.....+++..+..++.|++.||+|||.. +|+|+||||+||++++++.++|+|||++....... .
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 9999999998888899999999999999999999954 99999999999999999999999999987653322 2
Q ss_pred ccccccccccchhccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~-~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
....++..|+|||.+. +..++.++||||||+++|||++|..||..........+.. ..... .. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~------~~----~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTV------NV----EL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----HhhcC------Cc----CC
Confidence 2346899999999886 4568999999999999999999999986443322221111 11000 00 01
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+++.+||+.||++||+
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcC
Confidence 1123456889999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=280.12 Aligned_cols=245 Identities=28% Similarity=0.363 Sum_probs=198.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+++.+.||+|++|.||+++... .++.|++|++..... ...+.+.+|+..+.+++|+||+++++++...+..++|+||+
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 4566889999999999999876 456799999865433 44678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.....+++..+..++.|+++||+|||+. .+++|+||+|+||+++.++.++|+|||.+..+...... .
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~ 157 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--C 157 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--c
Confidence 9999999998778899999999999999999999950 59999999999999999999999999999876443322 1
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....++..|+|||.+....++.++|+||||+++|+|++|+.|+..........+...+ .......+ .
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~---------~ 224 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPPSL---------P 224 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCCCCC---------C
Confidence 2345788999999998888999999999999999999999998654421111111111 11111111 1
Q ss_pred HH-HHHHHHHHHHhccccCcCCCCC
Q 040134 722 LK-RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~-~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ....+.+++.+||+++|++|||
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~ 249 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPS 249 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCC
Confidence 11 3457889999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.59 Aligned_cols=198 Identities=28% Similarity=0.371 Sum_probs=169.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+++.+.||+|++|.||++.... .++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECC-CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4567889999999999999865 356799998864322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.++......+++.+++.++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++..+......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-- 156 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-- 156 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--
Confidence 99999998887666789999999999999999999965 9999999999999999999999999998765433221
Q ss_pred cccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 233457889999999865 4578899999999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.99 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=188.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||+++.... ++.|++|.++.. .......+.+|++++++++||||+++++++.+....++|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~-g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCC-CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 45667899999999999998653 567999998642 222345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++ +|.+++.. ...+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++..+......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 974 78777754 46789999999999999999999965 9999999999999999999999999999865432211
Q ss_pred ccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc------ccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN------LDKLA 712 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~ 712 (745)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.|+...... .+.+. .+.+...... ...+.
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLK-RIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHH-HHHHHhCCCChHHhHHhhhcc
Confidence 2234568899999998764 4789999999999999999999987543322 11111 1111110000 00000
Q ss_pred c----ccccc-----cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 E----NDEEV-----KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~----~~~~~-----~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+ +.... .........+.+++.+||+.||.+|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 274 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC
Confidence 0 00000 001123456789999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.07 Aligned_cols=241 Identities=28% Similarity=0.461 Sum_probs=189.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|++|.||++.... ++.+++|.+... ......+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC--CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35567889999999999998754 346999988643 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..++++.+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~- 157 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS- 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence 999999998754 4578999999999999999999965 99999999999999999999999999987654322111
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++.+|+|||.+.+..++.++||||||+++|||++ |..||..... . .+ . +....+. ....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~-~~---~-~~~~~~~--~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--S-EV---V-ETINAGF--RLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--H-HH---H-HHHhCCC--CCCCCCC---
Confidence 122234678999999988889999999999999999998 8888753221 1 11 1 1111110 1111111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++.+||+.+|++|||
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~ 247 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPS 247 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCC
Confidence 2356889999999999999997
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.13 Aligned_cols=199 Identities=28% Similarity=0.358 Sum_probs=171.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+++.+.||+|++|.||++..... ++.|++|.++.. .....+.+.+|++++++++|+||+++++++..++..+++|||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKAT-GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCC-CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 55678899999999999998664 567999998643 233457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++.+..++.....+++.++..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++..+.......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~- 157 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP- 157 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc-
Confidence 99988877776667789999999999999999999965 99999999999999999999999999988765443211
Q ss_pred cccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.....++..|+|||.+... .++.++||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2335678889999999887 889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=281.01 Aligned_cols=239 Identities=26% Similarity=0.357 Sum_probs=191.6
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.+.||+|++|.||++.... .++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEECC-CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 3589999999999998765 356799998865444556678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 645 (745)
|.+++.. .++++.++..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+......... .....
T Consensus 103 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~ 176 (285)
T cd06648 103 LTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLV 176 (285)
T ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--ccccc
Confidence 9999876 6788999999999999999999954 9999999999999999999999999988765432211 22345
Q ss_pred ccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHH
Q 040134 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRV 725 (745)
Q Consensus 646 gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (745)
++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ..... ........+.. .....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~----~~~~~-~~~~~~~~~~~-------~~~~~ 242 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--L----QAMKR-IRDNLPPKLKN-------LHKVS 242 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--H----HHHHH-HHhcCCCCCcc-------cccCC
Confidence 78899999999888899999999999999999999999853221 1 11111 11111111110 11123
Q ss_pred HHHHHHHHhccccCcCCCCC
Q 040134 726 ERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 726 ~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+++.+||+.+|++|||
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt 262 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRAT 262 (285)
T ss_pred HHHHHHHHHHcccChhhCcC
Confidence 56899999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=281.30 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=187.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-----ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 555 (745)
+.+.+.||+|+||.||++.... +++.|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcC-CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4456889999999999998765 45679999875321 12245788899999999999999999988763 5678
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
++|||+++++|.+++.....+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999999998777788999999999999999999965 9999999999999999999999999998865432
Q ss_pred ccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ... +.+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~----~~~~~~~~-~~~---- 228 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--MAA----IFKIATQP-TNP---- 228 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch--HHH----HHHHhcCC-CCC----
Confidence 111 112234578899999999888899999999999999999999999853211 111 11111111 000
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+|+. +|++|||
T Consensus 229 ----~~~~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 229 ----VLPPHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred ----CCchhhCHHHHHHHHHHhc-ChhhCCC
Confidence 1122334567788888885 8999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.70 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=189.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
..||+|+||.||++.... .++.||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEKH-TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEECC-CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 569999999999998765 3567999998655555567789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccc
Q 040134 567 ASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646 (745)
Q Consensus 567 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 646 (745)
.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++......... .....+
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~ 180 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVG 180 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cceeec
Confidence 998854 4688999999999999999999954 9999999999999999999999999998765332211 223457
Q ss_pred cccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHH
Q 040134 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVE 726 (745)
Q Consensus 647 t~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (745)
+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+ ..+.. .....+.. ......
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~-~~~~~-----~~~~~~~~------~~~~~~ 246 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAM-RRIRD-----NLPPRVKD------SHKVSS 246 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH-HHHHh-----cCCCcccc------ccccCH
Confidence 8899999999888899999999999999999999999864322 1111 11111 11111100 111234
Q ss_pred HHHHHHHhccccCcCCCCC
Q 040134 727 RLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 727 ~l~~li~~Cl~~dp~~RPT 745 (745)
.+..++.+|++.||++|||
T Consensus 247 ~~~~li~~~l~~~P~~Rpt 265 (292)
T cd06658 247 VLRGFLDLMLVREPSQRAT 265 (292)
T ss_pred HHHHHHHHHccCChhHCcC
Confidence 5778999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=279.95 Aligned_cols=248 Identities=29% Similarity=0.397 Sum_probs=194.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||.|++|+||+|.... .++.+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++++|++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 4567889999999999998765 45679999986422 235678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999754 4578999999999999999999954 9999999999999999999999999998876543322
Q ss_pred c--ccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 639 A--ARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 639 ~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
. ......++..|+|||.+... ..+.++|+||||+++|||++|+.||..... ...+... . ....... ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~----~-~~~~~~~-~~~ 230 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLT----L-QNDPPSL-ETG 230 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--hhhHHHH----h-cCCCCCc-CCc
Confidence 1 22334678899999998776 789999999999999999999999853322 1111111 1 1111110 000
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+|++.||++|||
T Consensus 231 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06610 231 ---ADYKKYSKSFRKMISLCLQKDPSKRPT 257 (267)
T ss_pred ---cccccccHHHHHHHHHHcCCChhhCcC
Confidence 001133466889999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.67 Aligned_cols=233 Identities=28% Similarity=0.352 Sum_probs=189.2
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||.|+||.||-++... +.+.||||++.- ...+...++..|+..|++++|||++.+-|++..+...+||||||-
T Consensus 32 rEIGHGSFGAVYfArd~~-n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHhcCCccceeEEeeccC-ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 469999999999999876 457899999863 333445789999999999999999999999999999999999995
Q ss_pred CCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 564 GSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 564 gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
|+-.+++.-+ +++.+.++..|.++.+.||+||| +.+.||||||..|||+.+.|.+||+|||.|....+ ..
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 4777777533 67889999999999999999999 55999999999999999999999999999976543 34
Q ss_pred cccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.++||+.|||||++. .+.|+-|+||||||++-.||.-.++|..... .+...+. +......- -
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYH-IAQNesPt--------L 245 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYH-IAQNESPT--------L 245 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHH-HHhcCCCC--------C
Confidence 568999999999884 4679999999999999999999888864211 1111111 11111111 1
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+-...+..++..||++-|.+|||
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRpt 271 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPT 271 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCc
Confidence 14455677899999999999999997
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=280.62 Aligned_cols=247 Identities=26% Similarity=0.332 Sum_probs=190.9
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEEEEEEe
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~ 560 (745)
.+.+.||.|++|.||++.... .++.+|+|.+.... ......+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred EEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 456789999999999999865 45779999986432 2345678999999999999999999998865 3478999999
Q ss_pred cCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+++++|.+++.. ...+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999988643 34578889999999999999999965 99999999999999999999999999987653222
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC--chhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN--PEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ....+..++. ......+.+.
T Consensus 160 ----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 231 (287)
T cd06621 160 ----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELKDE 231 (287)
T ss_pred ----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhccC
Confidence 12345678899999998889999999999999999999999998755331 1111112111 1111111111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .........+.+++.+||+.+|++|||
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt 259 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPT 259 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCC
Confidence 1 111223467889999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=280.64 Aligned_cols=241 Identities=23% Similarity=0.333 Sum_probs=190.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccC---CCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.+.+.||+|+||.||+|.... .++.|++|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVP-TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcC-CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4456789999999999999765 4567999998643 3344567889999999986 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++..+......
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 99999999999865 4788999999999999999999965 9999999999999999999999999999876543321
Q ss_pred cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....|+..|+|||.+.. ..++.++|+||||+++|+|++|..||...... ... ......... ...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~-~~~~~~~~~-----~~~ 223 (277)
T cd06917 158 --RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAM-MLIPKSKPP-----RLE 223 (277)
T ss_pred --cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhh-hccccCCCC-----CCC
Confidence 233468889999998865 45789999999999999999999998532211 111 011111111 111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. .....+.+++.+||+.||++|||
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 224 DN---GYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred cc---cCCHHHHHHHHHHcCCCcccCcC
Confidence 10 13356889999999999999997
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=275.00 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=197.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLVYE 559 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 559 (745)
...+.||+|++|.||+|.... .++.|++|.+.... ....+.+.+|+..+++++|+||+++++.+... ...++++|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred eeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345789999999999999875 45679999986543 24567899999999999999999999999988 89999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 999999999998877899999999999999999999964 99999999999999999999999999998765543211
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
......++..|+|||.+.....+.++||||||+++++|++|..|+...... ..........+....+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~-------- 225 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGEPPEI-------- 225 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCCCcCC--------
Confidence 123356788999999998888999999999999999999999998654411 1111111111111111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.||++|||
T Consensus 226 -~~~~~~~l~~~i~~~l~~~p~~Rp~ 250 (260)
T cd06606 226 -PEHLSEEAKDFLRKCLRRDPKKRPT 250 (260)
T ss_pred -CcccCHHHHHHHHHhCcCChhhCCC
Confidence 1122456889999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=290.85 Aligned_cols=194 Identities=27% Similarity=0.375 Sum_probs=162.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC------Ce
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 553 (745)
.+.+.+.||+|+||.||++.... +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTR-LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECC-CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 35556789999999999998765 45679999986422 22345677899999999999999999987543 45
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++++|++ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 78999987 779988775 35689999999999999999999965 99999999999999999999999999998654
Q ss_pred ccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.. .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 170 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 32 233468999999999876 5688999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=264.48 Aligned_cols=241 Identities=24% Similarity=0.370 Sum_probs=188.1
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEccc-ccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+...||.|..|+|++.+..+ .+..+|||.+.. .+.+..+.+...+.++.+-+ +|+||+.+|+|......++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcc-cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 45679999999999999887 457899999965 34455577888888877664 9999999999999999999999884
Q ss_pred CCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
- .++.++... +++++.-+-++...+++||.||.+. ++|+|||+||+|||+|+.|++||+|||++..+-+... .
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---h 248 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---H 248 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc---c
Confidence 3 455555433 5677888889999999999999985 5999999999999999999999999999988765544 4
Q ss_pred ccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
+...|-+.|||||.+.- ..|+-++||||||+.|+||.||+.|+.....+ -+.+ ..+..... ..++...
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~l-----tkvln~eP-P~L~~~~-- 319 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVL-----TKVLNEEP-PLLPGHM-- 319 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHH-----HHHHhcCC-CCCCccc--
Confidence 45678899999999853 46889999999999999999999998654332 1111 11112112 2222222
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+++++..||++|+.+||-
T Consensus 320 ----gFSp~F~~fv~~CL~kd~r~RP~ 342 (391)
T KOG0983|consen 320 ----GFSPDFQSFVKDCLTKDHRKRPK 342 (391)
T ss_pred ----CcCHHHHHHHHHHhhcCcccCcc
Confidence 23456889999999999999993
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=280.03 Aligned_cols=237 Identities=28% Similarity=0.360 Sum_probs=187.0
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||+|+||+||++.... .++.+++|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcC-CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 6899999999998765 45679999986422 2234567789999999999999999999999999999999999999
Q ss_pred HHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccc
Q 040134 566 LASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643 (745)
Q Consensus 566 L~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 643 (745)
|.+++.... .+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~ 153 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence 999997654 688999999999999999999965 999999999999999999999999999876543211 223
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (745)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ..+.+....... .....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEMAV----------EYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccccc----------cCCcc
Confidence 45778999999998888999999999999999999999998644331111 111111111000 00111
Q ss_pred HHHHHHHHHHhccccCcCCCCC
Q 040134 724 RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 724 ~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+++.+||+.||++||+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~ 242 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLG 242 (277)
T ss_pred CCHHHHHHHHHHccCChhHccC
Confidence 2456789999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=275.91 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=192.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+||.+|++.... +++.|++|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4567889999999999999765 4567999988542 233446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999998654 3568889999999999999999954 9999999999999999999999999999765433221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+...+.++|+||||+++++|++|+.|+..... .+.+.... .+.....
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~------- 221 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-RGSYPPV------- 221 (256)
T ss_pred --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-cCCCCCC-------
Confidence 1234578899999999888899999999999999999999999864321 11122221 1211111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (256)
T cd08218 222 --SSHYSYDLRNLVSQLFKRNPRDRPS 246 (256)
T ss_pred --cccCCHHHHHHHHHHhhCChhhCcC
Confidence 1122446889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=263.26 Aligned_cols=261 Identities=22% Similarity=0.275 Sum_probs=200.0
Q ss_pred CccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEe
Q 040134 471 RSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCD 549 (745)
Q Consensus 471 ~~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 549 (745)
..-+++++.+-+. +.||+|+|+.|-.++.-. ++..+|||++.+.....+..+.+|++++.+. .|+||++++++|+
T Consensus 71 ~~g~F~d~YkLt~---e~LGeGAyasVqtcv~i~-t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 71 LSGKFEDMYKLTS---ELLGEGAYASVQTCVSIQ-TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred ccchHHHHHHhHH---HHhcCccceeeeeeeeec-cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 3445666655543 689999999998887654 4566999999988777888999999999999 4999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---ceEEeec
Q 040134 550 EGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---TPRISDF 626 (745)
Q Consensus 550 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Df 626 (745)
++...|||||-|.||+|..+|.+++.+++.++.++.++|+.||.|||.+ ||.||||||+|||..... -+||+||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999999999999999999999999999999954 999999999999996543 5799999
Q ss_pred cCcccccccc-----cccccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC------
Q 040134 627 GLAKLLLAEQ-----TQAARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTN------ 690 (745)
Q Consensus 627 g~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~------ 690 (745)
.+..-+.... ........+|+..|||||+.. ...|+.++|.||||||||-|++|.+||......
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875432221 111234467899999999863 236889999999999999999999999653322
Q ss_pred --chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 691 --PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 691 --~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
....-.....+.+.+|..+-. .+.......+..+++...+-.|+.+|-
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFP------dkdWahIS~eakdlisnLlvrda~~rl 353 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFP------DKDWAHISSEAKDLISNLLVRDAKQRL 353 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCC------hhhhHHhhHHHHHHHHHHHhccHHhhh
Confidence 222223333344444433321 122333445566677777777877763
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=281.58 Aligned_cols=238 Identities=27% Similarity=0.372 Sum_probs=190.7
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||.|++|.||+++... .++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999865 356799999865332 445678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc------cc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT------QA 639 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~~ 639 (745)
|.+++.....+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999998777889999999999999999999965 999999999999999999999999999876533221 11
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
......++..|+|||.+.....+.++||||||+++|+|++|..||..... .. . . .....+.....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~-~---~-~~~~~~~~~~~-------- 221 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--EE-I---F-QNILNGKIEWP-------- 221 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HH-H---H-HHHhcCCcCCC--------
Confidence 12334578899999999888899999999999999999999999854331 11 1 1 11111111110
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|++|||
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt 247 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLG 247 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCC
Confidence 01112456889999999999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=284.25 Aligned_cols=253 Identities=23% Similarity=0.259 Sum_probs=189.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-----CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-----GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
+.+.+.||+|++|.||+|..... ++.|++|.++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKET-GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCC-CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 34567899999999999997654 567999998653322 345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+ +++|.+++.... .+++..+..++.||++||+|||+. +|+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999997765 789999999999999999999954 99999999999999999999999999998764432
Q ss_pred cccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC---------
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK--------- 706 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 706 (745)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|..+|..... ...+ ..+.+.....
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQL-GKIFEALGTPTEENWPGVT 231 (298)
T ss_pred cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHH-HHHHHHcCCCchhhhhhcc
Confidence 11 222345778999998854 4678999999999999999999776643221 1111 1111111000
Q ss_pred cccccccccccccc-----cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKN-----DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.............. .......+.+++.+||+.||++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC
Confidence 00000000000000 1122467889999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=283.26 Aligned_cols=199 Identities=24% Similarity=0.374 Sum_probs=165.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|++|.||+|.... .++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 35567889999999999999765 45679999986432 22235577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++ +|.+++... ..+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 985 899988654 4678899999999999999999954 9999999999999999999999999998754322111
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122346788999998865 45889999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=304.52 Aligned_cols=201 Identities=23% Similarity=0.344 Sum_probs=159.0
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEE--------------cc---cccccCHHHHHHHHHHHhccCCCCce
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKK--------------LD---KVEQQGEKEFRTEVSVIGQTHHKNLV 542 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~nIv 542 (745)
...|.+.+.||+|+||+||++......++.+++|. +. .........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 45677889999999999999877543333222221 10 01122345688999999999999999
Q ss_pred eEEEEEecCCeEEEEEEecCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGI-----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 543 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
++++++...+..++|+|++. ++|.+++... ......++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 4677766432 2234567788999999999999954 9999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
++.+||+|||+++.+....... .....|+..|+|||.+.+..++.++|||||||++|||++|..++.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 9999999999998765432211 233568999999999999999999999999999999999986543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=283.09 Aligned_cols=243 Identities=24% Similarity=0.393 Sum_probs=185.5
Q ss_pred cchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------e
Q 040134 484 GFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------H 553 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 553 (745)
.+.++||+|+||.||+|.+... .++.||||++... .....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 3567899999999999987542 4578999998642 2334567889999999999999999999886532 2
Q ss_pred EEEEEEecCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 554 RLLVYEYMSNGSLASFLFGI------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
.++++||+++++|..++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 47889999999999887422 2467888999999999999999954 99999999999999999999999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
+++...............++..|++||.+....++.++||||||+++|||++ |+.|+.... ...+...+. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~----~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLI----KG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHH----cC
Confidence 9987643332221223345678999999988889999999999999999999 777764221 122222111 11
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... ........+.+++.+|++.+|++|||
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps 261 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPS 261 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 1100 01123457899999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=274.99 Aligned_cols=240 Identities=26% Similarity=0.381 Sum_probs=191.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|++|.||++.... .++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKA-DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEcC-CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4567889999999999998765 4567999988542 233456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CceEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~ 637 (745)
+++++|.+++... ..+++..+..++.|++.+|+|||+. +++|+||+|+||+++++ +.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999764 3578899999999999999999965 99999999999999855 4689999999987644322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... .. . +.... .+....+.+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~-~---~~~~~-~~~~~~~~~---- 223 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--PA-L---VLKIM-SGTFAPISD---- 223 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--HH-H---HHHHH-hcCCCCCCC----
Confidence 2234578899999999988899999999999999999999999853321 11 1 11111 111111111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.+|++|||
T Consensus 224 -----~~~~~l~~li~~~l~~~p~~Rpt 246 (256)
T cd08220 224 -----RYSPDLRQLILSMLNLDPSKRPQ 246 (256)
T ss_pred -----CcCHHHHHHHHHHccCChhhCCC
Confidence 12345889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=280.20 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=190.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|.... .++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC-CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34556789999999999998754 35679999875432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.. ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++..+......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 157 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh--
Confidence 999999999864 4678999999999999999999964 9999999999999999999999999998765432211
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....++..|+|||.+....++.++|+||||+++|+|++|..|+..... . .. ........... +
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~-~~----~~~~~~~~~~~-~-------- 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--M-KV----LFLIPKNNPPT-L-------- 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--H-HH----HHHHhcCCCCC-C--------
Confidence 2234578899999999888899999999999999999999999853221 1 11 11111111111 1
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++||+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPT 246 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcC
Confidence 1122355788999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=281.80 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=185.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEe-----cCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCD-----EGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-----~~~~~~ 555 (745)
.+.+.+.||+|+||.||+++... .++.+|+|.++.. ......+.+|+.+++++ +||||+++++++. .++..+
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECC-CCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 34566789999999999999865 4567999987642 22346788899999999 7999999999874 456789
Q ss_pred EEEEecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceee
Confidence 99999999999998752 35678889999999999999999954 999999999999999999999999999876
Q ss_pred ccccccccccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
+...... .....|+..|+|||.+.. ..++.++||||||+++|||++|+.|+...... ..+. . ....
T Consensus 174 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~----~-~~~~ 244 (286)
T cd06638 174 LTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALF----K-IPRN 244 (286)
T ss_pred cccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHh----h-cccc
Confidence 6432211 233468899999998853 45788999999999999999999998643221 1110 1 0111
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+..+. .....+.+++.+||+.||++|||
T Consensus 245 ~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps 276 (286)
T cd06638 245 PPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPT 276 (286)
T ss_pred CCCcccCCC-------CcCHHHHHHHHHHccCCcccCCC
Confidence 111111110 12345889999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=282.17 Aligned_cols=243 Identities=27% Similarity=0.369 Sum_probs=192.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||++..... ++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVAT-GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCC-CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 455678899999999999986543 4569999986544455677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.+ ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~ 172 (293)
T cd06647 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 172 (293)
T ss_pred CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--c
Confidence 99999999865 3578889999999999999999955 9999999999999999999999999988765433221 2
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....+++.|+|||.+....++.++||||||+++|+|++|+.||........ +. .....+. ......
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~----~~~~~~~--------~~~~~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNGT--------PELQNP 238 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--ee----ehhcCCC--------CCCCCc
Confidence 234578899999999888899999999999999999999999864322111 00 0000000 001111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.+|++|||
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~ 262 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGS 262 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcC
Confidence 122346788999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=282.49 Aligned_cols=254 Identities=24% Similarity=0.269 Sum_probs=191.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||+|..... ++.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRET-GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCC-CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 45678899999999999997653 5679999986533 33356889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+ +++|.+++... ..+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998643 5689999999999999999999954 999999999999999999999999999987654322 1
Q ss_pred ccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc-----------
Q 040134 640 ARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN----------- 707 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~----------- 707 (745)
......++..|+|||.+.+. .++.++||||||++++||++|.+++.... +...+ ..+...+....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--DIEQL-AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC--HHHHH-HHHHHHcCCCChHHHhhccCcc
Confidence 12334688899999988654 46899999999999999999976664222 11111 11111110000
Q ss_pred -cccccccccc----ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 -LDKLAENDEE----VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 -~~~~~~~~~~----~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+..+... .....+....+.+++.+||+.||++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 0000000000 0000122367889999999999999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=273.22 Aligned_cols=241 Identities=27% Similarity=0.393 Sum_probs=195.4
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
.+.+.||+|++|.||++.... +++.+++|++........+.+.+|++++++++|+||+++++++......++++||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred eeeeeeccCCceEEEEEEECC-CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 455789999999999999865 4567999998765545667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 564 GSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 564 gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
++|.+++... ..+++..+..++.|++.||++||+ .+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 9999999776 678999999999999999999995 5999999999999999999999999999987654332 23
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...++..|+|||.+.....+.++||||||+++|+|++|+.|+...... ... ... .......+.. ..
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~-~~~~~~~~~~-------~~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KAL----FKI-ATNGPPGLRN-------PE 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHH----HHH-HhcCCCCcCc-------cc
Confidence 345788999999998888999999999999999999999998643221 111 111 0111111111 11
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t 244 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPT 244 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCC
Confidence 12356889999999999999997
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=279.36 Aligned_cols=242 Identities=29% Similarity=0.386 Sum_probs=193.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.+.||+|++|.||++..... ++.+++|.+..... ..+.+.+|++.+++++|+||+++++.+...+..++|+||++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRAT-GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccC-CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 34557899999999999998753 46799999875433 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+++|.+++.... .+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 173 (286)
T cd06614 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KR 173 (286)
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hh
Confidence 999999998776 88999999999999999999995 4999999999999999999999999999876543221 12
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... .... . . ........... .
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--~~~~-~---~-~~~~~~~~~~~-------~ 239 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--LRAL-F---L-ITTKGIPPLKN-------P 239 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHH-H---H-HHhcCCCCCcc-------h
Confidence 234577899999999888899999999999999999999999853221 1111 1 1 11111111111 1
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+|++.+|.+|||
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt 263 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPS 263 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcC
Confidence 112356889999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=277.96 Aligned_cols=235 Identities=28% Similarity=0.415 Sum_probs=184.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc---CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 3466788999999999999875 3456999998642 2346789999999999999999999998664 47899999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 9999999999754 3578889999999999999999954 9999999999999999999999999998764322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... .+. .....+.....
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~------ 218 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVK----ECVEKGYRMEP------ 218 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHH----HHHhCCCCCCC------
Confidence 112234568999999988889999999999999999998 88887533221 111 11111111110
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~Rp~ 243 (254)
T cd05083 219 ---PEGCPADVYVLMTSCWETEPKKRPS 243 (254)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCcC
Confidence 1122356789999999999999997
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=281.05 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=186.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEec------CCeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE------GDHR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~ 554 (745)
.+.+.+.||.|+||.||+|.... .++.+|+|.+.... ....++..|+.+++++ +|+||+++++++.. .+..
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcC-CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 44566789999999999999865 45679999885432 3346788899999998 79999999999853 4678
Q ss_pred EEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 555 LLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||+|+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 9999999999999998653 4577888899999999999999965 9999999999999999999999999998765
Q ss_pred cccccccccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
..... ......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ... .. .....
T Consensus 172 ~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~----~~-~~~~~ 242 (282)
T cd06636 172 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RAL----FL-IPRNP 242 (282)
T ss_pred hcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhh----hh-HhhCC
Confidence 32221 123356888999999885 346788999999999999999999998533211 111 00 00000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+ . .......+.+++.+||+.||.+|||
T Consensus 243 ~~~~-----~---~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (282)
T cd06636 243 PPKL-----K---SKKWSKKFIDFIEGCLVKNYLSRPS 272 (282)
T ss_pred CCCC-----c---ccccCHHHHHHHHHHhCCChhhCcC
Confidence 0000 0 1122356889999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=281.61 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=163.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
|.+.+.||+|+||.||+|..... ++.|++|.+.... ......+.+|+.+++.++|+||+++++++..+...++|+||+
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRIN-GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCC-CcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 45678899999999999987654 4569999986432 233356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
. ++|.+++.. ...+.+..+..++.|++.||+|||.. +|+|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 159 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-- 159 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--
Confidence 6 577666644 35577888999999999999999954 9999999999999999999999999998764322111
Q ss_pred cccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 223346889999999875 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=289.74 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=197.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
.++...||.|+||.||+++.+. ++...|-|.+...+....++|.-|++||....||+|+++++.+..++.+++..|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nke-t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKE-TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhccc-chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3456679999999999999763 556677888887777788899999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
||-.+.++... ..+.+.++.-+..|++.||.|||. .+|||||||+.|||++-+|.++|+|||.+....... ...
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH--hhh
Confidence 99999987654 668999999999999999999995 599999999999999999999999999987643222 224
Q ss_pred ccccccccccchhcc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 642 TGIRGTVGYFAPEWF-----RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~-----~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
..+.||+.|||||++ .+.+|+.++||||||++|.||..+.+|...-. .+..+. .+......-++.+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVll-KiaKSePPTLlqPS- 259 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLL-KIAKSEPPTLLQPS- 259 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHH-HHhhcCCCcccCcc-
Confidence 567899999999986 46789999999999999999999998864211 111111 12223333333332
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.-...+.++...||..||..||+
T Consensus 260 ------~Ws~~F~DfLk~cL~Knp~~Rp~ 282 (1187)
T KOG0579|consen 260 ------HWSRSFSDFLKRCLVKNPRNRPP 282 (1187)
T ss_pred ------hhhhHHHHHHHHHHhcCCccCCC
Confidence 22456788999999999999996
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=284.55 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=166.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCC-CcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASD-SKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 556 (745)
+.+.+.||+|++|.||+|..... .++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 45667899999999999998653 45789999987632 34456788899999999999999999999988 88999
Q ss_pred EEEecCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC----CCceEEeecc
Q 040134 557 VYEYMSNGSLASFLFGI-----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD----YFTPRISDFG 627 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~Dfg 627 (745)
||||+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 676666422 2578889999999999999999954 9999999999999999 8999999999
Q ss_pred Cccccccccc-ccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 628 LAKLLLAEQT-QAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 628 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
++..+..... ........++..|+|||.+.+ ..++.++||||||+++++|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9987643322 111233457889999998766 457899999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=278.32 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=192.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 558 (745)
+++.+.||.|++|.||++.... .++.+++|.+... .....+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecC-CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4566789999999999998765 4567999988532 23345678899999999999999999997753 45689999
Q ss_pred EecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 559 EYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEEC--STQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 559 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
||+++++|.+++.. ...+++..++.++.||+.||+|||..+ +.+++|+||+|+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999864 356889999999999999999999432 349999999999999999999999999999876
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
...... .....++..|+|||.+....++.++|+||||+++++|++|+.|+.... ...+. +....+....+
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~~~- 230 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLA----SKIKEGKFRRI- 230 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHH----HHHhcCCCCCC-
Confidence 543321 223467899999999988889999999999999999999999986433 11111 22222221111
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 231 --------~~~~~~~~~~l~~~~l~~~p~~Rp~ 255 (265)
T cd08217 231 --------PYRYSSELNEVIKSMLNVDPDKRPS 255 (265)
T ss_pred --------ccccCHHHHHHHHHHccCCcccCCC
Confidence 1123456889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=287.52 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=197.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+...||+|.|+.|..++.... +..||||.+++.. ......+.+|++++..++||||++++.+......+|+|||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t-~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILT-GTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCC-CceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 455678999999999999998764 5669999997632 3334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+.+|.+.+++.++.++.+.++..++.|+..|++|||.+ +|||||||++||||+.+.++||+|||++..+.....
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~-- 210 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM-- 210 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccc--
Confidence 999999999999999999999999999999999999955 999999999999999999999999999988764332
Q ss_pred ccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....|++.|.|||++.+.++ .+++|+||+|++||.|+.|..||+......- -.+.+ .+ ....
T Consensus 211 -lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------r~rvl-~g--------k~rI 274 (596)
T KOG0586|consen 211 -LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------RPRVL-RG--------KYRI 274 (596)
T ss_pred -ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc------cchhe-ee--------eecc
Confidence 456789999999999998876 5899999999999999999999974432110 00111 11 1111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.--..++.++++++|-.+|.+|+|
T Consensus 275 --p~~ms~dce~lLrk~lvl~Pskr~~ 299 (596)
T KOG0586|consen 275 --PFYMSCDCEDLLRKFLVLNPSKRGP 299 (596)
T ss_pred --cceeechhHHHHHHhhccCccccCC
Confidence 1111234668899999999999986
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=279.16 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=186.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC-----CeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG-----DHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-----~~~~l 556 (745)
+.+.+.||+|+||.||++.... .++.+|+|.+.... .....+.+|+.+++++ +||||+++++++... ...++
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKK-DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECC-CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 4456789999999999998765 45679999986432 2346778899999999 899999999998653 36899
Q ss_pred EEEecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 557 VYEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
|+||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..+
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 9999999999998753 35688999999999999999999965 9999999999999999999999999998865
Q ss_pred cccccccccccccccccccchhccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKA-----SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
...... .....++..|+|||.+... .++.++||||||+++|||++|+.|+..... ...+.. .....
T Consensus 179 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~~-----~~~~~ 249 (291)
T cd06639 179 TSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFK-----IPRNP 249 (291)
T ss_pred cccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHHH-----HhcCC
Confidence 432221 2234578899999988543 368999999999999999999999853321 111111 11111
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.+ ..+....+.+++.+||+.+|++|||
T Consensus 250 ~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps 280 (291)
T cd06639 250 PPTLLH-------PEKWCRSFNHFISQCLIKDFEARPS 280 (291)
T ss_pred CCCCCc-------ccccCHHHHHHHHHHhhcChhhCcC
Confidence 111111 1122346889999999999999997
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=278.47 Aligned_cols=244 Identities=28% Similarity=0.380 Sum_probs=189.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC------e
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD------H 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------~ 553 (745)
..+.+.+.||+|++|.||+|..... ++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++.... .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKT-GQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCC-CcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 3456778999999999999998653 5679999886533 2346789999999999 7999999999997644 4
Q ss_pred EEEEEEecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 554 RLLVYEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence 8999999999999998864 35788999999999999999999954 9999999999999999999999999998
Q ss_pred ccccccccccccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ...+.. ..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~-----~~ 231 (275)
T cd06608 161 AQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFK-----IP 231 (275)
T ss_pred eecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHH-----hh
Confidence 76543221 1233457889999998753 3467899999999999999999999853211 111111 11
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... ..........+.+++.+||+.||++|||
T Consensus 232 ~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt 265 (275)
T cd06608 232 RNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPF 265 (275)
T ss_pred ccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcC
Confidence 111111 1112224457889999999999999997
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=279.48 Aligned_cols=199 Identities=24% Similarity=0.312 Sum_probs=166.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 557 (745)
.+.+.+.||+|++|.||+|.... .++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECC-CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35567889999999999999865 45679999986432 22334677899999999999999999998877 899999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+||+++ +|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 899888654 4589999999999999999999965 99999999999999999999999999998765432
Q ss_pred cccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.. .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 161 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 161 KP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 2234568899999998754 4689999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=279.89 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=185.6
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.||+|+||.||++.... .++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECC-CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 45789999999999999765 45779999986432 234567889999999996 9999999999999999999999986
Q ss_pred CCCHHHHh---c--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 563 NGSLASFL---F--GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 563 ~gsL~~~l---~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
. +|.++. . ....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++..+.....
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 555433 2 235688999999999999999999952 4899999999999999999999999999876543221
Q ss_pred ccccccccccccccchhccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKA---SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.....++..|+|||.+... .++.++||||||+++|||++|+.||.... .....+.+.. .+....+
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~~~~~--- 231 (288)
T cd06616 164 ---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGDPPIL--- 231 (288)
T ss_pred ---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCCCCcC---
Confidence 2234578899999998765 68999999999999999999999986432 1111111111 1111111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...........+.+++.+||+.||++|||
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 260 (288)
T cd06616 232 --SNSEEREFSPSFVNFINLCLIKDESKRPK 260 (288)
T ss_pred --CCcCCCccCHHHHHHHHHHccCChhhCcC
Confidence 11111223456889999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=279.65 Aligned_cols=196 Identities=25% Similarity=0.388 Sum_probs=164.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+..+.||.|++|.||+|+... +++.|+||.+.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred eeeeeecCCCceEEEEEEECC-CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 456789999999999999765 45679999886422 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
. ++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..+......
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 6 5898888643 5678999999999999999999954 9999999999999999999999999998765432211
Q ss_pred ccccccccccccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.....++..|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22234678899999886644 68899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=272.90 Aligned_cols=236 Identities=24% Similarity=0.307 Sum_probs=183.5
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHH-hccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVI-GQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.||+|++|.||+|.... .++.||+|.+..... .....+..|..++ ...+|+||+++++++...+..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecC-CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 468999999999998765 356799999864321 1223345555544 44589999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... ..
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 999999998878889999999999999999999954 999999999999999999999999999875432 22
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...++..|+|||.+.+..++.++||||||+++|||++|..||..... .. . ......+.... ......
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~-~----~~~~~~~~~~~------~~~~~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DA-V----FDNILSRRINW------PEEVKE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HH-H----HHHHHhcccCC------CCcccc
Confidence 34578899999999888889999999999999999999999853221 11 1 11111111110 000011
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~ 241 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLG 241 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccC
Confidence 23456889999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=290.45 Aligned_cols=198 Identities=30% Similarity=0.449 Sum_probs=170.8
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------eEEEE
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------HRLLV 557 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv 557 (745)
..+.||+|+||.||+|+.+. +++.||||.+... .....+..-+|++++++++|+|||+++++-++.. ...+|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnke-tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKE-TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccc-cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 45789999999999999765 5678999999763 3344567778999999999999999999876544 56899
Q ss_pred EEecCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCC--ceEEeeccCcc
Q 040134 558 YEYMSNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD--DYF--TPRISDFGLAK 630 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~--~~~--~~kl~Dfg~a~ 630 (745)
||||.+|+|...|.+. ..+++.+.+.++.++..||.|||++ ||+||||||.||++- ++| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999999754 5689999999999999999999976 999999999999983 333 56999999999
Q ss_pred cccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
.+.++. .....+||..|.+||.... +.++...|.|||||++|+.+||..||..-..
T Consensus 173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 987665 3667899999999999984 8899999999999999999999999965444
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=279.76 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=188.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.||.|++|.||+|.... +++.||+|++.... ......+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcC-CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999765 45679999886432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+ ++|.+++.... .+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++..+......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999987665 689999999999999999999964 9999999999999999999999999999765332211
Q ss_pred ccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC------------
Q 040134 640 ARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK------------ 706 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------------ 706 (745)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ...+...........
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1223467889999988654 578999999999999999999999864322 111212111100000
Q ss_pred ---cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 ---NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........... .........+.+++.+|+++||++|||
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt 273 (283)
T cd07835 233 YKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRIS 273 (283)
T ss_pred hhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcC
Confidence 00000000000 001112356889999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=282.36 Aligned_cols=237 Identities=28% Similarity=0.343 Sum_probs=185.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|++|.||+|.... .++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 5566789999999999999765 35679999885322 2234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|++ ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 577776643 45689999999999999999999954 9999999999999999999999999998764322
Q ss_pred cccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... ... .... .......+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--~~~----~~~~-~~~~~~~~---- 234 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA----LYHI-AQNDSPTL---- 234 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--HHH----HHHH-hcCCCCCC----
Confidence 2345778999999874 45688999999999999999999999853221 111 1111 11111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rp~ 260 (307)
T cd06607 235 ----SSNDWSDYFRNFVDSCLQKIPQDRPS 260 (307)
T ss_pred ----CchhhCHHHHHHHHHHhcCChhhCcC
Confidence 01123456899999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=272.30 Aligned_cols=234 Identities=22% Similarity=0.255 Sum_probs=180.1
Q ss_pred cchhh--cCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 484 GFRQI--LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~--Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+. ||+|+||.||++..... ++.+|+|.+....... .|+.....+ +||||+++++.+...+..++||||
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPT-QKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCC-CcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 34444 59999999999987654 5678999876432111 122222222 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++++|.+++.....+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---- 163 (267)
T PHA03390 91 IKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---- 163 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----
Confidence 99999999998877899999999999999999999954 999999999999999988 9999999998765322
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+... . ..... .
T Consensus 164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~-~~~~~-~-------- 229 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q-QKKLP-F-------- 229 (267)
T ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h-cccCC-c--------
Confidence 22357889999999998899999999999999999999999987332221 111111111 1 11110 0
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|.+|||
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~ 254 (267)
T PHA03390 230 -IKNVSKNANDFVQSMLKYNINYRLT 254 (267)
T ss_pred -ccccCHHHHHHHHHHhccChhhCCc
Confidence 1123456889999999999999995
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=278.93 Aligned_cols=253 Identities=24% Similarity=0.285 Sum_probs=189.9
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLVYE 559 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 559 (745)
.+.+.||+|++|.||+|+... .++.+|+|.+.... ......+.+|++++++++|+|++++++++... ...++|+|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKK-TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred eeeEEeccCCCeEEEEEEECC-CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456789999999999999865 35679999997542 33446788999999999999999999999888 89999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++ +|.+++... ..+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 898888665 5789999999999999999999965 9999999999999999999999999999876544321
Q ss_pred cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc---Cccccccc-
Q 040134 639 AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG---KNLDKLAE- 713 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~- 713 (745)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+ ..+.+.... .......+
T Consensus 157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 157 D-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQL-EKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred c-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHH-HHHHHHhCCCchhhccccccc
Confidence 1 223346788999998765 4678999999999999999999999854332 1111 111111100 00000000
Q ss_pred -------cccccc----ccH-H-HHHHHHHHHHhccccCcCCCCC
Q 040134 714 -------NDEEVK----NDL-K-RVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 -------~~~~~~----~~~-~-~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... ... . +...+.+++.+||+.+|++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 277 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC
Confidence 000000 000 1 2567899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=279.09 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=182.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHH-HhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSV-IGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|+||.||+++... +++.||+|+++... ......+..|+.+ ++.++||||+++++++...+..+++|||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcC-CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 4466789999999999999765 46789999986532 2234456666665 5566899999999999999999999999
Q ss_pred cCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
++ ++|.+++.. ...+++..++.++.||+.||+|||+. .+++||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 96 688777643 24678999999999999999999952 389999999999999999999999999988654322
Q ss_pred cccccccccccccccchhcccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
. .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... .+.+. ... .+....+.
T Consensus 159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~-~~~~~~~~ 229 (283)
T cd06617 159 A---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLK----QVV-EEPSPQLP 229 (283)
T ss_pred c---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHH----HHH-hcCCCCCC
Confidence 1 223457889999998864 45688999999999999999999998532211 11111 111 11111110
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 230 --------~~~~~~~l~~li~~~l~~~p~~Rp~ 254 (283)
T cd06617 230 --------AEKFSPEFQDFVNKCLKKNYKERPN 254 (283)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcC
Confidence 0112356889999999999999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=285.55 Aligned_cols=197 Identities=27% Similarity=0.297 Sum_probs=164.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------C
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------D 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 552 (745)
..+...+.||+|+||.||++.... .++.||+|.+... .....+.+.+|+.++++++|+||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTV-TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECC-CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 345566889999999999999765 4567999998642 233345678899999999999999999988543 3
Q ss_pred eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 553 HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
..++||||+.+ +|.+.+... ++...+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 57999999964 888877543 78889999999999999999954 9999999999999999999999999999875
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 43222 22345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.54 Aligned_cols=250 Identities=19% Similarity=0.214 Sum_probs=184.3
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccC-CCCceeEEEEEecC--CeEEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEG--DHRLLVYE 559 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e 559 (745)
.+.+.||+|++|.||++.... .++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRK-TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred ceEeeccccccceEEEEEEcC-CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999765 45679999986532 222334457888888885 99999999999887 88999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|++ ++|.+++... ..+++.++..++.|++.||+|||+. +++|+||+|+||+++. +.+||+|||++..+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 4787777653 5689999999999999999999965 9999999999999999 9999999999987643322
Q ss_pred cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh-----------hcC
Q 040134 639 AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY-----------IGK 706 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~-----------~~~ 706 (745)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||...... + ....+...+ ...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--D-QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--H-HHHHHHHHcCCCCHHHHHhhccc
Confidence 223457889999997644 56789999999999999999999998543221 1 111111111 000
Q ss_pred cccccccccccc----cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEV----KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.... .........+.+++.+||+.+|++|||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 000000000000 001123577999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=281.96 Aligned_cols=237 Identities=27% Similarity=0.320 Sum_probs=184.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+...+.||+|+||.||+++... .++.||+|.+.... ....+.+.+|++++++++|+|++++++++.+++..++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4456789999999999999765 35679999986422 2234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++ +|.+.+.. ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9975 77777643 45689999999999999999999965 999999999999999999999999999875432
Q ss_pred cccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... ...+.... .......
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~-----~~~~~~~---- 244 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIA-----QNESPTL---- 244 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHH-----hccCCCC----
Confidence 22345788999999873 45688999999999999999999999853211 11111111 1111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.+|.+|||
T Consensus 245 ----~~~~~~~~l~~li~~~l~~~p~~Rpt 270 (317)
T cd06635 245 ----QSNEWSDYFRNFVDSCLQKIPQDRPT 270 (317)
T ss_pred ----CCccccHHHHHHHHHHccCCcccCcC
Confidence 01122345889999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=277.17 Aligned_cols=238 Identities=25% Similarity=0.360 Sum_probs=189.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
..||+|++|.||++.... .++.||+|++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcC-CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 579999999999998765 4567999998654445567789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccc
Q 040134 567 ASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646 (745)
Q Consensus 567 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 646 (745)
.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..+...... .....+
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~ 178 (292)
T cd06657 105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVG 178 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccccc
Confidence 998754 4678999999999999999999965 9999999999999999999999999998765432211 223457
Q ss_pred cccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHH
Q 040134 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVE 726 (745)
Q Consensus 647 t~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (745)
+..|+|||.+....++.++|+||||+++|+|++|..|+..... .. ....+.... ..... .......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~-~~~~~~~~~-----~~~~~------~~~~~~~ 244 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LK-AMKMIRDNL-----PPKLK------NLHKVSP 244 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH-HHHHHHhhC-----CcccC------CcccCCH
Confidence 8899999999888889999999999999999999999853221 11 111111111 10000 0011234
Q ss_pred HHHHHHHhccccCcCCCCC
Q 040134 727 RLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 727 ~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+++.+||+.||.+|||
T Consensus 245 ~l~~li~~~l~~~P~~R~~ 263 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRAT 263 (292)
T ss_pred HHHHHHHHHHhCCcccCcC
Confidence 5778999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=286.27 Aligned_cols=200 Identities=29% Similarity=0.417 Sum_probs=165.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC--CeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG--DHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~~ 555 (745)
..+.+.+.||+|+||.||+|.... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcC-CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345677899999999999999765 3567999988532 233445677899999999 999999999988653 4689
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++..+...
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999988765 778899999999999999999954 9999999999999999999999999999876443
Q ss_pred ccc---cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 636 QTQ---AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 636 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 321 12233568889999998755 4678999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=278.46 Aligned_cols=240 Identities=29% Similarity=0.349 Sum_probs=194.6
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.-++||+|+||.|+-..... +++.+|.|++.+ ....++..-.+|-.+|.+++.+.||.+--.+++.+.+++|+..|
T Consensus 189 ~~RvlGkGGFGEV~acqvra-TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRA-TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeEEEecccccceeEEEEec-chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 34689999999999887665 567789888854 23445567789999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
.||+|.-+|.+.+ .++++.++.++.+|+.||++||.+ +||.||+||+|||+|++|+++|+|+|+|..+......
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 9999999998765 789999999999999999999965 9999999999999999999999999999988766543
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
...+||.+|||||++.+..|+...|.|||||+||||+.|+.||......... +.+.+...+. ..+
T Consensus 344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~----------~~e 408 (591)
T KOG0986|consen 344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLED----------PEE 408 (591)
T ss_pred --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcc----------hhh
Confidence 3347999999999999999999999999999999999999999643322111 1111111111 111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.+....++...+....|+.||++|-
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhc
Confidence 2233345567777788999999884
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=276.84 Aligned_cols=246 Identities=26% Similarity=0.287 Sum_probs=191.0
Q ss_pred hcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc----ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 555 (745)
+.+.+.||+|+||.||++.... ..++.||+|++.... ....+.+.+|+.+++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 3466789999999999998743 245779999986422 22346788899999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+|+||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998878889999999999999999999964 9999999999999999999999999999876433
Q ss_pred ccccccccccccccccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKA--SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... .....++..|+|||.+... .++.++||||||+++|+|++|+.|+...... ............ ....
T Consensus 159 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~---- 230 (290)
T cd05613 159 EVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK-SEPP---- 230 (290)
T ss_pred cccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc-cCCC----
Confidence 2211 2234578899999998653 4678999999999999999999998643221 111121211111 1100
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......+.+++.+||+.||++||+
T Consensus 231 --~----~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 231 --Y----PQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred --C----CccCCHHHHHHHHHHhcCCHHHhcC
Confidence 0 1112345788999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=274.54 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=188.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-----cccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-----EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 555 (745)
+.+.+.||+|++|.||++.... +++.|++|.+... .......+.+|++++++++|+||+++++++.+. ...+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcC-CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 4567899999999999998765 4567999987421 123346788999999999999999999998664 4688
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+++||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998777788999999999999999999955 9999999999999999999999999999865332
Q ss_pred cc-ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QT-QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .... +.+..... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~----~~~~~~~~-~~~~--- 229 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAA----IFKIATQP-TKPM--- 229 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HHHH----HHHHHcCC-CCCC---
Confidence 11 111223457889999999988889999999999999999999999985321 1111 11111111 1111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+.+++.+|++ +|..|||
T Consensus 230 -----~p~~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 230 -----LPDGVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred -----CCcccCHHHHHHHHHHhc-CcccCcc
Confidence 111233568889999999 5799997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.51 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=188.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||.|++|.||+|+... +++.||+|.++... ......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECC-CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 3456789999999999999865 45679999986532 233467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++ +|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888887643 3578999999999999999999954 999999999999999999999999999976533221
Q ss_pred cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC---------cc
Q 040134 639 AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK---------NL 708 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~ 708 (745)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.+.. +.+..... ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLK-IFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHH-HHHHhCCCChhhHHHHhcC
Confidence 1223456788999998865 4578899999999999999999999864332 111111 11110000 00
Q ss_pred ccccccccc------ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEE------VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~------~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......... ..........+.+++.+|++.||.+|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 000000000 0001122456889999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=274.83 Aligned_cols=235 Identities=27% Similarity=0.301 Sum_probs=181.2
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHH---HHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVS---VIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+||+|+||.||++.... .++.||+|.+..... .....+..|.. .++...||+|+++++.+...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEec-CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999998765 456799999864221 12223444443 344457999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..+.... .
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 9999999998778899999999999999999999964 99999999999999999999999999987653322 2
Q ss_pred ccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........... ......... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~------~~---- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAV------EL---- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhccCC------CC----
Confidence 234688999999998754 689999999999999999999999865432221111 111111000 00
Q ss_pred cHHHHHHHHHHHHhccccCcCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......+.+++.+|++.+|.+||
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhcc
Confidence 011235688999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=281.44 Aligned_cols=197 Identities=31% Similarity=0.373 Sum_probs=163.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 558 (745)
+++.+.||+|++|.||+|.... .++.||+|.++... ......+.+|+.++++++|+||+++++++... +..++||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECC-CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 5567789999999999999865 45679999986432 22234567899999999999999999998754 5689999
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++ +|.+++... ..+++.++..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99975 888887653 6689999999999999999999965 999999999999999999999999999987654321
Q ss_pred ccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 638 QAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 164 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 164 P--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred C--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 222345788999999865 5678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=281.61 Aligned_cols=197 Identities=24% Similarity=0.302 Sum_probs=160.2
Q ss_pred hhcCcc--eeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 487 QILGRG--AFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 487 ~~Ig~G--~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
..||+| +|++||++.... .++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 457777 899999998754 4577999998642 22334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-
Q 040134 563 NGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA- 639 (745)
Q Consensus 563 ~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 639 (745)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998754 4578888999999999999999954 99999999999999999999999998654432211110
Q ss_pred ----ccccccccccccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 640 ----ARTGIRGTVGYFAPEWFRKA--SITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 640 ----~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 00112345679999999763 4789999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=270.94 Aligned_cols=241 Identities=29% Similarity=0.448 Sum_probs=194.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||+++.... ++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLET-GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCC-CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 34567899999999999987653 46799999865433 3456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 9999999999887889999999999999999999995 49999999999999999999999999999876543321
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
.....++..|+|||.+.....+.++||||||+++|+|++|+.|+.... ..... .... ......+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~----~~~~-~~~~~~~--------- 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PMAAL----FRIV-QDDHPPL--------- 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHH----HHHh-ccCCCCC---------
Confidence 233457889999999988888999999999999999999999985332 11111 1111 1111111
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~ 244 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPT 244 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcC
Confidence 1112356789999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=278.70 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=187.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------ 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 552 (745)
..+.+.+.||+|++|.||+|..... ++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCC-CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 4456778999999999999998753 5679999986432 233457788999999999999999999987655
Q ss_pred ----eEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeecc
Q 040134 553 ----HRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFG 627 (745)
Q Consensus 553 ----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 627 (745)
..++|+||+++ +|...+... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 676666543 5689999999999999999999965 99999999999999999999999999
Q ss_pred Ccccccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
++..+....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+.. +.+.....
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~-~~~~~~~~ 237 (302)
T cd07864 162 LARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLEL-ISRLCGSP 237 (302)
T ss_pred ccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH-HHHHhCCC
Confidence 998764433211 222345778999998865 4578999999999999999999998864322 111111 11111100
Q ss_pred c---cccccc--------ccccc-----cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 N---LDKLAE--------NDEEV-----KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~---~~~~~~--------~~~~~-----~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ...+.. ..... .........+.+++.+||+.||++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 292 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC
Confidence 0 000000 00000 000012456889999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=277.39 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=184.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe-----E
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH-----R 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-----~ 554 (745)
+.+.+.||+|+||.||+|.... +++.||+|.++... ......+.+|+.+++++ +|+||+++++++...+. .
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~-~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKN-TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred ceEeeEecccCCeEEEEEEECC-CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4556789999999999999865 45679999875432 22346788899999999 56999999999987665 8
Q ss_pred EEEEEecCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccC
Q 040134 555 LLVYEYMSNGSLASFLFGI-----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGL 628 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~ 628 (745)
++||||+++ +|.+++... ..+++..++.++.||+.||+|||+. +|+||||+|+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999986 788887542 3578999999999999999999954 9999999999999998 88999999999
Q ss_pred cccccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 629 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
+..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...+.... +.+....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~-~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIF-KLLGTPT 232 (295)
T ss_pred ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH-HHhCCCC
Confidence 8765332211 122346788999998865 4578999999999999999999998864322 11111111 1110000
Q ss_pred ---cccccc-----------ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 ---LDKLAE-----------NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ---~~~~~~-----------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... +.............+.+++.+||+.||++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~ 284 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence 000000 00000000123456889999999999999997
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=280.11 Aligned_cols=201 Identities=23% Similarity=0.351 Sum_probs=163.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-------
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------- 552 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 552 (745)
.+.+.+.||+|++|.||++.... +++.||||.+.... ......+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKK-TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECC-CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 35667889999999999999765 45779999885422 222345678999999999999999999986654
Q ss_pred -eEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 553 -HRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 553 -~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
..++||||+.+ +|.+++... ..+++.++..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999965 788777654 3689999999999999999999965 99999999999999999999999999998
Q ss_pred cccccccc--cccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 631 LLLAEQTQ--AARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 631 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 76433221 112234567889999988654 4788999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=275.34 Aligned_cols=246 Identities=26% Similarity=0.293 Sum_probs=190.7
Q ss_pred hcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc----ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 555 (745)
+.+.+.||+|++|.||+++... ..++.||||.++... ....+.+.+|+.++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 3456789999999999998642 245679999986422 22345688999999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||+++++|.+++.....+++..+..++.|++++|.|||+. +++|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998777789999999999999999999954 9999999999999999999999999998765433
Q ss_pred ccccccccccccccccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKAS--ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... .....++..|+|||.+.+.. .+.++||||||+++|||++|..|+....... ......... ......
T Consensus 159 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~-~~~~~~---- 230 (288)
T cd05583 159 EEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRI-LKSKPP---- 230 (288)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHH-HccCCC----
Confidence 2211 22345788999999987654 7889999999999999999999986432211 111111111 111100
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......+.+++.+||+.||++|||
T Consensus 231 --~----~~~~~~~l~~li~~~l~~~p~~R~t 256 (288)
T cd05583 231 --F----PKTMSAEARDFIQKLLEKDPKKRLG 256 (288)
T ss_pred --C----CcccCHHHHHHHHHHhcCCHhhccC
Confidence 0 0112245778999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=268.64 Aligned_cols=241 Identities=24% Similarity=0.353 Sum_probs=195.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||.|++|.||++.... +++.+++|++.... ....+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcC-CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3456789999999999999865 45679999986532 24567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998764 6789999999999999999999965 99999999999999999999999999998764433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.|+..... . ... ..........+..
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~----~~~-~~~~~~~~~~~~~--- 225 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--L----ELA-LKILKGQYPPIPS--- 225 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--H----HHH-HHHhcCCCCCCCC---
Confidence 1 12334678899999999888899999999999999999999999854321 1 111 1112222221110
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.+|++|||
T Consensus 226 ------~~~~~~~~~i~~~l~~~p~~Rp~ 248 (258)
T cd08215 226 ------QYSSELRNLVSSLLQKDPEERPS 248 (258)
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcC
Confidence 22356889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=261.64 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=200.7
Q ss_pred CCCCCcCccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhcc-CCCCce
Q 040134 465 PSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQT-HHKNLV 542 (745)
Q Consensus 465 ~~~~~~~~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv 542 (745)
+....+..|+.+.|+.- ..||.|+||+|++-..+. .++..|||+++.... ...++++.|.+...+- +.||||
T Consensus 53 p~~~~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~-sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IV 126 (361)
T KOG1006|consen 53 PDDAHLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKP-SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIV 126 (361)
T ss_pred CCcccccccccchHHHH-----HHhcCCcchhhhhhhcCc-cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHH
Confidence 44455667776666543 469999999999988766 567899999976433 4456788888876655 799999
Q ss_pred eEEEEEecCCeEEEEEEecCCCCHHHHhc-----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLF-----GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 543 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
+++|.+..+...++.||.|. .+|+.+.+ ....+++.-+-+|....+.||.||.+. ..|||||+||+|||++.
T Consensus 127 kfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 127 KFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDR 203 (361)
T ss_pred HHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEec
Confidence 99999999999999999994 47766543 336678888888999999999999985 69999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l 695 (745)
.|.+||+|||++..+..... .+...|-..|||||.+.. +.++-++||||||++|||+.||+.|+..-. .+
T Consensus 204 ~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----sv 275 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SV 275 (361)
T ss_pred CCCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HH
Confidence 99999999999987654332 445668899999999853 468999999999999999999999985322 23
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+.+. ..|....+..... ..+....++.++..||-+|..+||.
T Consensus 276 feql~~V-v~gdpp~l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpk 320 (361)
T KOG1006|consen 276 FEQLCQV-VIGDPPILLFDKE----CVHYSFSMVRFINTCLIKDRSDRPK 320 (361)
T ss_pred HHHHHHH-HcCCCCeecCccc----ccccCHHHHHHHHHHhhcccccCcc
Confidence 3333333 3444444433222 2345567889999999999999994
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=269.91 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=190.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||++..... +..+|+|.+... .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSD-SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCC-CceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 34567899999999999998764 456899998542 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 637 (745)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+..+.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999986543 468999999999999999999954 999999999999998875 569999999887643321
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....+++.|+|||.+....++.++|+||||++++||++|+.|+..... ...+.+.. ......+
T Consensus 158 ~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~------ 222 (257)
T cd08225 158 L--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-QGYFAPI------ 222 (257)
T ss_pred c--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cccCCCC------
Confidence 1 2224578899999999888899999999999999999999999853221 11222211 1111111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt 247 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPS 247 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcC
Confidence 1112346889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.53 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=190.8
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.||+|++|.||++.... +++.+++|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred ccceeeecCCCceEEEEEcCC-CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345689999999999999765 456799999865322 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++ +|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 75 888877653 5789999999999999999999965 999999999999999999999999999987654431 1
Q ss_pred cccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC---ccccccc---
Q 040134 641 RTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK---NLDKLAE--- 713 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~~--- 713 (745)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... +.+.. +.+.+... ....+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFK-IFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHHHcCCCchHhcccchhhhh
Confidence 2234577889999998776 7899999999999999999999888543321 11111 11111000 0000000
Q ss_pred ------c---ccc-ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 ------N---DEE-VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ------~---~~~-~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+ ... ..........+.+++.+||+.||.+|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 273 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC
Confidence 0 000 0011223567899999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.29 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=165.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 555 (745)
+.+.+.||+|+||.||+++... .++.||||.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSE-TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecC-CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4556789999999999999765 4577999998642 233345678899999999999999999987654 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+|+||+. ++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 68999998878899999999999999999999954 9999999999999999999999999999876433
Q ss_pred ccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.. ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 162 GD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred cc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 21 1233457889999998865 4688999999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-33 Score=311.32 Aligned_cols=238 Identities=27% Similarity=0.358 Sum_probs=191.5
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 564 (745)
..||.|.||.||.++..+ +++..|+|.+.- ......+.+.+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1241 ~~Ig~G~fG~VYtavN~~-tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLD-TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEeecCC-ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 479999999999999765 567789998753 33445678899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc--ccccc
Q 040134 565 SLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT--QAART 642 (745)
Q Consensus 565 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~ 642 (745)
+|.+.+...+..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|+.|||.|..+..... .....
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999998777777777888999999999999976 999999999999999999999999999998865431 22234
Q ss_pred cccccccccchhccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKA---SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~---~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
...||+.|||||++.+. ...-++||||||||+.||+||++|+..-+.+ -.+ + -.+..|....+..
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aI---M-y~V~~gh~Pq~P~------ 1464 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAI---M-YHVAAGHKPQIPE------ 1464 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHH---H-hHHhccCCCCCch------
Confidence 56799999999999653 4567899999999999999999999633321 111 1 1222233333211
Q ss_pred ccHHHHHHHHHHHHhccccCcCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLR 743 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~R 743 (745)
....+=.+++.+||+.||++|
T Consensus 1465 ---~ls~~g~dFle~Cl~~dP~~R 1485 (1509)
T KOG4645|consen 1465 ---RLSSEGRDFLEHCLEQDPKMR 1485 (1509)
T ss_pred ---hhhHhHHHHHHHHHhcCchhh
Confidence 123345678999999999998
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=285.33 Aligned_cols=256 Identities=22% Similarity=0.270 Sum_probs=190.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEec----CCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----GDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 555 (745)
.+.+.+.||+|++|.||++..... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~-~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRS-GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCC-CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 455678899999999999987654 5679999986432 2345677889999999999999999998753 45789
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 58999998777899999999999999999999965 9999999999999999999999999999765432
Q ss_pred ccc--cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh---------
Q 040134 636 QTQ--AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY--------- 703 (745)
Q Consensus 636 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~--------- 703 (745)
... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... .+ ..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~-~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QL-KLILSVLGSPSEEVLN 237 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HH-HHHHHHhCCChhHhhh
Confidence 221 11223468889999999865 468899999999999999999999986433211 11 1110100
Q ss_pred --hcCccccccc---ccccc---cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 --IGKNLDKLAE---NDEEV---KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 --~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+....+ ..... .........+.+++.+||+.+|++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 287 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC
Confidence 0000000000 00000 001123567899999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=275.18 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=188.0
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEec
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.||+|++|.||+|+... .++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred eeheeeccCCceEEEEEEECC-CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999865 356799999865322 22334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++|.+++.... .+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 789999999999999999999965 999999999999999999999999999986543222
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHH------------HHHHHhhcC
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD------------WVYRCYIGK 706 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~------------~~~~~~~~~ 706 (745)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.||......+ .+.. |........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhhhhc
Confidence 223457889999998754 567899999999999999999998885443211 1100 000000000
Q ss_pred cccccccccccc---cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEV---KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+...... .........+.+++.+||+.||++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 111100000000 000011356889999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=275.96 Aligned_cols=252 Identities=20% Similarity=0.208 Sum_probs=177.9
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccccccCH-----------HHHHHHHHHHhccCCCCceeE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQQGE-----------KEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~l 544 (745)
+....+.+.++||+|+||.||+|...... .+.+|+|.......... .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 33345678889999999999999976541 34566665432111110 112233445567789999999
Q ss_pred EEEEecCC----eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 040134 545 LGFCDEGD----HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620 (745)
Q Consensus 545 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~ 620 (745)
++.+.... ..++++|++. .++.+.+......++..+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 99765543 4467788764 36767665555567888999999999999999954 9999999999999999999
Q ss_pred eEEeeccCcccccccccc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhh-
Q 040134 621 PRISDFGLAKLLLAEQTQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEA- 694 (745)
Q Consensus 621 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~- 694 (745)
++|+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432211 11223468999999999999999999999999999999999999996543221111
Q ss_pred --HHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 695 --LMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 695 --l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..++..+ +..+.. ... .....+.+++..|++.+|++||+
T Consensus 245 ~~~~~~~~~-~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~rp~ 285 (294)
T PHA02882 245 AAKCDFIKR-LHEGKI--------KIK---NANKFIYDFIECVTKLSYEEKPD 285 (294)
T ss_pred HhHHHHHHH-hhhhhh--------ccC---CCCHHHHHHHHHHHhCCCCCCCC
Confidence 0111111 111111 111 11356889999999999999997
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=271.22 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=193.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||++.... +++.+++|.+... .......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEECC-CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3466789999999999998765 4567899998642 233456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999865 3567889999999999999999995 499999999999999999999999999998765441
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ..+. .....+....+
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~~~----- 221 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLR----YKVQRGKYPPI----- 221 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHhcCCCCCC-----
Confidence 2234578899999999998999999999999999999999999853321 1111 11112222211
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+|++.+|++|||
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPN 246 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCC
Confidence 1133456899999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=281.54 Aligned_cols=253 Identities=23% Similarity=0.245 Sum_probs=187.4
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC--------------HHHHHHHHHHHhccCCCCceeEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG--------------EKEFRTEVSVIGQTHHKNLVRLLGFCDE 550 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 550 (745)
+.+.||+|+||.||++.... .++.||+|.++...... ...+.+|++++++++|+||+++++++..
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhcccCCCceeEEEEEECC-CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34679999999999999765 45679999885432211 1257789999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 551 GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 551 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
++..++||||++ ++|.+++.....+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 69999998777899999999999999999999954 99999999999999999999999999997
Q ss_pred ccccccc------------ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHH
Q 040134 631 LLLAEQT------------QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD 697 (745)
Q Consensus 631 ~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~ 697 (745)
....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .+.+ .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~-~ 244 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE--IDQL-G 244 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH-H
Confidence 6641110 1111223467889999998764 468999999999999999999999864332 1111 1
Q ss_pred HHHHHhhcCcc---ccc--------cccccc---ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 698 WVYRCYIGKNL---DKL--------AENDEE---VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 698 ~~~~~~~~~~~---~~~--------~~~~~~---~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+......... ... ...... ..........+.+++.+||+.+|++|||
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 306 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS 306 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC
Confidence 11111110000 000 000000 0000112456889999999999999997
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=302.21 Aligned_cols=202 Identities=27% Similarity=0.352 Sum_probs=179.7
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...+.+.++||+|+||.|..++.+. +++.+|+|++.+ .......-|..|-.++..-+.+=|++++-.|+++.++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~-t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKS-TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeec-cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3455677899999999999999876 567899999976 334455678999999998899999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||||+||+|-.++.+..++++.-+..++..|+.||.-|| +.|+|||||||+|||||..|++||+|||.+..+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999999999988889999999999999999999999 5699999999999999999999999999999887655
Q ss_pred cccccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
... ....+|||.|.+||++.. +.|.+.+|.||+||++|||+.|..||+.
T Consensus 230 ~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 230 TVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 433 455689999999999952 5688999999999999999999999973
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.85 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=184.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||+|.... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRV-TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecC-CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4567789999999999999765 35679999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~ 637 (745)
++ ++|.+++.... ..++..+..++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||++........
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 96 57887775443 346778889999999999999954 9999999999999985 56799999999976533211
Q ss_pred ccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc---
Q 040134 638 QAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE--- 713 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--- 713 (745)
......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||..... ...+.... ..+.. .......
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~--~~~~~~~~-~~~~~-~~~~~~~~~~ 232 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE--IDELFKIF-RILGT-PNEETWPGVT 232 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH-HHhCC-CChhhccccc
Confidence 1223456889999998865 4578999999999999999999999864322 11111111 11100 0000000
Q ss_pred ---------ccccc----cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 ---------NDEEV----KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ---------~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.... .........+.+++.+|++.+|++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 277 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT 277 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC
Confidence 00000 001122355789999999999999997
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=284.47 Aligned_cols=199 Identities=26% Similarity=0.381 Sum_probs=163.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 555 (745)
.+.+.+.||+|++|.||+|+... +++.||+|.+... .......+.+|+.++++++|+||+++++++... ...+
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcC-CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 35667899999999999998765 4567999998642 223346688899999999999999999987654 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+++||+++ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999975 88877743 5688999999999999999999955 9999999999999999999999999998765432
Q ss_pred cccc-ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 636 QTQA-ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2211 1223467889999998754 5689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=273.25 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=194.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.+.+.||+|++|.||++.... +++.|++|++... .....+.+.+|++++++++ |+||+++++++...+..++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcC-CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 4566789999999999999865 4567999998642 2233467889999999998 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|++++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998888899999999999999999999965 9999999999999999999999999998876443321
Q ss_pred ------------------cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 040134 639 ------------------AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700 (745)
Q Consensus 639 ------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~ 700 (745)
.......++..|+|||.+.....+.++||||||++++++++|+.|+..... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~----- 231 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTF----- 231 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHH-----
Confidence 112234578899999999888899999999999999999999999864331 1111
Q ss_pred HHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+....... .........+.+++.+||+.+|++|||
T Consensus 232 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 232 QKILKLEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred HHHHhcCC----------CCCCccCHHHHHHHHHHhcCCHhhCCC
Confidence 11111000 001112456889999999999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.25 Aligned_cols=234 Identities=29% Similarity=0.323 Sum_probs=189.8
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
||+|++|.||++.... .++.+++|.+..... .....+.+|+.++++++|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6899999999999765 456799999865322 245678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 645 (745)
|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 999998877889999999999999999999964 999999999999999999999999999987643321 123456
Q ss_pred ccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHH
Q 040134 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRV 725 (745)
Q Consensus 646 gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (745)
++..|+|||.+.+...+.++|+||||+++|+|++|+.||..... ......+ ...... ......
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~----------~~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI----LKDPLR----------FPEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----hcCCCC----------CCCCCC
Confidence 78899999999888889999999999999999999999853321 1111111 111110 011113
Q ss_pred HHHHHHHHhccccCcCCCCC
Q 040134 726 ERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 726 ~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+++.+||+.||++|||
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCC
Confidence 56789999999999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=270.48 Aligned_cols=252 Identities=26% Similarity=0.288 Sum_probs=186.1
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhcc---CCCCceeEEEEEecCCe-----
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQT---HHKNLVRLLGFCDEGDH----- 553 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 553 (745)
++.+.||+|++|.||+|+... .++.+|+|+++... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred eEEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999865 45679999986422 22234566787777655 69999999999988776
Q ss_pred EEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 554 RLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
.+++|||+.+ +|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 898888654 3588999999999999999999965 999999999999999999999999999987
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc-
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK- 710 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~- 710 (745)
+..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+.+...............
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--EADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--hHHHHHHHHHHcCCCChHhcC
Confidence 643322 223346889999999998899999999999999999999988875432 22222222211110000000
Q ss_pred --------ccccccc---ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 --------LAENDEE---VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 --------~~~~~~~---~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....... .....+....+.+++.+||+.||++|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~ 277 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC
Confidence 0000000 0011223466789999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=276.95 Aligned_cols=238 Identities=26% Similarity=0.327 Sum_probs=184.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+...+.||+|++|.||+|+... .++.+++|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcC-CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34455789999999999999865 3567999987532 2233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+. ++|.+++.. ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 577777643 45678999999999999999999955 9999999999999999999999999998765322
Q ss_pred ccccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
....++..|+|||.+. ...++.++||||||+++|+|++|..|+..... ...+.. ...+......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~-----~~~~~~~~~~-- 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH-----IAQNESPALQ-- 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--HHHHHH-----HhhcCCCCcC--
Confidence 2345788999999874 35678899999999999999999999753221 111111 1111111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|++|||
T Consensus 236 ------~~~~~~~~~~li~~cl~~~P~~Rp~ 260 (308)
T cd06634 236 ------SGHWSEYFRNFVDSCLQKIPQDRPT 260 (308)
T ss_pred ------cccccHHHHHHHHHHhhCCcccCCC
Confidence 1123355789999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=273.75 Aligned_cols=196 Identities=18% Similarity=0.176 Sum_probs=160.5
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.+|.|+++.|+++.. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 344556666666666544 4567999998643 34455789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc---
Q 040134 563 NGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT--- 637 (745)
Q Consensus 563 ~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 637 (745)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||.+..+.....
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999753 4578889999999999999999965 999999999999999999999999998876532211
Q ss_pred --ccccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 638 --QAARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 638 --~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
........++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 111223456778999999866 3578999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=275.71 Aligned_cols=193 Identities=29% Similarity=0.501 Sum_probs=169.1
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
.++||+|.||+||-|+.+. +++.||||++++ .....+.++++|+.||++++||.||.+.-.|+..+..++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRk-tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK-TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecc-cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 4689999999999999876 567899999976 3445568899999999999999999999999999999999999965
Q ss_pred CCHHHHh-cC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCcccccccccc
Q 040134 564 GSLASFL-FG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 564 gsL~~~l-~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+..+.| .. .+++++..-..++.||+.||.|||.+ +|+|+||||+|||+.+ -.++||+|||+|+.+.....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555554 33 37788888888999999999999965 9999999999999954 35899999999999876654
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
....+||+.|+|||+++.+.|...-|+||.|+|+|--++|..||..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 4567899999999999999999999999999999999999999963
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=274.12 Aligned_cols=234 Identities=28% Similarity=0.368 Sum_probs=182.0
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
.+.||+|++|.||+|+... .++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred ceeeccCCCeEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 4569999999999998765 456799999864222 233568889999999999999999999999999999999996
Q ss_pred CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++|.+++.. ...+++.++..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++..... .
T Consensus 105 -~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~ 174 (313)
T cd06633 105 -GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------A 174 (313)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC------C
Confidence 477777654 45688999999999999999999954 999999999999999999999999999864321 2
Q ss_pred ccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
....++..|+|||.+. ...++.++||||||+++|||++|..|+..... ...+ ..... .......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~----~~~~~-~~~~~~~------ 241 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSAL----YHIAQ-NDSPTLQ------ 241 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHH----HHHHh-cCCCCCC------
Confidence 2346788999999984 45688999999999999999999999753321 1111 11111 1111111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.+|.+|||
T Consensus 242 --~~~~~~~l~~li~~~l~~~P~~Rp~ 266 (313)
T cd06633 242 --SNEWTDSFRGFVDYCLQKIPQERPA 266 (313)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcC
Confidence 1112245788999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=282.18 Aligned_cols=200 Identities=29% Similarity=0.386 Sum_probs=170.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-----eEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-----HRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 555 (745)
+.+.+.||+|++|.||+++... .++.|++|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCC-CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4567889999999999999765 35679999986533 344578999999999999999999999998775 789
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
++|||++ ++|.+++.....+++..++.++.||+.||+|||+. +|+|+||||+||++++++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 48999998777899999999999999999999954 9999999999999999999999999999876543
Q ss_pred ccc-cccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 636 QTQ-AARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 210 112334578889999999887 8899999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=272.05 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=184.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|++|.||++.... .++.||||.++... ......+..|+.++.+. .|+||+++++++.+....+++|||
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred heeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 4567899999999999999865 35779999986532 23345667787777766 499999999999999999999999
Q ss_pred cCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++ +|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 96 ~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-- 170 (296)
T cd06618 96 MST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-- 170 (296)
T ss_pred cCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--
Confidence 854 67776654 35688899999999999999999952 4899999999999999999999999999876543222
Q ss_pred ccccccccccccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKAS----ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....++..|+|||.+.... ++.++||||||+++|||++|+.||...... .+.+ ... .......+..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----~~~-~~~~~~~~~~-- 241 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVL----TKI-LQEEPPSLPP-- 241 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHH----HHH-hcCCCCCCCC--
Confidence 12235778999999987553 788999999999999999999998532211 1111 111 1111111100
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+++.+||+.||++|||
T Consensus 242 -----~~~~~~~l~~li~~~l~~~p~~Rp~ 266 (296)
T cd06618 242 -----NEGFSPDFCSFVDLCLTKDHRKRPK 266 (296)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCC
Confidence 0122356889999999999999997
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=270.85 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=190.1
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.||+|.+|.||+|+... .++.+++|.+.... ....+.+..|+.++++++|+||+++++++.+....++|+||+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecC-CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345789999999999999865 35679999987542 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+ ++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--
Confidence 7 5899999776 5789999999999999999999965 9999999999999999999999999998776433211
Q ss_pred cccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhh---------------
Q 040134 641 RTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI--------------- 704 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~--------------- 704 (745)
.....++..|+|||.+... .++.++||||||+++|||++|+.||..... ...+ ..+.+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQL-FKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHH-HHHHHHhCCCcHHHHHhhccccc
Confidence 2223456789999998766 789999999999999999999888754321 1111 11111100
Q ss_pred -cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 -GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
............ ..........+.+++.+||+.||++|||
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 272 (282)
T cd07829 232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRIS 272 (282)
T ss_pred ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCC
Confidence 000000000000 0001112456899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.36 Aligned_cols=201 Identities=28% Similarity=0.325 Sum_probs=164.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCC-CcEEEEEEEcccc--cccCHHHHHHHHHHHhcc-CCCCceeEEEEEec----CCeE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASD-SKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE----GDHR 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~ 554 (745)
+.+.+.||+|+||.||+++.... .++.||+|++... .....+.+.+|+++++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 45667899999999999998653 1567999998642 222346788899999999 59999999997543 2457
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++++||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..+..
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88889886 68999998888899999999999999999999954 999999999999999999999999999987643
Q ss_pred cccc--cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 635 EQTQ--AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 635 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 3221 11233568899999998765 56899999999999999999999988643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.35 Aligned_cols=219 Identities=23% Similarity=0.158 Sum_probs=174.4
Q ss_pred ceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhc
Q 040134 492 GAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571 (745)
Q Consensus 492 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 571 (745)
|.++.||+++.... ++.+|+|.+.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~-~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRT-QQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccC-CcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 88999999998664 5679999986532 23445555556679999999999999999999999999999999998
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccccccccc
Q 040134 572 GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651 (745)
Q Consensus 572 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 651 (745)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+...... .....++..|+
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 777789999999999999999999965 9999999999999999999999999987655332 12234567899
Q ss_pred chhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHH
Q 040134 652 APEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMV 731 (745)
Q Consensus 652 aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 731 (745)
|||.+....++.++||||+|+++|||++|+.|+....... .. ...+ .........+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~--~~~~-------~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT--HTTL-------NIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc--cccc-------CCcccCCHHHHHH
Confidence 9999988889999999999999999999998764221100 00 0000 0011123467889
Q ss_pred HHhccccCcCCCCC
Q 040134 732 ALWCIQEDASLRPQ 745 (745)
Q Consensus 732 i~~Cl~~dp~~RPT 745 (745)
+.+|++.||++|||
T Consensus 209 i~~~l~~dp~~R~~ 222 (237)
T cd05576 209 LQQLLQFNPTERLG 222 (237)
T ss_pred HHHHccCCHHHhcC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=257.56 Aligned_cols=238 Identities=25% Similarity=0.300 Sum_probs=191.7
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.|.++||+|.||+|-.++-+. +++.+|+|++++.- .+....-..|-++|+..+||.+..+.-.|+..+++++||||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKa-t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKA-TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hHHHHhcCCccceEEEEeecc-cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 467899999999999988765 56889999997632 23334456788999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
..||.|.-+|...+.+++.....+-..|+.||.|||. .+||.||||.+|+|+|.+|++||+|||+++.-... ...
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g~t 324 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--GDT 324 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc--cce
Confidence 9999999999888889999999999999999999994 59999999999999999999999999999853222 223
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
....+||+.|+|||++.+..|..+.|.|.+|+++|||++|+.||+..+. +.+.+.+.- ..+. .
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~----ed~k----------F 387 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILM----EDLK----------F 387 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHh----hhcc----------C
Confidence 5668999999999999999999999999999999999999999974432 222222211 1111 1
Q ss_pred cHHHHHHHHHHHHhccccCcCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
......+...+....|.+||.+|-
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhc
Confidence 111223345566777788888873
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=295.54 Aligned_cols=240 Identities=27% Similarity=0.363 Sum_probs=180.5
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEec---------------
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--------------- 550 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------------- 550 (745)
++||+||||.||+++.+- +++.+|||++.-. +......+.+|+..|.+|+|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEeecc-cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 579999999999999876 4678999998642 34445678899999999999999999753100
Q ss_pred --------------------------------------------------------------------------------
Q 040134 551 -------------------------------------------------------------------------------- 550 (745)
Q Consensus 551 -------------------------------------------------------------------------------- 550 (745)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeEEEEEEecCCCCHHHHhcCCCCC-ChhhHHHHHHHHHHHHHHHHhcCCCCeee
Q 040134 551 ----------------G--------DHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIH 605 (745)
Q Consensus 551 ----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 605 (745)
+ ..+||-||||+..+|.+++..+... .....++++.+|++||+|+|+. ||||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 0 1247889999998888888766544 5778899999999999999965 9999
Q ss_pred CCCCCCCEEECCCCceEEeeccCccccc----------------ccccccccccccccccccchhccccC---CCCccch
Q 040134 606 CDIKPQNILLDDYFTPRISDFGLAKLLL----------------AEQTQAARTGIRGTVGYFAPEWFRKA---SITVKVD 666 (745)
Q Consensus 606 ~dikp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~D 666 (745)
|||||.||+++++..+||+|||+|.... ........+..+||.-|+|||++.+. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999998721 00111134567899999999999765 4999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 667 VYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 667 vwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+|||||||+||+. ||. ..-++ ..+...+..+.+... + ....++...=.++|.|++++||.+|||
T Consensus 801 mYSLGIVlFEM~y---PF~--TsMER----a~iL~~LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFG--TSMER----ASILTNLRKGSIPEP--A----DFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hHHHHHHHHHHhc---cCC--chHHH----HHHHHhcccCCCCCC--c----ccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999984 442 22111 112233333433332 1 112233444568999999999999998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.10 Aligned_cols=200 Identities=28% Similarity=0.369 Sum_probs=161.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC--------
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-------- 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 551 (745)
.+.+.+.||+|++|.||+|..... ++.+|+|++.... ......+.+|++++++++|+||+++++++.+.
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKT-GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCC-CcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 455678899999999999997653 4568999885432 22234678899999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 552 DHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
...++|+||+.. +|...+.. ...+++..+..++.|+++||+|||.. +|+|+||||+||++++++.++|+|||++.
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999975 67666654 35789999999999999999999954 99999999999999999999999999998
Q ss_pred ccccccccc---------ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 631 LLLAEQTQA---------ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 631 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 654332211 1123456788999998765 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=276.69 Aligned_cols=200 Identities=24% Similarity=0.363 Sum_probs=163.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecC----------
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG---------- 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---------- 551 (745)
.+.+.+.||.|+||.||+|.... +++.||+|.+........+.+.+|++++++++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~-~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSD-CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECC-CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 45567889999999999998765 4567999998765556667889999999999999999999776543
Q ss_pred ----CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEEeec
Q 040134 552 ----DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDF 626 (745)
Q Consensus 552 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Df 626 (745)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++ +++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 589888754 4678999999999999999999965 999999999999997 4567899999
Q ss_pred cCccccccccccc-ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 627 GLAKLLLAEQTQA-ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 627 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
|++..+....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9997653322111 1122357889999998754 56788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=294.82 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=194.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCC------CcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASD------SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 552 (745)
....+.+.||+|.||+|++|..... ....||||.++.. .....+.+..|+++++.+ +|+||+.++|+|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3335667999999999999986521 2567999999753 334567899999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 553 HRLLVYEYMSNGSLASFLFGIT----------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
..++|+||++.|+|.++|+..+ .+...+.+.++.|||.|++||++ .++|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999997655 37788999999999999999995 4999999999999999
Q ss_pred CCCceEEeeccCccccccccccccc-ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAAR-TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l 695 (745)
++..+||+|||+++........... ....-+..|||||.+....++.|+||||||++||||+|...+.+.+-.... .+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-EL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-HH
Confidence 9999999999999976544332211 111135679999999999999999999999999999997766554422122 12
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+ .+.+|...+ .+..+..++.++|+.||+.+|++|||
T Consensus 532 ~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~ 568 (609)
T KOG0200|consen 532 LE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPT 568 (609)
T ss_pred HH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCC
Confidence 22 232332211 12223456889999999999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.92 Aligned_cols=232 Identities=24% Similarity=0.275 Sum_probs=186.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+...+|.|+|+.|-++..... .+..++|++.+. ..+..+|+.++.+. +||||+++.+.+.++.+.++|||.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t-~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPT-DQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhccccccCCCCccceeeeecccc-ccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 355677799999999999887664 456899998754 22345677666666 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-CCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL-DDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+.++-|.+.+...+... .++..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 99999988887766655 78889999999999999965 99999999999999 58899999999999887554
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
....+-|..|.|||++....+++++|+||||++||+|++|+.||...... .. +...+..+..
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~~----------- 531 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPKF----------- 531 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCcc-----------
Confidence 12234578999999999999999999999999999999999999754433 11 1122211111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+...+|+.+|||.||.+|||
T Consensus 532 -s~~vS~~AKdLl~~LL~~dP~~Rl~ 556 (612)
T KOG0603|consen 532 -SECVSDEAKDLLQQLLQVDPALRLG 556 (612)
T ss_pred -ccccCHHHHHHHHHhccCChhhCcC
Confidence 1233456788999999999999997
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=261.69 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=196.0
Q ss_pred HHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC
Q 040134 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG 551 (745)
Q Consensus 476 ~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 551 (745)
..+.....+|..+||+|+||+|.++..+. +.+.+|||++++. ..+..+--..|-++|... +-|.+++++..++.-
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkg-tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccC-cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 34555667899999999999999998654 5678999999752 223334445677777776 678899999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+++|+||||+.+|+|--++++-+++.+..+..++..||-||-+||+ .||+.||||.+|||++.+|.+||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999999999998999999999999999999999995 5999999999999999999999999999975
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
---+ ........||+.|+|||++...+|....|.||||++||||+.|++||+.. +++.+...+.+. .+
T Consensus 500 ni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~eh----nv--- 567 (683)
T KOG0696|consen 500 NIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEH----NV--- 567 (683)
T ss_pred cccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHc----cC---
Confidence 3222 22245688999999999999999999999999999999999999999633 223332322221 11
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.+......+...+....|-+.|.+|-
T Consensus 568 -------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 -------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11222334566777777888888873
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=276.04 Aligned_cols=192 Identities=28% Similarity=0.389 Sum_probs=158.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------CeE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DHR 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~ 554 (745)
+.+.+.||+|++|.||+|+... .++.||+|++... .......+.+|+.++++++||||+++++++... ...
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCC-CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3445789999999999998764 3567999998642 222345688999999999999999999998654 356
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++|+||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 96 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 96 YLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred EEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 899999964 7777652 4578899999999999999999965 999999999999999999999999999876432
Q ss_pred cccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 223456888999999876 4688999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=269.83 Aligned_cols=194 Identities=28% Similarity=0.352 Sum_probs=161.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 559 (745)
+.+.+.||.|+||.||++.... .++.||+|++... .....+.+.+|++++++++||||+++++++.. ....++|+|
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred eEEEEeecccCCeEEEEEEECC-CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4556889999999999998765 4567999987532 22345678899999999999999999998865 567899999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+|+||+|+||++++++.++|+|||.+......
T Consensus 91 ~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 91 LL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred hh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 98 5689888754 4567888889999999999999954 9999999999999999999999999998754321
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 223456788999998765 56899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=274.71 Aligned_cols=193 Identities=27% Similarity=0.376 Sum_probs=159.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC------CeE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DHR 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~ 554 (745)
+.+.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 3445789999999999998765 45679999986432 22346688899999999999999999988543 346
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 98 ~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 98 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred EEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 7888876 7799888754 4689999999999999999999965 999999999999999999999999999876432
Q ss_pred cccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 173 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 173 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred c-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 223457889999999866 5688999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=262.26 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=184.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc-----ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK-----VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
|.+.+.||+|++|.||+++.... ...+++|.++. ........+..|+.++++++||||+++++++.+....++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKA-VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCC-CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 45678999999999999987643 23344454432 1222344677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 558 YEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 35688999999999999999999965 9999999999999976 569999999987654
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... ........ ..+....
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~-~~~~~~~--- 224 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRI-VEGPTPS--- 224 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-HcCCCCC---
Confidence 32221 223457889999999988888999999999999999999999985221 11111111 1111111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+|++.+|++|||
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~ 250 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPS 250 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcC
Confidence 11233456889999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=269.59 Aligned_cols=193 Identities=28% Similarity=0.371 Sum_probs=161.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------eE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------HR 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~ 554 (745)
+.+.+.||+|++|.||++.... .++.||||++... .....+.+.+|++++++++||||+++++++.... ..
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECC-CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 4456789999999999998765 4567999998542 2223456889999999999999999999886543 45
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 8999998 6799888754 5688999999999999999999954 999999999999999999999999999986533
Q ss_pred cccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 223456889999999876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=255.01 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=192.1
Q ss_pred chhhcCcceeEEEEEEEeeCCC----cEEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEEEEE
Q 040134 485 FRQILGRGAFGTVYKGVLASDS----KRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRLLVY 558 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~ 558 (745)
+..++-+|.||.||+|.+...+ .+.|.+|.++. .++-....+..|...+..+.|||+..+.+++.+ ....++++
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 4567899999999999876432 34467777754 333345678889999999999999999999865 45788999
Q ss_pred EecCCCCHHHHhcCC--------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 559 EYMSNGSLASFLFGI--------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 559 e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
.++.-|+|..+|... +.+...+...++.|++.|++|||.+ ++||.||..+|.+||+..++||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 999999999999721 3456778889999999999999955 99999999999999999999999999999
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
.+.+............+..||+||.+.+..++.++||||||++||||+| |+.|+..-+ +.+ +...+..|
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfE-----m~~ylkdG--- 514 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFE-----MEHYLKDG--- 514 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHH-----HHHHHhcc---
Confidence 9887776665666667889999999999999999999999999999987 455553222 111 11222221
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+..++..++++|..+|.-||..+|++|||
T Consensus 515 ------yRlaQP~NCPDeLf~vMacCWallpeeRPs 544 (563)
T KOG1024|consen 515 ------YRLAQPFNCPDELFTVMACCWALLPEERPS 544 (563)
T ss_pred ------ceecCCCCCcHHHHHHHHHHHhcCcccCCC
Confidence 222234456778999999999999999997
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=247.71 Aligned_cols=238 Identities=23% Similarity=0.233 Sum_probs=187.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEec----CCeEEEEEEec
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE----GDHRLLVYEYM 561 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lv~e~~ 561 (745)
++||-|-.|.|.....+. +++..|+|++... ..-++|+++.-+. .|||||.+++++.. ...+.+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~-T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKR-TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEecc-chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 689999999999888766 4456899998642 3446788876665 69999999998754 45788999999
Q ss_pred CCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCcccccccc
Q 040134 562 SNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 562 ~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~ 636 (745)
+||.|...+..++ .+++.++..|++||..|+.||| +.+|.||||||+|+|... +-.+||+|||+|+......
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 9999999998764 4899999999999999999999 569999999999999964 4579999999998754322
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....+-|+.|.|||++...+++...|+||+||++|-|++|.+||+-.... .+..-+.+.+..+...-
T Consensus 219 ---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy~F------ 286 (400)
T KOG0604|consen 219 ---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQYEF------ 286 (400)
T ss_pred ---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCccC------
Confidence 244567799999999999999999999999999999999999999754431 12122233333333222
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..-...+...++|+..|..+|.+|-|
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlT 315 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLT 315 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhhee
Confidence 11223345677888999999999999965
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=248.29 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=199.1
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+..+||+|+|.+|..+++.. +.+.+|+|++++ .+.+..+-++.|-.+..+- +||.+|.++.+|+.+..+++|.||
T Consensus 254 ll~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeecCcchhhhhheehcc-cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 55789999999999999876 457899999875 3344556677788888776 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++|+|--++...++++++.+..+...|..||.|||++ ||+.||||.+|+|+|..|.+||+|+|+++.-... ...
T Consensus 333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~--gd~ 407 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDT 407 (593)
T ss_pred ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC--Ccc
Confidence 99999999998889999999999999999999999966 9999999999999999999999999999863222 222
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC-CchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTT-NPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
....+||+.|.|||++.+..|....|.|+||++++||+.|+.||+.-.. ++++...++..+.+.++.+....
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr------- 480 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR------- 480 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-------
Confidence 5668999999999999999999999999999999999999999986443 34444444445554444332211
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
....+...+.+.-|.+||.+|-
T Consensus 481 ---slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhc
Confidence 1122345677788889999883
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=274.67 Aligned_cols=194 Identities=29% Similarity=0.394 Sum_probs=162.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe------E
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH------R 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~ 554 (745)
+.+...||+|++|.||+|+... .++.||+|++... .....+.+.+|+.++++++|+||+++++++...+. .
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred eEEEEEeccCCceEEEEEEECC-CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4556789999999999999866 3567999998642 22334667889999999999999999988766554 8
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.....
T Consensus 96 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 9999998 5699998865 5689999999999999999999954 999999999999999999999999999986533
Q ss_pred cccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 223457888999999865 46789999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=286.50 Aligned_cols=144 Identities=28% Similarity=0.416 Sum_probs=128.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
|.+.+.||+|+||.||+|.... .++.||||+++... ......+..|+.++..++|+||+++++.+......++|||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4567889999999999999865 45679999986432 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
|+++++|.+++.....+++..++.++.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998777889999999999999999999964 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=259.36 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=199.2
Q ss_pred cCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC--CC----CceeEEE
Q 040134 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH--HK----NLVRLLG 546 (745)
Q Consensus 473 ~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----nIv~l~~ 546 (745)
+...+.....+.+...+|+|.||.|-+..+... +..||||+++.... ..++-+-|+++|+++. .| -++.+.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 444555567788889999999999999988765 78899999986543 3455677999999993 22 2788888
Q ss_pred EEecCCeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------
Q 040134 547 FCDEGDHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD------- 617 (745)
Q Consensus 547 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~------- 617 (745)
+|+..++.++|+|.+ |-++.++|..+ .+++...+..++.|++++++|||+ .+++|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEe
Confidence 899999999999998 66999999775 567889999999999999999995 59999999999999831
Q ss_pred -------------CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 618 -------------YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 618 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
+..++|+|||.|....... ..++.|..|.|||++.+-.++.++||||+||||.|+.||...|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3458999999998754333 4567899999999999999999999999999999999999998
Q ss_pred CCCCCCchhhHHHHHHHHh--------------hcCcccc-----------ccccc----ccccccHHHHHHHHHHHHhc
Q 040134 685 VFGTTNPEEALMDWVYRCY--------------IGKNLDK-----------LAEND----EEVKNDLKRVERLVMVALWC 735 (745)
Q Consensus 685 ~~~~~~~~~~l~~~~~~~~--------------~~~~~~~-----------~~~~~----~~~~~~~~~~~~l~~li~~C 735 (745)
+.-...+...+++.+...+ ..+.++. ..++. .-...+-.+..+|++|+..|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 7655333333333332111 1111110 00000 00011234567799999999
Q ss_pred cccCcCCCCC
Q 040134 736 IQEDASLRPQ 745 (745)
Q Consensus 736 l~~dp~~RPT 745 (745)
|..||.+|+|
T Consensus 390 L~fDP~~RiT 399 (415)
T KOG0671|consen 390 LEFDPARRIT 399 (415)
T ss_pred HccCcccccc
Confidence 9999999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=257.32 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=188.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---c----cCHHHHHHHHHHHhccCCCCceeEEEEEe-cCCe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---Q----QGEKEFRTEVSVIGQTHHKNLVRLLGFCD-EGDH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~ 553 (745)
.|-+.++||+|+|+.||++.+-. ..++||+|+-.... . ...+-..+|.++.+.|.||.||++++++. +.+.
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~-EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLT-EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccc-hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 34456789999999999997654 56899999863211 1 11234557899999999999999999986 4567
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCceEEeeccCcc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAK 630 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~a~ 630 (745)
++-|+||++|.+|+-||+.++.++++++..|+.||+.||.||.+. +.+|||-||||.|||+. ..|.+||+|||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 789999999999999999999999999999999999999999998 88999999999999995 45889999999999
Q ss_pred ccccccccc-----ccccccccccccchhcccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 040134 631 LLLAEQTQA-----ARTGIRGTVGYFAPEWFRK----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR 701 (745)
Q Consensus 631 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~ 701 (745)
.+.++.... ......||..|++||.+.- .+++.|.||||.|||+|+.+.|+.||.......+ .+.+ .
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-ILqe---N 697 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-ILQE---N 697 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-HHhh---h
Confidence 987655432 2234578999999998742 3578999999999999999999999964433211 1100 0
Q ss_pred H-hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCC
Q 040134 702 C-YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLR 743 (745)
Q Consensus 702 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 743 (745)
. +...++.-.. .+....+...+|.+||+.--++|
T Consensus 698 TIlkAtEVqFP~--------KPvVsseAkaFIRRCLaYRKeDR 732 (775)
T KOG1151|consen 698 TILKATEVQFPP--------KPVVSSEAKAFIRRCLAYRKEDR 732 (775)
T ss_pred chhcceeccCCC--------CCccCHHHHHHHHHHHHhhhhhh
Confidence 0 0011111111 11223446678999998877766
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=245.56 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=165.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~ 555 (745)
.|+....||+|.||.||+++-..... +.+|||+++.... .....-.+|+.+++.++||||+.+..++.+ +..++
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 35567789999999999996654332 3689999875322 122456789999999999999999998877 78899
Q ss_pred EEEEecCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CceEEeec
Q 040134 556 LVYEYMSNGSLASFLFGI-----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY----FTPRISDF 626 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~----~~~kl~Df 626 (745)
+++||.+. +|..+|+-+ +.++......|+.||+.|+.|||+. -|+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999977 888888633 4577888899999999999999954 89999999999999876 99999999
Q ss_pred cCcccccccccc-cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 627 GLAKLLLAEQTQ-AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 627 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
|+++.+...-.. ......+-|.-|.|||++.+ +.|+++.||||.|||+.||+|-++.|...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999987654322 23445678999999999887 46899999999999999999999888543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=248.99 Aligned_cols=233 Identities=30% Similarity=0.356 Sum_probs=187.9
Q ss_pred eeEEEEEEEeeCCCcEEEEEEEcccccccC-HHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhc
Q 040134 493 AFGTVYKGVLASDSKRFVAIKKLDKVEQQG-EKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571 (745)
Q Consensus 493 ~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 571 (745)
+||.||+++... +++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKK-TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECC-CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999865 35679999987654444 6899999999999999999999999999999999999999999999997
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccccccccc
Q 040134 572 GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651 (745)
Q Consensus 572 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 651 (745)
....+++..+..++.+++.+|.+||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 766689999999999999999999965 99999999999999999999999999998765432 133455788999
Q ss_pred chhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHH
Q 040134 652 APEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMV 731 (745)
Q Consensus 652 aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 731 (745)
+||.+....++.++||||||+++++|++|..|+..... ..... +............ .......+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~----~~~~~~~~~~~~~-------~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELF----KKIGKPKPPFPPP-------EWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHH----HHHhccCCCCccc-------cccCCHHHHHH
Confidence 99999888899999999999999999999999854311 11111 1111111111000 00033568899
Q ss_pred HHhccccCcCCCCC
Q 040134 732 ALWCIQEDASLRPQ 745 (745)
Q Consensus 732 i~~Cl~~dp~~RPT 745 (745)
+.+|++.+|++|||
T Consensus 221 i~~~l~~~p~~Rp~ 234 (244)
T smart00220 221 IRKLLVKDPEKRLT 234 (244)
T ss_pred HHHHccCCchhccC
Confidence 99999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=263.43 Aligned_cols=237 Identities=22% Similarity=0.250 Sum_probs=193.7
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
...||-|+||.|-.+..+... ...|+|++++. +....+.+..|-+++...+.|.|++++..|.+...+|+.||-|-
T Consensus 425 iaTLGvGgFGRVELV~~~~~~-~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQK-ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhcccCccceEEEEEecccc-hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 346999999999998886543 24788888653 33445567789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
||.|...|...+.++......++..+++|++||| ++|||.|||||+|++++.+|-+||.|||+|+.+..... ..
T Consensus 504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---Tw 577 (732)
T KOG0614|consen 504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TW 577 (732)
T ss_pred CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---ee
Confidence 9999999999999999999999999999999999 45999999999999999999999999999999865543 56
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
.++||+.|.|||++.++..+.++|.||||+++|||++|.+||...++ ...+..+...+ +.+.- +.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGi-----d~i~~-------Pr 642 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGI-----DKIEF-------PR 642 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhh-----hhhhc-------cc
Confidence 78999999999999999999999999999999999999999964332 22223232221 11111 11
Q ss_pred HHHHHHHHHHHhccccCcCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......++++.....+|.+|-
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhh
Confidence 2233456677777788999883
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=267.77 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=199.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEec-----CCeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE-----GDHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-----~~~~~l 556 (745)
.+|.++||.|.+|.||+++... .++.+|+|++.. ..+..++++.|.++++.+ +|||++.++|++.. ++.++|
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~-~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVK-TGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred cEEEEEEeeccceeEEEEeeee-cCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 4577899999999999998765 456788888764 345567888999999988 79999999999853 568999
Q ss_pred EEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 557 VYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
|||||.+|+..+++++. .++.|..+..|++.++.||.+||.. .++|||||-.|||++.++.+||.|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999998754 6788999999999999999999954 999999999999999999999999999987654
Q ss_pred cccccccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
... ......||+.|||||++.- ..|+.++|+||||++..||.-|.+|+....+- .. .+.
T Consensus 176 T~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--ra------------LF~ 239 (953)
T KOG0587|consen 176 TVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--RA------------LFL 239 (953)
T ss_pred ccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--hh------------hcc
Confidence 332 2455789999999999853 34778999999999999999999998543321 11 122
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+..+....-..++.++|..||..|-++||+
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc
Confidence 333445555556677889999999999999999996
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=224.81 Aligned_cols=102 Identities=39% Similarity=0.714 Sum_probs=75.3
Q ss_pred CCeEEEeecCCCCCC---CCcceEEecCceEEEEcCCCCEEEec-cCCCC--CceEEEEecCccEEEEcCCccccccccc
Q 040134 53 EKTIVWSANGDDPAP---RGSQVKLTNSGELVLYDPQGHELWQK-PKDGS--KSSWATMQDDGNFVLLGGDSNPIWESFK 126 (745)
Q Consensus 53 ~~t~vW~Anr~~p~~---~~~~l~l~~~G~Lvl~~~~~~~vWst-~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd 126 (745)
++||||+|||++|+. ....|.|+.||+|+|+|..++++|++ ++.+. ....|+|+|+|||||+|.++.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 479999999999993 34789999999999999999999999 55544 3778999999999999999999999999
Q ss_pred cCcCcccCCcccCCC------ceEEecCCCCCCC
Q 040134 127 EPTDTLLPGQILNSP------INITSRRTQHNYS 154 (745)
Q Consensus 127 ~PtDtlLpg~~l~~~------~~L~S~~s~~dps 154 (745)
|||||+||||+|+.+ ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999873 3499999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=243.02 Aligned_cols=202 Identities=23% Similarity=0.367 Sum_probs=163.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEec--------CC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--------GD 552 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~ 552 (745)
+.-..+||+|.||.||+++....+ +.||+|++-. ....--..-.+|+.+|..++|+|++.++.+|.. ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~-kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTG-KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCcc-chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 333468999999999999987654 4588876532 222223456789999999999999999988843 23
Q ss_pred eEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 553 HRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
.+|+|+.+++. +|.-+|... .+++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 58999999976 788888665 678999999999999999999994 5999999999999999999999999999987
Q ss_pred cccccc--ccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 632 LLAEQT--QAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 632 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
+..... ....+..+-|..|.+||.+.+ +.++++.|||.-|||+.||.|+.+-+.....
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 654332 222445567999999998875 6799999999999999999999988764443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=260.49 Aligned_cols=200 Identities=25% Similarity=0.386 Sum_probs=171.5
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||-|+||.|.++.-.+ +...+|+|.+++.+ .....-++.|-.||..-+.+=||+|+-.|++.+.+|+||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~KvD-T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVD-TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecc-hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 469999999999987544 56789999997633 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc---------c
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL---------A 634 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~---------~ 634 (745)
|++-.+|-+.+.+.+..+..++..+..|+++.| ..|+|||||||+|||||.+|.+||+|||++.-+. .
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 999999999999999999999999999999999 5699999999999999999999999999985331 0
Q ss_pred cc-------------------------------cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 040134 635 EQ-------------------------------TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSS 683 (745)
Q Consensus 635 ~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p 683 (745)
.. ........+||+.|+|||++....++..+|.||.|||||||+.|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 00 00011235799999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 040134 684 VVFGTTN 690 (745)
Q Consensus 684 ~~~~~~~ 690 (745)
|......
T Consensus 871 f~~~tp~ 877 (1034)
T KOG0608|consen 871 FLADTPG 877 (1034)
T ss_pred ccCCCCC
Confidence 9765543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=227.61 Aligned_cols=197 Identities=27% Similarity=0.363 Sum_probs=164.6
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
.+.||+|++|.|-+-++.. ++...|+|.+... ..+..++..+|+.+..+. .+|.+|+++|....+...++.||.|.
T Consensus 51 i~elGrGayG~vekmrh~~-sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQ-SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhcCCccchhhheeecc-CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 3569999999998887765 5678999999653 344456788899887776 79999999999999999999999995
Q ss_pred CCHHHHh----cCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 564 GSLASFL----FGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 564 gsL~~~l----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
.+|+.+- .....+++.-+-+|+..+++||.|||++ ..++|||+||+||||+.+|++|++|||.+..+.+.-.
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-- 204 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-- 204 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence 4776653 4557788999999999999999999985 6999999999999999999999999999987754432
Q ss_pred ccccccccccccchhccc----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFR----KASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
.+...|...|||||.+. .+.|+-|+||||||+.+.||.+++.|++....
T Consensus 205 -kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 205 -KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred -HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 33345788999999884 34789999999999999999999999865443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=271.52 Aligned_cols=195 Identities=24% Similarity=0.288 Sum_probs=136.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCC---CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEE------EecCC
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASD---SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGF------CDEGD 552 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~~~~ 552 (745)
.+.+.+.||+|+||.||+|++... .++.||+|++..... .+....| .+....+.++..++.. .....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 355678999999999999998764 145799998754221 1111111 1222222222222211 24567
Q ss_pred eEEEEEEecCCCCHHHHhcCCCC--------------------CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 040134 553 HRLLVYEYMSNGSLASFLFGITR--------------------PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQN 612 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~N 612 (745)
..++|+||+++++|.+++..... .....+..++.||+.||+|||+. +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 89999999999999999864321 11234567999999999999965 99999999999
Q ss_pred EEECC-CCceEEeeccCcccccccccccccccccccccccchhccccC----------------------CCCccchhHH
Q 040134 613 ILLDD-YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA----------------------SITVKVDVYS 669 (745)
Q Consensus 613 Ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~Dvws 669 (745)
||+++ ++.+||+|||+++.+....... .....+++.|+|||.+... .++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99986 5799999999998654332221 3345688999999966322 2345679999
Q ss_pred HHHHHHHHHhCCCCC
Q 040134 670 FGVLLLELICCKSSV 684 (745)
Q Consensus 670 lG~vl~elltg~~p~ 684 (745)
|||+||||+++..+.
T Consensus 365 lGviL~el~~~~~~~ 379 (566)
T PLN03225 365 AGLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHHhCcCCC
Confidence 999999999876553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=217.15 Aligned_cols=196 Identities=24% Similarity=0.392 Sum_probs=164.3
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
.++||+|.||+||+++... +.+.||+|.++- .++.....-.+|+-+++.++|.||+++++....++...+|+||+..
T Consensus 7 mekigegtygtvfkarn~~-t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCC-ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 3679999999999999765 567899999864 2333345678999999999999999999999999999999999954
Q ss_pred CCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 564 GSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 564 gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+|..+.... +.++.+....++.|+++||.|+|. +++.|||+||+|++|+.+|.+||+|||+++.++-.-. ...
T Consensus 86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--cys 159 (292)
T KOG0662|consen 86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYS 159 (292)
T ss_pred -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eee
Confidence 788877543 678899999999999999999995 5999999999999999999999999999987653321 233
Q ss_pred cccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 643 GIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
..+-|..|.+|.++.+. .|+...|+||-|||+.|+.....|...+.
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 44678999999998774 68999999999999999987766654443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=255.72 Aligned_cols=192 Identities=26% Similarity=0.358 Sum_probs=166.8
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--------ccCHHHHHHHHHHHhccC---CCCceeEEEEEecCCeE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--------QQGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~ 554 (745)
.+.+|+|+||.|+.++++.+ ...|+||.+.+.. ....-.+-.|+.||..++ |+||++++++|++.+.+
T Consensus 566 lq~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35799999999999999876 5679999986421 111123557999999997 99999999999999999
Q ss_pred EEEEEec-CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 555 LLVYEYM-SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 555 ~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
||+||-. ++.+|.++|..++.+++.++.-|++|++.|+++||++ +|||||||-+|+.++.+|-+||+|||.+....
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999976 5679999999999999999999999999999999955 99999999999999999999999999998765
Q ss_pred ccccccccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~ 685 (745)
... ....+||..|.|||++.+.+| ...-|||++|++||.++....|++
T Consensus 722 sgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 433 455789999999999998876 567999999999999998888875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=264.47 Aligned_cols=234 Identities=26% Similarity=0.365 Sum_probs=178.8
Q ss_pred hhhcCcceeE-EEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 486 RQILGRGAFG-TVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 486 ~~~Ig~G~~g-~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
.+++|.|+.| .||+|... ++.||||++-. +...-..+|+..|+.- +||||+++++.-.+.+..|+..|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE---GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC---CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 3578899887 57999984 57899999853 2334567899999887 69999999999999999999999995
Q ss_pred CCHHHHhcCC-CC---CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---C--CceEEeeccCcccccc
Q 040134 564 GSLASFLFGI-TR---PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---Y--FTPRISDFGLAKLLLA 634 (745)
Q Consensus 564 gsL~~~l~~~-~~---~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~--~~~kl~Dfg~a~~~~~ 634 (745)
.+|++++... .. ......+.+..|++.||++|| +.+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 5999999774 11 112456889999999999999 459999999999999965 2 5789999999999876
Q ss_pred ccccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 635 EQTQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICC-KSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 635 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
+.... ......||.+|+|||++....-+.+.||||||||+|+.++| ..||......+. .+..+......
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------NIl~~~~~L~~ 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------NILTGNYTLVH 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------hhhcCccceee
Confidence 65432 24557799999999999988888899999999999999998 778753222111 01111111100
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+...++ ...+||.+|+.++|..|||
T Consensus 735 -----L~~~~d~--eA~dLI~~ml~~dP~~RPs 760 (903)
T KOG1027|consen 735 -----LEPLPDC--EAKDLISRMLNPDPQLRPS 760 (903)
T ss_pred -----eccCchH--HHHHHHHHhcCCCcccCCC
Confidence 0011111 5778999999999999997
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=209.99 Aligned_cols=110 Identities=30% Similarity=0.553 Sum_probs=100.4
Q ss_pred CCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEEcCCCCEEEeccCCC
Q 040134 18 DSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDG 97 (745)
Q Consensus 18 ~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~ 97 (745)
++++|+|++|.|++|||++......+++|||.+++ +++||.||++.|....+.|.|+.||+|+|+|.+|.++|+|++++
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~ 84 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR 84 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC
Confidence 67899999999999999986554599999998877 89999999999977778899999999999999999999999875
Q ss_pred -CCceEEEEecCccEEEEcCCccccccccccC
Q 040134 98 -SKSSWATMQDDGNFVLLGGDSNPIWESFKEP 128 (745)
Q Consensus 98 -~~~~~a~LldsGNlVl~~~~~~~lWQSFd~P 128 (745)
....+|+|+|+|||||++.++++||||||||
T Consensus 85 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 85 VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 5567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=234.81 Aligned_cols=198 Identities=28% Similarity=0.386 Sum_probs=165.1
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-----eEEEEE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-----HRLLVY 558 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~ 558 (745)
.+-||.|+||.||-+.++.+ ++.|++|++... +-...+.+.+|+.+|..++|.|++..+++.+-.. .+|++.
T Consensus 58 DRPIGYGAFGVVWsVTDPRd-grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRS-GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCC-ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 35799999999999988764 567999988642 2233578889999999999999999888765443 467788
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|.|.. +|..+|-....++...+.-+..||++||+||| +.+|.||||||.|+|++.+-.+||+|||+++.-..+...
T Consensus 137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 88854 88888888888999999999999999999999 559999999999999999999999999999976554443
Q ss_pred cccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 639 AARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
. .+..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+-.|.....
T Consensus 213 h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 213 N-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred h-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 3 4455678899999999874 689999999999999999988888865544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=257.00 Aligned_cols=199 Identities=25% Similarity=0.320 Sum_probs=146.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeC---------------CCcEEEEEEEcccccccCHHH--------------HHHHHHH
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS---------------DSKRFVAIKKLDKVEQQGEKE--------------FRTEVSV 532 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~---------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~ 532 (745)
.+.+.++||+|+||.||+|.+.. ..++.||||++........++ ...|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 45567899999999999997521 234579999986433222223 3346667
Q ss_pred HhccCCCCc-----eeEEEEEec--------CCeEEEEEEecCCCCHHHHhcCC------------------------CC
Q 040134 533 IGQTHHKNL-----VRLLGFCDE--------GDHRLLVYEYMSNGSLASFLFGI------------------------TR 575 (745)
Q Consensus 533 l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------~~ 575 (745)
+.+++|.++ ++++++|.. ....++||||+++++|.++++.. ..
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766554 677777643 35689999999999999988642 12
Q ss_pred CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhc
Q 040134 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655 (745)
Q Consensus 576 ~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 655 (745)
+++..+..++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||++..+....... .....+++.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhh
Confidence 34567888999999999999964 99999999999999999999999999997654322111 112234789999998
Q ss_pred cccCCC----------------------CccchhHHHHHHHHHHHhCCC-CC
Q 040134 656 FRKASI----------------------TVKVDVYSFGVLLLELICCKS-SV 684 (745)
Q Consensus 656 ~~~~~~----------------------s~~~DvwslG~vl~elltg~~-p~ 684 (745)
+..... ..+.||||+||++|||+++.. |+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 754321 134799999999999999875 54
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=218.90 Aligned_cols=200 Identities=22% Similarity=0.408 Sum_probs=166.3
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecC--CeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEG--DHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv 557 (745)
..+++.+++|+|.++.||.|....+ .+.++||+++.. ..+.+.+|+.+|+.|. ||||++++++..++ ....||
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~-~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITN-NEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCC-CceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3566778999999999999986553 445899999753 3578899999999997 99999999998764 466799
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 636 (745)
+||+.+.+...+. +.++..++..++.++++||.|+| +.||.|||+||.|++||. ...++|+|+|+|.......
T Consensus 114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999988777664 56777889999999999999999 669999999999999985 4679999999999876655
Q ss_pred cccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
... ..+.+.-|--||++.+ ..++..-|+|||||+|..|+..+.||..+..+.++
T Consensus 188 eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ 242 (338)
T KOG0668|consen 188 EYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 242 (338)
T ss_pred eee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH
Confidence 422 2345667889999876 46889999999999999999999999887776443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=221.90 Aligned_cols=203 Identities=36% Similarity=0.559 Sum_probs=175.9
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCHH
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLA 567 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 567 (745)
||+|.+|.||++.... .++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999865 3567999998754332 3578999999999999999999999999999999999999999999
Q ss_pred HHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCccccccccccccccccc
Q 040134 568 SFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQTQAARTGIR 645 (745)
Q Consensus 568 ~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 645 (745)
+++... ..+++..+..++.+++.+|++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 999765 5688999999999999999999965 9999999999999999 89999999999987644321 122345
Q ss_pred ccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHH
Q 040134 646 GTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKR 724 (745)
Q Consensus 646 gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (745)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67889999999877 788999999999999998
Q ss_pred HHHHHHHHHhccccCcCCCCC
Q 040134 725 VERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 725 ~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+++..|++.||++|||
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcC
Confidence 45788999999999999997
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=230.27 Aligned_cols=141 Identities=28% Similarity=0.437 Sum_probs=115.7
Q ss_pred cCccCHHHHHH-HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-----C---CC
Q 040134 470 VRSFTYKELEE-ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-----H---KN 540 (745)
Q Consensus 470 ~~~~~~~~l~~-~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~n 540 (745)
.....+.+... +.|-+.++||-|-|++||++.+.. ..++||+|+.+.. ....+.-..|+++|++++ | ..
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 33444555555 677788999999999999998765 5789999998753 334466788999999883 3 36
Q ss_pred ceeEEEEEec----CCeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 040134 541 LVRLLGFCDE----GDHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNIL 614 (745)
Q Consensus 541 Iv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIl 614 (745)
||+++++|.. +.+++||+|++ |.+|..+|... +.++...+.+|++||+.||.|||.+| ||||.||||+|||
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvL 220 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVL 220 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceee
Confidence 9999999964 66999999999 66888888644 67899999999999999999999976 9999999999999
Q ss_pred E
Q 040134 615 L 615 (745)
Q Consensus 615 l 615 (745)
+
T Consensus 221 l 221 (590)
T KOG1290|consen 221 L 221 (590)
T ss_pred e
Confidence 8
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=200.18 Aligned_cols=108 Identities=30% Similarity=0.546 Sum_probs=98.7
Q ss_pred CCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEEcCCCCEEEeccCC-
Q 040134 18 DSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKD- 96 (745)
Q Consensus 18 ~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~- 96 (745)
+++.|+|+++.|++|||.+... ..+++|||++.+ +++||+|||+.|+.+++.|.|+.||+|+|+|.+|.++|+|++.
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~ 83 (114)
T smart00108 6 SGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTG 83 (114)
T ss_pred CCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccC
Confidence 6789999999999999998644 689999999887 8999999999999777889999999999999999999999987
Q ss_pred CCCceEEEEecCccEEEEcCCcccccccccc
Q 040134 97 GSKSSWATMQDDGNFVLLGGDSNPIWESFKE 127 (745)
Q Consensus 97 ~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 127 (745)
+....+|+|+|+|||||++..+++|||||||
T Consensus 84 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 84 ANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 5556789999999999999999999999997
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=222.51 Aligned_cols=197 Identities=31% Similarity=0.471 Sum_probs=171.0
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
.+.+.||+|+++.||++.... .++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 356789999999999999875 3456999999764444 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCC-CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFGITR-PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+++|.+++..... +++..+..++.+++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 9999999987666 89999999999999999999965 9999999999999999999999999999876544211 12
Q ss_pred ccccccccccchhcc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 642 TGIRGTVGYFAPEWF-RKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~-~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
....++..|++||.+ ....++.++|+|+||++++||++|+.||.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 334577889999998 66778889999999999999999999994
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=237.58 Aligned_cols=210 Identities=24% Similarity=0.244 Sum_probs=175.3
Q ss_pred cCccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC------CCCcee
Q 040134 470 VRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH------HKNLVR 543 (745)
Q Consensus 470 ~~~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~ 543 (745)
.-.+.+.|+....|.+....|+|-|++|.+|...... ..||||++.... .-.+.=+.|+++|++|+ --++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~-~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARG-QEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCC-CeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3355678888888999999999999999999986644 479999997532 22344567999999995 347999
Q ss_pred EEEEEecCCeEEEEEEecCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-C
Q 040134 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGIT---RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-F 619 (745)
Q Consensus 544 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~ 619 (745)
++..|...++++||+|-+ ..+|.++|++.+ .+....+..++.|+..||..|... ||+|.||||+|||+++. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999988 459999997653 477888999999999999999955 99999999999999876 5
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
.+||||||.|........ +...-+.-|.|||++.+.+|+...|+||.||+||||.||+-.|+....
T Consensus 575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 789999999987655443 223345679999999999999999999999999999999999875544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-26 Score=244.11 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=198.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+++.+.+|.|.||.|||++... .++..|+|.++-...+...-++.|+-+++..+||||+.++|-+...+..++.|||+.
T Consensus 17 yellqrvgsgTygdvyKaRd~~-s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKR-SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred hhheeeecCCcccchhhhcccc-cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4466789999999999999876 457899999987777777888999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+|+|++.-+...++++.++....+..++||+||| +.+=+|||||-.||++++.|.+|++|||.+..+...- ....
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~Krk 170 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRK 170 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh--hhhh
Confidence 9999999988899999999999999999999999 5588999999999999999999999999988764322 2245
Q ss_pred cccccccccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 643 GIRGTVGYFAPEWF---RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 643 ~~~gt~~y~aPE~~---~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
...||+.|||||+. +...|..++|||++|+...|+--.++|...-.. ...+ -...+..++. ...+
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l-----~LmTkS~~qp-----p~lk 238 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRAL-----FLMTKSGFQP-----PTLK 238 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHH-----HHhhccCCCC-----Cccc
Confidence 57899999999976 356789999999999999999877777532211 1111 1111111111 1122
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....-.+.+-++++.|+-.+|++|||
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRpt 264 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPT 264 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCC
Confidence 23344566888999999999999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=212.50 Aligned_cols=243 Identities=18% Similarity=0.281 Sum_probs=175.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEE-EEecCCeEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLG-FCDEGDHRLLVY 558 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~-~~~~~~~~~lv~ 558 (745)
..+.+.+.+|+|.||.+-++.++. .+..+++|.+... ....++|.+|..---.| .|.||+.-++ .|+..+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccC-CceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 346778899999999999999876 4567999988652 33457888888765555 6999998776 567788888999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-C-CCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL-D-DYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll-~-~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||++.|+|.+-+.. ..+.+....+++.|++.||.|+| +.++||||||.+|||| + +..++||+|||..+..+..
T Consensus 102 E~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred ccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 99999999998854 45677788899999999999999 5599999999999999 3 4458999999998865322
Q ss_pred cccccccccccccccchhccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKA-----SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
......+..|.+||..... ...+.+|||.||++++.++||+.|++.....+... .+ +..+.++....+
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y-~~--~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY-WE--WEQWLKRKNPAL 249 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-HH--HHHHhcccCccC
Confidence 1223346679999976432 34678999999999999999999998444333222 22 222222222211
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLR 743 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 743 (745)
. +.... ..+++.++..+-+.++|++|
T Consensus 250 P--~~F~~----fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 250 P--KKFNP----FSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred c--hhhcc----cCHHHHHHHHHhcCCccccc
Confidence 1 11111 12345556666777777766
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=209.49 Aligned_cols=187 Identities=31% Similarity=0.355 Sum_probs=152.8
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec------CCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE------GDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~lv~e 559 (745)
.++.|+- .|-.+-+. -.+++||+|++... .....+.-.+|...+..++|+||++++.++.- ....|+|||
T Consensus 24 p~~~g~~-~v~~a~D~-v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQ-VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred ccCCCCc-eEEecchh-hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 4566665 34333332 24567999987532 23345667889999999999999999998843 346799999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+|. .+|.+.+. -.++-+.+..|+.|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.-... .
T Consensus 102 ~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~ 172 (369)
T KOG0665|consen 102 LMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---F 172 (369)
T ss_pred hhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---c
Confidence 995 58888876 55677888999999999999999 569999999999999999999999999999864433 3
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
..+..+.+.-|.|||++.+..+.+.+||||+||++.||++|+.-|.
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 3566788999999999998889999999999999999999998886
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=211.40 Aligned_cols=199 Identities=25% Similarity=0.402 Sum_probs=163.1
Q ss_pred cchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 484 GFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
...++||+|.|++||++.+... ..+.||+|.+...+ ....+.+|+++|..+ -+.||+++.+++..++...+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 3457899999999999988663 56789999986532 345689999999999 599999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCcccccccc---
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQ--- 636 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~--- 636 (745)
++.....+++. .++..++..+++.++.||+++|. .|||||||||+|+|.+. .+.-.|+|||+|.......
T Consensus 117 ~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 117 FEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred cCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 99999888874 45688999999999999999995 59999999999999975 4678999999997321000
Q ss_pred ----------cc-----------------------------cccccccccccccchhcccc-CCCCccchhHHHHHHHHH
Q 040134 637 ----------TQ-----------------------------AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLE 676 (745)
Q Consensus 637 ----------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~e 676 (745)
.. .......||++|.|||++.. ...+++.||||.|+|++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 00 00112458999999999866 457899999999999999
Q ss_pred HHhCCCCCCCCCCC
Q 040134 677 LICCKSSVVFGTTN 690 (745)
Q Consensus 677 lltg~~p~~~~~~~ 690 (745)
+++++.||.....+
T Consensus 271 lls~~~PFf~a~dd 284 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDD 284 (418)
T ss_pred hhccccccccCccc
Confidence 99999999655443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-24 Score=250.75 Aligned_cols=189 Identities=20% Similarity=0.218 Sum_probs=131.1
Q ss_pred ccCC-CCceeEEEEE-------ecCCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeee
Q 040134 535 QTHH-KNLVRLLGFC-------DEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605 (745)
Q Consensus 535 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 605 (745)
.++| +||.++++.| .+...+++++|++ +++|.++|... ..+++.+++.++.||++||+|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4455 5788888877 2334667888987 56999999753 5689999999999999999999954 9999
Q ss_pred CCCCCCCEEECCCC-------------------ceEEeeccCccccccccc--------------ccccccccccccccc
Q 040134 606 CDIKPQNILLDDYF-------------------TPRISDFGLAKLLLAEQT--------------QAARTGIRGTVGYFA 652 (745)
Q Consensus 606 ~dikp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~a 652 (745)
|||||+||||+..+ .+||+|||+++....... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 455666666543211000 000112357888999
Q ss_pred hhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHH
Q 040134 653 PEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVA 732 (745)
Q Consensus 653 PE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 732 (745)
||++.+..++.++|||||||+||||++|..|+... ...+... .. .. ..+. ..........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----~~~~~~~-~~----~~----~~~~-----~~~~~~~~~~~~ 245 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----SRTMSSL-RH----RV----LPPQ-----ILLNWPKEASFC 245 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----HHHHHHH-HH----hh----cChh-----hhhcCHHHHHHH
Confidence 99999999999999999999999999988775311 1111111 00 00 1110 011223456788
Q ss_pred HhccccCcCCCCC
Q 040134 733 LWCIQEDASLRPQ 745 (745)
Q Consensus 733 ~~Cl~~dp~~RPT 745 (745)
.+||++||.+|||
T Consensus 246 ~~~L~~~P~~Rps 258 (793)
T PLN00181 246 LWLLHPEPSCRPS 258 (793)
T ss_pred HHhCCCChhhCcC
Confidence 9999999999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=194.94 Aligned_cols=155 Identities=22% Similarity=0.138 Sum_probs=115.4
Q ss_pred CCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 564 GSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 564 gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
|+|.+++... ..+++.+++.++.|++.||+|||+. + ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999764 5689999999999999999999965 3 999999999999999 99987654321
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..|++.|+|||++.+..++.++|||||||++|||+||+.||...... ...+...... ..... .... ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~-~~~~~-----~~~~--~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNG-MPADD-----PRDR--SNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHH-hccCC-----cccc--ccHH
Confidence 25789999999999999999999999999999999999998533221 1111111111 11100 0000 0111
Q ss_pred HHH--HHHHHHHHhccccCcCCCCC
Q 040134 723 KRV--ERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~--~~l~~li~~Cl~~dp~~RPT 745 (745)
... ..+.+++.+||+.||++|||
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~ 158 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREA 158 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccC
Confidence 122 26899999999999999997
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=209.96 Aligned_cols=166 Identities=20% Similarity=0.151 Sum_probs=127.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-----cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-----EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..|.+.++||+|+||+||+|.....+++.||||++... .....+.+.+|++++++++|+|+++.+.. ....+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 34667789999999999999987655677899986532 12235679999999999999999853322 24579
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI-KPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~di-kp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+||||+++++|... ... ....++.|++++|.|||+. ||+|||| ||+|||++.++.+||+|||+++.+..
T Consensus 95 LVmE~~~G~~L~~~-~~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RPH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEEccCCCCHHHh-Ccc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 99999999999732 111 1256889999999999954 9999999 99999999999999999999997754
Q ss_pred cccccc------cccccccccccchhccccC
Q 040134 635 EQTQAA------RTGIRGTVGYFAPEWFRKA 659 (745)
Q Consensus 635 ~~~~~~------~~~~~gt~~y~aPE~~~~~ 659 (745)
...... .+...+++.|+|||.+...
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 332111 1346688899999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=200.24 Aligned_cols=203 Identities=23% Similarity=0.255 Sum_probs=165.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC----CCceeEEEEE-ecCCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH----KNLVRLLGFC-DEGDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l 556 (745)
.+.+.+.||+|+||.||.+.......+.+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566788999999999999997665445688888765433333377888888888863 6899999999 57888999
Q ss_pred EEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CceEEeeccCc
Q 040134 557 VYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-----FTPRISDFGLA 629 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-----~~~kl~Dfg~a 629 (745)
||+.+ +.+|.++.... +.++..+.++|+.|++.+|++||+. |++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 77999987543 6789999999999999999999955 99999999999999754 46999999999
Q ss_pred c--cccccccc---cc---cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 630 K--LLLAEQTQ---AA---RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 630 ~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
+ .+...... .. ....+||.+|++++...+.+.+.+.|+||++.++.|++.|..|+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9 43222211 11 234669999999999999999999999999999999999999985444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-22 Score=190.64 Aligned_cols=235 Identities=23% Similarity=0.363 Sum_probs=177.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcc--cccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.++.-+|.+...|..|+|++..++ +++|++. .......++|..|.-.|+.+.||||+.+++.|....+..+|..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd---ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND---IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc---hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 345567899999999999997644 6777764 34445557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe--eccCcccccccc
Q 040134 561 MSNGSLASFLFGITR--PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS--DFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~--Dfg~a~~~~~~~ 636 (745)
|+.|+|..+|+.... .+..++.+++.++++|++|||.. ..-|.---|....++||++.+.+|. |--++.
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee------
Confidence 999999999987644 46788999999999999999975 3334444688899999999887764 321111
Q ss_pred cccccccccccccccchhccccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASIT---VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
......-.+.||+||.++.++.+ .++|+|||.++||||.|.+.||..-..-+.. +..+.+
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--mkiale------------ 404 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--MKIALE------------ 404 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--hhhhhc------------
Confidence 11222346889999999887654 5799999999999999999999654432111 111111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.++....+.....+.+++.-|+..||.+||.
T Consensus 405 -glrv~ippgis~hm~klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 405 -GLRVHIPPGISRHMNKLMNICMNEDPGKRPK 435 (448)
T ss_pred -cccccCCCCccHHHHHHHHHHhcCCCCcCCC
Confidence 1222223344567889999999999999994
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-19 Score=190.62 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=189.5
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc---CHHHHHHHHHHHhccCCC-CceeEEEEEecCCeEEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---GEKEFRTEVSVIGQTHHK-NLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred eeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 45678999999999999876 45899998653332 367899999999999888 79999999988878899999
Q ss_pred ecCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCccccccc
Q 040134 560 YMSNGSLASFLFGIT---RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAE 635 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~ 635 (745)
++.++++.+++.... .+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999998876664 788999999999999999999965 899999999999999988 7999999999865444
Q ss_pred cccc----ccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCC-chhhHHHHHHHHhhcCc
Q 040134 636 QTQA----ARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTN-PEEALMDWVYRCYIGKN 707 (745)
Q Consensus 636 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~-~~~~l~~~~~~~~~~~~ 707 (745)
.... ......++..|+|||.+.. ...+...|+||+|++++++++|..|+...... ........+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence 3221 2456789999999999987 57889999999999999999999996544321 011121222211111 0
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......... ......+.+++..|+..+|..|.+
T Consensus 235 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~ 268 (384)
T COG0515 235 LASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLS 268 (384)
T ss_pred cccccCcccc----chhhHHHHHHHHHHHhcCchhcCC
Confidence 0000000000 122345778888999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=174.62 Aligned_cols=215 Identities=21% Similarity=0.233 Sum_probs=175.0
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 556 (745)
+....+.+.+.||.|+||.+|.|..-. .++.||||.-+. .....++..|..+.+.|+ ...|..+..+..+...-.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeecc-CCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 344567788999999999999998765 456799998654 233457788999999996 4678888889999999999
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCcccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKLL 632 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~~ 632 (745)
||+.+ +.+|++++.-. +.++.++.+.++-|++.-++|+|.+ +++||||||+|+|+.- ...+.|+|||+++.+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99998 77999988643 6789999999999999999999965 9999999999999953 357899999999987
Q ss_pred cccccc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH
Q 040134 633 LAEQTQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWV 699 (745)
Q Consensus 633 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~ 699 (745)
.+.... .......||.+|.+-....+.+.+.+.|+-|+|.+|.+..-|..|++.-.......-.+-+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 654432 1234567999999999998889999999999999999999999999765554443333333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-21 Score=216.21 Aligned_cols=247 Identities=21% Similarity=0.249 Sum_probs=183.4
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcc----c-ccc-cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLD----K-VEQ-QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..++|.|++|.|+........+ ..+.|..+ . ... .....+..|+.+-..++|+|++..+....+....+-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~-~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLK-SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCCCc-cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4679999999777665543222 12333221 1 111 111226667778888999999888887777777777799
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ- 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 638 (745)
|+++ +|..++.....+...++..+++|++.|++|||. .||.|||+|++|+++..++.+||+|||.+.........
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 999999887789999999999999999999995 59999999999999999999999999999876554443
Q ss_pred -cccccccccccccchhccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 639 -AARTGIRGTVGYFAPEWFRKASITVK-VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 639 -~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.......|+..|+|||.+.+.+|.+. .||||.|+++..|++|+.||......+.... .. ...........
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~---~~~~~~~~~~~ 549 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TN---NYSDQRNIFEG 549 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hh---ccccccccccC
Confidence 44567889999999999999999865 8999999999999999999987666544320 00 00000011111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..........+...++.+|||.||.+|-|
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheec
Confidence 11123344566788999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=175.21 Aligned_cols=202 Identities=21% Similarity=0.269 Sum_probs=170.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..+.+.++||+|+||.++.|+.-- ++++||||.-.. .....++..|.+..+.| ..+.|..++-|..++.+-.||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~-nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY-NNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccc-cCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 346678899999999999998654 467899998543 23346788899999888 57999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCceEEeeccCccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-----YFTPRISDFGLAKLLL 633 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-----~~~~kl~Dfg~a~~~~ 633 (745)
.+ |-+|+++..-. ++++.++...++.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 98 77999987543 6789999999999999999999965 9999999999999953 3468999999999886
Q ss_pred cccccc-----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 634 AEQTQA-----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 634 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
+..... ......||.+||+-....+++.+.+.|+-|||-++.+.|-|..||..-..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 654321 23446799999999999999999999999999999999999999975443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=177.48 Aligned_cols=173 Identities=12% Similarity=0.077 Sum_probs=131.4
Q ss_pred HHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHH---------HHHHHHHHhccCCCCceeEEEE
Q 040134 477 ELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---------FRTEVSVIGQTHHKNLVRLLGF 547 (745)
Q Consensus 477 ~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~nIv~l~~~ 547 (745)
++....++..+++|.|+||.||.... . ...+|||.+........+. +.+|+..+.+++|++|..+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-C--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 34455667788999999999999654 2 3359999997543333322 6899999999999999999988
Q ss_pred EecC--------CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 548 CDEG--------DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 548 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
+... ...+++|||++|.+|.++.. ++. ....+++.+|..||+. |++|||+||+||++++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 6533 35789999999999988732 222 3466999999999965 999999999999999988
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHH
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ell 678 (745)
++|+|||........... ...+....+..++|+|+||+.+....
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654322211 11334455677999999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=174.59 Aligned_cols=139 Identities=15% Similarity=0.114 Sum_probs=107.5
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc--C-------HH-----------------HHHHHHHHHhccCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ--G-------EK-----------------EFRTEVSVIGQTHHK 539 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ 539 (745)
.+.||+|++|.||+|... +++.||||+++..... . .. ....|++.+.++.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 357999999999999985 4678999998653211 1 11 223499999999887
Q ss_pred CceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEECCC
Q 040134 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYL-HEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 540 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dikp~NIll~~~ 618 (745)
++.....+... ..++||||++++++...+.....++..++..++.|++.+|.+| |+ .||+||||||+||++++
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~~- 153 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEEC-
Confidence 76443333222 2389999999987766544456788899999999999999999 64 49999999999999984
Q ss_pred CceEEeeccCcccc
Q 040134 619 FTPRISDFGLAKLL 632 (745)
Q Consensus 619 ~~~kl~Dfg~a~~~ 632 (745)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=168.72 Aligned_cols=141 Identities=15% Similarity=0.095 Sum_probs=109.8
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc---------------------C-----HHHHHHHHHHHhccCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ---------------------G-----EKEFRTEVSVIGQTHHK 539 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ 539 (745)
...||+|++|+||+|... +++.||||+++..... . ...+..|.+.+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 357999999999999876 4678999998653211 0 11245789999999999
Q ss_pred CceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 540 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
++.....+.... .++||||++++++.........++..+...++.|++.+|.+||+. .||+||||||+||+++ ++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CC
Confidence 875544443332 489999999886544433345677889999999999999999961 4999999999999999 78
Q ss_pred ceEEeeccCccccc
Q 040134 620 TPRISDFGLAKLLL 633 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~ 633 (745)
.++|+|||++..+.
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=185.47 Aligned_cols=204 Identities=26% Similarity=0.419 Sum_probs=155.0
Q ss_pred HhccCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 040134 533 IGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQ 611 (745)
Q Consensus 533 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~ 611 (745)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ..+++.....++++|++||+|||.. .-..|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 35689999999999999999999999999999999999874 6789999999999999999999964 33399999999
Q ss_pred CEEECCCCceEEeeccCcccccccccccccccccccccccchhccccC-------CCCccchhHHHHHHHHHHHhCCCCC
Q 040134 612 NILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-------SITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 612 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
|.++|....+||+|||+....................-|.|||.+... ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876431111112233345679999999763 2467899999999999999999999
Q ss_pred CCCCCCch-hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 685 VFGTTNPE-EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 685 ~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........ ..+...+.. .-...+.+.... ..+..+.+..++..||..+|++||+
T Consensus 159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred ccccccCChHHHHHHHHh-----cCCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCcc
Confidence 87554432 222222222 111111222211 1133347899999999999999996
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-18 Score=197.47 Aligned_cols=204 Identities=20% Similarity=0.187 Sum_probs=160.1
Q ss_pred cCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC---CCCceeEEEEEe
Q 040134 473 FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH---HKNLVRLLGFCD 549 (745)
Q Consensus 473 ~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~ 549 (745)
.+.-++....+.+...||+|+||+||+|.... ++.||+|+-+...... |.--.+++.+|+ -+.|..+...+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 33444555566778899999999999999765 6789999976543322 111222333333 233444555555
Q ss_pred cCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-------CCCceE
Q 040134 550 EGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-------DYFTPR 622 (745)
Q Consensus 550 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-------~~~~~k 622 (745)
-.+..+||+||.+.|+|.+++...+.+++...+.++.|++..++.||.. +||||||||+|+||. +...++
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 6778899999999999999999889999999999999999999999965 999999999999994 345799
Q ss_pred EeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 623 ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 623 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
|+|||.+..+.--..........+|-.+--+|...+++++.++|.|.|+.+++-||.|+.--
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 99999997764433333355667889999999999999999999999999999999998543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.2e-18 Score=170.76 Aligned_cols=227 Identities=19% Similarity=0.248 Sum_probs=145.2
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCC----------CCceeEEEEEe---
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHH----------KNLVRLLGFCD--- 549 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~nIv~l~~~~~--- 549 (745)
.+.||.|+++.||.+++.. +++.+|+|+... ......+++++|.-.+..+.+ -.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~-t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVE-TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETT-TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred ccccccCCceEEEEEEEcc-CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4689999999999999865 567899998743 233345677777766665432 22333333221
Q ss_pred ------cC---C-----eEEEEEEecCCCCHHHHhcC---CC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 040134 550 ------EG---D-----HRLLVYEYMSNGSLASFLFG---IT----RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI 608 (745)
Q Consensus 550 ------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~di 608 (745)
.. . ..+++|+-+ .++|.+++.. .. .+....++.+..|+++.+++||.. |++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11 1 235677777 4588887531 11 122344567779999999999965 9999999
Q ss_pred CCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhcccc--------CCCCccchhHHHHHHHHHHHhC
Q 040134 609 KPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK--------ASITVKVDVYSFGVLLLELICC 680 (745)
Q Consensus 609 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwslG~vl~elltg 680 (745)
+|+|++++++|.++|+||+.....+..... ...+..|.|||.... -.++.+.|.|+||+++|.|.++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999888765443321 234578999997743 2578899999999999999999
Q ss_pred CCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCC
Q 040134 681 KSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLR 743 (745)
Q Consensus 681 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 743 (745)
+.||........... .-..+. +..+.+..+|..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999975433211100 111223 556778899999999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9e-18 Score=160.81 Aligned_cols=183 Identities=18% Similarity=0.099 Sum_probs=134.6
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC----HHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEe
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG----EKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
...|++|+||+|+.+.. .++.++.+.+.....-. ...+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 7 ~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 45799999999996543 44557777765432211 125889999999995 5889999886 457999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCceEEeeccCcccccccccc-
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDI-KPQNILLDDYFTPRISDFGLAKLLLAEQTQ- 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~di-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 638 (745)
+++.+|...+.. ....++.|++.+|+++|+. ||+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998765321 1245788999999999965 9999999 799999999999999999999855432210
Q ss_pred ---c-------ccccccccccccchhccccC-CCC-ccchhHHHHHHHHHHHhCCCCCC
Q 040134 639 ---A-------ARTGIRGTVGYFAPEWFRKA-SIT-VKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 639 ---~-------~~~~~~gt~~y~aPE~~~~~-~~s-~~~DvwslG~vl~elltg~~p~~ 685 (745)
. .......++.|++|+...-- ..+ .+.+.++-|.-+|.++|++.+..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00112356778888754321 233 56788999999999999998763
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-18 Score=148.65 Aligned_cols=86 Identities=26% Similarity=0.548 Sum_probs=70.0
Q ss_pred eEEEEeCceeEEEEEecccccccceEEEEEEccCCcEEEEEcCCCCcccCcceeeeccccccccccccccCCCCCCCCCc
Q 040134 205 YIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHPKYETACNFTWRMEERIPQDICVAITGDIGSGACGYNS 284 (745)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~~~~W~~~~~~p~~~Cd~~~~~~~~g~CG~~g 284 (745)
+.|+.+.++..+.+... ..+.++|++||.+|++++|.|.+ ....|...|.+|.|+||+ |+.||+||
T Consensus 25 ~~fv~~~~e~~~t~~~~----~~s~~~r~~ld~~G~l~~~~w~~----~~~~W~~~~~~p~d~Cd~------y~~CG~~g 90 (110)
T PF00954_consen 25 YSFVSNNEEVYYTYSLS----NSSVLSRLVLDSDGQLQRYIWNE----STQSWSVFWSAPKDQCDV------YGFCGPNG 90 (110)
T ss_pred EEEEECCCeEEEEEecC----CCceEEEEEEeeeeEEEEEEEec----CCCcEEEEEEecccCCCC------ccccCCcc
Confidence 44555555555555432 46789999999999999999983 456899999999999999 59999999
Q ss_pred ccccCCCCCcccCCCCCcccc
Q 040134 285 ICAEINGEPKCLCPDNYSYLN 305 (745)
Q Consensus 285 ~C~~~~~~~~C~C~~gf~~~~ 305 (745)
+|+. +..+.|+||+||+|++
T Consensus 91 ~C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 91 ICNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EeCC-CCCCceECCCCcCCCc
Confidence 9954 5678999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.9e-19 Score=195.94 Aligned_cols=240 Identities=24% Similarity=0.249 Sum_probs=168.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHH--HhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSV--IGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..+.+.+|++.|=+|.+++.+.+ .|+||++-+.. .-..+.|.++++- ...++|||.+++.-.-......|||-+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG---~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREG---LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCc---eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 34567899999999999988654 28999985433 3334455544444 445589999998877777777888889
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc-cccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA-EQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~ 638 (745)
|..+ +|.+.|..++-+...+...|+.|++.||..+|+. ||+|||||.+||||+.-.=+.|+||..-+...- ....
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8865 8999998878888899999999999999999965 999999999999999999999999987754321 1111
Q ss_pred ccccc----ccccccccchhccccC----------C-CCccchhHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHH
Q 040134 639 AARTG----IRGTVGYFAPEWFRKA----------S-ITVKVDVYSFGVLLLELICC-KSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 639 ~~~~~----~~gt~~y~aPE~~~~~----------~-~s~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
..... .+.-..|.|||.+... . .+++.||||+||++.||++- +++|.... -+.++.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------L~aYr~ 249 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------LLAYRS 249 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------HHhHhc
Confidence 11111 2233469999987431 2 67899999999999999875 55553211 111111
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
-.....+.++.. .. -..+.+++..|+|.||++|-|
T Consensus 250 ~~~~~~e~~Le~-Ie-------d~~~Rnlil~Mi~rdPs~RlS 284 (1431)
T KOG1240|consen 250 GNADDPEQLLEK-IE-------DVSLRNLILSMIQRDPSKRLS 284 (1431)
T ss_pred cCccCHHHHHHh-Cc-------CccHHHHHHHHHccCchhccC
Confidence 100111111100 00 124778999999999999964
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=158.91 Aligned_cols=133 Identities=23% Similarity=0.309 Sum_probs=103.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-----CCCCceeEEEEEecCC---eEE-EE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-----HHKNLVRLLGFCDEGD---HRL-LV 557 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-lv 557 (745)
+.||+|+++.||. .+.... .+||++........+.+.+|+.+++.+ +||||++++|+++++. ..+ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~--k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQ--RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CCCCcC--eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999996 443332 368887654444567899999999999 5799999999998864 333 78
Q ss_pred EEe--cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCCEEECC----CCceEEeeccCc
Q 040134 558 YEY--MSNGSLASFLFGITRPDWNQRVQIAFGIARGL-MYLHEECSTQIIHCDIKPQNILLDD----YFTPRISDFGLA 629 (745)
Q Consensus 558 ~e~--~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~Dfg~a 629 (745)
+|| .++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999653 34444 45678888777 999965 9999999999999973 348999995444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-18 Score=182.57 Aligned_cols=188 Identities=27% Similarity=0.293 Sum_probs=156.3
Q ss_pred hcCcceeEEEEEEEee--CCCcEEEEEEEcccccccC--HHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecC
Q 040134 488 ILGRGAFGTVYKGVLA--SDSKRFVAIKKLDKVEQQG--EKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
++|+|.||.|+.++-- .+.+..+++|.+++..... ......|..++...+ ||.+++++-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3689999999876432 1234567777775422111 114456778888886 9999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+|.|...+.......+.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+.+..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999998888888888888999999999999965 9999999999999999999999999999876443322
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999997 678899999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=159.61 Aligned_cols=141 Identities=16% Similarity=0.162 Sum_probs=108.6
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc------------------------CHHHHHHHHHHHhccCCC
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ------------------------GEKEFRTEVSVIGQTHHK 539 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~ 539 (745)
.+.+.||+|++|.||+|++...+++.||+|+++..... ....+..|++.+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 45678999999999999833335678999998643210 012356899999999753
Q ss_pred --CceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEEC
Q 040134 540 --NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ-IIHCDIKPQNILLD 616 (745)
Q Consensus 540 --nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dikp~NIll~ 616 (745)
.++++++. ...++||||+++.+|.............+...++.|++.+|++||+. + ++|+||||+||+++
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~ 183 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH 183 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE
Confidence 34455543 23589999999988877654445556667789999999999999965 8 99999999999999
Q ss_pred CCCceEEeeccCcccc
Q 040134 617 DYFTPRISDFGLAKLL 632 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~ 632 (745)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=160.37 Aligned_cols=189 Identities=21% Similarity=0.241 Sum_probs=132.5
Q ss_pred CCCCceeEEEEEec---------------------------CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHH
Q 040134 537 HHKNLVRLLGFCDE---------------------------GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIA 589 (745)
Q Consensus 537 ~h~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~ 589 (745)
+|||||+++++|.+ +...|+||..++ .+|.+++.... .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 68999988887633 346789998874 49999986543 46667778999999
Q ss_pred HHHHHHHhcCCCCeeeCCCCCCCEEE--CCCC--ceEEeeccCccccccccc----ccccccccccccccchhccccCC-
Q 040134 590 RGLMYLHEECSTQIIHCDIKPQNILL--DDYF--TPRISDFGLAKLLLAEQT----QAARTGIRGTVGYFAPEWFRKAS- 660 (745)
Q Consensus 590 ~~L~~LH~~~~~~ivH~dikp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~- 660 (745)
+|+.|||++ ||.|||+|.+|||+ |+++ .+.|+|||++..-....- ........|...-||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999966 99999999999998 4443 578999998753221111 11122345778899999985432
Q ss_pred ----C-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhc
Q 040134 661 ----I-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWC 735 (745)
Q Consensus 661 ----~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~C 735 (745)
. -.|+|.|+.|.+.||+++...||+....- .+. .+.+.+..+..+.+.- ...+.+++...
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~---~r~Yqe~qLPalp~~v---------pp~~rqlV~~l 493 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLD---TRTYQESQLPALPSRV---------PPVARQLVFDL 493 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchh---eec---hhhhhhhhCCCCcccC---------ChHHHHHHHHH
Confidence 1 25899999999999999999999753221 111 1223333343332221 22367888999
Q ss_pred cccCcCCCCC
Q 040134 736 IQEDASLRPQ 745 (745)
Q Consensus 736 l~~dp~~RPT 745 (745)
|+.||++||+
T Consensus 494 L~r~pskRvs 503 (598)
T KOG4158|consen 494 LKRDPSKRVS 503 (598)
T ss_pred hcCCccccCC
Confidence 9999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=152.27 Aligned_cols=134 Identities=21% Similarity=0.292 Sum_probs=110.9
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc--------CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ--------GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.||+|++|.||+|... +..|++|+....... ....+.+|++++..++|++|.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL---GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEeeC---CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 46899999999999873 345888876432111 1245788999999999999888777777778889999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
||+++++|.+++..... .+..++.+++.+|.+||+. +++|+|++|+||+++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999864332 7889999999999999955 999999999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=150.19 Aligned_cols=130 Identities=21% Similarity=0.297 Sum_probs=104.5
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-c-------CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-Q-------GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.||+|++|.||+|... ++.|++|....... . ....+.+|++++..++|+++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~~---~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL---GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeecC---CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 4899999999999853 34588888543211 1 12567789999999998876655555666677899999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
|+++++|.+++..... .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999998754321 7899999999999954 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9e-17 Score=168.84 Aligned_cols=168 Identities=23% Similarity=0.274 Sum_probs=127.1
Q ss_pred eEEEEEEecCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 553 HRLLVYEYMSNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
+.|+.|++++..+|.++|... ...++...+.+++|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999754 345778889999999999999 3 8999999999999999999999999998
Q ss_pred ccccccc----cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 630 KLLLAEQ----TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 630 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
....... .....+...||..||+||.+.+..|+.|+||||||+||+||+. -..++. . ......+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r----~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------R----IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------H----HHhhhhhh
Confidence 7765444 2223566789999999999999999999999999999999996 222211 0 01112222
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+++.+..+ .++ =..+..+++.+.|.+||+
T Consensus 474 ~g~ip~~~~~d-----~p~----e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 474 DGIIPPEFLQD-----YPE----EYTLLQQLLSPSPEERPS 505 (516)
T ss_pred cCCCChHHhhc-----CcH----HHHHHHHhcCCCcccCch
Confidence 33333221111 111 236788999999999994
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-15 Score=145.69 Aligned_cols=137 Identities=18% Similarity=0.159 Sum_probs=106.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc----------------------cCHHHHHHHHHHHhccCCC-
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ----------------------QGEKEFRTEVSVIGQTHHK- 539 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~- 539 (745)
+.+.+.||+|++|.||++... +++.||||++..... .....+..|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 556688999999999999875 456799998653210 0112367788889988877
Q ss_pred -CceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 040134 540 -NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 540 -nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~ 618 (745)
.+++.++. ...++||||+++++|..... ......++.+++.++.++|+. +|+|+||||+||+++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 45555542 34589999999999887642 134567899999999999964 99999999999999999
Q ss_pred CceEEeeccCcccccc
Q 040134 619 FTPRISDFGLAKLLLA 634 (745)
Q Consensus 619 ~~~kl~Dfg~a~~~~~ 634 (745)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=168.19 Aligned_cols=133 Identities=20% Similarity=0.300 Sum_probs=108.2
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEc-ccc-c------ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKL-DKV-E------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.||+|+||.||+|.+.... +++|+. .+. . ....+.+.+|++++++++|++++....++......++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~---~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD---AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc---ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3578999999999999875432 333332 111 1 1123568899999999999999988888877778899
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
||||+++++|.+++. ....++.+++++|.+||+. +++||||||+||++ +++.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999999874 4578999999999999965 99999999999999 6779999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-15 Score=165.95 Aligned_cols=203 Identities=24% Similarity=0.318 Sum_probs=133.3
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.++|..|+||.||..+++. ..+..|+|+-+.. ..+++ ++.....|.++ |+
T Consensus 88 IklisngAygavylvrh~~-trqrfa~kiNkq~-----lilRn---ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKE-TRQRFAMKINKQN-----LILRN---ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eEeeccCCCCceeeeeccc-cccchhhcccccc-----hhhhc---cccccCCccee---------------------ch
Confidence 4689999999999998765 3445676543221 01111 22222233222 34
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc---------
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ--------- 636 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~--------- 636 (745)
-...++..+.++.. ++.+++||| +.+|+|||+||+|.+|+.-|.+|+.|||+.+......
T Consensus 138 c~tllk~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhhcccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 44445444444332 278999999 5599999999999999999999999999987642111
Q ss_pred ----cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 637 ----TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 637 ----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
........+||+.|.|||++..+.|....|.|++|+|+||.+.|..||.... +++.+...+...+ .. .
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--peelfg~visd~i-----~w-p 278 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVISDDI-----EW-P 278 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--HHHHHhhhhhhhc-----cc-c
Confidence 1112234689999999999999999999999999999999999999985332 2333322222211 10 0
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLR 743 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 743 (745)
+. +.....+..+++.+.|+.+|.+|
T Consensus 279 E~------dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 279 EE------DEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred cc------CcCCCHHHHHHHHHHHHhChHhh
Confidence 00 11222346677778888888877
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.5e-14 Score=130.60 Aligned_cols=134 Identities=22% Similarity=0.218 Sum_probs=113.1
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC--CCceeEEEEEecCCeEEEEEEecCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH--KNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
.+.|++|.++.||++.... +.+++|....... ...+.+|+..++.++| .++++++.+....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD---EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC---CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3568999999999999754 4589999865332 5678999999999976 5899999998888899999999998
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
..+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 5566778899999999999975445899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.6e-14 Score=136.42 Aligned_cols=138 Identities=18% Similarity=0.167 Sum_probs=96.3
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc--CHHH----------------------HHHHHHHHhccCCC--
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ--GEKE----------------------FRTEVSVIGQTHHK-- 539 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~-- 539 (745)
.+.||+|+||+||++... +++.||||++...... .... ...|.+.+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 457999999999999876 4567999987642211 1111 13556666666433
Q ss_pred CceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 540 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
.+.+.++. ...++||||++++.+.......... ..++..++.+++.++.++|.. .+|+|+||||+||+++ ++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CC
Confidence 34555543 2358999999985432211111011 166788999999999999961 5999999999999999 88
Q ss_pred ceEEeeccCccccc
Q 040134 620 TPRISDFGLAKLLL 633 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~ 633 (745)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2e-15 Score=170.26 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=186.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.+.||+|+++.|-...........+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++.|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4456679999999998887766666678888775432 223344556777777786 9999999999999999999999
Q ss_pred ecCCCCHHHHh-cCCC-CCChhhHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCcccccc-
Q 040134 560 YMSNGSLASFL-FGIT-RPDWNQRVQIAFGIARGLMYLH-EECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLA- 634 (745)
Q Consensus 560 ~~~~gsL~~~l-~~~~-~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~- 634 (745)
|..++++.+.+ .... ..+...+-.++.|+..++.|+| +. ++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999988 5443 6677888899999999999999 55 999999999999999999 999999999998876
Q ss_pred cccccccccccc-cccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 635 EQTQAARTGIRG-TVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 635 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......... ..|.... +.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~---~~~~~~- 253 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK---GRFTQL- 253 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc---cccccC-
Confidence 444444455677 9999999999885 45678999999999999999999987665543211 1111110 000000
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..........++...++..+|..|.|
T Consensus 254 -------~~~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 254 -------PWNSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred -------ccccCChhhhhcccccccCCchhccc
Confidence 01111234556777777788888864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3e-13 Score=136.30 Aligned_cols=134 Identities=16% Similarity=0.150 Sum_probs=101.7
Q ss_pred hhcC-cceeEEEEEEEeeCCCcEEEEEEEcccc-------------cccCHHHHHHHHHHHhccCCCCc--eeEEEEEec
Q 040134 487 QILG-RGAFGTVYKGVLASDSKRFVAIKKLDKV-------------EQQGEKEFRTEVSVIGQTHHKNL--VRLLGFCDE 550 (745)
Q Consensus 487 ~~Ig-~G~~g~V~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~ 550 (745)
.+|| .|+.|+||.+... +..++||.+... .......+.+|++++.+++|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4576 8888899988764 345888877421 11223567889999999998875 677776543
Q ss_pred CC----eEEEEEEecCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 551 GD----HRLLVYEYMSN-GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 551 ~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
.. ..++|+|++++ .+|.+++... .++. ..+.+|+.+|.+||+. ||+|+||||+|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 23599999997 6999888543 3333 2467899999999965 999999999999999988999999
Q ss_pred ccCccc
Q 040134 626 FGLAKL 631 (745)
Q Consensus 626 fg~a~~ 631 (745)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=102.80 Aligned_cols=57 Identities=26% Similarity=0.479 Sum_probs=49.1
Q ss_pred eeeEeccCCCCCCCcccccccCCcChHHHHHhhccCCceeeeEec----CCceEEeccCCCC
Q 040134 335 VDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYN----GDYCWKKKYPLSN 392 (745)
Q Consensus 335 ~~f~~~~~~~~p~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~y~----~~~C~~~~~~l~~ 392 (745)
++|++++++++|+..... +..++++++|++.||+||||+||+|. +++|++|.++|.+
T Consensus 5 d~F~~l~~~~~p~~~~~~-~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAI-VDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCccee-eecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 469999999999986554 33568999999999999999999995 4789999998876
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-11 Score=135.77 Aligned_cols=140 Identities=21% Similarity=0.210 Sum_probs=96.3
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC----------------------------------------HHHH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG----------------------------------------EKEF 526 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 526 (745)
+.||.|++|+||+|++.+ ++.||||+.+...... +-+|
T Consensus 123 ~plasaSigQVh~A~l~~--G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD--GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEecC--CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 359999999999999874 4679999975421110 0124
Q ss_pred HHHHHHHhccC----CCCceeEEEEE-ecCCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHH-HHHHHHhcC
Q 040134 527 RTEVSVIGQTH----HKNLVRLLGFC-DEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIAR-GLMYLHEEC 599 (745)
Q Consensus 527 ~~E~~~l~~l~----h~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~-~L~~LH~~~ 599 (745)
.+|++.+.++. |.+-+.+-.++ ......++||||++|++|.++.... ... ...+++.+++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh--
Confidence 45555555542 22222322222 2345679999999999998876422 111 34456666666 4677885
Q ss_pred CCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
.|++|+|+||.||++++++.++|+|||++..+..
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.5e-12 Score=126.14 Aligned_cols=153 Identities=24% Similarity=0.292 Sum_probs=116.9
Q ss_pred HHHHhccCCCCceeEEEEEecC-----CeEEEEEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCC
Q 040134 530 VSVIGQTHHKNLVRLLGFCDEG-----DHRLLVYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECS 600 (745)
Q Consensus 530 ~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~ 600 (745)
...|-++.|.||++++.|+.+. ....++.|||..|+|..+|++. ..+......++..||+.||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445566799999999988543 4578999999999999999753 5577788889999999999999976 8
Q ss_pred CCeeeCCCCCCCEEECCCCceEEeeccCcccc--cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHH
Q 040134 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLL--LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678 (745)
Q Consensus 601 ~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ell 678 (745)
..|+|+++..+.|++..++-+|+.--.-.... .............+-++|.+||.-.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999998888887432111100 0000111122345678999999877777788999999999999998
Q ss_pred hCCCC
Q 040134 679 CCKSS 683 (745)
Q Consensus 679 tg~~p 683 (745)
.+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 87754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-11 Score=133.13 Aligned_cols=209 Identities=22% Similarity=0.221 Sum_probs=162.4
Q ss_pred cCHHHHHHHHhcchhhcCc--ceeEEEEEEEe--eCCCcEEEEEEEccc--ccccCHHHHHHHHHHHhcc-CCCCceeEE
Q 040134 473 FTYKELEEATRGFRQILGR--GAFGTVYKGVL--ASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQT-HHKNLVRLL 545 (745)
Q Consensus 473 ~~~~~l~~~~~~~~~~Ig~--G~~g~V~~~~~--~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 545 (745)
-...+......++.+.+|. |.+|.+|.+.. .. ....+|+|.-+. ..+.....=.+|+...+++ .|+|.++.+
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~-s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSE-SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCccc-CCcccccccccCCCCCccccccccchhhcccccCccccccccC
Confidence 3444555666677788999 99999999987 44 345678877432 1222233335677777777 599999999
Q ss_pred EEEecCCeEEEEEEecCCCCHHHHhcCCCC-CChhhHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCEEECCC-C
Q 040134 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRVQIAFGIAR----GLMYLHEECSTQIIHCDIKPQNILLDDY-F 619 (745)
Q Consensus 546 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~dikp~NIll~~~-~ 619 (745)
..+...+..++-.|.+. .+|.++...... ++...++.+..+... ||.++| +.+++|-|+||.||++..+ .
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccc
Confidence 99999999999999985 688888776544 777888888888888 999999 5599999999999999998 8
Q ss_pred ceEEeeccCcccccccccccc---cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 620 TPRISDFGLAKLLLAEQTQAA---RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
..+++|||+...+........ .....+...|++||.++ ..++.++|+|++|.++.+..++..++..+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999999999998876553221 12235778899999884 56788999999999999999988776544
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-11 Score=101.09 Aligned_cols=72 Identities=19% Similarity=0.349 Sum_probs=60.4
Q ss_pred eeeeEeccCCCCCCCcccccccCCcChHHHHHhhccCCceeeeEec--CCceEEeccCCCCCCccccccceeeeecC
Q 040134 334 LVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYN--GDYCWKKKYPLSNGRRSTSVNRIALVKVP 408 (745)
Q Consensus 334 ~~~f~~~~~~~~p~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~y~--~~~C~~~~~~l~~~~~~~~~~~~~~lkv~ 408 (745)
.++|+.++++++|+..+.. .+.++++|++.||+||+|+||+|. +++|++|..++.+.+.....+..+|+||+
T Consensus 11 ~~~f~~~~~~~~~~~~~~~---~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI---TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhh---ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3479999999999775432 568999999999999999999995 57899999999887765555689999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=111.04 Aligned_cols=130 Identities=18% Similarity=0.127 Sum_probs=94.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc-eeEEEEEecCCeEEEEEEecCCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL-VRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
+.|+.|..+.||++... ++.+++|....... ....+.+|+.+++.+.+.++ .+++.+.. ...++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC---CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 45789999999998864 45699998754321 23456889999998865554 45555433 34579999999988
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC--STQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+.+. ......++.+++++|+.||... ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7643 0112346789999999999651 12369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-10 Score=109.22 Aligned_cols=138 Identities=14% Similarity=0.150 Sum_probs=98.6
Q ss_pred hhcCcceeEEEEEEEeeCC-----CcEEEEEEEcccc-------------c---------ccCHHHHH----HHHHHHhc
Q 040134 487 QILGRGAFGTVYKGVLASD-----SKRFVAIKKLDKV-------------E---------QQGEKEFR----TEVSVIGQ 535 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 535 (745)
..||.|.-+.||.|....+ .+..+|||+.+.. + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999986432 2357999986420 0 01123344 79999999
Q ss_pred cC--CCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCC
Q 040134 536 TH--HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYL-HEECSTQIIHCDIKPQN 612 (745)
Q Consensus 536 l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dikp~N 612 (745)
+. .-++++++++ ...++||||+.+..+..-......++.++...+..+++.+|..| |+ .++|||||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 85 3567777765 46789999997654422111222344556778889999999999 74 499999999999
Q ss_pred EEECCCCceEEeeccCcccc
Q 040134 613 ILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 613 Ill~~~~~~kl~Dfg~a~~~ 632 (745)
|++.+ +.+.|+|||.+...
T Consensus 156 IL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-CcEEEEECCCceeC
Confidence 99974 68999999988765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-10 Score=124.30 Aligned_cols=164 Identities=15% Similarity=0.198 Sum_probs=125.7
Q ss_pred CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHH
Q 040134 506 SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA 585 (745)
Q Consensus 506 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~ 585 (745)
.+.+|.|...+...........+-++.|+.++||||+++++........|+|+|.+. .|..++.... .....--+
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl 110 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGL 110 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHH
Confidence 345688887765555445667888999999999999999999999999999999874 5777765433 55666788
Q ss_pred HHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccc
Q 040134 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665 (745)
Q Consensus 586 ~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 665 (745)
.||+.||.|||+. .+++|++|..+.|++++.|.-||.+|.++........ ......--..|..|+.+.... -..
T Consensus 111 ~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 111 FQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cch
Confidence 9999999999975 4999999999999999999999999998865432221 111122234566776553322 346
Q ss_pred hhHHHHHHHHHHHhC
Q 040134 666 DVYSFGVLLLELICC 680 (745)
Q Consensus 666 DvwslG~vl~elltg 680 (745)
|.|-||++++|++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-10 Score=126.94 Aligned_cols=138 Identities=17% Similarity=0.098 Sum_probs=90.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc----------------------------------CH------HHH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ----------------------------------GE------KEF 526 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~------~~~ 526 (745)
+.||.|++|+||+|++.. +++.||||+++..... -. -++
T Consensus 125 ~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 369999999999999975 3567999998643110 00 124
Q ss_pred HHHHHHHhccC----CCCceeEEEEEec-CCeEEEEEEecCCCCHHHHh--cCCC----CCChhhHHHHHHHHHHHHHHH
Q 040134 527 RTEVSVIGQTH----HKNLVRLLGFCDE-GDHRLLVYEYMSNGSLASFL--FGIT----RPDWNQRVQIAFGIARGLMYL 595 (745)
Q Consensus 527 ~~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~----~~~~~~~~~i~~~i~~~L~~L 595 (745)
.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++- ...+ .+....+..++.|+.
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 44555554442 4443443333332 55678999999999998752 2211 112222222333332
Q ss_pred HhcCCCCeeeCCCCCCCEEECCCC----ceEEeeccCccccccc
Q 040134 596 HEECSTQIIHCDIKPQNILLDDYF----TPRISDFGLAKLLLAE 635 (745)
Q Consensus 596 H~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~a~~~~~~ 635 (745)
..|++|+|+||.||+++.++ .++++|||++..+...
T Consensus 278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 34999999999999999887 9999999999877543
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-10 Score=93.80 Aligned_cols=64 Identities=13% Similarity=0.105 Sum_probs=55.4
Q ss_pred eeEeccCCCCCCCcccccccCCcChHHHHHhhcc---CCceeeeEec--CCceEEeccCC-CCCCccccccceeeee
Q 040134 336 DFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCRE---DCFCAAAIYN--GDYCWKKKYPL-SNGRRSTSVNRIALVK 406 (745)
Q Consensus 336 ~f~~~~~~~~p~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~A~~y~--~~~C~~~~~~l-~~~~~~~~~~~~~~lk 406 (745)
.|+++.++++|+... +++++|++.|++ ||||+||+|. +.+|++|..++ .+.++..+.+.++|+|
T Consensus 10 ~fl~~~~~klpd~~~-------~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-------NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-------cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 488899999997632 589999999999 9999999994 46899999999 8888877778889887
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-09 Score=99.85 Aligned_cols=131 Identities=21% Similarity=0.296 Sum_probs=100.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEc-cccccc-------CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL-DKVEQQ-------GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
..|++|+-+.++.+.+.. ..+++|.= .+.... ......+|+.++.+++--.|...+-+..+.+...++|
T Consensus 2 ~~i~~GAEa~i~~~~~~g---~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG---LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeeccC---cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 358899999999986632 23666643 221111 1245678999999987767766666777888889999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
||+++..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999998654 256777888888899954 999999999999998875 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=106.66 Aligned_cols=142 Identities=18% Similarity=0.232 Sum_probs=108.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-cCHHHHHHHHHHHhccCC--CCceeEEEEEecCC---eEEEEEEe
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEFRTEVSVIGQTHH--KNLVRLLGFCDEGD---HRLLVYEY 560 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~---~~~lv~e~ 560 (745)
+.|+.|..+.+|++.... ++.+++|....... .....+..|+++++.+.+ .++.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC--CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 458899999999998753 34689998754322 245678999999999965 45677888776543 66899999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC----------------------------------------- 599 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 599 (745)
+++.++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999888776532 34667777888888888888888521
Q ss_pred ------------CCCeeeCCCCCCCEEECC--CCceEEeeccCccc
Q 040134 600 ------------STQIIHCDIKPQNILLDD--YFTPRISDFGLAKL 631 (745)
Q Consensus 600 ------------~~~ivH~dikp~NIll~~--~~~~kl~Dfg~a~~ 631 (745)
...++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.6e-09 Score=95.57 Aligned_cols=140 Identities=21% Similarity=0.288 Sum_probs=102.7
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEc-cccc-------ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKL-DKVE-------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...|.+|+-+.|+++... ++..+||.- .+.. .-..+..++|++.|.+++--.|.-..-++.+...-.++
T Consensus 12 l~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred ceeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 357899999999999874 344555542 2211 11235678899999998766665555567777777899
Q ss_pred EEecCC-CCHHHHhcCC-CCCChhh-HHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---ceEEeeccCccc
Q 040134 558 YEYMSN-GSLASFLFGI-TRPDWNQ-RVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---TPRISDFGLAKL 631 (745)
Q Consensus 558 ~e~~~~-gsL~~~l~~~-~~~~~~~-~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~a~~ 631 (745)
|||+++ .++.+++... ......+ ...++.+|-+.+.-||. .+|+||||..+||++..++ .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999977 5788887654 2222333 36888999999999995 4999999999999997654 458999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.5e-10 Score=119.15 Aligned_cols=192 Identities=20% Similarity=0.206 Sum_probs=144.5
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHH--HHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEec
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE--FRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+...||.+.|+.|+....+..++..+++|.+.+.......+ -..|+.+...+ .|.+++++...+....+.|+=-||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 44579999999999987664566678888876533322222 22455555555 5888888887777777888889999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++...+.-...+++...+++..|++.++.++| ++.++|+|++|+||++..+ +..++.||+....+.-...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--- 422 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--- 422 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc---
Confidence 99998887754566788889999999999999999 5699999999999999876 7889999999865322111
Q ss_pred ccccccccccc--chhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 641 RTGIRGTVGYF--APEWFRKASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 641 ~~~~~gt~~y~--aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
.....-+++ +|++.....+-.+.|++|||.-+.+.+++....
T Consensus 423 --~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 423 --VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred --cccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 112233344 566667778889999999999999999887654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=8e-08 Score=97.96 Aligned_cols=137 Identities=15% Similarity=0.069 Sum_probs=97.0
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccccc-----------cCHHHHHHHHHHHhccCCCC--ceeEEEEEec-----
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-----------QGEKEFRTEVSVIGQTHHKN--LVRLLGFCDE----- 550 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~----- 550 (745)
+..-....|.+..+ .++.+.||....... .....+.+|.+.+.++...+ .++++.+...
T Consensus 30 v~~~~~rrvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 30 FRELEGRRTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EecCCCceEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333344666655 245689997643211 11124778999998885433 3445555543
Q ss_pred CCeEEEEEEecCCC-CHHHHhcC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------CCc
Q 040134 551 GDHRLLVYEYMSNG-SLASFLFG--ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-------YFT 620 (745)
Q Consensus 551 ~~~~~lv~e~~~~g-sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-------~~~ 620 (745)
....++|+|++++. +|.+++.. ....+......++.+++..+.-||+. ||+|+|+++.|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999986 89998853 24455667789999999999999965 9999999999999975 468
Q ss_pred eEEeeccCccc
Q 040134 621 PRISDFGLAKL 631 (745)
Q Consensus 621 ~kl~Dfg~a~~ 631 (745)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=91.54 Aligned_cols=125 Identities=21% Similarity=0.216 Sum_probs=80.8
Q ss_pred EEEEEEeeCCCcEEEEEEEccccc-------------cc-------------CHHHHHHHHHHHhccCCC--CceeEEEE
Q 040134 496 TVYKGVLASDSKRFVAIKKLDKVE-------------QQ-------------GEKEFRTEVSVIGQTHHK--NLVRLLGF 547 (745)
Q Consensus 496 ~V~~~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--nIv~l~~~ 547 (745)
.||.|.... +..+|||..+... .. .....++|.+.|.++... ++++++.+
T Consensus 1 ~Vy~~~~~~--~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDPD--GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEECT--TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECCC--CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 378888654 4579999864210 00 113467899999999755 57777755
Q ss_pred EecCCeEEEEEEecC--CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHH-HHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 548 CDEGDHRLLVYEYMS--NGSLASFLFGITRPDWNQRVQIAFGIARGLMY-LHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 548 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
. ...+||||++ +..+..+... .++..+...++.+++..+.. +| ..||+||||.+.||+++++ .+.|+
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred e----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 3 3479999998 6555444321 11245667788888886665 46 4599999999999999988 99999
Q ss_pred eccCcccc
Q 040134 625 DFGLAKLL 632 (745)
Q Consensus 625 Dfg~a~~~ 632 (745)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.4e-09 Score=117.16 Aligned_cols=149 Identities=23% Similarity=0.216 Sum_probs=117.7
Q ss_pred CCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 537 ~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
+||-+++..--+.-....+|+++|..+++|...|+.....+.+-....+..+..++++||. ..+.|+|++|.|+++.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhc
Confidence 3455554443344566789999999999999999888877777777788888999999994 3699999999999999
Q ss_pred CCCceEEeeccCccccccc-------------------------ccc----cccccccccccccchhccccCCCCccchh
Q 040134 617 DYFTPRISDFGLAKLLLAE-------------------------QTQ----AARTGIRGTVGYFAPEWFRKASITVKVDV 667 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv 667 (745)
.++..++.||+........ ... .......+|+.|.+||.+.+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 9999999999843322100 000 11233578999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 040134 668 YSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 668 wslG~vl~elltg~~p~~~~~ 688 (745)
|++|++++|.++|..||....
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcc
Confidence 999999999999999986443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.8e-07 Score=96.60 Aligned_cols=167 Identities=20% Similarity=0.230 Sum_probs=125.7
Q ss_pred eEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEe----cCCeEEEEEEecCC-CCHHH
Q 040134 494 FGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD----EGDHRLLVYEYMSN-GSLAS 568 (745)
Q Consensus 494 ~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 568 (745)
-.+.|++....+ +..+++|++.............-+++++++.|+|||++.+++. ....+++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~D-G~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVD-GNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccC-CceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 457788876654 4568889984433333334455688999999999999999886 34578899999986 57777
Q ss_pred HhcCC---------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 569 FLFGI---------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 569 ~l~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
+-... ...++..++.++.|+..||.++|.. |+.-+-|.|.+|+++.+.+++|...|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65322 2346788999999999999999954 99999999999999999999998888776554
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSS 683 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p 683 (745)
.+.. |.+. --.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3331 1111 12467999999999999999655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.3e-07 Score=87.20 Aligned_cols=106 Identities=20% Similarity=0.240 Sum_probs=86.1
Q ss_pred HHHHHHHHHHHhccC--CCCceeEEEEEecCC----eEEEEEEecCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHH
Q 040134 523 EKEFRTEVSVIGQTH--HKNLVRLLGFCDEGD----HRLLVYEYMSN-GSLASFLFGITRPDWNQRVQIAFGIARGLMYL 595 (745)
Q Consensus 523 ~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~L 595 (745)
.....+|...+.++. .-..++.+++..... ..++|+|++++ .+|.+++.....++......++.++++.++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 446788888888885 334566677665532 45899999987 48999997755577778899999999999999
Q ss_pred HhcCCCCeeeCCCCCCCEEECCCC---ceEEeeccCccc
Q 040134 596 HEECSTQIIHCDIKPQNILLDDYF---TPRISDFGLAKL 631 (745)
Q Consensus 596 H~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~a~~ 631 (745)
|+. ||+|+|+++.|||++.+. .+.|+||+.++.
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 965 999999999999998887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3e-07 Score=101.51 Aligned_cols=142 Identities=17% Similarity=0.189 Sum_probs=92.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc----------------------------------------CHHHH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ----------------------------------------GEKEF 526 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~ 526 (745)
+-|+.++-|+||+|++.+ ++.||||+.+..-.. .+-++
T Consensus 131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 358899999999999986 567999997532111 01123
Q ss_pred HHHHHHHhccC-----CCCceeEEEEEecCCeEEEEEEecCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCC
Q 040134 527 RTEVSVIGQTH-----HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECS 600 (745)
Q Consensus 527 ~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 600 (745)
.+|+..+.+++ .++|.-..-+.+-.....|+|||++|..+.+... +....+.+.+.....++.--.-+-|
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d---- 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD---- 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 44555444442 3333222223344567889999999998888742 2234443343333333222222334
Q ss_pred CCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 601 ~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|++|.|.+|.||+++.++.+.+.|||+...+.+.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999877543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-06 Score=82.99 Aligned_cols=136 Identities=16% Similarity=0.100 Sum_probs=103.1
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEccc------ccccCHHHHHHHHHHHhccCC--CCceeEEEEEe-c----CCeEE
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK------VEQQGEKEFRTEVSVIGQTHH--KNLVRLLGFCD-E----GDHRL 555 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~-~----~~~~~ 555 (745)
-++||.+.|++..+... .+-+|+... ..+.+...|.+|...|++|.. -.+.++. ++. . ....+
T Consensus 26 ~~rgG~SgV~r~~~~g~---~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK---KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeCCc---EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 36789999999776432 478887652 114567899999999999853 3345555 332 1 22467
Q ss_pred EEEEecCC-CCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--eEEeeccCcc
Q 040134 556 LVYEYMSN-GSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT--PRISDFGLAK 630 (745)
Q Consensus 556 lv~e~~~~-gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~--~kl~Dfg~a~ 630 (745)
||+|-+++ .+|.+++.+. .+++..+...++.+++..|.-||+. |+.|+|+-+.||+++.++. ++++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997764 6899888653 4567788889999999999999965 9999999999999986666 9999998776
Q ss_pred c
Q 040134 631 L 631 (745)
Q Consensus 631 ~ 631 (745)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.1e-07 Score=88.39 Aligned_cols=135 Identities=18% Similarity=0.156 Sum_probs=95.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc----------------------ccCHHHHHHHHHHHhccCCC-
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE----------------------QQGEKEFRTEVSVIGQTHHK- 539 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~- 539 (745)
+.+...||-|.-+.||.|.... +..+|||.-+... .-....-++|.++|++|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~--g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK--GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECCC--CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456789999999999999874 3458888642100 01123466899999999654
Q ss_pred -CceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 040134 540 -NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 540 -nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~ 618 (745)
.+++.+++ +...+|||++++-.|...- ++.+..-.++..|++-+..+-. .||||+|+.+-||+++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 77777765 4567999999986665442 1333444445555555544443 399999999999999999
Q ss_pred CceEEeeccCccc
Q 040134 619 FTPRISDFGLAKL 631 (745)
Q Consensus 619 ~~~kl~Dfg~a~~ 631 (745)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976554
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.1e-06 Score=77.56 Aligned_cols=76 Identities=30% Similarity=0.572 Sum_probs=59.4
Q ss_pred ceEEecCceEEEEcCC-CCEEEeccCCCC--CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEec
Q 040134 71 QVKLTNSGELVLYDPQ-GHELWQKPKDGS--KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSR 147 (745)
Q Consensus 71 ~l~l~~~G~Lvl~~~~-~~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 147 (745)
.+.+..||+||+++.. +.++|++++... ....+.|.++|||||++.++.++|+|=. -
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t-----~--------------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT-----T--------------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc-----c---------------
Confidence 3445678999999765 589999997532 3357899999999999998899998711 1
Q ss_pred CCCCCCCCceEEEEEecCCceEEE
Q 040134 148 RTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 148 ~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
...|.+.+.|+.+|+++++
T Consensus 83 -----~~~~~~~~~L~ddGnlvl~ 101 (114)
T smart00108 83 -----GANGNYVLVLLDDGNLVIY 101 (114)
T ss_pred -----CCCCceEEEEeCCCCEEEE
Confidence 1356789999999999886
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.7e-08 Score=104.77 Aligned_cols=98 Identities=22% Similarity=0.399 Sum_probs=75.8
Q ss_pred HHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc-------ccccccccccccccchhccc
Q 040134 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-------QAARTGIRGTVGYFAPEWFR 657 (745)
Q Consensus 585 ~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~ 657 (745)
+.+++.||.|+|. +.++||++|.|++|.++..+..||+.|+.+........ .....-..-...|.|||.+.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455599999997 56999999999999999999999999998765433111 01111123456799999999
Q ss_pred cCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 658 KASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 658 ~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
+...+.++|+||+|+++|.+..|..+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i 209 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSI 209 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcch
Confidence 888899999999999999999444443
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.9e-06 Score=76.32 Aligned_cols=76 Identities=28% Similarity=0.539 Sum_probs=59.8
Q ss_pred eEEec-CceEEEEcCC-CCEEEeccCCC--CCceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEec
Q 040134 72 VKLTN-SGELVLYDPQ-GHELWQKPKDG--SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSR 147 (745)
Q Consensus 72 l~l~~-~G~Lvl~~~~-~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 147 (745)
+.+.. ||+||+++.. ++++|++++.. .....+.|.++|||||++.++.++|||=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~-------------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc--------------------
Confidence 34455 8999999765 58999999864 345578999999999999999999986421
Q ss_pred CCCCCCCCceEEEEEecCCceEEEe
Q 040134 148 RTQHNYSTGRFRFLLKENGNLELSS 172 (745)
Q Consensus 148 ~s~~dps~G~~~~~~~~~g~~~~~~ 172 (745)
.+.+.+.+.|+.+|+++++-
T Consensus 84 -----~~~~~~~~~L~ddGnlvl~~ 103 (116)
T cd00028 84 -----RVNGNYVLVLLDDGNLVLYD 103 (116)
T ss_pred -----CCCCceEEEEeCCCCEEEEC
Confidence 02577899999999998864
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.3e-06 Score=92.86 Aligned_cols=158 Identities=16% Similarity=0.165 Sum_probs=100.3
Q ss_pred CCcCccCHHHHHHHHh------------cch-hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-------------
Q 040134 468 TNVRSFTYKELEEATR------------GFR-QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ------------- 521 (745)
Q Consensus 468 ~~~~~~~~~~l~~~~~------------~~~-~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~------------- 521 (745)
...++++++|+.+.-. .|. +-|+..+.++|++++++. ++.||||+.+..-+.
T Consensus 135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~ 212 (538)
T KOG1235|consen 135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLA 212 (538)
T ss_pred ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHH
Confidence 3456677776554322 233 469999999999999987 556999987532111
Q ss_pred ------------------------CHHHHHHHHHHHhcc----CCCC------ceeEEEEEecCCeEEEEEEecCCCCHH
Q 040134 522 ------------------------GEKEFRTEVSVIGQT----HHKN------LVRLLGFCDEGDHRLLVYEYMSNGSLA 567 (745)
Q Consensus 522 ------------------------~~~~~~~E~~~l~~l----~h~n------Iv~l~~~~~~~~~~~lv~e~~~~gsL~ 567 (745)
.+-+|.+|++...++ .|-+ |.+++. .-.....|+|||++|..+.
T Consensus 213 ~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~ 290 (538)
T KOG1235|consen 213 KVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKIN 290 (538)
T ss_pred HHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCC
Confidence 011244455444333 3555 333332 2345788999999998777
Q ss_pred HHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC----CCceEEeeccCcccccc
Q 040134 568 SFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD----YFTPRISDFGLAKLLLA 634 (745)
Q Consensus 568 ~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~Dfg~a~~~~~ 634 (745)
+.-. ....++...+..-+.++..-+-+-| |++|+|-+|.||++.. ++.+.+-|||+...+..
T Consensus 291 Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 291 DLDAIDKRGISPHDILNKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CHHHHHHcCCCHHHHHHHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 6532 1233454544444444333333334 9999999999999983 67899999999887644
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-06 Score=69.67 Aligned_cols=69 Identities=22% Similarity=0.239 Sum_probs=52.0
Q ss_pred eeEeccCCCCCCCcccccccCCcChHHHHHhhcc-CCceeeeEec--CCceEEec-cCCCCCCccccccceeeee
Q 040134 336 DFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCRE-DCFCAAAIYN--GDYCWKKK-YPLSNGRRSTSVNRIALVK 406 (745)
Q Consensus 336 ~f~~~~~~~~p~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~A~~y~--~~~C~~~~-~~l~~~~~~~~~~~~~~lk 406 (745)
.|..++++.+++..... ....++++|++.|++ +|+|.||.|+ ++.|++|. ..+.+.......+..+|.|
T Consensus 5 ~f~~~~~~~l~~~~~~~--~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 5 CFVRLPNTKLPGFSRIV--ISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred eeEEecCccCCCCccee--EcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEEe
Confidence 48899999998554432 246799999999999 9999999996 67899998 6666665444444555544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=78.28 Aligned_cols=134 Identities=15% Similarity=0.134 Sum_probs=80.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHH---------HHHHHHHHhccCCC---CceeEEEEE--
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE---------FRTEVSVIGQTHHK---NLVRLLGFC-- 548 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~---nIv~l~~~~-- 548 (745)
+...+++.......|.+.... ++..++|..+......++. ..+++..+.+++.. ....++-+.
T Consensus 33 ~~~~kv~k~~~r~~ValIei~---~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEID---GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred ceEEEeecCCCccEEEEEEEC---CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 334445555555555554442 3447788775433222222 22344444444322 222222222
Q ss_pred ---ecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 549 ---DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 549 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
......+++|||++|..|.++.. +++ .+...+.++|.-||+. |++|+|.+|.|++++++ .++++|
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEE
Confidence 22345678999999988776531 221 3556677889999965 99999999999999865 499999
Q ss_pred ccCccc
Q 040134 626 FGLAKL 631 (745)
Q Consensus 626 fg~a~~ 631 (745)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.4e-05 Score=78.13 Aligned_cols=137 Identities=12% Similarity=0.173 Sum_probs=84.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC--ceeEEEEEecCCeEEEEEEecCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN--LVRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g 564 (745)
..|++|..+.||+.. .+ ..++|..... .......+|.++++.+..-. +.+++++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~~----~~-~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TG-KWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEec----CC-CEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 468999999999831 22 3678887542 23456789999999886433 577888888888888999999986
Q ss_pred C-HHHHh---------------------cCC--CCCChhhH-HHHHH----------HHHH-HHHHHHhc-CCCCeeeCC
Q 040134 565 S-LASFL---------------------FGI--TRPDWNQR-VQIAF----------GIAR-GLMYLHEE-CSTQIIHCD 607 (745)
Q Consensus 565 s-L~~~l---------------------~~~--~~~~~~~~-~~i~~----------~i~~-~L~~LH~~-~~~~ivH~d 607 (745)
. +...+ +.. ........ .++.. .+.+ ...+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 22111 111 00010000 00000 0011 11222211 134579999
Q ss_pred CCCCCEEECCCCceEEeeccCccc
Q 040134 608 IKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 608 ikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
++|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.2e-06 Score=84.13 Aligned_cols=187 Identities=16% Similarity=0.166 Sum_probs=122.9
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEE-------ecCCeEEEE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFC-------DEGDHRLLV 557 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~-------~~~~~~~lv 557 (745)
...||+|+-+.+|..-.-.+ -+-|+..........+. +..|... .||-+..-+.+- ..+...-+.
T Consensus 16 gr~LgqGgea~ly~l~e~~d----~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD----QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecchhhc----hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 45689999999996432211 34466654333222222 2223333 566443311111 112225567
Q ss_pred EEecCCC-CHHHHhc------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 558 YEYMSNG-SLASFLF------GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 558 ~e~~~~g-sL~~~l~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
|+.+.+. ....++. .....+|...++.++.++.+.+.||+. |.+-||+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 7777654 2223322 124468999999999999999999976 99999999999999999999999866544
Q ss_pred cccccccccccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCC
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICC-KSSVV 685 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg-~~p~~ 685 (745)
.-.. .......+|...|.+||... +..-+...|.|.||+++++++.| +.||.
T Consensus 166 i~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 166 INAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred eccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 3211 11133457889999999765 33556789999999999999888 77774
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.4e-05 Score=77.62 Aligned_cols=136 Identities=14% Similarity=0.091 Sum_probs=83.7
Q ss_pred cCccee-EEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 489 LGRGAF-GTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 489 Ig~G~~-g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
|..|.. ..||+..... ..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~~---~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGKN---PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCCC---CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 344444 7889876532 358888875432 345678999988883 45577888888777778999999999877
Q ss_pred HHHh-------------------cCCCC--CChh----hHHHHHH--------------------HHHHHHHHHHhc---
Q 040134 567 ASFL-------------------FGITR--PDWN----QRVQIAF--------------------GIARGLMYLHEE--- 598 (745)
Q Consensus 567 ~~~l-------------------~~~~~--~~~~----~~~~i~~--------------------~i~~~L~~LH~~--- 598 (745)
.... +.... .... ....... .+...+..|-..
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6442 11100 0000 0000000 011111222111
Q ss_pred -CCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 599 -CSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 599 -~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13459999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.2e-05 Score=74.28 Aligned_cols=137 Identities=19% Similarity=0.237 Sum_probs=93.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-------------------CHH-----HHHHHHHHHhccC--CCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-------------------GEK-----EFRTEVSVIGQTH--HKN 540 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~~~~E~~~l~~l~--h~n 540 (745)
..|+.|.-+.||+|... .+..+|+|+.+..... ..+ -..+|...|.++. +-.
T Consensus 54 g~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 54 GCISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eeecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 36888999999998753 4567999997532111 111 1335777777773 455
Q ss_pred ceeEEEEEecCCeEEEEEEecCCCCHH-HHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 541 LVRLLGFCDEGDHRLLVYEYMSNGSLA-SFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 541 Iv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
+.+.+.+. .-.|||||+....+. -.|.. -.+...+...+..++++.+.-|-.. .++||+||+.-|||+. ++
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence 66666654 346999999654111 11111 1222336778888899988888852 4999999999999999 78
Q ss_pred ceEEeeccCccccc
Q 040134 620 TPRISDFGLAKLLL 633 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~ 633 (745)
.+.|+||+.+....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887653
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.98 E-value=8e-05 Score=65.45 Aligned_cols=100 Identities=29% Similarity=0.516 Sum_probs=65.7
Q ss_pred CceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeec-CCCCCCCCcceEEecCceEEEEcCCCCEEEeccCCCC
Q 040134 20 NPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSAN-GDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGS 98 (745)
Q Consensus 20 ~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~An-r~~p~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~ 98 (745)
+++.+.+|.+.|-|-.-+ -|-|.- ...++||..+ -..+....+.+.|..||||||+|..+.++|+|.. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dG-----nLvl~~---~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-~p 82 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDG-----NLVLYD---SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD-YP 82 (114)
T ss_dssp EEEEECETTEEEEEETTS-----EEEEEE---TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT-SS
T ss_pred cccccccccccceECCCC-----eEEEEc---CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC-CC
Confidence 456555588888876533 233332 2257799994 3333335678999999999999999999999943 33
Q ss_pred CceEEEEec--CccEEEEcCCccccccccccCc
Q 040134 99 KSSWATMQD--DGNFVLLGGDSNPIWESFKEPT 129 (745)
Q Consensus 99 ~~~~a~Lld--sGNlVl~~~~~~~lWQSFd~Pt 129 (745)
..+.+..++ .||++ ......+.|.|=+.|+
T Consensus 83 tdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 83 TDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp S-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred ccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 456677777 89998 7667788998877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.6e-05 Score=75.25 Aligned_cols=102 Identities=25% Similarity=0.372 Sum_probs=82.7
Q ss_pred HHHHHHHhccCC-CCceeEEEEEecCCeEEEEEEecCCCCHHHH---hcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 040134 527 RTEVSVIGQTHH-KNLVRLLGFCDEGDHRLLVYEYMSNGSLASF---LFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602 (745)
Q Consensus 527 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ 602 (745)
.+|.-+++.+++ +++++++|+|- .+++.||...+++... +..-...+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888865 69999999993 4789999987655421 112235689999999999999999999764456
Q ss_pred eeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 603 ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
+.-.|++|+|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.87 E-value=8e-05 Score=74.96 Aligned_cols=140 Identities=23% Similarity=0.216 Sum_probs=82.3
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCC--CceeEEEEEec---CCeEEEEEEec
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHK--NLVRLLGFCDE---GDHRLLVYEYM 561 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~---~~~~~lv~e~~ 561 (745)
+.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~---~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD---GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT---SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC---cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 357889999999988654 25889987543 3456788899998888433 35677764432 33578999999
Q ss_pred CCCCHHH----------------Hh---cCC----CCCChh---------hHHHH------------HHHHHH-HHHHHH
Q 040134 562 SNGSLAS----------------FL---FGI----TRPDWN---------QRVQI------------AFGIAR-GLMYLH 596 (745)
Q Consensus 562 ~~gsL~~----------------~l---~~~----~~~~~~---------~~~~i------------~~~i~~-~L~~LH 596 (745)
++..+.. .+ +.. ...... ..... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 011 111100 00000 111222 233333
Q ss_pred hc----CCCCeeeCCCCCCCEEEC-CCCceEEeeccCccc
Q 040134 597 EE----CSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKL 631 (745)
Q Consensus 597 ~~----~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~a~~ 631 (745)
+. ....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 21 245799999999999999 666668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=67.27 Aligned_cols=128 Identities=18% Similarity=0.256 Sum_probs=88.9
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCcee-EEEEEecCCeEEEEEEecCC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVR-LLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lv~e~~~~ 563 (745)
..+.|++|.+|.||++.+.. ..+|+|+-+. ......+..|+++|..+.-.++.+ ++.+..+ ++.|||+.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~---~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG---GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhcccccEEEEeeccC---ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 34679999999999999864 3589998764 344678999999999998777654 4443322 345999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCC-CCCEEECCCCceEEeeccCccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIK-PQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dik-p~NIll~~~~~~kl~Dfg~a~~ 631 (745)
..|.+.-... +.+ -...+++.---|- ..||-|+.|. |..++|.++..+.|+||..|..
T Consensus 97 ~~L~~~~~~~---~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG---DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc---cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887764321 222 2333444433333 3589999986 5666666666999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00032 Score=67.99 Aligned_cols=130 Identities=20% Similarity=0.248 Sum_probs=90.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccc----------------ccCHHHHHHHHHHHhccC------CCCceeE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE----------------QQGEKEFRTEVSVIGQTH------HKNLVRL 544 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~l 544 (745)
..||+|+.-.||. ++.+.. ..||+..... ....++..+|+.....+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~--~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPN--LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CCCCCC--eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4699999999996 343333 6788876543 123466777777666665 8899999
Q ss_pred EEEEecCCeEEEEEEecCC------CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 040134 545 LGFCDEGDHRLLVYEYMSN------GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~ 618 (745)
+|+.++....-+|+|.+.+ .+|.+++... .++. ...+.+. +-..||-+. +|+.+|++|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEEec
Confidence 9999999999999998753 4688888443 3443 3333333 344566643 89999999999999532
Q ss_pred ---C-ceEEee-ccC
Q 040134 619 ---F-TPRISD-FGL 628 (745)
Q Consensus 619 ---~-~~kl~D-fg~ 628 (745)
. .+.|+| ||.
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 2 577777 343
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00044 Score=82.80 Aligned_cols=80 Identities=13% Similarity=0.280 Sum_probs=56.0
Q ss_pred hhcCcceeEEEEEEEeeCCCc-EEEEEEEccccc-ccCHHHHHHHHHHHhccC-CCCc--eeEEEEEecC---CeEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSK-RFVAIKKLDKVE-QQGEKEFRTEVSVIGQTH-HKNL--VRLLGFCDEG---DHRLLVY 558 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv~ 558 (745)
+.|+.|.+..+|+.....+.. ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 457889999999877654321 346677654321 223457889999999995 6665 8888888664 4678999
Q ss_pred EecCCCCH
Q 040134 559 EYMSNGSL 566 (745)
Q Consensus 559 e~~~~gsL 566 (745)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=6.4e-06 Score=89.63 Aligned_cols=181 Identities=19% Similarity=0.145 Sum_probs=127.7
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC-ceeEEEEEecCCeEEEEEEecCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN-LVRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~g 564 (745)
-+-++++++++++|.+... .+....+.+... ....-++++|.+.+||| .++.++-++.+....+.++++..+
T Consensus 247 fh~fvK~altknpKkRpta--eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTA--EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCCh--hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 3457888999999876432 222334444321 45566889999999999 777777777788889999998776
Q ss_pred -C-HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 565 -S-LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 565 -s-L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+ ....-...-.+...+...+.+.-.++|++||.. .=+|+| ||+..+ +..+..||+.+..+.... ...
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 2 111111112233344455666677889999943 347888 776665 688999999988775543 234
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
...+++.++|||......+..+-|+|+++.--.+|.-|.+|.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 567899999999999999999999999998777777776664
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00034 Score=70.59 Aligned_cols=72 Identities=11% Similarity=0.157 Sum_probs=44.9
Q ss_pred hcCcceeE-EEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCC---CceeEEEEEecCC---eEEEEEEe
Q 040134 488 ILGRGAFG-TVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHK---NLVRLLGFCDEGD---HRLLVYEY 560 (745)
Q Consensus 488 ~Ig~G~~g-~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~---~~~lv~e~ 560 (745)
.|+.|+.. .||+.. . .+++|.... ......+.+|.+.+..+... -+.++++.....+ ..+++||+
T Consensus 4 ~~~~gG~~n~vy~~~----~--~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 4 PVDSGGTDNATFRLG----D--DMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eccCCCcccceEEcC----C--ceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 46666665 588741 1 266776543 22345788999999888532 3455555443322 34789999
Q ss_pred cCCCCHH
Q 040134 561 MSNGSLA 567 (745)
Q Consensus 561 ~~~gsL~ 567 (745)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00086 Score=70.09 Aligned_cols=75 Identities=7% Similarity=0.026 Sum_probs=54.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC---CCceeEEEEEec---CCeEEEEEEe
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH---KNLVRLLGFCDE---GDHRLLVYEY 560 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~---~~~~~lv~e~ 560 (745)
+.|+.|..+.||+....+ ++ +++|..+. ......+..|.+.++.+.- ..+.++++++.. .+..++|||+
T Consensus 20 ~~i~~G~~~~vy~~~~~~--~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDSQ--GN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcCC--CC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 469999999999976433 22 66676432 1133588999999998842 468889988754 3668999999
Q ss_pred cCCCCH
Q 040134 561 MSNGSL 566 (745)
Q Consensus 561 ~~~gsL 566 (745)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00093 Score=67.43 Aligned_cols=75 Identities=13% Similarity=0.129 Sum_probs=46.0
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC-CCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH-KNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
.|..|-...+|+.....+..+.+++|....... ......+|+.+++.+.. .-.+++++.... .++|||+++.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCcC
Confidence 466777789998865431234588887654222 12234578888888843 334555544332 379999998776
Q ss_pred H
Q 040134 567 A 567 (745)
Q Consensus 567 ~ 567 (745)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00099 Score=68.22 Aligned_cols=135 Identities=11% Similarity=0.068 Sum_probs=76.2
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc-eeEEEEEecCCeEEEEEEecCCCCHH
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL-VRLLGFCDEGDHRLLVYEYMSNGSLA 567 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~ 567 (745)
+..|-...+|+... .++.+++|..............+|.++++.+....+ .+++.... ..+|+||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 55677788998763 234577887643222211235778888888854333 44454432 36899999987654
Q ss_pred HH-----------------hcCCC----CCChhh-HHHHHHHH---------HHHHHHHHhc-----CCCCeeeCCCCCC
Q 040134 568 SF-----------------LFGIT----RPDWNQ-RVQIAFGI---------ARGLMYLHEE-----CSTQIIHCDIKPQ 611 (745)
Q Consensus 568 ~~-----------------l~~~~----~~~~~~-~~~i~~~i---------~~~L~~LH~~-----~~~~ivH~dikp~ 611 (745)
.- |+... +++... +..+..++ ...+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 11111 111111 11111111 1112222111 1235899999999
Q ss_pred CEEECCCCceEEeeccCccc
Q 040134 612 NILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 612 NIll~~~~~~kl~Dfg~a~~ 631 (745)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0014 Score=68.59 Aligned_cols=138 Identities=15% Similarity=0.162 Sum_probs=83.0
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCC--CceeEEEE------EecCCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHK--NLVRLLGF------CDEGDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~------~~~~~~~~lv~e 559 (745)
.|..|....+|+..... ..+++|+... .....+..|++++..+.+. .+++++.. ....+..++|++
T Consensus 21 ~i~~G~~n~~y~v~~~~---~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 21 GISAGIENTNYFVTTDS---GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred cccCccccceEEEEeCC---CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 46777778999876533 2478888754 2345677788888877433 24454432 233456789999
Q ss_pred ecCCCCHHH----Hh----------cC----CC-------CCChhhH----------HHHHHHHHHHHHHHHh----cCC
Q 040134 560 YMSNGSLAS----FL----------FG----IT-------RPDWNQR----------VQIAFGIARGLMYLHE----ECS 600 (745)
Q Consensus 560 ~~~~gsL~~----~l----------~~----~~-------~~~~~~~----------~~i~~~i~~~L~~LH~----~~~ 600 (745)
|++|..+.. .. +. .. ...|... ......+..++.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 10 10 00 0011110 0011123334444443 123
Q ss_pred CCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 601 ~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
.+++|+|++|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999987789999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00028 Score=56.55 Aligned_cols=48 Identities=25% Similarity=0.403 Sum_probs=36.5
Q ss_pred ccCCCCCCCcccccccCCcChHHHHHhhccCCceeeeEec--CCceEEeccC
Q 040134 340 YENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAAAIYN--GDYCWKKKYP 389 (745)
Q Consensus 340 ~~~~~~p~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~y~--~~~C~~~~~~ 389 (745)
+++++++..+.... ...+.++|++.|+.+|+|.||.|+ .+.|+++...
T Consensus 9 ~~~~~~~g~d~~~~--~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 9 GSNVDFRGGDLSTV--FASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred cCCCccccCCccee--ecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 34666665544433 356999999999999999999995 4789998764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0025 Score=61.33 Aligned_cols=136 Identities=24% Similarity=0.375 Sum_probs=93.0
Q ss_pred CCCcCccCHHHHHHHHhcchhhcCccee-EEEEEEEeeCCCcEEEEEEEccc---ccc------------------cCHH
Q 040134 467 ATNVRSFTYKELEEATRGFRQILGRGAF-GTVYKGVLASDSKRFVAIKKLDK---VEQ------------------QGEK 524 (745)
Q Consensus 467 ~~~~~~~~~~~l~~~~~~~~~~Ig~G~~-g~V~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~ 524 (745)
.+.+.+|+.. ....+|.+.||.|.- |.||++... ++.+|+|.++. ... ....
T Consensus 26 gPKL~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 26 GPKLEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CCCcCCcCCC---CCcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 4456667662 256678899999999 999999985 45799999321 000 1123
Q ss_pred HHHHHHHHHhccC---CCCc--eeEEEEEecC------------------CeEEEEEEecCCCCHHHHhcCCCCCChhhH
Q 040134 525 EFRTEVSVIGQTH---HKNL--VRLLGFCDEG------------------DHRLLVYEYMSNGSLASFLFGITRPDWNQR 581 (745)
Q Consensus 525 ~~~~E~~~l~~l~---h~nI--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 581 (745)
-|..|.+...+|+ +.++ ++.+||..-. ....||.||++... ...
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~ 166 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ 166 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc
Confidence 5788999888884 4456 9999987321 12346777765432 122
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 582 ~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
.+-+.+|.+-|..+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 3345667777888885 49999999999986 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0075 Score=65.06 Aligned_cols=76 Identities=14% Similarity=0.187 Sum_probs=53.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-----c--ccCHHHHHHHHHHHhccC---CCCceeEEEEEecCCeEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-----E--QQGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l 556 (745)
+.||.|.+..||++....+ .+.|+||.-... . +...+....|.+.|+.+. -.++++++.+ +.+..++
T Consensus 32 ~elggGn~N~VyrV~~~~g-~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEG-GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCCC-CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999987643 246999985321 1 123456777888888762 3457777776 3456789
Q ss_pred EEEecCCCC
Q 040134 557 VYEYMSNGS 565 (745)
Q Consensus 557 v~e~~~~gs 565 (745)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0022 Score=75.29 Aligned_cols=154 Identities=21% Similarity=0.175 Sum_probs=110.5
Q ss_pred HHHHHHHHHhccCCCCceeEEEEEecCCeEE----EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCC
Q 040134 525 EFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL----LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600 (745)
Q Consensus 525 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 600 (745)
....|++.+.++.|+|++.++.|..+....- +..|++..-++...+......+....+.+..++.+||+|+|..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 3445777788889999999999886654333 3457788888888888778888999999999999999999965
Q ss_pred CCeeeCCCCCC---CEEECCCCceEEe--eccCcccccccccccccccccccccccchhccccCCCCcc--chhHHHHHH
Q 040134 601 TQIIHCDIKPQ---NILLDDYFTPRIS--DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK--VDVYSFGVL 673 (745)
Q Consensus 601 ~~ivH~dikp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~--~DvwslG~v 673 (745)
...|.-+..+ +...+..+...+. ||+....+...... ....-+..+.+||.........+ .|+|.+|..
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 3333333333 3334555666666 88888776543321 12234556888888876655544 799999999
Q ss_pred HHHHHhCCCCC
Q 040134 674 LLELICCKSSV 684 (745)
Q Consensus 674 l~elltg~~p~ 684 (745)
+..+..|..+.
T Consensus 382 ~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 382 LLQLSQGEDIS 392 (1351)
T ss_pred HhhhhhcCccc
Confidence 99999887664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0097 Score=63.10 Aligned_cols=138 Identities=10% Similarity=0.129 Sum_probs=75.0
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC--CCceeEEE------EEecCCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH--KNLVRLLG------FCDEGDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~------~~~~~~~~~lv~e 559 (745)
.|..|....+|+.....+ .+++|+... ...+.+..|+..++.|.. -.+.+++. +....+..++++|
T Consensus 29 ~l~~G~~n~~y~v~t~~g---~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG---EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred hhccccccceEEEEeCCC---cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 466777778998775432 378887652 123444455566555532 12334332 1223556789999
Q ss_pred ecCCCCHHH-----------Hh---cCC-C----------CCCh-hhHHH------------HHHH-HHHHHHHHHhc--
Q 040134 560 YMSNGSLAS-----------FL---FGI-T----------RPDW-NQRVQ------------IAFG-IARGLMYLHEE-- 598 (745)
Q Consensus 560 ~~~~gsL~~-----------~l---~~~-~----------~~~~-~~~~~------------i~~~-i~~~L~~LH~~-- 598 (745)
|++|..+.. .| +.. . .+.+ ..... .+.+ +...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875321 11 100 0 0001 11110 1111 11122222211
Q ss_pred --CCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 599 --CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 599 --~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...+++|+|++|.||+++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 245899999999999999776668999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0082 Score=63.25 Aligned_cols=140 Identities=14% Similarity=0.193 Sum_probs=80.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCC--CceeEEEEE------ecCCeEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHK--NLVRLLGFC------DEGDHRLLVY 558 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~------~~~~~~~lv~ 558 (745)
+.++.|....+|+.... ++ .+++|+.... .....+..|++++..|... .+++++... ...+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t~--~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD--VG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEeC--CC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 34677777889987643 23 3667876432 1234556677777776422 244444421 2245678999
Q ss_pred EecCCCCHHH-----------H---hcCC-CC-----------CChhhHH------------HHHHHHHHHHHHHHh---
Q 040134 559 EYMSNGSLAS-----------F---LFGI-TR-----------PDWNQRV------------QIAFGIARGLMYLHE--- 597 (745)
Q Consensus 559 e~~~~gsL~~-----------~---l~~~-~~-----------~~~~~~~------------~i~~~i~~~L~~LH~--- 597 (745)
||++|..+.. . ++.. .. ..|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998855321 1 1110 00 0111100 011123334555542
Q ss_pred -cCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 598 -ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 598 -~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
....+++|+|+++.||++++++...|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2246899999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0084 Score=63.00 Aligned_cols=139 Identities=22% Similarity=0.251 Sum_probs=80.5
Q ss_pred hcCcceeEEEEEEEeeCC-----CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC-ceeEEEEEecCCeEEEEEEec
Q 040134 488 ILGRGAFGTVYKGVLASD-----SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN-LVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+..|-...+|+.....+ .++.+++|+..... .......+|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 345566668888775431 13568888865432 23345678888888874333 3455655542 3589999
Q ss_pred CCCCHHHH-h----------------cCCC-CC--------C--hhhHHH--------------------------HHHH
Q 040134 562 SNGSLASF-L----------------FGIT-RP--------D--WNQRVQ--------------------------IAFG 587 (745)
Q Consensus 562 ~~gsL~~~-l----------------~~~~-~~--------~--~~~~~~--------------------------i~~~ 587 (745)
+|..+... + +... .. + +..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88776431 1 1110 00 0 000000 1112
Q ss_pred HHHHHHHHHh------cCCCCeeeCCCCCCCEEECCC----CceEEeeccCccc
Q 040134 588 IARGLMYLHE------ECSTQIIHCDIKPQNILLDDY----FTPRISDFGLAKL 631 (745)
Q Consensus 588 i~~~L~~LH~------~~~~~ivH~dikp~NIll~~~----~~~kl~Dfg~a~~ 631 (745)
+...+..|.. .....++|+|+.+.||+++++ +.+.|+||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334432 124579999999999999885 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.017 Score=61.83 Aligned_cols=138 Identities=17% Similarity=0.199 Sum_probs=79.7
Q ss_pred cCcceeEEEEEEEeeCC---CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc-eeEEEEEecCCeEEEEEEecCCC
Q 040134 489 LGRGAFGTVYKGVLASD---SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL-VRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g 564 (745)
|..|-.-.+|+.....+ ..+.+++|+........ -.-.+|..+++.+...++ .++++.+..+ .|.||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44566778888765332 23568888875533222 233678888888854444 4566665433 579999877
Q ss_pred CHHHH-----------------hcCCCC-----C-ChhhHHHHHHH-----------------HHHHHHHHHh-----cC
Q 040134 565 SLASF-----------------LFGITR-----P-DWNQRVQIAFG-----------------IARGLMYLHE-----EC 599 (745)
Q Consensus 565 sL~~~-----------------l~~~~~-----~-~~~~~~~i~~~-----------------i~~~L~~LH~-----~~ 599 (745)
+|... ++.... . .+..+.++..+ +...+..|.+ ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 111110 1 12222222211 1111222221 12
Q ss_pred CCCeeeCCCCCCCEEECC-CCceEEeeccCccc
Q 040134 600 STQIIHCDIKPQNILLDD-YFTPRISDFGLAKL 631 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~ 631 (745)
...++|+|+++.||++++ ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 47899999988764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.017 Score=55.64 Aligned_cols=150 Identities=19% Similarity=0.185 Sum_probs=89.6
Q ss_pred eeEEEEEEEeeCCCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhc
Q 040134 493 AFGTVYKGVLASDSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571 (745)
Q Consensus 493 ~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 571 (745)
+-++.-.+..+-+ +..+|++....-. ...-|.++.+++++++ .|+++.. .....+-+|.|+|-....
T Consensus 74 gNsTl~~~kt~iG---~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG---PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CceEEEEeccccc---hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-----
Confidence 3344444443332 2667777553333 4466788888888875 4566652 234456688898843110
Q ss_pred CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccccccccc
Q 040134 572 GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651 (745)
Q Consensus 572 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 651 (745)
. -..++..=+.+|.-.|.. +.+.+|||..|+||+-|..|.+||.|=+....- +.-|.
T Consensus 142 -------~-~~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~v 198 (308)
T PF07387_consen 142 -------N-FSNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMV 198 (308)
T ss_pred -------c-hhHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEE
Confidence 0 012222224678888866 679999999999999999999999997654210 01111
Q ss_pred chhccccCCCCccchhHHHHHHHHHHHhC
Q 040134 652 APEWFRKASITVKVDVYSFGVLLLELICC 680 (745)
Q Consensus 652 aPE~~~~~~~s~~~DvwslG~vl~elltg 680 (745)
-- .....++++.+=+|=.-+++++..
T Consensus 199 N~---~Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 199 NI---EYESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred ee---eccccChHHHHHHHHHHHHHHHHH
Confidence 10 112346667776666666666643
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.038 Score=57.52 Aligned_cols=136 Identities=21% Similarity=0.240 Sum_probs=78.2
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcc-cccccCHHHHHHHHHHHhccCC--CCceeEEEEEecCC--eEEEEEEecCC
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQTHH--KNLVRLLGFCDEGD--HRLLVYEYMSN 563 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~--~~~lv~e~~~~ 563 (745)
+..|..-.+|..... ++..++++-. ...........+|.++++.+.- --+.+.++.|.++. ..+.||+|.++
T Consensus 33 ~~~G~sn~t~~~~~~---~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 33 ISGGWSNDTFRLGDT---GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred ccCCcccceEEEecC---CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 333433444444432 3446666211 1222334556778888877743 34556677777766 67999999988
Q ss_pred CCHHHHhcCCCCCChhhHHHHH-HHHHHHH--------------------------------------------------
Q 040134 564 GSLASFLFGITRPDWNQRVQIA-FGIARGL-------------------------------------------------- 592 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~-~~i~~~L-------------------------------------------------- 592 (745)
..+.+.+..... . .+++ ..+++.|
T Consensus 110 e~~~~~~~~~~~---~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 110 EVVWSALPPESL---G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred eeccCcCCcccc---h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 433222211000 0 0111 1333333
Q ss_pred HHHHhcC-----CCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 593 MYLHEEC-----STQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 593 ~~LH~~~-----~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
.+|++.. ...++|||+++.||+++++.-+-++||+++..-
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3444321 245999999999999999988999999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.072 Score=57.37 Aligned_cols=79 Identities=16% Similarity=0.149 Sum_probs=51.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc----cc---cCHHHHHHHHHHHhccC---CCCceeEEEEEecCCeEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV----EQ---QGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l 556 (745)
+.||.|....||+.... +..++||+-... .. .....-..|++.|+.+. ...+++++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~~---~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS---SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEcC---CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 46899999999997753 234889986411 11 12334445566666553 357888888887 44678
Q ss_pred EEEecCC--CCHHHHh
Q 040134 557 VYEYMSN--GSLASFL 570 (745)
Q Consensus 557 v~e~~~~--gsL~~~l 570 (745)
+||++++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999976 3454444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.078 Score=56.06 Aligned_cols=80 Identities=18% Similarity=0.126 Sum_probs=49.5
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccc-------cccCHHHHHHHHHHHhccC--CC-CceeEEEEEecCCeEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-------EQQGEKEFRTEVSVIGQTH--HK-NLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv 557 (745)
.||.|....||++.... +.+.|+||.-... -+-..+....|.+.|+... -| .+++++.+ ++....+|
T Consensus 2 EigdGnlN~VfrV~~~~-g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE-GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCC-CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 57999999999999753 2356999985321 1223345556777776652 34 45555543 44556799
Q ss_pred EEecCC-CCHHHHh
Q 040134 558 YEYMSN-GSLASFL 570 (745)
Q Consensus 558 ~e~~~~-gsL~~~l 570 (745)
||+++. ..|...|
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 999864 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.066 Score=55.36 Aligned_cols=72 Identities=14% Similarity=0.253 Sum_probs=46.2
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC---CCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+++++++....+..+||+||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 357888889999876 244568888865 333467888988888883 45688899998887788999999986
Q ss_pred C
Q 040134 564 G 564 (745)
Q Consensus 564 g 564 (745)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.0042 Score=74.64 Aligned_cols=157 Identities=10% Similarity=-0.069 Sum_probs=108.2
Q ss_pred HHHHHHHHhccCCCCceeEEEEEe--cCCeEEEEEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcC
Q 040134 526 FRTEVSVIGQTHHKNLVRLLGFCD--EGDHRLLVYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEEC 599 (745)
Q Consensus 526 ~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~ 599 (745)
...|...++...|+++.....-.. +....+..++|+..|.+.+.|.+. ..++..-......+......-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 334444555667888776554332 334567889999999999988654 22233333333333355555555432
Q ss_pred --CCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHH
Q 040134 600 --STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677 (745)
Q Consensus 600 --~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~el 677 (745)
+.--+|+++|+-|.+|..+.++|+.++|+.+....... ......+++-|++|++...-+++.++|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 22368999999999999999999999999983322211 12334567789999999888899999999999999999
Q ss_pred HhCCCCC
Q 040134 678 ICCKSSV 684 (745)
Q Consensus 678 ltg~~p~ 684 (745)
.-|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.022 Score=56.26 Aligned_cols=31 Identities=29% Similarity=0.426 Sum_probs=22.1
Q ss_pred CCeeeCCCCCCCEEE-CCCCceEEeeccCccc
Q 040134 601 TQIIHCDIKPQNILL-DDYFTPRISDFGLAKL 631 (745)
Q Consensus 601 ~~ivH~dikp~NIll-~~~~~~kl~Dfg~a~~ 631 (745)
.-++|+|+.|.||++ +.++.++|+||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 368999999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.0098 Score=60.62 Aligned_cols=134 Identities=13% Similarity=0.096 Sum_probs=86.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc--c-------cc--------c-----CHHHHHHHHHHHhccC-C-
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--V-------EQ--------Q-----GEKEFRTEVSVIGQTH-H- 538 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~--~-------~~--------~-----~~~~~~~E~~~l~~l~-h- 538 (745)
+.+.+.||-|.-+.||.+....+ .+.++|.-+. . .. . .+-...+|...++.|. |
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G--~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG--NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecCCC--CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 44678999999999999987643 4466664211 0 00 0 1123456777777774 2
Q ss_pred CCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 040134 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 539 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~ 618 (745)
--+++.+++ +..++|||++.+-.|...-+- .+.. .+...+..-+.-|. ..|+||+|..-=||+++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHH---HcCceecccchheeEEecC
Confidence 234555544 456789999988777655321 1222 23333334444555 3499999999999999999
Q ss_pred CceEEeeccCccc
Q 040134 619 FTPRISDFGLAKL 631 (745)
Q Consensus 619 ~~~kl~Dfg~a~~ 631 (745)
+.++++||--...
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999965443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.12 Score=53.30 Aligned_cols=31 Identities=32% Similarity=0.556 Sum_probs=25.8
Q ss_pred CCeeeCCCCCCCEEECCCCc-eEEeeccCccc
Q 040134 601 TQIIHCDIKPQNILLDDYFT-PRISDFGLAKL 631 (745)
Q Consensus 601 ~~ivH~dikp~NIll~~~~~-~kl~Dfg~a~~ 631 (745)
..++|+|++|.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.1 Score=55.55 Aligned_cols=139 Identities=15% Similarity=0.243 Sum_probs=77.9
Q ss_pred hcCcceeEEEEEEEeeCCC--cEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc-eeEEEEEecCCeEEEEEEecCCC
Q 040134 488 ILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL-VRLLGFCDEGDHRLLVYEYMSNG 564 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g 564 (745)
.|..|-.-.+|+....... ...|++|+....... .-.-.+|..+++.+...++ +++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 3445666778887654321 235888887543322 2234678888888865555 4566665322 589999876
Q ss_pred CHHHH-------h----------cCCCC-----C-ChhhHHHHHHH----------------------HHHHHHHHHhc-
Q 040134 565 SLASF-------L----------FGITR-----P-DWNQRVQIAFG----------------------IARGLMYLHEE- 598 (745)
Q Consensus 565 sL~~~-------l----------~~~~~-----~-~~~~~~~i~~~----------------------i~~~L~~LH~~- 598 (745)
.|..- + +.... + -+..+.++..+ +..-+..+.+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 1 11110 1 12222222211 11112222211
Q ss_pred ----CCCCeeeCCCCCCCEEECC-CCceEEeeccCccc
Q 040134 599 ----CSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKL 631 (745)
Q Consensus 599 ----~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~ 631 (745)
...-++|+|+.+.||++++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1124899999999999974 57899999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 745 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-35 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-22 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-21 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-21 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-124
Identities = 120/285 (42%), Positives = 165/285 (57%), Gaps = 12/285 (4%)
Query: 469 NVRSFTYKELEEATRGFRQ--ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG-EKE 525
++ F+ +EL+ A+ F ILGRG FG VYKG LA + VA+K+L + QG E +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL--VAVKRLKEERTQGGELQ 73
Query: 526 FRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP----DWNQR 581
F+TEV +I H+NL+RL GFC RLLVY YM+NGS+AS L DW +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+IA G ARGL YLH+ C +IIH D+K NILLD+ F + DFGLAKL+ + T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 192
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEA--LMDWV 699
T +RGT+G+ APE+ + K DV+ +GV+LLELI + + ++ L+DWV
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 700 YRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
K L+ L + D + + VE+L+ VAL C Q RP
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-116
Identities = 108/298 (36%), Positives = 152/298 (51%), Gaps = 28/298 (9%)
Query: 464 SPSATNVRSFTYKELEEATRGFRQ--------ILGRGAFGTVYKGVLASDSKRFVAIKKL 515
S T SF++ EL+ T F + +G G FG VYKG + ++ VA+KKL
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTT-VAVKKL 62
Query: 516 DKVE----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571
+ ++ +++F E+ V+ + H+NLV LLGF +GD LVY YM NGSL L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 572 GITRP---DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGL 628
+ W+ R +IA G A G+ +LHE IH DIK NILLD+ FT +ISDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179
Query: 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT 688
A+ + I GT Y APE R IT K D+YSFGV+LLE+I +V
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 689 TNPEEALMDWVYRCYI-GKNLDKLAENDEEVKN-DLKRVERLVMVALWCIQEDASLRP 744
+ L+D K ++ D+++ + D VE + VA C+ E + RP
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYI--DKKMNDADSTSVEAMYSVASQCLHEKKNKRP 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-113
Identities = 106/290 (36%), Positives = 154/290 (53%), Gaps = 11/290 (3%)
Query: 461 SVSSPSATNVRSFTYKELEEATRGFRQ--ILGRGAFGTVYKGVLASDSKRFVAIKKLDKV 518
S S +LEEAT F ++G G FG VYKGVL VA+K+
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL--RDGAKVALKRRTPE 74
Query: 519 EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-- 576
QG +EF TE+ + H +LV L+GFCDE + +L+Y+YM NG+L L+G P
Sbjct: 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134
Query: 577 --DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634
W QR++I G ARGL YLH IIH D+K NILLD+ F P+I+DFG++K
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEA 694
T ++GT+GY PE+F K +T K DVYSFGV+L E++C +S++V
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 695 LMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
L +W + L+++ + + K + + + A+ C+ + RP
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-71
Identities = 76/309 (24%), Positives = 122/309 (39%), Gaps = 41/309 (13%)
Query: 466 SATNVRSFTYKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE 523
++ + L + + ++ RG FG V+K L + +VA+K ++Q
Sbjct: 7 HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN---EYVAVKIFPIQDKQSW 63
Query: 524 KEFRTEVSVIGQTHHKNLVRLLGFCDEGDH----RLLVYEYMSNGSLASFLFGITRPDWN 579
+ EV + H+N+++ +G G L+ + GSL+ FL WN
Sbjct: 64 -QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWN 121
Query: 580 QRVQIAFGIARGLMYLHEECSTQ-------IIHCDIKPQNILLDDYFTPRISDFGLAKLL 632
+ IA +ARGL YLHE+ I H DIK +N+LL + T I+DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 633 LAEQTQAARTGIRGTVGYFAPEWFRKA-----SITVKVDVYSFGVLLLELICCKSSVVFG 687
A ++ G GT Y APE A +++D+Y+ G++L EL ++
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 688 TTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKR------------VERLVMVALWC 735
+ + L + E V + KR + L C
Sbjct: 242 VDEYMLPFEEEI------GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 736 IQEDASLRP 744
DA R
Sbjct: 296 WDHDAEARL 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-60
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 16/212 (7%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKEFRTEVSV 532
+ +L ++ +G G+FGTV++ VA+K L + EF EV++
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWHG---SDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 533 IGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIA 589
+ + H N+V +G + + +V EY+S GSL L D +R+ +A+ +A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
+G+ YLH + I+H ++K N+L+D +T ++ DFGL++L T + GT
Sbjct: 148 KGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPE 204
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
+ APE R K DVYSFGV+L EL +
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-58
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIG 534
YKE+E +++GRGAFG V K + VAIK+++ + K F E+ +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW---RAKDVAIKQIE--SESERKAFIVELRQLS 56
Query: 535 QTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARG 591
+ +H N+V+L G C + LV EY GSL + L G + ++G
Sbjct: 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 592 LMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
+ YLH +IH D+KP N+LL +I DFG A + Q T +G+ +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAW 169
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCK 681
APE F ++ + K DV+S+G++L E+I +
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-57
Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKL----DKVEQQGEKEFRTEV 530
+ EL +I+G G FG VY+ D VA+K D+ Q + R E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEA 57
Query: 531 SVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR 590
+ H N++ L G C + + LV E+ G L L G R + V A IAR
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIAR 116
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPR--------ISDFGLAKLLLAEQTQAART 642
G+ YLH+E IIH D+K NIL+ I+DFGLA+ E + +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKM 172
Query: 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
G + APE R + + DV+S+GVLL EL+ +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-57
Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHKNLV 542
Q +G G+FGTVYKG D VA+K L Q + F+ EV V+ +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECST 601
+G+ +V ++ SL L + + + IA ARG+ YLH +
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AK 139
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
IIH D+K NI L + T +I DFGLA + G++ + APE R
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 662 ---TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN-DEE 717
+ + DVY+FG++L EL+ + + + N + +++ V R + +L K+ N +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
+K + C+++ RP
Sbjct: 258 MKRLMAE----------CLKKKRDERP 274
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-57
Identities = 78/309 (25%), Positives = 118/309 (38%), Gaps = 44/309 (14%)
Query: 473 FTYKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEV 530
E + +++GRG +G VYKG L +R VA+K + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSF---ANRQNFINEK 56
Query: 531 SV--IGQTHHKNLVRLLGFCDEGD-----HRLLVYEYMSNGSLASFLFGITRPDWNQRVQ 583
++ + H N+ R + + LLV EY NGSL +L DW +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCR 115
Query: 584 IAFGIARGLMYLHEECST------QIIHCDIKPQNILLDDYFTPRISDFGLAKLL----- 632
+A + RGL YLH E I H D+ +N+L+ + T ISDFGL+ L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 633 -LAEQTQAARTGIRGTVGYFAPEWFRKA-------SITVKVDVYSFGVLLLELIC-CKSS 683
+ A GT+ Y APE A S +VD+Y+ G++ E+ C
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 684 VVFGTTNPEE-ALMDWVYRCYIGKNLDKLAEND-------EEVKNDLKRVERLVMVALWC 735
+ + A V +++ L + E K + V L C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 736 IQEDASLRP 744
+DA R
Sbjct: 296 WDQDAEARL 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 29/234 (12%)
Query: 463 SSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG 522
S + + + E+E + + +G+G FG V+KG L D K VAIK L + +G
Sbjct: 6 SEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKD-KSVVAIKSLILGDSEG 59
Query: 523 E-------KEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITR 575
E +EF+ EV ++ +H N+V+L G +V E++ G L L
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 576 P-DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-----FTPRISDFGLA 629
P W+ ++++ IA G+ Y+ + I+H D++ NI L +++DFGL+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASI--TVKVDVYSFGVLLLELICCK 681
+ + + +G+ G + APE T K D YSF ++L ++ +
Sbjct: 177 Q----QSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 6e-55
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSV 532
+K+L F L G ++KG + +K L + + ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 533 IGQTHHKNLVRLLGFCDE--GDHRLLVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGI 588
+ H N++ +LG C H L+ +M GSL + L T D +Q V+ A +
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
ARG+ +LH I + +++++D+ T RIS + G
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAP 172
Query: 649 GYFAPEWFRKA---SITVKVDVYSFGVLLLELICCK 681
+ APE +K + D++SF VLL EL+ +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-55
Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 51/309 (16%)
Query: 456 KKLLRSVSSPSATNVRSFT--YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIK 513
+ +S ++ ++ + +++LE +++G+G FG VY G + VAI+
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLE-----IGELIGKGRFGQVYHGRWHGE----VAIR 61
Query: 514 KLDKVEQQGE--KEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571
+D + K F+ EV QT H+N+V +G C H ++ +L S +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 572 GITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
D N+ QIA I +G+ YLH + I+H D+K +N+ D+ I+DFGL
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFS 177
Query: 631 LLLAEQTQAAR---TGIRGTVGYFAPEWFRKASI---------TVKVDVYSFGVLLLELI 678
+ Q G + + APE R+ S + DV++ G + EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 679 CCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL---AENDEEVKNDLKRVERLVMVALWC 735
+ F T E + W +G + +E+ + L C
Sbjct: 238 ARE--WPFKTQPAEAII--WQ----MGTGMKPNLSQIGMGKEISDILLF----------C 279
Query: 736 IQEDASLRP 744
+ RP
Sbjct: 280 WAFEQEERP 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-54
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
++LG+G FG K + + +K+L + +++ ++ F EV V+ H N+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGE-VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQI 603
+G + + EY+ G+L + + W+QRV A IA G+ YLH S I
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA------------ARTGIRGTVGYF 651
IH D+ N L+ + ++DFGLA+L++ E+TQ R + G +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 652 APEWFRKASITVKVDVYSFGVLLLELICCK 681
APE S KVDV+SFG++L E+I
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 26/218 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSV--IGQTHHKNLV 542
+ +G+G +G V++G VA+K + EK + E + H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSW---QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENIL 65
Query: 543 RLLGFCDEGDHR----LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
+ H L+ Y GSL +L T D ++I IA GL +LH E
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIE 124
Query: 599 CSTQ-----IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT--QAARTGIRGTVGYF 651
I H D+K +NIL+ I+D GLA + GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 652 APEWFRKASITV------KVDVYSFGVLLLELICCKSS 683
APE + +VD+++FG++L E+ S
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G+G +G V+ G VA+K E+ TE+ H+N++
Sbjct: 41 MVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGF 96
Query: 545 LGFCDEGDHR----LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
+ +G L+ +Y NGSL +L T D +++A+ GL +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 601 TQ-----IIHCDIKPQNILLDDYFTPRISDFGLAKLLLA--EQTQAARTGIRGTVGYFAP 653
+ I H D+K +NIL+ T I+D GLA ++ + GT Y P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 654 EWFRKASITV------KVDVYSFGVLLLELICCKSS 683
E ++ D+YSFG++L E+ S
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 26/218 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSV--IGQTHHKNLV 542
++ +G+G FG V++G VA+K + E+ + E + H+N++
Sbjct: 46 LQESIGKGRFGEVWRGKW---RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENIL 99
Query: 543 RLLGFC----DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
+ LV +Y +GSL +L T +++A A GL +LH E
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 158
Query: 599 CSTQ-----IIHCDIKPQNILLDDYFTPRISDFGLAKLL--LAEQTQAARTGIRGTVGYF 651
I H D+K +NIL+ T I+D GLA + A GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 652 APEWFRKASITV------KVDVYSFGVLLLELICCKSS 683
APE + + D+Y+ G++ E+ S
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 28/267 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLV 542
F +GRG+F TVYKG L +++ VA + K+ + + F+ E ++ H N+V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 543 RLLGFC---DEGDHRLLVY-EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
R +G +++ E M++G+L ++L I +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 599 CSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
+ IIH D+K NI + + +I D GLA L + + GT + APE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY- 202
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
+ VDVY+FG+ +LE+ + + + V + DK+A E
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVA--IPE 258
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
VK ++ CI+++ R
Sbjct: 259 VKEIIEG----------CIRQNKDERY 275
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+ +GRG FG V+ G L +D+ VA+K + + + +F E ++ Q H N+VR
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
L+G C + +V E + G +FL R +Q+ A G+ YL +
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-----IRGTVGYFAPEWFR 657
IH D+ +N L+ + +ISDFG+++ + AA G ++ T APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWT----APEALN 288
Query: 658 KASITVKVDVYSFGVLLLELI 678
+ + DV+SFG+LL E
Sbjct: 289 YGRYSSESDVWSFGILLWETF 309
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-40
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 8/210 (3%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G +G VY+GV S VA+K L K + +EF E +V+ + H NLV+L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLT-VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
LG C ++ E+M+ G+L +L + +A I+ + YL ++
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH ++ +N L+ + +++DFGL++L+ T A G + + + APE +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+K DV++FGVLL E+ S G +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 470 VRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRF---VAIKKL-DKVEQQGEKE 525
++ + +E ++LG G FGTV+KGV + + V IK + DK +Q +
Sbjct: 3 MKVLA-RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 526 FRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQI 584
+ IG H ++VRLLG C G LV +Y+ GSL + +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
IA+G+ YL E ++H ++ +N+LL +++DFG+A LL + Q +
Sbjct: 121 GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ + + A E T + DV+S+GV + EL+
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF---VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKN 540
++LG GAFGTVYKG+ + ++ VAIK+L + + KE E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEEC 599
+ RLLG C L+ + M G L ++ + IA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
++H D+ +N+L+ +I+DFGLAKLL AE+ + G + + + A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 660 SITVKVDVYSFGVLLLELI 678
T + DV+S+GV + EL+
Sbjct: 195 IYTHQSDVWSYGVTVWELM 213
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F Q +G G FG V+ G + K VAIK + + E++F E V+ + H LV+L
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDK--VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
G C E LV E+M +G L+ +L + + + G+ YL E +
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFRKAS 660
IH D+ +N L+ + ++SDFG+ + +L +Q ++ ++ +PE F +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181
Query: 661 ITVKVDVYSFGVLLLELI 678
+ K DV+SFGVL+ E+
Sbjct: 182 YSSKSDVWSFGVLMWEVF 199
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-39
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG+G FG V+ G ++ VAIK L K + F E V+ + H+ LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
E + +V EYMS GSL FL Q V +A IA G+ Y+
Sbjct: 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+H D++ NIL+ + +++DFGLA+ L+ + AR G + + + APE T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+K DV+SFG+LL EL G N E
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNRE 389
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG+G FG V+ G ++ VAIK L K + F E V+ + H+ LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
E + +V EYMS GSL FL Q V +A IA G+ Y+
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+H D++ NIL+ + +++DFGLA+ L+ + AR G + + + APE T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPE 692
+K DV+SFG+LL EL G N E
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNRE 472
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 12/221 (5%)
Query: 463 SSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG 522
S+ + E G R +LG+G +G VY G ++ +AIK++ + + +
Sbjct: 4 STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRY 62
Query: 523 EKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL---FGITRPDWN 579
+ E+++ HKN+V+ LG E + E + GSL++ L +G + +
Sbjct: 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ 122
Query: 580 QRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQTQ 638
I GL YLH+ QI+H DIK N+L++ Y +ISDFG +K L
Sbjct: 123 TIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGIN 177
Query: 639 AARTGIRGTVGYFAPEWFRKASI--TVKVDVYSFGVLLLEL 677
GT+ Y APE K D++S G ++E+
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 10/225 (4%)
Query: 456 KKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKL 515
+KL S E+ + + LG G FG V+ +K VA+K +
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTM 220
Query: 516 DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF--GI 573
K + F E +V+ H LV+L + + ++ E+M+ GSL FL
Sbjct: 221 -KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG 278
Query: 574 TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633
++ + + + IA G+ ++ + IH D++ NIL+ +I+DFGLA+++
Sbjct: 279 SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335
Query: 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ AR G + + + APE S T+K DV+SFG+LL+E++
Sbjct: 336 -DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F + LG G FG V G VAIK + K E EF E V+ H+ LV+L
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD--VAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
G C + ++ EYM+NG L ++L R Q +++ + + YL + Q
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFRKAS 660
+H D+ +N L++D ++SDFGL++ +L ++ ++ +R + PE +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSK 197
Query: 661 ITVKVDVYSFGVLLLELI 678
+ K D+++FGVL+ E+
Sbjct: 198 FSSKSDIWAFGVLMWEIY 215
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G FG V G + VA+K + K E EF E + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKW--KGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
G C + +V EY+SNG L ++L + +Q +++ + + G+ +L Q
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFRKAS 660
IH D+ +N L+D ++SDFG+ + +L +Q ++ ++ + APE F
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 661 ITVKVDVYSFGVLLLELI 678
+ K DV++FG+L+ E+
Sbjct: 182 YSSKSDVWAFGILMWEVF 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 75/287 (26%), Positives = 124/287 (43%), Gaps = 34/287 (11%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGV---LASDSKRFVAIKKLDKVEQQGEKEFRTEVSVI 533
+ EE F Q LG+G FG+V L ++ VA+KKL ++ ++F E+ ++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 534 GQTHHKNLVRLLGFCDEGDHR--LLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIAR 590
H N+V+ G C R L+ EY+ GSL +L R D + +Q I +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTGIRGTVG 649
G+ YL + + IH D+ +NIL+++ +I DFGL K+L ++ + +
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709
++APE ++ +V DV+SFGV+L EL T + + IG +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELF---------TYIEKSKSPPAEFMRMIGNDKQ 233
Query: 710 KLAENDEEVKNDLKRVERL------------VMVALWCIQEDASLRP 744
+ LK RL +M W + + RP
Sbjct: 234 GQMIV-FHLIELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRP 277
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 30/251 (11%)
Query: 450 AYLFYHKKLLRSVSSPSATNVRSFTYKELEEATRGF-----------RQILGRGAFGTVY 498
+Y +H + + + + +A F ++++G G FG VY
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVY 61
Query: 499 KGVLASDSKRF---VAIKKL--DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553
KG+L + S + VAIK L E+Q +F E ++GQ H N++RL G +
Sbjct: 62 KGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120
Query: 554 RLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQN 612
+++ EYM NG+L FL Q V + GIA G+ YL +H D+ +N
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARN 177
Query: 613 ILLDDYFTPRISDFGLAKLLLA-EQTQAARTG----IRGTVGYFAPEWFRKASITVKVDV 667
IL++ ++SDFGL+++L + +G IR T APE T DV
Sbjct: 178 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSASDV 233
Query: 668 YSFGVLLLELI 678
+SFG+++ E++
Sbjct: 234 WSFGIVMWEVM 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 72/214 (33%), Positives = 111/214 (51%), Gaps = 20/214 (9%)
Query: 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKR--FVAIKKL-DKVEQQGEKEFRTEVSV 532
+E+E + +I+G G G V G L +R VAIK L ++ ++F +E S+
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 533 IGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARG 591
+GQ H N++RL G G ++V EYM NGSL +FL + Q V + G+ G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTG----IRG 646
+ YL + +H D+ +N+L+D ++SDFGL+++L + A TG IR
Sbjct: 164 MRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 647 TVGYFAPE--WFRKASITVKVDVYSFGVLLLELI 678
T APE FR S DV+SFGV++ E++
Sbjct: 221 T----APEAIAFRTFSS--ASDVWSFGVVMWEVL 248
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF---VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKN 540
++LG GAFGTVYKG+ + ++ VAIK+L + + KE E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEEC 599
+ RLLG C L+ + M G L ++ + IA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
++H D+ +N+L+ +I+DFGLAKLL AE+ + G + + + A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 660 SITVKVDVYSFGVLLLELI 678
T + DV+S+GV + EL+
Sbjct: 195 IYTHQSDVWSYGVTVWELM 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF-VAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+ LG G FGTV KG VA+K K + + + E E +V+ Q + +VR
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
++G C E + +LV E G L +L +++ ++ G+ YL E
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTGIRGTVGYFAPEWFRKASIT 662
+H D+ +N+LL +ISDFGL+K L A++ A+T + V ++APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 663 VKVDVYSFGVLLLELI 678
K DV+SFGVL+ E
Sbjct: 199 SKSDVWSFGVLMWEAF 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 38/281 (13%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKR---FVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKN 540
+ LG G FG V + VA+K L + + + E+ ++ +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 541 LVRLLGFC--DEGDHRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHE 597
+V+ G C D G+ L+ E++ +GSL +L + + Q+++ A I +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG- 143
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTGIRGTVGYFAPEWF 656
S Q +H D+ +N+L++ +I DFGL K + ++ + V ++APE
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 657 RKASITVKVDVYSFGVLLLELI-CCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715
++ + DV+SFGV L EL+ C S ++P + + + +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSD-----SSPMALFLKMIGPTHGQMTV------- 249
Query: 716 EEVKNDLKRVERL------------VMVALWCIQEDASLRP 744
+ N LK +RL +M W + S R
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW--EFQPSNRT 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKR---FVAIKKLDKVEQQGEKEFRTEVSV 532
EE + LG+G FG+V VA+K+L +++F+ E+ +
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 533 IGQTHHKNLVRLLGFCDEGDHR--LLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIA 589
+ H +V+ G + LV EY+ +G L FL R D ++ + + I
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ-TQAARTGIRGTV 648
+G+ YL S + +H D+ +NIL++ +I+DFGLAKLL ++ R + +
Sbjct: 138 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELI 678
++APE + + DV+SFGV+L EL
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 8e-38
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G +G VY+GV S VA+K L K + +EF E +V+ + H NLV+L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLT-VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
LG C ++ E+M+ G+L +L + +A I+ + YL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFRKA 659
IH D+ +N L+ + +++DFGL++L+ + A I+ T APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 660 SITVKVDVYSFGVLLLELI 678
++K DV++FGVLL E+
Sbjct: 188 KFSIKSDVWAFGVLLWEIA 206
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 75/287 (26%), Positives = 124/287 (43%), Gaps = 34/287 (11%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGV---LASDSKRFVAIKKLDKVEQQGEKEFRTEVSVI 533
+ EE F Q LG+G FG+V L ++ VA+KKL ++ ++F E+ ++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 534 GQTHHKNLVRLLGFCDEGDHR--LLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIAR 590
H N+V+ G C R L+ EY+ GSL +L R D + +Q I +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AARTGIRGTVG 649
G+ YL + + IH D+ +NIL+++ +I DFGL K+L ++ + +
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709
++APE ++ +V DV+SFGV+L EL T + + IG +
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELF---------TYIEKSKSPPAEFMRMIGNDKQ 264
Query: 710 KLAENDEEVKNDLKRVERL------------VMVALWCIQEDASLRP 744
+ LK RL +M W + + RP
Sbjct: 265 GQMIV-FHLIELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRP 308
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 459 LRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKR--FVAIKKL- 515
L +++ V+ F +++GRG FG VY G L + + A+K L
Sbjct: 68 LSALNPELVQAVQHV-VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 516 DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH-RLLVYEYMSNGSLASFLFGIT 574
+ +F TE ++ H N++ LLG C + L+V YM +G L +F+ T
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 186
Query: 575 R-PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633
P + +A+G+ +L S + +H D+ +N +LD+ FT +++DFGLA+ +
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 634 AEQTQAARTG------IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
++ + ++ A E + T K DV+SFGVLL EL+
Sbjct: 244 DKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 459 LRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRF--VAIKKL- 515
L +++ V+ F +++GRG FG VY G L + + A+K L
Sbjct: 4 LSALNPELVQAVQHVV-IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 516 DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH-RLLVYEYMSNGSLASFLFGIT 574
+ +F TE ++ H N++ LLG C + L+V YM +G L +F+ T
Sbjct: 63 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 122
Query: 575 R-PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633
P + +A+G+ YL S + +H D+ +N +LD+ FT +++DFGLA+ +
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179
Query: 634 ------AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
A+ ++ A E + T K DV+SFGVLL EL+
Sbjct: 180 DKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 38/288 (13%)
Query: 477 ELEEATRGFRQILGRGAFGTVYKGVL---ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSV 532
+ + LG G FG V + VA+K L Q ++ E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 533 IGQTHHKNLVRLLGFCDEGDHR--LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR 590
+ +H+++++ G C++ LV EY+ GSL +L Q + A I
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICE 145
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AARTGIRGTVG 649
G+ YLH + IH D+ +N+LLD+ +I DFGLAK + R V
Sbjct: 146 GMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELI-CCKSSVVFGTTNPEEALMDWVYRCYIGKNL 708
++APE ++ DV+SFGV L EL+ C SS +P ++ + +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS-----QSPPTKFLELIGIAQGQMTV 257
Query: 709 DKLAENDEEVKNDLKRVERL------------VMVALWCIQEDASLRP 744
+ L+R ERL +M W + +AS RP
Sbjct: 258 -------LRLTELLERGERLPRPDKCPAEVYHLMKNCW--ETEASFRP 296
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 485 FRQILGRGAFGTVYKGVL------ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH 538
F + LG+G F ++KGV + V +K LDK + + F S++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHE 597
K+LV G C GD +LV E++ GSL ++L + ++++A +A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPR--------ISDFGLAKLLLAEQTQAARTGIRGTVG 649
+IH ++ +NILL + +SD G++ +L + R I
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER--IPWV-- 184
Query: 650 YFAPEWFRKASI-TVKVDVYSFGVLLLELI 678
PE + D +SFG L E+
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 11/221 (4%)
Query: 464 SPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKR--FVAIKKL--DKVE 519
V F KEL+ +++G G FG V G L SK+ VAIK L E
Sbjct: 29 EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 520 QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDW 578
+Q ++F E S++GQ H N++RL G + ++V EYM NGSL SFL +
Sbjct: 88 KQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
Q V + GIA G+ YL + +H D+ +NIL++ ++SDFGL ++L +
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 639 A-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
A G + + + +PE T DV+S+G++L E++
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G FG V+ G +K VA+K L K F E +++ Q H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK--VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
+ + ++ EYM NGSL FL + N+ + +A IA G+ ++ E
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH D++ NIL+ D + +I+DFGLA+L+ + AR G + + + APE + T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 663 VKVDVYSFGVLLLELI 678
+K DV+SFG+LL E++
Sbjct: 189 IKSDVWSFGILLTEIV 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN 540
++ LG GAFG V+ + K VA+K L K+F+ E ++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-----------------VQ 583
+V+ G C +GD ++V+EYM +G L FL PD +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA-HGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
IA IA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 644 ----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
IR PE T + DV+SFGV+L E+
Sbjct: 195 TMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNL 541
+++G+G FG VY G ++ AIK L E Q + F E ++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 542 VRLLGFCDEGD-HRLLVYEYMSNGSLASFLFGITR-PDWNQRVQIAFGIARGLMYLHEEC 599
+ L+G + ++ YM +G L F+ R P + +ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG------IRGTVGYFAP 653
+ +H D+ +N +LD+ FT +++DFGLA+ +L + + + ++ T A
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197
Query: 654 EWFRKASITVKVDVYSFGVLLLELI 678
E + T K DV+SFGVLL EL+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNL 541
+ILG G FG VY+GV + VA+K +++F +E ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECS 600
V+L+G +E + ++ E G L +L V + I + + YL
Sbjct: 76 VKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFR 657
+H DI +NIL+ ++ DFGL++ + E A I+ +PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187
Query: 658 KASITVKVDVYSFGVLLLELI 678
T DV+ F V + E++
Sbjct: 188 FRRFTTASDVWMFAVCMWEIL 208
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRF-VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
LG G FG+V +GV K+ VAIK L E+ +E E ++ Q + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
L+G C + + +LV E G L FL G + ++ ++ G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AARTGIRGTVGYFAPEWFRKASI 661
+H D+ +N+LL + +ISDFGL+K L A+ + AR+ + + ++APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 662 TVKVDVYSFGVLLLELI 678
+ + DV+S+GV + E +
Sbjct: 191 SSRSDVWSYGVTMWEAL 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNL 541
+ +G G FG V++G+ S VAIK + ++F E + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECS 600
V+L+G E + ++ E + G L SFL D + A+ ++ L YL +
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFR 657
+ +H DI +N+L+ ++ DFGL++ + A G I+ APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190
Query: 658 KASITVKVDVYSFGVLLLELI 678
T DV+ FGV + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-36
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
Q +G+G FG V G VA+K + K + F E SV+ Q H NLV+L
Sbjct: 197 LLQTIGKGEFGDVMLGDY---RGNKVAVKCI-K-NDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 545 LGFCDEGDHRL-LVYEYMSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHEECST 601
LG E L +V EYM+ GSL +L G + + ++ + + + YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+H D+ +N+L+ + ++SDFGL K + + ++ T APE R+
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVKWT----APEALREKKF 363
Query: 662 TVKVDVYSFGVLLLELI 678
+ K DV+SFG+LL E+
Sbjct: 364 STKSDVWSFGILLWEIY 380
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 19/205 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKL---DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG G+FG V +G + S + VA+K L + + +F EV+ + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEE 598
NL+RL G +V E GSL L + A +A G+ YL +
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ-----TQAARTGIRGTVGYFAP 653
+ IH D+ +N+LL +I DFGL + L + + AP
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----AP 193
Query: 654 EWFRKASITVKVDVYSFGVLLLELI 678
E + + + D + FGV L E+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN 540
+ LG GAFG V+ K VA+K L + + ++F+ E ++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFL---------------FGITRPDWNQRVQIA 585
+VR G C EG L+V+EYM +G L FL Q + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-- 643
+A G++YL +H D+ +N L+ +I DFG+++ + +
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 644 --IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
IR PE T + DV+SFGV+L E+
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
F + LG FG VYKG L + + VAIK L DK E +EFR E + + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFL----------------FGITRPDWNQRVQ 583
N+V LLG + +++ Y S+G L FL + + V
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
+ IA G+ YL S ++H D+ +N+L+ D +ISD GL + + A
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 644 ----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
IR APE ++ D++S+GV+L E+
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG GAFG VY+G + S VA+K L + +Q E +F E +I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--------VQIAFGIARG 591
N+VR +G + R ++ E M+ G L SFL TRP +Q + +A IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGLAKLLLAEQTQAARTG----I 644
YL IH DI +N LL +I DFG+A+ + +
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ PE F + T K D +SFGVLL E+
Sbjct: 210 KWM----PPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 485 FRQILGRGAFGTVYKGVLAS----DSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG+G+FG VY+GV + + VAIK + + + EF E SV+ + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFL----------FGITRPDWNQRVQIAFGIA 589
++VRLLG +G L++ E M+ G L S+L + P ++ +Q+A IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG----IR 645
G+ YL+ + + +H D+ +N ++ + FT +I DFG+ + + +R
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+PE + T DV+SFGV+L E+
Sbjct: 206 WM----SPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 37/231 (16%)
Query: 459 LRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKK--LD 516
L+ V V T++ +GRG+FG V++ + A+KK L+
Sbjct: 46 LKPVDYEYREEVHWMTHQPR----------VGRGSFGEVHRM-KDKQTGFQCAVKKVRLE 94
Query: 517 KVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGIT 574
+ E+ +V L G EG + E + GSL + G
Sbjct: 95 VFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 575 RPDWNQRVQIAF---GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP-RISDFGLAK 630
D + + GL YLH +I+H D+K N+LL + + DFG A
Sbjct: 148 PED-----RALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 631 LLLAEQTQAARTG---IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
L + + I GT + APE KVD++S ++L ++
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKN 540
+ILG G FG+V +G L + VA+K KLD Q+ +EF +E + + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 541 LVRLLGFCDEGD-----HRLLVYEYMSNGSLASFL------FGITRPDWNQRVQIAFGIA 589
++RLLG C E +++ +M G L ++L G ++ IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG----IR 645
G+ YL + +H D+ +N +L D T ++DFGL+K + + ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
A E T K DV++FGV + E+
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 23/230 (10%)
Query: 463 SSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG 522
P Y L + +GRG F VY+ VA+KK+ +
Sbjct: 16 FQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMD 72
Query: 523 EKE---FRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD-- 577
K E+ ++ Q +H N+++ E + +V E G L+ + +
Sbjct: 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132
Query: 578 ------WNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631
W VQ+ L ++H +++H DIKP N+ + ++ D GL +
Sbjct: 133 IPERTVWKYFVQLC----SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR- 184
Query: 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
+ +T AA + + GT Y +PE + K D++S G LL E+ +
Sbjct: 185 FFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
Q +G+G FG V G + VA+K + K + F E SV+ Q H NLV+L
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNK---VAVKCI-K-NDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 545 LGFCDEGDHRL-LVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEECST 601
LG E L +V EYM+ GSL +L G + + ++ + + + YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 136
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+H D+ +N+L+ + ++SDFGL K + + ++ T APE R+
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVKWT----APEALREKKF 191
Query: 662 TVKVDVYSFGVLLLELI 678
+ K DV+SFG+LL E+
Sbjct: 192 STKSDVWSFGILLWEIY 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-35
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 19/229 (8%)
Query: 465 PSATNVRSFTYKELEEATRGFRQI-----------LGRGAFGTVYKGVLASDSKRF-VAI 512
P T+V + + EE + LG G FG+V +GV K+ VAI
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 513 KKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF 571
K L E+ +E E ++ Q + +VRL+G C + + +LV E G L FL
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 427
Query: 572 GI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
G + ++ ++ G+ YL E+ +H ++ +N+LL + +ISDFGL+K
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK 484
Query: 631 LLLAEQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
L A+ + AR+ + + ++APE + + DV+S+GV + E +
Sbjct: 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKN 540
++LG+G FG+V + L + F VA+K K D + +EF E + + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 541 LVRLLGFCDEGDHR------LLVYEYMSNGSLASFLFGITRPDWNQR-------VQIAFG 587
+ +L+G + +++ +M +G L +FL +R N V+
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQTLVRFMVD 145
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
IA G+ YL S IH D+ +N +L + T ++DFGL++ + + +
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
V + A E TV DV++FGV + E++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+LG+GAFG V K A D R+ AIKK+ E++ +EV ++ +H+ +VR
Sbjct: 10 EIAVLGQGAFGQVVKARNALD-SRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRY 67
Query: 545 LGFCDEGDHRL-------------LVYEYMSNGSLASFLFGITRPDWNQRVQIA--FG-I 588
E + + + EY NG+L + + QR + F I
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQI 125
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA-------- 640
L Y+H + IIH D+KP NI +D+ +I DFGLAK +
Sbjct: 126 LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 641 ----RTGIRGTVGYFAPE-WFRKASITVKVDVYSFGVLLLELIC 679
T GT Y A E K+D+YS G++ E+I
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG GAFG VY+G + S VA+K L + +Q E +F E +I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--------VQIAFGIARG 591
N+VR +G + R ++ E M+ G L SFL TRP +Q + +A IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGLAKLLLAEQTQAARTG----I 644
YL IH DI +N LL +I DFG+A+ + +
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ PE F + T K D +SFGVLL E+
Sbjct: 251 KWM----PPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-35
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNL 541
+ +G G FG V++G+ S VAIK + ++F E + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECS 600
V+L+G E + ++ E + G L SFL D + A+ ++ L YL S
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG---IRGTVGYFAPEWFR 657
+ +H DI +N+L+ ++ DFGL++ + A G I+ APE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 658 KASITVKVDVYSFGVLLLELI 678
T DV+ FGV + E++
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 485 FRQILGRGAFGTVYKG----VLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-THH 538
F + LG GAFG V + + D+ VA+K L ++ +E+ ++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--------------FGITRPDWNQRVQI 584
+N+V LLG C G L++ EY G L +FL + +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 585 AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGI 644
+ +A+G+ +L S IH D+ +N+LL + +I DFGLA+ ++ + +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
R V + APE TV+ DV+S+G+LL E+
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLL 545
Q LGRG FG V++ D + AIK++ ++ +E EV + + H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNY-AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 546 GFCDEGD---------HRLLVY---EYMSNGSLASFLF---GITRPDWNQRVQIAFGIAR 590
E + ++ +Y + +L ++ I + + + I IA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL----------LAEQTQAA 640
+ +LH S ++H D+KP NI ++ DFGL + A
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
TG GT Y +PE S + KVD++S G++L EL+
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNL--V 542
+ +G G V++ + ++ K+ AIK ++ + Q +R E++ + + + +
Sbjct: 34 KQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
RL + + +V E N L S+L D +R + + +H+
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-------- 654
I+H D+KP N L+ D ++ DFG+A + + T + GTV Y PE
Sbjct: 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 655 ---WFRKASITVKVDVYSFGVLLLELICCK 681
K+ I+ K DV+S G +L + K
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 485 FRQILGRGAFGTVYKG----VLASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-THH 538
F + LG GAFG V + ++ SD+ VA+K L + +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL------------------FGITRPDWNQ 580
N+V LLG C G L++ EY G L +FL D
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 581 RVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
+ ++ +A+G+ +L S IH D+ +NILL +I DFGLA+ + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 641 RTG----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ ++ APE T + DV+S+G+ L EL
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 57/242 (23%), Positives = 91/242 (37%), Gaps = 28/242 (11%)
Query: 463 SSPSATNVRSFTYKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ 520
S F + + + Q LG G F V V F A+K++ EQ
Sbjct: 9 HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQ 67
Query: 521 QGEKEFRTEVSVIGQTHHKNLVRLLGFC----DEGDHRLLVYEYMSNGSLASFLFGITRP 576
Q +E + E + +H N++RL+ +C L+ + G+L + +
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLK 125
Query: 577 DWNQR------VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
D + + GI RGL +H + H D+KP NILL D P + D G
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
Query: 631 LLLAEQTQAARTGI-------RGTVGYFAPEWF---RKASITVKVDVYSFGVLLLELICC 680
+ + R T+ Y APE F I + DV+S G +L ++
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 681 KS 682
+
Sbjct: 243 EG 244
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 460 RSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIK--KLDK 517
S S+ +V+ Y L++ +G G V++ + ++ K+ AIK L++
Sbjct: 43 ASSSANECISVKGRIYSILKQ--------IGSGGSSKVFQVL--NEKKQIYAIKYVNLEE 92
Query: 518 VEQQGEKEFRTEVSVIGQTHHKNL--VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITR 575
+ Q +R E++ + + + +RL + + +V E N L S+L
Sbjct: 93 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS 151
Query: 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
D +R + + +H+ I+H D+KP N L+ D ++ DFG+A + +
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 207
Query: 636 QTQAARTGIRGTVGYFAPE-----------WFRKASITVKVDVYSFGVLLLELICCK 681
T + G V Y PE K+ I+ K DV+S G +L + K
Sbjct: 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIG--QTHHKNLV 542
+ +G G V++ + ++ K+ AIK ++ + Q +R E++ + Q H ++
Sbjct: 15 KQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
RL + + +V E N L S+L D +R + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-------- 654
I+H D+KP N L+ D ++ DFG+A + + T + GTV Y PE
Sbjct: 129 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 655 ---WFRKASITVKVDVYSFGVLLLELICCK 681
K+ I+ K DV+S G +L + K
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 39/274 (14%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
+ +LG GA GT+ R VA+K++ + EV ++ + H N++R
Sbjct: 28 PKDVLGHGAEGTIVYR--GMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN----QRVQIAFGIARGLMYLHEEC 599
+ + + E + +L + + + D+ + + + GL +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 600 STQIIHCDIKPQNILL-----DDYFTPRISDFGLAKLLLAEQ-TQAARTGIRGTVGYFAP 653
S I+H D+KP NIL+ ISDFGL K L + + + R+G+ GT G+ AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 654 EWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710
E K + T VD++S G + +I + S FG + +A + + L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVI-SEGSHPFGKSLQRQANI--LLGACSLDCLHP 252
Query: 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
D + +++ I D RP
Sbjct: 253 EKHEDVIARELIEK----------MIAMDPQKRP 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 37/219 (16%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKR-FVAIKKL-DKVEQQGEKEFRTEVSVIGQ-THHKNL 541
F+ ++G G FG V K + D R AIK++ + + ++F E+ V+ + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL----------------FGITRPDWNQRVQIA 585
+ LLG C+ + L EY +G+L FL + Q + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK-LLLAEQTQAARTGI 644
+ARG+ YL Q IH D+ +NIL+ + + +I+DFGL++ + + R +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 645 RGTVGYFAPEWFRKASI-----TVKVDVYSFGVLLLELI 678
R A E S+ T DV+S+GVLL E++
Sbjct: 206 RWM----AIE-----SLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 18/240 (7%)
Query: 463 SSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG 522
SS + ++ +E+ R Q +G G+FG V +++ R IK+++ +
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRL--QKIGEGSFGKAIL-VKSTEDGRQYVIKEINI-SRMS 63
Query: 523 EKEFRT---EVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL---FGITRP 576
KE EV+V+ H N+V+ +E +V +Y G L + G+
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 577 DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636
+ +Q + I L ++H+ +I+H DIK QNI L T ++ DFG+A+ +L
Sbjct: 124 E-DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNST 178
Query: 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696
+ AR I GT Y +PE K D+++ G +L EL K F + + ++
Sbjct: 179 VELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--AFEAGSMKNLVL 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 60/229 (26%), Positives = 88/229 (38%), Gaps = 28/229 (12%)
Query: 463 SSPSATNVRSFT---YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE 519
+ SF ++ L LG G++G V+K V + + R A+K+
Sbjct: 44 PGYDPSRPESFFQQSFQRLSR--------LGHGSYGEVFK-VRSKEDGRLYAVKRSMS-P 93
Query: 520 QQGEKE---FRTEVSVIGQ-THHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL--FGI 573
+G K+ EV + H VRL +EG L E SL +G
Sbjct: 94 FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGA 152
Query: 574 TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633
+ P+ Q L +LH S ++H D+KP NI L ++ DFGL L
Sbjct: 153 SLPE-AQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL- 207
Query: 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
A G Y APE + S DV+S G+ +LE+ C
Sbjct: 208 -GTAGAGEVQE-GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-THH 538
+ LGRGAFG V + + + R VA+K L + + +E+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 539 KNLVRLLGFC-DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR---------------- 581
N+V LLG C G +++ E+ G+L+++L R ++
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 582 -VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
+ +F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + +
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ R + + APE T++ DV+SFGVLL E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 485 FRQILGRGAFGTVYKGVL------ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-T 536
+ LG GAFG V VA+K L D ++ + +E+ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--------------- 581
HKN++ LLG C + ++ EY S G+L +L RP +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFK 157
Query: 582 --VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639
V + +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 640 ARTG----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
T ++ APE T + DV+SFGVL+ E+
Sbjct: 215 KTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 485 FRQILGRGAFGTVYKGVLA----SDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
+ LG G FG V K VA+K L + ++ +E +V+ Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFL------------------------FGITR 575
++++L G C + LL+ EY GSL FL
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
+ A+ I++G+ YL +++H D+ +NIL+ + +ISDFGL++ + E
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ R+ R V + A E T + DV+SFGVLL E++
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 485 FRQILGRGAFGTVYKGVL------ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-T 536
+ LG G FG V VA+K L D ++ + +E+ ++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--------------- 581
HKN++ LLG C + ++ EY S G+L +L RP +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFK 203
Query: 582 --VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639
V + +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 640 ARTG----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
T ++ APE T + DV+SFGVL+ E+
Sbjct: 261 KTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKE----FRTEVSVIGQTHHKN 540
LG G TVY A D+ VAIK + + + ++E F EV Q H+N
Sbjct: 17 DKLGGGGMSTVYL---AEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
+V ++ +E D LV EY+ +L+ ++ + + I G+ + H+
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+I+H DIKPQNIL+D T +I DFG+AK L+E + + GTV YF+PE + +
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 661 ITVKVDVYSFGVLLLELI 678
D+YS G++L E++
Sbjct: 189 TDECTDIYSIGIVLYEML 206
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 50/232 (21%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHK 539
+ + +G GAFG V++ + VA+K L ++ + +F+ E +++ + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFL------------------------FGITR 575
N+V+LLG C G L++EYM+ G L FL G
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
+++ IA +A G+ YL + +H D+ +N L+ + +I+DFGL++ + +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 636 QTQAARTG----IRGTVGYFAPEWFRKASI-----TVKVDVYSFGVLLLELI 678
A IR PE SI T + DV+++GV+L E+
Sbjct: 228 DYYKADGNDAIPIRWM----PPE-----SIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 485 FRQILGRGAFGTVYKGVL------ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-T 536
+ LG GAFG V + VA+K L ++ + +E+ ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--------------- 581
HKN++ LLG C + ++ EY S G+L +L RP +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSK 191
Query: 582 --VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639
V A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 640 ARTG----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
T ++ APE T + DV+SFGVLL E+
Sbjct: 249 KTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-THH 538
F ++LG GAFG V + VA+K L +K + + +E+ ++ Q H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----------------------FGITR 575
+N+V LLG C L++EY G L ++L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
+ + A+ +A+G+ +L +H D+ +N+L+ +I DFGLA+ ++++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 636 QTQAARTG----IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
R ++ APE + T+K DV+S+G+LL E+
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-QGEKEF-RTEVSVIGQTHHKNLVRL 544
+G G++G K + + + K+LD + EK+ +EV+++ + H N+VR
Sbjct: 12 YTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 545 LG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPD--------WNQRVQIAFGIARGLMY 594
D + L +V EY G LAS + T+ Q+ L
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT----LALKE 126
Query: 595 LHE--ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
H + ++H D+KP N+ LD ++ DFGLA+ +L T A+T + GT Y +
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFV-GTPYYMS 184
Query: 653 PEWFRKASITVKVDVYSFGVLLLELICCK 681
PE + S K D++S G LL EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+++G G FG V+K D K + IK++ ++ E+E V + + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTY-VIKRVKYNNEKAERE----VKALAKLDHVNIVHYNG 71
Query: 547 FCDEGDHRL----------------LVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGI 588
D D+ + E+ G+L ++ + D +++ I
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
+G+ Y+H S ++I+ D+KP NI L D +I DFGL L + GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSK-GTL 185
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y +PE +VD+Y+ G++L EL+
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 34/215 (15%), Positives = 66/215 (30%), Gaps = 23/215 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN 540
+LG GAF VY+ +K+ +K + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDW-----NQRVQIAFGIARGLMYL 595
++ + +LV E S G+L + + + A + + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTP-----------RISDFGLAKLLLAEQTQAARTGI 644
H +IIH DIKP N +L + F + D G + + T
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 645 RGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
T G+ E ++D + + ++
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVR 543
ILG+GA V++G + AIK + + + E V+ + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 544 LLGFCDEGDHRL--LVYEYMSNGSLASFLFGITRPDW---NQRVQIAFGIARGLMYLHEE 598
L +E R L+ E+ GSL + L + ++ + + + G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 599 CSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
I+H +IKP NI+ D +++DFG A+ L E + + + GT Y P+
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVS-LYGTEEYLHPD 185
Query: 655 WFRKASI--------TVKVDVYSFGVLLLELIC 679
+ +A + VD++S GV
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
+G+GA GTVY + + + VAI++++ +Q ++ E+ V+ + + N+V L
Sbjct: 28 IGQGASGTVYTAM-DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQIIH 605
GD +V EY++ GSL + QIA + L +LH S Q+IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
DIK NILL + +++DFG + Q+ R+ + GT + APE + + KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 666 DVYSFGVLLLELI 678
D++S G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548
+G G+ G V S R VA+K +D +QQ + EV ++ H N+V +
Sbjct: 53 IGEGSTGIVCLAR-EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQIIH 605
G+ ++ E++ G+L I QIA + + L YLH + +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIH 164
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
DIK +ILL ++SDFG + + R + GT + APE ++ +V
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222
Query: 666 DVYSFGVLLLELI 678
D++S G++++E++
Sbjct: 223 DIWSLGIMVIEMV 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVR 543
LG+G FG VY LA + SK +A+K L K + E + R EV + H N++R
Sbjct: 17 LGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
L G+ + L+ EY G++ L +++ D + +A L Y H S ++
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRV 130
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH DIKP+N+LL +I+DFG + + + RT + GT+ Y PE
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDE 186
Query: 664 KVDVYSFGVLLLELIC 679
KVD++S GVL E +
Sbjct: 187 KVDLWSLGVLCYEFLV 202
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKE----FRTEVSVIGQTHHKN 540
+ILG G V+ A D + R VA+K L + + + FR E +H
Sbjct: 18 EILGFGGMSEVHL---ARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 541 LVRLL--GFCDEGDHRLLVY---EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYL 595
+V + G E L Y EY+ +L + + +++ + L +
Sbjct: 74 IVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-IRGTVGYFAPE 654
H+ IIH D+KP NI++ ++ DFG+A+ + +T + GT Y +PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 655 WFRKASITVKVDVYSFGVLLLELI 678
R S+ + DVYS G +L E++
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVL 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVR 543
ILG+GA V++G + AIK + + + E V+ + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 544 LLGFCDEGDHRL--LVYEYMSNGSLASFLFGITRPDW---NQRVQIAFGIARGLMYLHEE 598
L +E R L+ E+ GSL + L + ++ + + + G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 599 CSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
I+H +IKP NI+ D +++DFG A+ L E + + GT Y P+
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLY-GTEEYLHPD 185
Query: 655 WFRKASI--------TVKVDVYSFGVLLLELIC 679
+ +A + VD++S GV
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 45/226 (19%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKK--LDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
+ +G G FG+V+K + AIK+ E+ EV H ++VR
Sbjct: 17 EKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPD--------WNQRVQIAFGIARGLMYL 595
E DH L+ EY + GSLA + R + +Q+ RGL Y+
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG----RGLRYI 131
Query: 596 HEECSTQIIHCDIKPQNILLD-------------------DYFTPRISDFGLAKLLLAEQ 636
H ++H DIKP NI + + +I D G + + Q
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 637 TQAARTGIRGTVGYFAPE-WFRKASITVKVDVYSFGVLLLELICCK 681
+ G + A E + K D+++ + ++ +
Sbjct: 189 VE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF-----------------RTEVS 531
L +G F + L +F A+KK +K + +++F + E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR- 590
+I ++ + G D ++YEYM N S+ F D N I + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 591 -------GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG 643
Y+H E I H D+KP NIL+D ++SDFG ++ G
Sbjct: 156 IIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESE----YMVDKKIKG 209
Query: 644 IRGTVGYFAPEWF--RKASITVKVDVYSFGVLLLELIC 679
RGT + PE+F + KVD++S G+ L +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-31
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVR 543
++ LG G FG V + + D+ VAIK+ + +E + E+ ++ + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWI-HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 544 LLGFCDE------GDHRLLVYEYMSNGSLASFLFGITRPDW---NQRVQIAFGIARGLMY 594
D D LL EY G L +L + I+ L Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 595 LHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
LHE +IIH D+KP+NI+L +I D G AK L +Q + GT+ Y
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQYL 190
Query: 652 APEWFRKASITVKVDVYSFGVLLLELIC 679
APE + TV VD +SFG L E I
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 16/200 (8%)
Query: 486 RQILGRGAFGTVYKGVLASDSK--RFVAIKKLDKVEQQGEKEFRT----EVSVIGQTHHK 539
R+++GRG G VY A D+ R VA+K + + FRT E G+
Sbjct: 39 RRLVGRGGMGDVY---EAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC 599
++V + F + + ++ LA+ L + V I I L H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-IRGTVGYFAPEWFRK 658
H D+KP+NIL+ + DFG+A + + G GT+ Y APE F +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 659 ASITVKVDVYSFGVLLLELI 678
+ T + D+Y+ +L E +
Sbjct: 210 SHATYRADIYALTCVLYECL 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 489 LGRGAFGTVYKGVLA--SDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVR 543
LG+G FG VY LA +K +A+K L K ++ E + R E+ + H N++R
Sbjct: 22 LGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+ + + L+ E+ G L L R D + +A L Y H ++
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH DIKP+N+L+ +I+DFG + + + RT + GT+ Y PE +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR---RT-MCGTLDYLPPEMIEGKTHDE 191
Query: 664 KVDVYSFGVLLLELIC 679
KVD++ GVL E +
Sbjct: 192 KVDLWCAGVLCYEFLV 207
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 39/225 (17%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVR 543
+ILG G+ GTV S R VA+K++ E+ ++ ++ H N++R
Sbjct: 19 SEKILGYGSSGTVVFQG--SFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLA-------SFLFGITRPDWNQRVQIAFGIARGLMYLH 596
+ E N +L + + + IA G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPR-------------ISDFGLAKLLLAEQTQAART- 642
S +IIH D+KPQNIL+ ISDFGL K L + Q+
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 643 -GIRGTVGYFAPE-------WFRKASITVKVDVYSFGVLLLELIC 679
GT G+ APE K +T +D++S G + ++
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 16/194 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQTHHKNLVRLLG- 546
LG G G V+K S +A K + +++ + E+ V+ + + +V G
Sbjct: 41 LGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 547 FCDEGDHRLLVY---EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
F +G+ + E+M GSL L R +++ + +GL YL E+ +I
Sbjct: 100 FYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 153
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
+H D+KP NIL++ ++ DFG++ L+ A + + GT Y +PE + +V
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFV-GTRSYMSPERLQGTHYSV 209
Query: 664 KVDVYSFGVLLLEL 677
+ D++S G+ L+E+
Sbjct: 210 QSDIWSMGLSLVEM 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
LG GAFG VYK ++ A K ++ ++ +++ E+ ++ H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAK-NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQI 603
++ E+ G++ + + + R QI + L +LH + +I
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-----WFRK 658
IH D+K N+L+ R++DFG++ +T R GT + APE +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 659 ASITVKVDVYSFGVLLLELI 678
K D++S G+ L+E+
Sbjct: 197 TPYDYKADIWSLGITLIEMA 216
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRL 544
R++L G F VY+ + A+K+L E++ + EV + + + H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGRE-YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 545 LGFC-------DEGDHRLLVYEYMSNGSLASFLFGITRPDW---NQRVQIAFGIARGLMY 594
D G L+ + G L FL + + ++I + R + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL--------AEQTQAARTGI-- 644
+H IIH D+K +N+LL + T ++ DFG A + A++ I
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 645 RGTVGYFAPE---WFRKASITVKVDVYSFGVLLLELICCKS 682
T Y PE + I K D+++ G +L L +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 27/200 (13%)
Query: 489 LGRGAFGTVYKGVLASD---SKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ G G +Y LA D + R V +K L + + + E + + H ++V++
Sbjct: 88 IAHGGLGWIY---LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 545 LGFCDEGDHRL-----LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC 599
F + D +V EY+ SL + + + I L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI- 201
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-IRGTVGYFAPEWFRK 658
+++ D+KP+NI+L + ++ D G + G + GT G+ APE R
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NS---FGYLYGTPGFQAPEIVRT 251
Query: 659 ASITVKVDVYSFGVLLLELI 678
TV D+Y+ G L L
Sbjct: 252 GP-TVATDIYTVGRTLAALT 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLL 545
+ +G+G+FG V+KG+ + +++ VAIK +D E + E E + E++V+ Q + +
Sbjct: 28 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQ 602
G + ++ EY+ GS + P QIA I +GL YLH S +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALD----LLEPGPLDETQIATILREILKGLDYLH---SEK 139
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH DIK N+LL ++ +++DFG+A L TQ R GT + APE ++++
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 663 VKVDVYSFGVLLLELI 678
K D++S G+ +EL
Sbjct: 198 SKADIWSLGITAIELA 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+ LG G++G+VYK + ++ + VAIK++ VE +E E+S++ Q ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAI-HKETGQIVAIKQVP-VESD-LQEIIKEISIMQQCDSPHVVKYYG 91
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECSTQI 603
+ +V EY GS++ + + +IA +GL YLH +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLH---FMRK 146
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH DIK NILL+ +++DFG+A L T A R + GT + APE ++
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 664 KVDVYSFGVLLLELI 678
D++S G+ +E+
Sbjct: 205 VADIWSLGITAIEMA 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F ++LG GAF V+ + + A+K + K + E++V+ + H+N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 545 LGFCDEGDHRLLVYEYMSNGSL--------------ASFLFGITRPDWNQRVQIAFGIAR 590
+ H LV + +S G L AS + Q+ +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI----------QQVLSAVK- 120
Query: 591 GLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
YLH I+H D+KP+N+L ++ I+DFGL+K+ + GT
Sbjct: 121 ---YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGT 170
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
GY APE + + VD +S GV+ L+C
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQT-HHKNLVRLLG 546
LGRGA+G V K S + +A+K++ V Q +K ++ + +T V G
Sbjct: 15 LGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 547 -FCDEGDHRLLVY---EYMSNGSLASFLFGITRPDWNQRV------QIAFGIARGLMYLH 596
EGD V+ E M + SL F + Q + +IA I + L +LH
Sbjct: 74 ALFREGD----VWICMELM-DTSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLH 126
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-- 654
+ +IH D+KP N+L++ ++ DFG++ L A G Y APE
Sbjct: 127 SK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDA-GCKPYMAPERI 181
Query: 655 --WFRKASITVKVDVYSFGVLLLEL 677
+ +VK D++S G+ ++EL
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 26/263 (9%), Positives = 57/263 (21%), Gaps = 48/263 (18%)
Query: 455 HKKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKK 514
+ + + P + E + L G V+ + A+K
Sbjct: 36 MVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVR-DVERLEDFALKV 94
Query: 515 LDKVEQQGEKE---FRTEVSVIGQTHHKNLVRLLGFC----------------------- 548
+ E + ++
Sbjct: 95 FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154
Query: 549 ---DEGDHRLLVYEYMSNGSLASFLFGITR-------PDWNQRVQIAFGIARGLMYLHEE 598
+ LL+ S L + + + R L
Sbjct: 155 QDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ-- 211
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF-- 656
S ++H P N+ + + D + V Y E+
Sbjct: 212 -SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNA 265
Query: 657 RKASITVKVDVYSFGVLLLELIC 679
A+ T ++ + G+ + + C
Sbjct: 266 STATFTHALNAWQLGLSIYRVWC 288
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLL 545
+++G G +G VYKG + + AIK +D V E+E + E++++ + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGR-HVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 546 G-----FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLH 596
G D +L LV E+ GS+ L T+ + + IA+ I RGL +LH
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-- 654
+ ++IH DIK QN+LL + ++ DFG++ L ++T R GT + APE
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVI 201
Query: 655 ---WFRKASITVKVDVYSFGVLLLELI 678
A+ K D++S G+ +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDK--VEQQG-EKEFRTEVSVIGQTHHKNLVR 543
LG+G+F VY A + VAIK +DK + + G + + EV + Q H +++
Sbjct: 19 LGKGSFAGVY---RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG-IARGLMYLHEECSTQ 602
L + ++ ++ LV E NG + +L +P + I G++YLH S
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHG 132
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
I+H D+ N+LL +I+DFGLA L + + GT Y +PE +++
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 663 VKVDVYSFGVLLLELIC 679
++ DV+S G + L+
Sbjct: 191 LESDVWSLGCMFYTLLI 207
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 36/263 (13%), Positives = 77/263 (29%), Gaps = 59/263 (22%)
Query: 464 SPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE 523
+ V S + RG +LG+ + ++ + E+
Sbjct: 58 TGQPFRVESELGERPRTLVRG--TVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPS 114
Query: 524 KE----------------------------FRTEVSVIGQTHHKNLVRLLGFCDEGD--H 553
F ++ K ++R+ +
Sbjct: 115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 174
Query: 554 RLLVYEYM--SNGSLASFLFGITR----PDWNQRVQIAFGIARGLMYLHEECSTQIIHCD 607
R +Y M + + L + + R+Q+ + R L LH ++H
Sbjct: 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTY 231
Query: 608 IKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF----------- 656
++P +I+LD ++ F AR + G+ PE
Sbjct: 232 LRPVDIVLDQRGGVFLTGFEHLVRD------GARVVSSVSRGFEPPELEARRATISYHRD 285
Query: 657 RKASITVKVDVYSFGVLLLELIC 679
R+ +T D ++ G+++ + C
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWC 308
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
+ LG GA+G V AIK + K V + EV+V+ H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVER-AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECS 600
+L F ++ + LV E G L F I R +N+ I + G+ YLH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGEL--FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---K 154
Query: 601 TQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
I+H D+KP+N+LL + +I DFGL+ + ++ GT Y APE R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLR 211
Query: 658 KASITVKVDVYSFGVLLLELIC 679
K K DV+S GV+L L+
Sbjct: 212 K-KYDEKCDVWSIGVILFILLA 232
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+++LG+G+FG V + A+K + K ++ ++ EV ++ Q H N+
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEEC 599
++L F ++ + LV E + G L F I+R +++ +I + G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSGITYMH--- 143
Query: 600 STQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
+I+H D+KP+N+LL RI DFGL+ A + GT Y APE
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVL 200
Query: 657 RKASITVKVDVYSFGVLLLELIC 679
+ K DV+S GV+L L+
Sbjct: 201 HG-TYDEKCDVWSTGVILYILLS 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 24/210 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK-----KLDKVEQQGEKEFRTEVSVIGQTHHK 539
+++G+G F V + + ++F A+K K ++ + E S+ H
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQF-AVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV-------QIAFGIARGL 592
++V LL +V+E+M L F I + V I L
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 593 MYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
Y H IIH D+KP +LL ++ ++ FG+A L ++ G GT
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 198
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELIC 679
+ APE ++ VDV+ GV+L L+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLS 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 30/224 (13%)
Query: 468 TNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIK-----KLDKVEQQG 522
+ V Y+ EE LG G F V K + + A K +L +
Sbjct: 1 SMVEDH-YEMGEE--------LGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGV 50
Query: 523 EKE-FRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR 581
+E EV+++ + H N++ L + +L+ E +S G L F F + +
Sbjct: 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTED 108
Query: 582 --VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP----RISDFGLAKLLLAE 635
Q I G+ YLH S +I H D+KP+NI+L D P ++ DFG+A + E
Sbjct: 109 EATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--E 163
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
+ I GT + APE + ++ D++S GV+ L+
Sbjct: 164 AGNEFKN-IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVR 543
+ILG G FG V+K + + +A K + + ++E + E+SV+ Q H NL++
Sbjct: 92 SKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFG-ITRPDWN----QRVQIAFGIARGLMYLHEE 598
L + + +LV EY+ G LF I +N + I G+ ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH-- 204
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRI--SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
I+H D+KP+NIL + +I DFGLA+ + + + GT + APE
Sbjct: 205 -QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNF-GTPEFLAPEVV 260
Query: 657 RKASITVKVDVYSFGVLLLELIC 679
++ D++S GV+ L+
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVR 543
F++ LG GAFG V+ S S IK ++K Q E E+ V+ H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR------VQIAFGIARGLMYLHE 597
+ ++ + +V E G L ++ + ++ + L Y H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGEL--LERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 598 ECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
+ ++H D+KP+NIL + +I DFGLA+L +++ T GT Y APE
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPE 196
Query: 655 WFRKASITVKVDVYSFGVLLLELIC 679
F++ +T K D++S GV++ L+
Sbjct: 197 VFKR-DVTFKCDIWSAGVVMYFLLT 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKE-FRTEVSVIGQTHHKNLVRLL 545
LG+G F ++ A +K A K + K + + ++E E+S+ H+++V
Sbjct: 49 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
GF ++ D +V E SL + I G YLH ++IH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIH 164
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
D+K N+ L++ +I DFGLA + E + + GT Y APE K + +V
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 666 DVYSFGVLLLELIC 679
DV+S G ++ L+
Sbjct: 223 DVWSIGCIMYTLLV 236
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQT-HHKNLVRLLG 546
+GRGA+G+V K V S + +A+K++ V+++ +K+ ++ V+ ++ +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 547 -FCDEGDHRLLVY---EYMSNGSLASFLFGITRPDWNQRV------QIAFGIARGLMYLH 596
EGD + E M + S F + + +I + L +L
Sbjct: 89 ALFREGD----CWICMELM-STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-- 654
E +IIH DIKP NILLD ++ DFG++ L+ + A G Y APE
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDA-GCRPYMAPERI 197
Query: 655 --WFRKASITVKVDVYSFGVLLLEL 677
+ V+ DV+S G+ L EL
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 9/194 (4%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKE-FRTEVSVIGQTHHKNLVRLL 545
LG+G F ++ A D+K A K + K + + ++E E+S+ H+++V
Sbjct: 23 LGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
GF ++ D +V E SL + I G YLH ++IH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIH 138
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
D+K N+ L++ +I DFGLA + E + + GT Y APE K + +V
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 666 DVYSFGVLLLELIC 679
DV+S G ++ L+
Sbjct: 197 DVWSIGCIMYTLLV 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 456 KKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKL 515
KK + +V + Y LEE LG GAFG V++ V + + R K +
Sbjct: 35 KKYVPQPVEVKQGSVYDY-YDILEE--------LGSGAFGVVHRCVEKA-TGRVFVAKFI 84
Query: 516 DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG-IT 574
+ + + E+S++ Q HH L+ L ++ +L+ E++S G LF I
Sbjct: 85 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE----LFDRIA 140
Query: 575 RPDWNQRVQIAFGIAR----GLMYLHEECSTQIIHCDIKPQNILLDDYFTPR--ISDFGL 628
D+ R GL ++H I+H DIKP+NI+ + I DFGL
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
A L + + T + APE + + D+++ GVL L+
Sbjct: 198 ATKL--NPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
+LG+G+FG V K + + A+K ++K + + EV ++ + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEY-AVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECS 600
+L ++ +V E + G L F I R +++ +I + G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIKQVFSGITYMH---K 139
Query: 601 TQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
I+H D+KP+NILL + +I DFGL+ GT Y APE R
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLR 196
Query: 658 KASITVKVDVYSFGVLLLELIC 679
+ K DV+S GV+L L+
Sbjct: 197 G-TYDEKCDVWSAGVILYILLS 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK-----KLDKVEQQGEKE-FRTEVSVIGQTHH 538
+ LG G F V K S + A K + + +E EVS++ Q H
Sbjct: 16 IGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG--IARGLMYLH 596
N++ L + +L+ E +S G L F F + ++ +F I G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 597 EECSTQIIHCDIKPQNILLDDYFTP----RISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
+ +I H D+KP+NI+L D P ++ DFGLA + E + I GT + A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGTPEFVA 186
Query: 653 PEWFRKASITVKVDVYSFGVLLLELIC 679
PE + ++ D++S GV+ L+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVI 533
Y+ E +G GA V + K VAIK+++ + Q + E+ +
Sbjct: 17 YELQEV--------IGSGATAVVQAAY-CAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 534 GQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-----VQIAF-- 586
Q HH N+V D LV + +S GS+ + I ++ IA
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 587 -GIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+ GL YLH+ IH D+K NILL + + +I+DFG++ LA R +R
Sbjct: 128 REVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVR 183
Query: 646 GT-VG---YFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700
T VG + APE + K D++SFG+ +EL + + P + LM
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA--TGAAPYHKYPPMKVLM---- 237
Query: 701 RCYIGKN----LDKLAENDEEVKN---DLKRVERLVMVALWCIQEDASLRP 744
+N L+ ++ E +K ++ M++L C+Q+D RP
Sbjct: 238 --LTLQNDPPSLETGVQDKEMLKKYGKSFRK-----MISL-CLQKDPEKRP 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
++ LG+GAF V + V + F A K ++ + + ++ E + + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEF-AAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLMYLHEECS 600
RL E LV++ ++ G L F + R +++ I + Y H S
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCH---S 123
Query: 601 TQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
I+H ++KP+N+LL +++DFGLA + + A G GT GY +PE +
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 180
Query: 658 KASITVKVDVYSFGVLLLELIC 679
K + VD+++ GV+L L+
Sbjct: 181 KDPYSKPVDIWACGVILYILLV 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK-----KLDKVEQQGEKE-FRTEVSVIGQTHH 538
+ LG G F V K S + A K + + +E EVS++ Q H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEY-AAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLH 596
N++ L + +L+ E +S G L F F + ++ I G+ YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 597 EECSTQIIHCDIKPQNILLDDYFTP----RISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
+ +I H D+KP+NI+L D P ++ DFGLA + E + I GT + A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGTPEFVA 186
Query: 653 PEWFRKASITVKVDVYSFGVLLLELIC 679
PE + ++ D++S GV+ L+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK-------------VEQQGEKEFRTEVS 531
+ LG GA+G V + AIK + K ++ +E E+S
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEK-AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIA 589
++ H N+++L ++ + LV E+ G L F I R +++ I I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDAANIMKQIL 156
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
G+ YLH I+H DIKP+NILL + +I DFGL+ + G
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLG 210
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
T Y APE +K K DV+S GV++ L+C
Sbjct: 211 TAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 38/207 (18%), Positives = 80/207 (38%), Gaps = 21/207 (10%)
Query: 487 QILGRGA--FGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHKNL 541
++G+G TV + +V +++++ +E + + E+ V +H N+
Sbjct: 31 TVIGKGFEDLMTVNLA-RYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEE 598
V + +V +M+ GS L D + IA+ G+ + L Y+H
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT--QAARTGIRGTVG---YFAP 653
+H +K +IL+ +S +++ + + +V + +P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 654 EWFRKASI--TVKVDVYSFGVLLLELI 678
E ++ K D+YS G+ EL
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELA 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 15/200 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+GRG++G V V ++ A KK+ K + F+ E+ ++ H N++RL
Sbjct: 13 LENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECSTQ 602
++ LV E + G L F + + + + +I + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGEL--FERVVHKRVFRESDAARIMKDVLSAVAYCH---KLN 126
Query: 603 IIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
+ H D+KP+N L ++ DFGLA + GT Y +P+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG- 182
Query: 660 SITVKVDVYSFGVLLLELIC 679
+ D +S GV++ L+C
Sbjct: 183 LYGPECDEWSAGVMMYVLLC 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LGRGA VY+ +++ A+K L K +K RTE+ V+ + H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKG-TQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECSTQ 602
+ LV E ++ G L F + + +++R I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGEL--FDRIVEKGYYSERDAADAVKQILEAVAYLH---ENG 168
Query: 603 IIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
I+H D+KP+N+L +I+DFGL+K++ + + GT GY APE R
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGC 225
Query: 660 SITVKVDVYSFGVLLLELIC 679
+ +VD++S G++ L+C
Sbjct: 226 AYGPEVDMWSVGIITYILLC 245
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--------VEQQGEKEFRTEVSVIGQT 536
+ LG GA G V K+ AI+ + K E TE+ ++ +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKV-AIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLMY 594
+H ++++ F D D+ +V E M G L F + + + + + Y
Sbjct: 198 NHPCIIKIKNFFDAEDY-YIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 595 LHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
LHE IIH D+KP+N+LL ++ +I+DFG +K+L +T RT GT Y
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYL 308
Query: 652 APE---WFRKASITVKVDVYSFGVLLLELIC 679
APE A VD +S GV+L +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
++ +G G++ + + + + F A+K +DK ++ E+ ++ + H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEF-AVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECST 601
L D+G + +V E M G L + + +++R + F I + + YLH +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREASAVLFTITKTVEYLH---AQ 135
Query: 602 QIIHCDIKPQNILL----DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
++H D+KP NIL + + RI DFG AK L AE T + APE
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLE 193
Query: 658 KASITVKVDVYSFGVLLLELIC 679
+ D++S GVLL ++
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLT 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 21/200 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLD-KVEQQGEKEFRTEVSVIGQTH-HKNLVRLLG 546
+G G G V+K + +A+K++ ++ K ++ V+ ++H +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 547 -FCDEGDHRLLVY---EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
F D V+ E M + ++ I + L YL E+
Sbjct: 92 TFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-----WFR 657
+IH D+KP NILLD+ ++ DFG++ L+ +A G Y APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSA-GCAAYMAPERIDPPDPT 202
Query: 658 KASITVKVDVYSFGVLLLEL 677
K ++ DV+S G+ L+EL
Sbjct: 203 KPDYDIRADVWSLGISLVEL 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
+LG+G+FG V K +++ A+K ++K + + EV ++ + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECS 600
+L ++ +V E + G L F I R +++ +I + G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 601 TQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
I+H D+KP+NILL + +I DFGL+ GT Y APE R
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLR 196
Query: 658 KASITVKVDVYSFGVLLLELIC 679
+ K DV+S GV+L L+
Sbjct: 197 G-TYDEKCDVWSAGVILYILLS 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK-----KLDKVEQQGEKE-FRTEVSVIGQTHH 538
+ LG G F V K S + A K + + +E EVS++ + H
Sbjct: 15 TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLH 596
N++ L + +L+ E ++ G L F F + + + I G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 597 EECSTQIIHCDIKPQNILLDDYFTP----RISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
S QI H D+KP+NI+L D P +I DFGLA + + + I GT + A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN-IFGTPEFVA 185
Query: 653 PEWFRKASITVKVDVYSFGVLLLELIC 679
PE + ++ D++S GV+ L+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 20/238 (8%)
Query: 452 LFYHKKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVA 511
+ +H V N+ + + + LGRG F V + + S + + A
Sbjct: 1 MHHHHHHSSGVDL-GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS-TGQEYA 58
Query: 512 IKKLDK--VEQQGEKEFRTEVSVIGQ-THHKNLVRLLGFCDEGDHRLLVYEYMSNGSLAS 568
K L K Q E E++V+ ++ L + +L+ EY + G +
Sbjct: 59 AKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-- 116
Query: 569 FLFGITRPDWN----QRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTP 621
F + +++ I G+ YLH I+H D+KPQNILL
Sbjct: 117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 622 RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
+I DFG+++ + I GT Y APE IT D+++ G++ L+
Sbjct: 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 51/225 (22%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---------VEQQGEKEFRTEVSVIGQ 535
++ILGRG V + + K + A+K +D Q+ + EV ++ +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEY-AVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 536 -THHKNLVRLLGFCDEGDHRLLVYEYMSNGSL--------------ASFLFGITRPDWNQ 580
+ H N+++L + LV++ M G L +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM--------- 130
Query: 581 RVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
+ I LH I+H D+KP+NILLDD +++DFG + L +
Sbjct: 131 -RALLEVIC----ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--- 179
Query: 641 RTGIRGTVGYFAPEWFRKASITV------KVDVYSFGVLLLELIC 679
+ GT Y APE + +VD++S GV++ L+
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
++ LG+GAF V + V + F A K ++ + + ++ E + + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEF-AAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLMYLHEECS 600
RL E LV++ ++ G L F + R +++ I + Y H S
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCH---S 146
Query: 601 TQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
I+H ++KP+N+LL +++DFGLA + + A G GT GY +PE +
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 203
Query: 658 KASITVKVDVYSFGVLLLELIC 679
K + VD+++ GV+L L+
Sbjct: 204 KDPYSKPVDIWACGVILYILLV 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 34/235 (14%), Positives = 67/235 (28%), Gaps = 50/235 (21%)
Query: 488 ILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGE---KEFRTEVSVI----GQTHH 538
+LG+ A+D + + E+ K+ + EV + G +
Sbjct: 85 VLGQEDPYAYL---EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141
Query: 539 KNLVRLLGFCDEGDH-----------------------RLLVYEYM--SNGSLASFLFGI 573
K L F D R +Y M + + L
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201
Query: 574 TR----PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
+ + R+Q+ + R L LH ++H ++P +I+LD ++ F
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 630 KLLLAEQTQAARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELIC 679
+ A +T D ++ G+ + + C
Sbjct: 259 V-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 73/233 (31%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 466 SATNVRSFTYKELEEATRG---FRQI--LGRGAFGTVYKGVLASDSKRFVAIKKLDK--- 517
S +R +K LE G F LGRG FG V+ + + A KKL+K
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF-ACQMKATGKLYACKKLNKKRL 223
Query: 518 VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRP 576
+++G + E ++ + H + +V L + E L LV M+ G + + I
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI---RYHIYNV 279
Query: 577 DWNQRVQIAFGIAR----------GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDF 626
D + F R GL +LH+ II+ D+KP+N+LLDD RISD
Sbjct: 280 DEDNPG---FQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333
Query: 627 GLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
GLA L A QT+ G GT G+ APE VD ++ GV L E+I
Sbjct: 334 GLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 49/200 (24%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LGRG FG V++ V S SK+ K + + + + E+S++ H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHL 66
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRVQIAFG--IARGLMYLHEECST 601
+ + ++++E++S + F T + N+R +++ + L +LH S
Sbjct: 67 HESFESMEELVMIFEFISGLDI--FERINTSAFELNEREIVSYVHQVCEALQFLH---SH 121
Query: 602 QIIHCDIKPQNILLDDYFTP--RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
I H DI+P+NI+ + +I +FG A+ L + R Y+APE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAPEYYAPEVHQHD 178
Query: 660 SITVKVDVYSFGVLLLELIC 679
++ D++S G L+ L+
Sbjct: 179 VVSTATDMWSLGTLVYVLLS 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG GAFG V++ + + A K + + ++ R E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 545 LGFCDEGDHRLLVYEYMSNGSL----ASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
++ + +++YE+MS G L A ++ + + ++ + +GL ++H
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ---VCKGLCHMH---E 273
Query: 601 TQIIHCDIKPQNILLDDYFTPRI--SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
+H D+KP+NI+ + + DFGL L + Q+ + GT + APE
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTT-GTAEFAAPEVAEG 330
Query: 659 ASITVKVDVYSFGVLLLELIC 679
+ D++S GVL L+
Sbjct: 331 KPVGYYTDMWSVGVLSYILLS 351
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
+ LG+GAF V + V + + A ++ + + ++ E + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECS 600
RL E H L+++ ++ G L F + R +++ I +++ H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADASHCIQQILEAVLHCH---Q 128
Query: 601 TQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
++H ++KP+N+LL +++DFGLA + EQ A G GT GY +PE R
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLR 186
Query: 658 KASITVKVDVYSFGVLLLELIC 679
K VD+++ GV+L L+
Sbjct: 187 KDPYGKPVDLWACGVILYILLV 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/246 (22%), Positives = 87/246 (35%), Gaps = 55/246 (22%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIK-----KLDKVEQQGEKEFRTEVSVIGQTHHK 539
+ +G+G++G V + AIK K+ ++ + + +TEV ++ + HH
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIR-AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSL------------------------------ASF 569
N+ RL ++ + LV E G L
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 570 LFGITRPDWNQRVQIAFG----------IARGLMYLHEECSTQIIHCDIKPQNILL--DD 617
+ + + + I L YLH + I H DIKP+N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNK 205
Query: 618 YFTPRISDFGLAKLLLAEQTQAAR--TGIRGTVGYFAPEWFRKA--SITVKVDVYSFGVL 673
F ++ DFGL+K T GT + APE S K D +S GVL
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 674 LLELIC 679
L L+
Sbjct: 266 LHLLLM 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE---KEFRTEVSVIGQTHHKNLVR 543
+ +G G+FG VY + VAIKK+ +Q ++ EV + + H N ++
Sbjct: 60 REIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAF---GIARGLMYLHEECS 600
G LV EY GS + L +P Q V+IA G +GL YLH S
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH---S 172
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE---WFR 657
+IH D+K NILL + ++ DFG A + GT + APE
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAP--ANSFVGTPYWMAPEVILAMD 226
Query: 658 KASITVKVDVYSFGVLLLELI 678
+ KVDV+S G+ +EL
Sbjct: 227 EGQYDGKVDVWSLGITCIELA 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRL 544
+LG GA V + S+ + A+K ++K EV ++ Q H+N++ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEY-AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEECSTQ 602
+ F +E D LV+E M GS+ S + R +N+ + +A L +LH +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLH---NKG 131
Query: 603 IIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIR-----GTVGYFAPE 654
I H D+KP+NIL + +I DF L + + + G+ Y APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 655 WFRKASITVK-----VDVYSFGVLLLELIC 679
S D++S GV+L L+
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLS 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 59/223 (26%), Positives = 89/223 (39%), Gaps = 50/223 (22%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--------VEQQGEKEFRTEVSVIGQT 536
+ LG GA G V + + VAIK + K E TE+ ++ +
Sbjct: 14 MSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSL--------------ASFLFGITRPDWNQRV 582
+H ++++ F D D+ +V E M G L F Q
Sbjct: 73 NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYF-------YQ-- 122
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQA 639
+ + YLH IIH D+KP+N+LL ++ +I+DFG +K+L +T
Sbjct: 123 -----MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 640 ARTGIRGTVGYFAPE---WFRKASITVKVDVYSFGVLLLELIC 679
RT GT Y APE A VD +S GV+L +
Sbjct: 173 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLL 545
+ LG G+F K V ++ F A+K + K + E + E++ + H N+V+L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAF-AVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFG--ITRPDWNQR--VQIAFGIARGLMYLHEECST 601
+ H LV E ++ G LF + +++ I + + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVSHMH---DV 125
Query: 602 QIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
++H D+KP+N+L +D +I DFG A+L + T+ Y APE +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQ 183
Query: 659 ASITVKVDVYSFGVLLLELIC 679
D++S GV+L ++
Sbjct: 184 NGYDESCDLWSLGVILYTMLS 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 50/224 (22%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--------VEQQGEKEFRTEVSVIGQ- 535
+ ++GRG V + V + F A+K ++ ++ + R E ++ Q
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEF-AVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 536 THHKNLVRLLGFCDEGDHRLLVYEYMSNGSL--------------ASFLFGITRPDWNQR 581
H +++ L+ + LV++ M G L +
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM---------- 206
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+ ++ +LH + I+H D+KP+NILLDD R+SDFG + L +
Sbjct: 207 RSLLEAVS----FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---L 256
Query: 642 TGIRGTVGYFAPEWFRKASITV------KVDVYSFGVLLLELIC 679
+ GT GY APE + + +VD+++ GV+L L+
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
++LG+G FG V + + A KKL+K +++GE E ++ + + + +
Sbjct: 188 QYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 542 VRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWN-QRVQI-AFGIARGLMYLHEE 598
V L + E L LV M+ G L ++ + + + R A I GL LH E
Sbjct: 247 VSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR-GTVGYFAPEWFR 657
+I++ D+KP+NILLDD+ RISD GLA + R GTVGY APE +
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 658 KASITVKVDVYSFGVLLLELIC 679
T D ++ G LL E+I
Sbjct: 359 NERYTFSPDWWALGCLLYEMIA 380
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHKNL 541
F +ILG G+F TV + R AIK L+K E + E V+ + H
Sbjct: 34 FGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 542 VRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIARGLMYLHEE 598
V+L F D+ +L Y NG L ++ I D + I L YLH
Sbjct: 93 VKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTAEIVSALEYLH-- 147
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
IIH D+KP+NILL++ +I+DFG AK+L E QA GT Y +PE +
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 659 ASITVKVDVYSFGVLLLELIC 679
S D+++ G ++ +L+
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSV---IGQTHHKNL 541
I+GRG FG VY G +D+ + A+K LDK +QGE E + + +
Sbjct: 196 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 542 VRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
V + + +L + + M+ G L L A I GL ++H
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-- 311
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFRKA 659
+++ D+KP NILLD++ RISD GLA ++ GT GY APE +
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGV 366
Query: 660 SITVKVDVYSFGVLLLELIC 679
+ D +S G +L +L+
Sbjct: 367 AYDSSADWFSLGCMLFKLLR 386
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRL 544
+Q+LG G G V + ++ A+K L + R EV Q + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKC-ALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 545 LGFCDEGDHR----LLVYEYMSNGSLASFLFGITRPDWNQR--VQIAFGIARGLMYLHEE 598
L + H L++ E M G L S + + +R +I I + +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-- 145
Query: 599 CSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
S I H D+KP+N+L + +++DFG AK TQ A T Y APE
Sbjct: 146 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEV 200
Query: 656 FRKASITVKVDVYSFGVLLLELIC 679
D++S GV++ L+C
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLC 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-23
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 16/177 (9%)
Query: 516 DKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL---FG 572
++ + KN V L + + + +L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 573 ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632
+ + + I IA + +LH + ++H D+KP NI ++ DFGL +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 633 LAEQTQA----------ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
++ + TG GT Y +PE + + KVD++S G++L EL+
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 2/78 (2%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNLVRLL 545
Q +GRG FG V++ D AIK++ ++ +E EV + + H +VR
Sbjct: 12 QCMGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 546 GFCDEGDHRLLVYEYMSN 563
E E
Sbjct: 71 NAWLETPPEKWQEEMDEI 88
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 38/213 (17%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
Q+LG G G V + ++F A+K L + R EV + + + ++VR
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKF-ALKMLQDCP-----KARREVELHWRASQCPHIVR 119
Query: 544 LLGFCDEG----DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFG----------IA 589
++ + L+V E + G L I R AF I
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQ-----DRGDQAFTEREASEIMKSIG 171
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
+ YLH S I H D+KP+N+L +++DFG AK + + T
Sbjct: 172 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCY 225
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679
T Y APE D++S GV++ L+C
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKE-FRTEVSVIGQTHHKNL 541
+++GRGAFG V V ++ + A+K L+K E ++ E FR E V+ K +
Sbjct: 78 ILKVIGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 542 VRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG----------IA 589
L F D+ L LV +Y G L + L + + +
Sbjct: 137 TTLHYAFQDDN--NLYLVMDYYVGGDLLTLL---------SKFEDRLPEEMARFYLAEMV 185
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
+ +H +H DIKP NIL+D R++DFG L+ + T + + GT
Sbjct: 186 IAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241
Query: 650 YFAPE-----WFRKASITVKVDVYSFGVLLLELIC 679
Y +PE K + D +S GV + E++
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 44/217 (20%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+++G G+FG VY+ L DS VAIK KV Q + R E+ ++ + H N+VRL
Sbjct: 60 KVIGNGSFGVVYQAKL-CDSGELVAIK---KVLQDKRFKNR-ELQIMRKLDHCNIVRLRY 114
Query: 547 -FCDEGDHRL-----LVYEYMSNGSLASFLFGITRPDWNQRVQI--------AFGIARGL 592
F G+ + LV +Y+ ++ + R + + + + R L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 593 MYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
Y+H S I H DIKPQN+LLD D ++ DFG AK L+ + V Y
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---------NVSYI 217
Query: 652 APEWFRKASI-------TVKVDVYSFGVLLLELICCK 681
++R + T +DV+S G +L EL+ +
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 27/195 (13%), Positives = 51/195 (26%), Gaps = 42/195 (21%)
Query: 489 LGRGAFGTVYKGVLASDSK--RFVAIKKLD---KVEQQGEKEFRTEVSVIGQTHHKNLVR 543
G ++ A D+ R VA+ +D + +E + + + + R
Sbjct: 39 HGGVPPLQFWQ---ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+L L+V E++ GSL P ++ +A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRA---GV 150
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
P + +S G L
Sbjct: 151 ALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA-------NP 181
Query: 664 KVDVYSFGVLLLELI 678
+ D+ G L L+
Sbjct: 182 QDDIRGIGASLYALL 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 53/219 (24%), Positives = 82/219 (37%), Gaps = 51/219 (23%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK-------VEQQGEKEFRTEVS----VIGQTH 537
LG+G FGTV+ G +D + VAIK + + EV+ V
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQ-VAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 538 HKNLVRLLGFCDEGDHRLLVYEYMSNG---------------SLASFLFGITRPDWNQRV 582
H ++RLL + + + +LV E + F
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF----------G 146
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAAR 641
Q+ I + H S ++H DIK +NIL+D ++ DFG LL +
Sbjct: 147 QVVAAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYT 196
Query: 642 TGIRGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELIC 679
GT Y PEW + V+S G+LL +++C
Sbjct: 197 DFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFR---TEVSVIGQTHHKNLVRLL 545
+G+G+FG V V +D+K+ A+K ++K + E R E+ ++ H LV L
Sbjct: 23 IGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 546 G-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIARGLMYLHEECSTQ 602
F DE D + +V + + G L L + V++ + L YL + +
Sbjct: 82 YSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFK-EETVKLFICELVMALDYLQ---NQR 135
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI- 661
IIH D+KP NILLD++ I+DF +A +L E T + GT Y APE F
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGA 192
Query: 662 --TVKVDVYSFGVLLLELIC 679
+ VD +S GV EL+
Sbjct: 193 GYSFAVDWWSLGVTAYELLR 212
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 36/216 (16%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKE-FRTEVSVIGQTHHKNL 541
+++GRGAF V V + + A+K ++K + ++GE FR E V+ + +
Sbjct: 65 ILKVIGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 542 VRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR---------- 590
+L F + ++ L LV EY G L + L +
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLL---------SKFGERIPAEMARFYLAEIVM 173
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
+ +H +H DIKP NILLD R++DFG L A+ T + + GT Y
Sbjct: 174 AIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDY 229
Query: 651 FAPEWFRKASITVKVDVY-------SFGVLLLELIC 679
+PE + Y + GV E+
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 20/199 (10%)
Query: 489 LGRGAFGTVYKGVLA--SDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+G+G F V LA + R VAIK +DK + ++ EV ++ +H N+V+L
Sbjct: 23 IGKGNFAKVK---LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQII 604
+ L+ EY S G + +L R + I + Y H++ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ---TQAARTGIRGTVGYFAPEWFR-KAS 660
H D+K +N+LLD +I+DFG + G Y APE F+ K
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC------GAPPYAAPELFQGKKY 190
Query: 661 ITVKVDVYSFGVLLLELIC 679
+VDV+S GV+L L+
Sbjct: 191 DGPEVDVWSLGVILYTLVS 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 45/215 (20%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK--------VEQQGEKEFRTEVSVIGQTHHKN 540
LG GAFG V+ V +K V +K + K +E + E++++ + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKE-VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNG---------------SLASFLFGITRPDWNQRVQIA 585
++++L + LV E +G LAS++F Q+
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF----------RQLV 140
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+ YL IIH DIK +NI++ + FT ++ DFG A L E+ + T
Sbjct: 141 SAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFC- 190
Query: 646 GTVGYFAPEWFR-KASITVKVDVYSFGVLLLELIC 679
GT+ Y APE +++++S GV L L+
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 47/216 (21%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK------VEQQGEKEFRTEVSVIGQTHHK--N 540
LG G FG+VY G+ SD+ VAIK ++K E EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNG---------------SLASFLFGITRPDWNQRVQIA 585
++RLL + + D +L+ E LA F Q+
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----------WQVL 159
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGI 644
+ + H + ++H DIK +NIL+D + ++ DFG LL +
Sbjct: 160 EAVR----HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 209
Query: 645 RGTVGYFAPEWFR-KASITVKVDVYSFGVLLLELIC 679
GT Y PEW R V+S G+LL +++C
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
LG GA+G V V ++ VA+K +D E + E+ + +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRV---QIAFGIARGLMYLHEECSTQ 602
EG+ + L EY S G L + P+ + + Q+ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF-RKASI 661
I H DIKP+N+LLD+ +ISDFGLA + + + GT+ Y APE R+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 662 TVKVDVYSFGVLLLELIC 679
VDV+S G++L ++
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 31/213 (14%)
Query: 485 FRQILGRGAFGTVY--KGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKN 540
++LG+G+FG V+ K + SD+++ A+K L K ++ + + E ++ + +H
Sbjct: 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 541 LVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG----------IA 589
+V+L + + + +L L+ +++ G L + L + + F +A
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDLFTRL---------SKEVM-FTEEDVKFYLAELA 136
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
L +LH S II+ D+KP+NILLD+ +++DFGL+K + + + A + GTV
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYS-FCGTVE 191
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE + T D +SFGVL+ E++
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-21
Identities = 62/248 (25%), Positives = 104/248 (41%), Gaps = 50/248 (20%)
Query: 455 HKKLLRSVSSPSATN-VRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIK 513
K+++ ++S T R Y + ++G G+FG V++ L + VAIK
Sbjct: 21 PNKVIKVLASDGKTGEQREIAYTNCK--------VIGNGSFGVVFQAKLVESDE--VAIK 70
Query: 514 KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL------LVYEYMSNGSLA 567
KV Q + R E+ ++ H N+V L F + LV EY+ ++
Sbjct: 71 ---KVLQDKRFKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 568 SFLFGITRPDWNQR-----VQ-IAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFT 620
Q ++ + + R L Y+H S I H DIKPQN+LLD
Sbjct: 126 RASR--HYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGV 180
Query: 621 PRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI-------TVKVDVYSFGVL 673
++ DFG AK+L+A + V Y ++R + T +D++S G +
Sbjct: 181 LKLIDFGSAKILIAGEP---------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCV 231
Query: 674 LLELICCK 681
+ EL+ +
Sbjct: 232 MAELMQGQ 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 31/211 (14%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+++GRGAFG V V +++ A+K L K +++ F E ++ + +
Sbjct: 73 VVKVIGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 542 VRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR--------GL 592
V+L F D+ + +V EYM G L + + + AR L
Sbjct: 132 VQLFYAFQDD-RYLYMVMEYMPGGDLVNLM---------SNYDVPEKWARFYTAEVVLAL 181
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
+H S IH D+KP N+LLD +++DFG + E T + GT Y +
Sbjct: 182 DAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 653 PEWFRKASITVK----VDVYSFGVLLLELIC 679
PE + D +S GV L E++
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG GA+G V LA + ++ VA+K +D E + E+ + +H+N+V+
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKF 70
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRV---QIAFGIARGLMYLHEECS 600
G EG+ + L EY S G L + P+ + + Q+ G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF-RKA 659
I H DIKP+N+LLD+ +ISDFGLA + + + GT+ Y APE R+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 660 SITVKVDVYSFGVLLLELIC 679
VDV+S G++L ++
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA 203
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 61/210 (29%), Positives = 85/210 (40%), Gaps = 43/210 (20%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G FG L D +K VA+K +++ E R E+ H N+VR
Sbjct: 28 IGSGNFGVAR---LMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKE 83
Query: 547 FCDEGDHRLLVYEYMSNGSL--------------ASFLFGITRPDWNQRVQIAFGIARGL 592
H ++ EY S G L A F F Q Q+ G++
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF--------Q--QLLSGVS--- 130
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPR--ISDFGLAKLLLAEQTQAARTGIRGTVGY 650
Y H S QI H D+K +N LLD PR I DFG +K + ++ + GT Y
Sbjct: 131 -YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV-GTPAY 183
Query: 651 FAPEWF-RKASITVKVDVYSFGVLLLELIC 679
APE R+ DV+S GV L ++
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/247 (24%), Positives = 94/247 (38%), Gaps = 54/247 (21%)
Query: 463 SSPSATNVRSFTYKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ 520
S + N + + + F+ ++ G+G FGTV G + VAIK KV Q
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKE-KSTGMSVAIK---KVIQ 58
Query: 521 QGEKEFRT--EVSVIGQTHHKNLVRLL------GFCDEGDHRL-LVYEYMSNGSLASFLF 571
R + + HH N+V+L G D D L +V EY+ L
Sbjct: 59 DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLH 113
Query: 572 GITRPDWNQRVQI--------AFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPR- 622
R + ++V F + R + LH S + H DIKP N+L++
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVN----EAD 168
Query: 623 ----ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI-------TVKVDVYSFG 671
+ DFG AK L + V Y ++R + T VD++S G
Sbjct: 169 GTLKLCDFGSAKKLSPSEP---------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219
Query: 672 VLLLELI 678
+ E++
Sbjct: 220 CIFAEMM 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 25/206 (12%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK----VEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG G++G V + + S++ A+K L K GE + E+ ++ + HKN+++L
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 545 LG--FCDEGDHRLLVYEYMSNGSLASFLFG-ITR---PDWNQR---VQIAFGIARGLMYL 595
+ + +E +V EY G + + P Q+ G+ YL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H S I+H DIKP N+LL T +IS G+A+ L +G+ + PE
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 656 FR--KASITVKVDVYSFGVLLLELIC 679
KVD++S GV L +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 485 FRQILGRGAFGTVY--KGVLASDSKRFVAIKKLDK---VEQQGEKEF-RTEVSVIGQTHH 538
++LG+G +G V+ + V +++ + A+K L K V + + E +++ + H
Sbjct: 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 539 KNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR------- 590
+V L+ + + +L L+ EY+S G L L +R I F
Sbjct: 81 PFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL---------EREGI-FMEDTACFYLAE 129
Query: 591 ---GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
L +LH++ II+ D+KP+NI+L+ +++DFGL K + + T GT
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHT-FCGT 184
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
+ Y APE ++ VD +S G L+ +++
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 485 FRQILGRGAFGTVY--KGVLASDSKRFVAIKKLDK---VEQQGEKEF-RTEVSVIGQT-H 537
++LG GA+G V+ + + D+ + A+K L K V++ E RTE V+
Sbjct: 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 538 HKNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR------ 590
LV L + + + +L L+ +Y++ G L + L + + F
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHL---------SQRER-FTEHEVQIYVG 166
Query: 591 ----GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRG 646
L +LH II+ DIK +NILLD ++DFGL+K +A++T+ A G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222
Query: 647 TVGYFAPEWFRKASI--TVKVDVYSFGVLLLELICCKS 682
T+ Y AP+ R VD +S GVL+ EL+ S
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 10/145 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVRLL 545
+G G++G V+K D+ + VAIKK + + E+ ++ Q H NLV LL
Sbjct: 11 IGEGSYGVVFKCR-NRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECSTQII 604
LV+EY + ++ L R V+ I + + + + H I
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124
Query: 605 HCDIKPQNILLDDYFTPRISDFGLA 629
H D+KP+NIL+ + ++ DFG A
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFA 149
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLV 542
+ +G GA G V A D +R VAIKKL + Q R E+ ++ +HKN++
Sbjct: 31 KPIGSGAQGIVCA---AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 543 RLLG-FCDEGDHRL-----LVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYL 595
LL F + +V E M +L I ++R+ + + + G+ +L
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQV---IQMELDHERMSYLLYQMLCGIKHL 143
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H S IIH D+KP NI++ T +I DFGLA+ T T T Y APE
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 197
Query: 656 FRKASITVKVDVYSFGVLLLELICCK 681
VD++S G ++ E+I
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKE-FRTEVSVIGQTHHKNL 541
+ LG G+FG V V +S A+K LDK V + + E E ++ + L
Sbjct: 45 RIKTLGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQI-AFGIARGLMYLHEECS 600
V+L + + +V EY++ G + S L I R + A I YLH S
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLH---S 159
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+I+ D+KP+N+L+D +++DFG AK T + GT APE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPEALAPEIILSKG 214
Query: 661 ITVKVDVYSFGVLLLELIC 679
VD ++ GVL+ E+
Sbjct: 215 YNKAVDWWALGVLIYEMAA 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF---RTEVSVIGQTHHKNL 541
+ ++LG+G FG V V + R+ A+K L K + E TE V+ + H L
Sbjct: 152 YLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 542 VRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR---------- 590
L + + RL V EY + G L L R ++ F R
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHL---------SRERV-FSEDRARFYGAEIVS 259
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
L YLH E + +++ D+K +N++LD +I+DFGL K + + +T GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKT-FCGTPEY 315
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
APE VD + GV++ E++C +
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIK---KLDKVEQQGEKEFR-----TEVSVIGQT 536
+ LG G F TV LA D + VA+K + E E + + +
Sbjct: 25 RKLGWGHFSTV---WLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 537 H--HKNLVRLLGF----CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV-------Q 583
++++LL G H ++V+E + +L + + + R Q
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIK-----KYEHRGIPLIYVKQ 135
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD------YFTPRISDFGLAKLLLAEQT 637
I+ + GL Y+H C IIH DIKP+N+L++ +I+D G A T
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
+ +T Y +PE A D++S L+ ELI
Sbjct: 194 NSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 47/145 (32%), Positives = 70/145 (48%), Gaps = 10/145 (6%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT---EVSVIGQTHHKNLVRLL 545
+G G++G V K D+ R VAIKK + + E+ ++ Q H+NLV LL
Sbjct: 33 VGEGSYGMVMKCR-NKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECSTQII 604
C + LV+E++ + ++ L Q VQ F I G+ + H S II
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146
Query: 605 HCDIKPQNILLDDYFTPRISDFGLA 629
H DIKP+NIL+ ++ DFG A
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFA 171
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQTHHK 539
+ ++LG+G FG V L + R+ A+K L K + + E TE V+ T H
Sbjct: 9 YLKLLGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 540 NLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR-------- 590
L L + + RL V EY + G L F + R ++ F R
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGEL---FFHL------SRERV-FTEERARFYGAEI 114
Query: 591 --GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
L YLH +++ DIK +N++LD +I+DFGL K +++ +T GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KT-FCGTP 169
Query: 649 GYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE VD + GV++ E++C +
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKE-FRTEVSVIGQTHHKNL 541
+ LG G+FG V+ + + + R+ A+K L K V + + E E ++ H +
Sbjct: 10 ILRTLGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 542 VRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG----------IA 589
+R+ G F D ++ ++ +Y+ G L S L ++ Q F +
Sbjct: 69 IRMWGTFQDAQ--QIFMIMDYIEGGELFSLL---------RKSQR-FPNPVAKFYAAEVC 116
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
L YLH S II+ D+KP+NILLD +I+DFG AK T + GT
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYT-LCGTPD 168
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELIC 679
Y APE +D +SFG+L+ E++
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 24/158 (15%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSV---IGQTHHK 539
+G GA+G V+K + RFVA+K++ +V+ +E R EV+V + H
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQT--GEEGMPLSTIR-EVAVLRHLETFEHP 74
Query: 540 NLVRLL----GFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGL 592
N+VRL + + +L LV+E++ L ++L + P + F + RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
+LH S +++H D+KPQNIL+ +++DFGLA+
Sbjct: 134 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 17/150 (11%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNLV 542
+G G +G VYK + VA+KK+ +++ E E R E+S++ + +H N+V
Sbjct: 11 IGEGTYGVVYKAR-NKLTGEVVALKKI-RLDT--ETEGVPSTAIR-EISLLKELNHPNIV 65
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARGLMYLHEECS 600
+LL + LV+E++ L F+ + F + +GL + H S
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 121
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
+++H D+KPQN+L++ +++DFGLA+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 21/200 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQG--EKEFRTEVSVIGQTHHKNLVRL 544
LG G FG V G + VA+K L++ + K R E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRV---QIAFGIARGLMYLHEECS 600
+V EY+S G L ++ R + R QI + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---R 129
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR-KA 659
++H D+KP+N+LLD + +I+DFGL+ ++ + RT G+ Y APE +
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSC-GSPNYAAPEVISGRL 186
Query: 660 SITVKVDVYSFGVLLLELIC 679
+VD++S GV+L L+C
Sbjct: 187 YAGPEVDIWSCGVILYALLC 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 39/149 (26%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNLV 542
+G G +GTV+K ++ VA+K++ +++ + E R E+ ++ + HKN+V
Sbjct: 10 IGEGTYGTVFKA-KNRETHEIVALKRV-RLDD--DDEGVPSSALR-EICLLKELKHKNIV 64
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECST 601
RL LV+E+ L + + V+ F + +GL + H S
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SR 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAK 630
++H D+KPQN+L++ ++++FGLA+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNLV 542
LG G +G VYK + + + VAIK++ ++E E+E R EVS++ + H+N++
Sbjct: 42 LGEGTYGEVYKAI-DTVTNETVAIKRI-RLEH--EEEGVPGTAIR-EVSLLKELQHRNII 96
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
L L++EY N L ++ + + G+ + H S +
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152
Query: 603 IIHCDIKPQNILLDDYFTPR-----ISDFGLAK 630
+H D+KPQN+LL I DFGLA+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 17/149 (11%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNLV 542
+G G +G VYK ++ A+KK+ ++E+ E E R E+S++ + H N+V
Sbjct: 10 IGEGTYGVVYKAQ--NNYGETFALKKI-RLEK--EDEGIPSTTIR-EISILKELKHSNIV 63
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECST 601
+L +LV+E++ L L + + G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAK 630
+++H D+KPQN+L++ +I+DFGLA+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRL 544
+G GA+G+V + S VAIKKL + Q R E+ ++ H+N++ L
Sbjct: 30 THVGSGAYGSVCS-AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 545 L------GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHE 597
L LV +M L + +++Q + + + +GL Y+H
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFM-QTDLQKI---MGLKFSEEKIQYLVYQMLKGLKYIH- 143
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
S ++H D+KP N+ +++ +I DFGLA+ AE T GY W+R
Sbjct: 144 --SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----------GYVVTRWYR 190
Query: 658 KASI-------TVKVDVYSFGVLLLELICCK 681
+ VD++S G ++ E++ K
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 51/209 (24%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
Q+LG G G V + ++F A+K L + R EV + + + ++VR
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKF-ALKMLQDCP-----KARREVELHWRASQCPHIVR 75
Query: 544 LLGFCDEG----DHRLLVYEYMSNGSLASFLFG--ITRPDWN----QRVQIAFGIARGLM 593
++ + L+V E + G LF R D + +I I +
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 594 YLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650
YLH S I H D+KP+N+L +++DFG AK E Y
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------KY 175
Query: 651 FAPEWFRKASITVKVDVYSFGVLLLELIC 679
D++S GV++ L+C
Sbjct: 176 -----------DKSCDMWSLGVIMYILLC 193
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 45/177 (25%), Positives = 85/177 (48%), Gaps = 22/177 (12%)
Query: 463 SSPSATNVRSFTYKELEEATRGFRQI--LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ 520
++ + ++ L E ++++ +G G +G VYK R VA+K++ +++
Sbjct: 4 HHHHSSGRENLYFQGLMEK---YQKLEKVGEGTYGVVYKAK--DSQGRIVALKRI-RLDA 57
Query: 521 QGEKE------FRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGIT 574
E E R E+S++ + HH N+V L+ LV+E+M L L
Sbjct: 58 --EDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK 113
Query: 575 RP-DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
+Q + + RG+ + H +I+H D+KPQN+L++ +++DFGLA+
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 52/233 (22%), Positives = 93/233 (39%), Gaps = 60/233 (25%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRT------------------ 528
+G+G++G V +D+ A+K L K + +Q R
Sbjct: 21 IGKGSYGVVKLAYNENDNTY-YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 529 ------EVSVIGQTHHKNLVRL---LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWN 579
E++++ + H N+V+L L +E DH +V+E ++ G + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPV----MEVPT---L 131
Query: 580 QRV----------QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
+ + + GI YLH +IIH DIKP N+L+ + +I+DFG++
Sbjct: 132 KPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV---KVDVYSFGVLLLELIC 679
+ T GT + APE + +DV++ GV L +
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLV 542
+ +G GA G V A D R VAIKKL + Q R E+ ++ +HKN++
Sbjct: 68 KPIGSGAQGIVCA---AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 543 RLL------GFCDEGDHRLLVYEYMSNGSLASFLFGITR-PDWNQRVQ-IAFGIARGLMY 594
LL +E LV E M + L + + ++R+ + + + G+ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
LH S IIH D+KP NI++ T +I DFGLA+ T T T Y APE
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPE 233
Query: 655 WFRKASITVKVDVYSFGVLLLELICCK 681
VD++S G ++ E++ K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQ-THH 538
+++GRG++ V L + R A+K + K V + ++ +TE V Q ++H
Sbjct: 13 LLRVIGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 539 KNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDW--NQRVQI-AFGIARGLMY 594
LV L C + + RL V EY++ G L +F + R + + + I+ L Y
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
LHE II+ D+K N+LLD +++D+G+ K L T GT Y APE
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-ST-FCGTPNYIAPE 180
Query: 655 WFRKASITVKVDVYSFGVLLLELICCKS 682
R VD ++ GVL+ E++ +S
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 53/246 (21%), Positives = 92/246 (37%), Gaps = 76/246 (30%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLL- 545
+ LG G+FG V + +S + A+KK V Q + R E+ ++ H N+++L+
Sbjct: 13 KTLGTGSFGIVCEVFD-IESGKRFALKK---VLQDPRYKNR-ELDIMKVLDHVNIIKLVD 67
Query: 546 GFCDEGDHRL-------------------------------------LVYEYMSNGSLAS 568
F GD ++ EY+
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----D 122
Query: 569 FLFGITRPDWNQRVQI--------AFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYF 619
L + + I + + R + ++H S I H DIKPQN+L++
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDN 179
Query: 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI-------TVKVDVYSFGV 672
T ++ DFG AK L+ + +V Y ++R + T +D++S G
Sbjct: 180 TLKLCDFGSAKKLIPSEP---------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 673 LLLELI 678
+ ELI
Sbjct: 231 VFGELI 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 20/196 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLLG- 546
LGRG + V++ + + V +K L V+ +K+ + E+ ++ N++ L
Sbjct: 44 LGRGKYSEVFEAI-NITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADI 99
Query: 547 FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECSTQII 604
D LV+E+++N +T D ++ + I + L Y H S I+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD----IRFYMYEILKALDYCH---SMGIM 152
Query: 605 HCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI-T 662
H D+KP N+++D ++ R+ D+GLA+ Q + + PE +
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYD 209
Query: 663 VKVDVYSFGVLLLELI 678
+D++S G +L +I
Sbjct: 210 YSLDMWSLGCMLASMI 225
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQ-THH 538
+++GRG++ V L + R A++ + K V + ++ +TE V Q ++H
Sbjct: 56 LLRVIGRGSYAKVL---LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 539 KNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDW--NQRVQI-AFGIARGLMY 594
LV L C + + RL V EY++ G L +F + R + + + I+ L Y
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
LHE II+ D+K N+LLD +++D+G+ K L T GT Y APE
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-ST-FCGTPNYIAPE 223
Query: 655 WFRKASITVKVDVYSFGVLLLELICCKS 682
R VD ++ GVL+ E++ +S
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 33/206 (16%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKV----EQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG G FG V G + VA+K L++ K R E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRV----------QIAFGIARGLMY 594
+V EY+S G L ++ N R+ QI G+ Y
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICK------NGRLDEKESRRLFQQILSGVD----Y 131
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
H ++H D+KP+N+LLD + +I+DFGL+ ++ + RT G+ Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSC-GSPNYAAPE 185
Query: 655 WFR-KASITVKVDVYSFGVLLLELIC 679
+ +VD++S GV+L L+C
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLC 211
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQ-THH 538
F +++G+G+FG V LA + F A+K L K + ++ E++ +E +V+ + H
Sbjct: 42 FLKVIGKGSFGKVL---LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 539 KNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG---------- 587
LV L F + +L V +Y++ G L L QR + F
Sbjct: 99 PFLVGLH-FSFQTADKLYFVLDYINGGELFYHL---------QRERC-FLEPRARFYAAE 147
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
IA L YLH S I++ D+KP+NILLD ++DFGL K + + T GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TST-FCGT 202
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE K VD + G +L E++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 24/159 (15%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKK--LDKVEQQGEKEF-----RTEVSV---IGQTHH 538
+G GA+GTVYK S FVA+K + G R EV++ + H
Sbjct: 17 IGVGAYGTVYKA-RDPHSGHFVALKSVRVPN-GGGGGGGLPISTVR-EVALLRRLEAFEH 73
Query: 539 KNLVRLL----GFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRV--QIAFGIARG 591
N+VRL+ + + ++ LV+E++ L ++L P + RG
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
L +LH + I+H D+KP+NIL+ T +++DFGLA+
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKE-FRTEVSVIGQ-THH 538
++LG+G+FG V+ LA + +F AIK L K V + E E V+ H
Sbjct: 21 LHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 539 KNLVRLLG-FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR------- 590
L + F + ++ V EY++ G L + Q F ++R
Sbjct: 78 PFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHI---------QSCHK-FDLSRATFYAAE 126
Query: 591 ---GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
GL +LH + I++ D+K NILLD +I+DFG+ K + T GT
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNT-FCGT 181
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE VD +SFGVLL E++ +S
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-17
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQ-THHKN 540
F +LG+G+FG V + A+K L K V Q + E E V+
Sbjct: 345 FLMVLGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 541 LVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC 599
L +L C + RL V EY++ G L + + R V A IA GL +L +
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK- 461
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA 659
II+ D+K N++LD +I+DFG+ K + + +T GT Y APE
Sbjct: 462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEIIAYQ 517
Query: 660 SITVKVDVYSFGVLLLELICCKS 682
VD ++FGVLL E++ ++
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 54/220 (24%), Positives = 82/220 (37%), Gaps = 41/220 (18%)
Query: 487 QILGRGAFGTVYKGVLASDSK-RFVAIKKLDKVEQQGEKEF---------RT--EVSVIG 534
+ + G++G V DS+ VAIK++ G R E+ ++
Sbjct: 28 RFISSGSYGAVCA---GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 535 QTHHKNLVRLL-----GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGI 588
HH N++ L LV E M LA + Q +Q + I
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
GL LH ++H D+ P NILL D I DF LA+ + A +T
Sbjct: 144 LLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKT------ 191
Query: 649 GYFAPEWFRKASI-------TVKVDVYSFGVLLLELICCK 681
Y W+R + T VD++S G ++ E+ K
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 15/150 (10%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE-------FRTEVSVIGQTHHKNL 541
LG G F TVYK ++ + VAIKK+ K+ + E + R E+ ++ + H N+
Sbjct: 18 LGEGQFATVYKA-RDKNTNQIVAIKKI-KLGHRSEAKDGINRTALR-EIKLLQELSHPNI 74
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQ-IAFGIARGLMYLHEECS 600
+ LL + LV+++M L + + ++ +GL YLH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---Q 130
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
I+H D+KP N+LLD+ +++DFGLAK
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 36/215 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQ-THH 538
F ++LG+G+FG V LA ++ A+K L K + Q + E TE ++ +H
Sbjct: 27 FIRVLGKGSFGKVM---LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 539 KNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIAR------- 590
L +L C + RL V E+++ G L +F I Q+ + F AR
Sbjct: 84 PFLTQLF-CCFQTPDRLFFVMEFVNGGDL---MFHI------QKSRR-FDEARARFYAAE 132
Query: 591 ---GLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
LM+LH++ II+ D+K N+LLD +++DFG+ K + T GT
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTAT-FCGT 187
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE ++ VD ++ GVLL E++C +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDK--VEQQGEKEF-RTEVSVIGQ-THH 538
F +LG+G+FG V L+ + A+K L K V Q + E E V+
Sbjct: 24 FLMVLGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 539 KNLVRLLGFCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQIAFG---------- 587
L +L C + RL V EY++ G L ++ I Q+V F
Sbjct: 81 PFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHI------QQVGR-FKEPHAVFYAAE 129
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
IA GL +L + II+ D+K N++LD +I+DFG+ K + + +T GT
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKT-FCGT 184
Query: 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS 682
Y APE VD ++FGVLL E++ ++
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRL 544
Q +G GA+G V + + VAIKKL + Q R E+ ++ H+N++ L
Sbjct: 31 QPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 545 L------GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDW--NQRVQ-IAFGIARGLMYL 595
L D+ LV +M + L + + + R+Q + + + +GL Y+
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H + IIH D+KP N+ +++ +I DFGLA+ +E T GY W
Sbjct: 145 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----------GYVVTRW 190
Query: 656 FRKASI-------TVKVDVYSFGVLLLELICCK 681
+R + T VD++S G ++ E+I K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 40/209 (19%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKV----EQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG G+FG V +++ VA+K + + + R E+S + H ++++L
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74
Query: 545 LGFCDEGDHRLLVYEY---------MSNGSL----ASFLFGITRPDWNQRVQIAFGIARG 591
++V EY + + F QI I
Sbjct: 75 YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF----------QQIICAIE-- 122
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
Y H +I+H D+KP+N+LLDD +I+DFGL+ ++ +T G+ Y
Sbjct: 123 --YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSC-GSPNYA 174
Query: 652 APEWFR-KASITVKVDVYSFGVLLLELIC 679
APE K +VDV+S G++L ++
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 45/152 (29%), Positives = 82/152 (53%), Gaps = 20/152 (13%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF-----RTEVSVIGQTHHKNLVR 543
LG G + TVYKG L + +VA+K++ K++ E+ R E+S++ + H+N+VR
Sbjct: 13 LGNGTYATVYKG-LNKTTGVYVALKEV-KLDS--EEGTPSTAIR-EISLMKELKHENIVR 67
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIA------FGIARGLMYLHE 597
L + LV+E+M N L ++ T + + +++ + + +GL + H
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
+I+H D+KPQN+L++ ++ DFGLA
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 47/222 (21%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLV 542
+LG GA+G V A+ + VAIKK++ ++ RT E+ ++ H+N++
Sbjct: 17 SLLGEGAYGVVCS---ATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHENII 72
Query: 543 RLL-----GFCDEGDHRLLVYEYM--------SNGSLASFLFGITRPDWNQRVQ-IAFGI 588
+ + + ++ E M S L+ + +Q +
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS-----------DDHIQYFIYQT 121
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTV 648
R + LH + +IH D+KP N+L++ ++ DFGLA+++ + + +
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 649 --GYFAPEWFRKASI-------TVKVDVYSFGVLLLELICCK 681
+ A W+R + + +DV+S G +L EL +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 13/147 (8%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEF-RT---EVSVIGQTHHKNLVRL 544
LG G + TVYKG + + VA+K++ ++E E+ T EVS++ H N+V L
Sbjct: 10 LGEGTYATVYKG-KSKLTDNLVALKEI-RLEH--EEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQI 603
LV+EY+ L +L + + F + RGL Y H ++
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAK 630
+H D+KPQN+L+++ +++DFGLA+
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 36/162 (22%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLV 542
++G G++G V + A D KR VAIKK+ +V + R E++++ + +H ++V
Sbjct: 59 HLIGTGSYGHVCE---AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 543 RLLGFC----DEGDHRL-LVYEYM---------SNGSLASFLFGITRPDWNQRVQ-IAFG 587
++L E L +V E + L ++ + +
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT-----------ELHIKTLLYN 164
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
+ G+ Y+H S I+H D+KP N L++ + ++ DFGLA
Sbjct: 165 LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 28/158 (17%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKE------FRTEVSVIGQTHHKNLV 542
+G+G FG V+K + + VA+KK+ +E EKE R E+ ++ H+N+V
Sbjct: 25 IGQGTFGEVFKA-RHRKTGQKVALKKV-LMEN--EKEGFPITALR-EIKILQLLKHENVV 79
Query: 543 RLLGFCDEGDHRL--------LVYEYMSN---GSLASFLFGITRPDWNQRVQIAFGIARG 591
L+ C LV+++ + G L++ L T + ++ + G
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS---EIKRVMQMLLNG 136
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
L Y+H +I+H D+K N+L+ +++DFGLA
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 50/244 (20%), Positives = 98/244 (40%), Gaps = 57/244 (23%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLV 542
++GRG++G VY A D +++ VAIKK++++ + R E++++ + ++
Sbjct: 32 HLIGRGSYGYVYL---AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 543 RLL-----GFCDEGDHRLLVYEYM---------SNGSLASFLFGITRPDWNQRVQ-IAFG 587
RL + D +V E + L + ++ I +
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT-----------EEHIKTILYN 137
Query: 588 IARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647
+ G ++H + IIH D+KP N LL+ + ++ DFGLA+ + +E+ +
Sbjct: 138 LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 648 VGYFAPE--------------WFRKASI-------TVKVDVYSFGVLLLELICCKSSVVF 686
W+R + T +D++S G + EL+ S +
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 687 GTTN 690
TN
Sbjct: 255 DPTN 258
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQTHHKNLVRL 544
+G GA+G+V + + VA+KKL + Q RT E+ ++ H+N++ L
Sbjct: 35 SPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 545 L------GFCDEGDHRLLVYEYMSNGSLASFLFGITR--PDWNQRVQ-IAFGIARGLMYL 595
L +E + LV M + L I + + VQ + + I RGL Y+
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H S IIH D+KP N+ +++ +I DFGLA+ E T GY A W
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----------GYVATRW 194
Query: 656 FRKASI-------TVKVDVYSFGVLLLELICCK 681
+R I VD++S G ++ EL+ +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 26/161 (16%)
Query: 489 LGRGAFGTVYKGV-LASDSKRFVAIKKLDKVEQQGEKE--FRTEVSVIGQTHHKNLVRLL 545
+GRG +G VYK + A+K+ +E G R E++++ + H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQ---IEGTGISMSACR-EIALLRELKHPNVISLQ 84
Query: 546 G-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDWNQRVQ---------IAFGIARGLMY 594
F D ++ L+++Y + L + N++ + + I G+ Y
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPR----ISDFGLAKL 631
LH + ++H D+KP NIL+ R I+D G A+L
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 40/240 (16%)
Query: 464 SPSATNVRSFTYKELEEATRGFR--QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVE 519
+ +A ++ + + +G GA+G V A D +K VAIKK+ E
Sbjct: 8 AAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCS---AYDNLNKVRVAIKKISPFE 64
Query: 520 QQGEKEFRT--EVSVIGQTHHKNLVRLL-----GFCDEGDHRLLVYEYMSNGSLASFLFG 572
Q + RT E+ ++ + H+N++ + ++ +V + M + L+
Sbjct: 65 HQTYCQ-RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYK 118
Query: 573 ITR--PDWNQRVQ-IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629
+ + N + + I RGL Y+H S ++H D+KP N+LL+ +I DFGLA
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 630 KLLLAEQTQAAR-TGIRGTVGYFAPEWFRKASI-------TVKVDVYSFGVLLLELICCK 681
++ + T Y A W+R I T +D++S G +L E++ +
Sbjct: 176 RVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 51/226 (22%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL---DKVEQQGEKEFRT--EVSVIGQTHHKNL 541
+ LG G G V+ V +D + VAIKK+ D + E+ +I + H N+
Sbjct: 17 KPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIRRLDHDNI 70
Query: 542 VRLL--------------GFCDEGDHRLLVYEYM--------SNGSLASFLFGITRPDWN 579
V++ G E + +V EYM G L
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL-----------E 119
Query: 580 QRVQ-IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQT 637
+ + + + RGL Y+H S ++H D+KP N+ ++ +I DFGLA+++ +
Sbjct: 120 EHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 638 QAAR-TGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCK 681
+ T Y +P + T +D+++ G + E++ K
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 41/211 (19%)
Query: 487 QILGRGAFGTVYKGVLASDSK--RFVAIK---KLDKVEQQGEKEFR--TEVSVIGQTHHK 539
+++G+G+FG V K A D K + VA+K + +Q +E R + + +
Sbjct: 103 KVIGKGSFGQVVK---AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 540 NLVRLLGFCDEGDHR--------LL---VYEYMSNGSLASFLFGITRPDWNQRVQIAFGI 588
N++ +L + R LL +YE + F + R A I
Sbjct: 160 NVIHML---ENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK-------FAHSI 209
Query: 589 ARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP--RISDFGLAKLLLAEQTQAARTGIRG 646
+ L LH+ +IIHCD+KP+NILL ++ DFG + + Q T I+
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ- 261
Query: 647 TVGYFAPEWFRKASITVKVDVYSFGVLLLEL 677
+ Y APE A + +D++S G +L EL
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 41/225 (18%)
Query: 487 QILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVEQQGEKEFRT--EVSVIGQ-THHKNL 541
+ LG+GA+G V+K + D + VA+KK+ Q RT E+ ++ + + H+N+
Sbjct: 15 KKLGKGAYGIVWK---SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI 71
Query: 542 VRLLG-FCDEGDHRL-LVYEYMSNGSLASFLFGITRPDW--NQRVQ-IAFGIARGLMYLH 596
V LL + D + LV++YM + L + R + Q + + + + + YLH
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-- 654
S ++H D+KP NILL+ +++DFGL++ + + + +
Sbjct: 127 ---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 655 -----------WFRKASI-------TVKVDVYSFGVLLLELICCK 681
W+R I T +D++S G +L E++C K
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 3/97 (3%)
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+ +F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
R + + APE T++ DV+SFGVLL E+
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKL-DKVEQQGEKEFRTEVSVIGQ-THH 538
+ LGRGAFG V + + + R VA+K L + + +E+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 539 KNLVRLLGFC-DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHE 597
N+V LLG C G +++ E+ G+L+++L ++R + +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630
+ I D+K + + + S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 59/276 (21%), Positives = 90/276 (32%), Gaps = 83/276 (30%)
Query: 489 LGRGAFGTVYKGVLASD--SKRFVAIK---KLDKVEQQGEKEFR--TEVSVIGQTH--HK 539
LG G F TV+ L+ D K+FVA+K + + E R V +
Sbjct: 45 LGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 540 NLVRLLGFCD-------EGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIAR 590
+V+LL D G H +V+E + + L ++ +I + +
Sbjct: 102 MVVQLL---DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 591 GLMYLHEECSTQIIHCDIKPQNILL----------------------------------- 615
GL YLH +C +IIH DIKP+NILL
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 616 --------------DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+ +I+D G A T T Y + E +
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEVLIGSGY 270
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD 697
D++S + EL +F + EE D
Sbjct: 271 NTPADIWSTACMAFELATGDY--LFEPHSGEEYTRD 304
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 487 QILGRGAFGTVYKGVLASDSKR--FVAIK---KLDKVEQQGEKEFR--TEVSVIGQTHHK 539
++G+G+FG V K A D +VAIK Q + E R ++
Sbjct: 60 SLIGKGSFGQVVK---AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFL-----FGITRPDWNQRVQ-IAFGIARGLM 593
+V L +H LV+E +S +L L G++ + A + L+
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLN----LTRKFAQQMCTALL 171
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTP--RISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
+L IIHCD+KP+NILL + +I DFG + + Q I+ + Y
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQ-SRFYR 225
Query: 652 APEWFRKASITVKVDVYSFGVLLLEL 677
+PE + +D++S G +L+E+
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEM 251
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 61/232 (26%)
Query: 487 QILGRGAFGTVYKGVLASDSKR--FVAIK---KLDKVEQQGEKEFRTEVSVIGQ-----T 536
+ +G G FG V + A+K + K + + E ++ +
Sbjct: 41 RKMGDGTFGRVLL---CQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDI 93
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL----FGITRPDWNQRVQ-IAFGIARG 591
++ N+V+ G DH L++E + SL + + + ++ I +
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNY---NGFHIEDIKLYCIEILKA 149
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDD--YFTPRISDFGLAKLLLAEQTQAARTGIR---- 645
L YL + + H D+KP+NILLDD + I+ + + + TGI+
Sbjct: 150 LNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 646 G--------------TVGYFAPE------WFRKASITVKVDVYSFGVLLLEL 677
G T Y APE W V D++SFG +L EL
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAEL 252
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 33/172 (19%), Positives = 64/172 (37%), Gaps = 27/172 (15%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIK---KLDKVEQQGEKEFR--TEVSVIGQTHHKNL 541
LG G FG V + + + K VA+K + K + E ++ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 542 VRLLGFCDEGDHRLLV--------YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLM 593
V + + + H + +E++ + + R +A+ + L
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH-------MAYQLCHALR 137
Query: 594 YLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+LHE Q+ H D+KP+NIL + + + + E+ T IR
Sbjct: 138 FLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC----EEKSVKNTSIR 182
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 7e-12
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 4/73 (5%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSW-ATMQDDGNFV 112
T VW++N +G + L + G V+YD +G LW ++ +Q+DGN V
Sbjct: 37 STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVV 96
Query: 113 LLGGDSNPIWESF 125
+ G + IW +
Sbjct: 97 IYG---SDIWSTG 106
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 32/144 (22%), Positives = 61/144 (42%), Gaps = 23/144 (15%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIK---KLDKVEQQGEKEFR--TEVSVIGQTHHKNL 541
LG GAFG V + + R VA+K +D+ + E + ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFL-------FGITRPDWNQRVQ-IAFGIARGLM 593
V++L + + H +V+E + S F+ F + ++ +A+ I + +
Sbjct: 80 VQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRL------DHIRKMAYQICKSVN 132
Query: 594 YLHEECSTQIIHCDIKPQNILLDD 617
+LH ++ H D+KP+NIL
Sbjct: 133 FLHSN---KLTHTDLKPENILFVQ 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 8e-11
Identities = 24/188 (12%), Positives = 44/188 (23%), Gaps = 51/188 (27%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKL--------DKVEQQGEKEFRTEVSV-------- 532
+G G FG V++ VAIK + + Q+ +E E+ +
Sbjct: 28 IGEGVFGEVFQ---TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 533 -IGQTHHKNLVRLLGFC-----------------------------DEGDHRLLVYEYMS 562
+ + L D +L +
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPR 622
G + I + L + H D+ N+LL +
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKK 202
Query: 623 ISDFGLAK 630
+ K
Sbjct: 203 LHYTLNGK 210
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-10
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 5/72 (6%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSW-ATMQDDGNFV 112
+W+ N G + L G LV+ + +WQ P G + +Q D N V
Sbjct: 48 NNPIWATNTGGLGN-GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 113 LLGGDSNPIWES 124
+ G + +W +
Sbjct: 107 IYG---DALWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-07
Identities = 21/150 (14%), Positives = 47/150 (31%), Gaps = 39/150 (26%)
Query: 40 DVFLLAIWFDKIPEKTIVWSANGDDPAPRGS-QVKLTNSGELVLYDPQGHELWQKPKDG- 97
+ + + D + + + + + + + LVLYD + +W G
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGL 59
Query: 98 SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGR 157
A +Q DG V++ ++ +W+S G
Sbjct: 60 GNGCRAVLQPDGVLVVITNENVTVWQS-------------------------PVAGKAGH 94
Query: 158 FRFLLKENGNLELSSVSLTTQVVYD-VYWS 186
+ +L+ + N+ V+Y W+
Sbjct: 95 YVLVLQPDRNV----------VIYGDALWA 114
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 41/192 (21%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G+FG +++G + + VAIK Q E+RT + G T + +
Sbjct: 18 IGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYY 73
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------VQIAFGIARGLMYLHEEC 599
F EG H +LV + + SL L D R A + + +H
Sbjct: 74 FGQEGLHNVLVIDLLGP-SLED-LL-----DLCGRKFSVKTVAMAAKQMLARVQSIH--- 123
Query: 600 STQIIHCDIKPQNILLDDYFTPR-----ISDFGLAKLLLAEQTQA-----ARTGIRGTVG 649
+++ DIKP N L+ + + DFG+ K T+ + + GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 650 YFAPEWFRKASI 661
Y SI
Sbjct: 184 Y--------MSI 187
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.7 bits (143), Expect = 7e-10
Identities = 31/235 (13%), Positives = 61/235 (25%), Gaps = 28/235 (11%)
Query: 19 SNPWRSPSGEFAFGFHHIDNQDVF--LLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTN 76
SP+ F N + +W + + AP
Sbjct: 26 GQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPLRNKKAPLAFY----V 81
Query: 77 SGELVLYDPQGHELWQKPKDGSKSSWAT------MQDDGNFVLLGGDSNPIWESFKEPTD 130
L D +W S+ +QDDGN VL+ +
Sbjct: 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVP 141
Query: 131 TLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE 190
+ +L + Y G + + + +GNL + +WN+
Sbjct: 142 GAIDSLLLAPG---SELVQGVVYGAGASKLVFQGDGNLVAYG--------PNGAATWNAG 190
Query: 191 AWNAD-SQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQY 244
+ +F G + + + + G + + R+ +G
Sbjct: 191 TQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA----SAVLRLQANGSIAIL 241
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.7 bits (130), Expect = 3e-08
Identities = 17/72 (23%), Positives = 26/72 (36%), Gaps = 4/72 (5%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVL 113
W+A + G LV+Y LW G S+ +Q +G+ +
Sbjct: 183 GAATWNAGTQGKG--AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAI 240
Query: 114 LGGDSNPIWESF 125
L D P+W F
Sbjct: 241 L--DEKPVWARF 250
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.2 bits (108), Expect = 2e-05
Identities = 26/137 (18%), Positives = 36/137 (26%), Gaps = 39/137 (28%)
Query: 75 TNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLP 134
G LV Y P G W G + A Q DGN V+ G + +W S
Sbjct: 171 QGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHS---------- 220
Query: 135 GQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNA 194
H L+ NG++ + D W +
Sbjct: 221 ----------------HTGGHASAVLRLQANGSI----------AILDEKPVWARFGFQP 254
Query: 195 DSQ---LIFDRAGYIYI 208
+ I I I
Sbjct: 255 TYRHIRKINPDQKPIDI 271
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 28/158 (17%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G G FG + G + +VAIK + Q E+R + + ++
Sbjct: 15 KKIGCGNFGELRLGK-NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQV 70
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------VQIAFGIARGLMYLHE 597
F G + +V E + SL LF D R + IA + + Y+H
Sbjct: 71 YYFGPCGKYNAMVLELLGP-SLED-LF-----DLCDRTFSLKTVLMIAIQLISRMEYVH- 122
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPR-----ISDFGLAK 630
S +I+ D+KP+N L+ I DF LAK
Sbjct: 123 --SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-09
Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 5/73 (6%)
Query: 53 EKTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWA-TMQDDGNF 111
W +N ++L + GEL++ D +W + + +QDDG
Sbjct: 40 GGKYGWQSNTHG-NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFG 98
Query: 112 VLLGGDSNPIWES 124
V+ G I+E+
Sbjct: 99 VIYG---PAIFET 108
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 19/124 (15%), Positives = 38/124 (30%), Gaps = 39/124 (31%)
Query: 68 RGSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFK 126
+ Q+ + LVLY WQ G+ + + + G ++ D IW S
Sbjct: 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSS-- 79
Query: 127 EPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD-VYW 185
+ + G + +L+++G V+Y +
Sbjct: 80 -----------------------RSSSKQGEYVLILQDDGFG----------VIYGPAIF 106
Query: 186 SWNS 189
+S
Sbjct: 107 ETSS 110
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 4e-04
Identities = 23/126 (18%), Positives = 44/126 (34%), Gaps = 24/126 (19%)
Query: 128 PTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSW 187
+ L GQ+L +T+ + +++ + NL V+Y + W
Sbjct: 5 TNNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNL----------VLYGGKYGW 45
Query: 188 NSEAWNADSQ--LIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYT 245
S L + G + IK + + + + S Q Y++ + DG Y
Sbjct: 46 QSNTHGNGEHCFLRLNHKGELIIKDDDFKT--IWSSRSSSKQGEYVL-ILQDDGFGVIYG 102
Query: 246 HPKYET 251
+ET
Sbjct: 103 PAIFET 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-09
Identities = 20/71 (28%), Positives = 31/71 (43%), Gaps = 5/71 (7%)
Query: 55 TIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQ-KPKDGSKSSWATMQDDGNFVL 113
VW++N G ++ L N+G LV+YD +WQ K +Q D N V+
Sbjct: 39 KPVWASNTGGLGS-GCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI 97
Query: 114 LGGDSNPIWES 124
G +W +
Sbjct: 98 YG---PVVWAT 105
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 38/115 (33%)
Query: 74 LTNSGELVLYDPQGHELWQKPKDG-SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTL 132
+ VLYD G +W G T+ ++GN V+ + IW++ T
Sbjct: 26 MQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT-----KT- 78
Query: 133 LPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD-VYWS 186
N + +L+++ N+ V+Y V W+
Sbjct: 79 -------------------NGKEDHYVLVLQQDRNV----------VIYGPVVWA 104
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 5e-09
Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 1/70 (1%)
Query: 55 TIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLL 114
VW++ + G +K+ N G LV+Y + + + +Q D N V+
Sbjct: 38 RAVWASG-TNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY 96
Query: 115 GGDSNPIWES 124
+N IW +
Sbjct: 97 DNSNNAIWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-06
Identities = 19/120 (15%), Positives = 38/120 (31%), Gaps = 26/120 (21%)
Query: 129 TDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD---VYW 185
+D L G L++ ++ G + F+++ + NL V+YD W
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNL----------VLYDNNRAVW 41
Query: 186 SWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYT 245
+ + + L G + I G++ I+ + D Y
Sbjct: 42 ASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNY----YLILQRDRNVVIYD 97
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-08
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 10/79 (12%)
Query: 58 WSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWA-TMQDDGNFVLLGG 116
W +N + R ++ LT+ GELV+ + G +W+ K ++A + DG V+ G
Sbjct: 40 WQSNTAN-NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG- 97
Query: 117 DSNPIWESFKEPTDTLLPG 135
++ D + G
Sbjct: 98 --PSVF-----KIDPWVRG 109
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-06
Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 22/119 (18%)
Query: 129 TDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWN 188
T+ LL GQ L++ + G F +++++ NL V+Y+ W N
Sbjct: 3 TNYLLSGQTLDTE---------GHLKNGDFDLVMQDDCNL----------VLYNGNWQSN 43
Query: 189 SEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHP 247
+ D +L G + IK G+ + K G +S++ Y A + DG +
Sbjct: 44 TANNGRDCKLTLTDYGELVIKNGDGST--VWKSGAQSVKGNYA-AVVHPDGRLVVFGPS 99
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 14/52 (26%), Positives = 23/52 (44%), Gaps = 5/52 (9%)
Query: 74 LTNSGELVLYDPQGHELWQKPKDG-SKSSWATMQDDGNFVLLGGDSNPIWES 124
+ + LVLY+ WQ + T+ D G V+ GD + +W+S
Sbjct: 27 MQDDCNLVLYNGN----WQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKS 74
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 16/72 (22%), Positives = 30/72 (41%), Gaps = 5/72 (6%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSW-ATMQDDGNFV 112
+W+ N R + + + G LV+Y P+ + +W G ++ +Q D N V
Sbjct: 37 DKPIWATN-TGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVV 95
Query: 113 LLGGDSNPIWES 124
+ G W +
Sbjct: 96 IYG---TARWAT 104
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 24/118 (20%), Positives = 38/118 (32%), Gaps = 38/118 (32%)
Query: 71 QVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPT 129
+ LVLYD +W G + +MQ DGN V+ +NPIW S
Sbjct: 22 VFIMQEDCNLVLYD-VDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWAS----- 75
Query: 130 DTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD-VYWS 186
G + +L+++ N+ V+Y W+
Sbjct: 76 --------------------NTGGENGNYVCVLQKDRNV----------VIYGTARWA 103
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 45/179 (25%), Positives = 69/179 (38%), Gaps = 31/179 (17%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G+FG +Y G + VAIK + Q E + + G + +
Sbjct: 17 IGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG---IPTIRW 72
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------VQIAFGIARGLMYLHEEC 599
EGD+ ++V E + SL LF ++ R + +A + + Y+H
Sbjct: 73 CGAEGDYNVMVMELLGP-SLED-LF-----NFCSRKFSLKTVLLLADQMISRIEYIH--- 122
Query: 600 STQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQTQA-----ARTGIRGTVGY 650
S IH D+KP N L+ I DFGLAK +T + GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 51/215 (23%), Positives = 82/215 (38%), Gaps = 47/215 (21%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIK--KLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+G G+FG +Y G + VAIK + Q E + + G T + +
Sbjct: 15 IGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG---IPNVRW 70
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------VQIAFGIARGLMYLHEEC 599
F EGD+ +LV + + SL LF ++ R + +A + + ++H +
Sbjct: 71 FGVEGDYNVLVMDLLGP-SLED-LF-----NFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 600 STQIIHCDIKPQNILLDDYFTPR---ISDFGLAKLLLAEQTQA-----ARTGIRGTVGYF 651
+H DIKP N L+ I DFGLAK T + GT Y
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY- 179
Query: 652 APEWFRKASITV--------KVDVYSFGVLLLELI 678
AS+ + D+ S G +L+ +
Sbjct: 180 -------ASVNTHLGIEQSRRDDLESLGYVLMYFL 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 37/194 (19%), Positives = 64/194 (32%), Gaps = 44/194 (22%)
Query: 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSV---------IGQTHHK 539
+G G FG +Y ++ A + KVE Q +E+ I + +
Sbjct: 45 IGSGGFGLIYLAF-PTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 540 NLVRLLGF----------CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR------VQ 583
+ LG +R +V E + L N +Q
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS------GQNGTFKKSTVLQ 155
Query: 584 IAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI--SDFGLAKLLLAEQTQAA- 640
+ + L Y+H + +H DIK N+LL ++ +D+GL+
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 641 ----RTGIRGTVGY 650
R G GT+ +
Sbjct: 213 QENPRKGHNGTIEF 226
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 6e-08
Identities = 15/72 (20%), Positives = 32/72 (44%), Gaps = 5/72 (6%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWA-TMQDDGNFV 112
IVW + + ++L +SGEL + D + + ++ G + + +Q +G V
Sbjct: 44 TNIVWESGTSG-RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAV 102
Query: 113 LLGGDSNPIWES 124
+ G +W +
Sbjct: 103 VYG---PAVWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 8/56 (14%), Positives = 21/56 (37%), Gaps = 2/56 (3%)
Query: 71 QVKLTNSGELVLYDP-QGHELWQKPKDG-SKSSWATMQDDGNFVLLGGDSNPIWES 124
+ + + LVL + + +W+ G + + + G + N ++ S
Sbjct: 27 SLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVS 82
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-08
Identities = 19/72 (26%), Positives = 33/72 (45%), Gaps = 5/72 (6%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSW-ATMQDDGNFV 112
+W++N D G ++ L + G LV+YD +++W G + +Q DG FV
Sbjct: 38 GRQIWASNTDRRG-SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFV 96
Query: 113 LLGGDSNPIWES 124
+ G +W
Sbjct: 97 IYG---PVLWSL 105
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-06
Identities = 22/121 (18%), Positives = 37/121 (30%), Gaps = 25/121 (20%)
Query: 130 DTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD---VYWS 186
+ LL GQ L++ H+ G + ++ NL V Y W+
Sbjct: 3 NVLLSGQTLHAD---------HSLQAGAYTLTIQNKCNL----------VKYQNGRQIWA 43
Query: 187 WNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTH 246
N++ + +L G + I N + Y + DG F Y
Sbjct: 44 SNTDRRGSGCRLTLLSDGNLVIYDHNNND--VWGSACWGDNGKY-ALVLQKDGRFVIYGP 100
Query: 247 P 247
Sbjct: 101 V 101
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 20/114 (17%), Positives = 33/114 (28%), Gaps = 36/114 (31%)
Query: 74 LTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLL 133
+ N LV Y T+ DGN V+ ++N +W S
Sbjct: 26 IQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGS--------- 76
Query: 134 PGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD-VYWS 186
G++ +L+++G V+Y V WS
Sbjct: 77 ----------------ACWGDNGKYALVLQKDGRF----------VIYGPVLWS 104
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 31/171 (18%), Positives = 64/171 (37%), Gaps = 40/171 (23%)
Query: 489 LGRGAFGTVYKG-------VLASDSKRFVAIKKLDKVEQQGEKEFRT--------EVSVI 533
R G +Y+ + K+ ++K LD + + E +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 534 GQTHHKNLV---RLLGF-CDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------- 581
+ + L+ +GF + +R LV + SL S L D + +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL------DVSPKHVLSERSV 161
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI--SDFGLAK 630
+Q+A + L +LH + +H ++ +NI +D ++ + +G A
Sbjct: 162 LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 32/170 (18%), Positives = 60/170 (35%), Gaps = 38/170 (22%)
Query: 489 LGRGAFGTVYKGVLASD----SKRFVAIKKLDKVEQQGEKEFRT-----EVSVIGQTHHK 539
+G+G FG +Y + S S +K E + + I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 540 NLVRLLGFC----------DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQR-------V 582
++ LG + +R ++ + + L + N + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY------EANAKRFSRKTVL 155
Query: 583 QIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI--SDFGLAK 630
Q++ I L Y+HE +H DIK N+LL+ ++ D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 5e-07
Identities = 32/248 (12%), Positives = 64/248 (25%), Gaps = 55/248 (22%)
Query: 46 IWFDKIPEKTIVWSANGDDPAPRGS-QVKLTNSGELVLYDPQGHELWQKPKDGSKSSWAT 104
I F E + + + S + + + LVL+D +W G+ A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAV 61
Query: 105 MQDDGNFVLLGGDSNPIWES-------------------------------------FKE 127
+Q DG V+L + W S
Sbjct: 62 LQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVA 121
Query: 128 PTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD---VY 184
+ + + + + +R ++ + NL V++D
Sbjct: 122 NNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNL----------VLFDRDDRV 171
Query: 185 WSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQY 244
WS N+ + + G + + + G Y + + D Y
Sbjct: 172 WSTNTAGKGTGCRAVLQPNGRMDVLTNQNIA--VWTSGNSRSAGRY-VFVLQPDRNLAIY 228
Query: 245 THPKYETA 252
+ T
Sbjct: 229 GGALWTTG 236
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-06
Identities = 12/72 (16%), Positives = 26/72 (36%), Gaps = 8/72 (11%)
Query: 57 VWSANGDDPAPRGSQVKLTNSGELVLYDPQGHE-LWQ---KPKDGSKSSWATMQDDGNFV 112
+ +N ++L N G+L ++ + +W + AT+ D +
Sbjct: 40 GFQSNTHGRG-VDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVT 98
Query: 113 LLGGDSNPIWES 124
+ G IW +
Sbjct: 99 IYG---PAIWST 107
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 17/121 (14%), Positives = 38/121 (31%), Gaps = 25/121 (20%)
Query: 131 TLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE 190
LL G ++++ + S F+++ + NL V+Y+ + S
Sbjct: 4 VLLTGDVIHTD---------NQLSYESAAFVMQGDCNL----------VLYNEAGGFQSN 44
Query: 191 AWNADS--QLIFDRAG--YIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTH 246
L + G I+ N ++ + +++ Y + D Y
Sbjct: 45 THGRGVDCTLRLNNRGQLEIHSANSNTPVW-VYPRSVNTVRGNYAA-TLGPDQHVTIYGP 102
Query: 247 P 247
Sbjct: 103 A 103
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-05
Identities = 78/676 (11%), Positives = 177/676 (26%), Gaps = 208/676 (30%)
Query: 150 QHNYSTGRFRFLLKEN--GNLELSSVS------LTTQVVYDVYWSWNSEAWNADSQLIFD 201
+H Y + ++ N + V L+ + + + S ++ + + +F
Sbjct: 13 EHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS---GTLRLFW 69
Query: 202 RAGYIYIKKGNQRIYNLTKIGTRSMQDF-YIMARIDYDGVFRQYTHPKYETACNFTWRME 260
+ K + + + ++ ++M+ I + Y + +
Sbjct: 70 ----TLLSKQEEMVQKF--VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 261 ERIPQ-DIC--------------------VAITGDIGSG-------ACGYNSICAEINGE 292
+ + ++ V I G +GSG C + +++ +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK 183
Query: 293 ------PKCLCPD-------NYSYLNQSDTSQGCKPNFPLPSCQDNGWETKYNELVDFKS 339
C P+ Y + + + + + + + + L+ K
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL-RIHSIQAELRRLLKSKP 242
Query: 340 YENTDWPLSD-YDLQIGNGVNRQTCEQLC--REDCFCAAAIYNGDYCWKKKYPLSNGRRS 396
YEN L + + + N N C+ L R + + LS +
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLS-CKILLTTRF-----KQVTDF---------LSAATTT 287
Query: 397 TSVNRIALVKVPKVDVSKLLEKKDQSTLVLVICLLLGSSVF---LNILLI--FAISVAAY 451
+ S L + +L+L L +L +S+ A
Sbjct: 288 ---------HISLDHHSMTLTPDEVKSLLL---KYLDCRPQDLPREVLTTNPRRLSIIAE 335
Query: 452 LFYHKKLLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVA 511
L N + +L
Sbjct: 336 SI-RDGLATW------DNWKHVNCDKLTTIIESS-------------------------- 362
Query: 512 IKKLDKVEQQGEKE----FRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLA 567
+ L+ E + + F + L + + D ++V + + SL
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVMVVVNK-LHKYSLV 417
Query: 568 SFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQ--------NILLDDYF 619
+ + I+ ++K + ++D Y
Sbjct: 418 -------EKQPK----------ESTISIPS------IYLELKVKLENEYALHRSIVDHYN 454
Query: 620 TPRISDF-GLAKLLLAEQTQAARTGIRGTVGYFAPEWF-----RKASITVKVDVYSFGVL 673
P+ D L L YF + ++ + F ++
Sbjct: 455 IPKTFDSDDLIPPYLD--------------QYFY--SHIGHHLKNIEHPERMTL--FRMV 496
Query: 674 LLEL------ICCKSSVVFGTTNPEEALMDW-VYRCYIGKNLDKLAENDEEVKNDLKRVE 726
L+ I S+ + + L Y+ YI N K + + L ++E
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE 556
Query: 727 ---------RLVMVAL 733
L+ +AL
Sbjct: 557 ENLICSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 77/538 (14%), Positives = 148/538 (27%), Gaps = 191/538 (35%)
Query: 97 GS-KSSWA--TMQDDGNFVLLGGDSNPIWESF---KEPTDTLLPGQILNSPI--NITSR- 147
GS K+ A V D W + P L Q L I N TSR
Sbjct: 160 GSGKTWVALDVCLSYK--VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 148 ------RTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFD 201
+ + + R LLK L V+ +V N++AWNA F+
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYEN----CLL--VLLNV---QNAKAWNA-----FN 263
Query: 202 RAGYIYIKKGNQRIYNLTKIGTR--SMQDF---YIMARIDYDGVFRQYTHPKYETAC-NF 255
+ +I LT TR + DF I D T + ++ +
Sbjct: 264 ---------LSCKIL-LT---TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 256 TWRMEERIPQDICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSYLNQSDTSQGCKP 315
+ +P+++ SI AE + DN+ ++N
Sbjct: 311 LDCRPQDLPREVL-----TTNPRRL---SIIAESIRDGLAT-WDNWKHVNCD-------- 353
Query: 316 NFPLPSCQDNGWETKYNELVDFKSYENTDWPLSDYDLQIGNGVNRQTCEQLCREDCFCAA 375
K +++ S L + + F
Sbjct: 354 --------------KLTTIIE-SSLNV----LEPAEYR----------------KMFDRL 378
Query: 376 AIYNGDYCWKKKYPLSNGRRSTSVNRIALVKVPKVDVSKLLEKKDQSTLVLVICLLLGSS 435
+++ +P + +S + +S +++V+ L S
Sbjct: 379 SVFPPS-----------------------AHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 436 V-----------FLNILLIFAISVAAYLFYHKKLLRSVSSPSATNVRSFT------Y--- 475
+ +I L + + H+ ++ + P + Y
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475
Query: 476 --------KELEEATRGFRQIL---------------GRGAFGTV---------YKGVLA 503
E E FR + A G++ YK +
Sbjct: 476 HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
Query: 504 SDSKRFVAIKK--LDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559
+ ++ + LD + + E ++ + +L+R + E + ++E
Sbjct: 536 DNDPKYERLVNAILDFLPKIEENLICSK--------YTDLLR-IALMAEDEA---IFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 8e-04
Identities = 51/367 (13%), Positives = 97/367 (26%), Gaps = 123/367 (33%)
Query: 409 KVDVSKLLEKKD--QSTLVLVICLLL-GSSV---FLNIL-------LIFAISV------- 448
K ++ ++ KD TL L LL + F+ + L+ I
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107
Query: 449 --AAYLFYHKKLLRSVSSPSATNV-RSFTYKELEEATRGFRQ-----ILGRGAFGTVYKG 500
Y+ +L + NV R Y +L +A R I G G K
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KT 164
Query: 501 VLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560
+A D + + + ++ + L C+ + L E
Sbjct: 165 WVALDVCLSYKV----------QCKMDFKIFWLN----------LKNCNSPETVL---EM 201
Query: 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620
+ L P+W R + I + + E + + ++L +
Sbjct: 202 LQK------LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 621 PRISD-FGL-AKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELI 678
+ + F L K+LL T T R +T + + + L+
Sbjct: 256 AKAWNAFNLSCKILL--------T----T---------RFKQVTDFLSAATTTHISLD-- 292
Query: 679 CCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQE 738
S+ P+E ++ +
Sbjct: 293 --HHSMTL---TPDEVKS---------------------------------LLLKYLDCR 314
Query: 739 DASLRPQ 745
L +
Sbjct: 315 PQDLPRE 321
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.82 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.79 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.65 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.62 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.6 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.55 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.55 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.52 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.38 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.31 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.24 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.17 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.09 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.96 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.93 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.92 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.49 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.5 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.25 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 88.95 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.15 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.1 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 83.03 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 80.8 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=417.80 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=204.3
Q ss_pred CHHHHHHHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEE
Q 040134 474 TYKELEEATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFC 548 (745)
Q Consensus 474 ~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 548 (745)
.+.|+...+.+|.++||+|+||+||+|++.. ..++.||||+++.. .....++|.+|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3344455566788999999999999999742 34578999999653 334567899999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 040134 549 DEGDHRLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQN 612 (745)
Q Consensus 549 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~N 612 (745)
.+++..+|||||+++|+|.++|... ..+++.++++|+.||+.||+|||+. +||||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence 9999999999999999999999643 3578999999999999999999965 99999999999
Q ss_pred EEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCc
Q 040134 613 ILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNP 691 (745)
Q Consensus 613 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~ 691 (745)
|||++++.+||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--- 252 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--- 252 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999998765544443455679999999999999999999999999999999999 888885322
Q ss_pred hhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 692 EEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+. ..+..+..... .......+.+|+.+||+.||++|||
T Consensus 253 ~~~~~----~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs 293 (308)
T 4gt4_A 253 NQDVV----EMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPR 293 (308)
T ss_dssp HHHHH----HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHH----HHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcC
Confidence 12222 22223322211 1123456889999999999999997
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=412.32 Aligned_cols=245 Identities=26% Similarity=0.455 Sum_probs=200.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+.||+|+||+||+|++.. .+++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 44577899999999999998753 34678999999876666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 558 YEYMSNGSLASFLFGI-------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
|||+++|+|.++|... ..+++.++++|+.||+.||+|||++ +||||||||+||||++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999643 4689999999999999999999965 99999999999999999999999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||+++...............||+.|||||.+.+..++.++|||||||+||||+| |+.||.... ...+.. .+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~----~i 243 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIE----CI 243 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHH----HH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HH
Confidence 9999987655443333344568999999999999999999999999999999999 899985322 122222 22
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..... +......+.+|+.+||+.||++|||
T Consensus 244 ~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs 276 (299)
T 4asz_A 244 TQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKN 276 (299)
T ss_dssp HHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcC
Confidence 22222111 1122356889999999999999997
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=407.74 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=192.1
Q ss_pred hcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
..+.++||+|+||+||+|++.. .+++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467889999999999998753 346789999998766667789999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC---------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEE
Q 040134 559 EYMSNGSLASFLFGI---------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI 623 (745)
Q Consensus 559 e~~~~gsL~~~l~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 623 (745)
||+++|+|.++|+.. .++++.++++|+.||+.||+|||+. +||||||||+||||++++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEE
Confidence 999999999999753 3588999999999999999999965 9999999999999999999999
Q ss_pred eeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 040134 624 SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||.... ...+...+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i--- 273 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCI--- 273 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHH---
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHH---
Confidence 99999987755443333445679999999999999999999999999999999999 899985332 12222222
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..... +......+.+|+.+||+.||++|||
T Consensus 274 -~~g~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs 306 (329)
T 4aoj_A 274 -TQGRELER---------PRACPPEVYAIMRGCWQREPQQRHS 306 (329)
T ss_dssp -HHTCCCCC---------CTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred -HcCCCCCC---------cccccHHHHHHHHHHcCcChhHCcC
Confidence 22211110 1112356889999999999999997
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=402.12 Aligned_cols=243 Identities=28% Similarity=0.350 Sum_probs=204.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|++.++||+|+||+||+++... +++.||||++.+. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEecccCeEEEEEEECC-CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 37788999999999999999765 4678999999642 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++|+|.++|...+.+++.++..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999998888999999999999999999999965 9999999999999999999999999999987655444
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......+||+.|||||++.+..++.++|||||||+||||+||+.||.... ...+.. .+..+.+.. ..
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~----~i~~~~~~~------p~ 255 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFA----KIIKLEYDF------PE 255 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHTCCCC------CT
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHcCCCCC------Cc
Confidence 44556789999999999999999999999999999999999999995321 222222 222222211 01
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....++.+|+.+||+.||++|||
T Consensus 256 ----~~s~~~~dli~~lL~~dp~~R~t 278 (311)
T 4aw0_A 256 ----KFFPKARDLVEKLLVLDATKRLG 278 (311)
T ss_dssp ----TCCHHHHHHHHHHSCSSGGGSTT
T ss_pred ----ccCHHHHHHHHHHccCCHhHCcC
Confidence 11345788999999999999997
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=399.35 Aligned_cols=244 Identities=29% Similarity=0.393 Sum_probs=188.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.||+|+||+||+|++.. .||||+++.. .....+.|.+|++++++++|||||++++++.+ +..+|||||
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~----~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG----DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS----EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred eEEeeEEeeCCCcEEEEEEECC----cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 3477899999999999998753 3899998642 33445789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++|+|.++|... ..+++.++++|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999754 6799999999999999999999965 99999999999999999999999999998765443333
Q ss_pred ccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
......||+.|||||++.+ .+++.++|||||||+||||+||+.||..... ...+.. ....+.......
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~----~~~~~~~~p~~~--- 260 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIF----MVGRGYASPDLS--- 260 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHH----HHHTTCCCCCST---
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHH----HHhcCCCCCCcc---
Confidence 3455689999999999964 3689999999999999999999999863322 222222 222221111110
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+|+.+||+.||++|||
T Consensus 261 --~~~~~~~~~l~~li~~cl~~dP~~RPs 287 (307)
T 3omv_A 261 --KLYKNCPKAMKRLVADCVKKVKEERPL 287 (307)
T ss_dssp --TSCTTSCHHHHHHHHHHTCSSSTTSCC
T ss_pred --cccccchHHHHHHHHHHcCCCHhHCcC
Confidence 011123456889999999999999997
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=403.11 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=200.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+++.+.||+|+||+||+|+... +++.||||+++.......+.+.+|++++++++|||||++++++.+++.+||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred cEEeEEeecCcCeEEEEEEECC-CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 5566789999999999999865 467899999976666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+|+|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 228 (346)
T 4fih_A 155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 228 (346)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--ccc
Confidence 9999999865 5689999999999999999999965 999999999999999999999999999987654332 134
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..+||+.|||||++.+..++.++|||||||+||||++|+.||.... ...+...+ ..+....+ +...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i----~~~~~~~~-------~~~~ 294 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMI----RDNLPPRL-------KNLH 294 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH----HHSSCCCC-------SCGG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH----HcCCCCCC-------Cccc
Confidence 5689999999999999999999999999999999999999995321 12222222 11111111 1111
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+|+.+||+.||++|||
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~t 317 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRAT 317 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcC
Confidence 22356889999999999999997
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=391.89 Aligned_cols=241 Identities=26% Similarity=0.390 Sum_probs=192.5
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec----CCeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----GDHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv 557 (745)
+|.++||+|+||+||+|.... +++.||+|++... .....+.|.+|++++++++|||||++++++.+ .+.++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 456789999999999999865 4567999998642 33345679999999999999999999999865 3568999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ ..+||||||||+||||+. ++.+||+|||+|+......
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 99999999999998888999999999999999999999965 223999999999999974 7899999999997643221
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....||+.|||||++.+ .++.++|||||||+||||+||+.||..... ... +.+.+..+......+.
T Consensus 187 ----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~----~~~~i~~~~~~~~~~~-- 253 (290)
T 3fpq_A 187 ----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPASFDK-- 253 (290)
T ss_dssp ----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGGGGG--
T ss_pred ----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHH----HHHHHHcCCCCCCCCc--
Confidence 345689999999999865 699999999999999999999999953221 111 2222222222111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....++.+|+.+||+.||++|||
T Consensus 254 ------~~~~~~~~li~~~L~~dP~~R~s 276 (290)
T 3fpq_A 254 ------VAIPEVKEIIEGCIRQNKDERYS 276 (290)
T ss_dssp ------CCCHHHHHHHHHHSCSSGGGSCC
T ss_pred ------cCCHHHHHHHHHHccCChhHCcC
Confidence 11235788999999999999997
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=402.24 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=192.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.|.+.+.||+|+||+||+|+... +++.||||++... .....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETT-TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46778899999999999999765 4678999998643 33345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++|+|.++|... ..+++.+++.++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999644 4568889999999999999999965 999999999999999999999999999987654322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......||+.|||||++.+..++.++|||||||+||||+||+.||.... ..+ + + ..+..+....+
T Consensus 181 --~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~-~---~-~~i~~~~~~~~------ 245 (350)
T 4b9d_A 181 --LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--MKN-L---V-LKIISGSFPPV------ 245 (350)
T ss_dssp --HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHH-H---H-HHHHHTCCCCC------
T ss_pred --cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHH-H---H-HHHHcCCCCCC------
Confidence 1334679999999999999999999999999999999999999996322 111 1 1 11222222211
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+|+.+||+.||++|||
T Consensus 246 ---~~~~s~~~~~li~~~L~~dP~~R~s 270 (350)
T 4b9d_A 246 ---SLHYSYDLRSLVSQLFKRNPRDRPS 270 (350)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcC
Confidence 1112346889999999999999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=403.47 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=200.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
|.+.+.||+|+||.||+|+... +++.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEeeeEeccCcCcEEEEEEECC-CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 5567889999999999999865 467899999976666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+|+|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 305 (423)
T 4fie_A 232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 305 (423)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBC
T ss_pred CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--ccc
Confidence 9999999864 5689999999999999999999965 999999999999999999999999999987654332 234
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ...+...+ ..+....+. ...
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i----~~~~~~~~~-------~~~ 371 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMI----RDNLPPRLK-------NLH 371 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH----HHSCCCCCS-------CTT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH----HcCCCCCCc-------ccc
Confidence 5689999999999999999999999999999999999999995321 11222222 122111111 111
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+|+.+||+.||++|||
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~t 394 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRAT 394 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcC
Confidence 12346889999999999999997
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=396.05 Aligned_cols=240 Identities=20% Similarity=0.190 Sum_probs=192.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.++||+|+||+||+|+... +++.||||+++.... ..+|+.++++++|||||++++++.+++..||||||++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~-~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eEeCcEeccCCCeEEEEEEECC-CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4456789999999999999765 467899999965321 2469999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCccccccccccc--
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQTQA-- 639 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~-- 639 (745)
+|+|.++|...+.+++.++..++.||+.||+|||+ .+||||||||+||||+.++ .+||+|||+|+.+.......
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999999888889999999999999999999995 4999999999999999987 69999999999875443211
Q ss_pred -ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 -ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 -~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......||+.|||||++.+..++.++|||||||+||||+||+.||...... ..+.. +.. +.... .
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~-i~~----~~~~~-~------ 276 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLK-IAS----EPPPI-R------ 276 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHH-HHH----SCCGG-G------
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHH-HHc----CCCCc-h------
Confidence 123357999999999999999999999999999999999999999643322 22211 111 11110 0
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++|||
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~s 303 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRAS 303 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcC
Confidence 011122356888999999999999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=383.11 Aligned_cols=239 Identities=21% Similarity=0.312 Sum_probs=185.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|.+.+.||+|+||+||+++... +++.||||++.+. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTT-TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47788999999999999999765 4678999998642 2344568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+ +|+|.+++.....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~- 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF- 167 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc-
Confidence 999 679999998888999999999999999999999965 999999999999999999999999999987644322
Q ss_pred cccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....||+.|||||++.+..+ +.++|||||||++|||+||+.||... ....+.. .+..+.... ..
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~----~i~~~~~~~--p~--- 233 (275)
T 3hyh_A 168 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFK----NISNGVYTL--PK--- 233 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCCCC--CT---
T ss_pred --cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHcCCCCC--CC---
Confidence 344679999999999998876 57999999999999999999999532 1222222 222222211 00
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 234 -----~~s~~~~~li~~~L~~dP~~R~s 256 (275)
T 3hyh_A 234 -----FLSPGAAGLIKRMLIVNPLNRIS 256 (275)
T ss_dssp -----TSCHHHHHHHHHHSCSSGGGSCC
T ss_pred -----CCCHHHHHHHHHHccCChhHCcC
Confidence 11245788999999999999997
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=393.39 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=192.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.|++.+.||+|+||+||+++... ..++.||||+++.. .......+.+|++++++++||||+++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46788999999999999998643 34678999998642 223345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++|+|.++|.+...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999999999998888999999999999999999999965 999999999999999999999999999986543322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......||+.|||||++.+..++.++|||||||+||||+||+.||... + ...+...+ ..+.... +
T Consensus 182 --~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--~-~~~~~~~i----~~~~~~~---p--- 246 (304)
T 3ubd_A 182 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--D-RKETMTMI----LKAKLGM---P--- 246 (304)
T ss_dssp --CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--S-HHHHHHHH----HHCCCCC---C---
T ss_pred --cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--C-HHHHHHHH----HcCCCCC---C---
Confidence 134567999999999999999999999999999999999999999532 2 12222222 2222211 0
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 247 ----~~~s~~~~~li~~~L~~dP~~R~t 270 (304)
T 3ubd_A 247 ----QFLSPEAQSLLRMLFKRNPANRLG 270 (304)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred ----CcCCHHHHHHHHHHcccCHHHCCC
Confidence 012345788999999999999997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=388.50 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=189.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC----eEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD----HRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~ 558 (745)
+.+.+.||+|+||+||+|++. ++.||||+++.... ....++.|+..+.+++||||+++++++.+++ .++|||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET---TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 446789999999999999973 56799999965322 1223345666667889999999999997654 679999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE-----CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
||+++|+|.++|+. ..++++.+.+++.|++.||+|||++ +..+||||||||+||||++++.+||+|||+++...
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999975 4689999999999999999999964 23489999999999999999999999999998765
Q ss_pred ccccc--cccccccccccccchhccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCC--------chhhHHH
Q 040134 634 AEQTQ--AARTGIRGTVGYFAPEWFRKA------SITVKVDVYSFGVLLLELICCKSSVVFGTTN--------PEEALMD 697 (745)
Q Consensus 634 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwslG~vl~elltg~~p~~~~~~~--------~~~~l~~ 697 (745)
..... .......||+.|||||++.+. .++.++|||||||+||||+||..|+...... .......
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 43321 122345799999999999754 4678999999999999999998876432211 0111112
Q ss_pred HHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 698 WVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+......+.....+.. .....+....+.+|+.+||+.||++|||
T Consensus 240 ~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt 284 (303)
T 3hmm_A 240 EMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcC
Confidence 22233333322221111 1123456678999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=394.91 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=198.7
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCC----CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCC-CCceeEEEEEec-CC
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHH-KNLVRLLGFCDE-GD 552 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~-~~ 552 (745)
...+.+.+.||+|+||+||+|.+... ..+.||||+++... ....++|.+|++++.+++| ||||+++|+|.+ ++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 44566788999999999999997643 34689999997533 3345679999999999965 999999999976 45
Q ss_pred eEEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 553 HRLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
..++||||+++|+|.++|+.. ..+++.+++.++.||++||+|||++ +||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence 789999999999999999642 3478999999999999999999965 999999999999999
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEAL 695 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l 695 (745)
+++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...... +.+
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~~~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999998765544333455679999999999999999999999999999999998 89998643322 222
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. .+..+...... .....++.+++.+||+.||++|||
T Consensus 298 ~~----~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt 334 (353)
T 4ase_A 298 CR----RLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPT 334 (353)
T ss_dssp HH----HHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HH----HHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcC
Confidence 22 22222211111 112346889999999999999997
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=374.09 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=179.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC--------
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-------- 552 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 552 (745)
.+++.+.||+|+||+||+|+... +++.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETT-TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 36677899999999999999765 45779999986533 233467899999999999999999999987544
Q ss_pred ----eEEEEEEecCCCCHHHHhcCCCCC---ChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 553 ----HRLLVYEYMSNGSLASFLFGITRP---DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 553 ----~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
..|+||||+++|+|.+++.....+ ++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 378999999999999999876544 4456889999999999999965 999999999999999999999999
Q ss_pred ccCccccccccccc----------ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 040134 626 FGLAKLLLAEQTQA----------ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695 (745)
Q Consensus 626 fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l 695 (745)
||+|+.+....... ......||+.|||||++.+..++.++|||||||+||||++ ||.. ..+..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~----~~~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST----QMERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS----HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC----ccHHH
Confidence 99998875433211 1234579999999999999999999999999999999996 5531 11111
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ............. ..+....+.+++.+||+.||++|||
T Consensus 235 -~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps 273 (299)
T 4g31_A 235 -R-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPE 273 (299)
T ss_dssp -H-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred -H-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcC
Confidence 1 1111122222111 1222345678999999999999997
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=364.12 Aligned_cols=228 Identities=18% Similarity=0.290 Sum_probs=183.9
Q ss_pred ccccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCC-----CcceEEec
Q 040134 2 AKAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPR-----GSQVKLTN 76 (745)
Q Consensus 2 ~~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~-----~~~l~l~~ 76 (745)
++.++|.+|++|+ .+++|+|++|+|+||||++ + ++|| |+ +.+ |||+||||+|+.+ ++.|+|+.
T Consensus 12 ~~~~~l~~g~~l~---~~~~l~S~~g~F~lgf~~~--~-~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~ 79 (276)
T 3m7h_A 12 VGTSVLPAYQTLS---AGQYLLSPNQRFKLLLQGD--G-NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAF 79 (276)
T ss_dssp TTSSEECTTEEBC---TTCEEECTTSSEEEEECTT--S-CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEE
T ss_pred ccCCEecCCCEec---CCCEEEcCCCcEEEEEECC--C-CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeC
Confidence 4678999999999 6789999999999999943 2 5788 76 777 9999999999976 67899999
Q ss_pred CceEEE--EcCCCCEEEeccCCC------CCceEEEEecCccEEEEcCCccccccccccCcCcccCCcc----cCCCceE
Q 040134 77 SGELVL--YDPQGHELWQKPKDG------SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQI----LNSPINI 144 (745)
Q Consensus 77 ~G~Lvl--~~~~~~~vWst~~~~------~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~----l~~~~~L 144 (745)
||+||| .|++|++||||+++. ..+++|+|+|+|||||+| +.+|||| ||||||||||| |..+++|
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L 155 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL 155 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc
Confidence 999999 788899999999764 345789999999999998 7899999 99999999999 6678888
Q ss_pred EecCCCCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCCCCCCCCceeeecccceEEEEeCceeEEEEEecccc
Q 040134 145 TSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTR 224 (745)
Q Consensus 145 ~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (745)
++.+||++|.|+++++++|.+.++ ... ...||+.+++..+. ..+.++..|.+.+.+.++..+..+...
T Consensus 156 ---~S~~dps~G~fsl~l~~dGnlvLy--~~~----~~~yW~Sgt~~~~~-~~l~l~~dGnLvl~d~~~~~vWsS~t~-- 223 (276)
T 3m7h_A 156 ---VQGVVYGAGASKLVFQGDGNLVAY--GPN----GAATWNAGTQGKGA-VRAVFQGDGNLVVYGAGNAVLWHSHTG-- 223 (276)
T ss_dssp ---CTTCEEEETTEEEEECTTSCEEEE--CTT----SSEEEECCCTTTTC-CEEEECTTSCEEEECTTSCEEEECSCT--
T ss_pred ---ccCCCCCCceEEEeecCCceEEEE--eCC----CeEEEECCCCCCcc-EEEEEcCCCeEEEEeCCCcEEEEecCC--
Confidence 567899999999999999976653 222 25788877765443 567777788777776655433332211
Q ss_pred cccceEEEEEEccCCcEEEEEcCCCCcccCcceeeecccccc
Q 040134 225 SMQDFYIMARIDYDGVFRQYTHPKYETACNFTWRMEERIPQD 266 (745)
Q Consensus 225 ~~~~~~~r~~L~~dG~l~~y~~~~~~~~~~~~W~~~~~~p~~ 266 (745)
....+|++|+.||+|++|.| ...|..++.+|+.
T Consensus 224 --~~~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 224 --GHASAVLRLQANGSIAILDE-------KPVWARFGFQPTY 256 (276)
T ss_dssp --TCTTCEEEECTTSCEEEEEE-------EEEEESSSCCTTS
T ss_pred --CCCCEEEEEcCCccEEEEcC-------CCeEEccCccCCc
Confidence 11237899999999999998 2469888887764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=370.71 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=194.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEec------CCe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE------GDH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 553 (745)
.|.+.+.||+|+||+||+|+... +++.||||+++... ....+.+.+|+++|++++||||+++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECC-CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 36678899999999999999765 46789999996432 2334678899999999999999999998753 467
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.||||||++ |+|.+++...+.+++.++..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 68999999889999999999999999999999965 99999999999999999999999999998764
Q ss_pred cccc--ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 634 AEQT--QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 634 ~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||.... ..+.+ ..+...........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l-~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQL-QLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHH-HHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHH-HHHHHhcCCCChHH
Confidence 4321 2224457899999999998775 56999999999999999999999996332 22222 22222111100000
Q ss_pred c-----------ccc-cccccccH-----HHHHHHHHHHHhccccCcCCCCC
Q 040134 711 L-----------AEN-DEEVKNDL-----KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~-----------~~~-~~~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ... ........ .....+.+|+.+||+.||++|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 338 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS 338 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC
Confidence 0 000 00000011 11346789999999999999997
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=364.75 Aligned_cols=200 Identities=22% Similarity=0.341 Sum_probs=169.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|++.+.||+|+||+||+|+.+. ..++.||||++... .....+.+|+++++++ +||||+++++++.+.++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 36678899999999999998753 35678999998653 3456788999999998 6999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++++|.+++. .+++.++..++.||+.||+|||+. ||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999983 589999999999999999999965 99999999999999876 7999999999986543221
Q ss_pred c--------------------------cccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 638 Q--------------------------AARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 638 ~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1 012335799999999999775 589999999999999999999999965443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=386.06 Aligned_cols=241 Identities=27% Similarity=0.294 Sum_probs=194.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHH---HHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRT---EVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
+.+.++||+|+||+||+++... +++.||||++++. .......+.+ ++.+++.++||||+++++++.+.+.+||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~-tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEecccCeEEEEEEECC-CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 5677899999999999999865 5678999999642 2223333444 4666777899999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++|+|.++|.....+++..+..++.||+.||+|||+ .|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 99999999999999888899999999999999999999995 599999999999999999999999999998765433
Q ss_pred cccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
....+||+.|||||++.. ..++.++|||||||+||||++|+.||..........+. +......+..
T Consensus 347 ----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~~~~~~----- 413 (689)
T 3v5w_A 347 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMAVEL----- 413 (689)
T ss_dssp ----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHHCCCCC-----
T ss_pred ----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcCCCCCC-----
Confidence 344689999999999964 57999999999999999999999999654333222221 2221221111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+|+.+||+.||++|++
T Consensus 414 -----p~~~S~~a~dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 414 -----PDSFSPELRSLLEGLLQRDVNRRLG 438 (689)
T ss_dssp -----CTTSCHHHHHHHHHHTCSCGGGCTT
T ss_pred -----CccCCHHHHHHHHHHccCCHhHCCC
Confidence 0112345789999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=380.57 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=199.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||.||+++... +++.||+|++........+.+.+|+++|++++||||+++++++.+.+.++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~-tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ccEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 46788999999999999999865 46789999997655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY--FTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++|+|.++|... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~- 312 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 312 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence 999999998654 6789999999999999999999965 99999999999999854 8999999999998754432
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.... ..+.+ ..+....... ....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--~~~~~-----~~i~~~~~~~--~~~~-- 379 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETL-----RNVKSCDWNM--DDSA-- 379 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHH-----HHHHTTCCCC--CSGG--
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHH-----HHHHhCCCCC--Cccc--
Confidence 334579999999999999999999999999999999999999995322 22211 1122221111 0000
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+|+.+||+.||++|||
T Consensus 380 --~~~~s~~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 380 --FSGISEDGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp --GTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcC
Confidence 1112345788999999999999997
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.73 Aligned_cols=258 Identities=38% Similarity=0.683 Sum_probs=221.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred cCccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 345678999999999999964 356799999876666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 563 NGSLASFLFGIT----RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 563 ~gsL~~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999997543 578999999999999999999965 9999999999999999999999999999875433322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||.............+.......+.+..++++....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence 22344568999999999998999999999999999999999999997665555555566666666666777777776666
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+....+.+++.+||+.||++|||
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps 302 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPS 302 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcC
Confidence 667788899999999999999999997
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.76 Aligned_cols=275 Identities=44% Similarity=0.740 Sum_probs=228.2
Q ss_pred CCcCccCHHHHHHHHhcc--hhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeE
Q 040134 468 TNVRSFTYKELEEATRGF--RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 468 ~~~~~~~~~~l~~~~~~~--~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l 544 (745)
..+..+++.++.....+| .+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 345678888888776555 578999999999999854 35679999986532 2233478999999999999999999
Q ss_pred EEEEecCCeEEEEEEecCCCCHHHHhcCCC----CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 040134 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGIT----RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT 620 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~ 620 (745)
++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+..+|+||||||+||++++++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999997653 4889999999999999999999765559999999999999999999
Q ss_pred eEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC--CCchhhHHHH
Q 040134 621 PRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT--TNPEEALMDW 698 (745)
Q Consensus 621 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~--~~~~~~l~~~ 698 (745)
+||+|||++.......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999998765433222 334568999999999998899999999999999999999999995321 2233445566
Q ss_pred HHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+...........+.+.........+....+.+++.+||+.||++|||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 298 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC
Confidence 66666667777777777777778888999999999999999999997
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.38 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=198.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||+||++.... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTT-TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeeeeccCCCeEEEEEEECC-CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 35567889999999999998755 45679999997666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... .
T Consensus 100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 173 (297)
T 3fxz_A 100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 173 (297)
T ss_dssp TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--B
T ss_pred CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--c
Confidence 999999999654 688999999999999999999965 9999999999999999999999999999876543322 3
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+. .....+.. .+. ..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~----~~~~~~~~-~~~-------~~ 239 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALY----LIATNGTP-ELQ-------NP 239 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH----HHHHHCSC-CCS-------CG
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHHhCCCC-CCC-------Cc
Confidence 345799999999999999999999999999999999999999853321 11111 11111111 110 01
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps 263 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGS 263 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cccCHHHHHHHHHHccCChhHCcC
Confidence 122345889999999999999997
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=339.43 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=197.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.|.+.+.||+|+||.||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 35677899999999999999765 4567999998653 33345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 169 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence 999999999998888899999999999999999999965 999999999999999999999999999986643322
Q ss_pred ccccccccccccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASIT-VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||.+.+..++ .++||||||+++|||++|+.||.... ...+. +.+..+.....
T Consensus 170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~----~~i~~~~~~~p------- 234 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELR----ERVLRGKYRIP------- 234 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCCCCC-------
T ss_pred -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHH----HHHHhCCCCCC-------
Confidence 3456799999999999888765 79999999999999999999985332 11111 12222221110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 235 ---~~~s~~~~~li~~~L~~dP~~R~t 258 (328)
T 3fe3_A 235 ---FYMSTDCENLLKRFLVLNPIKRGT 258 (328)
T ss_dssp ---TTSCHHHHHHHHHHCCSSTTTSCC
T ss_pred ---CCCCHHHHHHHHHHCCCChhHCcC
Confidence 012345788999999999999997
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=338.11 Aligned_cols=243 Identities=27% Similarity=0.450 Sum_probs=197.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||+||++.... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HeeccceecCCCCEEEEEEEECC-CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45567899999999999999865 45679999987666667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA- 639 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 639 (745)
++++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999976 46789999999999999999999965 99999999999999999999999999998764433211
Q ss_pred -----------ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh---hHHHHHHHHhhc
Q 040134 640 -----------ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE---ALMDWVYRCYIG 705 (745)
Q Consensus 640 -----------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~---~l~~~~~~~~~~ 705 (745)
......||+.|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--- 243 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT---
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc---
Confidence 011457899999999999999999999999999999999999998654332111 111111110
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......+.+++.+||+.||++|||
T Consensus 244 ------~--------~~~~~~~l~~li~~~l~~dP~~Rps 269 (310)
T 3s95_A 244 ------C--------PPNCPPSFFPITVRCCDLDPEKRPS 269 (310)
T ss_dssp ------C--------CTTCCTTHHHHHHHHTCSSGGGSCC
T ss_pred ------C--------CCCCCHHHHHHHHHHccCChhhCcC
Confidence 0 0111234788999999999999997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=333.83 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=205.9
Q ss_pred CccCHHHHHHHHhc------------chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC
Q 040134 471 RSFTYKELEEATRG------------FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH 538 (745)
Q Consensus 471 ~~~~~~~l~~~~~~------------~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 538 (745)
..++++++..++.. +.+.||+|+||.||+|+... +++.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC-CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 56788888887754 34579999999999999764 456799999977666677889999999999999
Q ss_pred CCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 040134 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 539 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~ 618 (745)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999999864 5689999999999999999999965 99999999999999999
Q ss_pred CceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHH
Q 040134 619 FTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDW 698 (745)
Q Consensus 619 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~ 698 (745)
+.+||+|||++..+...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~- 251 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMK- 251 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH-
T ss_pred CcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH-
Confidence 99999999999876543221 3345789999999999999999999999999999999999999863321 11111
Q ss_pred HHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.......+. ........+.+++.+||+.||++|||
T Consensus 252 ---~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps 288 (321)
T 2c30_A 252 ---RLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERAT 288 (321)
T ss_dssp ---HHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ---HHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcC
Confidence 11111111111 01112345888999999999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.39 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=198.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.++||+|+||+||+++... +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 45677899999999999999865 46789999997532 23345688899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 99999999999998888899999999999999999999965 99999999999999999999999999998632222
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc--hhhHHHHHHHHhhcCccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP--EEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.+.+..+.+...
T Consensus 208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 282 (396)
T 4dc2_A 208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 282 (396)
T ss_dssp -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----
T ss_pred -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----
Confidence 12345679999999999999999999999999999999999999996443221 11111222333322222111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 283 ------~~~s~~~~~li~~lL~~dP~~R~~ 306 (396)
T 4dc2_A 283 ------RSLSVKAASVLKSFLNKDPKERLG 306 (396)
T ss_dssp ------TTSCHHHHHHHHHHTCSCTTTSTT
T ss_pred ------CcCCHHHHHHHHHHhcCCHhHcCC
Confidence 112345789999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.41 Aligned_cols=240 Identities=24% Similarity=0.300 Sum_probs=197.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||+||+++... +++.||+|++++. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 35677899999999999999765 4678999999653 3445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999999998878899999999999999999999965 999999999999999999999999999986432221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+.. .+..+.+..
T Consensus 161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~----~i~~~~~~~-------- 224 (337)
T 1o6l_A 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFE----LILMEEIRF-------- 224 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCCCCC--------
T ss_pred -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHH----HHHcCCCCC--------
Confidence 1344679999999999999999999999999999999999999985322 111211 111111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......+.+++.+||+.||++||
T Consensus 225 --p~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 225 --PRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTST
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhc
Confidence 011234578899999999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.43 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=197.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC------CCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS------DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 552 (745)
..+.+.+.||+|+||.||+|.... ..+..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 345677899999999999998742 34567999999753 233456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 553 HRLLVYEYMSNGSLASFLFGIT----------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 9999999999999999997542 478899999999999999999965 999999999999999
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEAL 695 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l 695 (745)
.++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 999999999999987654433332344567889999999999999999999999999999999 8888864322 222
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... +..+..... .......+.+++.+||+.||++|||
T Consensus 315 ~~~----~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt 351 (370)
T 2psq_A 315 FKL----LKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPT 351 (370)
T ss_dssp HHH----HHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHH----HhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 221 112211110 1122346889999999999999997
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=338.67 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=196.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hceeeeEEecCCCEEEEEEEECC-CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 35677899999999999998765 45679999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999999998888899999999999999999999965 999999999999999999999999999987654443333
Q ss_pred cccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+. ..... ..+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-----~~~~~--~~~----- 230 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKTY--LNP----- 230 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH-----TTCTT--STT-----
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh-----ccccc--CCc-----
Confidence 445679999999999987775 77899999999999999999999654432211 11111 11100 000
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 231 -~~~~~~~~~~li~~~L~~dP~~R~t 255 (323)
T 3tki_A 231 -WKKIDSAPLALLHKILVENPSARIT 255 (323)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred -cccCCHHHHHHHHHHccCChhhCcC
Confidence 1112345778999999999999997
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=342.47 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=195.4
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
+....+.+.++||+|+||+||+++... +++.||||++++. .....+.+.+|.+++..+ +||||+++++++.+.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcC-CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 334456778899999999999999865 4577999998653 334556788999999988 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999998888899999999999999999999965 99999999999999999999999999998643
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+. +.+..+....
T Consensus 176 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~----~~i~~~~~~~--- 243 (353)
T 3txo_A 176 CNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLF----EAILNDEVVY--- 243 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCCCC---
T ss_pred cCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHH----HHHHcCCCCC---
Confidence 2221 1344679999999999999999999999999999999999999996332 11121 2222222111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 244 -------p~~~~~~~~~li~~lL~~dP~~R~~ 268 (353)
T 3txo_A 244 -------PTWLHEDATGILKSFMTKNPTMRLG 268 (353)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred -------CCCCCHHHHHHHHHHhhhCHHHccC
Confidence 0112345788999999999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.77 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=200.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46677899999999999999765 4678999998642 3345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+.....
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 170 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence 9999999999999888899999999999999999999965 999999999999999999999999999987643322
Q ss_pred cccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+...+.. .....
T Consensus 171 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~----- 239 (384)
T 4fr4_A 171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVVTY----- 239 (384)
T ss_dssp --BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCCCC-----
T ss_pred --eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----cccCC-----
Confidence 345679999999999964 4589999999999999999999999975544433322222111 11110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 240 -----p~~~s~~~~~li~~lL~~dP~~R~s 264 (384)
T 4fr4_A 240 -----PSAWSQEMVSLLKKLLEPNPDQRFS 264 (384)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred -----CCcCCHHHHHHHHHHhcCCHhHhcc
Confidence 1112346889999999999999996
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=336.49 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=198.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+.||+|+||.||+++... +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 35677899999999999999865 46789999997532 23345688999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999999998778899999999999999999999965 999999999999999999999999999986432221
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc--hhhHHHHHHHHhhcCccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP--EEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.+.+..+....
T Consensus 166 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----- 238 (345)
T 3a8x_A 166 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----- 238 (345)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC-----
T ss_pred --cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC-----
Confidence 1344679999999999999999999999999999999999999996532211 1111122222222222211
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 239 -----p~~~s~~~~~li~~lL~~dP~~R~~ 263 (345)
T 3a8x_A 239 -----PRSLSVKAASVLKSFLNKDPKERLG 263 (345)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred -----CCCCCHHHHHHHHHHhcCCHhHCCC
Confidence 0112345788999999999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=328.98 Aligned_cols=268 Identities=40% Similarity=0.608 Sum_probs=211.9
Q ss_pred CCcCccCHHHHHHHHhcch--------hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc----cccCHHHHHHHHHHHhc
Q 040134 468 TNVRSFTYKELEEATRGFR--------QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV----EQQGEKEFRTEVSVIGQ 535 (745)
Q Consensus 468 ~~~~~~~~~~l~~~~~~~~--------~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~ 535 (745)
.....|++.++.+++.+|. +.||+|+||.||+|... ++.||||++... .....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS---SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC---CceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 3467899999999998886 45999999999999863 456999998642 22335789999999999
Q ss_pred cCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 040134 536 THHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG---ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQN 612 (745)
Q Consensus 536 l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~N 612 (745)
++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 9999999999999999999999999999999999864 35689999999999999999999965 99999999999
Q ss_pred EEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch
Q 040134 613 ILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692 (745)
Q Consensus 613 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~ 692 (745)
|++++++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~- 241 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ- 241 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-
Confidence 9999999999999999987654333222334578999999998865 57899999999999999999999986543322
Q ss_pred hhHHHHHHHHhh-cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYI-GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+..+...... ...+...++... ..........+.+++.+||+.||++|||
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps 293 (307)
T 2nru_A 242 -LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPD 293 (307)
T ss_dssp -BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred -HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcC
Confidence 11111111111 111222222222 1234566788999999999999999997
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.18 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=198.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
.|.+.+.||+|+||.||+++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECC-CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 46678899999999999999765 456799999865322 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----ceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF----TPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~a~~ 631 (745)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999998888899999999999999999999965 999999999999998776 799999999987
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
+..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+ ..+..+....
T Consensus 169 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--~~~~~-----~~i~~~~~~~- 237 (361)
T 2yab_A 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETL-----ANITAVSYDF- 237 (361)
T ss_dssp CCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHH-----HHHHTTCCCC-
T ss_pred cCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHH-----HHHHhcCCCC-
Confidence 654322 334579999999999999999999999999999999999999985322 11111 1111211110
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+... .......+.+++.+||+.||++|||
T Consensus 238 -~~~~----~~~~s~~~~~li~~~L~~dP~~R~t 266 (361)
T 2yab_A 238 -DEEF----FSQTSELAKDFIRKLLVKETRKRLT 266 (361)
T ss_dssp -CHHH----HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred -Cchh----ccCCCHHHHHHHHHHCCCChhHCcC
Confidence 0000 0112345789999999999999997
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.41 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=195.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC----eEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD----HRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv 557 (745)
.+.+.++||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++|
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 4567789999999999999874 5779999986532 23445667899999999999999999998744 47999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhc-------CCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE-------CSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+. ++.+|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 999999999999965 4589999999999999999999942 12299999999999999999999999999998
Q ss_pred cccccccccccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHH---------
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM--------- 696 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~--------- 696 (745)
.+.............||+.|+|||.+.+ ..++.++||||||+++|||+||+.||............
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 7755444333444679999999999976 35567899999999999999999998654332111111
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.................... ........+.+++.+||+.||++|||
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcC
Confidence 11111111221211111111 12345567999999999999999997
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.89 Aligned_cols=247 Identities=27% Similarity=0.350 Sum_probs=193.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|.+.+.||+|+||.||+++... .++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECC-CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 46677899999999999998765 4567999998542 2233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+......
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999998878899999999999999999999965 9999999999999999999999999999876543322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .......... ..... .
T Consensus 168 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~----~~~~~~~~~~-~~~~~-----~ 234 (294)
T 4eqm_A 168 Q-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--V----SIAIKHIQDS-VPNVT-----T 234 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--H----HHHHHHHSSC-CCCHH-----H
T ss_pred c-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--H----HHHHHHhhcc-CCCcc-----h
Confidence 1 3345689999999999999999999999999999999999999854321 1 1111222111 11110 0
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++||+
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 011122356889999999999999994
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.11 Aligned_cols=245 Identities=26% Similarity=0.302 Sum_probs=198.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
..|.+.+.||+|+||.||++.... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECC-CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457788999999999999999765 456799999865322 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----ceEEeeccCcc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF----TPRISDFGLAK 630 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~a~ 630 (745)
++||||+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999998888899999999999999999999965 999999999999998887 89999999998
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
.+..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+.+ ..+.. .....
T Consensus 167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~-~~~~~----~~~~~ 236 (326)
T 2y0a_A 167 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETL-ANVSA----VNYEF 236 (326)
T ss_dssp ECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHH-HHHHH----TCCCC
T ss_pred ECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHH-HHHHh----cCCCc
Confidence 7643322 334568999999999998999999999999999999999999985322 11111 11111 11100
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... .......+.+++.+||+.||++|||
T Consensus 237 --~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt 265 (326)
T 2y0a_A 237 --EDEY----FSNTSALAKDFIRRLLVKDPKKRMT 265 (326)
T ss_dssp --CHHH----HTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred --Cccc----cccCCHHHHHHHHHHccCChhhCCC
Confidence 0000 0112345789999999999999997
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.78 Aligned_cols=242 Identities=26% Similarity=0.318 Sum_probs=198.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.+.+.||+|+||.||+++... +++.||||+++.. .....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 345677899999999999999865 5678999999753 234566788999999877 99999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999999999998778899999999999999999999965 99999999999999999999999999998643222
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+.. .+..+.... +
T Consensus 173 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~----~i~~~~~~~---p-- 238 (345)
T 1xjd_A 173 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFH----SIRMDNPFY---P-- 238 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCCCCC---C--
T ss_pred C--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHH----HHHhCCCCC---C--
Confidence 1 1345679999999999999999999999999999999999999985322 112211 111111110 0
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 239 -----~~~s~~~~~li~~lL~~dp~~R~~ 262 (345)
T 1xjd_A 239 -----RWLEKEAKDLLVKLFVREPEKRLG 262 (345)
T ss_dssp -----TTSCHHHHHHHHHHSCSSGGGSBT
T ss_pred -----cccCHHHHHHHHHHhcCCHhHcCC
Confidence 012345789999999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=334.38 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=198.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.+.++||+|+||.||+++... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT-EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 345677899999999999999764 5678999999653 234567788999999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999999999998778899999999999999999999965 99999999999999999999999999998643222
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+.. .+..+.+..
T Consensus 176 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~----~i~~~~~~~------ 240 (353)
T 2i0e_A 176 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQ----SIMEHNVAY------ 240 (353)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCCCCC------
T ss_pred c--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHH----HHHhCCCCC------
Confidence 1 1344679999999999999999999999999999999999999985322 122212 222222111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 241 ----p~~~s~~~~~li~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 241 ----PKSMSKEAVAICKGLMTKHPGKRLG 265 (353)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTSCTT
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 0112346889999999999999995
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.45 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=199.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...|.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567788999999999999999765 4567999998643 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CceEEeeccCcccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGLAKLLLA 634 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~a~~~~~ 634 (745)
|||+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999999998888899999999999999999999965 99999999999999765 4599999999987653
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ...+.. .+..+.......
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~----~i~~~~~~~~~~- 252 (362)
T 2bdw_A 184 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYA----QIKAGAYDYPSP- 252 (362)
T ss_dssp CCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHTCCCCCTT-
T ss_pred Ccc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHH----HHHhCCCCCCcc-
Confidence 322 334579999999999999899999999999999999999999985322 112212 122222111100
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 253 -----~~~~~~~~~~~li~~~L~~dP~~R~t 278 (362)
T 2bdw_A 253 -----EWDTVTPEAKSLIDSMLTVNPKKRIT 278 (362)
T ss_dssp -----GGGGSCHHHHHHHHHHSCSSGGGSCC
T ss_pred -----cccCCCHHHHHHHHHHcCCChhhCcC
Confidence 01112345789999999999999997
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.97 Aligned_cols=241 Identities=28% Similarity=0.431 Sum_probs=185.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+.+.||+|+||+||+++. .++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred HceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 456678999999999999986 35679999986532 3334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCC---CChhhHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 560 YMSNGSLASFLFGITR---PDWNQRVQIAFGIARGLMYLHEECSTQ--IIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~---~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
|+++++|.+++..... +++..++.++.||+.||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999987643 89999999999999999999965 7 99999999999999999999999999976543
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ....+. .......+
T Consensus 192 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~-~~~~~~---~~~~~~~~--- 260 (309)
T 3p86_A 192 TFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQ-VVAAVG---FKCKRLEI--- 260 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HH-HHHHHH---HSCCCCCC---
T ss_pred ccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH-HHHHHH---hcCCCCCC---
Confidence 221 13345789999999999999999999999999999999999999853321 11 111111 11111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 261 ------~~~~~~~l~~li~~~l~~dP~~Rps 285 (309)
T 3p86_A 261 ------PRNLNPQVAAIIEGCWTNEPWKRPS 285 (309)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------CccCCHHHHHHHHHHccCChhhCcC
Confidence 1112345889999999999999997
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.18 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=199.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC--eEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD--HRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~ 558 (745)
.|.+.++||+|+||+||+|.... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 35677899999999999999865 45679999997533 344677889999999999999999999998765 789999
Q ss_pred EecCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCceEEeeccCccc
Q 040134 559 EYMSNGSLASFLFGIT---RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKL 631 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~a~~ 631 (745)
||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997653 389999999999999999999965 99999999999999 7788899999999987
Q ss_pred ccccccccccccccccccccchhccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc-hhhHHHHHHHH
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFR--------KASITVKVDVYSFGVLLLELICCKSSVVFGTTNP-EEALMDWVYRC 702 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~-~~~l~~~~~~~ 702 (745)
+..... .....||+.|+|||++. +..++.++||||||+++|||++|+.||....... .......+...
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 654332 23456899999999986 5678999999999999999999999996443321 11221212111
Q ss_pred hhcCcccccc-----------cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLA-----------ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+. ...............+.+++.+||+.||++|||
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s 296 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence 1111111100 001111234566678899999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.68 Aligned_cols=237 Identities=25% Similarity=0.312 Sum_probs=196.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||+++... +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 35677899999999999999765 4678999998653 2345677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 999999999999888889999999999999999999995 49999999999999999999999999999875432
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .. ... +.+..+.+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~-~~~----~~i~~~~~~~-------- 222 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TM-KTY----EKILNAELRF-------- 222 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HH-HHH----HHHHHCCCCC--------
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HH-HHH----HHHHhCCCCC--------
Confidence 234578999999999999999999999999999999999999986432 11 111 1111221110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......+.+++.+||+.||++||
T Consensus 223 --p~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 223 --PPFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcC
Confidence 011224588999999999999999
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.74 Aligned_cols=238 Identities=24% Similarity=0.251 Sum_probs=198.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||+++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45667899999999999999765 4567999998643 2345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999998878899999999999999999999965 9999999999999999999999999999876432
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+ .+.+..+.+..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~----~~~i~~~~~~~-------- 257 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQI----YEKIVSGKVRF-------- 257 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHHCCCCC--------
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHH----HHHHHcCCCCC--------
Confidence 234578999999999999999999999999999999999999986322 1111 12222222111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 258 --p~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 258 --PSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhccC
Confidence 0112345889999999999999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.03 Aligned_cols=243 Identities=19% Similarity=0.271 Sum_probs=196.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||.||++.... +++.||+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceEeeeEEecCCCeEEEEEEECC-CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 35677899999999999999765 4678999998643 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD--YFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++++|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++..+.....
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence 999999999765 4789999999999999999999965 9999999999999987 78999999999987654332
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .. .... .+..+...... ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~-~~~~----~i~~~~~~~~~--~~-- 226 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ-QIIE----NIMNAEYTFDE--EA-- 226 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HH-HHHH----HHHHTCCCCCH--HH--
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--HH-HHHH----HHHcCCCCCCh--hh--
Confidence 334568999999999998889999999999999999999999985422 11 1111 11111111100 00
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 227 --~~~~s~~~~~li~~~L~~dp~~Rpt 251 (321)
T 1tki_A 227 --FKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp --HTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred --hccCCHHHHHHHHHHcCCChhHCcC
Confidence 0112356889999999999999997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.78 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=198.2
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...|.+.+.||+|+||.||++.... .++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~-~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETT-TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECC-CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3457788999999999999998765 4678999998642 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCceEEeeccCcccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~a~~~~~ 634 (745)
|||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999998888899999999999999999999965 999999999999998 567899999999987654
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...+. +.+..+........
T Consensus 166 ~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~----~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 166 EQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY----QQIKAGAYDFPSPE 236 (444)
T ss_dssp TCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH----HHHHHTCCCCCTTT
T ss_pred CCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHH----HHHHhCCCCCCccc
Confidence 3321 334679999999999999999999999999999999999999985322 12221 22222222111100
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 237 ------~~~~s~~~~~li~~~L~~dP~~Rpt 261 (444)
T 3soa_A 237 ------WDTVTPEAKDLINKMLTINPSKRIT 261 (444)
T ss_dssp ------TTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ------cccCCHHHHHHHHHHcCCChhHCCC
Confidence 0112345889999999999999997
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=337.63 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=194.5
Q ss_pred HHHhcchhhcCcceeEEEEEEEe---eCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVL---ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 554 (745)
...+.+.+.||+|+||.||++++ ....++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 34567788999999999999985 334578899999987666666789999999999999999999999855 4568
Q ss_pred EEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 555 LLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999765 4589999999999999999999965 99999999999999999999999999998765
Q ss_pred ccccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC---------CchhhHHHHHHHHh
Q 040134 634 AEQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTT---------NPEEALMDWVYRCY 703 (745)
Q Consensus 634 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~---------~~~~~l~~~~~~~~ 703 (745)
..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+..... ...........+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43321 112334567789999999999999999999999999999999998753210 01111111112222
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.... ........+.+++.+||+.||++|||
T Consensus 246 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps 278 (295)
T 3ugc_A 246 KNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPS 278 (295)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred hccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCC
Confidence 1111111 11123456889999999999999997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.96 Aligned_cols=244 Identities=20% Similarity=0.239 Sum_probs=176.3
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
+.||+|+||.||++.... +++.||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 17 ~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKK-SNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEETT-TCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 579999999999999865 456799999864 34567889999999996 9999999999999999999999999999
Q ss_pred HHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---ceEEeeccCcccccccccccccc
Q 040134 566 LASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---TPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 566 L~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++......... ..
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~ 167 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LK 167 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--cc
Confidence 999999888899999999999999999999965 999999999999997665 8999999999865433221 33
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...+|+.|+|||.+.+..++.++||||||+++|||++|+.||..............+...+..+..... .....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~------~~~~~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE------GEAWK 241 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC------SHHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC------ccccc
Confidence 456899999999999999999999999999999999999999654332111111112222222222110 00011
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt 264 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLK 264 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCC
T ss_pred CCCHHHHHHHHHHCCCChhHCCC
Confidence 23456889999999999999997
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.09 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=195.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...+.+.+.||+|+||.||+|.+... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 34556678999999999999998642 3457999999753 33445789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999755 6789999999999999999999965 9999999999999999999999999999876543
Q ss_pred cccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 636 QTQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. ..+..+....
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~----~~~~~~~~~~--- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVI----SSVEEGYRLP--- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHH----HHHHTTCCCC---
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHcCCCCC---
Confidence 3211 1223446778999999998999999999999999999999 9999853221 1111 1111111110
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 275 ------~~~~~~~~l~~li~~~l~~dp~~Rps 300 (325)
T 3kul_A 275 ------APMGCPHALHQLMLDCWHKDRAQRPR 300 (325)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------CCCCcCHHHHHHHHHHccCChhhCcC
Confidence 11122356889999999999999997
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.09 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=196.5
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-----ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
....|.+.+.||+|+||.||++.... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34568888999999999999998765 45679999985421 2246789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---eEEeec
Q 040134 554 RLLVYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT---PRISDF 626 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Df 626 (745)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998887532 3578999999999999999999965 9999999999999986654 999999
Q ss_pred cCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 627 GLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 627 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
|++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||... . ..+. ..+..+
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~-~~~~----~~i~~~ 247 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---K-ERLF----EGIIKG 247 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---H-HHHH----HHHHHT
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---H-HHHH----HHHHcC
Confidence 99987654322 123457999999999999999999999999999999999999999642 1 1111 111122
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..... +.. .......+.+++.+||+.||++|||
T Consensus 248 ~~~~~--~~~----~~~~s~~~~~li~~~L~~dP~~R~s 280 (351)
T 3c0i_A 248 KYKMN--PRQ----WSHISESAKDLVRRMLMLDPAERIT 280 (351)
T ss_dssp CCCCC--HHH----HTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCC--ccc----cccCCHHHHHHHHHHCCCChhHCcC
Confidence 11110 000 0112356889999999999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.73 Aligned_cols=239 Identities=22% Similarity=0.293 Sum_probs=195.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|.+.+.||+|+||.||+|.... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35677899999999999999765 4567999998642 2334568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+ +|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 999 789999998888899999999999999999999976 999999999999999999999999999987644332
Q ss_pred cccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ...+......
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~~~ 226 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCVYV 226 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSCCC
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCCCC
Confidence 334578999999999988776 7899999999999999999999964322110 0011000000
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||.+|||
T Consensus 227 --~p~~~s~~~~~li~~~L~~dP~~Rpt 252 (336)
T 3h4j_B 227 --MPDFLSPGAQSLIRRMIVADPMQRIT 252 (336)
T ss_dssp --CCTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred --CcccCCHHHHHHHHHHcCCChhHCcC
Confidence 01112345789999999999999997
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.56 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=189.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.+.+.||+|+||+||+|+...... ..||+|.+.. ......+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 446677899999999999999754332 2468888854 33455678999999999999999999999998765 788
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999764 6789999999999999999999965 9999999999999999999999999999877554
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+. .+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~~~~---- 239 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILE----KGERLP---- 239 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH----TTCCCC----
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHHH----cCCCCC----
Confidence 44333344567889999999999999999999999999999999 9999864322 12222111 111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 240 -----~~~~~~~~~~~li~~~l~~~p~~Rps 265 (327)
T 3poz_A 240 -----QPPICTIDVYMIMVKCWMIDADSRPK 265 (327)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSCGGGSCC
T ss_pred -----CCccCCHHHHHHHHHHcCCChhhCCC
Confidence 11122346889999999999999997
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.61 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=199.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|+||.||+|.... .++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCC-CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456778899999999999999765 4567999999776666778999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99999999998878899999999999999999999965 99999999999999 7889999999999987654332
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....+++.|+|||.+.+. ++.++||||||+++|||++|+.||.... ..+ .. ..+..+.......
T Consensus 165 ---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~-~~----~~~~~~~~~~~~~---- 229 (277)
T 3f3z_A 165 ---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--DSE-VM----LKIREGTFTFPEK---- 229 (277)
T ss_dssp ---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHH-HH----HHHHHCCCCCCHH----
T ss_pred ---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--HHH-HH----HHHHhCCCCCCch----
Confidence 3345689999999998654 8999999999999999999999985432 111 11 1111111111000
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~R~s 255 (277)
T 3f3z_A 230 --DWLNVSPQAESLIRRLLTKSPKQRIT 255 (277)
T ss_dssp --HHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred --hhhcCCHHHHHHHHHHccCChhhCcC
Confidence 00012356889999999999999997
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.63 Aligned_cols=244 Identities=24% Similarity=0.298 Sum_probs=197.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||+|.... +++.||+|.+..........+.+|++++++++||||+++++++.+....++||||+
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEEEEEecCCCEEEEEEEECC-CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 46677899999999999999765 45679999987654455668999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD--YFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++++|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++..+.....
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 206 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence 999999999765 4789999999999999999999965 9999999999999974 57899999999987654322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....+ ..+.. ..... ....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~-~~i~~----~~~~~--~~~~-- 273 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETL-QNVKR----CDWEF--DEDA-- 273 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHH-HHHHH----CCCCC--CSST--
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--HHHHH-HHHHh----CCCCC--Cccc--
Confidence 233468999999999999999999999999999999999999986322 11111 11111 11110 0000
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 274 --~~~~s~~~~~li~~~L~~dP~~Rpt 298 (387)
T 1kob_A 274 --FSSVSPEAKDFIKNLLQKEPRKRLT 298 (387)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcC
Confidence 0112346889999999999999997
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=334.77 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=197.4
Q ss_pred HHHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||+|... ...++.||||++... .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 345667789999999999999973 345678999999643 334457899999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCC-----------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 040134 554 RLLVYEYMSNGSLASFLFGIT-----------------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKP 610 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp 610 (745)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 999999999999999997653 268899999999999999999965 999999999
Q ss_pred CCEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 040134 611 QNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTT 689 (745)
Q Consensus 611 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~ 689 (745)
+||+++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987755443333344567889999999999999999999999999999998 9999864433
Q ss_pred CchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 690 NPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ..+... ...+.... . .......+.+++.+||+.||++|||
T Consensus 281 ~--~~~~~~----~~~~~~~~-~--------~~~~~~~l~~li~~~l~~dp~~Rps 321 (344)
T 1rjb_A 281 D--ANFYKL----IQNGFKMD-Q--------PFYATEEIYIIMQSCWAFDSRKRPS 321 (344)
T ss_dssp S--HHHHHH----HHTTCCCC-C--------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred H--HHHHHH----HhcCCCCC-C--------CCCCCHHHHHHHHHHcCCCchhCcC
Confidence 2 112121 11111110 0 1112356889999999999999997
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.30 Aligned_cols=247 Identities=17% Similarity=0.195 Sum_probs=196.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|+... +++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLY-TNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETT-TTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CeEEEEEeeccCCceEEEEEECC-CCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 35567899999999999999754 46789999986432 234688999999999 999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-----eEEeeccCcccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT-----PRISDFGLAKLLLA 634 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~-----~kl~Dfg~a~~~~~ 634 (745)
+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.+..
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 99999999763 6789999999999999999999965 9999999999999998887 99999999987654
Q ss_pred ccccc-----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 635 EQTQA-----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 635 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 33211 1235679999999999999999999999999999999999999997654433222222221111110000
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+ . +....+.+++.+||+.||.+|||
T Consensus 243 ~~------~----~~~p~~~~li~~~l~~~p~~RP~ 268 (330)
T 2izr_A 243 VL------C----ENFPEMATYLRYVRRLDFFEKPD 268 (330)
T ss_dssp HH------T----TTCHHHHHHHHHHHHCCTTCCCC
T ss_pred HH------h----ccChHHHHHHHHHHhCCCCCCCC
Confidence 00 0 00126889999999999999997
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.06 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=197.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..+.+.+.||+|+||.||+++... ..++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 345567899999999999999874 34578999999753 2334568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 040134 556 LVYEYMSNGSLASFLFGI------------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQ 611 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~ 611 (745)
+||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcc
Confidence 999999999999999753 5688999999999999999999965 9999999999
Q ss_pred CEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 040134 612 NILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTN 690 (745)
Q Consensus 612 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~ 690 (745)
||+++.++.+||+|||++..+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-- 281 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 281 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC--
Confidence 99999999999999999987654433232344567899999999998999999999999999999999 888885322
Q ss_pred chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 691 PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+ ...+..+...... ......+.+++.+||+.||++|||
T Consensus 282 -~~~~----~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 282 -HEEV----IYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp -HHHH----HHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -hHHH----HHHHhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCC
Confidence 1111 1222222221111 112346889999999999999997
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.73 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=195.8
Q ss_pred HHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC-e
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD-H 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~ 553 (745)
..+.+.+.||+|+||.||+|++. ...++.||||+++.. .....+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 44567789999999999999853 335678999999753 233346799999999999 8999999999998755 4
Q ss_pred EEEEEEecCCCCHHHHhcCCCC----------------------------------------------------------
Q 040134 554 RLLVYEYMSNGSLASFLFGITR---------------------------------------------------------- 575 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 575 (745)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999999999999976532
Q ss_pred --------CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccccccccc
Q 040134 576 --------PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGT 647 (745)
Q Consensus 576 --------~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 647 (745)
+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+.............+|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 78899999999999999999965 9999999999999999999999999999876544433334456788
Q ss_pred ccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHH
Q 040134 648 VGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVE 726 (745)
Q Consensus 648 ~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (745)
+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..+...+ ..+..... ......
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~~~~---------~~~~~~ 323 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRL----KEGTRMRA---------PDYTTP 323 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHH----HHTCCCCC---------CTTCCH
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHH----HcCCCCCC---------CCCCCH
Confidence 99999999999999999999999999999998 99998644332 1121211 11111111 011224
Q ss_pred HHHHHHHhccccCcCCCCC
Q 040134 727 RLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 727 ~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+++.+||+.||++|||
T Consensus 324 ~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHccCChhhCCC
Confidence 5889999999999999997
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.33 Aligned_cols=243 Identities=25% Similarity=0.308 Sum_probs=182.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||+++... .++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKG-TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECC-CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 35677899999999999999865 45679999987532 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 9999999998888899999999999999999999965 9999999999999975 88999999999987643321
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..+ .+.+......... +
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~----~~~i~~~~~~~~~-~---- 273 (349)
T 2w4o_A 207 --MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFM----FRRILNCEYYFIS-P---- 273 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHH----HHHHHTTCCCCCT-T----
T ss_pred --cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHH----HHHHHhCCCccCC-c----
Confidence 23456899999999999999999999999999999999999998643321 111 1222222211110 0
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+....+.+++.+||+.||++|||
T Consensus 274 -~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (349)
T 2w4o_A 274 -WWDEVSLNAKDLVRKLIVLDPKKRLT 299 (349)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred -hhhhCCHHHHHHHHHHccCChhhCcC
Confidence 01122346889999999999999997
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.47 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=187.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--------------------------cCHHHHHHHHHHHhc
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--------------------------QGEKEFRTEVSVIGQ 535 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 535 (745)
.|.+.+.||+|+||.||+|+... +++.||||++..... ...+.+.+|++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETT-TTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred ceEEEeEEeecCCEEEEEEEECC-CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 35677899999999999998765 467899999864321 123568899999999
Q ss_pred cCCCCceeEEEEEec--CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 536 THHKNLVRLLGFCDE--GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 536 l~h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
++||||+++++++.+ ....++||||+++++|.+++. ...+++.++..++.||+.||+|||+. +|+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 999999999999986 668999999999999988754 45789999999999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS---ITVKVDVYSFGVLLLELICCKSSVVFGTTN 690 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslG~vl~elltg~~p~~~~~~~ 690 (745)
+++.++.+||+|||++..+...... .....||+.|+|||.+.+.. .+.++||||||+++|||++|+.||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-- 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred EECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--
Confidence 9999999999999999876543221 23457899999999997655 3788999999999999999999985321
Q ss_pred chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 691 PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+. ..+......... .......+.+++.+||+.||++|||
T Consensus 245 -~~~~~----~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~R~s 286 (298)
T 2zv2_A 245 -IMCLH----SKIKSQALEFPD--------QPDIAEDLKDLITRMLDKNPESRIV 286 (298)
T ss_dssp -HHHHH----HHHHHCCCCCCS--------SSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred -HHHHH----HHHhcccCCCCC--------ccccCHHHHHHHHHHhhcChhhCCC
Confidence 11111 111111111110 1112345889999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.46 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=193.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+||+||++.... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceeeeEecCCCCeEEEEEEECC-CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 5667899999999999999765 45679999986432 23347788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++.+..+......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 157 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C 157 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--C
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--c
Confidence 98754444445567899999999999999999999965 999999999999999999999999999987643222 1
Q ss_pred cccccccccccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc---ccc---c
Q 040134 641 RTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD---KLA---E 713 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~---~ 713 (745)
.....+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+..... ....+ ..+.+........ ... +
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~~~~-~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQL-KRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHH-HHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HHHHH-HHHHHHhCCCChhhhhhhccccc
Confidence 33456899999999997765 79999999999999999999998754332 22222 2222221110000 000 0
Q ss_pred ---------ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 ---------NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ---------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..............+.+++.+||+.||++|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 276 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC
Confidence 00000011123456789999999999999997
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.93 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=194.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..+.+.+.||+|+||.||+|.... +++.||||.++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEec-CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345677899999999999999865 3567999998653 22334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999754 4589999999999999999999965 9999999999999999999999999999865433222
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.......++..|+|||.+....++.++||||||+++|||++ |..||..... ..... .+..+.....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~~~------ 336 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTRE----FVEKGGRLPC------ 336 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHH----HHHTTCCCCC------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCCCCC------
Confidence 21222345778999999998899999999999999999998 8888854321 11111 1212111110
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 337 ---~~~~~~~l~~li~~cl~~dP~~Rps 361 (377)
T 3cbl_A 337 ---PELCPDAVFRLMEQCWAYEPGQRPS 361 (377)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CCCCCHHHHHHHHHHcCCCchhCcC
Confidence 1112346889999999999999997
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.81 Aligned_cols=246 Identities=27% Similarity=0.393 Sum_probs=197.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..+.+.+.||+|+||.||++.... ..++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 345677899999999999998742 24578999999653 3344578899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC------------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 040134 556 LVYEYMSNGSLASFLFGIT------------------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQ 611 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~ 611 (745)
+||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchh
Confidence 9999999999999997543 278899999999999999999965 9999999999
Q ss_pred CEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 040134 612 NILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTN 690 (745)
Q Consensus 612 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~ 690 (745)
||++++++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999987654443333344567889999999999999999999999999999999 9999854332
Q ss_pred chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 691 PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+... +..+..... .......+.+++.+||+.||++|||
T Consensus 259 --~~~~~~----~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 259 --ERLFNL----LKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp --GGHHHH----HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --HHHHHH----hhcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcC
Confidence 122221 111111110 1122356889999999999999997
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.18 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=184.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+|+... ..++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 345667899999999999998762 24567999999753 334456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999765 4689999999999999999999965 99999999999999999999999999998765433
Q ss_pred ccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. +.+..+...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~----~~i~~~~~~----- 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVI----KAVDEGYRL----- 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHH----HHHHTTEEC-----
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCC-----
Confidence 211 1122345778999999999999999999999999999998 9999853321 1111 111111100
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++|||
T Consensus 270 ----~~~~~~~~~l~~li~~cl~~dp~~RPs 296 (373)
T 2qol_A 270 ----PPPMDCPAALYQLMLDCWQKDRNNRPK 296 (373)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSGGGSCC
T ss_pred ----CCCccccHHHHHHHHHHhCcChhhCcC
Confidence 011123456889999999999999997
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.09 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=187.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc----ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
..+.+.+.||+|+||.||+++... ..++.||+|+++... ......+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 346678899999999999998742 356789999986532 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999998778889999999999999999999965 999999999999999999999999999976433
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ......+ .......
T Consensus 174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~-~~~~~~i----~~~~~~~---- 240 (327)
T 3a62_A 174 DGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--R-KKTIDKI----LKCKLNL---- 240 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--H-HHHHHHH----HHTCCCC----
T ss_pred CCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--H-HHHHHHH----HhCCCCC----
Confidence 221 1234578999999999999999999999999999999999999986332 1 1111111 1111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 241 ------p~~~~~~~~~li~~~L~~dp~~R~~ 265 (327)
T 3a62_A 241 ------PPYLTQEARDLLKKLLKRNAASRLG 265 (327)
T ss_dssp ------CTTSCHHHHHHHHHHSCSCGGGSTT
T ss_pred ------CCCCCHHHHHHHHHHHhcCHhhccC
Confidence 0112345889999999999999994
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=330.67 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=188.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC----eE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD----HR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 554 (745)
.|.+.+.||+|+||.||+++... .++.||||++.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECC-CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 46678899999999999999765 46789999996532 223457889999999999999999999987654 34
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+++++|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999999998778899999999999999999999965 999999999999999999999999999987654
Q ss_pred cccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 635 EQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 635 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ...............
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~----~~~~~~~~~~~~~~~- 241 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VS----VAYQHVREDPIPPSA- 241 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH----HHHHHHHCCCCCHHH-
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HH----HHHHHhcCCCCCccc-
Confidence 3322 122345689999999999999999999999999999999999999853221 11 112222221111100
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 242 ------~~~~~~~~l~~li~~~l~~dP~~R~~ 267 (311)
T 3ork_A 242 ------RHEGLSADLDAVVLKALAKNPENRYQ 267 (311)
T ss_dssp ------HSTTCCHHHHHHHHHHTCSSGGGSCS
T ss_pred ------ccCCCCHHHHHHHHHHHhcCHhhChh
Confidence 00112356889999999999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.22 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=191.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.|.+.+.||+|+||+||+++... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETT--SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhHhhhhccCCCCeEEEEEEECC--CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 45667899999999999999753 5679999986432 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9985 787777654 5589999999999999999999965 9999999999999999999999999999876432221
Q ss_pred cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc-------
Q 040134 639 AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK------- 710 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------- 710 (745)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+ ..+...........
T Consensus 176 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~-~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 176 --YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QL-PKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HH-HHHHHHHCCCCTTTSGGGTTS
T ss_pred --ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHHHCCCChHHhhhhhcc
Confidence 334568999999999876 568999999999999999999999996544332 22 11222111110000
Q ss_pred ---------cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 ---------LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ---------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
................++.+++.+||+.||++|||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 294 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC
Confidence 00000000000112356789999999999999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.82 Aligned_cols=245 Identities=22% Similarity=0.262 Sum_probs=187.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||.||+++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETT-TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 46778899999999999999765 45679999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--eEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT--PRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~ 639 (745)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++.......
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-- 173 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 173 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC--
Confidence 9999999998778899999999999999999999965 9999999999999987765 99999999975332221
Q ss_pred ccccccccccccchhccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVK-VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||.+.+..++.+ +||||||+++|+|++|+.||...... ......+.+.. ......
T Consensus 174 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~-~~~~~~-------- 241 (361)
T 3uc3_A 174 -PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRIL-SVKYSI-------- 241 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHH-TTCCCC--------
T ss_pred -CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHh-cCCCCC--------
Confidence 234568999999999988887655 89999999999999999999644332 11222222211 111111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++|||
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps 268 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRIS 268 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcC
Confidence 001112345789999999999999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.85 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=195.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 554 (745)
...+.+.+.||+|+||.||+|.... ..++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3456678899999999999999642 24568999998643 344456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---ceEEe
Q 040134 555 LLVYEYMSNGSLASFLFGI-------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---TPRIS 624 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~ 624 (745)
++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999643 3578899999999999999999965 999999999999999554 59999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ...+.. .+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~----~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE----FV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH----HH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HH
Confidence 9999987644433333344567899999999999999999999999999999998 888885432 111211 12
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..... .......+.+++.+||+.||++|||
T Consensus 300 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps 332 (367)
T 3l9p_A 300 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPN 332 (367)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HcCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcC
Confidence 22111111 1112345889999999999999997
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.52 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=194.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||++.... ++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT--TEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hceeeheecCCCccEEEEEEecC--CCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 45677899999999999999764 456999998753 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS- 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS-
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc-
Confidence 999999999654 5689999999999999999999965 99999999999999999999999999998765433222
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... . ... .....+... ..+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~-~~~----~~~~~~~~~--~~~----- 229 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--S-EVV----EDISTGFRL--YKP----- 229 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H-HHH----HHHHTTCCC--CCC-----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--H-HHH----HHHhcCccC--CCC-----
Confidence 334456788999999998999999999999999999999 8888853221 1 111 111111110 001
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 230 --~~~~~~~~~li~~~l~~~p~~Rps 253 (269)
T 4hcu_A 230 --RLASTHVYQIMNHCWRERPEDRPA 253 (269)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CcCCHHHHHHHHHHccCCcccCcC
Confidence 111345889999999999999997
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.35 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=199.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..+.+.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECC-CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456778899999999999999765 45679999986432 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999998878899999999999999999999965 99999999999999999999999999998765433322
Q ss_pred ccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+ ...... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~~--~~~---- 230 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKKTY--LNP---- 230 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-----HTTCTT--STT----
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-----hhcccc--cCc----
Confidence 2345678999999999987765 7889999999999999999999965443221 11111 111110 000
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 231 --~~~~~~~~~~li~~~l~~~p~~Rps 255 (276)
T 2yex_A 231 --WKKIDSAPLALLHKILVENPSARIT 255 (276)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred --hhhcCHHHHHHHHHHCCCCchhCCC
Confidence 0112345788999999999999997
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=339.79 Aligned_cols=249 Identities=28% Similarity=0.368 Sum_probs=199.9
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeC------CCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEe
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLAS------DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCD 549 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 549 (745)
+....+.+.+.||+|+||.||+|+... ...+.||||++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 344566778899999999999998743 23467999998653 333457789999999999 9999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 550 EGDHRLLVYEYMSNGSLASFLFGIT----------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 550 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
+.+..++||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999997543 488999999999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCch
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPE 692 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~ 692 (745)
|+++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||.... .
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~ 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---V 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---H
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---H
Confidence 999999999999999987655433333444567889999999999999999999999999999999 888885332 1
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+. +.+..+..... .......+.+++.+||+.||++|||
T Consensus 300 ~~~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps 339 (382)
T 3tt0_A 300 EELF----KLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPT 339 (382)
T ss_dssp HHHH----HHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHH----HHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcC
Confidence 1121 22222211111 0112346889999999999999997
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.62 Aligned_cols=241 Identities=26% Similarity=0.322 Sum_probs=188.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHH-HhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSV-IGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+.||+|+||.||+++... +++.||||++++.. ....+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETT-TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46678899999999999999765 46789999996532 2234556677776 4678999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 99999999999998878899999999999999999999965 999999999999999999999999999986432221
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+. +.+..+.+.. .+
T Consensus 195 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~----~~i~~~~~~~--~~--- 260 (373)
T 2r5t_A 195 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMY----DNILNKPLQL--KP--- 260 (373)
T ss_dssp --CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHH----HHHHHSCCCC--CS---
T ss_pred --ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHH----HHHHhcccCC--CC---
Confidence 2345679999999999999999999999999999999999999985321 11121 2222221111 01
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++||+
T Consensus 261 -----~~~~~~~~li~~lL~~dp~~R~~ 283 (373)
T 2r5t_A 261 -----NITNSARHLLEGLLQKDRTKRLG 283 (373)
T ss_dssp -----SSCHHHHHHHHHHTCSSGGGSTT
T ss_pred -----CCCHHHHHHHHHHcccCHHhCCC
Confidence 11245788999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.30 Aligned_cols=240 Identities=25% Similarity=0.314 Sum_probs=189.1
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.+.||+|+||.||+|.... +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcC-CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 4579999999999998765 456799999976555566789999999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE--CCCCceEEeeccCcccccccccccccc
Q 040134 566 LASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL--DDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 566 L~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+..... ..
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence 99988654 4689999999999999999999965 99999999999999 6678999999999987654332 23
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...||+.|+|||++....++.++||||||+++|||++|+.||.... ..+.+.. +.. ...... .. ...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~-i~~----~~~~~~--~~----~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAETLNN-ILA----CRWDLE--DE----EFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHH-HHH----TCCCSC--SG----GGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH-HHh----ccCCCC--hh----hhc
Confidence 3468999999999998899999999999999999999999985332 2222211 111 111100 00 011
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps 336 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRIS 336 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCC
T ss_pred cCCHHHHHHHHHHcCCChhhCCC
Confidence 12356889999999999999997
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=334.25 Aligned_cols=202 Identities=16% Similarity=0.205 Sum_probs=174.2
Q ss_pred HhcchhhcCcc--eeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRG--AFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G--~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.|.+.+.||+| +||.||+++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcC-CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 46678899999 999999999865 45789999986532 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 558 YEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999765 6789999999999999999999965 9999999999999999999999999998765332
Q ss_pred ccc-----cccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 636 QTQ-----AARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 636 ~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 211 11223468899999999987 67899999999999999999999999643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.96 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=199.3
Q ss_pred HHhcchhhcCcceeEEEEEEEe----eCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVL----ASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 554 (745)
..+.+.+.||+|+||.||++.. ....++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4566788999999999999986 34467889999997533 23457899999999999 999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 555 LLVYEYMSNGSLASFLFGIT------------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 99999999999999997543 478999999999999999999965 999999999999999
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEAL 695 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l 695 (745)
.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..+
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 257 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKF 257 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--hHH
Confidence 999999999999987765443332334567889999999999999999999999999999999 89888644322 122
Q ss_pred HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.. + ..... .......+.+++.+||+.||++|||
T Consensus 258 ~~~~~~----~-~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps 294 (313)
T 1t46_A 258 YKMIKE----G-FRMLS--------PEHAPAEMYDIMKTCWDADPLKRPT 294 (313)
T ss_dssp HHHHHH----T-CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHhcc----C-CCCCC--------cccCCHHHHHHHHHHcCCCchhCcC
Confidence 222211 1 11111 1112346889999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.20 Aligned_cols=240 Identities=24% Similarity=0.393 Sum_probs=193.5
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCc------EEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSK------RFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||+|+...... +.||+|.+........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3456678899999999999999865432 5799999987666777889999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCC-CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------eEEe
Q 040134 554 RLLVYEYMSNGSLASFLFGITR-PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT--------PRIS 624 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~--------~kl~ 624 (745)
.++||||+++++|.+++..... +++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999976644 89999999999999999999965 9999999999999988877 9999
Q ss_pred eccCcccccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+....... . .... ..
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~-~~~~-~~-- 232 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-R-KLQF-YE-- 232 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-H-HHHH-HH--
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-H-HHHH-hh--
Confidence 99998765332 22357889999999987 778999999999999999999766654332211 1 1110 01
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........ ....+.+++.+||+.||++|||
T Consensus 233 ~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps 262 (289)
T 4fvq_A 233 DRHQLPAP------------KAAELANLINNCMDYEPDHRPS 262 (289)
T ss_dssp TTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCC
T ss_pred ccCCCCCC------------CCHHHHHHHHHHcCCChhHCcC
Confidence 11111110 0234778999999999999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=336.71 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=193.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||+||+++... +++.||+|++.+. .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEeCCCEEEEEEEEcC-CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4456789999999999999875 4678999998642 22233458899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999987 47899999999999999999999965 9999999999999999999999999999876543322
Q ss_pred cccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
. .....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.. ..+......-....
T Consensus 232 ~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--~~~~~-~~i~~~~~~~~~p~--- 304 (437)
T 4aw2_A 232 Q-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETY-GKIMNHKERFQFPT--- 304 (437)
T ss_dssp E-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHH-HHHHTHHHHCCCCS---
T ss_pred c-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--hhHHH-HhhhhccccccCCc---
Confidence 1 33467999999999997 4678999999999999999999999996322 12211 11111100001111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCC--CCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASL--RPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--RPT 745 (745)
.. ......+.+++.+||+.+|++ ||+
T Consensus 305 --~~----~~~s~~~~dLi~~lL~~~~~r~~r~~ 332 (437)
T 4aw2_A 305 --QV----TDVSENAKDLIRRLICSREHRLGQNG 332 (437)
T ss_dssp --SC----CCSCHHHHHHHHTTSSCGGGCTTTTT
T ss_pred --cc----ccCCHHHHHHHHHHhcccccccCCCC
Confidence 00 012345788999999888877 775
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.94 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=195.4
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
...+.+.+.||+|+||.||++.... +..||+|++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG--QYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecC--ceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3456678899999999999998753 456999998753 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999999765 4589999999999999999999965 9999999999999999999999999999876544322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ... ...+.... .+
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~----~~~-~~~~~~~~--~~--- 227 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEV----VLK-VSQGHRLY--RP--- 227 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHH----HHH-HHTTCCCC--CC---
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHH----HHH-HHcCCCCC--CC---
Confidence 2 233456778999999998899999999999999999999 9999853322 111 111 11111110 01
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps 251 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPT 251 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCC
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcC
Confidence 011245889999999999999997
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=323.77 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=192.3
Q ss_pred hcc-hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGF-RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~-~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+ .+.||+|+||.||++.... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSS-SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCceecCCceEEEEEEEEcC-CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 444 3679999999999998765 4567999999766666678899999999985 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---eEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT---PRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~ 637 (745)
+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++..+.....
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 93 MRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99999999998878899999999999999999999965 9999999999999988765 99999999986543221
Q ss_pred -----ccccccccccccccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh--------hHHHHH
Q 040134 638 -----QAARTGIRGTVGYFAPEWFRK-----ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE--------ALMDWV 699 (745)
Q Consensus 638 -----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~--------~l~~~~ 699 (745)
........||+.|+|||.+.. ..++.++||||||+++|||++|+.||......... .....+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 111223458999999999875 56889999999999999999999999754432100 001111
Q ss_pred HHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 700 YRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+..+...... . ........+.+++.+||+.||++|||
T Consensus 250 ~~~i~~~~~~~~~---~---~~~~~~~~~~~li~~~L~~dP~~Rps 289 (316)
T 2ac3_A 250 FESIQEGKYEFPD---K---DWAHISCAAKDLISKLLVRDAKQRLS 289 (316)
T ss_dssp HHHHHHCCCCCCH---H---HHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHhccCcccCc---h---hcccCCHHHHHHHHHHhhCChhhCCC
Confidence 2222222111100 0 00012346889999999999999997
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=322.30 Aligned_cols=243 Identities=27% Similarity=0.390 Sum_probs=193.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
...+.+.+.||+|+||.||++... .++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 345667789999999999999876 3556999999753 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999976 46789999999999999999999965 9999999999999999999999999999876543322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ..+..+.... . +
T Consensus 177 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~----~~~~~~~~~~-~-~--- 243 (283)
T 3gen_A 177 S-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETA----EHIAQGLRLY-R-P--- 243 (283)
T ss_dssp S-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH----HHHHTTCCCC-C-C---
T ss_pred c-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHH----HHHhcccCCC-C-C---
Confidence 2 333456788999999998899999999999999999998 9999854321 1111 1111111100 0 0
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 244 ----~~~~~~l~~li~~~l~~~p~~Rps 267 (283)
T 3gen_A 244 ----HLASEKVYTIMYSCWHEKADERPT 267 (283)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred ----CcCCHHHHHHHHHHccCChhHCcC
Confidence 011246889999999999999997
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=338.35 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=197.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|.+.+.||+|+||.||+|+... +++.||||++... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETT-TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35677899999999999999765 4567999998643 2234568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 999999999999888889999999999999999999995 4999999999999999999999999999987644322
Q ss_pred cccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... . .+ ...+..+.... +
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~-~~----~~~i~~~~~~~---p--- 236 (476)
T 2y94_A 172 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--P-TL----FKKICDGIFYT---P--- 236 (476)
T ss_dssp --BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--H-HH----HHHHHTTCCCC---C---
T ss_pred --ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--H-HH----HHHHhcCCcCC---C---
Confidence 334579999999999988765 6899999999999999999999864322 1 11 12222222111 0
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 237 ----~~~s~~~~~Li~~~L~~dP~~Rpt 260 (476)
T 2y94_A 237 ----QYLNPSVISLLKHMLQVDPMKRAT 260 (476)
T ss_dssp ----TTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred ----ccCCHHHHHHHHHHcCCCchhCcC
Confidence 011245788999999999999997
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=319.46 Aligned_cols=248 Identities=17% Similarity=0.202 Sum_probs=197.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|.... +++.||||++... ...+.+.+|+.+++++ +|+|++++++++.+....++||||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 45677899999999999999754 4678999998643 2335688999999999 899999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-----eEEeeccCcccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT-----PRISDFGLAKLLLA 634 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~-----~kl~Dfg~a~~~~~ 634 (745)
+ +++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||++..+..
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9 99999999765 458999999999999999999995 49999999999999987765 99999999987654
Q ss_pred cccc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 635 EQTQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 635 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 4321 11344678999999999999999999999999999999999999997654433332222222221111111
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+. ......+.+++.+||+.||++|||
T Consensus 244 ~~~---------~~~~~~l~~li~~~l~~dp~~RP~ 270 (298)
T 1csn_A 244 ELC---------AGFPEEFYKYMHYARNLAFDATPD 270 (298)
T ss_dssp HHT---------TTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred HHH---------hhCcHHHHHHHHHHhcCCcccCCC
Confidence 110 012356889999999999999997
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.89 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=195.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
...|.+.+.||+|+||.||++.... +++.||+|+++.... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3457778899999999999999765 467899999965432 235688888887 7999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CceEEeeccCcccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY----FTPRISDFGLAKLLLA 634 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~----~~~kl~Dfg~a~~~~~ 634 (745)
||+++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||++..+..
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999998888899999999999999999999965 99999999999998543 3599999999987644
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..||..........+.. .+..+.......
T Consensus 173 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~~~~~~- 245 (342)
T 2qr7_A 173 ENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKFSLSGG- 245 (342)
T ss_dssp TTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCCCCCST-
T ss_pred CCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCcccCcc-
Confidence 3221 334578999999999988889999999999999999999999997543333322222 222222211100
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 246 -----~~~~~s~~~~~li~~~L~~dP~~R~t 271 (342)
T 2qr7_A 246 -----YWNSVSDTAKDLVSKMLHVDPHQRLT 271 (342)
T ss_dssp -----TTTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred -----ccccCCHHHHHHHHHHCCCChhHCcC
Confidence 01112346889999999999999997
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.66 Aligned_cols=246 Identities=26% Similarity=0.301 Sum_probs=199.2
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------cCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||+++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC-CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3557788999999999999999865 456799999865322 135789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----ceEEeeccCc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF----TPRISDFGLA 629 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~a 629 (745)
.++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999998888899999999999999999999965 999999999999999887 7999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+.+ ..+......
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~-----~~i~~~~~~ 236 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETL-----ANITSVSYD 236 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHH-----HHHHTTCCC
T ss_pred eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--HHHHH-----HHHHhcccc
Confidence 87654322 234568999999999999999999999999999999999999985322 11111 111111111
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .... .......+.+++.+||+.||++|||
T Consensus 237 ~--~~~~----~~~~~~~~~~li~~~l~~dp~~Rps 266 (321)
T 2a2a_A 237 F--DEEF----FSHTSELAKDFIRKLLVKETRKRLT 266 (321)
T ss_dssp C--CHHH----HTTCCHHHHHHHHTTSCSSTTTSCC
T ss_pred c--Chhh----hcccCHHHHHHHHHHcCCChhhCcC
Confidence 0 0000 0112345889999999999999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=324.58 Aligned_cols=198 Identities=26% Similarity=0.416 Sum_probs=159.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|.... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKT-TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp -------------CEEEEEECSS-SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred ceeEeeEECCCCCEEEEEEEECC-CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 45567899999999999998765 45789999986432 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 561 MSNGSLASFLFGI------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 561 ~~~gsL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 5999988532 3578999999999999999999965 999999999999999999999999999987643
Q ss_pred cccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 221 1234568999999999976 4689999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.59 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=180.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCc--EEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE--
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSK--RFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR-- 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-- 554 (745)
..+.+.+.||+|+||.||+|......+ ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 456778899999999999999765433 26999998653 334467899999999999999999999999877655
Q ss_pred ----EEEEEecCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 555 ----LLVYEYMSNGSLASFLFGI------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 555 ----~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 9999999999999998543 2588999999999999999999965 99999999999999999999999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~----~~ 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN----YL 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH----HH
Confidence 9999987655443333344557889999999999999999999999999999999 88888543221 1111 11
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..... .......+.+++.+||+.||++|||
T Consensus 253 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps 285 (323)
T 3qup_A 253 IGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPS 285 (323)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred hcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcC
Confidence 11111110 1122356889999999999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.82 Aligned_cols=235 Identities=23% Similarity=0.297 Sum_probs=194.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--------ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 552 (745)
..|.+.+.||+|+||.||+++... .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETT-TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEECC-CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 456677899999999999998765 46789999986532 123346788999999999999999999999999
Q ss_pred eEEEEEEecCCC-CHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 553 HRLLVYEYMSNG-SLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 553 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
..++||||+..| +|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999776 9999999888899999999999999999999965 999999999999999999999999999987
Q ss_pred ccccccccccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
+..... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... .....
T Consensus 180 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~~~~--- 240 (335)
T 3dls_A 180 LERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TVEAA--- 240 (335)
T ss_dssp CCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GTTTC---
T ss_pred CCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HHhhc---
Confidence 654332 234568999999999988776 7899999999999999999999853110 00000
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..... .....+.+++.+||+.||++|||
T Consensus 241 -~~~~~------~~~~~l~~li~~~L~~dP~~Rps 268 (335)
T 3dls_A 241 -IHPPY------LVSKELMSLVSGLLQPVPERRTT 268 (335)
T ss_dssp -CCCSS------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -cCCCc------ccCHHHHHHHHHHccCChhhCcC
Confidence 00000 12345889999999999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.77 Aligned_cols=244 Identities=21% Similarity=0.259 Sum_probs=192.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||+||+++... +++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEEcCCCEEEEEEEECC-CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4556789999999999999865 4578999998642 22334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999865 4689999999999999999999965 99999999999999999999999999998765433211
Q ss_pred ccccccccccccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKAS----ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ..... ..+...... +.. +.
T Consensus 226 -~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~-~~i~~~~~~--~~~---p~ 296 (410)
T 3v8s_A 226 -CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTY-SKIMNHKNS--LTF---PD 296 (410)
T ss_dssp -CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHH-HHHHTHHHH--CCC---CT
T ss_pred -ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--hhhHH-HHHHhcccc--ccC---CC
Confidence 33567999999999998765 7899999999999999999999996322 11111 111111000 000 00
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCC--CCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASL--RPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~--RPT 745 (745)
.......+.+++.+||+.+|++ |||
T Consensus 297 -----~~~~s~~~~~li~~lL~~~~~rlgR~~ 323 (410)
T 3v8s_A 297 -----DNDISKEAKNLICAFLTDREVRLGRNG 323 (410)
T ss_dssp -----TCCCCHHHHHHHHHHSSCGGGCTTSSC
T ss_pred -----cccccHHHHHHHHHHccChhhhCCCCC
Confidence 0012345788999999988888 886
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=350.82 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=198.4
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
....+.+.+.||+|+||.||+|++.. .++.||||.++.. ....++|.+|+.++++++||||+++++++.+....++||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34456678899999999999999875 3577999999753 335678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999753 5588999999999999999999965 99999999999999999999999999998765433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....++..|+|||.+....++.++||||||++||||++ |..||..... ..+...+ ..+...
T Consensus 373 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~------ 438 (495)
T 1opk_A 373 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELL----EKDYRM------ 438 (495)
T ss_dssp EEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHH----HTTCCC------
T ss_pred eee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC------
Confidence 221 233456789999999999999999999999999999999 8888864322 1222211 111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+|+.+||+.||++|||
T Consensus 439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs 465 (495)
T 1opk_A 439 ---ERPEGCPEKVYELMRACWQWNPSDRPS 465 (495)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CCCCCCCHHHHHHHHHHcCcChhHCcC
Confidence 011122356889999999999999997
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.91 Aligned_cols=243 Identities=22% Similarity=0.289 Sum_probs=186.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCC--CCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHH--KNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv 557 (745)
.|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.++.+++| +||+++++++.+.+..++|
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3567789999999999999874 3567999998642 33345778999999999976 9999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|| +.+++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||++..+.....
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99 56889999999888899999999999999999999965 999999999999997 57899999999987755443
Q ss_pred ccccccccccccccchhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 638 QAARTGIRGTVGYFAPEWFRK-----------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... . ....... ..
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~----~~~~~~~-~~ 236 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-I----SKLHAII-DP 236 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-H----HHHHHHH-CT
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-H----HHHHHHh-cC
Confidence 333445679999999999865 67889999999999999999999998632221 1 1111111 11
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... .......+.+++.+||+.||++|||
T Consensus 237 ~~~~~~--------~~~~~~~l~~li~~~L~~dp~~Rpt 267 (343)
T 3dbq_A 237 NHEIEF--------PDIPEKDLQDVLKCCLKRDPKQRIS 267 (343)
T ss_dssp TSCCCC--------CCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CcccCC--------cccCCHHHHHHHHHHcCCChhHCCC
Confidence 111000 1111245789999999999999997
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.44 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=189.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+||+||++... .++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred chhhhhcccCCCEEEEEEEcC--CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 556789999999999999873 4567999998542 233457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 985 899988764 6789999999999999999999965 999999999999999999999999999986543221
Q ss_pred ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcc---cc---c-
Q 040134 640 ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNL---DK---L- 711 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~---~- 711 (745)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ....+.. +.+....... .. +
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMR-IFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH-HHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH-HHHHHCCCChhhchhhhccc
Confidence 1233468999999999976 458999999999999999999999986432 2222222 2221111000 00 0
Q ss_pred -ccccc-------cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 -AENDE-------EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 -~~~~~-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.++.. ...........+.+++.+||+.||++|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 274 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC
Confidence 00000 00000112356789999999999999997
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.30 Aligned_cols=245 Identities=24% Similarity=0.237 Sum_probs=189.4
Q ss_pred CHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhcc-CCCCceeEEEEEec
Q 040134 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE 550 (745)
Q Consensus 474 ~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 550 (745)
...++....+.+.++||+|+||+||+|+... +++.||||++.... ......+..|+..+.++ +||||+++++++.+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKE-DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETT-TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECC-CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 3445566778888999999999999999865 45679999875422 22334455666666555 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 551 GDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 551 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
++..++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999999 66898887654 5689999999999999999999965 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
........ .....||+.|+|||++.+ .++.++||||||+++|||++|..|+... .. ...+..+...
T Consensus 205 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~-----~~~~~~~~~~ 270 (311)
T 3p1a_A 205 VELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EG-----WQQLRQGYLP 270 (311)
T ss_dssp EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HH-----HHHHTTTCCC
T ss_pred eecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cH-----HHHHhccCCC
Confidence 87644322 334568999999999876 7899999999999999999997776421 11 1122222211
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .......+.+++.+||+.||++|||
T Consensus 271 ~~~--------~~~~~~~l~~li~~~L~~dP~~Rpt 298 (311)
T 3p1a_A 271 PEF--------TAGLSSELRSVLVMMLEPDPKLRAT 298 (311)
T ss_dssp HHH--------HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ccc--------ccCCCHHHHHHHHHHcCCChhhCcC
Confidence 111 1112356889999999999999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.50 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=188.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------- 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 552 (745)
..+.+.+.||+|+||.||+|+... +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETT-TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 346678899999999999999865 45679999986433 334578999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEecCCCCHHHHhcCCCC---CChh
Q 040134 553 --------------------------------------------------HRLLVYEYMSNGSLASFLFGITR---PDWN 579 (745)
Q Consensus 553 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~ 579 (745)
..++||||+++++|.+++..... ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999987643 3455
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc----------ccccccccccc
Q 040134 580 QRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ----------AARTGIRGTVG 649 (745)
Q Consensus 580 ~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~ 649 (745)
.++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 6899999999999999965 9999999999999999999999999999877544211 11234569999
Q ss_pred ccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHH
Q 040134 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLV 729 (745)
Q Consensus 650 y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 729 (745)
|+|||.+.+..++.++||||||+++|||++|..|+. .... ............ ........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~---------~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPL---------LFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCH---------HHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCc---------ccccCChhHH
Confidence 999999999999999999999999999999876531 1111 111111111111 1123345678
Q ss_pred HHHHhccccCcCCCCC
Q 040134 730 MVALWCIQEDASLRPQ 745 (745)
Q Consensus 730 ~li~~Cl~~dp~~RPT 745 (745)
+++.+||+.||++|||
T Consensus 304 ~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPE 319 (332)
T ss_dssp HHHHHHHCSSGGGSCC
T ss_pred HHHHHHccCCCCcCCC
Confidence 8999999999999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.74 Aligned_cols=244 Identities=21% Similarity=0.288 Sum_probs=196.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+.+.||+|+||.||++.... .++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcC-CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 35677899999999999998765 4567999998643 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---eEEeeccCcccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT---PRISDFGLAKLLLAEQ 636 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~ 636 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.......
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 999999999998878899999999999999999999965 9999999999999976655 9999999997764433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ....... ...+........
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~----~~~~~~~~~~~~-- 230 (284)
T 3kk8_A 163 A---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQ----IKAGAYDYPSPE-- 230 (284)
T ss_dssp B---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTCCCCCTTT--
T ss_pred c---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHH----HHhccccCCchh--
Confidence 2 234568999999999999999999999999999999999999985322 1111111 111211111100
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 231 ----~~~~~~~~~~li~~~l~~dp~~Rps 255 (284)
T 3kk8_A 231 ----WDTVTPEAKSLIDSMLTVNPKKRIT 255 (284)
T ss_dssp ----TTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ----hcccCHHHHHHHHHHcccChhhCCC
Confidence 0112345889999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.77 Aligned_cols=243 Identities=29% Similarity=0.338 Sum_probs=197.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.++||+|+||.||+++... +++.||+|++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 35567899999999999999765 4578999998642 2345577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999997654 489999999999999999999965 99999999999999999999999999998765432
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc-hhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP-EEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.. .+.......
T Consensus 341 ~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----~i~~~~~~~----- 408 (576)
T 2acx_A 341 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEVPEEY----- 408 (576)
T ss_dssp C---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH----HHHHCCCCC-----
T ss_pred c---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH----HhhcccccC-----
Confidence 2 234579999999999999899999999999999999999999997543321 122222 111111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 409 -----p~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 409 -----SERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred -----CccCCHHHHHHHHHhccCCHHHcCC
Confidence 0112346889999999999999993
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=319.93 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=189.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhc--cCCCCceeEEEEEec----CCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ--THHKNLVRLLGFCDE----GDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~ 555 (745)
.+.+.+.||+|+||+||+|+. .++.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 456778999999999999987 3567999998642 34556667776665 799999999998654 35689
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC-----STQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
+||||+++++|.+++.. ..+++..++.++.||+.||+|||... +.+|+||||||+|||++.++.+||+|||+++
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999999999954 57899999999999999999999211 3499999999999999999999999999997
Q ss_pred ccccccccc--ccccccccccccchhccccC------CCCccchhHHHHHHHHHHHhC----------CCCCCCCCCCch
Q 040134 631 LLLAEQTQA--ARTGIRGTVGYFAPEWFRKA------SITVKVDVYSFGVLLLELICC----------KSSVVFGTTNPE 692 (745)
Q Consensus 631 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwslG~vl~elltg----------~~p~~~~~~~~~ 692 (745)
......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 664433221 12334789999999999876 455799999999999999999 777754333221
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. . ................. ...........+.+++.+||+.||++|||
T Consensus 242 ~-~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 242 S-F-EDMRKVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp C-H-HHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred c-h-hhhhHHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 1 1 11112111111111111 11122345678999999999999999997
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=341.16 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=187.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HcEEeEEEeeCcCEEEEEEEEcC-CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 35677899999999999999765 4678999998653 3334467788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 304 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 304 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-
Confidence 9999999999998888899999999999999999999961 3999999999999999999999999999986433222
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......||+.|+|||++.+..++.++||||||++||||++|+.||.... ...+...+ .......
T Consensus 305 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i----~~~~~~~-------- 368 (446)
T 4ejn_A 305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELI----LMEEIRF-------- 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCCCCC--------
T ss_pred -ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHH----HhCCCCC--------
Confidence 1344679999999999999999999999999999999999999985332 12221211 1111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.......+.+++.+||+.||++||
T Consensus 369 --p~~~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 369 --PRTLGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTST
T ss_pred --CccCCHHHHHHHHHHcccCHHHhC
Confidence 011234588999999999999999
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=323.49 Aligned_cols=257 Identities=24% Similarity=0.284 Sum_probs=192.0
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-----ccCHHHHHHHHHHHhccC---CCCceeEEEEEe
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-----QQGEKEFRTEVSVIGQTH---HKNLVRLLGFCD 549 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~ 549 (745)
+....|.+.+.||+|+||+||+++... +++.||||++.... ......+.+|+.++++++ ||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT-TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 344567788999999999999999755 45789999986422 122356777888777664 999999999998
Q ss_pred cCC-----eEEEEEEecCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceE
Q 040134 550 EGD-----HRLLVYEYMSNGSLASFLFGITR--PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPR 622 (745)
Q Consensus 550 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~k 622 (745)
... ..++||||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 765 5899999997 599999987644 89999999999999999999965 999999999999999999999
Q ss_pred EeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 040134 623 ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 623 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
|+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+ ..+.+.
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~-~~i~~~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQL-GKIFDL 234 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHH-HHHHHH
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHH-HHHHHH
Confidence 999999987643322 344578999999999999999999999999999999999999985432 22222 222222
Q ss_pred hhcCccccc----------cccccc---ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKL----------AENDEE---VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~----------~~~~~~---~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......... ...... .....+....+.+++.+||+.||++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 290 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC
Confidence 111000000 000000 0001122356889999999999999997
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.74 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=196.0
Q ss_pred HHHHhcchhhcCcceeEEEEEEEe---eCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecC--C
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVL---ASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--D 552 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~---~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 552 (745)
....+.+.+.||+|+||.||++++ ....++.||+|++... .....+.+.+|++++++++||||+++++++.+. +
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 344567788999999999999985 2335688999998743 334567899999999999999999999999876 6
Q ss_pred eEEEEEEecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 553 HRLLVYEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 78999999999999999954 46789999999999999999999965 999999999999999999999999999987
Q ss_pred ccccccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC--------CCchhhHHHHHHHH
Q 040134 632 LLAEQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT--------TNPEEALMDWVYRC 702 (745)
Q Consensus 632 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~--------~~~~~~l~~~~~~~ 702 (745)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+.... ..........+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6544321 12334567888999999999999999999999999999999998863211 00011111111121
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.... ........+.+++.+||+.||++|||
T Consensus 256 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps 289 (302)
T 4e5w_A 256 LKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTS 289 (302)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCC
Confidence 11111111 11122356889999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=322.65 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=191.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEeeEEeecCCeEEEEEEeCC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 5567899999999999999865 45679999885432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-- 158 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--
Confidence 99999999998888899999999999999999999965 9999999999999999999999999999876533221
Q ss_pred cccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc-----------C-c
Q 040134 641 RTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG-----------K-N 707 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-----------~-~ 707 (745)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+ ..+...... . .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQL-YLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHHHhcccccccccccccccc
Confidence 234568999999999976 67899999999999999999999998643322 111 111111100 0 0
Q ss_pred cccccccccccccc-----HHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKND-----LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+....... ......+.+++.+||+.||++|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC
Confidence 00000000000000 122355889999999999999997
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.06 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=190.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+.||+|+||.||+|+...... ..|++|.+... .....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 35567899999999999999765432 24788887542 2334467788999999999999999999986 4568899
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999775 5789999999999999999999965 99999999999999999999999999999876554
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+ ..+..... +.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~--~~ 240 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLL----EKGERLAQ--PQ 240 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHH----HTTCBCCC--CT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHH----HcCCCCCC--CC
Confidence 4333455668889999999999999999999999999999999 99998644322 111111 11111110 00
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 241 -------~~~~~~~~li~~~l~~dp~~Rps 263 (325)
T 3kex_A 241 -------ICTIDVYMVMVKCWMIDENIRPT 263 (325)
T ss_dssp -------TBCTTTTHHHHHHTCSCTTTSCC
T ss_pred -------cCcHHHHHHHHHHcCCChhhCcC
Confidence 01224678999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.86 Aligned_cols=243 Identities=27% Similarity=0.358 Sum_probs=197.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||+||+++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 4455789999999999999865 4678999999642 23445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 560 YMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 560 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999998753 3688999999999999999999965 9999999999999999999999999999876543
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC-chhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN-PEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+. +.+.......
T Consensus 343 ~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~----~~i~~~~~~~---- 412 (543)
T 3c4z_A 343 QTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRVLEQAVTY---- 412 (543)
T ss_dssp CCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH----HHHHHCCCCC----
T ss_pred Ccc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH----HHHhhcccCC----
Confidence 321 23457999999999999999999999999999999999999999754322 112222 2222221111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++||+
T Consensus 413 ------p~~~s~~~~~li~~lL~~dP~~R~~ 437 (543)
T 3c4z_A 413 ------PDKFSPASKDFCEALLQKDPEKRLG 437 (543)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred ------CcccCHHHHHHHHHhccCCHhHCCC
Confidence 1112345788999999999999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.82 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=183.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+|..... ....||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 4566788999999999999998543 3467999998653 2334567899999999999999999999984 5678899
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999999755 4689999999999999999999965 99999999999999999999999999998765433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....+++.|+|||.+....++.++||||||+++|||++ |..||...... + ....+ ..+....+
T Consensus 171 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~-~~~~i----~~~~~~~~---- 238 (281)
T 1mp8_A 171 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--D-VIGRI----ENGERLPM---- 238 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G-HHHHH----HTTCCCCC----
T ss_pred ccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--H-HHHHH----HcCCCCCC----
Confidence 221 233456788999999998999999999999999999997 88888643221 1 11111 11111111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 239 -----~~~~~~~l~~li~~~l~~~p~~Rps 263 (281)
T 1mp8_A 239 -----PPNCPPTLYSLMTKCWAYDPSRRPR 263 (281)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcC
Confidence 1122356889999999999999997
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.62 Aligned_cols=242 Identities=22% Similarity=0.297 Sum_probs=187.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccC--CCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTH--HKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~ 558 (745)
|.+.+.||+|+||.||++.... ++.||||++... .....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC--CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 5677899999999999998754 567999998542 3344578999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
| +.+++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56889999998888889999999999999999999954 999999999999995 579999999999877544433
Q ss_pred cccccccccccccchhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 639 AARTGIRGTVGYFAPEWFRK-----------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
.......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ... .... ....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~----~~~~-~~~~ 284 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISK----LHAI-IDPN 284 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHH----HHHH-HCTT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-HHH----HHHH-hCcc
Confidence 22345679999999999865 36889999999999999999999999643221 111 1111 1111
Q ss_pred ccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... ......+.+++.+||+.||++|||
T Consensus 285 ~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps 314 (390)
T 2zmd_A 285 HEIEFP--------DIPEKDLQDVLKCCLKRDPKQRIS 314 (390)
T ss_dssp SCCCCC--------CCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred ccCCCC--------ccchHHHHHHHHHHcccChhhCCC
Confidence 111000 011245789999999999999997
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=338.79 Aligned_cols=235 Identities=27% Similarity=0.359 Sum_probs=189.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC-eEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD-HRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|... ++.||||+++.. ...+.|.+|++++++++||||+++++++.+.. ..++||||
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HeEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3456688999999999999874 457999999753 25678999999999999999999999987665 79999999
Q ss_pred cCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 99999999997643 368999999999999999999965 99999999999999999999999999998543221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
....++..|+|||.+.+..++.++||||||++||||++ |+.||....... +.. .+..+....
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~~------- 406 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKMD------- 406 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCCCC-------
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCCC-------
Confidence 22356889999999999999999999999999999998 999986443221 111 111221111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 407 --~p~~~~~~l~~li~~cl~~dp~~Rpt 432 (450)
T 1k9a_A 407 --APDGCPPAVYDVMKNCWHLDAATRPT 432 (450)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CCCcCCHHHHHHHHHHcCCChhHCcC
Confidence 01122356889999999999999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.81 Aligned_cols=239 Identities=28% Similarity=0.390 Sum_probs=192.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... .++.||+|++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEeeEEecCCCeEEEEEEEcc-CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 35567899999999999998765 4567999998542 2334577999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 9999999999998778899999999999999999999954 99999999999999999999999999986543322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+ .......
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~~-------- 226 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRI----SRVEFTF-------- 226 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH----HHTCCCC--------
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHH----HhCCCCC--------
Confidence 2345689999999999999999999999999999999999999863221 1111111 1111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 227 --~~~~~~~~~~li~~~l~~~p~~Rps 251 (279)
T 3fdn_A 227 --PDFVTEGARDLISRLLKHNPSQRPM 251 (279)
T ss_dssp --CTTSCHHHHHHHHHHCCSSGGGSCC
T ss_pred --CCcCCHHHHHHHHHHhccChhhCCC
Confidence 0112345788999999999999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.67 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=189.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..+.+.+.||+|+||.||++.... .++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEcc-CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467788999999999999999765 45679999986533 3456889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCcccc
Q 040134 560 YMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLL 632 (745)
Q Consensus 560 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~ 632 (745)
|+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998854 36789999999999999999999965 99999999999999 45678999999999876
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
..... .....+++.|+|||.+. ..++.++||||||+++|||++|+.||..... ..+.. .. .........
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~---~~-~~~~~~~~~ 246 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQ---KA-TYKEPNYAV 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HH-HHCCCCCCC
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHh---hh-ccCCccccc
Confidence 44322 33456899999999985 5689999999999999999999999853321 11111 11 111111110
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .....+.+++.+||+.||++|||
T Consensus 247 ~~~-------~~~~~~~~li~~~L~~dP~~Rps 272 (285)
T 3is5_A 247 ECR-------PLTPQAVDLLKQMLTKDPERRPS 272 (285)
T ss_dssp --C-------CCCHHHHHHHHHHTCSCTTTSCC
T ss_pred ccC-------cCCHHHHHHHHHHccCChhhCcC
Confidence 000 01345788999999999999997
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.17 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=194.0
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT--TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHeEEEEEcccCCceEEEEEEECC--ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345677899999999999999864 4569999997533 45788999999999999999999999986 5678999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999764 3678899999999999999999965 9999999999999999999999999999876543222
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+....++.++||||||++||||+| |+.||.... ...+...+. .+....
T Consensus 341 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~----~~~~~~------- 405 (454)
T 1qcf_A 341 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALE----RGYRMP------- 405 (454)
T ss_dssp T-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHH----HTCCCC-------
T ss_pred c-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCCC-------
Confidence 1 233456789999999998999999999999999999999 999985322 111212121 111100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 406 --~~~~~~~~l~~li~~cl~~dp~~RPt 431 (454)
T 1qcf_A 406 --RPENCPEELYNIMMRCWKNRPEERPT 431 (454)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcC
Confidence 01122356889999999999999997
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.56 Aligned_cols=245 Identities=27% Similarity=0.364 Sum_probs=186.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.+.+.||+|+||.||+|....... ..|++|.+.. ......+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 345677899999999999999765432 2367887754 34456688999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999764 5689999999999999999999965 9999999999999999999999999999877554
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+ ..+.....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~----~~~~~~~~--- 240 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL----EKGERLPQ--- 240 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTCCCCC---
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCCCCC---
Confidence 43333344557889999999999999999999999999999999 99998543222 221211 11111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 241 ------~~~~~~~l~~li~~~l~~dp~~Rps 265 (327)
T 3lzb_A 241 ------PPICTIDVYMIMRKCWMIDADSRPK 265 (327)
T ss_dssp ------CTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------CccCCHHHHHHHHHHcCCChhHCcC
Confidence 1112345889999999999999997
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.94 Aligned_cols=245 Identities=27% Similarity=0.407 Sum_probs=198.5
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
....+.+.+.||+|+||.||++.... .++.||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG-GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecC-CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34456678899999999999999875 4577999998653 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 559 EYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 559 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999753 4589999999999999999999976 99999999999999999999999999998765433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .+...+.. .....
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~----~~~~~----- 232 (288)
T 3kfa_A 166 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEK----DYRME----- 232 (288)
T ss_dssp SEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHT----TCCCC-----
T ss_pred ccc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc----cCCCC-----
Confidence 222 334557889999999999999999999999999999999 88888543321 12121111 10000
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 233 ----~~~~~~~~l~~li~~~l~~dp~~Rps 258 (288)
T 3kfa_A 233 ----RPEGCPEKVYELMRACWQWNPSDRPS 258 (288)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----CCCCCCHHHHHHHHHHhCCChhhCcC
Confidence 01112356889999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=312.91 Aligned_cols=240 Identities=26% Similarity=0.384 Sum_probs=190.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec----CCeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----GDHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 556 (745)
+.+.+.||+|+||.||+|.... .++.||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~-~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecC-CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3456789999999999998765 4567999998643 33445778999999999999999999998865 456899
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEC-CCCceEEeeccCccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ--IIHCDIKPQNILLD-DYFTPRISDFGLAKLLL 633 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dikp~NIll~-~~~~~kl~Dfg~a~~~~ 633 (745)
||||+++++|.+++.....+++..++.++.||+.||+|||+. + |+||||||+||+++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999998778899999999999999999999965 6 99999999999997 78999999999997543
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
... .....|++.|+|||.+. ..++.++||||||+++|+|++|+.||..... ... .......+.......
T Consensus 184 ~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~----~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPASFD 252 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGGGG
T ss_pred ccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHH----HHHHHhccCCccccC
Confidence 322 23456899999999886 4589999999999999999999999854322 111 112222221111111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .....+.+++.+||+.||++|||
T Consensus 253 ~--------~~~~~l~~li~~~l~~dp~~Rps 276 (290)
T 1t4h_A 253 K--------VAIPEVKEIIEGCIRQNKDERYS 276 (290)
T ss_dssp G--------CCCHHHHHHHHHHSCSSGGGSCC
T ss_pred C--------CCCHHHHHHHHHHccCChhhCCC
Confidence 1 11245889999999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.97 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=196.0
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
...+.+.+.||+|+||.||+++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECC-CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467788999999999999999765 456799999976555556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCcccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999999999998778899999999999999999999965 99999999999999 788999999999987643321
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+.. .+..+..... .
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~----~i~~~~~~~~--~-- 228 (304)
T 2jam_A 164 ----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFE----KIKEGYYEFE--S-- 228 (304)
T ss_dssp ----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH----HHHHCCCCCC--T--
T ss_pred ----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHH----HHHcCCCCCC--c--
Confidence 233468999999999999999999999999999999999999985432 111212 1222211110 0
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++|||
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~Rps 255 (304)
T 2jam_A 229 --PFWDDISESAKDFICHLLEKDPNERYT 255 (304)
T ss_dssp --TTTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcC
Confidence 001112356889999999999999997
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.32 Aligned_cols=240 Identities=23% Similarity=0.338 Sum_probs=174.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+.||+|+||.||+++... .++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEcc-CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 5567899999999999998754 4567999998642 22345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999865 6789999999999999999999965 9999999999999999999999999999876432221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .+ ........ ..
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~-----~~~~~~~~------~~-- 231 (278)
T 3cok_A 169 --HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TL-----NKVVLADY------EM-- 231 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSCC------CC--
T ss_pred --ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--HH-----HHHhhccc------CC--
Confidence 223568999999999998889999999999999999999999986443221 10 00000000 00
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 232 --~~~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 232 --PSFLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred --ccccCHHHHHHHHHHcccCHhhCCC
Confidence 1112346789999999999999997
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.45 Aligned_cols=256 Identities=23% Similarity=0.252 Sum_probs=193.6
Q ss_pred ccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-----cccCHHHHHHHHHHHhccCCCCceeEEE
Q 040134 472 SFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-----EQQGEKEFRTEVSVIGQTHHKNLVRLLG 546 (745)
Q Consensus 472 ~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 546 (745)
.-++.++. ..+.+.+.||+|+||.||+++... .++.||+|++... .....+.+.+|++++++++||||+++++
T Consensus 18 ~~~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 18 GGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp CBCHHHHH-HHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred Cchhhhhh-hheeecceeeecCCeEEEEEEECC-CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 33444443 457788999999999999998765 4567999998643 2345578999999999999999999999
Q ss_pred EEecCCeEEEEEEecCCCCHHHHhcCC----------------------------------------CCCChhhHHHHHH
Q 040134 547 FCDEGDHRLLVYEYMSNGSLASFLFGI----------------------------------------TRPDWNQRVQIAF 586 (745)
Q Consensus 547 ~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------------------------------~~~~~~~~~~i~~ 586 (745)
++.+.+..++||||+++++|.+++... ..+++..+..++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 999999999999999999999998521 1124667888999
Q ss_pred HHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC--ceEEeeccCcccccccccc--cccccccccccccchhcccc--CC
Q 040134 587 GIARGLMYLHEECSTQIIHCDIKPQNILLDDYF--TPRISDFGLAKLLLAEQTQ--AARTGIRGTVGYFAPEWFRK--AS 660 (745)
Q Consensus 587 ~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~ 660 (745)
||+.||+|||+. +|+||||||+||+++.++ .+||+|||++..+...... .......||+.|+|||.+.+ ..
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 999999999965 999999999999998776 8999999999876432221 11344568999999999975 67
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCc
Q 040134 661 ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDA 740 (745)
Q Consensus 661 ~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp 740 (745)
++.++||||||+++|||++|+.||..... .+.. .+.... ..... .+. .......+.+++.+||+.||
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~----~~~~~~-~~~~~-~~~-----~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVND--ADTI----SQVLNK-KLCFE-NPN-----YNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHC-CCCTT-SGG-----GGGSCHHHHHHHHHHSCSCT
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCCh--HHHH----HHHHhc-ccccC-Ccc-----cccCCHHHHHHHHHHcCCCh
Confidence 89999999999999999999999853321 1111 111111 11110 000 11123468899999999999
Q ss_pred CCCCC
Q 040134 741 SLRPQ 745 (745)
Q Consensus 741 ~~RPT 745 (745)
++|||
T Consensus 320 ~~Rps 324 (345)
T 3hko_A 320 DERFD 324 (345)
T ss_dssp TTSCC
T ss_pred hHCCC
Confidence 99997
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.76 Aligned_cols=246 Identities=26% Similarity=0.327 Sum_probs=195.3
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------cCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||++.... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC-CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3457788999999999999999865 456799999864321 236789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----ceEEeeccCc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF----TPRISDFGLA 629 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~a 629 (745)
.++||||+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999998778899999999999999999999965 999999999999998877 8999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+ ..+......
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~-----~~~~~~~~~ 229 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--QETL-----TNISAVNYD 229 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH-----HHHHTTCCC
T ss_pred eeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--HHHH-----HHhHhcccC
Confidence 87644322 2345689999999999989999999999999999999999999854321 1111 111111111
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .... .......+.+++.+||+.||++|||
T Consensus 230 ~--~~~~----~~~~~~~~~~li~~~l~~dp~~Rps 259 (283)
T 3bhy_A 230 F--DEEY----FSNTSELAKDFIRRLLVKDPKRRMT 259 (283)
T ss_dssp C--CHHH----HTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred C--cchh----cccCCHHHHHHHHHHccCCHhHCcC
Confidence 0 0000 0112346889999999999999997
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.25 Aligned_cols=256 Identities=27% Similarity=0.364 Sum_probs=192.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+.+.||+|+||.||+++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETT-TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECC-CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 45667899999999999999765 45679999985432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+......
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence 999999999988788899999999999999999999965 9999999999999999999999999999876443221
Q ss_pred ccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH----------Hhh----
Q 040134 640 ARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR----------CYI---- 704 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~----------~~~---- 704 (745)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+...+.. .+.
T Consensus 181 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 181 -YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2345689999999999775 789999999999999999999999864332 2222111110 000
Q ss_pred --cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 --GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+................+.+++.+||+.||++|||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 00111111111100001123467899999999999999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.82 Aligned_cols=239 Identities=25% Similarity=0.329 Sum_probs=196.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... .++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hceeeheecCCCCeEEEEEEEcC-CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46677899999999999999765 4678999998542 2334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 9999999999998778899999999999999999999954 99999999999999999999999999987654322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .. . ...+.......
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~-~----~~~~~~~~~~~-------- 231 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TE-T----HRRIVNVDLKF-------- 231 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HH-H----HHHHHTTCCCC--------
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--hH-H----HHHHhccccCC--------
Confidence 2345689999999999999999999999999999999999999854321 11 1 11111111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 232 --~~~~~~~~~~li~~~l~~~p~~Rps 256 (284)
T 2vgo_A 232 --PPFLSDGSKDLISKLLRYHPPQRLP 256 (284)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred --CCcCCHHHHHHHHHHhhcCHhhCCC
Confidence 0112345789999999999999997
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.23 Aligned_cols=246 Identities=28% Similarity=0.452 Sum_probs=196.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..+.+.+.||+|+||.||+|+... ..++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 456678899999999999998753 345789999986532 234457899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 556 LVYEYMSNGSLASFLFGI----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 999999999999998642 4568899999999999999999965 999999999999999999999999
Q ss_pred ccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 626 FGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 626 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+ .+...
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~----~~~~~ 254 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQV----LRFVM 254 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHH----HHHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHH----HHHHH
Confidence 999987654433332334567889999999999999999999999999999999 788875322 1111 12222
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+..... .......+.+++.+||+.||++|||
T Consensus 255 ~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps 286 (322)
T 1p4o_A 255 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPS 286 (322)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcC
Confidence 2221111 1112345889999999999999997
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=319.28 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=184.8
Q ss_pred HHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 476 ~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
.|+....+.+.+.||+|+||.||+|+... .||+|+++.. .....+.+.+|+.++++++||||++++++. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS----EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC----ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34455567788999999999999998643 3999998643 333457799999999999999999999965 4566
Q ss_pred EEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 554 RLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 89999999999999999644 5689999999999999999999965 9999999999999999999999999999866
Q ss_pred cccccccccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
.............|++.|+|||.+. ...++.++||||||+++|||++|+.||..... ...+...+.+ +...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~----~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGR----GSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHH----TSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcc----cccC
Confidence 5433333334467899999999986 56788999999999999999999999864332 2222222222 2111
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..... ........+.+++.+||+.||++|||
T Consensus 245 ~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps 275 (289)
T 3og7_A 245 PDLSK-----VRSNCPKRMKRLMAECLKKKRDERPS 275 (289)
T ss_dssp CCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cchhh-----ccccCCHHHHHHHHHHccCChhhCCC
Confidence 11110 01122356889999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=313.73 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=196.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECC-CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 35567899999999999999865 45679999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999998778899999999999999999999965 9999999999999999999999999999876432221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+. . ..........
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~----~-~~~~~~~~~~-------- 234 (294)
T 2rku_A 172 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KET----Y-LRIKKNEYSI-------- 234 (294)
T ss_dssp --BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHH----H-HHHHTTCCCC--------
T ss_pred --cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH----H-HHHhhccCCC--------
Confidence 2345689999999999998999999999999999999999999854321 111 1 1111111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 235 --~~~~~~~~~~li~~~l~~~p~~Rps 259 (294)
T 2rku_A 235 --PKHINPVAASLIQKMLQTDPTARPT 259 (294)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --ccccCHHHHHHHHHHcccChhhCcC
Confidence 0011245788999999999999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.93 Aligned_cols=244 Identities=23% Similarity=0.241 Sum_probs=191.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.++||+|+||+||+++... +++.||||++.+. .....+.+.+|..++.+++||||+++++++.+.+..++|||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 4456789999999999999865 4578999998642 22234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999764 4789999999999999999999965 9999999999999999999999999999876543321
Q ss_pred cccccccccccccchhccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 639 AARTGIRGTVGYFAPEWFR-------KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
. .....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.. ..+......-...
T Consensus 219 ~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~-~~i~~~~~~~~~p-- 292 (412)
T 2vd5_A 219 R-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--TAETY-GKIVHYKEHLSLP-- 292 (412)
T ss_dssp E-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHH-HHHHTHHHHCCCC--
T ss_pred c-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--HHHHH-HHHHhcccCcCCC--
Confidence 1 23457999999999997 3568999999999999999999999996432 11111 1111100000000
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
.. .......+.+++.+||+ +|++|+
T Consensus 293 ---~~----~~~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 293 ---LV----DEGVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp -----------CCCHHHHHHHHTTSS-CGGGCT
T ss_pred ---cc----ccCCCHHHHHHHHHHcC-ChhhcC
Confidence 00 01123468899999999 999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.62 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=196.7
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeC------CCcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLAS------DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG 551 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 551 (745)
...+.+.+.||+|+||.||+|.... ..++.||+|++... .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 4556778899999999999998742 24567999999753 233456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 040134 552 DHRLLVYEYMSNGSLASFLFGIT----------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL 615 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll 615 (745)
+..++||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997653 378899999999999999999965 99999999999999
Q ss_pred CCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 040134 616 DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEA 694 (745)
Q Consensus 616 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~ 694 (745)
+.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHH
Confidence 9999999999999987654433222344557889999999998899999999999999999999 998885332 111
Q ss_pred HHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 695 LMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 695 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+...+ ..+..... .......+.+++.+||+.||++|||
T Consensus 268 ~~~~~----~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps 305 (334)
T 2pvf_A 268 LFKLL----KEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPT 305 (334)
T ss_dssp HHHHH----HHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHH----hcCCCCCC---------CccCCHHHHHHHHHHccCChhhCcC
Confidence 22211 11111111 1112346889999999999999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=330.53 Aligned_cols=255 Identities=16% Similarity=0.173 Sum_probs=191.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC----cEEEEEEEccccccc-----------CHHHHHHHHHHHhccCCCCceeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS----KRFVAIKKLDKVEQQ-----------GEKEFRTEVSVIGQTHHKNLVRLL 545 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~----~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~ 545 (745)
..+.+.+.||+|+||.||+|.+..+. ++.||||++...... ....+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 45677889999999999999886542 467999998643211 112344566677788899999999
Q ss_pred EEEecC----CeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CC
Q 040134 546 GFCDEG----DHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD--DY 618 (745)
Q Consensus 546 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~--~~ 618 (745)
+++... ...++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++ .+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 998764 4589999999 99999999765 6789999999999999999999965 999999999999998 88
Q ss_pred CceEEeeccCccccccccccc-----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 619 FTPRISDFGLAKLLLAEQTQA-----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 619 ~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
+.+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~- 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK- 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH-
Confidence 999999999998765443221 11334599999999999999999999999999999999999999974333221
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......... ..+..+.+..... ......+.+++.+||+.||++|||
T Consensus 270 -~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 270 -YVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp -HHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred -HHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCC
Confidence 1111111111 1122222211110 112356889999999999999997
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.54 Aligned_cols=241 Identities=29% Similarity=0.395 Sum_probs=181.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc----ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+.||+|+||.||++... ++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 4567789999999999999874 5679999986432 23357889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--------CCceEEeeccCc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD--------YFTPRISDFGLA 629 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~--------~~~~kl~Dfg~a 629 (745)
|||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+||+++. ++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999999985 457899999999999999999999761122999999999999986 678999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .. ......... ..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~----~~~~~~~~~-~~ 232 (271)
T 3dtc_A 164 REWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LA----VAYGVAMNK-LA 232 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--HH----HHHHHHTSC-CC
T ss_pred ccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH----HHHhhhcCC-CC
Confidence 8654332 2234689999999999999999999999999999999999999863221 11 111111111 11
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .......+.+++.+||+.||++|||
T Consensus 233 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rps 260 (271)
T 3dtc_A 233 LPI--------PSTCPEPFAKLMEDCWNPDPHSRPS 260 (271)
T ss_dssp CCC--------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCC--------CcccCHHHHHHHHHHhcCCcccCcC
Confidence 111 1122356889999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.59 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=196.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|.+.+.||+|+||.||++.... .++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45567899999999999999765 4567999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999998778899999999999999999999965 9999999999999999999999999999876433221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.. ..+....... .
T Consensus 198 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~-----~~~~~~~~~~------~- 261 (335)
T 2owb_A 198 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETY-----LRIKKNEYSI------P- 261 (335)
T ss_dssp --BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH-----HHHHHTCCCC------C-
T ss_pred --ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--HHHH-----HHHhcCCCCC------C-
Confidence 3345689999999999999999999999999999999999999854321 1111 1111111110 0
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 262 ---~~~~~~~~~li~~~l~~dp~~Rps 285 (335)
T 2owb_A 262 ---KHINPVAASLIQKMLQTDPTARPT 285 (335)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---ccCCHHHHHHHHHHccCChhHCcC
Confidence 011245788999999999999997
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=321.67 Aligned_cols=239 Identities=26% Similarity=0.325 Sum_probs=190.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+...+.||+|+||.||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345667889999999999998755 4678999998642 223346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+. |+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99997 57887775 346789999999999999999999965 9999999999999999999999999999865432
Q ss_pred cccccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
....||+.|+|||.+. ...++.++||||||+++|||++|+.||..... .. ....... +....+..
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~----~~~~~~~-~~~~~~~~ 275 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MS----ALYHIAQ-NESPALQS 275 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH----HHHHHHH-SCCCCCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HH----HHHHHHh-cCCCCCCC
Confidence 2346899999999984 56789999999999999999999999853321 11 1112111 11111111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 276 --------~~~~~~l~~li~~~l~~dP~~Rps 299 (348)
T 1u5q_A 276 --------GHWSEYFRNFVDSCLQKIPQDRPT 299 (348)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --------CCCCHHHHHHHHHHcccChhhCcC
Confidence 112345788999999999999997
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=348.69 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=199.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 556 (745)
..+.+.++||+|+||.||+++... +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..++
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESS-SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECC-CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 345667899999999999999875 4678999998742 344567788999999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999999999998878899999999999999999999965 99999999999999999999999999998643222
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. ......||+.|+|||++.+..++.++||||||++||||++|+.||.... ...+ .+.+..+.+..
T Consensus 497 ~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~----~~~i~~~~~~~------ 561 (674)
T 3pfq_A 497 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDEL----FQSIMEHNVAY------ 561 (674)
T ss_dssp C--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHSSCCCC------
T ss_pred c--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHH----HHHHHhCCCCC------
Confidence 1 2345679999999999999999999999999999999999999996422 1111 22222222211
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+|+.+||+.||++||+
T Consensus 562 ----p~~~s~~~~~li~~lL~~dP~~R~~ 586 (674)
T 3pfq_A 562 ----PKSMSKEAVAICKGLMTKHPGKRLG 586 (674)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSSTTCTT
T ss_pred ----CccCCHHHHHHHHHHccCCHHHCCC
Confidence 1112346889999999999999996
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.94 Aligned_cols=246 Identities=26% Similarity=0.297 Sum_probs=195.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccc----ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 554 (745)
.+.+.+.||+|+||.||+++... ..++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 46678899999999999998743 356789999986432 23456678899999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999998778899999999999999999999965 999999999999999999999999999987644
Q ss_pred cccccccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
..... .....||+.|+|||.+.+ ..++.++||||||++||||++|+.||........ ........ .......
T Consensus 212 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~-~~~~~~~-- 285 (355)
T 1vzo_A 212 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRI-LKSEPPY-- 285 (355)
T ss_dssp GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHH-HHCCCCC--
T ss_pred CCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHH-hccCCCC--
Confidence 33222 334579999999999975 3578999999999999999999999975443221 11111111 1111110
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
..+....+.+++.+||+.||++||
T Consensus 286 --------~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 286 --------PQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGST
T ss_pred --------CcccCHHHHHHHHHHhhhCHHHhc
Confidence 111234578899999999999999
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.52 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=196.1
Q ss_pred HHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCC-e
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGD-H 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~ 553 (745)
..+.+.+.||+|+||.||+++.. ...++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 45667789999999999999863 2456889999987532 23446789999999999 7999999999987754 5
Q ss_pred EEEEEEecCCCCHHHHhcCCCC----------------CChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 554 RLLVYEYMSNGSLASFLFGITR----------------PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
.++||||+++++|.+++..... +++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 8999999999999999976543 78899999999999999999965 9999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALM 696 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~ 696 (745)
++.+||+|||++..+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..+.
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~ 261 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC 261 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--HHHH
Confidence 99999999999987654433332344567889999999999999999999999999999998 99998644322 1121
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+ ..+..... .......+.+++.+||+.||++|||
T Consensus 262 ~~~----~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 262 RRL----KEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp HHH----HHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHh----ccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 111 11111111 0112345889999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.05 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=185.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.|.+.+.||+|+||+||+++... .++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTV-TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECC-CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 46677899999999999998765 46789999996432 2234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-----CCCCceEEeeccCcccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL-----DDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll-----~~~~~~kl~Dfg~a~~~~~ 634 (745)
|+++ +|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||++..+..
T Consensus 114 ~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp CCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred cCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9985 9999998888899999999999999999999965 99999999999999 4555699999999987643
Q ss_pred cccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc---c--
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN---L-- 708 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~-- 708 (745)
.... .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||.... ....+.... +...... .
T Consensus 190 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~-~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 190 PIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIF-EVLGLPDDTTWPG 264 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH-HHHCCCCTTTSTT
T ss_pred cccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHH-HHhCCCchhhhhh
Confidence 3221 3345679999999999774 58999999999999999999999985432 222222221 1110000 0
Q ss_pred -----------cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 -----------DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 -----------~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...................+.+++.+||+.||++|||
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 0000000000000012356889999999999999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.67 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=184.0
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC---
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD--- 552 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 552 (745)
...+.+.+.||+|+||.||+|..... .++.||+|.+... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 34456678899999999999987653 4568999998643 2334567899999999999999999999997755
Q ss_pred --eEEEEEEecCCCCHHHHhc------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEe
Q 040134 553 --HRLLVYEYMSNGSLASFLF------GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRIS 624 (745)
Q Consensus 553 --~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 624 (745)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999983 336689999999999999999999954 99999999999999999999999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
|||++..+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .+...+
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~---- 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYL---- 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHH----
Confidence 9999987654433222334567889999999999999999999999999999999 78887543221 121111
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..... .......+.+++.+||+.||++|||
T Consensus 263 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps 295 (313)
T 3brb_A 263 LHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPT 295 (313)
T ss_dssp HTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcC
Confidence 11111111 1122346889999999999999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.00 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=198.6
Q ss_pred HHhcchhhcCcceeEEEEEEEe---eCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEe--cCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVL---ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD--EGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~ 555 (745)
..+.+.+.||+|+||.||++++ ....++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4566788999999999999985 33456889999998766666678999999999999999999999886 456789
Q ss_pred EEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999763 5689999999999999999999965 999999999999999999999999999987654
Q ss_pred cccc-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc--------hhhHHHHHHHHhhc
Q 040134 635 EQTQ-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP--------EEALMDWVYRCYIG 705 (745)
Q Consensus 635 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~--------~~~l~~~~~~~~~~ 705 (745)
.... .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .......+......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3321 12233567888999999999899999999999999999999999985321100 00000111111111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.. ..........+.+++.+||+.||++|||
T Consensus 260 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps 290 (327)
T 3lxl_A 260 GQR---------LPAPPACPAEVHELMKLCWAPSPQDRPS 290 (327)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccC---------CCCCCcccHHHHHHHHHHcCCChhhCcC
Confidence 111 1111223456889999999999999997
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=326.24 Aligned_cols=199 Identities=24% Similarity=0.342 Sum_probs=174.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeeecCCCCeEEEEEEECC-CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 45667889999999999999865 4567999998653 333457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+++++|.+++.....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 186 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc----
Confidence 99999999998878899999999999999999999963 289999999999999999999999999997653322
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23456899999999999999999999999999999999999999653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=329.18 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=198.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC--eEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD--HRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~ 558 (745)
.|.+.++||+|+||+||+|+... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEECC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 35677899999999999999865 45689999997533 344677889999999999999999999998755 789999
Q ss_pred EecCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCceEEeeccCccc
Q 040134 559 EYMSNGSLASFLFGIT---RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL----DDYFTPRISDFGLAKL 631 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~a~~ 631 (745)
||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997653 389999999999999999999965 99999999999999 7778899999999987
Q ss_pred ccccccccccccccccccccchhcccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCC-chhhHHHHHHHH
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRK--------ASITVKVDVYSFGVLLLELICCKSSVVFGTTN-PEEALMDWVYRC 702 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~-~~~~l~~~~~~~ 702 (745)
...... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..... +.+.
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~ 239 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV---MYKI 239 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH---HHHH
T ss_pred ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH---HHHH
Confidence 654332 234568999999999865 56788999999999999999999999643322 11111 2222
Q ss_pred hhcCcc---cccc-----------cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNL---DKLA-----------ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~---~~~~-----------~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... ..+. ...............+.+++.+||+.||++|||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 211111 0000 001111223566778899999999999999997
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.09 Aligned_cols=241 Identities=27% Similarity=0.464 Sum_probs=189.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC-------HHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG-------EKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
..+.+.+.||+|+||.||+++... +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETT-TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred ccceehhccccCCceeEEEEEEcC-CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 346677899999999999999865 45679999985432221 267899999999999999999999997765
Q ss_pred EEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCc-----eEEee
Q 040134 554 RLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQ--IIHCDIKPQNILLDDYFT-----PRISD 625 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dikp~NIll~~~~~-----~kl~D 625 (745)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999998888655 5789999999999999999999965 7 999999999999988776 99999
Q ss_pred ccCcccccccccccccccccccccccchhccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh
Q 040134 626 FGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR--KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 626 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
||+++..... .....|++.|+|||.+. ...++.++||||||+++|||++|+.||........... ..+..
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~-- 244 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMIRE-- 244 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHHHH--
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHHhc--
Confidence 9999754332 33456899999999984 45678999999999999999999999965443322111 11111
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....... .......+.+++.+||+.||++|||
T Consensus 245 --~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps 276 (287)
T 4f0f_A 245 --EGLRPTI--------PEDCPPRLRNVIELCWSGDPKKRPH 276 (287)
T ss_dssp --SCCCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --cCCCCCC--------CcccCHHHHHHHHHHhcCChhhCcC
Confidence 1111111 1122356889999999999999997
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=315.15 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=186.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.|.+.+.||+|+||.||++.... .++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTV-RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcC-CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45677899999999999999765 457899999865432 22467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 9999999999998778899999999999999999999965 9999999999999999999999999999876543322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... . .+...... .......
T Consensus 191 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~----~~~~~~~~-~~~~~~~----- 256 (309)
T 2h34_A 191 Q-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S----VMGAHINQ-AIPRPST----- 256 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H----HHHHHHHS-CCCCGGG-----
T ss_pred c-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H----HHHHHhcc-CCCCccc-----
Confidence 1 2345689999999999999999999999999999999999999853211 1 11111111 1111110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
........+.+++.+||+.||++||
T Consensus 257 -~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 257 -VRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp -TSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred -cCCCCCHHHHHHHHHhccCCHHHHH
Confidence 0111234588899999999999999
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.19 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=196.7
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCC----cEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDS----KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
...+.+.+.||+|+||.||+|...... .+.||+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 344567789999999999999975432 247999998653 233456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 554 RLLVYEYMSNGSLASFLFG--------------ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999864 23578999999999999999999965 999999999999999999
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDW 698 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~ 698 (745)
.+||+|||++..+.............+++.|+|||.+.+..++.++||||||+++|||+| |..||...... ..+...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHHH
Confidence 999999999987654433322334567889999999999999999999999999999999 88888643322 122222
Q ss_pred HHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.. +.... . .......+.+++.+||+.||.+|||
T Consensus 280 ~~~----~~~~~--~-------~~~~~~~l~~li~~~l~~~p~~Rps 313 (333)
T 2i1m_A 280 VKD----GYQMA--Q-------PAFAPKNIYSIMQACWALEPTHRPT 313 (333)
T ss_dssp HHH----TCCCC--C-------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred Hhc----CCCCC--C-------CCCCCHHHHHHHHHHhccChhhCcC
Confidence 211 11100 0 0111346889999999999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.37 Aligned_cols=238 Identities=29% Similarity=0.426 Sum_probs=183.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||+++.. ++.||+|++.. ....+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET---TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HeeeeeEeecCCCceEEEEEEC---CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 4567789999999999999874 46799999864 2345789999999999999999999998874 478999999
Q ss_pred CCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-eEEeeccCccccccccc
Q 040134 562 SNGSLASFLFGIT---RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT-PRISDFGLAKLLLAEQT 637 (745)
Q Consensus 562 ~~gsL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~ 637 (745)
++++|.+++.... .+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999998664 3678899999999999999999743369999999999999988876 799999999765432
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.. ..+......
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~----- 226 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAV-HNGTRPPLI----- 226 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHH-HTTCCCCCB-----
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHH-hcCCCCCcc-----
Confidence 22345899999999999999999999999999999999999998644332211 11111 111111111
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 227 ----~~~~~~l~~li~~~l~~dp~~Rps 250 (307)
T 2eva_A 227 ----KNLPKPIESLMTRCWSKDPSQRPS 250 (307)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----cccCHHHHHHHHHHhcCChhhCcC
Confidence 112345889999999999999997
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.07 Aligned_cols=243 Identities=27% Similarity=0.422 Sum_probs=191.5
Q ss_pred chhhcCcceeEEEEEEEeeCC--CcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE-EEEEEe
Q 040134 485 FRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR-LLVYEY 560 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~e~ 560 (745)
..++||+|+||.||+|..... ....||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 347899999999999987543 34479999986533 33457889999999999999999999999876655 999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc--
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT-- 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 637 (745)
+.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+.....
T Consensus 105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999999764 5688999999999999999999965 999999999999999999999999999987644332
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
........+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... ..+...+. .+.....
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~----~~~~~~~------ 249 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLA----QGRRLPQ------ 249 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHH----TTCCCCC------
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhh----cCCCCCC------
Confidence 12233456788999999999999999999999999999999977765433222 12222111 1111100
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 250 ---~~~~~~~l~~li~~~l~~~p~~Rps 274 (298)
T 3pls_A 250 ---PEYCPDSLYQVMQQCWEADPAVRPT 274 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CccchHHHHHHHHHHccCChhhCcC
Confidence 1112346889999999999999997
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.98 Aligned_cols=196 Identities=26% Similarity=0.338 Sum_probs=170.4
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-----CCCceeEEEEEecCCeE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-----HKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~ 554 (745)
...+.+.+.||+|+||.||+++... +++.||||+++.. ....+.+..|++++++++ ||||+++++++...+..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECC-CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3456677899999999999999865 4567999998642 334466788999999886 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---------------
Q 040134 555 LLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD--------------- 617 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~--------------- 617 (745)
++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 89999999755 3589999999999999999999965 9999999999999975
Q ss_pred ----------CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 618 ----------YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 618 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999864332 2345689999999999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.99 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=195.6
Q ss_pred CHHHHHHHHhcch-hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhcc-CCCCceeEEEEEe
Q 040134 474 TYKELEEATRGFR-QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCD 549 (745)
Q Consensus 474 ~~~~l~~~~~~~~-~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 549 (745)
...+.....+.+. +.||+|+||.||++.... +++.||+|++... .......+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 3334444555555 789999999999999865 4567999998643 334467899999999999 5799999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEe
Q 040134 550 EGDHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRIS 624 (745)
Q Consensus 550 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~ 624 (745)
+.+..++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999998654 6789999999999999999999965 9999999999999987 7899999
Q ss_pred eccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 625 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ..+...
T Consensus 177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~-~~i~~~-- 248 (327)
T 3lm5_A 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--QETY-LNISQV-- 248 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH-HHHHHT--
T ss_pred eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHH-HHHHhc--
Confidence 9999987643322 2345689999999999999999999999999999999999999854321 1111 111111
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... .........+.+++.+||+.||++|||
T Consensus 249 --~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (327)
T 3lm5_A 249 --NVDYSE------ETFSSVSQLATDFIQSLLVKNPEKRPT 281 (327)
T ss_dssp --CCCCCT------TTTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred --ccccCc------hhhcccCHHHHHHHHHHcCCChhhCcC
Confidence 111100 001122345889999999999999997
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=326.39 Aligned_cols=258 Identities=16% Similarity=0.186 Sum_probs=191.1
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEccccccc-----------CHHHHHHHHHHHhccCCCCceeE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKVEQQ-----------GEKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l 544 (745)
+....+.+.+.||+|+||.||+|.... ..++.||+|++...... ....+.+|+..+..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 334456778899999999999999864 13567999998643221 22346778889999999999999
Q ss_pred EEEEec----CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-
Q 040134 545 LGFCDE----GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF- 619 (745)
Q Consensus 545 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~- 619 (745)
++++.. ....++||||+ +++|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 999987 78899999999 999999998777899999999999999999999965 999999999999998877
Q ss_pred -ceEEeeccCcccccccccc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 620 -TPRISDFGLAKLLLAEQTQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 620 -~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
.+||+|||+++.+...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876543221 1123457899999999999999999999999999999999999999643322211
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ..............+..... .......+.+++.+||+.||++|||
T Consensus 270 -~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 270 -V-QTAKTNLLDELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp -H-HHHHHHHHHTTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred -H-HHHHHhhcccccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCC
Confidence 1 11111111111111100000 0022346889999999999999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=333.99 Aligned_cols=195 Identities=29% Similarity=0.325 Sum_probs=161.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------Ce
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 553 (745)
.|.+.+.||+|+||+||++.... .++.||||++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 35667899999999999998765 4678999999643 334456788999999999999999999999654 46
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 7999999976 46666643 488999999999999999999965 99999999999999999999999999998764
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 216 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 216 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp -CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3321 3446789999999999999999999999999999999999999954
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.02 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=192.2
Q ss_pred Hhcchh-hcCcceeEEEEEEEee-CCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQ-ILGRGAFGTVYKGVLA-SDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~-~Ig~G~~g~V~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+ .||+|+||.||+|.+. ...++.||||++.... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 345556 8999999999999764 3346789999987532 22357899999999999999999999999 56778999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999999998888899999999999999999999965 999999999999999999999999999987654332
Q ss_pred cc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 638 QA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 638 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+ ...+..+.....
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~~~---- 241 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV----TAMLEKGERMGC---- 241 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH----HHHHHTTCCCCC----
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCCCC----
Confidence 11 1222346788999999998889999999999999999999 9999864322 111 122222211111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 242 -----~~~~~~~l~~li~~~l~~dp~~Rps 266 (291)
T 1xbb_A 242 -----PAGCPREMYDLMNLCWTYDVENRPG 266 (291)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 1122356889999999999999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.73 Aligned_cols=244 Identities=29% Similarity=0.501 Sum_probs=181.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~ 558 (745)
+.+.+.||+|+||.||+|...... ...||+|.++.. .....+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 345678999999999999976433 456899998653 33445789999999999999999999998754 56789999
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999765 4578899999999999999999965 999999999999999999999999999987644322
Q ss_pred cc--ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 638 QA--ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 638 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.. ......+++.|+|||.+.+..++.++||||||+++|||+| |..||......+ ....+ ..+... ..+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~~~--~~p 318 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRRL--LQP 318 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTCCC--CCC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCCCC--CCC
Confidence 11 1233457789999999999999999999999999999999 555554332211 11111 111111 011
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 319 -------~~~~~~l~~li~~cl~~dp~~RPs 342 (373)
T 3c1x_A 319 -------EYCPDPLYEVMLKCWHPKAEMRPS 342 (373)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCCCHHHHHHHHHHcCCChhhCcC
Confidence 112346889999999999999997
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.96 Aligned_cols=245 Identities=27% Similarity=0.438 Sum_probs=187.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCC---cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDS---KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.+.+.||+|+||.||+|...... +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 3445678999999999999886433 356999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999754 6789999999999999999999965 99999999999999999999999999998765432
Q ss_pred ccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 637 TQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 637 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. +.+..+....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~----~~~~~~~~~~---- 270 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVM----KAINDGFRLP---- 270 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTCCCC----
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHCCCcCC----
Confidence 211 1222345788999999999999999999999999999999 9999853321 1111 1222221110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 271 -----~~~~~~~~l~~li~~~l~~~p~~Rps 296 (333)
T 1mqb_A 271 -----TPMDCPSAIYQLMMQCWQQERARRPK 296 (333)
T ss_dssp -----CCTTCBHHHHHHHHHHTCSSTTTSCC
T ss_pred -----CcccCCHHHHHHHHHHcCCChhhCcC
Confidence 01122346889999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.09 Aligned_cols=238 Identities=16% Similarity=0.143 Sum_probs=190.0
Q ss_pred HHhcchhhcCcceeEEEEEEEe----eCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC---CCCceeEEEEEecCCe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVL----ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~ 553 (745)
..+.+.+.||+|+||.||+|+. ....++.||||+++.. ...++..|++++++++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 3456678999999999999953 2234567999998643 4567788888888886 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhc-----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----------
Q 040134 554 RLLVYEYMSNGSLASFLF-----GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD----------- 617 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~----------- 617 (745)
.++||||+++|+|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999997 346789999999999999999999954 9999999999999998
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD 697 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~ 697 (745)
++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 899999999999866433333334556799999999999999999999999999999999999999853322110
Q ss_pred HHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 698 WVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+...+.. . ...+.+.+++..|++.+|.+||+
T Consensus 294 ---------~~~~~~~~-~------~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 294 ---------KPEGLFRR-L------PHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp ---------EECSCCTT-C------SSHHHHHHHHHHHHCCCCTTCCC
T ss_pred ---------eechhccc-c------CcHHHHHHHHHHHcCCCCCCcch
Confidence 01111100 0 11345667888899999999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.50 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=194.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||++.... ++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred heeeeeEecCCCceeEEEEEecC--CCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 45677899999999999999753 4579999997533 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~- 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS- 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS-
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc-
Confidence 999999999765 5689999999999999999999965 99999999999999999999999999998764432211
Q ss_pred cccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ..+..+.... .+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~i~~~~~~~--~~----- 227 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV----EDISTGFRLY--KP----- 227 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTCCCC--CC-----
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHH----HHHhcCCcCC--CC-----
Confidence 233456788999999998899999999999999999999 8888753221 1111 1111111110 00
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps 251 (267)
T 3t9t_A 228 --RLASTHVYQIMNHCWRERPEDRPA 251 (267)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --ccCcHHHHHHHHHHccCChhhCcC
Confidence 112346889999999999999997
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.56 Aligned_cols=245 Identities=29% Similarity=0.497 Sum_probs=187.8
Q ss_pred hcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEe-cCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD-EGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~ 558 (745)
+.+.+.||+|+||.||+|...... ...||+|.+... .....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 456689999999999999875432 346899998653 3334577899999999999999999999864 556889999
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+.....
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999764 5688999999999999999999965 999999999999999999999999999987654332
Q ss_pred c--cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 638 Q--AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 638 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
. .......+++.|+|||.+.+..++.++||||||+++|||++|..|+....... . ....+ ..+..... +
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~-~~~~~----~~~~~~~~--~- 254 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-D-ITVYL----LQGRRLLQ--P- 254 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-T-HHHHH----HTTCCCCC--C-
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-H-HHHHH----hcCCCCCC--C-
Confidence 1 12334567889999999999999999999999999999999655543322221 1 11111 11111110 0
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 255 ------~~~~~~l~~li~~~l~~~p~~Rps 278 (298)
T 3f66_A 255 ------EYCPDPLYEVMLKCWHPKAEMRPS 278 (298)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------ccCCHHHHHHHHHHcCCChhhCcC
Confidence 011245889999999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.22 Aligned_cols=245 Identities=25% Similarity=0.298 Sum_probs=192.9
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...|.+.+.||+|+||+||+++... .++.||+|++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT-TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467788999999999999999765 4567999998653 234467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CceEEeeccCcccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGLAKLLLA 634 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~a~~~~~ 634 (745)
|||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||++..+..
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999998778899999999999999999999965 99999999999999764 5599999999987654
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.... .. .+. ..+..+...... +
T Consensus 192 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~-~~~----~~i~~~~~~~~~-~ 259 (494)
T 3lij_A 192 QKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ-EIL----RKVEKGKYTFDS-P 259 (494)
T ss_dssp TBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HH-HHH----HHHHHTCCCCCS-G
T ss_pred Ccc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HH-HHH----HHHHhCCCCCCc-h
Confidence 332 33456999999999986 568999999999999999999999986332 11 111 112222111100 0
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......+.+++.+||+.||++|||
T Consensus 260 ~-----~~~~s~~~~~li~~~L~~dp~~R~s 285 (494)
T 3lij_A 260 E-----WKNVSEGAKDLIKQMLQFDSQRRIS 285 (494)
T ss_dssp G-----GTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred h-----cccCCHHHHHHHHHHCCCChhhCcc
Confidence 0 1112345889999999999999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=331.05 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=186.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--------ccCHHHHHHHHHHHhccCCCCceeEEEEEecC
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG 551 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 551 (745)
...+.+.+.||+|+||.||+|.... +++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECC-CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4457778899999999999999765 45679999986422 1122358899999999999999999999854
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CceEEeeccC
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGL 628 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~ 628 (745)
+..++||||+++++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 55899999999999999998888999999999999999999999965 99999999999999654 4599999999
Q ss_pred cccccccccccccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 629 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
++.+..... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||...... ..+...+ ..
T Consensus 289 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i----~~ 359 (419)
T 3i6u_A 289 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI----TS 359 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHH----HT
T ss_pred ceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHH----hc
Confidence 987654322 334578999999999853 56788999999999999999999999643322 1222211 11
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+....... . .......+.+++.+||+.||++|||
T Consensus 360 ~~~~~~~~--~----~~~~~~~~~~li~~~L~~dP~~Rps 393 (419)
T 3i6u_A 360 GKYNFIPE--V----WAEVSEKALDLVKKLLVVDPKARFT 393 (419)
T ss_dssp TCCCCCHH--H----HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCch--h----hcccCHHHHHHHHHHccCChhHCcC
Confidence 11111100 0 0112356889999999999999997
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.83 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=192.3
Q ss_pred hcchh-hcCcceeEEEEEEEee-CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQ-ILGRGAFGTVYKGVLA-SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~-~Ig~G~~g~V~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.+.+ .||+|+||.||+|... ...++.||+|+++.. .....+.+.+|++++++++||||+++++++ +.+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 33444 8999999999999864 334678999999753 334457899999999999999999999999 4567899999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+......
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999999999654 5689999999999999999999965 9999999999999999999999999999876543321
Q ss_pred -cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 639 -AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 639 -~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.. .+..+.....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~----~i~~~~~~~~----- 234 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMA----FIEQGKRMEC----- 234 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHH----HHHTTCCCCC-----
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHhcCCcCCC-----
Confidence 11233456889999999988899999999999999999998 9999864332 11111 1112211111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 235 ----~~~~~~~l~~li~~~l~~~p~~Rps 259 (287)
T 1u59_A 235 ----PPECPPELYALMSDCWIYKWEDRPD 259 (287)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred ----CCCcCHHHHHHHHHHcCCChhhCcC
Confidence 1122356889999999999999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.74 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=190.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||+|+.... .++.||+|.+... .....+.+.+|+.++++++||||+++++++.++ ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 456778999999999999987643 3457999998753 334457899999999999999999999998754 568999
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999754 4589999999999999999999965 999999999999999999999999999987654332
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.. +.....
T Consensus 169 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~----~~~~~~----- 235 (281)
T 3cc6_A 169 YK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK----GDRLPK----- 235 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH----TCCCCC-----
T ss_pred cc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc----CCCCCC-----
Confidence 21 233456889999999998999999999999999999998 99998643322 12121111 111110
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps 260 (281)
T 3cc6_A 236 ----PDLCPPVLYTLMTRCWDYDPSDRPR 260 (281)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----CCCCCHHHHHHHHHHccCCchhCcC
Confidence 0112345889999999999999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.53 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=196.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
...|.+.+.||+|+||+||+++... +++.||||++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT-TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC-CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568889999999999999999765 4567999998642 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCceEEeeccCcccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~a~~~~~ 634 (745)
|||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++..+..
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999998778899999999999999999999965 999999999999995 456899999999987644
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... ..+.+ ..+..+.......
T Consensus 177 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~-----~~i~~~~~~~~~~- 244 (486)
T 3mwu_A 177 NTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDIL-----KRVETGKYAFDLP- 244 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH-----HHHHHTCCCSCSG-
T ss_pred CCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHH-----HHHHhCCCCCCCc-
Confidence 322 334568999999999975 58999999999999999999999985322 11111 1122222111110
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 245 -----~~~~~s~~~~~li~~~L~~dp~~R~t 270 (486)
T 3mwu_A 245 -----QWRTISDDAKDLIRKMLTFHPSLRIT 270 (486)
T ss_dssp -----GGGGSCHHHHHHHHHHTCSSTTTSCC
T ss_pred -----ccCCCCHHHHHHHHHHcCCChhhCcC
Confidence 01122346889999999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=339.88 Aligned_cols=241 Identities=29% Similarity=0.413 Sum_probs=187.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|+||.||+|.+.. ...||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hHceeeeeecCCCCeEEEEEEECC--CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 345677899999999999999864 3569999997533 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999743 5689999999999999999999965 9999999999999999999999999999876543221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+....++.++||||||+++|||++ |+.||..... . .+. ..+..+....
T Consensus 337 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~-~~~----~~i~~~~~~~------- 401 (452)
T 1fmk_A 337 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--R-EVL----DQVERGYRMP------- 401 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--H-HHH----HHHHTTCCCC-------
T ss_pred c-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--H-HHH----HHHHcCCCCC-------
Confidence 1 233456789999999999999999999999999999999 8888853221 1 111 1111221110
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 402 --~~~~~~~~l~~li~~cl~~dP~~Rpt 427 (452)
T 1fmk_A 402 --CPPECPESLHDLMCQCWRKEPEERPT 427 (452)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcC
Confidence 11123456889999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=335.15 Aligned_cols=246 Identities=24% Similarity=0.285 Sum_probs=199.4
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
....|.+.+.||+|+||.||+++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC-CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567888999999999999999765 4567999998542 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCcccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLL 632 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~ 632 (745)
+||||+.+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999998888999999999999999999999965 99999999999999 56789999999999876
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... ..+ +.. .+..+......
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~-~~~----~i~~~~~~~~~ 248 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--EYD-ILK----KVEKGKYTFEL 248 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH-HHH----HHHHCCCCCCS
T ss_pred ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--HHH-HHH----HHHcCCCCCCC
Confidence 44322 334568999999999866 68999999999999999999999986322 111 111 12222211111
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ........+.+++.+||+.||++|||
T Consensus 249 ~------~~~~~s~~~~~li~~~L~~dp~~R~s 275 (484)
T 3nyv_A 249 P------QWKKVSESAKDLIRKMLTYVPSMRIS 275 (484)
T ss_dssp G------GGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred c------ccccCCHHHHHHHHHHCCCChhHCcC
Confidence 0 01122356889999999999999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=325.39 Aligned_cols=237 Identities=22% Similarity=0.267 Sum_probs=181.4
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhc-cCCCCceeEEEEEec----CCeEEEEEEec
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRLLGFCDE----GDHRLLVYEYM 561 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~lv~e~~ 561 (745)
++||+|+||+||++.... +++.||||+++. ...+.+|++++.+ .+||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~-~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETT-TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECC-CCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 689999999999999765 467899999853 2467788888754 589999999998865 56789999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCcccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~ 636 (745)
++|+|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 999999999865 3589999999999999999999965 9999999999999987 7899999999998654322
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch-hhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE-EALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+ ..+...... +
T Consensus 219 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~~~~-~- 289 (400)
T 1nxk_A 219 S---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPN-P- 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCCCCT-T-
T ss_pred c---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcccCCC-c-
Confidence 2 3345789999999999999999999999999999999999999965433211 1111111 111111100 0
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 290 ----~~~~~s~~~~~li~~~L~~dP~~Rpt 315 (400)
T 1nxk_A 290 ----EWSEVSEEVKMLIRNLLKTEPTQRMT 315 (400)
T ss_dssp ----TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred ----ccccCCHHHHHHHHHHCCCChhHCcC
Confidence 01112346889999999999999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.10 Aligned_cols=264 Identities=21% Similarity=0.284 Sum_probs=200.8
Q ss_pred cCccCHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhc--cCCCCceeEEEE
Q 040134 470 VRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ--THHKNLVRLLGF 547 (745)
Q Consensus 470 ~~~~~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~ 547 (745)
...+...+.....+.+.+.||+|+||.||+|+.. ++.||||++... ..+.+.+|++++.. ++||||++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 3444455666778889999999999999999873 577999998642 34677888888887 799999999999
Q ss_pred EecCC----eEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCC
Q 040134 548 CDEGD----HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC-----STQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 548 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dikp~NIll~~~ 618 (745)
+.... ..++||||+++++|.+++.. ..+++.+++.++.|++.||+|||... +.+|+||||||+||+++.+
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence 98876 89999999999999999965 46899999999999999999999210 2499999999999999999
Q ss_pred CceEEeeccCccccccccccc--ccccccccccccchhccccC------CCCccchhHHHHHHHHHHHhC----------
Q 040134 619 FTPRISDFGLAKLLLAEQTQA--ARTGIRGTVGYFAPEWFRKA------SITVKVDVYSFGVLLLELICC---------- 680 (745)
Q Consensus 619 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwslG~vl~elltg---------- 680 (745)
+.+||+|||++.......... ......|++.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999998765433211 13345789999999999765 234789999999999999999
Q ss_pred CCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 681 KSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 681 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..||........ .. ..+.+............... ...+....+.+++.+||+.||++|||
T Consensus 264 ~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 264 QLPYYDLVPSDP-SV-EEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp CCTTTTTSCSSC-CH-HHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred ccCccccCcCcc-cH-HHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCC
Confidence 667654332211 11 11222222222221111111 13356678999999999999999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=323.38 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=192.5
Q ss_pred cchhhcCcceeEEEEEEEee---CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLA---SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 557 (745)
.+.+.||+|+||.||++.+. ...++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67789999999999988753 2356789999997532 3345679999999999999999999999987 4688999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999654 489999999999999999999965 999999999999999999999999999987654332
Q ss_pred c-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC--------chhhHHHHHHHHhhcCcc
Q 040134 638 Q-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTN--------PEEALMDWVYRCYIGKNL 708 (745)
Q Consensus 638 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~--------~~~~l~~~~~~~~~~~~~ 708 (745)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........+....+..
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 1 1133455788899999999989999999999999999999999998532110 000000111111111111
Q ss_pred cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..........+.+++.+||+.||++|||
T Consensus 270 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps 297 (318)
T 3lxp_A 270 ---------LPRPDKCPAEVYHLMKNCWETEASFRPT 297 (318)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---------CCCCccccHHHHHHHHHHcCCCcccCcC
Confidence 1111223456889999999999999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.67 Aligned_cols=200 Identities=26% Similarity=0.437 Sum_probs=159.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccC-CCCceeEEEEEecCC--eEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGD--HRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~ 555 (745)
..|.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp TTEEEEEC-------CEEEEEETT-TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECC-CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 456678899999999999998765 4567999998542 2334567889999999997 999999999997544 789
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999997 589998865 5788999999999999999999965 9999999999999999999999999999865321
Q ss_pred c-------------------cccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 636 Q-------------------TQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 636 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 0111334579999999999976 6789999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.03 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=184.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETT-TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcC-CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46778899999999999999765 4567999998642 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 559 EYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 559 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999863 46689999999999999999999965 999999999999999999999999999987643
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||........ ... ..........+..
T Consensus 189 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 189 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLC-KKIEQCDYPPLPS- 260 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHH-HHHHTTCSCCCCT-
T ss_pred CCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHH-HHhhcccCCCCcc-
Confidence 3221 2334689999999999999999999999999999999999999864332211 111 1112222211111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 261 -------~~~~~~l~~li~~~l~~dp~~Rps 284 (310)
T 2wqm_A 261 -------DHYSEELRQLVNMCINPDPEKRPD 284 (310)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------cccCHHHHHHHHHHcCCChhhCCC
Confidence 112346889999999999999997
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.19 Aligned_cols=243 Identities=28% Similarity=0.437 Sum_probs=190.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcE-EEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKR-FVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~-~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+.+.+.||+|+||.||+++....... .|++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 3466788999999999999998764432 4689988642 334456789999999999 999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCce
Q 040134 558 YEYMSNGSLASFLFGIT----------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTP 621 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~ 621 (745)
|||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997654 689999999999999999999965 99999999999999999999
Q ss_pred EEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 040134 622 RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVY 700 (745)
Q Consensus 622 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~ 700 (745)
||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ..
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~----~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE----LY 251 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH----HH
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HH----HH
Confidence 9999999875432211 233456889999999998889999999999999999998 9999853321 11 11
Q ss_pred HHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+..+.... ........+.+++.+||+.||++|||
T Consensus 252 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps 287 (327)
T 1fvr_A 252 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPS 287 (327)
T ss_dssp HHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcC
Confidence 2222221110 01112346889999999999999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.24 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=194.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--------cCHHHHHHHHHHHhcc-CCCCceeEEEEEecC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--------QGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG 551 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 551 (745)
..+.+.+.||+|+||.||++++.. +++.||||++..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecCCCEEEEEEEECC-CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 446667899999999999999864 356799999864321 1245688999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...++||||+++++|.+++.....+++..+..++.||+.||.|||+. ||+|+||||+||+++.++.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999999999998777899999999999999999999965 999999999999999999999999999987
Q ss_pred ccccccccccccccccccccchhcccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRK------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..... +.+..
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~----~~i~~ 319 (365)
T 2y7j_A 250 LEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML----RMIME 319 (365)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHH
T ss_pred cCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHH----HHHHh
Confidence 654322 334578999999999863 358899999999999999999999985322 11111 11112
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+...... +.. ......+.+++.+||+.||++|||
T Consensus 320 ~~~~~~~-~~~-----~~~~~~~~~li~~~L~~dP~~Rps 353 (365)
T 2y7j_A 320 GQYQFSS-PEW-----DDRSSTVKDLISRLLQVDPEARLT 353 (365)
T ss_dssp TCCCCCH-HHH-----SSSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCC-ccc-----ccCCHHHHHHHHHHcCCChhHCcC
Confidence 2111100 000 012345889999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.82 Aligned_cols=240 Identities=23% Similarity=0.331 Sum_probs=188.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+.+.+.||+|+||.||++.... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECC-CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 35567899999999999999865 4567999998643 2344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 9999999999998778899999999999999999999976 999999999999999999999999999987644322
Q ss_pred cccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ...+. +.+..+.... +
T Consensus 167 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~~---~--- 231 (276)
T 2h6d_A 167 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLF----KKIRGGVFYI---P--- 231 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCCCC---C---
T ss_pred --eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHH----HHhhcCcccC---c---
Confidence 233468899999999987765 689999999999999999999985321 11111 1111111110 0
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 232 ----~~~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 232 ----EYLNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----hhcCHHHHHHHHHHccCChhhCCC
Confidence 011245788999999999999997
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.16 Aligned_cols=241 Identities=30% Similarity=0.451 Sum_probs=192.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+.+.+.||+|+||.||+|.... ++.||+|.+... ....+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEEEcC--CcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 346677899999999999998753 456999998653 2346789999999999999999999999864 568999999
Q ss_pred cCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999997653 689999999999999999999965 9999999999999999999999999999876543322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... . .+. ..+..+.... .
T Consensus 166 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~-~~~----~~~~~~~~~~-~----- 231 (279)
T 1qpc_A 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--P-EVI----QNLERGYRMV-R----- 231 (279)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--H-HHH----HHHHTTCCCC-C-----
T ss_pred c-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--H-HHH----HHHhcccCCC-C-----
Confidence 1 233456789999999998889999999999999999999 8888753221 1 111 1111111100 0
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps 256 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPT 256 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---cccccHHHHHHHHHHhccChhhCCC
Confidence 1112356889999999999999997
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.55 Aligned_cols=248 Identities=19% Similarity=0.240 Sum_probs=193.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEE-ecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC-DEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||+|+... .++.||||++.... ..+.+.+|+.++++++|++++..+.++ .+.+..++||||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 35667899999999999999754 46789999986432 335689999999999988766665555 667788999999
Q ss_pred cCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+ +++|.+++. ....+++.+++.++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9 899999997 346789999999999999999999965 99999999999999 488899999999998765443
Q ss_pred ccc-----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 637 TQA-----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 637 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..............+.+.........+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 211 123457899999999999999999999999999999999999999765443322222222222111111110
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ......+.+++.+||+.||++|||
T Consensus 243 ~---------~~~~~~l~~li~~~l~~dp~~Rps 267 (296)
T 3uzp_A 243 C---------KGYPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp T---------TTSCHHHHHHHHHHHTSCTTCCCC
T ss_pred H---------hhCCHHHHHHHHHHHhcCcCcCCC
Confidence 0 112346889999999999999997
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=326.65 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=196.8
Q ss_pred HHhcchhhcCcceeEEEEEEEe---eCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC--eEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVL---ASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD--HRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~ 555 (745)
..+.+.+.||+|+||.||+++. ....++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4456788999999999999985 23457889999998766666778999999999999999999999987654 789
Q ss_pred EEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999765 5689999999999999999999965 999999999999999999999999999987654
Q ss_pred ccccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC---------CCchhhHHHHHHHHhh
Q 040134 635 EQTQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT---------TNPEEALMDWVYRCYI 704 (745)
Q Consensus 635 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~---------~~~~~~l~~~~~~~~~ 704 (745)
..... ......++..|+|||.+.+..++.++||||||+++|||+||..|+.... ..........+.+.+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 33211 1223456778999999998889999999999999999999998875321 0011111111112221
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.... ........+.+++.+||+.||++|||
T Consensus 278 ~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps 309 (326)
T 2w1i_A 278 NNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPS 309 (326)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred cCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcC
Confidence 111110 11122356889999999999999997
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.61 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=192.0
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEE-ecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFC-DEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e 559 (745)
..+.+.+.||+|+||.||+|+... .++.||||++.... ....+.+|++++++++|++++..+..+ ...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcC-CCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 456778999999999999999755 46789999865422 234578899999999888776666655 67788899999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|+ +++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||++ ++++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 9999999974 46789999999999999999999965 99999999999999 78899999999999876544
Q ss_pred ccc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 636 QTQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 636 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..............+...........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 321 112346789999999999999999999999999999999999999976544333222222222111111110
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+. ......+.+++.+||+.||++|||
T Consensus 242 ~~---------~~~~~~l~~li~~~l~~~p~~Rpt 267 (296)
T 4hgt_A 242 LC---------KGYPSEFATYLNFCRSLRFDDKPD 267 (296)
T ss_dssp HT---------TTSCHHHHHHHHHHHTSCTTCCCC
T ss_pred hh---------ccCCHHHHHHHHHHHhcCCCCCCC
Confidence 00 011346889999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.95 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=192.6
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--------ccCHHHHHHHHHHHhccCCCCceeEEEEEec
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--------QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE 550 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 550 (745)
....|.+.+.||+|+||.||++.... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC-CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34567888999999999999999765 45789999986422 1223458899999999999999999999876
Q ss_pred CCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---eEEeecc
Q 040134 551 GDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT---PRISDFG 627 (745)
Q Consensus 551 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg 627 (745)
.+ .++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 65 899999999999999998888899999999999999999999965 9999999999999987654 9999999
Q ss_pred Ccccccccccccccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
++........ .....|++.|+|||.+. ...++.++||||||+++|+|++|+.||...... ..+...+..
T Consensus 163 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~--- 234 (322)
T 2ycf_A 163 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS--- 234 (322)
T ss_dssp TCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHH---
T ss_pred cceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHh---
Confidence 9987643321 22346899999999974 467899999999999999999999998644332 122222211
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+..... +.. .......+.+++.+||+.||++|||
T Consensus 235 -~~~~~~--~~~----~~~~~~~~~~li~~~l~~dP~~Rps 268 (322)
T 2ycf_A 235 -GKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFT 268 (322)
T ss_dssp -TCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred -CccccC--chh----hhhcCHHHHHHHHHHcccCHhhCCC
Confidence 111110 000 0112356889999999999999997
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=312.97 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=191.2
Q ss_pred HHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc--CCCCceeEEEEEecC-
Q 040134 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT--HHKNLVRLLGFCDEG- 551 (745)
Q Consensus 475 ~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~- 551 (745)
..+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34444567888899999999999999874 567999998542 234455566666554 899999999999887
Q ss_pred ---CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCCCceEE
Q 040134 552 ---DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC-----STQIIHCDIKPQNILLDDYFTPRI 623 (745)
Q Consensus 552 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dikp~NIll~~~~~~kl 623 (745)
...++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+||+++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999965 46899999999999999999999431 229999999999999999999999
Q ss_pred eeccCccccccccccc--ccccccccccccchhccccCCCCcc------chhHHHHHHHHHHHhC----------CCCCC
Q 040134 624 SDFGLAKLLLAEQTQA--ARTGIRGTVGYFAPEWFRKASITVK------VDVYSFGVLLLELICC----------KSSVV 685 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~DvwslG~vl~elltg----------~~p~~ 685 (745)
+|||++..+....... ......||+.|+|||.+.+...+.+ +||||||+++|||+|| +.|+.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998764433221 1224578999999999987766655 9999999999999999 55554
Q ss_pred CCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 686 FGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 686 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........ .................... ....+....+.+++.+||+.||++|||
T Consensus 264 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (337)
T 3mdy_A 264 DLVPSDPS--YEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLT 318 (337)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred hhcCCCCc--hhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCC
Confidence 32222111 11112222111111111111 112356778999999999999999997
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=312.27 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=187.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
.+||+|+||.||+|.... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETT-TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECC-CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 489999999999999765 4567999999766666678899999999999999999999999999999999999999999
Q ss_pred HHHhcCC---CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCcccccccccccccc
Q 040134 567 ASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 567 ~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ...
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 181 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTE 181 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--ccc
Confidence 9999754 2456888899999999999999965 9999999999999987 89999999999987643221 123
Q ss_pred cccccccccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKAS--ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~--~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
...|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........ ... ..... ..... .
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---~~~~~-~~~~~-----~---- 247 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMF---KVGMF-KVHPE-----I---- 247 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHH---HHHHH-CCCCC-----C----
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHH---hhccc-ccccc-----c----
Confidence 456899999999997643 78999999999999999999999863322111 110 11110 10001 1
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps 272 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRAC 272 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCC
T ss_pred cccCCHHHHHHHHHHccCChhhCCC
Confidence 1112346788999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.60 Aligned_cols=247 Identities=25% Similarity=0.307 Sum_probs=190.3
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEe----cCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD----EGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~l 556 (745)
..+.+.+.||+|+||.||+++... .++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecC-CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 346678899999999999999755 45789999987655566778999999999999999999999986 3457899
Q ss_pred EEEecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 557 VYEYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
||||+++++|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999864 46789999999999999999999965 9999999999999999999999999998765
Q ss_pred ccccccc-------ccccccccccccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 040134 633 LAEQTQA-------ARTGIRGTVGYFAPEWFRKAS---ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 633 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
....... ......|++.|+|||.+.... ++.++||||||+++|||++|+.||........ .+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence 3221110 012345789999999987553 68999999999999999999999843111111 1111 1
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .... .........+.+++.+||+.||++|||
T Consensus 260 ~~~-~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps 293 (317)
T 2buj_A 260 VQN-QLSI--------PQSPRHSSALWQLLNSMMTVDPHQRPH 293 (317)
T ss_dssp HHC-C--C--------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhc-cCCC--------CccccCCHHHHHHHHHHhhcChhhCCC
Confidence 111 0000 011122356889999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.21 Aligned_cols=255 Identities=19% Similarity=0.261 Sum_probs=190.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec--------C
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--------G 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 551 (745)
.|.+.+.||+|+||.||+++... +++.||+|++... .......+.+|++++++++||||+++++++.. .
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETT-TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred ceeEEEEEecCCCcEEEEEEECC-CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 46677899999999999999765 4567999998543 23335678899999999999999999999977 4
Q ss_pred CeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
+..++||||+++ +|.+.+... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 568999999986 676666544 6789999999999999999999965 99999999999999999999999999998
Q ss_pred ccccccc--ccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc
Q 040134 631 LLLAEQT--QAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN 707 (745)
Q Consensus 631 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 707 (745)
.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... . .....+.+.... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~-~~~~~i~~~~~~-~ 248 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--Q-HQLALISQLCGS-I 248 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--H-HHHHHHHHHHCC-C
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--H-HHHHHHHHHhCC-C
Confidence 7643222 112344568999999999876 5689999999999999999999999864322 1 122222221111 1
Q ss_pred ccccccc-------------cccccccHHH------HHHHHHHHHhccccCcCCCCC
Q 040134 708 LDKLAEN-------------DEEVKNDLKR------VERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~~~~~~-------------~~~~~~~~~~------~~~l~~li~~Cl~~dp~~RPT 745 (745)
....... ........+. ...+.+++.+||+.||++|||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 1000000 0000000111 245889999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.61 Aligned_cols=244 Identities=21% Similarity=0.311 Sum_probs=190.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||.||+|+... +++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETT-TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred ceeecceeccCCCeEEEEEEEcC-CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 45677899999999999999865 45679999997766667789999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 173 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--K 173 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--c
Confidence 99999998865 46689999999999999999999965 999999999999999999999999998764322211 1
Q ss_pred cccccccccccchhcc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 641 RTGIRGTVGYFAPEWF-----RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~-----~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....|++.|+|||.+ ....++.++||||||+++|+|++|+.|+..... ... ..... .........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~-~~~~~~~~~-- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRV----LLKIA-KSDPPTLLT-- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH----HHHHH-HSCCCCCSS--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--HHH----HHHHh-ccCCcccCC--
Confidence 2334689999999998 366789999999999999999999999864321 111 11111 111111111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 245 -----~~~~~~~l~~li~~~l~~dp~~Rps 269 (302)
T 2j7t_A 245 -----PSKWSVEFRDFLKIALDKNPETRPS 269 (302)
T ss_dssp -----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred -----ccccCHHHHHHHHHHcccChhhCCC
Confidence 1112346889999999999999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.50 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=192.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
...+.+.+.||+|+||.||+|.... +++.||+|.+... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETT-TCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECC-CCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4456677899999999999998765 4567999998653 345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++. ....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++..+......
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 999999999986 346789999999999999999999965 9999999999999999999999999999876443221
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .... .. ...........
T Consensus 182 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~----~~-~~~~~~~~~~~----- 247 (314)
T 3com_A 182 --RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAI----FM-IPTNPPPTFRK----- 247 (314)
T ss_dssp --BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----HH-HHHSCCCCCSS-----
T ss_pred --cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--HHHH----HH-HhcCCCcccCC-----
Confidence 2345689999999999999999999999999999999999999863321 1111 11 11111111100
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 248 --~~~~~~~l~~li~~~l~~dp~~Rpt 272 (314)
T 3com_A 248 --PELWSDNFTDFVKQCLVKSPEQRAT 272 (314)
T ss_dssp --GGGSCHHHHHHHHHHTCSCTTTSCC
T ss_pred --cccCCHHHHHHHHHHccCChhhCcC
Confidence 1112346889999999999999997
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=314.43 Aligned_cols=196 Identities=21% Similarity=0.364 Sum_probs=169.3
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEec--CCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDE--GDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv 557 (745)
..+.+.+.||+|+||.||+++... +++.||||+++. ...+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECC-CCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 345677899999999999998765 456799999864 34578999999999997 9999999999987 6788999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++++|.+++. .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++.......
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999984 478899999999999999999965 999999999999999776 89999999998764433
Q ss_pred cccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 2 234568899999999977 6789999999999999999999999965443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.83 Aligned_cols=194 Identities=26% Similarity=0.395 Sum_probs=154.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec-----CCeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-----GDHR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~ 554 (745)
.|.+.+.||+|+||.||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TEEECCC-------CEEEEEECC---CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CeEEeeEeeecCCeEEEEEEECC-CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 46678899999999999998765 4567999998642 23345678999999999999999999999943 3578
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+ +++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 579999998888899999999999999999999965 999999999999999999999999999987643
Q ss_pred cccc-------------------------cccccccccccccchhcc-ccCCCCccchhHHHHHHHHHHHhC
Q 040134 635 EQTQ-------------------------AARTGIRGTVGYFAPEWF-RKASITVKVDVYSFGVLLLELICC 680 (745)
Q Consensus 635 ~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwslG~vl~elltg 680 (745)
.... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 2211 113445789999999976 566799999999999999999994
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=348.17 Aligned_cols=239 Identities=27% Similarity=0.376 Sum_probs=188.9
Q ss_pred hhcCcceeEEEEEEEeeC-CCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.||+|+||.||+|.+.. ..++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 479999999999997653 345789999997532 3346789999999999999999999999965 458899999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-cccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AART 642 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 642 (745)
++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999998888899999999999999999999965 9999999999999999999999999999876543321 1123
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
...+++.|+|||++.+..++.++||||||++||||++ |+.||..... ..+ ...+..+..... .
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~----~~~i~~~~~~~~---------p 594 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV----TAMLEKGERMGC---------P 594 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH----HHHHHTTCCCCC---------C
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCCCCCC---------C
Confidence 3456789999999999999999999999999999998 9999853322 111 122222221111 1
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs 618 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPG 618 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcC
Confidence 122356889999999999999997
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.64 Aligned_cols=240 Identities=28% Similarity=0.394 Sum_probs=195.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.+.||+|+||.||+|+... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHhhhhcccCCeEEEEEEECC-CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 5567889999999999998765 45679999986432 345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++..+...... .
T Consensus 103 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 176 (303)
T 3a7i_A 103 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--R 176 (303)
T ss_dssp TTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--B
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc--c
Confidence 99999999864 5689999999999999999999965 9999999999999999999999999999876543321 2
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ........+ ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~~~-----~~--- 241 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFL----IPKNNPPTL-----EG--- 241 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH----HHHSCCCCC-----CS---
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHH----hhcCCCCCC-----cc---
Confidence 345689999999999999999999999999999999999999853221 111111 111111111 11
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 242 -~~~~~l~~li~~~l~~dp~~Rps 264 (303)
T 3a7i_A 242 -NYSKPLKEFVEACLNKEPSFRPT 264 (303)
T ss_dssp -SCCHHHHHHHHHHCCSSGGGSCC
T ss_pred -ccCHHHHHHHHHHcCCChhhCcC
Confidence 11245889999999999999997
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.47 Aligned_cols=236 Identities=24% Similarity=0.339 Sum_probs=188.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC--CeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG--DHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 557 (745)
.+.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 4567789999999999999974 567999998643 234456799999999999999999999999887 788999
Q ss_pred EEecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 558 YEYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQ--IIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
|||+++++|.+++.... .+++.+++.++.||+.||+|||+. + |+||||||+||+++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999998765 489999999999999999999965 7 9999999999999999999999998875432
Q ss_pred ccccccccccccccccccchhccccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITV---KVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
.....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||..... .. ........+....
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~----~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--ME----IGMKVALEGLRPT 231 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--HH----HHHHHHHSCCCCC
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--HH----HHHHHHhcCCCCC
Confidence 22346789999999998765544 79999999999999999999853321 11 1112211211111
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+ .......+.+++.+||+.||++|||
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~~p~~Rps 257 (271)
T 3kmu_A 232 I---------PPGISPHVSKLMKICMNEDPAKRPK 257 (271)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 1 1112345889999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.24 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=176.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.+.||+|+||.||++.... .++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhheeccccceEEEEEEECC-CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 45677899999999999998764 35679999986432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcC--------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 561 MSNGSLASFLFG--------ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 561 ~~~gsL~~~l~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999863 35689999999999999999999965 9999999999999999999999999998766
Q ss_pred ccccc---ccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcc
Q 040134 633 LAEQT---QAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNL 708 (745)
Q Consensus 633 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 708 (745)
..... ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+.. .. ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~----~~-~~~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLML----TL-QNDP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHH----HH-TSSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHH----Hh-ccCC
Confidence 43321 111234568999999999876 56899999999999999999999998643321 11111 11 1111
Q ss_pred cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+................+.+++.+||+.||++|||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 281 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcC
Confidence 1110000000001112346889999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.07 Aligned_cols=244 Identities=22% Similarity=0.316 Sum_probs=195.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---------ccCHHHHHHHHHHHhccC-CCCceeEEEEEecC
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---------QQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEG 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 551 (745)
.+.+.+.||+|+||.||++.... +++.||||++.... ....+.+.+|+++++++. ||||+++++++...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccceeeeecCCCceEEEEEEEcC-cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 45567899999999999999865 46789999986432 122457889999999995 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+..++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999998778899999999999999999999965 999999999999999999999999999987
Q ss_pred ccccccccccccccccccccchhccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFR------KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
+..... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.... ..... +.+..
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~ 243 (298)
T 1phk_A 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML----RMIMS 243 (298)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHH
T ss_pred cCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH----HHHhc
Confidence 644322 23456899999999985 4568899999999999999999999985322 11111 11222
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+....... ........+.+++.+||+.||++|||
T Consensus 244 ~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps 277 (298)
T 1phk_A 244 GNYQFGSP------EWDDYSDTVKDLVSRFLVVQPQKRYT 277 (298)
T ss_dssp TCCCCCTT------TGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred CCcccCcc------cccccCHHHHHHHHHHccCCcccCCC
Confidence 22111110 01122356889999999999999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.59 Aligned_cols=237 Identities=23% Similarity=0.317 Sum_probs=190.2
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 556 (745)
...+.+.+.||+|+||.||++.... +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC-CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3456778899999999999999865 4567999998643 233456788999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---------------
Q 040134 557 VYEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD--------------- 617 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~--------------- 617 (745)
||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999754 6689999999999999999999965 9999999999999984
Q ss_pred ----CCceEEeeccCcccccccccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCch
Q 040134 618 ----YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPE 692 (745)
Q Consensus 618 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~ 692 (745)
...+||+|||.+....... ...|++.|+|||.+.+. .++.++||||||+++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 4479999999998764322 23489999999999765 5668999999999999999998775321
Q ss_pred hhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 693 EALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ...+..+....+.. .....+.+++.+||+.||++|||
T Consensus 235 ~~-----~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps 273 (289)
T 1x8b_A 235 DQ-----WHEIRQGRLPRIPQ---------VLSQEFTELLKVMIHPDPERRPS 273 (289)
T ss_dssp HH-----HHHHHTTCCCCCSS---------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hH-----HHHHHcCCCCCCCc---------ccCHHHHHHHHHHhCCCcccCCC
Confidence 11 11122222221110 12345889999999999999997
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=331.74 Aligned_cols=243 Identities=24% Similarity=0.307 Sum_probs=192.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-------------cCHHHHHHHHHHHhccCCCCceeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-------------QGEKEFRTEVSVIGQTHHKNLVRLLGFC 548 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 548 (745)
.|.+.+.||+|+||+||+++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECC-CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46677899999999999999765 456799999864321 3357899999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---ceEEee
Q 040134 549 DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF---TPRISD 625 (745)
Q Consensus 549 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~D 625 (745)
.+....++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999998878899999999999999999999965 999999999999998775 699999
Q ss_pred ccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 626 FGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 626 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
||++..+..... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.... .. .+. ..+..
T Consensus 193 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~-~~~----~~i~~ 261 (504)
T 3q5i_A 193 FGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ-DII----KKVEK 261 (504)
T ss_dssp CTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HH-HHH----HHHHH
T ss_pred CCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HH-HHH----HHHHc
Confidence 999987654322 33456899999999986 468999999999999999999999986322 11 111 11222
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+........ .......+.+++.+||+.||.+|||
T Consensus 262 ~~~~~~~~~------~~~~s~~~~~li~~~L~~dp~~R~t 295 (504)
T 3q5i_A 262 GKYYFDFND------WKNISDEAKELIKLMLTYDYNKRCT 295 (504)
T ss_dssp CCCCCCHHH------HTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCccc------cCCCCHHHHHHHHHHcCCChhHCCC
Confidence 221110000 0112356889999999999999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.27 Aligned_cols=250 Identities=17% Similarity=0.197 Sum_probs=193.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCC-------CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCcee----------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASD-------SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVR---------- 543 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------- 543 (745)
..+.+.+.||+|+||.||+|+.... .++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3466778999999999999998753 3567999998643 46789999999999999887
Q ss_pred -----EEEEEec-CCeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 040134 544 -----LLGFCDE-GDHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL 615 (745)
Q Consensus 544 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll 615 (745)
+++++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6777765 78899999999 99999999875 7799999999999999999999965 99999999999999
Q ss_pred CCCC--ceEEeeccCccccccccccc-----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 616 DDYF--TPRISDFGLAKLLLAEQTQA-----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 616 ~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
+.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 99999999998765433211 1233578999999999999999999999999999999999999997544
Q ss_pred CCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 689 TNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 689 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... .+...... +.. ....+...... .......+.+++.+||+.||++|||
T Consensus 273 ~~~~-~~~~~~~~-~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps 323 (352)
T 2jii_A 273 PNTE-DIMKQKQK-FVD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPP 323 (352)
T ss_dssp TCHH-HHHHHHHH-HHH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cCHH-HHHHHHHh-ccC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCC
Confidence 3322 22222211 111 11111111110 0011356889999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=317.41 Aligned_cols=249 Identities=28% Similarity=0.382 Sum_probs=190.9
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD 552 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 552 (745)
+....+.+.+.||+|+||.||+|+.. ...++.||||.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34456778899999999999999853 224567999999643 3344567899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceE
Q 040134 553 HRLLVYEYMSNGSLASFLFGI-------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPR 622 (745)
Q Consensus 553 ~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~k 622 (745)
..++||||+++++|.+++... ..+++.+++.++.||+.||.|||+. +|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999754 3478889999999999999999965 9999999999999984 45699
Q ss_pred EeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHH
Q 040134 623 ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYR 701 (745)
Q Consensus 623 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 701 (745)
|+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |..||.... ...+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~---- 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE---- 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH----
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHH----
Confidence 999999986544333222334567889999999999999999999999999999998 888875332 111212
Q ss_pred HhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 702 CYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+..+..... .......+.+++.+||+.||++|||
T Consensus 257 ~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps 291 (327)
T 2yfx_A 257 FVTSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPN 291 (327)
T ss_dssp HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcC
Confidence 1112111111 1112346889999999999999997
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=342.09 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=187.8
Q ss_pred hcCcceeEEEEEEEeeC-CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCCCC
Q 040134 488 ILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
.||+|+||.||+|.+.. ..+..||||+++.. .....+++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 69999999999998764 24567999999764 33456889999999999999999999999976 56899999999999
Q ss_pred HHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc-cccc
Q 040134 566 LASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTG 643 (745)
Q Consensus 566 L~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 643 (745)
|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 5689999999999999999999965 99999999999999999999999999998765433211 1222
Q ss_pred ccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 644 IRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
..+++.|+|||++....++.++||||||++||||++ |+.||...... .+.. .+..+.... ...
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~~---------~p~ 562 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRME---------CPP 562 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH----HHHTTCCCC---------CCT
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcCCCCC---------CCC
Confidence 345689999999999999999999999999999998 99998643321 1212 222221111 111
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+|+.+||+.||++|||
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs 585 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPD 585 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcC
Confidence 23356889999999999999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.22 Aligned_cols=238 Identities=22% Similarity=0.356 Sum_probs=192.5
Q ss_pred HHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec-----
Q 040134 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----- 550 (745)
Q Consensus 476 ~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----- 550 (745)
.......+.+.+.||+|+||.||+++... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETT-TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cchhccccceeeeeccCCceEEEEEEEcC-CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 34455667788999999999999999864 45679999986432 356789999999999999999998854
Q ss_pred -----------CCeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 551 -----------GDHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 551 -----------~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+||++++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 44589999999999999999643 5789999999999999999999965 9999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD 697 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~ 697 (745)
++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+.. .. .
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~---~ 226 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TS---K 226 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH---H
T ss_pred CCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH---H
Confidence 99999999999987654332 2345689999999999999999999999999999999999988631 00 1
Q ss_pred HHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 698 WVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+..+.+... ....+.+++.+||+.||++|||
T Consensus 227 -~~~~~~~~~~~~~------------~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 227 -FFTDLRDGIISDI------------FDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp -HHHHHHTTCCCTT------------SCHHHHHHHHHHTCSSGGGSCC
T ss_pred -HHHHhhccccccc------------CCHHHHHHHHHHccCChhhCcC
Confidence 1112222221111 1234778999999999999997
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=331.85 Aligned_cols=231 Identities=13% Similarity=0.150 Sum_probs=178.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHH---HHhccCCCCceeEE-------EEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVS---VIGQTHHKNLVRLL-------GFCD 549 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~---~l~~l~h~nIv~l~-------~~~~ 549 (745)
+.+.+.||+|+||+||+|+... +++.||||++.. ......+.+.+|+. ++++++||||++++ +++.
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-C-CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred EEEcceeecCCCEEEEEEEECC-CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 3456789999999999999754 456799999863 23344578899994 55556899999998 7766
Q ss_pred cCCe-----------------EEEEEEecCCCCHHHHhcCCCCCCh-------hhHHHHHHHHHHHHHHHHhcCCCCeee
Q 040134 550 EGDH-----------------RLLVYEYMSNGSLASFLFGITRPDW-------NQRVQIAFGIARGLMYLHEECSTQIIH 605 (745)
Q Consensus 550 ~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~i~~~i~~~L~~LH~~~~~~ivH 605 (745)
..+. .++||||+ +|+|.+++.....+++ ..++.++.||+.||+|||+. +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 5542 78999999 6799999976544444 78888999999999999965 9999
Q ss_pred CCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhccccC-----------CCCccchhHHHHHHH
Q 040134 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-----------SITVKVDVYSFGVLL 674 (745)
Q Consensus 606 ~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DvwslG~vl 674 (745)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||.+.+. .++.++||||||+++
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999864321 234457 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 675 LELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 675 ~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
|||++|+.||....... ....+..... .....+.+++.+||+.||++|||
T Consensus 304 ~elltg~~Pf~~~~~~~---------------~~~~~~~~~~------~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 304 YWIWCADLPITKDAALG---------------GSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHSSCCC------C---------------CSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHHCCCCCccccccc---------------chhhhhhhcc------CCCHHHHHHHHHHcCCCchhCCC
Confidence 99999999985332211 1111111100 11245889999999999999997
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.56 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=185.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
|.+.+.||+|+||.||+|+... +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKL-TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eEEEEEEcCCCCEEEEEEEECC-CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 5567899999999999999765 4567999998643221 1224567999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 156 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 156 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence 7 5888888654 5589999999999999999999965 9999999999999999999999999999865432221
Q ss_pred cccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc---ccccccc--
Q 040134 641 RTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN---LDKLAEN-- 714 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~~-- 714 (745)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .+ ....+.+...... .......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EE-QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HH-HHHHHHHHhCCCChHhchhhhcchh
Confidence 233467999999999876 5689999999999999999999999864322 22 2222222211110 0000000
Q ss_pred -------cccc----cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 -------DEEV----KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 -------~~~~----~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... .........+.+++.+||+.||++|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 275 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC
Confidence 0000 000112356789999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=311.75 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=190.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEe--cCCeEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD--EGDHRLLV 557 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv 557 (745)
.+.+.+.||+|+||.||++.... +++.||+|.+... .....+.+.+|+.++++++||||+++++++. .....++|
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECC-CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 45667899999999999999765 4567999998642 2334567999999999999999999999874 46789999
Q ss_pred EEecCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCCEEECCCCceEEeeccC
Q 040134 558 YEYMSNGSLASFLFGI----TRPDWNQRVQIAFGIARGLMYLHEECSTQ-----IIHCDIKPQNILLDDYFTPRISDFGL 628 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dikp~NIll~~~~~~kl~Dfg~ 628 (745)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999998643 4489999999999999999999976 6 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcc
Q 040134 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNL 708 (745)
Q Consensus 629 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 708 (745)
+......... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+. ..+..+..
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~i~~~~~ 233 (279)
T 2w5a_A 163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELA----GKIREGKF 233 (279)
T ss_dssp HHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHTCC
T ss_pred heeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHH----HHHhhccc
Confidence 9876433211 223468999999999999899999999999999999999999986432 11121 22222222
Q ss_pred cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+. ......+.+++.+||+.||++|||
T Consensus 234 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rps 261 (279)
T 2w5a_A 234 RRIP---------YRYSDELNEIITRMLNLKDYHRPS 261 (279)
T ss_dssp CCCC---------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccCC---------cccCHHHHHHHHHHcCCCcccCCC
Confidence 2111 112346889999999999999997
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.01 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=183.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHH--HhccCCCCceeEEEEEec-----CCeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSV--IGQTHHKNLVRLLGFCDE-----GDHR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~-----~~~~ 554 (745)
.+.+.+.||+|+||.||+|+. .++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 355678999999999999976 35789999986432 3444445554 445899999999986532 3367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCCEEECCCCceEEeeccC
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC------STQIIHCDIKPQNILLDDYFTPRISDFGL 628 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 628 (745)
++||||+++++|.+++... ..++..+..++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 8999999999999999654 4488999999999999999999431 11999999999999999999999999999
Q ss_pred ccccccccc------ccccccccccccccchhcccc-------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh--
Q 040134 629 AKLLLAEQT------QAARTGIRGTVGYFAPEWFRK-------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE-- 693 (745)
Q Consensus 629 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~-- 693 (745)
+..+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987653321 111234568999999999976 45678999999999999999998887544332111
Q ss_pred hH---------HHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 AL---------MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+ ................+.. ...........+.+++.+||+.||++|||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcc
Confidence 00 0111111111111111111 11123345667999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.30 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=165.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 554 (745)
.|.+.+.||+|+||.||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CEEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 46678899999999999999765 5678999999652 233456889999999999999999999999766 579
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||++ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999986 59999998888899999999999999999999965 999999999999999999999999999987654
Q ss_pred cccc--------------------cccccccccccccchhcc-ccCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 635 EQTQ--------------------AARTGIRGTVGYFAPEWF-RKASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 635 ~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
.... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 3221 113456789999999986 5667999999999999999999864444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.96 Aligned_cols=255 Identities=24% Similarity=0.266 Sum_probs=189.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-----cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-----QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..|.+.+.||+|+||.||+++... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred cccEEEeEEeecCCEEEEEEEECC-CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 346677899999999999999765 456799999864221 11346889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999986 888888765 4688999999999999999999965 999999999999999999999999999987643
Q ss_pred cccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc---
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK--- 710 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 710 (745)
... ......+|+.|+|||.+.+. .++.++||||||+++|||++|..||.... ..+.+.. +.+.........
T Consensus 165 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~-i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 165 PNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTR-IFETLGTPTEEQWPD 239 (346)
T ss_dssp CCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH-HHHHHCCCCTTTSSS
T ss_pred Ccc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHH-HHHHcCCCChhhhhh
Confidence 322 13345689999999999654 58999999999999999999998875332 2222222 222111100000
Q ss_pred c------cccccccccc-----HHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 L------AENDEEVKND-----LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~------~~~~~~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .......... ......+.+++.+||+.||++|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 0 0000000000 112356889999999999999997
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.11 Aligned_cols=242 Identities=29% Similarity=0.412 Sum_probs=193.9
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
...+.+.+.||+|+||.||+|.+.. ...||||+++... ...++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECC--CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456677899999999999999864 3569999997533 345789999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999743 5689999999999999999999965 999999999999999999999999999987654322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.. .....++..|+|||.+....++.++||||||++||||++ |+.||..... ..+. ..+..+....
T Consensus 419 ~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~----~~i~~~~~~~------ 484 (535)
T 2h8h_A 419 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVL----DQVERGYRMP------ 484 (535)
T ss_dssp HT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHH----HHHHTTCCCC------
T ss_pred ec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCCC------
Confidence 11 233456789999999999999999999999999999999 8888853221 1111 1122221111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+|+.+||+.||++|||
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 01122356889999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.93 Aligned_cols=197 Identities=25% Similarity=0.354 Sum_probs=170.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCC------CceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHK------NLVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~~ 554 (745)
..+.+.+.||+|+||.||++......++.||||+++.. ....+.+.+|+++++.++|+ +|+++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35677889999999999999885556788999998653 23456788999999888665 499999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---------------
Q 040134 555 LLVYEYMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD--------------- 617 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~--------------- 617 (745)
++||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 889999987654 678999999999999999999965 9999999999999987
Q ss_pred ----CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 618 ----YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 618 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999764322 23456899999999999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=323.32 Aligned_cols=245 Identities=11% Similarity=0.034 Sum_probs=172.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhcc--CCCCceeEE-------EEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQT--HHKNLVRLL-------GFCDE 550 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~~~ 550 (745)
+.+.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECC-CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4567899999999999999765 46789999997532 23345677885544444 699988755 45443
Q ss_pred C-----------------CeEEEEEEecCCCCHHHHhcCC-CCCChhhH------HHHHHHHHHHHHHHHhcCCCCeeeC
Q 040134 551 G-----------------DHRLLVYEYMSNGSLASFLFGI-TRPDWNQR------VQIAFGIARGLMYLHEECSTQIIHC 606 (745)
Q Consensus 551 ~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~------~~i~~~i~~~L~~LH~~~~~~ivH~ 606 (745)
. ...++||||++ ++|.+++... ..+.+..+ ..++.||+.||+|||+. +|+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 3 34899999998 8999999764 33455555 67889999999999965 99999
Q ss_pred CCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 607 DIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 607 dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
||||+|||++.++.+||+|||+++...... ....+++.|+|||.+.+ ..++.++||||||++||||++|+.||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998764322 13456799999999987 68999999999999999999999999
Q ss_pred CCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 685 VFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 685 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........... ........................+.+++.+||+.||++|||
T Consensus 294 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 346 (371)
T 3q60_A 294 GLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346 (371)
T ss_dssp TBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred CCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence 75533211100 000000000111111111123456889999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.15 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=195.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccC-----------------HHHHHHHHHHHhccCCCCceeE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG-----------------EKEFRTEVSVIGQTHHKNLVRL 544 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l 544 (745)
.+.+.+.||+|+||.||++.. +++.||+|++....... .+.+.+|+.++++++||||+++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 456778999999999999998 56789999986432211 1789999999999999999999
Q ss_pred EEEEecCCeEEEEEEecCCCCHHHH------hcC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 545 LGFCDEGDHRLLVYEYMSNGSLASF------LFG--ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 545 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
++++.+.+..++||||+++++|.++ +.. ...+++..++.++.||+.||+|||+ ..+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 665 5678999999999999999999996 14999999999999999
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCchhh
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-SITV-KVDVYSFGVLLLELICCKSSVVFGTTNPEEA 694 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DvwslG~vl~elltg~~p~~~~~~~~~~~ 694 (745)
.++.+||+|||++....... .....++..|+|||.+.+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred CCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999998764431 3445689999999999877 6666 999999999999999999998644332 11
Q ss_pred HHHHHHHHhhcCcccccccccc---------cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 695 LMDWVYRCYIGKNLDKLAENDE---------EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 695 l~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+ .+.+..+.......... ...........+.+++.+||+.||++|||
T Consensus 261 ~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps 316 (348)
T 2pml_X 261 L----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316 (348)
T ss_dssp H----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC
T ss_pred H----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC
Confidence 1 12222222211110000 00000123456889999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=308.01 Aligned_cols=242 Identities=24% Similarity=0.269 Sum_probs=188.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc----ccCHHHHHHHHHHHhccCCCCceeEEEEE--ecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE----QQGEKEFRTEVSVIGQTHHKNLVRLLGFC--DEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~ 555 (745)
.|.+.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+.+..+
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTT-TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred ceeEeeEEecCCCeEEEEEEECC-CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 35677899999999999998755 45679999986532 23457899999999999999999999998 4456889
Q ss_pred EEEEecCCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 556 LVYEYMSNGSLASFLFG--ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
+||||++++ |.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999876 7776654 35689999999999999999999965 99999999999999999999999999998765
Q ss_pred ccccccccccccccccccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKAS--ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
............|++.|+|||.+.+.. .+.++||||||+++|||++|+.||.... .... .+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~----~~~i~~~~~~~- 232 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKL----FENIGKGSYAI- 232 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHH----HHHHHHCCCCC-
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHH----HHHHhcCCCCC-
Confidence 433333234456899999999997644 3789999999999999999999986322 1111 11122221110
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 233 ---------~~~~~~~l~~li~~~l~~dp~~Rps 257 (305)
T 2wtk_C 233 ---------PGDCGPPLSDLLKGMLEYEPAKRFS 257 (305)
T ss_dssp ---------CSSSCHHHHHHHHHHTCSSTTTSCC
T ss_pred ---------CCccCHHHHHHHHHHccCChhhCCC
Confidence 0112345788999999999999997
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=310.49 Aligned_cols=236 Identities=27% Similarity=0.365 Sum_probs=182.9
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecC-CeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-DHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e 559 (745)
..+.+.+.||+|+||.||++... ++.||||.++.. ...+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhceEEeEEecCCCceEEEEEEc---CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 34667789999999999999873 567999998753 3457899999999999999999999997654 47899999
Q ss_pred ecCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 560 YMSNGSLASFLFGIT--RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 999999999997553 378899999999999999999965 99999999999999999999999999987654322
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.. ....+....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~~~------ 234 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP----RVEKGYKMD------ 234 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHH----HHTTTCCCC------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCCCC------
Confidence 22356889999999999999999999999999999998 9998864322 11111 111111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 235 ---~~~~~~~~l~~li~~~l~~~p~~Rps 260 (278)
T 1byg_A 235 ---APDGCPPAVYEVMKNCWHLDAAMRPS 260 (278)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CcccCCHHHHHHHHHHhcCChhhCCC
Confidence 01122356889999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.18 Aligned_cols=249 Identities=22% Similarity=0.259 Sum_probs=184.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec-----------
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----------- 550 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----------- 550 (745)
.+.+.+.||+|+||.||+|.... +++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETT-TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred eEEEEEEEEeccCEEEEEEEECC-CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 46677899999999999999765 456799999864322 23479999999999999999999843
Q ss_pred ---------------------------CCeEEEEEEecCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHHHhcC
Q 040134 551 ---------------------------GDHRLLVYEYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGLMYLHEEC 599 (745)
Q Consensus 551 ---------------------------~~~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 599 (745)
....++||||+++ +|.+.+. ....+++..+..++.||+.||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 3348899999984 7666654 45778999999999999999999995
Q ss_pred CCCeeeCCCCCCCEEEC-CCCceEEeeccCcccccccccccccccccccccccchhccccC-CCCccchhHHHHHHHHHH
Q 040134 600 STQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLEL 677 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~el 677 (745)
.+|+||||||+||+++ .++.+||+|||+++.+..... .....+++.|+|||.+.+. .++.++||||||+++|||
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 4999999999999997 688999999999987644332 3345679999999998765 589999999999999999
Q ss_pred HhCCCCCCCCCCCchhhHHHHHHHHhhcC---------------cccccccccccccccHHHHHHHHHHHHhccccCcCC
Q 040134 678 ICCKSSVVFGTTNPEEALMDWVYRCYIGK---------------NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASL 742 (745)
Q Consensus 678 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 742 (745)
++|+.||.... ..+.+...+. ..... ....+................+.+++.+||+.||++
T Consensus 236 l~g~~pf~~~~--~~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 236 ILGKPLFSGET--SIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHSSCSSCCSS--HHHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HhCCCCCCCCC--hHHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999986432 2222222221 11000 000000000000011112356889999999999999
Q ss_pred CCC
Q 040134 743 RPQ 745 (745)
Q Consensus 743 RPT 745 (745)
|||
T Consensus 313 R~t 315 (383)
T 3eb0_A 313 RIN 315 (383)
T ss_dssp SCC
T ss_pred CCC
Confidence 997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=324.60 Aligned_cols=248 Identities=19% Similarity=0.235 Sum_probs=195.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC-CCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH-KNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+.+.++||+|+||.||+|+... .++.||||++.... ...++.+|+++++.++| ++|..+..++.+.+..++||||
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETT-TCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEeeCCCEEEEEEEECC-CCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 45677899999999999999755 45679999876432 23457899999999976 6666777777888899999999
Q ss_pred cCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL---DDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+ +++|.+++.. ...+++.+++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 9999999974 46789999999999999999999965 99999999999999 688999999999998765443
Q ss_pred ccc-----ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 637 TQA-----ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 637 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
... ......||+.|+|||.+.+..++.++||||||++||||++|+.||..............+........+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 211 123567999999999999999999999999999999999999999765544333333322222221111111
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ....++.+++..||+.||++|||
T Consensus 241 ~~---------~~p~~l~~li~~cl~~dP~~RPs 265 (483)
T 3sv0_A 241 CR---------GYPTEFASYFHYCRSLRFDDKPD 265 (483)
T ss_dssp HT---------TSCHHHHHHHHHHHTCCTTCCCC
T ss_pred hc---------CCcHHHHHHHHHHhcCChhhCcC
Confidence 11 11346889999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.62 Aligned_cols=195 Identities=29% Similarity=0.319 Sum_probs=159.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------e
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------H 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 553 (745)
.|.+.+.||+|+||.||++.... .++.||||++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred heeEeeeeEecCCEEEEEEEECC-CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 35667899999999999998765 4678999998642 2334467889999999999999999999997655 7
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++||||+++ +|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 8999999975 7888875 4588999999999999999999965 99999999999999999999999999998764
Q ss_pred ccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 179 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 3321 2345689999999999999999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.11 Aligned_cols=246 Identities=23% Similarity=0.299 Sum_probs=185.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
..+.+.+.||+|+||.||+|++.... ...||+|+++.. .....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 35667889999999999999875433 346899998643 2344578899999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 556 LVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
+|+||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999998754 5689999999999999999999965 999999999999999999999999999987654
Q ss_pred ccccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 635 EQTQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 635 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. + ......... ...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~-~---~~~~~~~~~-~~~- 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQ-I---LHKIDKEGE-RLP- 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH-H---HHHHHTSCC-CCC-
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HH-H---HHHHHccCC-CCC-
Confidence 33211 1233457788999999998889999999999999999999 9999853321 11 1 111111111 110
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++|||
T Consensus 246 -------~~~~~~~~l~~li~~~l~~~p~~Rps 271 (291)
T 1u46_A 246 -------RPEDCPQDIYNVMVQCWAHKPEDRPT 271 (291)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCcCcCHHHHHHHHHHccCCcccCcC
Confidence 01122356889999999999999997
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=318.97 Aligned_cols=241 Identities=22% Similarity=0.269 Sum_probs=174.0
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEe--------cC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCD--------EG 551 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~ 551 (745)
..+.+.++||+|+||.||+++... .++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECC-CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346678899999999999999765 45679999986655566678999999999995 999999999994 34
Q ss_pred CeEEEEEEecCCCCHHHHhcC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCceEEeec
Q 040134 552 DHRLLVYEYMSNGSLASFLFG---ITRPDWNQRVQIAFGIARGLMYLHEECSTQ--IIHCDIKPQNILLDDYFTPRISDF 626 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dikp~NIll~~~~~~kl~Df 626 (745)
...++||||+. |+|.+++.. ...+++.+++.++.||+.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999996 699888754 46789999999999999999999965 7 999999999999999999999999
Q ss_pred cCccccccccccc----------ccccccccccccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 627 GLAKLLLAEQTQA----------ARTGIRGTVGYFAPEWF---RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 627 g~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
|++.......... ......+++.|+|||.+ .+..++.++||||||+++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998765432211 11234589999999998 5667899999999999999999999998532211
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ..+....... ......+.+++.+||+.||++|||
T Consensus 260 ---~~-----~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps 295 (337)
T 3ll6_A 260 ---RI-----VNGKYSIPPH--------DTQYTVFHSLIRAMLQVNPEERLS 295 (337)
T ss_dssp --------------CCCCTT--------CCSSGGGHHHHHHHSCSSGGGSCC
T ss_pred ---Hh-----hcCcccCCcc--------cccchHHHHHHHHHccCChhhCcC
Confidence 00 0111111000 011123778999999999999997
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.96 Aligned_cols=194 Identities=29% Similarity=0.385 Sum_probs=161.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------e
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------H 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 553 (745)
.|.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECC-CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 35667889999999999999765 4567999998542 2233467889999999999999999999997653 4
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 69999999 7899999865 5689999999999999999999965 99999999999999999999999999998754
Q ss_pred ccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 180 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 180 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 32 334568999999999877 6799999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=303.04 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=197.6
Q ss_pred HHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe
Q 040134 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 476 ~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 553 (745)
+......+.+.+.||+|+||.||+++... .++.||+|++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcC-CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34445677888999999999999999765 4567999998643 23456789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CceEEeeccCcc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY---FTPRISDFGLAK 630 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~a~ 630 (745)
.++|+||+++++|.+++.....+++.+++.++.||+.||+|||+. +|+|+||||+||+++.+ +.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999999988777899999999999999999999965 99999999999999754 479999999998
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ...+. ..+..+....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL----KRVETGKYAF 241 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCCCC
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHH----HHHHcCCCCC
Confidence 7643322 223458899999999865 48999999999999999999999985432 11111 1222222111
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ........+.+++.+||+.||++|||
T Consensus 242 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps 270 (287)
T 2wei_A 242 DLP------QWRTISDDAKDLIRKMLTFHPSLRIT 270 (287)
T ss_dssp CSG------GGTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred Cch------hhhhcCHHHHHHHHHHcccChhhCcC
Confidence 110 00112346889999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=310.55 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=177.4
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
..+.+.+.||+|+||.||+++... +++.||+|++.... ....+.+.++...++.++||||+++++++.+++..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecC-CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 346677899999999999999765 46789999986532 222234455555678889999999999999999999999
Q ss_pred EecCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 559 EYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 559 e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
||+++ +|.+++. ....+++..+..++.||+.||+|||+. .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 8877764 356789999999999999999999953 2999999999999999999999999999987644
Q ss_pred cccccccccccccccccchhcc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWF----RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||...... ...+ ....... ...
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~-~~~ 233 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQL----KQVVEEP-SPQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHH----HHHHHSC-CCC
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHH----HHHhccC-CCC
Confidence 332 2334689999999996 5567899999999999999999999998643221 1111 1111111 111
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ......+.+++.+||+.||++|||
T Consensus 234 ~~~--------~~~~~~~~~li~~~l~~~p~~Rpt 260 (290)
T 3fme_A 234 LPA--------DKFSAEFVDFTSQCLKKNSKERPT 260 (290)
T ss_dssp CCT--------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccc--------ccCCHHHHHHHHHHhhcChhhCcC
Confidence 110 112345889999999999999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.83 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=196.4
Q ss_pred CHHHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC--------CCCceeEE
Q 040134 474 TYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH--------HKNLVRLL 545 (745)
Q Consensus 474 ~~~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~ 545 (745)
...++....|.+.+.||+|+||+||+++... +++.||||++... ....+.+.+|++++++++ |+||++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecC-CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3334444567788899999999999998765 4678999999643 334567889999999885 78899999
Q ss_pred EEEe----cCCeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 040134 546 GFCD----EGDHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF 619 (745)
Q Consensus 546 ~~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~ 619 (745)
+++. .....++||||+ +++|.+.+... ..+++..++.++.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccc
Confidence 9987 566899999999 55666655433 5689999999999999999999953 2899999999999998775
Q ss_pred -------------------------------------------------ceEEeeccCcccccccccccccccccccccc
Q 040134 620 -------------------------------------------------TPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650 (745)
Q Consensus 620 -------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 650 (745)
.+||+|||++...... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999999876432 2334689999
Q ss_pred cchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCch---hhHHHHHHHHhhc--------Ccc-----------
Q 040134 651 FAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPE---EALMDWVYRCYIG--------KNL----------- 708 (745)
Q Consensus 651 ~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~---~~l~~~~~~~~~~--------~~~----------- 708 (745)
+|||++.+..++.++|||||||+||||++|+.||........ ......+.+.... +..
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 999999999999999999999999999999999975543321 1111111111100 000
Q ss_pred ccccccc---------ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAEND---------EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~---------~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.... .......+....+.+|+.+||+.||++|||
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 385 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC
Confidence 0000000 001124556778999999999999999997
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=292.17 Aligned_cols=211 Identities=17% Similarity=0.268 Sum_probs=156.8
Q ss_pred ccccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEE
Q 040134 2 AKAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELV 81 (745)
Q Consensus 2 ~~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lv 81 (745)
++.++|.+|++|. .+++| ++|.|+|||+.+++ +.+|+. +|+||+|||+.| ..+.|+|+.||+||
T Consensus 6 ~~~~~i~~g~~L~---~g~~l--~~g~f~l~f~~~gn-----l~ly~~----~~~vW~an~~~~--~~~~l~l~~dGnLv 69 (236)
T 1dlp_A 6 GLSHEGSHPQTLH---AAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA--TGCRAVLQSDGLLV 69 (236)
T ss_dssp CSSSSSCSCSCCC---TTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC--SCCBCCBCSSSCBC
T ss_pred eccceeCCCCEEC---CCCEE--EcCCEEEEECCCCc-----EEEEEC----CEEEEECCCCCC--CCeEEEEcCCCcEE
Confidence 5789999999999 66678 49999999986543 223332 799999999999 66789999999999
Q ss_pred EEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcc----------cCCcccCCC-ceEEecCC
Q 040134 82 LYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTL----------LPGQILNSP-INITSRRT 149 (745)
Q Consensus 82 l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtl----------Lpg~~l~~~-~~L~S~~s 149 (745)
|+|++|++||+|++... ....|+|+|+|||||++. ++||||||||||+ +||||++.+ ++|+|
T Consensus 70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s--- 143 (236)
T 1dlp_A 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA--- 143 (236)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---
T ss_pred EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---
Confidence 99999999999998643 345799999999999964 8999999998655 777776654 46774
Q ss_pred CCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCCCCCCCCceeeecccceEEEEeCcee-EEEEEecccccccc
Q 040134 150 QHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYIKKGNQR-IYNLTKIGTRSMQD 228 (745)
Q Consensus 150 ~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 228 (745)
.+||++|.|++.++++|.+.+ +... ..||+.+++.........+...|.+++...++. .+..... .. .
T Consensus 144 ~~d~s~G~~~l~l~~dG~LvL--~~~~-----~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~--~~-~- 212 (236)
T 1dlp_A 144 TQSLQLSPYRLSMETDCNLVL--FDRD-----DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS--RS-A- 212 (236)
T ss_dssp SCCCBCSSCEEEEETTTEEEE--EBTT-----BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC--CS-S-
T ss_pred CcEeecCcEEEEECCCCcEEE--EcCC-----EeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCC--CC-C-
Confidence 789999999999999996444 4433 368877665332234456666776555544433 3332211 11 1
Q ss_pred eEEEEEEccCCcEEEEE
Q 040134 229 FYIMARIDYDGVFRQYT 245 (745)
Q Consensus 229 ~~~r~~L~~dG~l~~y~ 245 (745)
..+|++|++||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 34789999999999994
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=308.77 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=191.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhcc---CCCCceeEEEEEe-----cC
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQT---HHKNLVRLLGFCD-----EG 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~ 551 (745)
.|.+.+.||+|+||.||++......++.||+|++.... ......+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 35677899999999999999865567889999986432 22234566777777666 8999999999987 56
Q ss_pred CeEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLA 629 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a 629 (745)
...++||||++ ++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 68899999998 6999998754 3489999999999999999999965 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 630 KLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 630 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+.. +..........
T Consensus 168 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~-i~~~~~~~~~~ 241 (326)
T 1blx_A 168 RIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGK-ILDVIGLPGEE 241 (326)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH-HHHHHCCCCGG
T ss_pred ccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHH-HHHHcCCCCcc
Confidence 87643322 334568999999999999999999999999999999999999986432 2222222 22211100000
Q ss_pred c----------ccc---ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 K----------LAE---NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~----------~~~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ... ..............+.+++.+||+.||++|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 290 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC
Confidence 0 000 00000011122356789999999999999997
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=308.81 Aligned_cols=241 Identities=27% Similarity=0.410 Sum_probs=184.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEec------CCeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE------GDHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~ 555 (745)
+.+.+.||+|+||.||+|+... .++.||||++... ....+.+.+|+.+++++ +||||+++++++.. .+..+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred EEEEEEeccCCCEEEEEEEECC-CCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 5567899999999999999865 4567999998643 33457889999999999 89999999999976 56889
Q ss_pred EEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 556 LVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++..+.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 999999999999999754 5688999999999999999999965 99999999999999999999999999998764
Q ss_pred ccccccccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcc
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNL 708 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 708 (745)
..... .....|++.|+|||.+. ...++.++||||||+++|+|++|+.||..... ...+ . .......
T Consensus 181 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~----~-~~~~~~~ 251 (326)
T 2x7f_A 181 RTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRAL----F-LIPRNPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----H-HHHHSCC
T ss_pred cCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHH----H-HhhcCcc
Confidence 32211 23356899999999986 56789999999999999999999999853221 1111 1 1111111
Q ss_pred cccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+... .....+.+++.+||+.||++|||
T Consensus 252 ~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps 280 (326)
T 2x7f_A 252 PRLKSK--------KWSKKFQSFIESCLVKNHSQRPA 280 (326)
T ss_dssp CCCSCS--------CSCHHHHHHHHHHCCSSGGGSCC
T ss_pred ccCCcc--------ccCHHHHHHHHHHhccChhhCCC
Confidence 111111 11346889999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.87 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=185.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccC--CCCceeEEEEEecCCeEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTH--HKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~l 556 (745)
..|.+.+.||+|+||.||++.... ++.||||++... .....+.+.+|++++.+++ |+||+++++++.+.+..++
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT--CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCC--CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346677899999999999998753 567999998542 3334578899999999997 5999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||| +.+++|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||++++ +.+||+|||++..+....
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 56889999998888899999999999999999999965 9999999999999965 899999999998765443
Q ss_pred cccccccccccccccchhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-----------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
.........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ... ..... .
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~----~~~~~-~ 254 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISK----LHAII-D 254 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHH----HHHHH-C
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HHH----HHHHH-h
Confidence 3322334568999999999865 46888999999999999999999998643221 111 11111 1
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....... .......+.+++.+||+.||++|||
T Consensus 255 ~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps 286 (313)
T 3cek_A 255 PNHEIEF--------PDIPEKDLQDVLKCCLKRDPKQRIS 286 (313)
T ss_dssp TTSCCCC--------CCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred cccccCC--------cccchHHHHHHHHHHccCCcccCcC
Confidence 1111000 0011245889999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=321.63 Aligned_cols=249 Identities=24% Similarity=0.285 Sum_probs=183.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecC------CeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l 556 (745)
|.+.+.||+|+||.||+|+... .++.||||++.... +...+|++++++++||||+++++++... ...++
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECC-CCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5567899999999999999865 45679999985432 2234799999999999999999988431 24678
Q ss_pred EEEecCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CceEEeeccCccc
Q 040134 557 VYEYMSNGSLASFLF----GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-FTPRISDFGLAKL 631 (745)
Q Consensus 557 v~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~a~~ 631 (745)
||||+++ +|.+.+. ....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 5655543 35778999999999999999999995 499999999999999965 6789999999987
Q ss_pred ccccccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH-------h
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC-------Y 703 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~-------~ 703 (745)
+..... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||.... ..+.+...+... +
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCCHHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHH
Confidence 643322 2345689999999998764 78999999999999999999999986432 222232222210 0
Q ss_pred h--cCccccccccccccc-----ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 I--GKNLDKLAENDEEVK-----NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~--~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .........+..... ........+.+|+.+||+.||++|||
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 0 000111111111000 01112356889999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=320.04 Aligned_cols=195 Identities=24% Similarity=0.315 Sum_probs=167.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc------CCCCceeEEEEEecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT------HHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~ 555 (745)
.+.+.++||+|+||+||+|.... .++.||||++... ....+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEcccCccEEEEEEEECC-CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 36677899999999999998765 4678999999653 23345677888888776 5779999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--eEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT--PRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~--~kl~Dfg~a~~ 631 (745)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 6999988755 3589999999999999999999976 9999999999999999887 99999999976
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 4322 23356899999999999999999999999999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.30 Aligned_cols=197 Identities=22% Similarity=0.353 Sum_probs=152.0
Q ss_pred hhhcCcceeEEEEEEEeeC-CCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEe--cCCeEEEEEEecC
Q 040134 486 RQILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD--EGDHRLLVYEYMS 562 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e~~~ 562 (745)
.++||+|+||.||+|+... ..++.||||++... .....+.+|+.++++++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 3579999999999999753 24567999999643 23457889999999999999999999994 4778999999997
Q ss_pred CCCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCceEEeeccCc
Q 040134 563 NGSLASFLFGI---------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL----DDYFTPRISDFGLA 629 (745)
Q Consensus 563 ~gsL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~a 629 (745)
+ +|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4 788777421 2488999999999999999999965 99999999999999 67789999999999
Q ss_pred ccccccccc-cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 040134 630 KLLLAEQTQ-AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGT 688 (745)
Q Consensus 630 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~ 688 (745)
+.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 876543221 12344678999999999987 458999999999999999999999996543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=314.93 Aligned_cols=194 Identities=27% Similarity=0.386 Sum_probs=150.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecC------Ce
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG------DH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 553 (745)
.|.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TEEEEEECC----CCEEEEEETT-TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECC-CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 45567899999999999998765 5678999998642 233456788999999999999999999999654 56
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++|+|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 6899998865 6789999999999999999999965 99999999999999999999999999998754
Q ss_pred ccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 184 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 184 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 32 234578999999999877 6789999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.49 Aligned_cols=255 Identities=22% Similarity=0.256 Sum_probs=184.7
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEe------------
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCD------------ 549 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~------------ 549 (745)
.+.+.+.||+|+||.||+|.... .++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TEEEEEECC-----CEEEEEETT-TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred ceeEEEEeccCCCeEEEEEEECC-CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 35567889999999999999765 46789999987655566678999999999999999999999873
Q ss_pred --cCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEEeec
Q 040134 550 --EGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDF 626 (745)
Q Consensus 550 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Df 626 (745)
+....++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 4468899999998 699999864 5688999999999999999999965 999999999999997 5679999999
Q ss_pred cCcccccccccc-cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 627 GLAKLLLAEQTQ-AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 627 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
|++......... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ...+.. +.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~-~~~~~~ 242 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--LEQMQL-ILESIP 242 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-HHHHSC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHhcC
Confidence 999876433221 11233457899999998865 6789999999999999999999999864322 111111 111100
Q ss_pred c----------Cccccccccccc-ccc-----cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 G----------KNLDKLAENDEE-VKN-----DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~----------~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ..+......... ... .......+.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 0 000000000000 000 0112456889999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.89 Aligned_cols=255 Identities=22% Similarity=0.267 Sum_probs=191.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 555 (745)
.|.+.+.||+|+||.||++.... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred cEEEEEEeecCCCeEEEEEEECC-CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 46677899999999999998765 46789999986432 33346789999999999999999999999654 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||++ ++|.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9999997 599998865 4689999999999999999999965 9999999999999999999999999999876544
Q ss_pred cccc-ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc--
Q 040134 636 QTQA-ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL-- 711 (745)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 711 (745)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... +.+ ..+...........+
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQL-NHILGILGSPSQEDLNC 258 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHH-HHHHHHHCSCCHHHHHT
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHH-HHHHHHhCCCCHHHHHH
Confidence 3221 1234578999999998754 55899999999999999999999998643322 222 111111100000000
Q ss_pred -c---------cccccccc-----cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 -A---------ENDEEVKN-----DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 -~---------~~~~~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ........ .......+.+++.+||+.||++|||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 307 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 0 00000000 0112356889999999999999997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=318.42 Aligned_cols=250 Identities=23% Similarity=0.280 Sum_probs=182.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------eEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------HRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 555 (745)
.|.+.++||+|+||.||+++.... ++ ||+|++..... ...+|+++++.++||||+++++++.... ..+
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~-~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVES-DE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTT-EE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCC-Ce-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356778999999999999997653 33 88887754222 2236999999999999999999995433 378
Q ss_pred EEEEecCCCCHHHHh---cCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFL---FGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~a~~ 631 (745)
+||||++++.+.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875443332 2356789999999999999999999965 999999999999998 789999999999987
Q ss_pred ccccccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH--------
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC-------- 702 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~-------- 702 (745)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.+...+...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHH
Confidence 644332 2345689999999998764 58999999999999999999999986432 222222222110
Q ss_pred ------hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 ------YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+........................+.+++.+||+.||++|||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 0000011100000000001112356889999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.94 Aligned_cols=255 Identities=24% Similarity=0.230 Sum_probs=177.6
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe-------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH------- 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------- 553 (745)
..+.+.+.||+|+||.||+|+... +++.||||++... ......+.+|++.+..++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp TTEEEC----------CEEEEETT-TCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred cceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 346677899999999999999865 4567999988543 2334466778888999999999999999965433
Q ss_pred EEEEEEecCCCCHHHH----hcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccC
Q 040134 554 RLLVYEYMSNGSLASF----LFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGL 628 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~----l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~ 628 (745)
.++||||++++ |... +.....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 101 LNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 78999999874 4433 34557788999999999999999999933 459999999999999996 89999999999
Q ss_pred cccccccccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC-
Q 040134 629 AKLLLAEQTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK- 706 (745)
Q Consensus 629 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~- 706 (745)
+..+..... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.... ....+.... +.....
T Consensus 179 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~~~-~~~~~~~ 252 (360)
T 3e3p_A 179 AKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN--SAGQLHEIV-RVLGCPS 252 (360)
T ss_dssp CBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH-HHHCCCC
T ss_pred ceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC--hHHHHHHHH-HHcCCCC
Confidence 987654332 2345689999999998664 48999999999999999999999986432 222222221 111000
Q ss_pred ----------cc-cccccc------cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 ----------NL-DKLAEN------DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ----------~~-~~~~~~------~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ...... .............+.+++.+||+.||++|||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 308 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC
Confidence 00 000000 0000011123567899999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=312.51 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=168.3
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC------ceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN------LVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~ 554 (745)
..|.+.+.||+|+||.||++.....+++.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 45677889999999999999987666678999999643 234567888999999987665 99999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-----------------
Q 040134 555 LLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILL----------------- 615 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll----------------- 615 (745)
++||||+ +++|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 56777766544 4689999999999999999999954 99999999999999
Q ss_pred --CCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 616 --DDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 616 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999764322 23456899999999999999999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.31 Aligned_cols=250 Identities=23% Similarity=0.223 Sum_probs=180.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-----------CHHHHHHHHHHHhccCCCCceeEEEEEec-
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-----------GEKEFRTEVSVIGQTHHKNLVRLLGFCDE- 550 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~- 550 (745)
+.+.+.||+|+||.||+|.... ++.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTT--SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred eEEeEEeccCCCEEEEEEECCC--CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 4566899999999999998754 567999998542221 13789999999999999999999999843
Q ss_pred ----CCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 551 ----GDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 551 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
....++||||++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 447899999998 5888877654 4689999999999999999999965 999999999999999999999999
Q ss_pred ccCcccccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhh
Q 040134 626 FGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYI 704 (745)
Q Consensus 626 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 704 (745)
||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ...+.. +.....
T Consensus 178 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~-i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--YNQLNK-IVEVVG 251 (362)
T ss_dssp TTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH-HHHHHC
T ss_pred cCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHcC
Confidence 999975443322 334568899999999876 6789999999999999999999999864321 111111 111111
Q ss_pred cC-------------------cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 705 GK-------------------NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 705 ~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ........ ............+.+++.+||+.||++|||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPAR-AWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChh-hHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 00 00000000 000001112356889999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.29 Aligned_cols=196 Identities=26% Similarity=0.341 Sum_probs=166.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CC-----CceeEEEEEecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HK-----NLVRLLGFCDEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~ 555 (745)
.+.+.+.||+|+||+||+|.... +++.||||+++.. .....++..|+.+++.++ |+ +|+++++++...+..+
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcC-CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 46677899999999999998765 4678999999642 233466778888888874 44 4999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD--DYFTPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~--~~~~~kl~Dfg~a~~ 631 (745)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||++..
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999996 5999998755 4689999999999999999999953 45999999999999994 478899999999987
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 211 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 211 LGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 6432 2345689999999999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.23 Aligned_cols=193 Identities=27% Similarity=0.373 Sum_probs=162.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeE-----
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHR----- 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----- 554 (745)
.+.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECC-CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 35567789999999999998765 4678999998653 223356788999999999999999999999877655
Q ss_pred -EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 555 -LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 555 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 68888874 3489999999999999999999965 99999999999999999999999999998654
Q ss_pred ccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 196 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 196 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 32 234568999999999977 6889999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.11 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=183.1
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec----------
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE---------- 550 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 550 (745)
..+.+.+.||+|+||.||+|+... +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcC-CCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356778899999999999999765 456799999864 23445788999999999999999999998865
Q ss_pred ---CCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeec
Q 040134 551 ---GDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDF 626 (745)
Q Consensus 551 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 626 (745)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 45789999999999999999744 4577889999999999999999965 9999999999999999999999999
Q ss_pred cCccccccccc------------ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 627 GLAKLLLAEQT------------QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 627 g~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
|++........ ........|++.|+|||.+.+. .++.++||||||+++|||++ |+.... ...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~ 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERV 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHH
Confidence 99987643210 1112345689999999999764 68999999999999999998 432110 111
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ...+...... ..+ .........+.+++.+||+.||++|||
T Consensus 236 ---~~-~~~~~~~~~~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps 277 (303)
T 1zy4_A 236 ---NI-LKKLRSVSIE--FPP----DFDDNKMKVEKKIIRLLIDHDPNKRPG 277 (303)
T ss_dssp ---HH-HHHHHSTTCC--CCT----TCCTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred ---HH-HHhccccccc--cCc----cccccchHHHHHHHHHHHhcCcccCcC
Confidence 11 1111111111 001 112223456789999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=308.90 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=168.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHH-HHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVS-VIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|+||.||++.... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||||
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETT-TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhehheeccCCCEEEEEEEEcC-CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 4566789999999999999765 46789999986532 223345556665 67778999999999999999999999999
Q ss_pred cCCCCHHHHhcC-----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 561 MSNGSLASFLFG-----ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 561 ~~~gsL~~~l~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+++ +|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 985 88887752 56789999999999999999999952 29999999999999999999999999999876443
Q ss_pred ccccccccccccccccchhcc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWF----RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
.. .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||....... +.. .....+....+
T Consensus 180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~-~~~~~~~~~~~ 250 (327)
T 3aln_A 180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL-TQVVKGDPPQL 250 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCC
T ss_pred cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH-HHHhcCCCCCC
Confidence 22 2234689999999998 45678999999999999999999999986432110 000 01111111111
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. .........+.+++.+||+.||++|||
T Consensus 251 ~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps 279 (327)
T 3aln_A 251 SN-----SEEREFSPSFINFVNLCLTKDESKRPK 279 (327)
T ss_dssp CC-----CSSCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CC-----cccccCCHHHHHHHHHHhhCChhhCcC
Confidence 11 011122356889999999999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=312.09 Aligned_cols=200 Identities=23% Similarity=0.357 Sum_probs=166.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 555 (745)
.+.+.+.||+|+||.||+|.... +++.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECC-CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 35567899999999999999765 46789999986432 23346788999999999999999999988654 6789
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
+||||+. ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999997 589998865 5689999999999999999999965 9999999999999999999999999999876533
Q ss_pred cccc--------ccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 636 QTQA--------ARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 636 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2211 1223468999999998764 67899999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.25 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=190.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc------CHHHHHHHHHHHhccC--CCCceeEEEEEecCC
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ------GEKEFRTEVSVIGQTH--HKNLVRLLGFCDEGD 552 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 552 (745)
..+.+.+.||+|+||.||+|+... +++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETT-TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CceEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 446678899999999999998765 4678999998653221 2356778999999996 599999999999999
Q ss_pred eEEEEEEecCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEEeeccCcc
Q 040134 553 HRLLVYEYMSN-GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAK 630 (745)
Q Consensus 553 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~a~ 630 (745)
..++|+|++.+ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||++.
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999986 89999998878899999999999999999999965 999999999999999 78999999999998
Q ss_pred cccccccccccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
...... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||... . . ...+...
T Consensus 199 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~---~-----~~~~~~~ 261 (320)
T 3a99_A 199 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----E---E-----IIRGQVF 261 (320)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H---H-----HHHCCCC
T ss_pred cccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----h---h-----hhccccc
Confidence 765332 234568999999999987765 68899999999999999999998521 0 0 0011110
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... .....+.+++.+||+.||++|||
T Consensus 262 --~~~--------~~~~~~~~li~~~l~~dp~~Rps 287 (320)
T 3a99_A 262 --FRQ--------RVSSECQHLIRWCLALRPSDRPT 287 (320)
T ss_dssp --CSS--------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --ccc--------cCCHHHHHHHHHHccCChhhCcC
Confidence 000 11245889999999999999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.21 Aligned_cols=241 Identities=27% Similarity=0.368 Sum_probs=185.2
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+.+.||+|+||.||+|.... .||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HeEEeeEeccCCceEEEEEEEcC----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 45677899999999999998753 2899998642 23344668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc-
Q 040134 560 YMSNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT- 637 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 637 (745)
|+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||++........
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999997754 689999999999999999999965 999999999999998 67999999999876532211
Q ss_pred --ccccccccccccccchhcccc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 638 --QAARTGIRGTVGYFAPEWFRK---------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 638 --~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||..... ... . .....+
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---~-~~~~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAI---I-WQMGTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHH---H-HHHHTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---H-HHhccC
Confidence 112233568999999999864 3578899999999999999999999864321 111 1 111222
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......... ....+.+++.+||+.||++|||
T Consensus 259 ~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt 289 (319)
T 2y4i_B 259 MKPNLSQIG--------MGKEISDILLFCWAFEQEERPT 289 (319)
T ss_dssp CCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCC
T ss_pred CCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcC
Confidence 221111111 1234789999999999999997
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=331.40 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=190.6
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCC--CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASD--SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...+.+.+.||+|+||.||+|.+... ....||||.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 34566778999999999999998543 3567999998653 3334478999999999999999999999985 456899
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999754 4689999999999999999999965 9999999999999999999999999999876543
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... . .+...+ ..+....+
T Consensus 545 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~-~~~~~i----~~~~~~~~--- 613 (656)
T 2j0j_A 545 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--N-DVIGRI----ENGERLPM--- 613 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H-HHHHHH----HHTCCCCC---
T ss_pred ccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--H-HHHHHH----HcCCCCCC---
Confidence 3221 233456789999999998999999999999999999997 8888853221 1 111111 11111111
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 614 ------~~~~~~~l~~li~~~l~~dP~~RPs 638 (656)
T 2j0j_A 614 ------PPNCPPTLYSLMTKCWAYDPSRRPR 638 (656)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------CccccHHHHHHHHHHcCCChhHCcC
Confidence 1112356889999999999999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.23 Aligned_cols=239 Identities=24% Similarity=0.385 Sum_probs=184.2
Q ss_pred HHHHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------cCHHHHHHHHHHHhcc----CCCCceeEE
Q 040134 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------QGEKEFRTEVSVIGQT----HHKNLVRLL 545 (745)
Q Consensus 476 ~~l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~nIv~l~ 545 (745)
.+.....|.+.+.||+|+||.||+|+... +++.||||++..... .....+.+|+.++.++ +||||++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLT-DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTT-TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEcc-CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34445668888999999999999998755 456799999864322 1223456788988888 899999999
Q ss_pred EEEecCCeEEEEEEe-cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEE
Q 040134 546 GFCDEGDHRLLVYEY-MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRI 623 (745)
Q Consensus 546 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl 623 (745)
+++...+..++|+|+ +.+++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||+++ +++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 78999999998878899999999999999999999976 999999999999999 8899999
Q ss_pred eeccCcccccccccccccccccccccccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 040134 624 SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT-VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRC 702 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~ 702 (745)
+|||++....... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||... . . +
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~---~-~--- 245 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q---E-I--- 245 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H---H-H---
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H---H-H---
Confidence 9999998765432 2345689999999999877664 5899999999999999999998521 0 0 0
Q ss_pred hhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 703 YIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....... .......+.+++.+||+.||++|||
T Consensus 246 -~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps 277 (312)
T 2iwi_A 246 -LEAELHF----------PAHVSPDCCALIRRCLAPKPSSRPS 277 (312)
T ss_dssp -HHTCCCC----------CTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred -hhhccCC----------cccCCHHHHHHHHHHccCChhhCcC
Confidence 1111110 0112345789999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.62 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=185.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe------E
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH------R 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~ 554 (745)
+.+.+.||+|+||.||+|+... +++.||||++... .....+.+.+|+.++++++||||+++++++..... .
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred EEEeeeEecCCCeEEEEEEECC-CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 5567889999999999998765 4678999998642 22334678899999999999999999999987654 4
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999997 58888874 3589999999999999999999965 999999999999999999999999999986543
Q ss_pred cccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC-------
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK------- 706 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------- 706 (745)
. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+.. +.+.....
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~-i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQ-ILKVTGVPGTEFVQK 250 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHH-HHHHHCBCCHHHHTT
T ss_pred C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHhCCCCHHHHHH
Confidence 2 233468999999999877 6789999999999999999999999864322 111111 11110000
Q ss_pred -----------cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 -----------NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+........ ..........+.+++.+||+.||++|||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt 299 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLT 299 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCC
Confidence 0000000000 0001123456889999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.43 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=191.1
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-----------CCCceeEEEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-----------HKNLVRLLGFC 548 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~ 548 (745)
...+.+.+.||+|+||.||+++... .++.||||++... ....+.+.+|+.++++++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC-CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3457788999999999999998765 4678999998642 234567889999998886 89999999998
Q ss_pred ecCC----eEEEEEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC------
Q 040134 549 DEGD----HRLLVYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD------ 616 (745)
Q Consensus 549 ~~~~----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~------ 616 (745)
.... ..++|||++ +++|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCc
Confidence 7654 789999999 88999998753 4589999999999999999999952 2999999999999994
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc----h
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP----E 692 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~----~ 692 (745)
..+.+||+|||++...... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 233468999999999999999999999999999999999999997543221 1
Q ss_pred hhHHHHHHHHhhc-------------------Ccccccccc---------cccccccHHHHHHHHHHHHhccccCcCCCC
Q 040134 693 EALMDWVYRCYIG-------------------KNLDKLAEN---------DEEVKNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 693 ~~l~~~~~~~~~~-------------------~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
..+.. +.+.... +....+... .............+.+++.+||+.||++||
T Consensus 248 ~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 248 DHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111 1111100 000000000 001122345677899999999999999999
Q ss_pred C
Q 040134 745 Q 745 (745)
Q Consensus 745 T 745 (745)
|
T Consensus 327 t 327 (373)
T 1q8y_A 327 D 327 (373)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.42 Aligned_cols=243 Identities=21% Similarity=0.209 Sum_probs=162.9
Q ss_pred Hhcc-hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec----CCeEEE
Q 040134 482 TRGF-RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----GDHRLL 556 (745)
Q Consensus 482 ~~~~-~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 556 (745)
.|.+ .++||+|+||.||++.... +++.||||++... .....+....++.++||||+++++++.. ....++
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRR-TGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECC-CCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 3455 3579999999999999875 4567999998542 2222333334566799999999999876 456899
Q ss_pred EEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCccc
Q 040134 557 VYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKL 631 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~ 631 (745)
||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 99999999999999765 3689999999999999999999965 9999999999999976 45699999999986
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ..............
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~- 252 (336)
T 3fhr_A 181 TTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQYGF- 252 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CC-
T ss_pred ccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccccc-
Confidence 54322 23456799999999998888999999999999999999999998644322110 00001111110000
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...........+.+++.+||+.||++|||
T Consensus 253 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (336)
T 3fhr_A 253 -----PNPEWSEVSEDAKQLIRLLLKTDPTERLT 281 (336)
T ss_dssp -----CTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred -----CchhhccCCHHHHHHHHHHCCCChhHCcC
Confidence 00001122456889999999999999997
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=297.17 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=170.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
.+.+.+.||+|+||.||++.... +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GEEEEEEC------CEEEEEETT-TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred cccccceeeecCCeeEEEEEEec-CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 35567889999999999999865 456799999864322 222344455567888899999999999999999999999
Q ss_pred ecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+ ++.+..+... ...+++..+..++.||+.||+|||+. .+|+|+||||+||+++.++.+||+|||++..+.....
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 99 4555555543 46789999999999999999999962 2899999999999999999999999999976644322
Q ss_pred cccccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ... ...... +....+..
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~----~~~~~~-~~~~~~~~ 252 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEV----LTKVLQ-EEPPLLPG 252 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHH----HHHHHH-SCCCCCCS
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-HHH----HHHHhc-cCCCCCCc
Confidence 23456899999999994 456889999999999999999999998643221 111 111111 11111100
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||.+|||
T Consensus 253 -------~~~~~~~l~~li~~~l~~dp~~Rps 277 (318)
T 2dyl_A 253 -------HMGFSGDFQSFVKDCLTKDHRKRPK 277 (318)
T ss_dssp -------SSCCCHHHHHHHHHHTCSCTTTSCC
T ss_pred -------cCCCCHHHHHHHHHHccCChhHCcC
Confidence 0112345889999999999999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.85 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=191.8
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEec------CCe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE------GDH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 553 (745)
..+.+.+.||+|+||.||++.... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~-tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT-TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 457788999999999999998765 4567999998653 34445779999999999999999999998765 677
Q ss_pred EEEEEEecCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---eEEeecc
Q 040134 554 RLLVYEYMSNGSLASFLFGIT---RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFT---PRISDFG 627 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg 627 (745)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997653 588999999999999999999965 9999999999999987664 9999999
Q ss_pred CcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH-------
Q 040134 628 LAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY------- 700 (745)
Q Consensus 628 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~------- 700 (745)
++........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..|..
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 9987654332 33457899999999999999999999999999999999999998643210 00000
Q ss_pred -HHh----hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 -RCY----IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 -~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ..+.....................+.+++.+||+.||++|||
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT 291 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence 000 000000000000011122335677899999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.98 Aligned_cols=240 Identities=24% Similarity=0.282 Sum_probs=176.5
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
..++||+|+||+||.+... .++.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+.
T Consensus 19 ~~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEECSTTCEEEEEES--SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred ccCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3568999999999765433 4567999998642 345678999999876 89999999999999999999999996
Q ss_pred CCHHHHhcCCCCC-------ChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-------------CceEE
Q 040134 564 GSLASFLFGITRP-------DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY-------------FTPRI 623 (745)
Q Consensus 564 gsL~~~l~~~~~~-------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~-------------~~~kl 623 (745)
++|.+++...... .+..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999765332 3345678999999999999965 99999999999999654 48999
Q ss_pred eeccCccccccccccc--ccccccccccccchhcccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 040134 624 SDFGLAKLLLAEQTQA--ARTGIRGTVGYFAPEWFRK-------ASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEE 693 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~ 693 (745)
+|||++..+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 9999998875443211 1234579999999999965 578999999999999999999 888885332211
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... . +.... +.............+.+++.+||+.||++|||
T Consensus 248 --~~i~-~----~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (434)
T 2rio_A 248 --SNII-R----GIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289 (434)
T ss_dssp --HHHH-H----TCCCC---CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred --HHHh-c----CCCCc---ccccccccccchHHHHHHHHHHhhCChhhCCC
Confidence 1111 1 11110 00111123455678899999999999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=331.38 Aligned_cols=229 Identities=22% Similarity=0.295 Sum_probs=184.5
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCe-----E
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDH-----R 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~ 554 (745)
..+.+.+.||+|+||.||++.+...+++.||||++... .......+.+|++++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 34677889999999999999987645678999998643 33445678999999999999999999999987665 7
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+++++|.+++.. .+++.+++.++.||+.||+|||+. +|+||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999998754 789999999999999999999965 99999999999999986 999999999987643
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccc
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 714 (745)
. ....||+.|+|||++.+.. +.++||||||+++|+|++|..|+...... .+.
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~~~-- 285 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------GLP-- 285 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------SCC--
T ss_pred C------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------------ccc--
Confidence 2 3456899999999987654 89999999999999999998886421110 000
Q ss_pred cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 715 DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 715 ~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...........+.+++.+||+.||++|||
T Consensus 286 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~ 314 (681)
T 2pzi_A 286 --EDDPVLKTYDSYGRLLRRAIDPDPRQRFT 314 (681)
T ss_dssp --TTCHHHHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred --ccccccccCHHHHHHHhhhccCChhhCCC
Confidence 00011223456889999999999999996
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.84 Aligned_cols=240 Identities=24% Similarity=0.294 Sum_probs=174.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+.++||+|+||+|+..... .++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 445678999999986543322 356799999864322 2356899999999 8999999999999999999999999
Q ss_pred CCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCceEEeeccCccccccc
Q 040134 562 SNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-----YFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 562 ~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-----~~~~kl~Dfg~a~~~~~~ 635 (745)
. ++|.+++.... ...+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.+...
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 59999997653 456667889999999999999965 9999999999999953 336889999999876543
Q ss_pred ccc-cccccccccccccchhccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 636 QTQ-AARTGIRGTVGYFAPEWFR---KASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... . ............
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~-----~~~~~~~~~~~~ 249 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--Q-----ANILLGACSLDC 249 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--H-----HHHHTTCCCCTT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--H-----HHHHhccCCccc
Confidence 221 1234467999999999997 4567889999999999999999 88887432211 0 111111111111
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. ........+.+++.+||+.||++|||
T Consensus 250 -~~------~~~~~~~~~~~li~~~L~~dP~~Rps 277 (432)
T 3p23_A 250 -LH------PEKHEDVIARELIEKMIAMDPQKRPS 277 (432)
T ss_dssp -SC------TTCHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred -cC------ccccccHHHHHHHHHHHhCCHhhCCC
Confidence 11 11223445788999999999999997
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=283.26 Aligned_cols=215 Identities=22% Similarity=0.284 Sum_probs=166.7
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHH-hccCCCCceeEEEEEec----CCeEEEEEEec
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVI-GQTHHKNLVRLLGFCDE----GDHRLLVYEYM 561 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~lv~e~~ 561 (745)
++||+|+||.||++.... +++.||+|+++. ...+.+|+.++ +.++||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEETT-TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEcC-CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 679999999999999765 456899999853 34677888888 55699999999999876 67889999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCcccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~ 636 (745)
++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 999999999765 3689999999999999999999965 9999999999999998 7899999999986432
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
+..++.++||||||+++|||++|+.||........ .......+.....
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQY 219 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCC
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhccc
Confidence 23467899999999999999999999854322100 0000111111111
Q ss_pred ccc--ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVK--NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~--~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ........+.+++.+||+.||++|||
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps 250 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 250 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCC
Confidence 000 00122456889999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=281.94 Aligned_cols=220 Identities=14% Similarity=0.065 Sum_probs=170.2
Q ss_pred HHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 480 EATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 480 ~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
...|.+.+.||+|+||.||+|.... .++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT-TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC-CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3457788999999999999999765 467899999975332 234788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++++|.+++... ....++.+++.||+.||+|||+. ||+||||||+|||++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999543 45667899999999999999965 99999999999999999999998443
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
|++ .++.++||||||+++|||+||+.||........... +.+. ..+.....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~-~~~~~~~~----- 225 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERD-TAGQPIEP----- 225 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBC-TTSCBCCH-----
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHH-hccCCCCh-----
Confidence 333 368899999999999999999999975433210000 0000 00000000
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..........+.+++.+||+.||++| |
T Consensus 226 -~~~~~~~~~~l~~li~~~l~~dP~~R-s 252 (286)
T 3uqc_A 226 -ADIDRDIPFQISAVAARSVQGDGGIR-S 252 (286)
T ss_dssp -HHHCTTSCHHHHHHHHHHHCTTSSCC-C
T ss_pred -hhcccCCCHHHHHHHHHHcccCCccC-C
Confidence 00011223568899999999999999 6
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=298.02 Aligned_cols=229 Identities=15% Similarity=0.120 Sum_probs=168.7
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCC-CCc---------eeEE------
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHH-KNL---------VRLL------ 545 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~nI---------v~l~------ 545 (745)
+.++||+|+||.||+|.... +++.||||++... .....+.+.+|+.+++.++| +|. +..+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEETTEEEEEEEETT-TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EecccccCCCEEEEEEEecC-CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 45789999999999999765 4567999998732 22336789999999999977 221 1111
Q ss_pred ------EEEec-----CCeEEEEEEecCCCCHHHHhc------C-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 040134 546 ------GFCDE-----GDHRLLVYEYMSNGSLASFLF------G-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCD 607 (745)
Q Consensus 546 ------~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~d 607 (745)
.++.. ....+++|+++ +++|.+++. . ...+++..++.++.||+.||+|||+. +|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 11111 22456677765 679999884 1 23467788999999999999999965 999999
Q ss_pred CCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhcc----------ccCCCCccchhHHHHHHHHHH
Q 040134 608 IKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF----------RKASITVKVDVYSFGVLLLEL 677 (745)
Q Consensus 608 ikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DvwslG~vl~el 677 (745)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999998875433 233457 999999999 555688999999999999999
Q ss_pred HhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 678 ICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 678 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
++|+.||....... ....++..... ....+.+++.+||+.||++|||
T Consensus 311 ltg~~Pf~~~~~~~---------------~~~~~~~~~~~------~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 311 WCADLPNTDDAALG---------------GSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHSSCCCCTTGGGS---------------CSGGGGSSCCC------CCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCcchhh---------------hHHHHHhhccc------CCHHHHHHHHHHccCChhhCcC
Confidence 99999985432111 11111111111 1256889999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=291.37 Aligned_cols=237 Identities=13% Similarity=0.079 Sum_probs=178.3
Q ss_pred HHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--------ccCHHHHHHHHHHHhccC---------CCCc
Q 040134 479 EEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--------QQGEKEFRTEVSVIGQTH---------HKNL 541 (745)
Q Consensus 479 ~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~nI 541 (745)
....+.+.+.||+|+||+||+|+. .++.||||++.... ....+.+.+|+.++++++ ||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred ccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 345677889999999999999987 35789999996532 233478899999988885 8888
Q ss_pred eeEEEEEe------------------------------cCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHH
Q 040134 542 VRLLGFCD------------------------------EGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARG 591 (745)
Q Consensus 542 v~l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~ 591 (745)
+++.+.+. ..+..++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 88777642 26789999999999977766644 668999999999999999
Q ss_pred HHHHH-hcCCCCeeeCCCCCCCEEECCCC--------------------ceEEeeccCcccccccccccccccccccccc
Q 040134 592 LMYLH-EECSTQIIHCDIKPQNILLDDYF--------------------TPRISDFGLAKLLLAEQTQAARTGIRGTVGY 650 (745)
Q Consensus 592 L~~LH-~~~~~~ivH~dikp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 650 (745)
|+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 76 999999999999999887 8999999999876432 24689999
Q ss_pred cchhccccCCCCccchhHHHHHH-HHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccHHHHHHHH
Q 040134 651 FAPEWFRKASITVKVDVYSFGVL-LLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLV 729 (745)
Q Consensus 651 ~aPE~~~~~~~s~~~DvwslG~v-l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 729 (745)
+|||++.+.. +.++|||||+++ .+++++|..||.. ........+.+...... ...............+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTF---KTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCC---SSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhcc---CcccchhhhhhcCHHHH
Confidence 9999998776 899999998777 7778888888731 10001111111111000 00111112334567899
Q ss_pred HHHHhccccC
Q 040134 730 MVALWCIQED 739 (745)
Q Consensus 730 ~li~~Cl~~d 739 (745)
+++.+||+.|
T Consensus 314 dli~~~L~~d 323 (336)
T 2vuw_A 314 EFHRTMLNFS 323 (336)
T ss_dssp HHHHHGGGSS
T ss_pred HHHHHHhccC
Confidence 9999999977
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=275.37 Aligned_cols=185 Identities=19% Similarity=0.103 Sum_probs=128.5
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccc----------cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEE
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKV----------EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 557 (745)
.+.|+.|....++..- .++.+++|.+... .....++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 242 ~~~~~~~~h~~~rr~~-fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYF-FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp -C--------CCEEEE-ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred cccCCccccccccccc-ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4455555444433211 2345899988532 123346799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||++|++|.++|....+++.. +|+.||+.||+|||++ |||||||||+||||++++.+||+|||+++.......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999988877654 5889999999999965 999999999999999999999999999987654332
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSS 683 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p 683 (745)
. .....||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 395 ~--~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 W--PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c--ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 3446799999999999754 57789999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=244.11 Aligned_cols=183 Identities=17% Similarity=0.219 Sum_probs=143.4
Q ss_pred hhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--------cCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--------QGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 486 ~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
.++||+|+||.||++... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 341 ~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEECS---SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 468999999999999543 34588887532111 1134589999999999999999666666677788999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999865 678999999999999965 9999999999999999 999999999998755332
Q ss_pred cc-----ccccccccccccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 638 QA-----ARTGIRGTVGYFAPEWFRK--ASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 638 ~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
.. ......||+.|||||++.. ..|+...|+|+..+-..+.+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1235679999999999977 56788899999999988888777664
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=8.1e-21 Score=167.25 Aligned_cols=107 Identities=21% Similarity=0.412 Sum_probs=92.1
Q ss_pred ccccccCCCCeeeecCCCCcee--cCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCce
Q 040134 2 AKAANINLESSLLATKDSNPWR--SPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGE 79 (745)
Q Consensus 2 ~~~~~i~~~~~l~~~~~~~~~~--S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~ 79 (745)
+++++|.+|++|. .+++|+ |++|.|+|+|+.+++ . +||++ +++||+||++.| ..++.+.|..|||
T Consensus 6 ~~~~~l~~g~~L~---~g~~l~~~S~~g~~~L~~~~dgn---l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dGN 72 (119)
T 1b2p_A 6 SKQPDDNHPQILH---ATESLEILFGTHVYRFIMQTDCN---L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDGV 72 (119)
T ss_dssp CSCSSSCCCCEEE---TTCEEEEEETTEEEEEEECTTSC---E---EEEET---TEEEEECCCTTS-CSSCEEEECTTSC
T ss_pred ecCcccCCCCEEc---CCCEEEEeCCCCCEEEEEecCCC---E---EEEEC---CEEEEeCCCccC-CCceEEEEccCCE
Confidence 5788999999999 777899 999999999998654 2 58875 799999999877 3457899999999
Q ss_pred EEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccc
Q 040134 80 LVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWES 124 (745)
Q Consensus 80 Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 124 (745)
|||+|.++.++|+|++..+ +...++|+|+|||||++ .++|||
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 9999999999999997643 45579999999999998 389998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-21 Score=197.86 Aligned_cols=141 Identities=13% Similarity=0.072 Sum_probs=113.0
Q ss_pred chhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------------------cCHHHHHHHHHHHhccCCCCceeEEE
Q 040134 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------------------QGEKEFRTEVSVIGQTHHKNLVRLLG 546 (745)
Q Consensus 485 ~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 546 (745)
+.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|++++++++| +++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~ 168 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK 168 (282)
T ss_dssp EEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred ecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence 457899999999999998 3567899999864221 124568999999999984 55555
Q ss_pred EEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeec
Q 040134 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDF 626 (745)
Q Consensus 547 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 626 (745)
++.. +..++||||+++++|.+ +. ......++.|++.||.|||+. +|+||||||+|||++ ++.+||+||
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 4433 45699999999999998 42 234567999999999999965 999999999999999 999999999
Q ss_pred cCcccccccccccccccccccccccchhccc
Q 040134 627 GLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657 (745)
Q Consensus 627 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 657 (745)
|+++. +..++|||.+.
T Consensus 237 G~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE---------------TTSTTHHHHHH
T ss_pred CCCeE---------------CCCCCHHHHHH
Confidence 99863 34578999874
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-20 Score=162.39 Aligned_cols=109 Identities=23% Similarity=0.480 Sum_probs=92.2
Q ss_pred ccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEE
Q 040134 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83 (745)
Q Consensus 4 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~ 83 (745)
+++|.+|++|. .+++|+ ++|.|+|+|+..++ | |||+ ..++||.||++.|. .++.+.|..||||||+
T Consensus 1 ~d~l~~g~~L~---~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~ 66 (110)
T 3a0c_A 1 VNSLSSPNSLF---TGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVIY 66 (110)
T ss_dssp CCEEETTCEEC---TTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEEC---CCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEEE
Confidence 47899999999 777899 99999999987654 2 6776 37999999998773 4568999999999999
Q ss_pred cCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCc
Q 040134 84 DPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPT 129 (745)
Q Consensus 84 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~Pt 129 (745)
|.+|.++|+|++..+ +...++|+|+|||||++. .+||||+||.
T Consensus 67 ~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 999999999998744 344799999999999975 7999999983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=158.11 Aligned_cols=103 Identities=23% Similarity=0.461 Sum_probs=87.4
Q ss_pred cccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEEc
Q 040134 5 ANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYD 84 (745)
Q Consensus 5 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~~ 84 (745)
++|.+|++|. .++.|+| |.|.|.|...+ .|.++. ..++||+|||+.|..+.+.|.|+.||||||+|
T Consensus 2 n~L~~g~~L~---~g~~L~s--g~y~l~~q~Dg-----NLvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d 67 (105)
T 4h3o_A 2 NILDNNEGLY---AGQSLDV--EPYHFIMQDDC-----NLVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYD 67 (105)
T ss_dssp CEECTTEEEC---TTCEEEE--TTEEEEECTTS-----CEEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEEEC
T ss_pred CCcCCCCEEc---CCCEEEE--CCEEEEECCCC-----eEEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEEEC
Confidence 5788999998 6678987 88999997554 356654 35899999999999888899999999999999
Q ss_pred CCCCEEEeccCCC-CCceEEEEecCccEEEEcCCccccccc
Q 040134 85 PQGHELWQKPKDG-SKSSWATMQDDGNFVLLGGDSNPIWES 124 (745)
Q Consensus 85 ~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQS 124 (745)
+++++||+|+++. ....+|+|+|+|||||++. .||||
T Consensus 68 ~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 68 SSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 9999999999864 4456899999999999964 69998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=159.07 Aligned_cols=109 Identities=20% Similarity=0.441 Sum_probs=91.0
Q ss_pred ccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEE
Q 040134 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83 (745)
Q Consensus 4 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~ 83 (745)
.+||.+||+|. .+++|+ +|.|+|+|+..++ .. +|+ ..++||+||++.|. .++.|.|..+|||||+
T Consensus 2 ~dtl~~gq~L~---~g~~L~--~g~~~L~~~~dgn---lv---ly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~ 66 (115)
T 2dpf_A 2 DNVLLSGQTLH---ADHSLQ--AGAYTLTIQNKCN---LV---KYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVIY 66 (115)
T ss_dssp CCEEETTCEEE---TTEEEE--ETTEEEEECTTSC---EE---EEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEEC---CCCEEE--CCCEEEEEcCCCc---EE---EEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEEE
Confidence 47899999999 667898 8999999986543 33 354 37999999999884 4578999999999999
Q ss_pred cCCCCEEEeccCCC-CCceEEEEecCccEEEEcCCccccccccccCcC
Q 040134 84 DPQGHELWQKPKDG-SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTD 130 (745)
Q Consensus 84 ~~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtD 130 (745)
|.++.++|+|++.. ....+++|+|+|||||++. ++||||.+++.
T Consensus 67 d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 67 DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 99999999999863 3445799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=155.49 Aligned_cols=109 Identities=21% Similarity=0.475 Sum_probs=90.8
Q ss_pred ccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEE
Q 040134 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83 (745)
Q Consensus 4 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~ 83 (745)
+|||.+||+|. .+++| ++|.|+|+|+.+++- +||.+ .++||+||++.+ ..++.+.|..+|||||+
T Consensus 1 tdtl~~gq~L~---~g~~L--~~~~~~L~~~~dgnl------vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~ 65 (112)
T 1xd5_A 1 SDRLNSGHQLD---TGGSL--AEGGYLFIIQNDCNL------VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEEC---TTCEE--EETTEEEEECTTSCE------EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEE
T ss_pred CCCCCCCCEEC---CCCEE--eCCCEEEEEcCCCcE------EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEE
Confidence 58999999999 67788 589999999987642 35754 689999999764 23468999999999999
Q ss_pred cCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccC
Q 040134 84 DPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEP 128 (745)
Q Consensus 84 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~P 128 (745)
| ++.++|+|.+..+ +...++|+++|||||++..+.++||||+|.
T Consensus 66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 9 8889999987643 345799999999999997788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=143.72 Aligned_cols=103 Identities=21% Similarity=0.469 Sum_probs=84.4
Q ss_pred cccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEEc
Q 040134 5 ANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYD 84 (745)
Q Consensus 5 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~~ 84 (745)
.||.+||+|. .+++|+ +|.|.|+|...++ .+| |.. .++||+||++.+ ..++.+.|..||||||+|
T Consensus 2 ntL~~gq~L~---~g~~L~--~g~~~L~~q~dGn---Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~ 66 (109)
T 3dzw_A 2 NILYSGETLS---PGEFLN--NGRYVFIMQEDCN---LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVYS 66 (109)
T ss_dssp CEEETTEEEC---TTCEEE--ETTEEEEECTTSC---EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEEC
T ss_pred CCcCCCCEeC---CCCEEE--CCCEEEEEcCCCc---EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEEC
Confidence 4789999998 667786 7999999987653 333 543 589999999876 345689999999999999
Q ss_pred CCCCEEEeccCCCCC-ceEEEEecCccEEEEcCCcccccccc
Q 040134 85 PQGHELWQKPKDGSK-SSWATMQDDGNFVLLGGDSNPIWESF 125 (745)
Q Consensus 85 ~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSF 125 (745)
.++.++|+|++.+.. ..+|+|+|+|||||++. ++|||=
T Consensus 67 ~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 67 PRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp TTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred CCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 999999999986443 35799999999999984 899983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=168.15 Aligned_cols=136 Identities=15% Similarity=0.140 Sum_probs=104.4
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEE--EEEEEccccccc------------------------CHHHHHHHHHHHhccC
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRF--VAIKKLDKVEQQ------------------------GEKEFRTEVSVIGQTH 537 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 537 (745)
.+.+.||+|+||.||+|.... +++. ||||+++..... ....+.+|+.++.+++
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999998743 3456 999986432111 1136889999999998
Q ss_pred CCCc--eeEEEEEecCCeEEEEEEecCC-C----CHHHHhcCCCCCChhhHHHHHHHHHHHHHHHH-hcCCCCeeeCCCC
Q 040134 538 HKNL--VRLLGFCDEGDHRLLVYEYMSN-G----SLASFLFGITRPDWNQRVQIAFGIARGLMYLH-EECSTQIIHCDIK 609 (745)
Q Consensus 538 h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~dik 609 (745)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +. +|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 8754 445543 356899999942 3 77776532 235678899999999999999 65 99999999
Q ss_pred CCCEEECCCCceEEeeccCcccc
Q 040134 610 PQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 610 p~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.3e-16 Score=135.02 Aligned_cols=103 Identities=17% Similarity=0.273 Sum_probs=81.0
Q ss_pred cccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEE
Q 040134 3 KAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVL 82 (745)
Q Consensus 3 ~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl 82 (745)
+++||.+||+|. .+++|+| |.|.|-|-..+ + |.+ |.. ++||.+|++.. ..++.+.|..||||||
T Consensus 5 ~~dtL~~gq~L~---~g~~L~s--g~~~L~~q~dG---n--Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNLvl 68 (110)
T 3r0e_B 5 TNNLLFSGQVLY---GDGRLTA--KNHQLVMQGDC---N--LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGELII 68 (110)
T ss_dssp BTTEEETTCEEE---TTEEEEC--SSCEEEECTTS---C--EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCEEE
T ss_pred ccCEECCCCEec---CCCEEEe--CCEEEEEcCCC---e--EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcEEE
Confidence 578999999999 6778998 45888553322 2 444 543 48999999863 2346899999999999
Q ss_pred EcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccc
Q 040134 83 YDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWES 124 (745)
Q Consensus 83 ~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 124 (745)
+|.++.++|+|++... ...+|+|+|+|||||++ ..+|+|
T Consensus 69 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 69 KDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 9999999999998643 33689999999999998 489987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.62 E-value=3.1e-15 Score=130.43 Aligned_cols=106 Identities=17% Similarity=0.293 Sum_probs=84.6
Q ss_pred cccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEE
Q 040134 3 KAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVL 82 (745)
Q Consensus 3 ~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl 82 (745)
..++|.+||+|. .+++|.+ |.|.|-|...++ |-++..+ ..++||.+|+..+- ..+.+.|..||||||
T Consensus 5 ~~~tL~~gq~L~---~g~~L~~--g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNLVl 71 (113)
T 3mez_B 5 VRNVLFSSQVMY---DNAQLAT--RDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGELDI 71 (113)
T ss_dssp CSSEEETTCEEE---TTCEEEE--TTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred cCCEeCCCCEEC---CCCEeEc--CCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcEEE
Confidence 467899999999 6667874 889999865432 5554321 36899999998763 356899999999999
Q ss_pred EcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccc
Q 040134 83 YDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWES 124 (745)
Q Consensus 83 ~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 124 (745)
+|.++.++|+|++... ...+|+|+|+|||||++ ..+|+|
T Consensus 72 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 72 TDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp ECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred ECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 9999999999998643 34689999999999997 689987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=132.91 Aligned_cols=88 Identities=22% Similarity=0.489 Sum_probs=71.8
Q ss_pred CCcceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEe
Q 040134 68 RGSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITS 146 (745)
Q Consensus 68 ~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 146 (745)
....|.|+.||||||++ .+++||++++... ....++|+|+|||||++.++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t-------------------- 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT-------------------- 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC--------------------
Confidence 45689999999999998 5889999998643 3458999999999999998999999993
Q ss_pred cCCCCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCCC
Q 040134 147 RRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE 190 (745)
Q Consensus 147 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~ 190 (745)
++++|.|++.++++|++.++ .. .||+..+.
T Consensus 79 -----~~~~g~~~l~l~~dGnlvl~--~~-------~~W~S~~~ 108 (110)
T 3a0c_A 79 -----NGKEDHYVLVLQQDRNVVIY--GP-------VVWATGSG 108 (110)
T ss_dssp -----CCSSSCCEEEECTTSCEEEE--CS-------EEEECSCC
T ss_pred -----CCCCCCEEEEEeCCccEEEE--CC-------CEecCCCc
Confidence 45679999999999997664 21 47876543
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=125.54 Aligned_cols=107 Identities=21% Similarity=0.438 Sum_probs=83.5
Q ss_pred cccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEE
Q 040134 3 KAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVL 82 (745)
Q Consensus 3 ~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl 82 (745)
+.+||.+||.|. .+++| .+|.|.|.|...++ ..| |.. +|.+|+..+ ..++.|.|..||||||
T Consensus 2 ~~dtL~~gq~L~---~g~~L--~~g~~~L~~q~dGN---Lvl---~~~------~Wssnt~~~-~~~~~l~l~~dGnLvl 63 (109)
T 3r0e_A 2 GTNYLLSGQTLD---TEGHL--KNGDFDLVMQDDCN---LVL---YNG------NWQSNTANN-GRDCKLTLTDYGELVI 63 (109)
T ss_dssp CCSEEETTCEEC---TTCEE--EETTEEEEECTTSC---EEE---ETT------TEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred ccCCcCCCCCcC---CCCEe--ECCCEEEEEecCCe---EEE---EeC------eEEcCCCCC-CCcEEEEEcCCCeEEE
Confidence 468999999998 66678 57999999865443 222 432 699998765 3357899999999999
Q ss_pred EcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCC
Q 040134 83 YDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPG 135 (745)
Q Consensus 83 ~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg 135 (745)
+|.++.++|++++... ...+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 64 ~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 64 KNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred EeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 9999999999987643 34579999999999997 689987 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=127.41 Aligned_cols=85 Identities=22% Similarity=0.502 Sum_probs=70.3
Q ss_pred cceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEecC
Q 040134 70 SQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRR 148 (745)
Q Consensus 70 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~ 148 (745)
..|.|..||+|+|++. +++||++++... ....|+|+|+|||||+|.++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence 4688889999999987 899999997643 346899999999999999999999999
Q ss_pred CCCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCC
Q 040134 149 TQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNS 189 (745)
Q Consensus 149 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~ 189 (745)
++|++|.|++.++++|++.++ . ..||+.++
T Consensus 88 --~~~~~g~~~l~l~~~Gnlvl~--~-------~~~W~Sg~ 117 (119)
T 1b2p_A 88 --VAGKAGHYVLVLQPDRNVVIY--G-------DALWATQT 117 (119)
T ss_dssp --CCCCSSCEEEEECTTSCEEEE--E-------SEEEECCC
T ss_pred --CCCCCCCEEEEEECCCcEEEE--C-------ccEeCCCC
Confidence 355789999999999996664 2 25787654
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=124.57 Aligned_cols=89 Identities=27% Similarity=0.557 Sum_probs=71.4
Q ss_pred CcceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEec
Q 040134 69 GSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSR 147 (745)
Q Consensus 69 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 147 (745)
...|.|..||+|+|++. +++||++++... ....|+|+|+|||||+| ++.++||||+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------------- 76 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------------- 76 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC---------------------
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc---------------------
Confidence 45789999999999987 789999997643 34689999999999999 7889999995
Q ss_pred CCCCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCCC
Q 040134 148 RTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSE 190 (745)
Q Consensus 148 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~ 190 (745)
+|++|.|++.++++|++.++ ... ...||+...+
T Consensus 77 ----~~~~g~~~l~l~~dGnlvl~--~~~----~~~~W~S~~~ 109 (112)
T 1xd5_A 77 ----NRQNGNYYLILQRDRNVVIY--DNS----NNAIWATHTN 109 (112)
T ss_dssp ----CCSCCCCEEEECTTSCEEEE--CTT----SCEEEECCCC
T ss_pred ----cCCCCCEEEEEeCCCcEEEE--CCC----CceEEECCCc
Confidence 44678999999999996664 222 1467876554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-15 Score=157.20 Aligned_cols=135 Identities=12% Similarity=0.077 Sum_probs=97.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc--------------cCHH--------HHHHHHHHHhccCCCC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ--------------QGEK--------EFRTEVSVIGQTHHKN 540 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~n 540 (745)
|.+...||.|++|.||+|... .++.||||+++.... .... ...+|...|.++.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 456788999999999999875 356799998753110 0011 1234666677775444
Q ss_pred c--eeEEEEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 040134 541 L--VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY 618 (745)
Q Consensus 541 I--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~ 618 (745)
+ ...++.. ..+|||||+++++|..+.. ......++.||+.+|.+||+. |||||||||.|||++++
T Consensus 175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 3 2333321 2379999999988876542 234567899999999999965 99999999999999877
Q ss_pred C----------ceEEeeccCcccc
Q 040134 619 F----------TPRISDFGLAKLL 632 (745)
Q Consensus 619 ~----------~~kl~Dfg~a~~~ 632 (745)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987654
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=9.8e-14 Score=121.55 Aligned_cols=88 Identities=24% Similarity=0.539 Sum_probs=71.7
Q ss_pred CcceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEec
Q 040134 69 GSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSR 147 (745)
Q Consensus 69 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 147 (745)
...|.|..||+|+|++ .+++||++++... .+..++|+++|||||+|.++.++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC-------------------
Confidence 4578888999999998 5789999997643 346899999999999998889999999983
Q ss_pred CCCCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCCCC
Q 040134 148 RTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEA 191 (745)
Q Consensus 148 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~ 191 (745)
++|.|++.++++|++.++ .. .||+..++.
T Consensus 81 ------~~g~~~l~l~~dGnlvl~--~~-------~~W~S~~~~ 109 (115)
T 2dpf_A 81 ------DNGKYALVLQKDGRFVIY--GP-------VLWSLGPNG 109 (115)
T ss_dssp ------SSSCCEEEECTTSCEEEE--CS-------EEECSSTTC
T ss_pred ------CCCCEEEEEeCCCeEEEE--CC-------CEEECCCCC
Confidence 568899999999996664 21 578766654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.38 E-value=7.6e-13 Score=114.74 Aligned_cols=102 Identities=18% Similarity=0.308 Sum_probs=78.8
Q ss_pred ccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEE
Q 040134 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83 (745)
Q Consensus 4 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~ 83 (745)
+++|.+||.|. .+++| .+|.|.|-|...++ ..| |.. .. ||.+|+..+ ...+.+.|..||||||+
T Consensus 2 ~~~l~~gq~L~---~g~~L--~~g~~~L~~q~dGn---Lvl---~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~ 65 (111)
T 3mez_A 2 NNVLLTGDVIH---TDNQL--SYESAAFVMQGDCN---LVL---YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIH 65 (111)
T ss_dssp TTEEETTCEEC---TTCEE--EETTEEEEECTTSC---EEE---ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEE
T ss_pred cCEeCCCCEeC---CCCEE--ecCCEEEEEccCCe---EEE---ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEE
Confidence 57899999999 66678 37899999964432 222 432 23 999999876 33578999999999999
Q ss_pred cCCCC-EEEeccCC---CCCceEEEEecCccEEEEcCCccccccc
Q 040134 84 DPQGH-ELWQKPKD---GSKSSWATMQDDGNFVLLGGDSNPIWES 124 (745)
Q Consensus 84 ~~~~~-~vWst~~~---~~~~~~a~LldsGNlVl~~~~~~~lWQS 124 (745)
|.++. ++|+|++. .....+++|+|+|||||++ ..+|+|
T Consensus 66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 99876 59999863 2234589999999999997 689987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.3e-12 Score=128.76 Aligned_cols=113 Identities=17% Similarity=0.355 Sum_probs=87.5
Q ss_pred ccccccCCCCe----eeecCCCCceecCCCcEEEeeeeCC--CCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEe
Q 040134 2 AKAANINLESS----LLATKDSNPWRSPSGEFAFGFHHID--NQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLT 75 (745)
Q Consensus 2 ~~~~~i~~~~~----l~~~~~~~~~~S~~g~F~lGF~~~~--~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~ 75 (745)
+.+||+.||+. |. .++.|+|+ ..++.|+|+.. ...+.+| |.+ ..+++|.+++..+-. ..+.|.
T Consensus 134 ~ptdtlLpg~~~~~~l~---~g~~L~S~-~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~~--~~l~l~ 202 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLA---PGSELVQG-VVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKGA--VRAVFQ 202 (276)
T ss_dssp CTTSCCCCSCTTCEEEC---SSEEECTT-CEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTTC--CEEEEC
T ss_pred ccccccccccccccccc---cCcccccC-CCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCcc--EEEEEc
Confidence 46789999998 65 45567654 57777777652 2223444 332 258999999988732 678999
Q ss_pred cCceEEEEcCCCCEEEeccCCCCCceEEEEecCccEEEEcCCcccccccccc
Q 040134 76 NSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKE 127 (745)
Q Consensus 76 ~~G~Lvl~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 127 (745)
.+|+|+++|.++.++|++++.+....+|+|+++|||||++. +.+||||||
T Consensus 203 ~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 203 GDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999999998899999998755567899999999999986 689999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=106.21 Aligned_cols=78 Identities=19% Similarity=0.382 Sum_probs=63.3
Q ss_pred CcceEEecCceEEEEcCCCCEEEeccCCCCC-ceEEEEecCccEEEEcCCcc-ccccccccCcCcccCCcccCCCceEEe
Q 040134 69 GSQVKLTNSGELVLYDPQGHELWQKPKDGSK-SSWATMQDDGNFVLLGGDSN-PIWESFKEPTDTLLPGQILNSPINITS 146 (745)
Q Consensus 69 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~-~lWQSFd~PtDtlLpg~~l~~~~~L~S 146 (745)
...|.|..||||||++.++ +|++++.... ...++|+|+|||||++.+++ ++|||.-+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 4578999999999999877 9999986433 36899999999999998776 59998731
Q ss_pred cCCCCCCCCceEEEEEecCCceEEE
Q 040134 147 RRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 147 ~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
.....|.|.+.++.+|+++++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly 100 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIY 100 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEE
T ss_pred ----cCCCCcCEEEEECCCCeEEEe
Confidence 111357899999999999887
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=105.89 Aligned_cols=84 Identities=15% Similarity=0.322 Sum_probs=66.9
Q ss_pred CCCCC-CCcceEEecCceEEEEcC-CCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccC
Q 040134 63 DDPAP-RGSQVKLTNSGELVLYDP-QGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILN 139 (745)
Q Consensus 63 ~~p~~-~~~~l~l~~~G~Lvl~~~-~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~ 139 (745)
+.|+. ....|.|..||||||++. .++++|++++... ....++|+|+|||||+|.++.++|||=.+-
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~----------- 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG----------- 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC-----------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC-----------
Confidence 44553 345789999999999998 5899999998643 345799999999999998889999984310
Q ss_pred CCceEEecCCCCCCCCceEEEEEecCCceEEE
Q 040134 140 SPINITSRRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 140 ~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
..|.|.+.++.+|+++++
T Consensus 87 --------------~~~~~~~~L~~dGnlvly 104 (113)
T 3mez_B 87 --------------QEGDYVLILQINGQAVVY 104 (113)
T ss_dssp --------------SSSCCEEEECTTSCEEEE
T ss_pred --------------CCCCEEEEEcCCceEEEe
Confidence 135689999999999886
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=9.7e-11 Score=119.27 Aligned_cols=140 Identities=15% Similarity=0.029 Sum_probs=109.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+...++.|+.+.||+.... ++.+++|............+.+|+++++.+. +..+.++++++...+..++||||+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE---NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS---SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceeEeeccCCCCCeEEEEECC---CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 344567788888999998743 3469999986532233456889999999884 778889999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC------------------------------------------ 599 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------ 599 (745)
+|.+|.+.+. +......++.+++++|..||+..
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999988642 22344578899999999999710
Q ss_pred --------------CCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 600 --------------STQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 600 --------------~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876666799998775
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=9.4e-11 Score=101.32 Aligned_cols=78 Identities=27% Similarity=0.516 Sum_probs=64.2
Q ss_pred CCcceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEe
Q 040134 68 RGSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITS 146 (745)
Q Consensus 68 ~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 146 (745)
....|.|..||+|||++. ++++|++++... ....++|+++|||||+|.++.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------ 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC------------------
Confidence 346788999999999987 689999998643 345799999999999998889999986421
Q ss_pred cCCCCCCCCceEEEEEecCCceEEE
Q 040134 147 RRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 147 ~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
..+.|.+.++.+|++.++
T Consensus 80 -------~~~~~~~~L~ddGNlvly 97 (109)
T 3dzw_A 80 -------ENGNYVCVLQKDRNVVIY 97 (109)
T ss_dssp -------SSSCEEEEECTTSCEEEE
T ss_pred -------CCCCEEEEEeCCCEEEEE
Confidence 135689999999999886
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.09 E-value=2e-10 Score=99.24 Aligned_cols=77 Identities=21% Similarity=0.464 Sum_probs=62.6
Q ss_pred CCcceEEecCceEEEEcCCCCEEEeccCCCCC-ceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEe
Q 040134 68 RGSQVKLTNSGELVLYDPQGHELWQKPKDGSK-SSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITS 146 (745)
Q Consensus 68 ~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 146 (745)
.+..|.|..||||||++. .++|++++.... ...++|+|+|||||+|.++.++|||-.+-
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------ 83 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------ 83 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC------------------
Confidence 346788999999999977 589999976433 35799999999999999889999986421
Q ss_pred cCCCCCCCCceEEEEEecCCceEEE
Q 040134 147 RRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 147 ~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
..|.|.+.++.+|+++++
T Consensus 84 -------~~~~~~~~L~~dGNlvly 101 (110)
T 3r0e_B 84 -------KQGEYVLILQDDGFGVIY 101 (110)
T ss_dssp -------SSSCCEEEECTTSCEEEE
T ss_pred -------CCCCEEEEEcCCccEEEe
Confidence 134589999999999886
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-09 Score=108.49 Aligned_cols=77 Identities=22% Similarity=0.457 Sum_probs=62.9
Q ss_pred CcceEEecCceEEEEcCCCCEEEeccCCCCCceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEecC
Q 040134 69 GSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRR 148 (745)
Q Consensus 69 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~ 148 (745)
...|.|..+|+|+|++. +++||++|........++|+++|||||+|.++.++|+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~-------------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG-------------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC--------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc--------------------
Confidence 35677778899999886 789999997655556799999999999999999999999751
Q ss_pred CCCCCCCceEEEEEecCCceEEE
Q 040134 149 TQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 149 s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
++|.|.+.++.+|+++++
T Consensus 86 -----~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 86 -----SIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp -----CSSCCEEEECSSSCEEEE
T ss_pred -----cCCcEEEEEeCCCCEEEe
Confidence 245678888888888775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-09 Score=109.55 Aligned_cols=129 Identities=13% Similarity=0.056 Sum_probs=95.6
Q ss_pred CcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC--ceeEEEEEecCCeEEEEEEecCCCCHH
Q 040134 490 GRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN--LVRLLGFCDEGDHRLLVYEYMSNGSLA 567 (745)
Q Consensus 490 g~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~ 567 (745)
+.|..+.||++... +++.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~--~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQ--GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECT--TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecC--CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 45666999998653 2345899987543 2346788999999885434 567899888888899999999998884
Q ss_pred HHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 040134 568 SFLFGITRPDWNQRVQIAFGIARGLMYLHEEC------------------------------------------------ 599 (745)
Q Consensus 568 ~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------------ 599 (745)
... .....++.++++.|..||...
T Consensus 104 --~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 123367788888888888631
Q ss_pred -------CCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 600 -------STQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 600 -------~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.8e-09 Score=93.10 Aligned_cols=80 Identities=21% Similarity=0.439 Sum_probs=61.8
Q ss_pred CCCCC-CCcceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCC
Q 040134 63 DDPAP-RGSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNS 140 (745)
Q Consensus 63 ~~p~~-~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~ 140 (745)
+.|++ ....|.|..||||||+++ +|+|++... ....++|+++|||||+|.++.++|+|-..
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~------------- 77 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ------------- 77 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC-------------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc-------------
Confidence 34443 335789999999999985 799998743 34679999999999999888999975210
Q ss_pred CceEEecCCCCCCCCceEEEEEecCCceEEE
Q 040134 141 PINITSRRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 141 ~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
...+.|.+.++.+|+++++
T Consensus 78 ------------~~~~~~~~~L~~dGNlvly 96 (109)
T 3r0e_A 78 ------------SVKGNYAAVVHPDGRLVVF 96 (109)
T ss_dssp ------------CSSSCCEEEEETTTEEEEE
T ss_pred ------------CCCcCEEEEEcCCCeEEEE
Confidence 1236789999999999886
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.92 E-value=3.5e-09 Score=90.48 Aligned_cols=76 Identities=25% Similarity=0.550 Sum_probs=62.0
Q ss_pred cceEEecCceEEEEcCCCCEEEeccCCC--CCceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEec
Q 040134 70 SQVKLTNSGELVLYDPQGHELWQKPKDG--SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSR 147 (745)
Q Consensus 70 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 147 (745)
-.|.+..||||||++. +++||++++.. .....++|.++|||||+|.+++++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 4688899999999975 57999999753 34457999999999999999999998621
Q ss_pred CCCCCCCCceEEEEEecCCceEEE
Q 040134 148 RTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 148 ~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
....+.+.+.|+.+|++.++
T Consensus 79 ----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----CCCSSCEEEEECTTSCEEEE
T ss_pred ----CCCCCCEEEEEeCCCeEEEE
Confidence 12356789999999999886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.5e-09 Score=110.46 Aligned_cols=140 Identities=16% Similarity=0.236 Sum_probs=104.4
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcc--ccc-ccCHHHHHHHHHHHhccC--CCCceeEEEEEecC---CeEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLD--KVE-QQGEKEFRTEVSVIGQTH--HKNLVRLLGFCDEG---DHRLLVY 558 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~ 558 (745)
+.|+.|.++.||+..... ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. ...++||
T Consensus 44 ~~l~~G~sn~~y~v~~~~---~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG---QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECSS---CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEECC---ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 458899999999987643 357888765 321 123457888999999986 45688999998776 4589999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC--------------------------------------- 599 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 599 (745)
||+++..+.+.. ...++..+...++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999998775422 134677888899999999999999720
Q ss_pred ----------------CCCeeeCCCCCCCEEECCCCc--eEEeeccCccc
Q 040134 600 ----------------STQIIHCDIKPQNILLDDYFT--PRISDFGLAKL 631 (745)
Q Consensus 600 ----------------~~~ivH~dikp~NIll~~~~~--~kl~Dfg~a~~ 631 (745)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=5.2e-09 Score=108.88 Aligned_cols=185 Identities=19% Similarity=0.157 Sum_probs=120.1
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCC--ceeEEEEEecCC---eEEEEEEec
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKN--LVRLLGFCDEGD---HRLLVYEYM 561 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~e~~ 561 (745)
.++.|....||+.. ..+++|+.... .....+.+|+++++.+ .+.. +.+++....... ..|+|||++
T Consensus 27 ~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred ecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 47889999999853 12888886432 3356788999999887 3333 455555544333 347899999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC------------------------------------------ 599 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------ 599 (745)
+|.+|.+... ..++..++..++.++++.|+.||...
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988875432 34567777888888888888888510
Q ss_pred -------------CCCeeeCCCCCCCEEECC--CCceEEeeccCccccccccccccccc------------ccccccccc
Q 040134 600 -------------STQIIHCDIKPQNILLDD--YFTPRISDFGLAKLLLAEQTQAARTG------------IRGTVGYFA 652 (745)
Q Consensus 600 -------------~~~ivH~dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~------------~~gt~~y~a 652 (745)
...++|+|++|.||++++ ...+.|+||+.+..-.....-..... .....+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 135899999999999988 55688999999865322110000000 000001111
Q ss_pred -hhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 040134 653 -PEWFRKASITVKVDVYSFGVLLLELICCKSSV 684 (745)
Q Consensus 653 -PE~~~~~~~s~~~DvwslG~vl~elltg~~p~ 684 (745)
|+.... .....+.|+++.++|++.+|..++
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222111 112368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=7.1e-06 Score=83.36 Aligned_cols=135 Identities=16% Similarity=0.098 Sum_probs=96.9
Q ss_pred cCcceeE-EEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecCCCCH
Q 040134 489 LGRGAFG-TVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMSNGSL 566 (745)
Q Consensus 489 Ig~G~~g-~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 566 (745)
+..|..+ .||+.....+ +..+++|+-... ....+.+|...|+.+. +--+.+++.++.+.+..++|||++++.++
T Consensus 32 ~~~G~S~~~v~rl~~~~~-~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPN-APELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTT-CCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCC-CeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 3344443 6888765543 345888876432 3457888999998874 44578899999999999999999999888
Q ss_pred HHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 040134 567 ASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC----------------------------------------------- 599 (745)
Q Consensus 567 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------------- 599 (745)
.+.... .......+..+++..|.-||...
T Consensus 108 ~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 108 FQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 776432 22344556677777777777521
Q ss_pred --------CCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 600 --------STQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 600 --------~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...++|+|+++.||++++++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11389999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=9.2e-06 Score=84.20 Aligned_cols=134 Identities=18% Similarity=0.176 Sum_probs=93.4
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCC---CceeEEEEEe-cCCeEEEEEEecCC
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHK---NLVRLLGFCD-EGDHRLLVYEYMSN 563 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~ 563 (745)
.++.|....||+. . . .+++|+-.. ......+.+|.++++.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 26 ~l~~G~~n~v~~v---g-~--~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 26 SLGEGFRNYAILV---N-G--DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEECSSEEEEEE---T-T--TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred ecCCCcceeEEEE---C-C--EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 4678888899986 1 2 277887432 23356789999999999642 3667777774 45567899999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE--------------------------------------------- 598 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------- 598 (745)
.+|.+... ..++..+...++.++++.|+.||..
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88876321 2234455555666666666666642
Q ss_pred ------------CCCCeeeCCCCCCCEEECC---CCc-eEEeeccCccc
Q 040134 599 ------------CSTQIIHCDIKPQNILLDD---YFT-PRISDFGLAKL 631 (745)
Q Consensus 599 ------------~~~~ivH~dikp~NIll~~---~~~-~kl~Dfg~a~~ 631 (745)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.2e-05 Score=85.18 Aligned_cols=82 Identities=9% Similarity=0.023 Sum_probs=55.5
Q ss_pred hhc-CcceeEEEEEEEee---CC--CcEEEEEEEccccc---ccCHHHHHHHHHHHhccC-C--CCceeEEEEEecC---
Q 040134 487 QIL-GRGAFGTVYKGVLA---SD--SKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTH-H--KNLVRLLGFCDEG--- 551 (745)
Q Consensus 487 ~~I-g~G~~g~V~~~~~~---~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~--- 551 (745)
+.| +.|....+|+.... .+ .++.+++|...... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88888999988754 10 14568888765422 111246788888888884 3 3578888887665
Q ss_pred CeEEEEEEecCCCCHHH
Q 040134 552 DHRLLVYEYMSNGSLAS 568 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~ 568 (745)
...++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=7.6e-05 Score=80.37 Aligned_cols=75 Identities=19% Similarity=0.144 Sum_probs=48.0
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc-------cCHHHHHHHHHHHhccCC--C-CceeEEEEEecCCeEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ-------QGEKEFRTEVSVIGQTHH--K-NLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~l 556 (745)
+.||.|..+.||++....+ ++.++||....... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~~~-~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEH-DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EECCCCceEEEEEEEECCC-CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4689999999999975432 35689997643211 123456788888887732 3 34566654 3445689
Q ss_pred EEEecCCC
Q 040134 557 VYEYMSNG 564 (745)
Q Consensus 557 v~e~~~~g 564 (745)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00055 Score=71.71 Aligned_cols=137 Identities=17% Similarity=0.205 Sum_probs=77.9
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC--CCCceeEEE------EEecCCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH--HKNLVRLLG------FCDEGDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~------~~~~~~~~~lv~e 559 (745)
.|+.|....||+.... ++ .+++|+... ....+..|..+++.|. .-.+++++. +....+..+++||
T Consensus 39 ~l~gG~~n~~~~v~~~--~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--SG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET--TE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC--CC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3556678899998753 23 388888764 1234445556555552 112333332 1234667899999
Q ss_pred ecCCCCHH-----------HH---hc----CCC-C---------CChhhH------------------------------
Q 040134 560 YMSNGSLA-----------SF---LF----GIT-R---------PDWNQR------------------------------ 581 (745)
Q Consensus 560 ~~~~gsL~-----------~~---l~----~~~-~---------~~~~~~------------------------------ 581 (745)
|++|..+. .. ++ ... + ..|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 01 11 110 0 112110
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 582 -VQIAFGIARGLMYLHE----------ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 582 -~~i~~~i~~~L~~LH~----------~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
..+..++..++++|++ .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666763 1256899999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00046 Score=71.17 Aligned_cols=74 Identities=16% Similarity=0.186 Sum_probs=57.8
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC---CCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH---HKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|. ...+++++.+....+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~~---~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE---VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEESS---SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEEC---CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35889999999998752 345788886532 3567889999988883 36788999998888899999999998
Q ss_pred CCH
Q 040134 564 GSL 566 (745)
Q Consensus 564 gsL 566 (745)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00063 Score=73.68 Aligned_cols=80 Identities=10% Similarity=0.000 Sum_probs=48.7
Q ss_pred CCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccccccccccccchhccccC---CCCccchhHHHHHHHHH
Q 040134 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKA---SITVKVDVYSFGVLLLE 676 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwslG~vl~e 676 (745)
...++|||++|.|||++.++ ++|+||+.+..-.....-. .....-...|.+|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 56899999999999998876 9999999887532211100 0000012346666655321 11223556677778887
Q ss_pred HHhCC
Q 040134 677 LICCK 681 (745)
Q Consensus 677 lltg~ 681 (745)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0022 Score=67.95 Aligned_cols=139 Identities=19% Similarity=0.243 Sum_probs=81.4
Q ss_pred hcCcceeEEEEEEEeeC------CCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEe
Q 040134 488 ILGRGAFGTVYKGVLAS------DSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.|..|-...+|+..... ...+.+++|+.... ......+.+|.++++.+. +.-..++++++.++ +||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 46667777889887642 12345888886332 234566778999998884 33346777776542 89999
Q ss_pred cCCCCHHHH-----------------hcCC-----CCCC--hhhHHHHHHHHHH-------------------HHHHHHh
Q 040134 561 MSNGSLASF-----------------LFGI-----TRPD--WNQRVQIAFGIAR-------------------GLMYLHE 597 (745)
Q Consensus 561 ~~~gsL~~~-----------------l~~~-----~~~~--~~~~~~i~~~i~~-------------------~L~~LH~ 597 (745)
+++.+|..- |+.. +... +.++.++..++.. .+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998655311 1111 1112 2344444433321 2233322
Q ss_pred c-----CCCCeeeCCCCCCCEEECCC----CceEEeeccCccc
Q 040134 598 E-----CSTQIIHCDIKPQNILLDDY----FTPRISDFGLAKL 631 (745)
Q Consensus 598 ~-----~~~~ivH~dikp~NIll~~~----~~~kl~Dfg~a~~ 631 (745)
. ....++|+|+.+.||+++++ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 13469999999999999876 7899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.003 Score=64.38 Aligned_cols=74 Identities=18% Similarity=0.160 Sum_probs=52.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-C--CCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-H--KNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
+.+|.|..+.||+..+.+ ++.+++|+...........|..|+..|+.|. . --+++++++. ..++||||++.
T Consensus 21 ~~~g~G~~~~vyrv~l~D--G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELAD--GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEETT--SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEECC--CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 357899999999998764 4569999876544444567889999998884 2 2355666543 23789999987
Q ss_pred CCH
Q 040134 564 GSL 566 (745)
Q Consensus 564 gsL 566 (745)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0024 Score=69.21 Aligned_cols=74 Identities=14% Similarity=0.141 Sum_probs=48.6
Q ss_pred hhcCcceeEEEEEEEeeCC------CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC-ceeEEEEEecCCeEEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASD------SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN-LVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e 559 (745)
+.|+.|-...+|+...... .++.+++|+.... .....+.+|..+++.+...+ .+++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3577888899999886531 1345888887431 12255668999998884333 3677776543 28999
Q ss_pred ecCCCCH
Q 040134 560 YMSNGSL 566 (745)
Q Consensus 560 ~~~~gsL 566 (745)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0038 Score=64.71 Aligned_cols=139 Identities=14% Similarity=0.144 Sum_probs=77.1
Q ss_pred hcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC--ceeEEEE------EecCCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN--LVRLLGF------CDEGDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e 559 (745)
.|+.|....+|+.....+ .+++|..... .....+..|+.+++.+.... +.+++.. ....+..+++++
T Consensus 29 ~i~~G~~n~~~~v~~~~g---~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD---PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEESSC---CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeCCc---cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 466787889999876432 3788887542 12235566777777663212 3333321 122456789999
Q ss_pred ecCCCCHHH----H----------hc----CC--CC---C---ChhhHH--------H----HHHHHHHHHHHHHhc---
Q 040134 560 YMSNGSLAS----F----------LF----GI--TR---P---DWNQRV--------Q----IAFGIARGLMYLHEE--- 598 (745)
Q Consensus 560 ~~~~gsL~~----~----------l~----~~--~~---~---~~~~~~--------~----i~~~i~~~L~~LH~~--- 598 (745)
|++|..+.. . ++ .. .. . .|.... . +...+.+.++.|++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998865321 0 11 10 10 0 111100 0 111244455555532
Q ss_pred -CCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 599 -CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 599 -~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...+++|+|+++.||+++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134799999999999999876668999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.002 Score=66.17 Aligned_cols=70 Identities=10% Similarity=0.094 Sum_probs=42.2
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc-eeEEEEEecCCeEEEEEEec-CCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL-VRLLGFCDEGDHRLLVYEYM-SNG 564 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~g 564 (745)
+.|+.|....+|+. . .+++|+....... .....+|+.+++.+....+ .+++.+. .+.-++|+||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-----~--~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----G--DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-----T--TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-----e--eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 45788888999997 1 2788887542211 1223568777777742223 4666543 33457899999 665
Q ss_pred CH
Q 040134 565 SL 566 (745)
Q Consensus 565 sL 566 (745)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0078 Score=65.49 Aligned_cols=74 Identities=18% Similarity=0.138 Sum_probs=46.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc-eeEEEEEecCCeEEEEEEecCCCC
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL-VRLLGFCDEGDHRLLVYEYMSNGS 565 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gs 565 (745)
+.|+.|-...+|+..... .++.+++|+....... .....+|..+++.|...++ .++++.+. +. +|+||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 457888889999987643 2355888876432211 1122578888888864444 56777763 22 5999998755
Q ss_pred H
Q 040134 566 L 566 (745)
Q Consensus 566 L 566 (745)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.011 Score=61.46 Aligned_cols=32 Identities=31% Similarity=0.318 Sum_probs=27.9
Q ss_pred CCCeeeCCCCCCCEEECCC----CceEEeeccCccc
Q 040134 600 STQIIHCDIKPQNILLDDY----FTPRISDFGLAKL 631 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~~~----~~~kl~Dfg~a~~ 631 (745)
...++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6899999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.02 Score=59.28 Aligned_cols=137 Identities=13% Similarity=0.095 Sum_probs=76.5
Q ss_pred cCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC--CCceeEEEE-----EecCCeEEEEEEec
Q 040134 489 LGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH--KNLVRLLGF-----CDEGDHRLLVYEYM 561 (745)
Q Consensus 489 Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~-----~~~~~~~~lv~e~~ 561 (745)
++ |....||+..... ++.+++|..... ......+..|..+++.+.. -.+++++.. ....+..+++||++
T Consensus 34 l~-g~~n~~y~v~~~~--g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 34 LN-SYENRVYQFQDED--RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EC-CSSSEEEEECCTT--CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ec-CcccceEEEEcCC--CCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 45 6677899865432 334889987532 1234567778888877742 123444432 12245668899999
Q ss_pred CCCCHH-----HH---------hc----CC-----CCCChhhH----HHH---------------HHHHHHHHHHHHhc-
Q 040134 562 SNGSLA-----SF---------LF----GI-----TRPDWNQR----VQI---------------AFGIARGLMYLHEE- 598 (745)
Q Consensus 562 ~~gsL~-----~~---------l~----~~-----~~~~~~~~----~~i---------------~~~i~~~L~~LH~~- 598 (745)
++..+. .. ++ .. ...++... ..+ ...+...++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 11 00 01111110 000 11111223333221
Q ss_pred ---CCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 599 ---CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 599 ---~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245689999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.011 Score=62.54 Aligned_cols=74 Identities=14% Similarity=0.086 Sum_probs=42.7
Q ss_pred hcCcceeEEEEEEEeeCC-------CcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC-ceeEEEEEecCCeEEEEEE
Q 040134 488 ILGRGAFGTVYKGVLASD-------SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN-LVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e 559 (745)
.|+.|....+|+.....+ ..+.+++|+....... ......|.++++.+...+ ..++++.. . -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 467777789999876431 1145888886542221 112467888888774333 45676554 2 268999
Q ss_pred ecCCCCH
Q 040134 560 YMSNGSL 566 (745)
Q Consensus 560 ~~~~gsL 566 (745)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.57 E-value=0.051 Score=56.60 Aligned_cols=32 Identities=25% Similarity=0.307 Sum_probs=28.3
Q ss_pred CCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999988765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.17 E-value=0.041 Score=52.38 Aligned_cols=98 Identities=11% Similarity=-0.021 Sum_probs=64.6
Q ss_pred CCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 564 GSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 564 gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
-+|.++|... .++++++++.++.|.+.+|.-+-.. ... ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 4789988654 7899999999999999998776221 011 1233457899999999988764 1110
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHh
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC 679 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt 679 (745)
.....+.|||... ...+.+.=|||||++||..+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888763 455678899999999999884
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.53 E-value=0.054 Score=58.05 Aligned_cols=74 Identities=9% Similarity=0.055 Sum_probs=45.9
Q ss_pred hcCcceeEEEEEEEeeCCC------cEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEe
Q 040134 488 ILGRGAFGTVYKGVLASDS------KRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 488 ~Ig~G~~g~V~~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.+..|-...+|+....... ++.+++|+...... ......+|..+++.+. +.-..++++.+. -++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 4667777889998765311 34588888643222 2223467888888774 333456665442 2689999
Q ss_pred cCCCCH
Q 040134 561 MSNGSL 566 (745)
Q Consensus 561 ~~~gsL 566 (745)
+++..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.25 E-value=1.1 Score=47.52 Aligned_cols=30 Identities=27% Similarity=0.331 Sum_probs=25.4
Q ss_pred CeeeCCCCCCCEEE------CCCCceEEeeccCccc
Q 040134 602 QIIHCDIKPQNILL------DDYFTPRISDFGLAKL 631 (745)
Q Consensus 602 ~ivH~dikp~NIll------~~~~~~kl~Dfg~a~~ 631 (745)
.++|+|+.+.|||+ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998864
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=88.95 E-value=0.31 Score=38.34 Aligned_cols=32 Identities=22% Similarity=0.571 Sum_probs=28.6
Q ss_pred CcChHHHHHhhccCCceeeeEec--CCceEEecc
Q 040134 357 GVNRQTCEQLCREDCFCAAAIYN--GDYCWKKKY 388 (745)
Q Consensus 357 ~~s~~~C~~~Cl~nCsC~A~~y~--~~~C~~~~~ 388 (745)
..++++|+..|+.+=.|.||.|| ...|+++..
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 46899999999999999999997 468999875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.15 E-value=1.3 Score=30.10 Aligned_cols=14 Identities=29% Similarity=0.266 Sum_probs=5.1
Q ss_pred hhhhHHHHHHHHHH
Q 040134 431 LLGSSVFLNILLIF 444 (745)
Q Consensus 431 ~~g~~v~l~i~~i~ 444 (745)
+.|++..+++++++
T Consensus 14 A~gVVgGv~~~~ii 27 (44)
T 2ks1_B 14 ATGMVGALLLLLVV 27 (44)
T ss_dssp THHHHHHHHHHHHH
T ss_pred EeehhHHHHHHHHH
Confidence 33333333333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.10 E-value=2.4 Score=40.37 Aligned_cols=112 Identities=12% Similarity=0.143 Sum_probs=76.1
Q ss_pred CCCCceeEEEEEecCCeEEEEEEecCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHH-HHHhcCCCCeeeCCCCCCCEE
Q 040134 537 HHKNLVRLLGFCDEGDHRLLVYEYMSN-GSLASFLFGITRPDWNQRVQIAFGIARGLM-YLHEECSTQIIHCDIKPQNIL 614 (745)
Q Consensus 537 ~h~nIv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~dikp~NIl 614 (745)
.||++ -..+-.+++.+.+.++--++ .++..+ ..++..++++++..|+.... +++ .-+|--|+|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 68888 44445777777777776533 333333 45678899999999887766 565 5588899999999
Q ss_pred ECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccch-hHHHHHHHHHHHhCCCCC
Q 040134 615 LDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVD-VYSFGVLLLELICCKSSV 684 (745)
Q Consensus 615 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D-vwslG~vl~elltg~~p~ 684 (745)
++.++.++|.-.|+-.. ++|..+ + ..| +-.+=+++..++.++..|
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999987775432 223211 1 112 235667778888777766
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=83.03 E-value=0.39 Score=31.80 Aligned_cols=25 Identities=20% Similarity=0.566 Sum_probs=20.5
Q ss_pred CCCCCCcccccCCCCCcccCCCCCc
Q 040134 278 GACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 278 g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
..|...|.|......-.|.|++||+
T Consensus 9 ~pC~ngg~C~~~~~~~~C~C~~G~~ 33 (39)
T 1edm_B 9 NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred CCCCCCCEeEcCCCceEeECCCCCc
Confidence 6899999997554556899999996
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=80.80 E-value=5 Score=39.78 Aligned_cols=37 Identities=5% Similarity=-0.013 Sum_probs=16.9
Q ss_pred eEEEEcCC-CCEEEeccCCC------CCceEEEEecCccEEEEc
Q 040134 79 ELVLYDPQ-GHELWQKPKDG------SKSSWATMQDDGNFVLLG 115 (745)
Q Consensus 79 ~Lvl~~~~-~~~vWst~~~~------~~~~~a~LldsGNlVl~~ 115 (745)
.++..|.+ |.++|+-.... .-...++++.+||+++.+
T Consensus 187 ~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 187 CFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp EEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred eEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 34445554 55666543210 012345555555555543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 745 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-09 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-15 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-13 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-07 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-05 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-08 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-05 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 5e-67
Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 27/267 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
Q +G G+FGTVYKG VA+K L+ Q + F+ EV V+ +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECST 601
+G+ +V ++ SL L I T+ + + + IA A+G+ YLH +
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR---K 658
IIH D+K NI L + T +I DFGLA + + G++ + APE R K
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 659 ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN-DEE 717
+ + DVY+FG++L EL+ + + + N + ++ V R Y+ +L K+ N +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
+K + C+++ RP
Sbjct: 242 MKR----------LMAECLKKKRDERP 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 5e-64
Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 470 VRSFTYKELEEATRGFR-----------QILGRGAFGTVYKGVLASDSKR--FVAIKKLD 516
+ FT+++ EA R F Q++G G FG V G L KR FVAIK L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 517 K-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG-IT 574
++ ++F +E S++GQ H N++ L G + +++ E+M NGSL SFL
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 575 RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634
+ Q V + GIA G+ YL + +H D+ +NIL++ ++SDFGL++ L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 635 EQTQAART---GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP 691
+ + T G + + + APE + T DV+S+G+++ E++ + TN
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 692 EEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ +++ + E D + + L + L C Q+D + RP
Sbjct: 241 D--VINAI-------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRP 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-60
Identities = 78/262 (29%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G FG V+ G + VA+K L + F E +++ Q H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
+ + ++ EYM NGSL FL + N+ + +A IA G+ ++ E
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH D++ NIL+ D + +I+DFGLA+L+ + AR G + + + APE + T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722
+K DV+SFG+LL E++ G TNPE ++ + R Y D
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCP---------- 236
Query: 723 KRVERLVMVALWCIQEDASLRP 744
E L + C +E RP
Sbjct: 237 ---EELYQLMRLCWKERPEDRP 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-59
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 23/260 (8%)
Query: 489 LGRGAFGTVYKGVL-ASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
LG G FG+V +GV + VAIK L + E+ +E E ++ Q + +VRL+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIH 605
C + + +LV E G L FL G + ++ ++ G+ YL E+ +H
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVH 132
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AARTGIRGTVGYFAPEWFRKASITVK 664
D+ +N+LL + +ISDFGL+K L A+ + AR+ + + ++APE + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKR 724
DV+S+GV + E + PE +M ++ + GK ++ E E+
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQ---GKRMECPPECPPELYA---- 243
Query: 725 VERLVMVALWCIQEDASLRP 744
+ C RP
Sbjct: 244 ------LMSDCWIYKWEDRP 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-59
Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 8/196 (4%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG G G V+K S +A K + ++ + E+ V+ + + +V
Sbjct: 12 SELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
G + E+M GSL L R +++ + +GL YL E+ I+H
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMH 128
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKV 665
D+KP NIL++ ++ DFG++ L+ GT Y +PE + +V+
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQS 184
Query: 666 DVYSFGVLLLELICCK 681
D++S G+ L+E+ +
Sbjct: 185 DIWSMGLSLVEMAVGR 200
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-58
Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 23/261 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F + LG G FG V G + VAIK + + E EF E V+ H+ LV+L
Sbjct: 8 FLKELGTGQFGVVKYGKW--RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQI 603
G C + ++ EYM+NG L ++L + Q +++ + + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
+H D+ +N L++D ++SDFGL++ + + + G + V + PE + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 664 KVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723
K D+++FGVL+ E+ TN E + +A+ + L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSE--------------TAEHIAQGLRLYRPHLA 226
Query: 724 RVERLVMVALWCIQEDASLRP 744
E++ + C E A RP
Sbjct: 227 -SEKVYTIMYSCWHEKADERP 246
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 72/261 (27%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
F Q +G G FG V+ G +K VAIK + + E++F E V+ + H LV+L
Sbjct: 9 FVQEIGSGQFGLVHLGYW--LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
G C E LV+E+M +G L+ +L + + + G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
IH D+ +N L+ + ++SDFG+ + +L +Q + TG + V + +PE F + +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSS 181
Query: 664 KVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723
K DV+SFGVL+ E+ +N E +++ + G L K V
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST---GFRLYKPRLASTHVYQ--- 233
Query: 724 RVERLVMVALWCIQEDASLRP 744
+ C +E RP
Sbjct: 234 -------IMNHCWKERPEDRP 247
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-57
Identities = 70/260 (26%), Positives = 112/260 (43%), Gaps = 23/260 (8%)
Query: 489 LGRGAFGTVYKGVLA-SDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
LG G FGTV KG + VA+K L + + E E +V+ Q + +VR++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
G C E + +LV E G L +L +++ ++ G+ YL E +H
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVH 130
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTGIRGTVGYFAPEWFRKASITVK 664
D+ +N+LL +ISDFGL+K L A++ A+T + V ++APE + K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKR 724
DV+SFGVL+ E G E + + + G+ + A E+ +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK---GERMGCPAGCPREMYD---- 241
Query: 725 VERLVMVALWCIQEDASLRP 744
+ C D RP
Sbjct: 242 ------LMNLCWTYDVENRP 255
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-57
Identities = 68/267 (25%), Positives = 111/267 (41%), Gaps = 28/267 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
F +GRG+F TVYKG+ +++ VA +L + + + F+ E ++ H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLD-TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 543 RLLGFC----DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
R +LV E M++G+L ++L I +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 599 CSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
IIH D+K NI + + +I D GLA L A + GT + APE +
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYE 186
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
+ VDVY+FG+ +LE+ + + + V + DK+A E
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEY--PYSECQNAAQIYRRVTSGVKPASFDKVA--IPE 241
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
VK + CI+++ R
Sbjct: 242 VKE----------IIEGCIRQNKDERY 258
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-57
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 46/289 (15%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF----VAIKKLDKVEQQGEKE-FRTEVSVIGQ-THH 538
F ++LG GAFG V SK VA+K L + E+E +E+ ++ Q H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF-----------------------GITR 575
+N+V LLG C L++EY G L ++L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 576 PDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
+ + A+ +A+G+ +L + +H D+ +N+L+ +I DFGLA+ ++++
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695
R R V + APE + T+K DV+S+G+LL E+ + G
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--- 274
Query: 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
N KL +N ++ E + ++ C D+ RP
Sbjct: 275 -----------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-57
Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNL 541
F +++GRG FG VY G L + K A+K L+++ GE +F TE ++ H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 542 VRLLGFCDEGD-HRLLVYEYMSNGSLASFLFGITR-PDWNQRVQIAFGIARGLMYLHEEC 599
+ LLG C + L+V YM +G L +F+ T P + +A+G+ +L +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA--RTGIRGTVGYFAPEWFR 657
+H D+ +N +LD+ FT +++DFGLA+ + ++ + +TG + V + A E +
Sbjct: 151 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
T K DV+SFGVLL EL+ + P+ D G+ L + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
+ V L C A +RP
Sbjct: 263 LYE----------VMLKCWHPKAEMRP 279
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 26/266 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG GAFG VYK ++ A K +D ++ +++ E+ ++ H N+V+L
Sbjct: 16 IIGELGDGAFGKVYKAQN-KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQI 603
L ++ ++ E+ + G++ + + + RP +Q + L YLH +I
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF-----RK 658
IH D+K NIL +++DFG++ +T R GT + APE +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 659 ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718
K DV+S G+ L+E+ + NP L+ I K+
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLK------IAKSEPPTLAQPSRW 241
Query: 719 KNDLKRVERLVMVALWCIQEDASLRP 744
++ K C++++ R
Sbjct: 242 SSNFKD------FLKKCLEKNVDARW 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-56
Identities = 78/262 (29%), Positives = 118/262 (45%), Gaps = 25/262 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
LG+G FG V+ G ++ VAIK L + F E V+ + H+ LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGIARGLMYLHEECSTQ 602
+ +V EYMS GSL FL G T Q V +A IA G+ Y+
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
+H D++ NIL+ + +++DFGLA+L+ + AR G + + + APE T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFT 192
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722
+K DV+SFG+LL EL G N E ++D V R G + E E + +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER---GYRMPCPPECPESLHD-- 245
Query: 723 KRVERLVMVALWCIQEDASLRP 744
+ C +++ RP
Sbjct: 246 --------LMCQCWRKEPEERP 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 9e-56
Identities = 73/263 (27%), Positives = 110/263 (41%), Gaps = 31/263 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
Q +G+G FG V G VA+K + + F E SV+ Q H NLV+L
Sbjct: 11 LLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 545 LGFCDEGDHRL-LVYEYMSNGSLASFLF--GITRPDWNQRVQIAFGIARGLMYLHEECST 601
LG E L +V EYM+ GSL +L G + + ++ + + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 123
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+H D+ +N+L+ + ++SDFGL K + + + V + APE R+
Sbjct: 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKF 177
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
+ K DV+SFG+LL E+ P L D V R G +D V
Sbjct: 178 STKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE- 231
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
V C DA++RP
Sbjct: 232 ---------VMKNCWHLDAAMRP 245
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 2e-55
Identities = 61/289 (21%), Positives = 117/289 (40%), Gaps = 47/289 (16%)
Query: 485 FRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHK 539
+ + +G GAFG V++ + VA+K L + + +F+ E +++ + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP----------------------- 576
N+V+LLG C G L++EYM+ G L FL ++
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 577 -DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635
+++ IA +A G+ YL E +H D+ +N L+ + +I+DFGL++ + +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695
A + + PE T + DV+++GV+L E+ +G + E +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--V 251
Query: 696 MDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ +V I + L + C + + RP
Sbjct: 252 IYYVRDGNILACPENC-------------PLELYNLMRLCWSKLPADRP 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 4e-55
Identities = 71/284 (25%), Positives = 111/284 (39%), Gaps = 41/284 (14%)
Query: 485 FRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVEQQGEKE-FRTEVSVIGQ-THH 538
F + LG GAFG V + SD+ VA+K L E+E +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG------------------ITRPDWNQ 580
N+V LLG C G L++ EY G L +FL D
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 581 RVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
+ ++ +A+G+ +L + IH D+ +NILL +I DFGLA+ + +
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700
+ R V + APE T + DV+S+G+ L EL SS G +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------- 256
Query: 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
K+ + + + + + C D RP
Sbjct: 257 -------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 75/286 (26%), Positives = 128/286 (44%), Gaps = 32/286 (11%)
Query: 459 LRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV 518
LRS+ S + Y E+ +G+GA GTVY + + + VAI++++
Sbjct: 9 LRSIVSVGDPKKK---YTRFEK--------IGQGASGTVYTAMDVAT-GQEVAIRQMNLQ 56
Query: 519 EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDW 578
+Q ++ E+ V+ + + N+V L GD +V EY++ GSL + T D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDE 115
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
Q + + L +LH Q+IH DIK NILL + +++DFG + EQ++
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDW 698
R+ + GT + APE + + KVD++S G++ +E+I + + NP AL
Sbjct: 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--PYLNENPLRALYL- 227
Query: 699 VYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
I N +N E++ + C+ D R
Sbjct: 228 -----IATNGTPELQNPEKLSAIFRD------FLNRCLDMDVEKRG 262
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 5e-55
Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 20/260 (7%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLL 545
Q LG GA+G V V ++ VA+K +D + + E+ + +H+N+V+
Sbjct: 11 QTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
G EG+ + L EY S G L + + + G++YLH I H
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITH 126
Query: 606 CDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI-TVK 664
DIKP+N+LLD+ +ISDFGLA + + + GT+ Y APE ++
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKR 724
VDV+S G++L ++ + ++ + DW + K+ D L +
Sbjct: 187 VDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLNPWKKI---DSAPLALLHK 242
Query: 725 VERLVMVALWCIQEDASLRP 744
+ E+ S R
Sbjct: 243 ----------ILVENPSARI 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-54
Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 33/285 (11%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
++ +G+G FG V++G VA+K E++ E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGF 62
Query: 545 LGFCDEGD----HRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEEC- 599
+ ++ + LV +Y +GSL +L +++A A GL +LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 600 ----STQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA--EQTQAARTGIRGTVGYFAP 653
I H D+K +NIL+ T I+D GLA + + A GT Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 654 EWF------RKASITVKVDVYSFGVLLLELICCKS--------SVVFGTTNPEEALMDWV 699
E + + D+Y+ G++ E+ S + + P + ++ +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 700 YRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ + L N + L+ + ++ C + + R
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKI---MRECWYANGAARL 283
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 1e-54
Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 23/262 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG G +G VY+GV VA+K L + + E EF E +V+ + H NLV+L
Sbjct: 21 MKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP--DWNQRVQIAFGIARGLMYLHEECSTQ 602
LG C ++ E+M+ G+L +L R + +A I+ + YL ++
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 135
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
IH D+ +N L+ + +++DFGL++L+ + A G + + + APE +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFS 194
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722
+K DV++FGVLL E+ S G + + +L E D ++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRMERPE 239
Query: 723 KRVERLVMVALWCIQEDASLRP 744
E++ + C Q + S RP
Sbjct: 240 GCPEKVYELMRACWQWNPSDRP 261
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-54
Identities = 68/263 (25%), Positives = 109/263 (41%), Gaps = 28/263 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNL 541
+ LG+G FG VY SK +A+K L K + E + R EV + H N+
Sbjct: 10 IGRPLGKGKFGNVYLARE-KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
+RL G+ + L+ EY G++ L +++ D + +A L Y H S
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SK 125
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
++IH DIKP+N+LL +I+DFG + + + + GT+ Y PE
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGRMH 181
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
KVD++S GVL E + K F +E Y+ E ++
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKP--PFEANTYQE-----TYKRISRVEFTFPDFVTEGARDL 234
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
+ R ++ + S RP
Sbjct: 235 ISR----------LLKHNPSQRP 247
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-54
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 29/270 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLV 542
+G G++G K SD + + K+LD + + ++ +EV+++ + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 543 RLLGFC-DEGDHRL-LVYEYMSNGSLASFLFGITRP----DWNQRVQIAFGIARGLMYLH 596
R D + L +V EY G LAS + T+ D +++ + L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 597 E--ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
+ ++H D+KP N+ LD ++ DFGLA++L + GT Y +PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPE 184
Query: 655 WFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEN 714
+ S K D++S G LL EL F + +E K
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELAGKIRE--------GKFRRI 234
Query: 715 DEEVKNDLKRVERLVMVALWCIQEDASLRP 744
++L + + RP
Sbjct: 235 PYRYSDELNE------IITRMLNLKDYHRP 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 4e-54
Identities = 65/276 (23%), Positives = 99/276 (35%), Gaps = 39/276 (14%)
Query: 475 YKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE---KEFRTEVS 531
+ +L E +G G+FG VY + VAIKK+ +Q ++ EV
Sbjct: 17 FSDLRE--------IGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARG 591
+ + H N ++ G LV EY + + + G +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
L YLH +IH D+K NILL + ++ DFG A ++ + GT +
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWM 178
Query: 652 APEWFRKAS---ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNL 708
APE KVDV+S G+ +EL K N AL
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALY------------ 224
Query: 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+A+N+ E C+Q+ RP
Sbjct: 225 -HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-53
Identities = 69/262 (26%), Positives = 113/262 (43%), Gaps = 22/262 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRF---VAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLV 542
++LG GAFGTVYKG+ + ++ VAIK+L + + KE E V+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 543 RLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
RLLG C +L+ L + IA+G+ YL + +
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 131
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASIT 662
++H D+ +N+L+ +I+DFGLAKLL AE+ + G + + + A E T
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722
+ DV+S+GV + EL+ S G E + + E E +
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERLPQPP 236
Query: 723 KRVERLVMVALWCIQEDASLRP 744
+ M+ + C DA RP
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRP 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-53
Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF-VAIKKLDKV-EQQGEKEFRTEVSVIGQ-THHKNL 541
F+ ++G G FG V K + D R AIK++ + + ++F E+ V+ + HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFG----------------ITRPDWNQRVQIA 585
+ LLG C+ + L EY +G+L FL + Q + A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 586 FGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIR 645
+ARG+ YL Q IH D+ +NIL+ + + +I+DFGL++ ++ +T R
Sbjct: 134 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGR 187
Query: 646 GTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705
V + A E + T DV+S+GVLL E++ + G T E L + + + G
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ---G 242
Query: 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
L+K D+EV + + C +E RP
Sbjct: 243 YRLEKPLNCDDEVYD----------LMRQCWREKPYERP 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-53
Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 488 ILGRGAFGTVYKGVLASDS---KRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVR 543
++G G FG VYKG+L + S + VAIK L ++ +F E ++GQ H N++R
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQ 602
L G + +++ EYM NG+L FL Q V + GIA G+ YL
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--- 130
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA-ARTGIRGTVGYFAPEWFRKASI 661
+H D+ +NIL++ ++SDFGL+++L + +G + + + APE
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
T DV+SFG+++ E++ + +N E + K + +
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAINDGFRLPTP 235
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
+ + + + C Q++ + RP
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRP 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-52
Identities = 61/267 (22%), Positives = 105/267 (39%), Gaps = 25/267 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKR--FVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHK 539
+ LG G+FG V +G + S + VA+K L + + +F EV+ + H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEE 598
NL+RL G + +V E GSL L + A +A G+ YL +
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AARTGIRGTVGYFAPEWFR 657
IH D+ +N+LL +I DFGL + L + + + APE +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
+ + D + FGV L E+ G + ++ + + G+ L + + ++
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKE--GERLPRPEDCPQD 243
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
+ N V + C RP
Sbjct: 244 IYN----------VMVQCWAHKPEDRP 260
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 8e-52
Identities = 62/264 (23%), Positives = 105/264 (39%), Gaps = 24/264 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRF--VAIKKLDKVEQQGEKE-FRTEVSVIGQTHHKNL 541
+ +G G FG V++G+ S VAIK +E F E + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECS 600
V+L+G E + ++ E + G L SFL D + A+ ++ L YL +
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
+H DI +N+L+ ++ DFGL++ + + T + + + + APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 661 ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720
T DV+ FGV + E++ G N D + R G+ L + +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERLPMPPNCPPTLYS 240
Query: 721 DLKRVERLVMVALWCIQEDASLRP 744
+ C D S RP
Sbjct: 241 ----------LMTKCWAYDPSRRP 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 8e-51
Identities = 66/263 (25%), Positives = 109/263 (41%), Gaps = 24/263 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
F +ILG G+F TV + R AIK L+K +++ E V+ + H
Sbjct: 12 FGKILGEGSFSTVVLARELAT-SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
V+L + + Y NG L ++ I D I L YLH +
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
IIH D+KP+NILL++ +I+DFG AK+L E QA GT Y +PE + S
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
D+++ G ++ +L+ F N +++ I D + + ++
Sbjct: 188 CKSSDLWALGCIIYQLVAGLP--PFRAGNEYL-----IFQKIIKLEYDFPEKFFPKARDL 240
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
+++ + DA+ R
Sbjct: 241 VEK----------LLVLDATKRL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-49
Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 485 FRQILGRGAFGTVYKGVL----ASDSKRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHK 539
+ LG+G+FG VY+GV + + VAIK +++ + EF E SV+ + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 540 NLVRLLGFCDEGDHRLLVYEYMSNGSLASFLF----------GITRPDWNQRVQIAFGIA 589
++VRLLG +G L++ E M+ G L S+L + P ++ +Q+A IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 590 RGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
G+ YL+ + +H D+ +N ++ + FT +I DFG+ + + V
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709
+ +PE + T DV+SFGV+L E+ G +N + ++ +V + D
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVMEGGLLDKPD 258
Query: 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ L + C Q + +RP
Sbjct: 259 NCP-------------DMLFELMRMCWQYNPKMRP 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 2e-48
Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 23/263 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ LG GAFG V++ + A K + + ++ R E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQI 603
++ + +++YE+MS G L + ++ V+ + +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 604 IHCDIKPQNILLDDYFTPRI--SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+H D+KP+NI+ + + DFGL L + + GT + APE +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
D++S GVL L+ S FG N +E L + V C + + E+ K+
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRN-VKSCDWNMDDSAFSGISEDGKDF 259
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
+++ + D + R
Sbjct: 260 IRK----------LLLADPNTRM 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 2e-47
Identities = 59/269 (21%), Positives = 99/269 (36%), Gaps = 25/269 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+ILG G V+ R VA+K L + FR E +H +
Sbjct: 11 LGEILGFGGMSEVHLARDLRL-HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 542 VRLLGFC----DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHE 597
V + G +V EY+ +L + + +++ + L +
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS-- 127
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTG-IRGTVGYFAPEWF 656
IIH D+KP NI++ ++ DFG+A+ + +T + GT Y +PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716
R S+ + DVYS G +L E++ + F +P V I + E
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPI-----PPSARHE 239
Query: 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745
+ DL V L + ++ R Q
Sbjct: 240 GLSADLDA------VVLKALAKNPENRYQ 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 75/284 (26%), Positives = 113/284 (39%), Gaps = 42/284 (14%)
Query: 485 FRQILGRGAFGTVYKGVLASDSK------RFVAIKKLDK-VEQQGEKEFRTEVSVIGQ-T 536
+ LG GAFG V K VA+K L ++ + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 537 HHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP----------------DWNQ 580
HKN++ LLG C + ++ EY S G+L +L P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 581 RVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640
V A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 641 RTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY 700
T R V + APE T + DV+SFGVLL E+ S G P E L +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLK 251
Query: 701 RCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
G +DK + E+ + C S RP
Sbjct: 252 E---GHRMDKPSNCTNELYM----------MMRDCWHAVPSQRP 282
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (426), Expect = 6e-47
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 23/261 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+ LG GAFG V++ V + R K ++ + + E+S++ Q HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 547 FCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQIIH 605
++ +L+ E++S G L + + + GL ++HE I+H
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 606 CDIKPQNILLDDYFTPRI--SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITV 663
DIKP+NI+ + + DFGLA L ++ T + APE + +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207
Query: 664 KVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDLK 723
D+++ GVL L+ S F + E + V RC + D + E K+ +K
Sbjct: 208 YTDMWAIGVLGYVLLSGLS--PFAGEDDLE-TLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 724 RVERLVMVALWCIQEDASLRP 744
+Q++ R
Sbjct: 265 N----------LLQKEPRKRL 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 9e-47
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 20/273 (7%)
Query: 475 YKELEEATRGFR--QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQG-EKEFRTEVS 531
+K+ E+ + +LG GAF V +++ VAIK + K +G E E++
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAED-KRTQKLVAIKCIAKKALEGKEGSMENEIA 59
Query: 532 VIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARG 591
V+ + H N+V L + G H L+ + +S G L + ++ F +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 592 LMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYF 651
+ YLH+ LD+ ISDFGL+K+ E + + GT GY
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 176
Query: 652 APEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711
APE + + VD +S GV+ L+C F N + L + + + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAK-LFEQILKAEYEFDSPYW 233
Query: 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ + K+ ++ +++D R
Sbjct: 234 DDISDSAKDFIRH----------LMEKDPEKRF 256
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 40/283 (14%)
Query: 485 FRQILGRGAFGTVYKGVLASDSK----RFVAIKKLDKVEQQGE-KEFRTEVSVIGQT-HH 538
+ LGRGAFG V + K R VA+K L + E + +E+ ++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 539 KNLVRLLGFC-DEGDHRLLVYEYMSNGSLASFLFGITRP----------------DWNQR 581
N+V LLG C G +++ E+ G+L+++L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 582 VQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641
+ +F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYR 701
R + + APE T++ DV+SFGVLL E+ +S + +E +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-PYPGVKIDEEFCRRLKE 252
Query: 702 CYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
G + E+ L C + S RP
Sbjct: 253 ---GTRMRAPDYTTPEMYQ----------TMLDCWHGEPSQRP 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 2e-46
Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 29/267 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEV---SVIGQTHH 538
+I+GRG FG VY +D+ + A+K LDK +QGE E S++
Sbjct: 8 VHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
+V + D + + M+ G L L A I GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
+++ D+KP NILLD++ RISD GLA ++ GT GY APE +K
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQK 179
Query: 659 A-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
+ D +S G +L +L+ F ++ + R + ++ E
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKD--KHEIDRMTLTMAVELPDSFSPE 235
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
+++ L+ +Q D + R
Sbjct: 236 LRSLLEG----------LLQRDVNRRL 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 65/265 (24%), Positives = 106/265 (40%), Gaps = 27/265 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQT-HHKN 540
++LG+G+FG V+ + +F AIK L K + + E V+ H
Sbjct: 6 LHKMLGKGSFGKVFLAEF-KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
L + ++ V EY++ G L + + D ++ A I GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 601 TQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS 660
I++ D+K NILLD +I+DFG+ K + + GT Y APE
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQK 179
Query: 661 ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720
VD +SFGVLL E++ +S F + EE ++ N ++E K+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQS--PFHGQDEEE-----LFHSIRMDNPFYPRWLEKEAKD 232
Query: 721 DLKRVERLVMVALWCIQEDASLRPQ 745
L + + R
Sbjct: 233 LLVK----------LFVREPEKRLG 247
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-45
Identities = 56/272 (20%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 476 KELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ 535
KEL E + LGRG FG V++ V + SK+ K + KV+ + + E+S++
Sbjct: 1 KELYEKYM-IAEDLGRGEFGIVHRCVE-TSSKKTYMAKFV-KVKGTDQVLVKKEISILNI 57
Query: 536 THHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMY 594
H+N++ L + + ++++E++S + + + + V + L +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 595 LHEECSTQIIHCDIKPQNILLD--DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
LH S I H DI+P+NI+ T +I +FG A+ L + Y+A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171
Query: 653 PEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712
PE + ++ D++S G L+ L+ + F ++ +++ + + +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQ-IIENIMNAEYTFDEEAFK 228
Query: 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
E E + + R + ++ R
Sbjct: 229 EISIEAMDFVDR----------LLVKERKSRM 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 3e-43
Identities = 56/276 (20%), Positives = 103/276 (37%), Gaps = 36/276 (13%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---------QQGEKEFRTEVSVIGQ 535
++ILGRG V + + + + A+K +D Q+ + EV ++ +
Sbjct: 7 PKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 536 TH-HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMY 594
H N+++L + LV++ M G L +L + +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 595 LHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE 654
LH I+H D+KP+NILLDD +++DFG + L + GT Y APE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPE 179
Query: 655 WFR------KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNL 708
+VD++S GV++ L+ F ++ +
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQML-MLRMIMSGNYQFGS 236
Query: 709 DKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ + + VK+ + R + R
Sbjct: 237 PEWDDYSDTVKDLVSR----------FLVVQPQKRY 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 2e-42
Identities = 68/264 (25%), Positives = 108/264 (40%), Gaps = 29/264 (10%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+ LG G+FG V+ + R+ A+K L K V + + E ++ H +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
+R+ G + ++ +Y+ G L S L R A + L YLH +
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
II+ D+KP+NILLD +I+DFG AK + + GT Y APE
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
+D +SFG+L+ E++ + F +N + Y + L +E+VK+
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP--FYDSNTMK-----TYEKILNAELRFPPFFNEDVKDL 231
Query: 722 LKRVERLVMVALWCIQEDASLRPQ 745
L R I D S R
Sbjct: 232 LSR----------LITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK-----VEQQGEKEFRTEVSVIGQTHHKNL 541
LG G F TVYK ++ + VAIKK+ + + E+ ++ + H N+
Sbjct: 4 DFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
+ LL + LV+++M + +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFRKAS 660
I+H D+KP N+LLD+ +++DFGLAK A T T Y APE F
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 661 ITVKVDVYSFGVLLLELIC 679
V VD+++ G +L EL+
Sbjct: 178 YGVGVDMWAVGCILAELLL 196
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 37/272 (13%)
Query: 486 RQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVRL 544
Q+LG G G V + ++ A+K L + R EV + + + ++VR+
Sbjct: 17 SQVLGLGINGKVLQIFN-KRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRI 70
Query: 545 LGFCD----EGDHRLLVYEYMSNGSLASFL--FGITRPDWNQRVQIAFGIARGLMYLHEE 598
+ + L+V E + G L S + G + +I I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 599 CSTQIIHCDIKPQNILLDDYFTP---RISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
S I H D+KP+N+L +++DFG AK + + T T Y APE
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEV 184
Query: 656 FRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN---LDKLA 712
D++S GV++ L+C F + + R +G+ + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
E EEVK ++ ++ + + R
Sbjct: 243 EVSEEVKMLIRN----------LLKTEPTQRM 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-40
Identities = 61/268 (22%), Positives = 101/268 (37%), Gaps = 30/268 (11%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE------KEFRTEVSVIGQTHHKN 540
+ LG G F V K S A K + K + ++ EVS++ + H N
Sbjct: 16 EELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 541 LVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECS 600
++ L + +L+ E ++ G L FL + + I G+ YLH
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ- 133
Query: 601 TQIIHCDIKPQNILLDDYFTPR----ISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
I H D+KP+NI+L D P+ I DFGLA + I GT + APE
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 188
Query: 657 RKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716
+ ++ D++S GV+ L+ F +E + V + +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQE-TLANVSAVNYEFEDEYFSNTSA 245
Query: 717 EVKNDLKRVERLVMVALWCIQEDASLRP 744
K+ ++R + +D R
Sbjct: 246 LAKDFIRR----------LLVKDPKKRM 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 7e-40
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 12/261 (4%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE-KEFRTEVSVIGQTHHKNLVRLL 545
+G GA+G V + K VAIKK+ E Q + E+ ++ + H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVN-KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 546 GFCDEGDHRLLVYEYMSNGSLASFLFGI---TRPDWNQRVQIAFGIARGLMYLHEECSTQ 602
+ Y+ + + L+ + + + I RGL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---N 129
Query: 603 IIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR-TGIRGTVGYFAPEWF-RKAS 660
++H D+KP N+LL+ +I DFGLA++ + T T Y APE
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 661 ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720
T +D++S G +L E++ + +F + + L + D + + +N
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRP--IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 721 DLKRVERLVMVALWCIQEDAS 741
L + V + +A
Sbjct: 248 YLLSLPHKNKVPWNRLFPNAD 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 2e-39
Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 24/267 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+ +G G+FG +Y G + VAIK + + E + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAA-GEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 547 FC-DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIH 605
+C EGD+ ++V E + F F + + +A + + Y+H + IH
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 606 CDIKPQNIL---LDDYFTPRISDFGLAKLLLAEQTQA-----ARTGIRGTVGYFAPEWFR 657
D+KP N L I DFGLAK +T + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 658 KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717
+ + D+ S G +L+ G+ + + Y + K++ E
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNL-------GSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 718 VKNDLKRVERLVMVALWCIQEDASLRP 744
+ +C +P
Sbjct: 240 LCKGYP--SEFATYLNFCRSLRFDDKP 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 19/207 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK------VEQQGEKEFRTEVSVIGQ--THH 538
+LG G FG+VY G+ SD VAIK ++K E EV ++ + +
Sbjct: 10 PLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 539 KNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHE 597
++RLL + + D +L+ E + + + + H
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 598 ECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWF 656
++H DIK +NIL+D + ++ DFG LL T GT Y PEW
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 657 R-KASITVKVDVYSFGVLLLELICCKS 682
R V+S G+LL +++C
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 457 KLLRSVSSPSATNVRS--FTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKK 514
K+ V++P R +Y + + ++G G+FG VY+ L DS VAIKK
Sbjct: 2 KVTTVVATPGQGPDRPQEVSYTDTK--------VIGNGSFGVVYQAKL-CDSGELVAIKK 52
Query: 515 LDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------HRLLVYEYMSNGSLAS 568
+ + ++ E+ ++ + H N+VRL F + LV +Y+
Sbjct: 53 VLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 569 FLFGITRP---DWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRIS 624
+ + R L Y+H S I H DIKPQN+LLD D ++
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC 165
Query: 625 DFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSV 684
DFG AK L + + + I F T +DV+S G +L EL+ +
Sbjct: 166 DFGSAKQL--VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP-- 221
Query: 685 VFGTTNPEEALMDWV 699
+F + + L++ +
Sbjct: 222 IFPGDSGVDQLVEII 236
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSV---IGQTHHKNL 541
+G GA+G V+K + RFVA+K++ E+ EV+V + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 542 VRLLGFC-----DEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYL 595
VRL C D LV+E++ + F + RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 596 HEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEW 655
H ++H D+KPQNIL+ +++DFGLA++ Q A T + T+ Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 186
Query: 656 FRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL------------MDWVYRCY 703
++S VD++S G + E+ K +F ++ + L DW
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKP--LFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRP 744
+ + K E + L C+ + + R
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 26/263 (9%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNL 541
+ ++LG+G FG V + R+ A+K L K + + TE V+ T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 542 VRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
L D V EY + G L L + I L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASI 661
+++ DIK +N++LD +I+DFGL K +++ GT Y APE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 182
Query: 662 TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721
VD + GV++ E++C + F + E ++ + + + E K+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRL--PFYNQDHER-----LFELILMEEIRFPRTLSPEAKSL 235
Query: 722 LKRVERLVMVALWCIQEDASLRP 744
L +++D R
Sbjct: 236 LAG----------LLKKDPKQRL 248
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 8e-38
Identities = 41/256 (16%), Positives = 85/256 (33%), Gaps = 18/256 (7%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
+ +G G+FG +++G + + VAIK + + + R E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 544 LLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQI 603
+ F EG H +LV + + + A + + +HE+ +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 604 IHCDIKPQNILLDDYFTP-----RISDFGLAKLLLAEQTQA-----ARTGIRGTVGYFAP 653
++ DIKP N L+ + + DFG+ K T+ + + GT Y +
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 654 EWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713
+ + D+ + G + + + + + + L +L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 714 N-DEEVKNDLKRVERL 728
EE + L
Sbjct: 243 GFPEEFYKYMHYARNL 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 6e-37
Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 10/212 (4%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G G +G VYK + A+KK+ +K ++ E+S++ + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQII 604
+LV+E++ + + G+ Y H+ ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H D+KPQN+L++ +I+DFGLA+ + I +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696
+D++S G + E++ +F + + LM
Sbjct: 182 IDIWSVGCIFAEMVNGTP--LFPGVSEADQLM 211
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 7e-37
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 22/249 (8%)
Query: 458 LLRSVSSPSATNVRSFTYKELEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK 517
L+ +PS + + ++ LG G+FG V +S A+K LDK
Sbjct: 26 FLKKWETPSQNTAQLDQFDRIKT--------LGTGSFGRVMLVKH-KESGNHYAMKILDK 76
Query: 518 ---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGIT 574
V+ + + E ++ + LV+L + + +V EY++ G + S L I
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 575 RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634
R A I YLH +I+ D+KP+N+L+D +++DFG AK
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK---- 189
Query: 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEA 694
+ + + GT APE VD ++ GVL+ E+ F P +
Sbjct: 190 -RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP--PFFADQPIQI 246
Query: 695 LMDWVYRCY 703
V
Sbjct: 247 YEKIVSGKV 255
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 8e-37
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 12/214 (5%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G G +G VYK VA+KK+ D + E+S++ + +H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRP-DWNQRVQIAFGIARGLMYLHEECSTQI 603
L + LV+E++ F + +GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 604 IHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKAS-IT 662
+H D+KPQN+L++ +++DFGLA+ T T+ Y APE +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 663 VKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696
VD++S G + E++ ++ +F + + L
Sbjct: 182 TAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLF 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-35
Identities = 41/222 (18%), Positives = 87/222 (39%), Gaps = 19/222 (8%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+G+G FG V+K + VA+KK+ ++ E+ ++ H+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 545 LGFCDEGDHR--------LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLH 596
+ C LV+++ + + + ++ ++ + GL Y+
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI- 133
Query: 597 EECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT--QAARTGIRGTVGYFAPE 654
+I+H D+K N+L+ +++DFGLA+ + T T+ Y PE
Sbjct: 134 --HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 655 WFR-KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEAL 695
+ +D++ G ++ E+ + + L
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRS--PIMQGNTEQHQL 231
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 44/208 (21%), Positives = 85/208 (40%), Gaps = 7/208 (3%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKL--DKVEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G G +GTV+K ++ VA+K++ D ++ E+ ++ + HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 545 LGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQII 604
LV+E+ F D F + +GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 605 HCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVK 664
H D+KPQN+L++ ++++FGLA+ + + F +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 665 VDVYSFGVLLLELICCKSSVVFGTTNPE 692
+D++S G + EL + G +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 485 FRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKV----EQQGEKEFRTEVSVIGQ-TH 537
++LG GA+G V+ S D+ + A+K L K + + + RTE V+
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 538 HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHE 597
LV L L+ +Y++ G L + L R ++ I L +LH+
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 598 ECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFR 657
II+ DIK +NILLD ++DFGL+K +A++T+ A GT+ Y AP+ R
Sbjct: 148 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVR 203
Query: 658 --KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715
+ VD +S GVL+ EL+ S F + + + + R + E
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGAS--PFTVDGEKNSQAE-ISRRILKSEPPYPQEMS 260
Query: 716 EEVKNDLKRVERLVMVALWCIQEDASLRP 744
K+ ++R + +D R
Sbjct: 261 ALAKDLIQR----------LLMKDPKKRL 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 28/284 (9%)
Query: 473 FTYKELEEATRGFR------QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEK 524
F +E+ + R Q +G GA+G V V + VAIKKL + + K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAK 62
Query: 525 EFRTEVSVIGQTHHKNLVRLLGFCDEGDHR------LLVYEYMSNGSLASFLFGITRPDW 578
E+ ++ H+N++ LL + LV +M G+ L +
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
++ + + + +GL Y+H IIH D+KP N+ +++ +I DFGLA+ Q
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QAD 172
Query: 639 AARTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMD 697
+ TG T Y APE T VD++S G ++ E+I K+ +F ++ + L +
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT--LFKGSDHLDQLKE 230
Query: 698 WVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDAS 741
+ +E KN +K + L I +AS
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 9e-32
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 20/218 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK--VEQQGEKEFRTEVSVIGQTHHKNLVRL 544
+ +G GA G V A R VAIKKL + Q K E+ ++ +HKN++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 545 LGFC------DEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE 598
L +E LV E M D + + + + G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 599 CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRK 658
IIH D+KP NI++ T +I DFGLA+ T T T Y APE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 659 ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696
VD++S G ++ E++ K ++F + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK--ILFPGRDYIDQWN 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 45/217 (20%), Positives = 89/217 (41%), Gaps = 18/217 (8%)
Query: 485 FRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQ-THHKNLVR 543
+ LGRG + V++ + ++ V +K L V+ +K+ + E+ ++ N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITN-NEKVVVKILKPVK---KKKIKREIKILENLRGGPNIIT 94
Query: 544 LLGFCDEGDHRL--LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECST 601
L + R LV+E+++N + I + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 602 QIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPE-WFRKA 659
I+H D+KP N+++D ++ R+ D+GLA+ Q + + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQ 205
Query: 660 SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696
+D++S G +L +I K G N ++ +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 472 SFTYKELEEATRGFR------QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGE-- 523
+F +EL + +G GA+G+V + + VA+KKL + Q
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHA 61
Query: 524 KEFRTEVSVIGQTHHKNLVRLLGFCDEGD-----HRLLVYEYMSNGSLASFLFGITRPDW 578
K E+ ++ H+N++ LL + + + ++ L + + +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTD 120
Query: 579 NQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638
+ + + I RGL Y+H IIH D+KP N+ +++ +I DFGLA+ T
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTD 172
Query: 639 AARTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCK 681
TG T Y APE VD++S G ++ EL+ +
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 44/212 (20%), Positives = 75/212 (35%), Gaps = 21/212 (9%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLG 546
+ LG G F TV+ + VA+K + ++ + E+ ++ + + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVN-NTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 547 FCDEGDHRLLVY----------------EYMSNGSLASFLFGITRPDWNQRVQIAFGIAR 590
+LL + N + QI+ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 591 GLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVG 649
GL Y+H C IIH DIKP+N+L++ + +A L A T T
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 650 YFAPEWFRKASITVKVDVYSFGVLLLELICCK 681
Y +PE A D++S L+ ELI
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 27/204 (13%), Positives = 60/204 (29%), Gaps = 32/204 (15%)
Query: 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDK----------VEQQGEKEFRTEVSVIGQT 536
+++G G V+ +K G+ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKF--GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 537 HHKNLVRLLGFCD----EGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGL 592
+ L +L G + ++ E + + R ++ I +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEEV 116
Query: 593 MYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFA 652
+ I+H D+ N+L+ + I DF + + E R + V
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEG---WREILERDVRNII 169
Query: 653 PEWFRKASITVKVDVYSFGVLLLE 676
+F + + + D+ S +L+
Sbjct: 170 -TYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 71.5 bits (175), Expect = 1e-15
Identities = 20/143 (13%), Positives = 40/143 (27%), Gaps = 37/143 (25%)
Query: 46 IWFDKIPEKTIVWSANGDDPAPRGS-QVKLTNSGELVLYDPQGHELWQKPKDGSKSSWAT 104
I + + + ++ + LVL+D A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 105 MQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKE 164
+Q +G +L + +W S ++ S GR+ F+L+
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQP 106
Query: 165 NGNLELSSVSLTTQVVYD-VYWS 186
+ NL +Y W+
Sbjct: 107 DRNL----------AIYGGALWT 119
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.4 bits (128), Expect = 3e-09
Identities = 22/152 (14%), Positives = 41/152 (26%), Gaps = 37/152 (24%)
Query: 103 ATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLL 162
+ ++GN +L N TL Q L +R +
Sbjct: 3 VVVANNGNSILYSTQGN------DNHPQTLHATQSLQ---------------LSPYRLSM 41
Query: 163 KENGNLELSSVSLTTQVVYD---VYWSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLT 219
+ + NL V++D WS N+ + + G + + +
Sbjct: 42 ETDCNL----------VLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTS 91
Query: 220 KIGTRSMQDFYIMARIDYDGVFRQYTHPKYET 251
G Y + + D Y + T
Sbjct: 92 --GNSRSAGRY-VFVLQPDRNLAIYGGALWTT 120
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 70.0 bits (171), Expect = 4e-15
Identities = 25/101 (24%), Positives = 43/101 (42%), Gaps = 13/101 (12%)
Query: 26 SGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDP 85
+ F Q+ L ++ T VW++N +G + L + G V+YD
Sbjct: 18 VEPYHFIM-----QEDCNLVLY----DHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA 68
Query: 86 QGHELWQ-KPKDGSKSSWATMQDDGNFVLLGGDSNPIWESF 125
+G LW G+ + +Q+DGN V+ G + IW +
Sbjct: 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---SDIWSTG 106
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.7 bits (160), Expect = 1e-13
Identities = 23/143 (16%), Positives = 41/143 (28%), Gaps = 38/143 (26%)
Query: 46 IWFDKIPEKTIVWSANGDDPAPRGS-QVKLTNSGELVLYDPQGHELWQKPKDGSKSSWAT 104
I F E + + + S + + + LVL+D +W G+ A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAV 61
Query: 105 MQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKE 164
+Q DG V+L + W S S G + +L+
Sbjct: 62 LQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQP 96
Query: 165 NGNLELSSVSLTTQVVYD-VYWS 186
+ + +Y W
Sbjct: 97 DRTV----------TIYGPGLWD 109
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 62.9 bits (152), Expect = 9e-13
Identities = 21/105 (20%), Positives = 40/105 (38%), Gaps = 10/105 (9%)
Query: 26 SGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDP 85
G + F + D V ++ + VW++ + A G +K+ N G LV+Y
Sbjct: 18 EGGYLFIIQN-DCNLV----LYDNNRA----VWASGTNGKA-SGCVLKMQNDGNLVIYSG 67
Query: 86 QGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTD 130
+ + + +Q D N V+ +N IW + +
Sbjct: 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 45.9 bits (108), Expect = 9e-07
Identities = 18/120 (15%), Positives = 39/120 (32%), Gaps = 20/120 (16%)
Query: 129 TDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWN 188
+D L G L++ ++ G + F+++ + NL L W+
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYD-------NNRAVWASG 44
Query: 189 SEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTHPK 248
+ + L G + I G++ I+ + Q+ + D Y +
Sbjct: 45 TNGKASGCVLKMQNDGNLVIYSGSRAIWA----SNTNRQNGNYYLILQRDRNVVIYDNSN 100
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.2 bits (135), Expect = 3e-10
Identities = 16/133 (12%), Positives = 39/133 (29%), Gaps = 27/133 (20%)
Query: 122 WESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVY 181
+ L + L + T +RF+++ + NL V+Y
Sbjct: 7 KQPDDNHPQILHATESLEI-----------LFGTHVYRFIMQTDCNL----------VLY 45
Query: 182 D---VYWSWNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYD 238
D W+ N+ + + G + + + + ++ + + + D
Sbjct: 46 DNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAG---HYVLVLQPD 102
Query: 239 GVFRQYTHPKYET 251
Y + T
Sbjct: 103 RNVVIYGDALWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.3 bits (130), Expect = 1e-09
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 5/72 (6%)
Query: 54 KTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGSKSSW-ATMQDDGNFV 112
+W+ N G + L G LV+ + +WQ P G + +Q D N V
Sbjct: 48 NNPIWATNTGGL-GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 113 LLGGDSNPIWES 124
+ G + +W +
Sbjct: 107 IYG---DALWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.1 bits (101), Expect = 1e-05
Identities = 17/117 (14%), Positives = 34/117 (29%), Gaps = 36/117 (30%)
Query: 74 LTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLL 133
+ LVLYD A +Q DG V++ ++ +W
Sbjct: 36 MQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVW----------- 84
Query: 134 PGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD-VYWSWNS 189
++ G + +L+ + N+ V+Y W+ +
Sbjct: 85 --------------QSPVAGKAGHYVLVLQPDRNV----------VIYGDALWATQT 117
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 48.9 bits (116), Expect = 8e-08
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 14/101 (13%)
Query: 26 SGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDP 85
G F F N L ++ P W+ N + R + + G LV+Y+P
Sbjct: 18 YGSFVFIMQEDCN-----LVLYDVDKPI----WATNTGGLS-RSCFLSMQTDGNLVVYNP 67
Query: 86 QGHELWQKPKDGSKSSW-ATMQDDGNFVLLGGDSNPIWESF 125
+W G ++ +Q D N V+ G W +
Sbjct: 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYG---TDRWATG 105
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 42.3 bits (99), Expect = 2e-05
Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 25/125 (20%)
Query: 130 DTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD---VYWS 186
+ L G+ L++ + G F F+++E+ NL V+YD W+
Sbjct: 2 NILYSGETLST---------GEFLNYGSFVFIMQEDCNL----------VLYDVDKPIWA 42
Query: 187 WNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYTH 246
N+ + L G + + + + + G ++ + + D Y
Sbjct: 43 TNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNG---NYVCILQKDRNVVIYGT 99
Query: 247 PKYET 251
++ T
Sbjct: 100 DRWAT 104
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 36.9 bits (85), Expect = 0.001
Identities = 23/117 (19%), Positives = 38/117 (32%), Gaps = 36/117 (30%)
Query: 74 LTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLL 133
+ LVLYD S+S + +MQ DGN V+ + PIW S
Sbjct: 25 MQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS--------- 75
Query: 134 PGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYD-VYWSWNS 189
G + +L+++ N+ V+Y W+ +
Sbjct: 76 ----------------NTGGQNGNYVCILQKDRNV----------VIYGTDRWATGT 106
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.82 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.72 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.55 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.29 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.97 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.94 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.94 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.91 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.48 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.04 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 91.18 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 90.52 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.0 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.72 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 88.7 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.33 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.19 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 86.31 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.85 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 83.66 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.33 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 82.26 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 81.84 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 81.08 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=389.26 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=198.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
|++.+.||+|+||+||+|+... +++.||||++.... .+..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 5677899999999999999865 45679999986432 334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+.........
T Consensus 86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999998888899999999999999999999965 9999999999999999999999999999987655444435
Q ss_pred ccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
....||+.|||||++.+..+ +.++|||||||+||||+||+.||......... ... ........ .+
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~-----~~~~~~~~--~~------ 228 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-----WKEKKTYL--NP------ 228 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH-----HHTTCTTS--TT------
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH-----HhcCCCCC--Cc------
Confidence 56789999999999988876 57899999999999999999999654332211 111 11111110 00
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcC
Confidence 1111245778999999999999997
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=379.24 Aligned_cols=238 Identities=29% Similarity=0.398 Sum_probs=199.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccc---ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDK---VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
|.+.+.||+|+||+||+|+... +++.||+|++.. ......+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECC-CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 6678899999999999999865 467899999864 234456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 999999999998888899999999999999999999965 99999999999999999999999999998764332
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.... ..+ + .+.+.......
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~-~----~~~i~~~~~~~--------- 223 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQE-T----YKRISRVEFTF--------- 223 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHH-H----HHHHHTTCCCC---------
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--HHH-H----HHHHHcCCCCC---------
Confidence 334579999999999999999999999999999999999999985321 111 1 12222222111
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+....+.+.+++.+||+.||++|||
T Consensus 224 -p~~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 224 -PDFVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred -CccCCHHHHHHHHHHccCCHhHCcC
Confidence 0012345788999999999999997
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=380.77 Aligned_cols=242 Identities=28% Similarity=0.376 Sum_probs=199.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
|.+.+.||+|+||+||+|+... +++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTT-TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 5667889999999999999765 457899999976666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccccc
Q 040134 563 NGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAART 642 (745)
Q Consensus 563 ~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 642 (745)
+|+|.+++.. ..+++.++..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~ 174 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RS 174 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--cc
Confidence 9999998765 5689999999999999999999965 9999999999999999999999999999877543322 34
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccccH
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKNDL 722 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (745)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.... ....+. .....+... +. ...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~----~~~~~~~~~-~~-------~~~ 240 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALY----LIATNGTPE-LQ-------NPE 240 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHH----HHHHHCSCC-CS-------SGG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--HHHHHH----HHHhCCCCC-CC-------Ccc
Confidence 5679999999999999999999999999999999999999985322 122221 111111111 10 111
Q ss_pred HHHHHHHHHHHhccccCcCCCCC
Q 040134 723 KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 723 ~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s 263 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGS 263 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCC
T ss_pred cCCHHHHHHHHHHccCChhHCcC
Confidence 22356889999999999999997
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=390.28 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=193.9
Q ss_pred cCccCHHHHHHHHhcc-----------hhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHHhc
Q 040134 470 VRSFTYKELEEATRGF-----------RQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQ 535 (745)
Q Consensus 470 ~~~~~~~~l~~~~~~~-----------~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~ 535 (745)
+..++|+++.+++.+| .++||+|+||+||+|++...+ ...||||.+... .....+.|.+|++++++
T Consensus 4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 83 (299)
T d1jpaa_ 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83 (299)
T ss_dssp CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT
T ss_pred cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence 4556777777777665 357999999999999986433 346899998643 34445789999999999
Q ss_pred cCCCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 040134 536 THHKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNIL 614 (745)
Q Consensus 536 l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIl 614 (745)
++||||++++|++.+++..++||||+++|+|.+++... ..+++.+++.++.||++||+|||+. +|+||||||+|||
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 99999999999999999999999999999999988764 5689999999999999999999965 9999999999999
Q ss_pred ECCCCceEEeeccCccccccccccc---ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 040134 615 LDDYFTPRISDFGLAKLLLAEQTQA---ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTN 690 (745)
Q Consensus 615 l~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~ 690 (745)
|+.++.+||+|||+++.+....... ......+|+.|||||.+.+..++.++|||||||+||||+| |+.||.....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999998775443322 1223457899999999999999999999999999999998 7888853221
Q ss_pred chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 691 PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+... +..+.... ...+....+.+|+.+||+.||++|||
T Consensus 240 --~~~~~~----i~~~~~~~---------~~~~~~~~l~~li~~cl~~~P~~RPs 279 (299)
T d1jpaa_ 240 --QDVINA----IEQDYRLP---------PPMDCPSALHQLMLDCWQKDRNHRPK 279 (299)
T ss_dssp --HHHHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred --HHHHHH----HHcCCCCC---------CCccchHHHHHHHHHHcCCCHhHCcC
Confidence 122222 22211111 11123456889999999999999997
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=381.94 Aligned_cols=242 Identities=28% Similarity=0.354 Sum_probs=198.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
|.+.+.||+|+||+||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 6788999999999999999865 4567999998642 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|+|.+++...+.+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999998888999999999999999999999965 99999999999999999999999999998876544433
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
......||+.|+|||++.+..++.++|||||||+||||++|+.||... +. ..+ .+.+..+.... .
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~-~~~----~~~i~~~~~~~--p------ 230 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NE-YLI----FQKIIKLEYDF--P------ 230 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SH-HHH----HHHHHTTCCCC--C------
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--CH-HHH----HHHHHcCCCCC--C------
Confidence 344567999999999999999999999999999999999999998632 11 111 12222222211 0
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++|||
T Consensus 231 --~~~s~~~~~li~~~L~~dP~~R~t 254 (288)
T d1uu3a_ 231 --EKFFPKARDLVEKLLVLDATKRLG 254 (288)
T ss_dssp --TTCCHHHHHHHHTTSCSSGGGSTT
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcC
Confidence 012345789999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=374.06 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=192.1
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec----CCeEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE----GDHRLLV 557 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv 557 (745)
+|.++||+|+||+||+|+... +++.||+|++... .....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~-~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 566789999999999999865 4567999998643 33345679999999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD-DYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++|+|.+++.....+++.++..++.||+.||+|||++ ..+|+||||||+|||++ +++.+||+|||+++......
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 99999999999998888899999999999999999999965 23399999999999996 57899999999997643322
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
.....||+.|||||++.+ .++.++|||||||++|||++|+.||..... ... +.+.+..+......+.
T Consensus 170 ----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~----~~~~i~~~~~~~~~~~-- 236 (270)
T d1t4ha_ 170 ----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPASFDK-- 236 (270)
T ss_dssp ----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGGGGG--
T ss_pred ----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHH----HHHHHHcCCCCcccCc--
Confidence 334679999999999865 599999999999999999999999853321 221 2222222222111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....++.+|+.+||+.||++|||
T Consensus 237 ------~~~~~~~~li~~~l~~dp~~R~s 259 (270)
T d1t4ha_ 237 ------VAIPEVKEIIEGCIRQNKDERYS 259 (270)
T ss_dssp ------CCCHHHHHHHHHHSCSSGGGSCC
T ss_pred ------cCCHHHHHHHHHHccCCHhHCcC
Confidence 11235788999999999999997
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-46 Score=387.10 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=201.3
Q ss_pred HHHHHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 478 LEEATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 478 l~~~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
+....+.+.+.||+|+||+||+|++.. +++.||||+++.. ....++|.+|++++++++||||+++++++.+++..++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGG-GTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECC-CCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344456778899999999999999865 4578999998653 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 558 YEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999998643 6789999999999999999999965 9999999999999999999999999999876544
Q ss_pred ccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.... .....|++.|+|||.+.+..++.++|||||||++|||++|+.|+..... ...+. +.+..+....
T Consensus 169 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~----~~i~~~~~~~----- 236 (287)
T d1opja_ 169 TYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY----ELLEKDYRME----- 236 (287)
T ss_dssp SSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH----HHHHTTCCCC-----
T ss_pred Ccee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH----HHHhcCCCCC-----
Confidence 3322 3345688999999999999999999999999999999998887754332 12222 2222221111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......++.+|+.+||+.||++|||
T Consensus 237 ----~~~~~~~~l~~li~~cl~~dP~~Rps 262 (287)
T d1opja_ 237 ----RPEGCPEKVYELMRACWQWNPSDRPS 262 (287)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----CCccchHHHHHHHHHHcCCCHhHCcC
Confidence 11122356889999999999999997
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=378.09 Aligned_cols=244 Identities=30% Similarity=0.450 Sum_probs=188.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
+.+.+.||+|+||+||+|+... .||||+++.. .....+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS----EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEeeCCCcEEEEEEECC----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 4567899999999999998642 3999998643 34456789999999999999999999998765 568999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+++|+|.+++... ..+++..++.++.||++||+|||+. +||||||||+|||++.++.+||+|||+++.........
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999754 6689999999999999999999965 99999999999999999999999999998775544433
Q ss_pred ccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
......||+.|||||++.. ..++.++|||||||+||||+||+.||..... ...+...+.+......+..
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~~~------ 233 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLSK------ 233 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCGGG------
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcchh------
Confidence 3455679999999999864 3579999999999999999999999864322 2222222222211111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+.+++.+||+.||++|||
T Consensus 234 ---~~~~~~~~l~~li~~cl~~dp~~RPt 259 (276)
T d1uwha_ 234 ---VRSNCPKAMKRLMAECLKKKRDERPL 259 (276)
T ss_dssp ---SCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---ccccchHHHHHHHHHHcCCCHhHCcC
Confidence 11122356889999999999999997
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=380.35 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=198.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
|++.+.||+|+||+||+|+... +++.||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEeEEEeeCCCcEEEEEEECC-CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 5667889999999999999765 457799999977666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+|+|.+++.+ ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~~ 167 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RR 167 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--HH
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--cc
Confidence 9999999764 46789999999999999999999965 999999999999999999999999999976543322 13
Q ss_pred ccccccccccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 642 TGIRGTVGYFAPEWFR-----KASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
....||+.|+|||++. +..++.++|||||||++|||+||+.||.... ..+.+.. +..+....+..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~~~~~~-----i~~~~~~~~~~--- 237 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLK-----IAKSEPPTLAQ--- 237 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHH-----HHHSCCCCCSS---
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHH-----HHcCCCCCCCc---
Confidence 3467999999999984 4568999999999999999999999985432 2222211 11122111111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 238 ----~~~~s~~~~~li~~~L~~dp~~R~t 262 (288)
T d2jfla1 238 ----PSRWSSNFKDFLKKCLEKNVDARWT 262 (288)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ----cccCCHHHHHHHHHHccCChhHCcC
Confidence 1122356889999999999999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=392.39 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=178.0
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
..|.+.+.||+|+||+||+|+... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.++.++|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETT-TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456677899999999999999765 5678999998653 33335688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|+|.+++.+...+++..+..++.||+.||.|||+. .+|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 999999999998888899999999999999999999963 289999999999999999999999999998764332
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3346799999999999999999999999999999999999999975443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=376.42 Aligned_cols=241 Identities=27% Similarity=0.407 Sum_probs=185.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.+.+.||+|+||+||+|++.. ++.||||+++. .....++|.+|++++++++||||++++|++.+++..++||||++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLN--KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETT--TEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred cEEEEEEeeCCCeEEEEEEECC--CCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4567899999999999999864 45699999975 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......... .
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-S 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee-e
Confidence 99999998755 5678999999999999999999965 99999999999999999999999999998765443322 3
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
....||+.|+|||.+.+..++.++|||||||++|||+|+..|+..... ...+...+.. +... ..+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~----~~~~--~~p------- 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDIST----GFRL--YKP------- 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHH----TCCC--CCC-------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHh----cCCC--CCc-------
Confidence 345789999999999999999999999999999999997665543222 2222222222 1111 111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....++.+++.+||+.||++|||
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps 248 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPA 248 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cccCHHHHHHHHHHccCCHhHCcC
Confidence 112346889999999999999997
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=374.12 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=185.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec--CCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--GDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 558 (745)
|++.+.||+|+||+||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++.+ .+..++||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 6678899999999999999765 4567999998643 33345678999999999999999999999864 45689999
Q ss_pred EecCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCceEEeeccCcccc
Q 040134 559 EYMSNGSLASFLFG----ITRPDWNQRVQIAFGIARGLMYLHEEC--STQIIHCDIKPQNILLDDYFTPRISDFGLAKLL 632 (745)
Q Consensus 559 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~ 632 (745)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999999853 367899999999999999999999751 135999999999999999999999999999887
Q ss_pred cccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc
Q 040134 633 LAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA 712 (745)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 712 (745)
...... .....||+.|||||++.+..++.++|||||||++|||+||+.||.... ...+. ..+..+....+.
T Consensus 165 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~----~~i~~~~~~~~~ 235 (269)
T d2java1 165 NHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELA----GKIREGKFRRIP 235 (269)
T ss_dssp -------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH----HHHHHTCCCCCC
T ss_pred ccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHH----HHHHcCCCCCCC
Confidence 543321 334679999999999999999999999999999999999999985321 12222 222223222211
Q ss_pred cccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 ENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+.+|+.+||+.||++|||
T Consensus 236 ---------~~~s~~l~~li~~~L~~dp~~Rps 259 (269)
T d2java1 236 ---------YRYSDELNEIITRMLNLKDYHRPS 259 (269)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---------cccCHHHHHHHHHHcCCChhHCcC
Confidence 112346889999999999999997
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=378.66 Aligned_cols=239 Identities=27% Similarity=0.382 Sum_probs=191.2
Q ss_pred hhcCcceeEEEEEEEeeC-CCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecCC
Q 040134 487 QILGRGAFGTVYKGVLAS-DSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMSN 563 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 563 (745)
++||+|+||+||+|.+.. ..++.||||+++.. +....++|.+|++++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 369999999999998754 34678999998643 23335689999999999999999999999965 457899999999
Q ss_pred CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-cccc
Q 040134 564 GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-AART 642 (745)
Q Consensus 564 gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 642 (745)
|+|.+++.....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999888999999999999999999999965 9999999999999999999999999999876544322 2233
Q ss_pred cccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccccc
Q 040134 643 GIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKND 721 (745)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (745)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+. ..+..+..... +
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~----~~i~~~~~~~~---------p 232 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVT----AMLEKGERMGC---------P 232 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHH----HHHHTTCCCCC---------C
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHH----HHHHcCCCCCC---------C
Confidence 4578999999999999999999999999999999998 899986322 11222 22222221111 1
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC
Q 040134 722 LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 722 ~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+|+.+||+.||++|||
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs 256 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPG 256 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred cccCHHHHHHHHHHcCCCHhHCcC
Confidence 112356889999999999999997
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=372.45 Aligned_cols=241 Identities=30% Similarity=0.460 Sum_probs=193.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.+.+.+.||+|+||+||+|+++. ++.||||+++.. ....+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT--TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeEEEecCCCcEEEEEEECC--CCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 45678899999999999999753 467999999753 3456789999999999999999999998865 5678999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++|+|.+++... ..+++.++++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+++.+.......
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999988654 3589999999999999999999965 99999999999999999999999999999875443322
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....|++.|+|||.+....++.++|||||||++|||+||+.|+..... ...+. +.+..+.... .+
T Consensus 167 -~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~----~~i~~~~~~~--~p----- 232 (272)
T d1qpca_ 167 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI----QNLERGYRMV--RP----- 232 (272)
T ss_dssp -CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH----HHHHTTCCCC--CC-----
T ss_pred -ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHH----HHHHhcCCCC--Cc-----
Confidence 3456789999999999999999999999999999999997776643322 11121 2222221111 01
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+.+|+.+||+.||++|||
T Consensus 233 --~~~~~~l~~li~~cl~~~P~~Rpt 256 (272)
T d1qpca_ 233 --DNCPEELYQLMRLCWKERPEDRPT 256 (272)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --ccChHHHHHHHHHHcCCCHhHCcC
Confidence 112346889999999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-45 Score=377.31 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=183.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.|++.+.||+|+||+||+|+... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETT-TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 36788999999999999999765 45779999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCceEEeeccCccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
+++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+||++. +++.+||+|||+++.......
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 99999999999888999999999999999999999965 999999999999994 578999999999987644332
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEE 717 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 717 (745)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.... ...+. ..+..+......
T Consensus 166 ---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~----~~i~~~~~~~~~----- 230 (307)
T d1a06a_ 166 ---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLF----EQILKAEYEFDS----- 230 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH----HHHHTTCCCCCT-----
T ss_pred ---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHH----HHHhccCCCCCC-----
Confidence 334679999999999999999999999999999999999999985322 11121 222222211110
Q ss_pred ccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 718 VKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 718 ~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.........+.+++.+||+.||++|||
T Consensus 231 -~~~~~~s~~~~~li~~~L~~dP~~R~s 257 (307)
T d1a06a_ 231 -PYWDDISDSAKDFIRHLMEKDPEKRFT 257 (307)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred -ccccCCCHHHHHHHHHHccCCHhHCcC
Confidence 001122346889999999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=385.76 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=197.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC----cEEEEEEEccc-ccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS----KRFVAIKKLDK-VEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 554 (745)
..+.+.++||+|+||+||+|+..... ...||+|.+.. ........+.+|+.++.++ +||||+++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 34667889999999999999986433 34699999854 3344557899999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC-----------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 040134 555 LLVYEYMSNGSLASFLFGIT-----------------------RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQ 611 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~ 611 (745)
++||||+++|+|.++|.... .+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999997542 478899999999999999999965 9999999999
Q ss_pred CEEECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 040134 612 NILLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTN 690 (745)
Q Consensus 612 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~ 690 (745)
|||++.++.+||+|||+|+...............||+.|||||.+.+..++.++|||||||+||||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999987765544333445678999999999999999999999999999999998 8888853332
Q ss_pred chhhHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 691 PEEALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+...+ ..+.... .+....+.+.+|+.+||+.||++|||
T Consensus 273 -~~~~~~~~----~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt 313 (325)
T d1rjba_ 273 -DANFYKLI----QNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPS 313 (325)
T ss_dssp -SHHHHHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -HHHHHHHH----hcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcC
Confidence 22222222 1211110 11112356889999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=368.48 Aligned_cols=240 Identities=27% Similarity=0.403 Sum_probs=197.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEecC
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYMS 562 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 562 (745)
+.|.++||+|+||+||+|+.+ +++.||||+++.. ....++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred CEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 357789999999999999975 4567999999753 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 563 NGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 563 ~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
+|+|.+++... ..+++..+++++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.+....... .
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-S 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC-C
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee-e
Confidence 99999997654 6688999999999999999999965 99999999999999999999999999998765543322 3
Q ss_pred ccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccccc
Q 040134 642 TGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVKN 720 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (745)
....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.... .. .+. ..+..+... ..+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~-~~~----~~i~~~~~~--~~p------ 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NS-ETA----EHIAQGLRL--YRP------ 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HH-HHH----HHHHTTCCC--CCC------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HH-HHH----HHHHhCCCC--CCc------
Confidence 44678999999999999999999999999999999998 788875332 11 122 222222111 111
Q ss_pred cHHHHHHHHHHHHhccccCcCCCCC
Q 040134 721 DLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 721 ~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
....+.+.+++.+||+.||++|||
T Consensus 224 -~~~~~~l~~li~~cl~~dP~~RPt 247 (258)
T d1k2pa_ 224 -HLASEKVYTIMYSCWHEKADERPT 247 (258)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred -ccccHHHHHHHHHHccCCHhHCcC
Confidence 112346889999999999999997
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-44 Score=373.57 Aligned_cols=239 Identities=25% Similarity=0.317 Sum_probs=195.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+...+.||+|+||+||+|+... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECC-CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46667889999999999999765 46789999986432 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++|+|..++.....+++.++..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999999988887778899999999999999999999965 999999999999999999999999999986543
Q ss_pred cccccccccccccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRK---ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||.... ..+. +.... .+....+...
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--~~~~----~~~i~-~~~~~~~~~~- 237 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSA----LYHIA-QNESPALQSG- 237 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHH----HHHHH-HSCCCCCSCT-
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--HHHH----HHHHH-hCCCCCCCCC-
Confidence 233569999999999864 468999999999999999999999985322 1111 11211 2222221111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+.+.+++.+||+.||++|||
T Consensus 238 -------~~s~~~~~li~~~L~~dP~~Rpt 260 (309)
T d1u5ra_ 238 -------HWSEYFRNFVDSCLQKIPQDRPT 260 (309)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCCHHHHHHHHHHCcCChhHCcC
Confidence 12346889999999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=370.45 Aligned_cols=241 Identities=27% Similarity=0.391 Sum_probs=193.0
Q ss_pred chh-hcCcceeEEEEEEEeeCC-CcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 485 FRQ-ILGRGAFGTVYKGVLASD-SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 485 ~~~-~Ig~G~~g~V~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
+.+ +||+|+||+||+|.+... .+..||||+++.. .....++|.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 445 499999999999987543 3457999999653 33445789999999999999999999999875 4689999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc-c
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ-A 639 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~ 639 (745)
++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999999998654 6789999999999999999999965 9999999999999999999999999999887554322 2
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......||+.|+|||.+....++.++|||||||++|||+| |+.||..... . .+. ..+..+.....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~-~~~----~~i~~~~~~~~------- 233 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--P-EVM----AFIEQGKRMEC------- 233 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--H-HHH----HHHHTTCCCCC-------
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--H-HHH----HHHHcCCCCCC-------
Confidence 2334568999999999999999999999999999999998 8999864322 1 122 22222222111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+|+.+||+.||++|||
T Consensus 234 --p~~~~~~l~~li~~cl~~~p~~RPs 258 (285)
T d1u59a_ 234 --PPECPPELYALMSDCWIYKWEDRPD 258 (285)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred --CCcCCHHHHHHHHHHcCCCHhHCcC
Confidence 1122356889999999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-44 Score=377.09 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=199.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||.||+|+... +++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47788999999999999999765 46789999997655556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD--DYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 99999999854 46799999999999999999999965 999999999999995 467899999999987754432
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|||||++.+..++.++|||||||++|||++|+.||... ...+.+ ..+ ........ ..
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~-~~i----~~~~~~~~--~~--- 247 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETL-RNV----KSCDWNMD--DS--- 247 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHH-HHH----HHTCCCSC--CG---
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--CHHHHH-HHH----HhCCCCCC--cc---
Confidence 33467899999999999999999999999999999999999998532 222222 111 11111110 00
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+.+++.+||+.||++|||
T Consensus 248 -~~~~~s~~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 248 -AFSGISEDGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp -GGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcC
Confidence 01112345789999999999999997
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=375.83 Aligned_cols=245 Identities=28% Similarity=0.452 Sum_probs=188.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCC---cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDS---KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+.+.++||+|+||+||+|.+.... ...||||++... ......+|.+|++++++++||||++++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 446678999999999999987543 357999998643 3334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
||+.+++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999987654 6789999999999999999999965 999999999999999999999999999987654332
Q ss_pred c-cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 Q-AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. .......||+.|+|||.+.+..++.++|||||||++|||+++..|+...... ..+. +.+..+....
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~~~~~------ 233 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAINDGFRLP------ 233 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHTTCCCC------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH----HHHhccCCCC------
Confidence 2 2233456899999999999999999999999999999999987776543322 2222 2222221111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+|+.+||+.||++|||
T Consensus 234 ---~~~~~~~~l~~li~~cl~~~p~~RPt 259 (283)
T d1mqba_ 234 ---TPMDCPSAIYQLMMQCWQQERARRPK 259 (283)
T ss_dssp ---CCTTCBHHHHHHHHHHTCSSTTTSCC
T ss_pred ---CchhhHHHHHHHHHHHCcCCHhHCcC
Confidence 11122356889999999999999997
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=374.01 Aligned_cols=240 Identities=24% Similarity=0.292 Sum_probs=200.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.+.||+|+||+||+++... +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 6678899999999999999765 4678999999642 34456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-- 160 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 160 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc--
Confidence 999999999999888999999999999999999999965 999999999999999999999999999987643322
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. +....+.+...
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~----~~i~~~~~~~p-------- 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF----ELILMEEIRFP-------- 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCCCCC--------
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHH----HHHhcCCCCCC--------
Confidence 23456799999999999999999999999999999999999999864321 1121 22222222110
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+++.+||+.||++||+
T Consensus 226 --~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 226 --RTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred --ccCCHHHHHHHHhhccCCchhhcc
Confidence 112345788999999999999984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-43 Score=375.91 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=199.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|++.+.||+|+||+||+|+... +++.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47788999999999999999765 46789999997655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD--DYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++|+|.+++... .++++.+++.++.||+.||+|||+. ||+||||||+||||+ .++.+||+|||++..+.....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999887655 4699999999999999999999965 999999999999997 678999999999988754432
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+ +...+ ..+.......
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~-~~~~i----~~~~~~~~~~----- 250 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLE-TLQNV----KRCDWEFDED----- 250 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHH-HHHHH----HHCCCCCCSS-----
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHH-HHHHH----HhCCCCCCcc-----
Confidence 334578999999999999999999999999999999999999985322 111 11111 1121111100
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+|+.+||+.||++|||
T Consensus 251 -~~~~~s~~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 251 -AFSSVSPEAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcC
Confidence 01112345789999999999999997
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=366.93 Aligned_cols=244 Identities=25% Similarity=0.287 Sum_probs=198.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc------cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV------EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 555 (745)
.|++.+.||+|+||+||+|+... +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46778899999999999999765 4577999998542 1223578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----ceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF----TPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~a~~ 631 (745)
+||||+++|+|.+++...+.+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998888899999999999999999999965 999999999999998776 599999999987
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+ ..+........
T Consensus 167 ~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~-----~~i~~~~~~~~ 236 (293)
T d1jksa_ 167 IDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETL-----ANVSAVNYEFE 236 (293)
T ss_dssp CTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH-----HHHHTTCCCCC
T ss_pred cCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--HHHHH-----HHHHhcCCCCC
Confidence 654332 334578999999999999999999999999999999999999986322 12111 11112211110
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. .........+.+++.+||+.||++|||
T Consensus 237 ~------~~~~~~s~~~~~li~~~L~~dP~~R~s 264 (293)
T d1jksa_ 237 D------EYFSNTSALAKDFIRRLLVKDPKKRMT 264 (293)
T ss_dssp H------HHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred c------hhcCCCCHHHHHHHHHHccCChhHCcC
Confidence 0 001112346789999999999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-43 Score=366.21 Aligned_cols=236 Identities=25% Similarity=0.314 Sum_probs=197.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.+.||+|+||+||+|+... +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 6678899999999999999765 4578999998642 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 560 YMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 560 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
|+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 99999999999988889999999999999999999995 49999999999999999999999999999876432
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEVK 719 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 719 (745)
.....||+.|||||++.+..++.++|||||||+||||+||+.||.... .. .+. ..+..+.... .
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~-~~~----~~i~~~~~~~--p------ 221 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TM-KTY----EKILNAELRF--P------ 221 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HH-HHH----HHHHHCCCCC--C------
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--HH-HHH----HHHHcCCCCC--C------
Confidence 334679999999999999999999999999999999999999996322 11 111 1222222111 0
Q ss_pred ccHHHHHHHHHHHHhccccCcCCCC
Q 040134 720 NDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 720 ~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
......+.+++.+||+.||.+||
T Consensus 222 --~~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 222 --PFFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp --TTSCHHHHHHHHHHTCSCTTTCT
T ss_pred --CCCCHHHHHHHHHHhhhCHHhcc
Confidence 11124578899999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=370.19 Aligned_cols=242 Identities=31% Similarity=0.440 Sum_probs=189.3
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
..+++.+.||+|+||+||+|++... +.||||+++.. ....+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~--~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT--EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC--CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 3467889999999999999998643 45999999653 4456789999999999999999999999865 567899999
Q ss_pred cCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 561 MSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 561 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
+++|+|..++... ..+++.+++.++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++.+......
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999998653 5689999999999999999999965 9999999999999999999999999999876544332
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
. .....||+.|+|||.+....++.++||||||++||||++|+.|+...... ..+...+ ..+.... .
T Consensus 170 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i----~~~~~~~-~------ 235 (285)
T d1fmka3 170 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV----ERGYRMP-C------ 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HTTCCCC-C------
T ss_pred e-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HhcCCCC-C------
Confidence 2 34467899999999999999999999999999999999988776544332 1122222 1221111 1
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+++.+++.+||+.||++|||
T Consensus 236 --~~~~~~~l~~li~~cl~~dP~~Rps 260 (285)
T d1fmka3 236 --PPECPESLHDLMCQCWRKEPEERPT 260 (285)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CcccCHHHHHHHHHHcccCHhHCcC
Confidence 1122346889999999999999997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-43 Score=372.54 Aligned_cols=241 Identities=27% Similarity=0.296 Sum_probs=193.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHH---HHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRT---EVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
|.+.++||+|+||.||+|+... +++.||||++... .......+.+ |+.+++.++||||+++++++.+.+..++
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECC-CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 5677899999999999999765 4678999998532 2223334444 4677778889999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 557 VYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
||||+++|+|.++|.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 999999999999998888899999999999999999999965 99999999999999999999999999998765433
Q ss_pred cccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
.....||+.|+|||++.. ..++.++|||||||+||||+||+.||.......... +.+.........
T Consensus 162 ----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~~~~----- 228 (364)
T d1omwa3 162 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAVEL----- 228 (364)
T ss_dssp ----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCCCCC-----
T ss_pred ----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCCCC-----
Confidence 334579999999999964 568999999999999999999999997544332211 111111111110
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ......+.+++.+||+.||++|||
T Consensus 229 -~----~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 229 -P----DSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp -C----SSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred -C----CCCCHHHHHHHHHHcccCHHHhCC
Confidence 0 012345789999999999999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-42 Score=354.97 Aligned_cols=244 Identities=22% Similarity=0.297 Sum_probs=197.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc---------cCHHHHHHHHHHHhccC-CCCceeEEEEEecC
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ---------QGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEG 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 551 (745)
.|++.+.||+|+||+||+++... +++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 35678899999999999998765 567899999864321 12246889999999996 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+..++||||+++|+|.++|.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999998888999999999999999999999965 999999999999999999999999999988
Q ss_pred ccccccccccccccccccccchhcccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRK------ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG 705 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 705 (745)
+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... ... . .+.+..
T Consensus 160 ~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~-~----~~~i~~ 229 (277)
T d1phka_ 160 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QML-M----LRMIMS 229 (277)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH-H----HHHHHH
T ss_pred ccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHH-H----HHHHHh
Confidence 754332 344679999999999853 356889999999999999999999996332 111 1 122222
Q ss_pred CcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 706 KNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+....... ......+++.+++.+||+.||++|||
T Consensus 230 ~~~~~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s 263 (277)
T d1phka_ 230 GNYQFGSP------EWDDYSDTVKDLVSRFLVVQPQKRYT 263 (277)
T ss_dssp TCCCCCTT------TGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred CCCCCCCc------ccccCCHHHHHHHHHHccCChhHCcC
Confidence 22221111 11122356889999999999999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-43 Score=363.27 Aligned_cols=245 Identities=25% Similarity=0.428 Sum_probs=196.1
Q ss_pred hcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
+++.+.||+|+||+||+|+... .+++.||||+++.. .....++|.+|++++++++||||+++++++.+.+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 5567899999999999999753 34678999999653 233457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC------------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 040134 558 YEYMSNGSLASFLFGI------------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNI 613 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NI 613 (745)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 9999999999998532 2378889999999999999999965 999999999999
Q ss_pred EECCCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchh
Q 040134 614 LLDDYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEE 693 (745)
Q Consensus 614 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~ 693 (745)
|++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++|..|+.... .+.+
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-~~~e 250 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-AHEE 250 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-CHHH
Confidence 999999999999999987755544443445678899999999999999999999999999999999975533222 2222
Q ss_pred hHHHHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 694 ALMDWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 694 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+. ..+..+...... ...+.++.+|+.+||+.||++|||
T Consensus 251 -~~----~~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 251 -VI----YYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp -HH----HHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -HH----HHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcC
Confidence 21 222233222111 112346889999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=364.04 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=197.4
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHh-ccCCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIG-QTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
|.+.++||+|+||+||+|+... +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~-t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECC-CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 5678899999999999999765 5678999999642 2344566777777765 689999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+++|+|.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 9999999999998888899999999999999999999965 999999999999999999999999999987643322
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. .+..+.....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~----~i~~~~~~~p------- 223 (320)
T d1xjda_ 159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFH----SIRMDNPFYP------- 223 (320)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCCCCCC-------
T ss_pred -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHH----HHHcCCCCCC-------
Confidence 2344679999999999999999999999999999999999999995322 222222 2222221110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......+.+|+.+||+.||++|||
T Consensus 224 ---~~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 224 ---RWLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp ---TTSCHHHHHHHHHHSCSSGGGSBT
T ss_pred ---ccCCHHHHHHHHHhcccCCCCCcC
Confidence 011345889999999999999997
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=369.78 Aligned_cols=243 Identities=27% Similarity=0.378 Sum_probs=188.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCc---EEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSK---RFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
+++.++||+|+||+||+|++...+. ..||+|+++. ......++|.+|++++++++||||+++++++.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 5677899999999999999865432 3589998864 3445678899999999999999999999999875 567888
Q ss_pred EecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
|++.+++|.+++... ..+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999887654 6789999999999999999999965 999999999999999999999999999998765544
Q ss_pred ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 638 QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
........||+.|+|||.+.+..++.++|||||||+||||+| |..||.... ...+...+.. +....
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~---~~~~~~~i~~----~~~~~------ 233 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEK----GERLP------ 233 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---GGGHHHHHHH----TCCCC------
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHc----CCCCC------
Confidence 433444578999999999999999999999999999999999 677764322 2222222222 21111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+......+.+|+.+||+.||++|||
T Consensus 234 ---~p~~~~~~~~~li~~cl~~dP~~RPs 259 (317)
T d1xkka_ 234 ---QPPICTIDVYMIMVKCWMIDADSRPK 259 (317)
T ss_dssp ---CCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---CCcccCHHHHHHHHHhCCCChhhCcC
Confidence 01122346889999999999999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=363.83 Aligned_cols=244 Identities=22% Similarity=0.319 Sum_probs=184.2
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLV 557 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 557 (745)
..+++.+.||+|+||+||+|++.... ...||||.++.. .....+.+.+|++++++++||||+++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 34677899999999999999876433 457899998653 3334567999999999999999999999996 4678999
Q ss_pred EEecCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccc
Q 040134 558 YEYMSNGSLASFLFG-ITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 636 (745)
|||+++|+|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999998754 45789999999999999999999965 99999999999999999999999999998765433
Q ss_pred cccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccccc
Q 040134 637 TQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAEND 715 (745)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 715 (745)
... .....||+.|+|||.+.+..++.++|||||||++|||+| |..||..... ..+... +..+....+
T Consensus 163 ~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~----i~~~~~~~~---- 230 (273)
T d1mp8a_ 163 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR----IENGERLPM---- 230 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH----HHTTCCCCC----
T ss_pred cee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCCCCC----
Confidence 222 344568999999999999999999999999999999998 7777754322 222222 222221111
Q ss_pred ccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 716 EEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 716 ~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+|+.+||+.||++|||
T Consensus 231 -----~~~~~~~~~~li~~cl~~dp~~Rps 255 (273)
T d1mp8a_ 231 -----PPNCPPTLYSLMTKCWAYDPSRRPR 255 (273)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----CCCCCHHHHHHHHHHcCCCHhHCcC
Confidence 1122356889999999999999997
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-42 Score=365.41 Aligned_cols=237 Identities=24% Similarity=0.244 Sum_probs=197.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 558 (745)
.+++.+.||+|+||.||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~-~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46677899999999999999865 4567999998642 3345578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
||+.+|+|..++...+.+++..+..++.||+.||.|||+. +||||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 9999999999998888999999999999999999999965 9999999999999999999999999999876432
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....||+.|||||++.+..++.++|||||||++|||+||+.||... . ...+.. .+..+.....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~-~~~~~~----~i~~~~~~~p------- 258 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--Q-PIQIYE----KIVSGKVRFP------- 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--S-HHHHHH----HHHHCCCCCC-------
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--C-HHHHHH----HHhcCCCCCC-------
Confidence 23457999999999999999999999999999999999999999532 1 111212 1222221110
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRP 744 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RP 744 (745)
......+.+++.+||+.||.+||
T Consensus 259 ---~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 259 ---SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp ---TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred ---ccCCHHHHHHHHHHhhhCHHhcc
Confidence 11234588999999999999995
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-42 Score=356.93 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=190.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc---ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC----eE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE---QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD----HR 554 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~ 554 (745)
.|.+.+.||+|+||+||+|+... +++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 36778899999999999999765 46789999996532 233467899999999999999999999987644 47
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
|+||||+++++|.+++...+.+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.++|+|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999998888999999999999999999999965 999999999999999999999999999876543
Q ss_pred ccc-ccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 635 EQT-QAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 635 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
... ........||+.|+|||++.+..++.++|||||||++|||+||+.||... ...+ ...+....+......
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~----~~~~~~~~~~~~~~~- 236 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVS----VAYQHVREDPIPPSA- 236 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHH----HHHHHHHCCCCCGGG-
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--CHHH----HHHHHHhcCCCCCch-
Confidence 322 22234467999999999999999999999999999999999999998532 2222 122222222211110
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
........+.+++.+||+.||++||+
T Consensus 237 ------~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 237 ------RHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp ------TSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred ------hccCCCHHHHHHHHHHccCCHhHCHh
Confidence 01112356889999999999999994
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=361.44 Aligned_cols=244 Identities=29% Similarity=0.500 Sum_probs=192.5
Q ss_pred cchhhcCcceeEEEEEEEeeCCC--cEEEEEEEccc-ccccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEEEEEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDK-VEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRLLVYE 559 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 559 (745)
+|.++||+|+||+||+|++...+ ...||||+++. ......++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 45678999999999999986543 34689999864 344455789999999999999999999999865 568999999
Q ss_pred ecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccc
Q 040134 560 YMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 560 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 638 (745)
|+++++|.+++... ..+++..+++++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998765 4567888999999999999999965 9999999999999999999999999999877544322
Q ss_pred c--ccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccc
Q 040134 639 A--ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDE 716 (745)
Q Consensus 639 ~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 716 (745)
. ......||+.|+|||.+....++.++||||||+++|||+||+.|+....... .+.. .+..+... ..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~----~i~~g~~~--~~p~- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV----YLLQGRRL--LQPE- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCC--CCCT-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHcCCCC--CCcc-
Confidence 1 2334568999999999999999999999999999999999988876433221 1111 12222111 1111
Q ss_pred cccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 717 EVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 717 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.....+.+++.+||+.||++|||
T Consensus 258 ------~~~~~l~~li~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 258 ------YCPDPLYEVMLKCWHPKAEMRPS 280 (311)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ------cCcHHHHHHHHHHcCCCHhHCcC
Confidence 12346889999999999999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=358.59 Aligned_cols=243 Identities=19% Similarity=0.274 Sum_probs=195.8
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
.|.+.+.||+|+||+||+|+... +++.||||.++... .....+.+|+++|++++||||+++++++.+.+..|+||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~-~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 36678899999999999998765 46789999997533 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CceEEeeccCcccccccccc
Q 040134 562 SNGSLASFLFGIT-RPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDY--FTPRISDFGLAKLLLAEQTQ 638 (745)
Q Consensus 562 ~~gsL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~ 638 (745)
++++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 9999999998664 789999999999999999999965 99999999999999854 5899999999987644332
Q ss_pred cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 639 AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... . ..+... +..+..... ...
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--~-~~~~~~----i~~~~~~~~--~~~-- 226 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--N-QQIIEN----IMNAEYTFD--EEA-- 226 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--H-HHHHHH----HHHTCCCCC--HHH--
T ss_pred --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--H-HHHHHH----HHhCCCCCC--hhh--
Confidence 334568999999999999999999999999999999999999986432 1 112111 111111110 000
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+++.+||+.||++|||
T Consensus 227 --~~~~s~~~~~li~~~L~~dp~~R~s 251 (321)
T d1tkia_ 227 --FKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp --HTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcC
Confidence 0012345789999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=361.11 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=186.7
Q ss_pred HHhcchhhcCcceeEEEEEEEeeCC----CcEEEEEEEcccc-cccCHHHHHHHHHHHhcc-CCCCceeEEEEEecC-Ce
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLASD----SKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEG-DH 553 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~ 553 (745)
..+.+.+.||+|+||.||+|+.... .++.||||+++.. .....+.+.+|..++.++ +|+||+++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 3467788999999999999997542 3578999999643 333456788888888777 799999999998664 46
Q ss_pred EEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 554 RLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
.++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 89999999999999998643 3478999999999999999999965 9999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCchhhHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKS-SVVFGTTNPEEALM 696 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~-p~~~~~~~~~~~l~ 696 (745)
++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||.. ||.. .... +.+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~-~~~~-~~~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-VKID-EEFC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCCS-HHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC-CCHH-HHHH
Confidence 99999999999987655544443455679999999999999999999999999999999999865 5532 2222 2222
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+ ..+...... .....++.+++.+||+.||++|||
T Consensus 248 ~~~----~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt 283 (299)
T d1ywna1 248 RRL----KEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPT 283 (299)
T ss_dssp HHH----HHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHH----hcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcC
Confidence 222 222211111 112345889999999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=359.52 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=185.0
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCC--cEEEEEEEcccc---cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDS--KRFVAIKKLDKV---EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
.+++.+.||+|+||+||+|++.... ...||||+++.. ..+..+.|.+|++++++++||||++++|++.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 3567789999999999999876543 347899998642 33345789999999999999999999999976 46789
Q ss_pred EEEecCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 557 VYEYMSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
||||+++++|.+++... ..+++..+++++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999999887654 5689999999999999999999965 9999999999999999999999999999987554
Q ss_pred cccc-ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 636 QTQA-ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+ . +......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~-~---~~~i~~~~~~~~~-- 236 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQ-I---LHKIDKEGERLPR-- 236 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHH-H---HHHHHTSCCCCCC--
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHH-H---HHHHHhCCCCCCC--
Confidence 3322 2334567889999999999999999999999999999998 88887532 1111 1 1121122211111
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.......+.+++.+||+.||++|||
T Consensus 237 -------~~~~~~~l~~li~~cl~~dp~~RPt 261 (273)
T d1u46a_ 237 -------PEDCPQDIYNVMVQCWAHKPEDRPT 261 (273)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------cccccHHHHHHHHHHcCCChhHCcC
Confidence 1112346889999999999999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=354.48 Aligned_cols=234 Identities=27% Similarity=0.380 Sum_probs=181.5
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec-CCeEEEEEEec
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE-GDHRLLVYEYM 561 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 561 (745)
+++.+.||+|+||.||+|++. ++.||||+++. ....+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred eEEeEEEecCCCeEEEEEEEC---CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 457789999999999999984 45699999965 3345789999999999999999999999865 45689999999
Q ss_pred CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 562 SNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 562 ~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
++|+|.++|... ..+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 999999999654 3589999999999999999999965 9999999999999999999999999999865432
Q ss_pred ccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHhhcCcccccccccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAENDEEV 718 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 718 (745)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.|+.... ...+...+ ..+....+
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i----~~~~~~~~------- 221 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGYKMDA------- 221 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH----TTTCCCCC-------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HcCCCCCC-------
Confidence 223457889999999999999999999999999999998 566654322 22222222 22211111
Q ss_pred cccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 719 KNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 719 ~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+|+.+||+.||++|||
T Consensus 222 --~~~~~~~~~~li~~cl~~dP~~Rps 246 (262)
T d1byga_ 222 --PDGCPPAVYEVMKNCWHLDAAMRPS 246 (262)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --CccCCHHHHHHHHHHcccCHhHCcC
Confidence 1112346889999999999999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=356.19 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=188.7
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEecCC----eEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD----HRLLVY 558 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~ 558 (745)
+-+.+.||+|+||+||+|++. ++.||||+++.... .....+.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET---TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 345688999999999999973 56799999864322 1222334555566789999999999997654 689999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEE-----CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
||+++|+|.++|++. .+++..+++++.|++.||+|||.. +.++|+||||||+||||+.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 999999999999754 689999999999999999999963 13699999999999999999999999999998775
Q ss_pred ccccc--cccccccccccccchhccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCc--------hhhHHH
Q 040134 634 AEQTQ--AARTGIRGTVGYFAPEWFRKAS------ITVKVDVYSFGVLLLELICCKSSVVFGTTNP--------EEALMD 697 (745)
Q Consensus 634 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwslG~vl~elltg~~p~~~~~~~~--------~~~l~~ 697 (745)
..... .......||+.|+|||.+.+.. ++.++|||||||+||||+||..|+....... ......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 43321 1234567999999999987643 5778999999999999999988874432211 011112
Q ss_pred HHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 698 WVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+......+....-+. ......+....+.+++.+||+.||++|||
T Consensus 240 ~~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps 284 (303)
T d1vjya_ 240 EMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence 2233333222221111 11113345677999999999999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=360.25 Aligned_cols=242 Identities=29% Similarity=0.451 Sum_probs=190.3
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCc-EEEEEEEccc-ccccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeEEEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSK-RFVAIKKLDK-VEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~-~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+++.++||+|+||+||+|++..++. ..||||+++. ......+.|.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 4567899999999999999876543 3588898854 3344566899999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEE
Q 040134 560 YMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRI 623 (745)
Q Consensus 560 ~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 623 (745)
|+++|+|.++|+.. ..+++..+.+++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999999654 5689999999999999999999965 9999999999999999999999
Q ss_pred eeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHh
Q 040134 624 SDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCY 703 (745)
Q Consensus 624 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 703 (745)
+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+ .+.+
T Consensus 169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~----~~~i 239 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAEL----YEKL 239 (309)
T ss_dssp CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH----HHHG
T ss_pred cccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHH----HHHH
Confidence 99999986543332 2345689999999999999999999999999999999998765432221 1112 2222
Q ss_pred hcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 704 IGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.... .......++.+|+.+||+.||++|||
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs 272 (309)
T d1fvra_ 240 PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPS 272 (309)
T ss_dssp GGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcC
Confidence 2221111 11122356889999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=361.25 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=200.5
Q ss_pred HHhcchhhcCcceeEEEEEEEee----CCCcEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCeE
Q 040134 481 ATRGFRQILGRGAFGTVYKGVLA----SDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDHR 554 (745)
Q Consensus 481 ~~~~~~~~Ig~G~~g~V~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 554 (745)
..+.+.++||+|+||.||+|++. ...++.||||+++... ......+.+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 45667889999999999999874 3456789999997533 33456789999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 040134 555 LLVYEYMSNGSLASFLFGI------------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD 616 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~ 616 (745)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 9999999999999998643 2578899999999999999999965 999999999999999
Q ss_pred CCCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHH
Q 040134 617 DYFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALM 696 (745)
Q Consensus 617 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~ 696 (745)
.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|++.|+....... ..+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 999999999999998765544444455789999999999999999999999999999999999666654333322 2222
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..+.+ +.... . .......+.+|+.+||+.||++|||
T Consensus 259 ~~i~~----~~~~~-~--------~~~~~~~l~~Li~~cl~~dP~~RPs 294 (311)
T d1t46a_ 259 KMIKE----GFRML-S--------PEHAPAEMYDIMKTCWDADPLKRPT 294 (311)
T ss_dssp HHHHH----TCCCC-C--------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHhc----CCCCC-C--------cccccHHHHHHHHHHcCCChhHCcC
Confidence 22222 11111 1 1112356889999999999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=358.62 Aligned_cols=250 Identities=23% Similarity=0.260 Sum_probs=190.6
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEccccccc-----CHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEec
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQ-----GEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEYM 561 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 561 (745)
++||+|+||+||+|+... +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECC-CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 679999999999999765 4567999998643221 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccccc
Q 040134 562 SNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAAR 641 (745)
Q Consensus 562 ~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 641 (745)
.++++..++.....+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--Y 157 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--C
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc--c
Confidence 9988888877778899999999999999999999965 9999999999999999999999999999876543322 3
Q ss_pred ccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccccc---c----
Q 040134 642 TGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLA---E---- 713 (745)
Q Consensus 642 ~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~---- 713 (745)
....||+.|+|||++.. ..++.++|||||||++|||+||+.||.... +.+.+ ..+.+........... .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l-~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQL-TRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH-HHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHH-HHHHHhcCCCChhhccchhccchh
Confidence 34578999999999865 467999999999999999999999885332 22222 2222221110000000 0
Q ss_pred --ccccccccH-----HHHHHHHHHHHhccccCcCCCCC
Q 040134 714 --NDEEVKNDL-----KRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 --~~~~~~~~~-----~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......... ...+.+.+++.+||+.||++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s 273 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC
Confidence 000000011 12356889999999999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=357.48 Aligned_cols=245 Identities=28% Similarity=0.366 Sum_probs=193.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCC------cEEEEEEEccccc-ccCHHHHHHHHHHHhcc-CCCCceeEEEEEecCCe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDS------KRFVAIKKLDKVE-QQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDEGDH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 553 (745)
.+.+.+.||+|+||.||+|+..... ...||||+++... .....++.+|...+.++ +||||+++++++.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 4667889999999999999875432 3579999996533 33457888999999888 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 040134 554 RLLVYEYMSNGSLASFLFGI----------------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD 617 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~ 617 (745)
.++||||+++|+|.++|... ..+++.+++.++.||+.||+|||+. +||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 99999999999999999654 3478999999999999999999965 9999999999999999
Q ss_pred CCceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCchhhHH
Q 040134 618 YFTPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELIC-CKSSVVFGTTNPEEALM 696 (745)
Q Consensus 618 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~l~ 696 (745)
++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||.... ...+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---~~~~- 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL- 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHH-
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---HHHH-
Confidence 99999999999998766555444555778999999999999999999999999999999998 566664222 1122
Q ss_pred HHHHHHhhcCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 697 DWVYRCYIGKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.+.+..+..... ......++.+|+.+||+.||++|||
T Consensus 247 ---~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps 283 (299)
T d1fgka_ 247 ---FKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPT 283 (299)
T ss_dssp ---HHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---HHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcC
Confidence 222222221111 1112346889999999999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=359.42 Aligned_cols=242 Identities=21% Similarity=0.238 Sum_probs=189.0
Q ss_pred hcch-hhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhcc-CCCCceeEEEEEec----CCeEEE
Q 040134 483 RGFR-QILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQT-HHKNLVRLLGFCDE----GDHRLL 556 (745)
Q Consensus 483 ~~~~-~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~l 556 (745)
|.+. ++||+|+||+||+|+... +++.||||+++. .+.+.+|++++.++ +||||+++++++.+ ....|+
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECC-CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 4444 569999999999999765 457799999853 35678899987655 89999999999865 467899
Q ss_pred EEEecCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCceEEeeccCccc
Q 040134 557 VYEYMSNGSLASFLFGI--TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD---YFTPRISDFGLAKL 631 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~a~~ 631 (745)
||||+++|+|.++|... ..+++.++..++.||+.||+|||+. +|+||||||+|||+++ .+.+||+|||+++.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeee
Confidence 99999999999999764 4689999999999999999999965 9999999999999975 56799999999987
Q ss_pred ccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
...... .....||+.|+|||++.+..++.++|||||||+||||+||+.||........ ...+......+...
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~~-- 235 (335)
T d2ozaa1 164 TTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYE-- 235 (335)
T ss_dssp CCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS--
T ss_pred ccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCCC--
Confidence 654332 3446799999999999999999999999999999999999999964332211 11111111111111
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
............+.+++.+||+.||++|||
T Consensus 236 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 265 (335)
T d2ozaa1 236 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265 (335)
T ss_dssp ----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCC
T ss_pred ----CCCcccccCCHHHHHHHHHHccCChhHCcC
Confidence 011111233467889999999999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=354.48 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=197.1
Q ss_pred HhcchhhcCcceeEEEEEEEeeC----CCcEEEEEEEcccc-cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLAS----DSKRFVAIKKLDKV-EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 556 (745)
.+.+.+.||+|+||+||+|.+.. ..++.||||+++.. .......|.+|++++++++||||+++++++...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 45577899999999999998753 23467999999753 33344578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeec
Q 040134 557 VYEYMSNGSLASFLFGI----------TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDF 626 (745)
Q Consensus 557 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 626 (745)
||||+++|+|.+++... ..+++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 99999999999998532 3468889999999999999999965 9999999999999999999999999
Q ss_pred cCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC
Q 040134 627 GLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK 706 (745)
Q Consensus 627 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 706 (745)
|+++.+.............+++.|+|||.+.+..++.++||||||+++|||+||..|+... ....+ . .+.+..+
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~-~----~~~i~~~ 251 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQ-V----LRFVMEG 251 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHH-H----HHHHHTT
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHH-H----HHHHHhC
Confidence 9999876655444445567899999999999999999999999999999999996443322 22221 1 1222222
Q ss_pred cccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 707 NLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...... ......+.+++.+||+.||++|||
T Consensus 252 ~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs 281 (308)
T d1p4oa_ 252 GLLDKP---------DNCPDMLFELMRMCWQYNPKMRPS 281 (308)
T ss_dssp CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCc---------ccchHHHHHHHHHHcCCChhHCcC
Confidence 221111 112346899999999999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=347.97 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=190.1
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|.+.+.||+|+||+||+|+... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CEeccEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 5567899999999999999865 4567999998643 233467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccccc
Q 040134 561 MSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQA 639 (745)
Q Consensus 561 ~~~gsL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 639 (745)
+.++.+..... ....+++.++..++.||+.||+|||+. +||||||||+|||++.++.+||+|||.++.......
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 97654444433 346789999999999999999999965 999999999999999999999999999987643322
Q ss_pred ccccccccccccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC---c---ccccc
Q 040134 640 ARTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK---N---LDKLA 712 (745)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~~~ 712 (745)
......||+.|+|||.+.... .+.++|||||||++|+|++|+.||.... ....+... ....... . .....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i-~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRI-FRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH-HHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHH-HHhcCCCchhhcccccccc
Confidence 234457999999999887665 5789999999999999999999986332 22222221 1111000 0 00000
Q ss_pred ccc----cccccc-----HHHHHHHHHHHHhccccCcCCCCC
Q 040134 713 END----EEVKND-----LKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 713 ~~~----~~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
+.. ...... ......+.+++.+||+.||++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 276 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC
Confidence 000 000000 112356889999999999999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=346.86 Aligned_cols=233 Identities=25% Similarity=0.391 Sum_probs=188.9
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------cCHHHHHHHHHHHhccC--CCCceeEEEEEecCCe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------QGEKEFRTEVSVIGQTH--HKNLVRLLGFCDEGDH 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 553 (745)
.|.+.++||+|+||+||+|+... +++.||||++..... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred eEEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46778899999999999999765 457799999864221 12244678999999986 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCceEEeeccCccc
Q 040134 554 RLLVYEYMSN-GSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-YFTPRISDFGLAKL 631 (745)
Q Consensus 554 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~a~~ 631 (745)
.++||||+.+ +++.+++.....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 68888888778899999999999999999999965 9999999999999985 47999999999986
Q ss_pred ccccccccccccccccccccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCcccc
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRKASI-TVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDK 710 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (745)
..... .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||... .. + ..+...
T Consensus 161 ~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~----i----~~~~~~- 222 (273)
T d1xwsa_ 161 LKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EE----I----IRGQVF- 222 (273)
T ss_dssp CCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH----H----HHCCCC-
T ss_pred ccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hH----H----hhcccC-
Confidence 54322 345679999999999987765 57799999999999999999998521 10 1 111111
Q ss_pred cccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 711 LAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 711 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
... ....++.+++.+||+.||++|||
T Consensus 223 -~~~--------~~s~~~~~li~~~L~~dp~~R~s 248 (273)
T d1xwsa_ 223 -FRQ--------RVSSECQHLIRWCLALRPSDRPT 248 (273)
T ss_dssp -CSS--------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -CCC--------CCCHHHHHHHHHHccCCHhHCcC
Confidence 111 11245889999999999999997
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=348.86 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=190.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhcc---CCCCceeEEEEEec-----C
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQT---HHKNLVRLLGFCDE-----G 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~ 551 (745)
.|++.+.||+|+||+||+|+....+++.||||+++.. .......+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4667789999999999999986666788999998642 222234566777777665 79999999999853 3
Q ss_pred CeEEEEEEecCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcc
Q 040134 552 DHRLLVYEYMSNGSLASFLF-GITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAK 630 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~ 630 (745)
...+++|||++++.+..... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 47899999999887765543 346789999999999999999999965 99999999999999999999999999988
Q ss_pred cccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhc-Cc--
Q 040134 631 LLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIG-KN-- 707 (745)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~-- 707 (745)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... +.+.+.. +.+.... ..
T Consensus 165 ~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~-i~~~~~~~~~~~ 238 (305)
T d1blxa_ 165 IYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGK-ILDVIGLPGEED 238 (305)
T ss_dssp CCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH-HHHHHCCCCGGG
T ss_pred hhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHH-HHHhhCCCchhc
Confidence 6543332 445679999999999999999999999999999999999999996332 2222222 2111110 00
Q ss_pred cc-------cccc---ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 708 LD-------KLAE---NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 708 ~~-------~~~~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.. .... ............+.+.+|+.+||+.||++|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s 286 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC
Confidence 00 0000 00000001112345788999999999999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-40 Score=343.72 Aligned_cols=253 Identities=20% Similarity=0.242 Sum_probs=192.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 556788999999999999875 4567999998643 344467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+.++.+..+......+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+.........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence 99888888887788899999999999999999999965 9999999999999999999999999999876443221
Q ss_pred cccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCc---c---ccccc
Q 040134 641 RTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKN---L---DKLAE 713 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~~~~ 713 (745)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... +.+.+.. +.+...... . .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~-i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMR-IFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHH-HHHhhCCCChhhccchhhhhh
Confidence 3344689999999998754 56899999999999999999999985332 2222222 111111000 0 00000
Q ss_pred ---------ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 ---------NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ---------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..............+.+++.+||+.||++|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s 274 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC
Confidence 00000001112346789999999999999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=340.07 Aligned_cols=246 Identities=26% Similarity=0.304 Sum_probs=197.7
Q ss_pred hcchhhcCcceeEEEEEEEeeC--CCcEEEEEEEcccc----cccCHHHHHHHHHHHhccCC-CCceeEEEEEecCCeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLAS--DSKRFVAIKKLDKV----EQQGEKEFRTEVSVIGQTHH-KNLVRLLGFCDEGDHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~--~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 555 (745)
|++.+.||+|+||+||+|+... .+++.||||+++.. +....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 7788999999999999998743 34678999998642 23345678899999999966 89999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
++|||+.+++|.+++.....+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999998888889999999999999999999965 9999999999999999999999999999876544
Q ss_pred ccccccccccccccccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccccc
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKA--SITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKLAE 713 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 713 (745)
.... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... .... +.+.........
T Consensus 183 ~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~-i~~~~~~~~~~~--- 255 (322)
T d1vzoa_ 183 ETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAE-ISRRILKSEPPY--- 255 (322)
T ss_dssp GGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHH-HHHHHHHCCCCC---
T ss_pred cccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHhcccCCCCC---
Confidence 4332 3446789999999999754 46889999999999999999999996554332 1111 222221111110
Q ss_pred ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
......++.+++.+||+.||++|||
T Consensus 256 -------~~~~s~~~~~li~~~l~~dP~~R~s 280 (322)
T d1vzoa_ 256 -------PQEMSALAKDLIQRLLMKDPKKRLG 280 (322)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred -------cccCCHHHHHHHHHHcccCHHHcCC
Confidence 1123456889999999999999995
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=338.74 Aligned_cols=200 Identities=21% Similarity=0.318 Sum_probs=167.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec--------C
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE--------G 551 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 551 (745)
.|.+.+.||+|+||+||+|+... +++.||||++... .....+.+.+|++++++++||||+++++++.. .
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CEEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 45677899999999999999865 4678999998542 33455788999999999999999999998855 3
Q ss_pred CeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 552 DHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 552 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
+..++||||++++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 46899999999888877777778889999999999999999999965 999999999999999999999999999987
Q ss_pred ccccccc--cccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 040134 632 LLAEQTQ--AARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVV 685 (745)
Q Consensus 632 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~ 685 (745)
+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 6543321 123335689999999998764 68999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=342.78 Aligned_cols=251 Identities=24% Similarity=0.267 Sum_probs=184.5
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCceeEEEEEec------CCeEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE------GDHRL 555 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 555 (745)
.|...++||+|+||+||+|+... +++.||||++..... ...+|++++++++||||+++++++.. ..+.+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECC-CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 34556789999999999999865 467899999865332 23479999999999999999999854 33578
Q ss_pred EEEEecCCCCHHHH---hcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCccc
Q 040134 556 LVYEYMSNGSLASF---LFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKL 631 (745)
Q Consensus 556 lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~ 631 (745)
+||||++++.+..+ ......+++.++..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999987643333 3455779999999999999999999995 5999999999999999775 899999999987
Q ss_pred ccccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH----------
Q 040134 632 LLAEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVY---------- 700 (745)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~---------- 700 (745)
+..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+.+.....
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHHHhCCChHHhh
Confidence 654332 334578999999998765 5789999999999999999999999864332 222222111
Q ss_pred HHhh----cCcccccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 701 RCYI----GKNLDKLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 701 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
.... .......................+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence 0000 00111110000000011122346889999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-38 Score=329.00 Aligned_cols=248 Identities=17% Similarity=0.201 Sum_probs=194.3
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCC-CCceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHH-KNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
.|.+.+.||+|+||+||+|+... +++.||||++.... ....+.+|++.++.++| +|++.+++++.+....++||||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46778899999999999999765 46789999885432 23457889999999965 8999999999999999999999
Q ss_pred cCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCceEEeeccCcccccc
Q 040134 561 MSNGSLASFLFGI-TRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDD-----YFTPRISDFGLAKLLLA 634 (745)
Q Consensus 561 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~-----~~~~kl~Dfg~a~~~~~ 634 (745)
+ +++|.+++... ..++...+..++.|++.||+|||+ .||+||||||+|||++. ++.+||+|||+++.+..
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 8 68999988654 568999999999999999999995 49999999999999964 57899999999988654
Q ss_pred cccc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccc
Q 040134 635 EQTQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLD 709 (745)
Q Consensus 635 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (745)
.... .......||+.|||||.+.+..++.++||||||+++|||+||+.||..............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 3221 12334679999999999999999999999999999999999999997554443332222222211111111
Q ss_pred ccccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 710 KLAENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
++. ...++++.+++..|++.+|++||+
T Consensus 239 ~l~---------~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 239 ELC---------AGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp HHT---------TTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred Hhc---------CCCCHHHHHHHHHHhcCCcccCcC
Confidence 111 011245888999999999999995
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-38 Score=331.87 Aligned_cols=248 Identities=19% Similarity=0.228 Sum_probs=185.6
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCC-ceeEEEEEecCCeEEEEEEe
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKN-LVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~ 560 (745)
.|.+.+.||+|+||.||+|+... +++.||||++.... ..+++..|++++++++|+| |+.+.++..+.+..++||||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeEEEeeCCCcEEEEEEECC-CCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46788999999999999999765 45789999876432 2345788999999997666 55556666888899999999
Q ss_pred cCCCCHHHHh-cCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCceEEeeccCcccccccc
Q 040134 561 MSNGSLASFL-FGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLD---DYFTPRISDFGLAKLLLAEQ 636 (745)
Q Consensus 561 ~~~gsL~~~l-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 636 (745)
+.+ +|...+ .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.+....
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 954 555554 4557899999999999999999999965 999999999999985 35579999999999875443
Q ss_pred cc-----cccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcCccccc
Q 040134 637 TQ-----AARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGKNLDKL 711 (745)
Q Consensus 637 ~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 711 (745)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..........................+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 21 1234467999999999999999999999999999999999999999754443222111111111111111110
Q ss_pred ccccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 712 AENDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 712 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
. ...+.++.+++..|++.||++|||
T Consensus 241 ~---------~~~p~~~~~li~~cl~~~p~~RP~ 265 (299)
T d1ckia_ 241 C---------KGYPSEFATYLNFCRSLRFDDKPD 265 (299)
T ss_dssp T---------TTSCHHHHHHHHHHHHSCTTCCCC
T ss_pred c---------cCCCHHHHHHHHHHccCChhHCcC
Confidence 0 012345889999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=331.21 Aligned_cols=255 Identities=21% Similarity=0.269 Sum_probs=198.0
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCCeEEEEEEe
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGDHRLLVYEY 560 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 560 (745)
|++.++||+|+||+||+|+... +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+....++++|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEeeeEEecCcCeEEEEEEECC-CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 5667899999999999999865 5678999998543 233457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccccccccc
Q 040134 561 MSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQTQAA 640 (745)
Q Consensus 561 ~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 640 (745)
+.+++|..++...+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-- 157 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-- 157 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc--
Confidence 99999999998888999999999999999999999965 9999999999999999999999999999876543322
Q ss_pred cccccccccccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHhhcC---ccc---cccc
Q 040134 641 RTGIRGTVGYFAPEWFRKAS-ITVKVDVYSFGVLLLELICCKSSVVFGTTNPEEALMDWVYRCYIGK---NLD---KLAE 713 (745)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslG~vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~---~~~~ 713 (745)
.....++..|+|||.+.... ++.++|||||||++|||++|+.||..+... .+.+ ..+....... ... ...+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHH-HHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHH-HHHHhhcCCCChhhhhhhhhccc
Confidence 33345788899999987654 689999999999999999999998543332 2222 2121111110 000 0000
Q ss_pred ---------ccccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 714 ---------NDEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 714 ---------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
..............+.+|+.+||+.||++|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC
Confidence 00000011122356788999999999999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-38 Score=331.94 Aligned_cols=195 Identities=22% Similarity=0.367 Sum_probs=167.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEec--CCeEEEEE
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDE--GDHRLLVY 558 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~ 558 (745)
.|++.++||+|+||+||+|+... +++.||||+++. ...+.+.+|+++|++++ ||||+++++++.. ....++||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 46778899999999999999765 567899999864 33578899999999995 9999999999974 45789999
Q ss_pred EecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-ceEEeeccCccccccccc
Q 040134 559 EYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF-TPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 559 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 637 (745)
||+++++|..+. +.+++.++..++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++.......
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999999998764 5689999999999999999999965 999999999999998654 699999999987654432
Q ss_pred ccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 040134 638 QAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVFGTT 689 (745)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~~~~ 689 (745)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.....
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 186 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 3445689999999998765 579999999999999999999999875544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-39 Score=339.34 Aligned_cols=200 Identities=25% Similarity=0.350 Sum_probs=164.2
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc-ccCHHHHHHHHHHHhccCCCCceeEEEEEecCC----eEEEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE-QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD----HRLLV 557 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv 557 (745)
|.+.+.||+|+||+||+|+... +++.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEETT-TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eEEEEEEeeccCeEEEEEEECC-CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 5667899999999999999765 46779999996533 333567899999999999999999999996543 33455
Q ss_pred EEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccccc
Q 040134 558 YEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAEQT 637 (745)
Q Consensus 558 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 637 (745)
++++.+++|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+|||+++++.+||+|||++........
T Consensus 89 ~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 566779999999965 4689999999999999999999965 999999999999999999999999999987655433
Q ss_pred c-cccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 638 Q-AARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 638 ~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
. .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 2 22344678999999999854 56789999999999999999999998543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=336.72 Aligned_cols=195 Identities=29% Similarity=0.383 Sum_probs=160.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEecCC------e
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEGD------H 553 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 553 (745)
.|.+.+.||+|+||+||+|+... +++.||||+++.. .....+.+.+|+++|++++||||+++++++...+ .
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 35567889999999999999765 4678999999642 2333567889999999999999999999997654 5
Q ss_pred EEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccc
Q 040134 554 RLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLL 633 (745)
Q Consensus 554 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~ 633 (745)
.++||||+ +.+|..++. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 79999999 557777664 46799999999999999999999965 99999999999999999999999999998764
Q ss_pred ccccccccccccccccccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 040134 634 AEQTQAARTGIRGTVGYFAPEWFRK-ASITVKVDVYSFGVLLLELICCKSSVVFG 687 (745)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslG~vl~elltg~~p~~~~ 687 (745)
.. .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 173 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 173 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 32 344578999999999876 45789999999999999999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=327.76 Aligned_cols=194 Identities=29% Similarity=0.311 Sum_probs=155.9
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccc--cccCHHHHHHHHHHHhccCCCCceeEEEEEec------CCeE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKV--EQQGEKEFRTEVSVIGQTHHKNLVRLLGFCDE------GDHR 554 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~ 554 (745)
|++.++||+|+||+||+|++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~-t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETT-TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCcCeEEEEEEECC-CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 5566899999999999999765 5688999999643 23344678899999999999999999999953 4688
Q ss_pred EEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCcccccc
Q 040134 555 LLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLA 634 (745)
Q Consensus 555 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~ 634 (745)
++||||+.++.+. .+ ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+++....
T Consensus 98 ~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 98 YLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc
Confidence 9999999765554 44 25688999999999999999999965 999999999999999999999999999886544
Q ss_pred cccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 635 EQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
... .....+|+.|+|||.+.+..+++++||||+||++|||++|+.||..
T Consensus 172 ~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 172 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 332 3445689999999999999999999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-37 Score=324.49 Aligned_cols=194 Identities=26% Similarity=0.348 Sum_probs=161.6
Q ss_pred hcchhhcCcceeEEEEEEEeeCCCcEEEEEEEccccc--ccCHHHHHHHHHHHhccCCCCceeEEEEEecC-----CeEE
Q 040134 483 RGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVE--QQGEKEFRTEVSVIGQTHHKNLVRLLGFCDEG-----DHRL 555 (745)
Q Consensus 483 ~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 555 (745)
|++.+.||+|+||+||+|+... +++.||||+++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETT-TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 5667899999999999998765 56789999996532 23346788999999999999999999998643 3456
Q ss_pred EEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEeeccCccccccc
Q 040134 556 LVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISDFGLAKLLLAE 635 (745)
Q Consensus 556 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 635 (745)
++++|+.+++|.+++.. +++++.++..++.||+.||+|||+. ||+||||||+|||++.++.+|++|||++......
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc
Confidence 77788889999999854 5799999999999999999999965 9999999999999999999999999999765332
Q ss_pred ccccccccccccccccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 040134 636 QTQAARTGIRGTVGYFAPEWFRKA-SITVKVDVYSFGVLLLELICCKSSVVF 686 (745)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslG~vl~elltg~~p~~~ 686 (745)
.....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||..
T Consensus 175 -----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 175 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp -----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 3345689999999987665 468999999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=1.8e-32 Score=292.88 Aligned_cols=254 Identities=20% Similarity=0.200 Sum_probs=181.4
Q ss_pred HhcchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-----------CCCceeEEEEEec
Q 040134 482 TRGFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-----------HKNLVRLLGFCDE 550 (745)
Q Consensus 482 ~~~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 550 (745)
.|.+.++||+|+||+||+|+... +++.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~-~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 47788999999999999999765 46789999997532 23467788998888775 5789999988754
Q ss_pred --CCeEEEEEEecCCCCHHHH---hcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC------
Q 040134 551 --GDHRLLVYEYMSNGSLASF---LFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYF------ 619 (745)
Q Consensus 551 --~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~------ 619 (745)
....++++++...+..... ......+++..+..++.||+.||+|||+. .||+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence 4566777776655432222 23446788899999999999999999962 4999999999999997654
Q ss_pred ceEEeeccCcccccccccccccccccccccccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCc----hhhH
Q 040134 620 TPRISDFGLAKLLLAEQTQAARTGIRGTVGYFAPEWFRKASITVKVDVYSFGVLLLELICCKSSVVFGTTNP----EEAL 695 (745)
Q Consensus 620 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG~vl~elltg~~p~~~~~~~~----~~~l 695 (745)
.++|+|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||....... ...+
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999765332 234568999999999999999999999999999999999999986443221 1111
Q ss_pred HHHHHHHhhc-------------------Ccccccccc---------cccccccHHHHHHHHHHHHhccccCcCCCCC
Q 040134 696 MDWVYRCYIG-------------------KNLDKLAEN---------DEEVKNDLKRVERLVMVALWCIQEDASLRPQ 745 (745)
Q Consensus 696 ~~~~~~~~~~-------------------~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~Cl~~dp~~RPT 745 (745)
...+ ..+.. .....+... .............+.+|+.+||+.||++|||
T Consensus 245 ~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 245 AQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 1111 10000 000000000 0011223456778999999999999999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=8.4e-21 Score=181.99 Aligned_cols=163 Identities=13% Similarity=0.123 Sum_probs=119.2
Q ss_pred cchhhcCcceeEEEEEEEeeCCCcEEEEEEEcccccc------------------cCHHHHHHHHHHHhccCCCCceeEE
Q 040134 484 GFRQILGRGAFGTVYKGVLASDSKRFVAIKKLDKVEQ------------------QGEKEFRTEVSVIGQTHHKNLVRLL 545 (745)
Q Consensus 484 ~~~~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~ 545 (745)
.+.++||+|+||+||+|+.. +++.||||+++.... ........|...+.++.|.+++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 35678999999999999875 356799998642110 0113345688899999999999988
Q ss_pred EEEecCCeEEEEEEecCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCceEEee
Q 040134 546 GFCDEGDHRLLVYEYMSNGSLASFLFGITRPDWNQRVQIAFGIARGLMYLHEECSTQIIHCDIKPQNILLDDYFTPRISD 625 (745)
Q Consensus 546 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 625 (745)
++.. .+++|||+++..+.+ ++......++.|++.+|+|||+. ||+||||||+|||++++ .++|+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 7642 379999998866543 34566778999999999999965 99999999999999965 589999
Q ss_pred ccCcccccccccccccccccccccccc------hhccccCCCCccchhHHHHHHH
Q 040134 626 FGLAKLLLAEQTQAARTGIRGTVGYFA------PEWFRKASITVKVDVYSFGVLL 674 (745)
Q Consensus 626 fg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~~DvwslG~vl 674 (745)
||.|......... .|.. .|.+ .+.++.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999765322211 1111 1111 35678899999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.82 E-value=2.3e-20 Score=160.96 Aligned_cols=111 Identities=22% Similarity=0.467 Sum_probs=91.5
Q ss_pred ccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEE
Q 040134 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83 (745)
Q Consensus 4 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~ 83 (745)
+|+|.+||+|. .++.|+| |.|.|.|...++ |.|+.. .++||.||++.|.. .+.+.|+.||+|+|+
T Consensus 1 tDtL~~gq~L~---~g~~l~~--g~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~-~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLD---TGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS-GCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEEC---TTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCS-SEEEEECTTSCEEEE
T ss_pred CCEecCCCEec---CCCEEEE--CCEEEEEcCCCC-----EEEEcC----CcEEEEccCccCCC-CcEEEEeccccEEEE
Confidence 58999999999 6667874 999999987653 555553 58999999998853 467999999999999
Q ss_pred cCCCCEEEeccCC-CCCceEEEEecCccEEEEcCCccccccccccCcC
Q 040134 84 DPQGHELWQKPKD-GSKSSWATMQDDGNFVLLGGDSNPIWESFKEPTD 130 (745)
Q Consensus 84 ~~~~~~vWst~~~-~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtD 130 (745)
|.+ .++|++++. .....+|+|+|+|||||++.+++++|||+.+|++
T Consensus 66 ~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 66 SGS-RAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp ETT-EEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred ecC-CeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 974 567777765 3345689999999999999999999999999985
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.80 E-value=1.8e-19 Score=153.52 Aligned_cols=106 Identities=25% Similarity=0.456 Sum_probs=88.3
Q ss_pred cccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEEc
Q 040134 5 ANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYD 84 (745)
Q Consensus 5 ~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~~ 84 (745)
++|.+|++|. .++.|+ +|.|.|+|...++ |-++. ..++||+||++.|....+.|.|+.||+|||+|
T Consensus 2 ~~L~~g~~L~---~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~ 67 (109)
T d1kj1a_ 2 NLLTNGEGLY---AGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVYD 67 (109)
T ss_dssp CEEETTCEEE---TTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEEC
T ss_pred CCccCCCEEe---CCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEEe
Confidence 5788999998 555676 4889999976543 44543 35899999999999888899999999999999
Q ss_pred CCCCEEEeccCC-CCCceEEEEecCccEEEEcCCcccccccccc
Q 040134 85 PQGHELWQKPKD-GSKSSWATMQDDGNFVLLGGDSNPIWESFKE 127 (745)
Q Consensus 85 ~~~~~vWst~~~-~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 127 (745)
++|++||+|+++ +....+|+|+|+|||||++. .+|||+-|
T Consensus 68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 999999999976 34556899999999999964 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=2.8e-19 Score=152.39 Aligned_cols=106 Identities=21% Similarity=0.402 Sum_probs=86.9
Q ss_pred ccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEE
Q 040134 4 AANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLY 83 (745)
Q Consensus 4 ~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~ 83 (745)
.++|.+|++|. .++.|. +|.|.|.|...++ |.|+.. .++||.||++.|- ..+.+.|+.+|+|+|.
T Consensus 1 ~~~L~~g~~L~---~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~ 65 (108)
T d1jpca_ 1 DNILYSGETLS---TGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGLS-RSCFLSMQTDGNLVVY 65 (108)
T ss_dssp CCEEETTEEEC---TTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCCccCCCEec---CCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCCC-CccEEEEeccceEEEE
Confidence 36788899998 555674 6999999997764 667653 5889999998883 3457999999999999
Q ss_pred cCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCcccccccccc
Q 040134 84 DPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKE 127 (745)
Q Consensus 84 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 127 (745)
|++|.+||+|++... ...+|+|+|+|||||++. .+||||+|
T Consensus 66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 999999999997644 344789999999999954 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.72 E-value=3.5e-18 Score=147.90 Aligned_cols=101 Identities=20% Similarity=0.406 Sum_probs=86.4
Q ss_pred EEEeCcCCCCeEEEeecCCCCCCCC-cceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccc
Q 040134 45 AIWFDKIPEKTIVWSANGDDPAPRG-SQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIW 122 (745)
Q Consensus 45 giw~~~~~~~t~vW~Anr~~p~~~~-~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lW 122 (745)
-|||.++++++++|++|++.|+..+ .+|.|..||||||++. +.++|++++... ....|+|+++|||||+|.++++||
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 4899999999999999999999654 5899999999999986 678999998754 346899999999999999999999
Q ss_pred cccccCcCcccCCcccCCCceEEecCCCCCCCCceEEEEEecCCceEEE
Q 040134 123 ESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 123 QSFd~PtDtlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
|||. +.++|.|.+.|++||++.+|
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9984 33578899999999999886
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=4.8e-17 Score=139.04 Aligned_cols=100 Identities=20% Similarity=0.349 Sum_probs=87.6
Q ss_pred EEeCcCCCCeEEEeecCCCCCCCC-cceEEecCceEEEEcCCCCEEEeccCCCCCceEEEEecCccEEEEcCCccccccc
Q 040134 46 IWFDKIPEKTIVWSANGDDPAPRG-SQVKLTNSGELVLYDPQGHELWQKPKDGSKSSWATMQDDGNFVLLGGDSNPIWES 124 (745)
Q Consensus 46 iw~~~~~~~t~vW~Anr~~p~~~~-~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQS 124 (745)
|||.-.++.+..|..+.+.|+.++ ..|.|..||||||++ .+.++|++++.+..+..|.|+|+|||||++.++.+||||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 788777788888999999999655 489999999999988 468999999887777889999999999999999999998
Q ss_pred cccCcCcccCCcccCCCceEEecCCCCCCCCceEEEEEecCCceEEE
Q 040134 125 FKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 125 Fd~PtDtlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
+. +.++|.|.+.|+++|++.+|
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY 103 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIY 103 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEE
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEe
Confidence 74 34689999999999998875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.55 E-value=1e-14 Score=125.28 Aligned_cols=104 Identities=22% Similarity=0.405 Sum_probs=81.9
Q ss_pred cccccCCCCeeeecCCCCceecCCCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEE
Q 040134 3 KAANINLESSLLATKDSNPWRSPSGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVL 82 (745)
Q Consensus 3 ~~~~i~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl 82 (745)
++.+|.++|+|. ..+..|.|.|.|-..++ |-+ |. ..++||.||+..|.. .+.|.|..||+|+|
T Consensus 13 ~~~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL 75 (119)
T d1b2pa_ 13 HPQILHATESLE-------ILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVV 75 (119)
T ss_dssp CCCEEETTCEEE-------EEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEE
T ss_pred CCCEEeCCCeEE-------EecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEE
Confidence 345677777775 47789999999987654 333 32 368899999987743 46899999999999
Q ss_pred EcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccc
Q 040134 83 YDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFK 126 (745)
Q Consensus 83 ~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd 126 (745)
.|++|.+||++++... ...+|+|+|+|||||++ ..+|||-.
T Consensus 76 ~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred ECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9999999999998654 34579999999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.29 E-value=2e-12 Score=109.94 Aligned_cols=87 Identities=24% Similarity=0.425 Sum_probs=68.4
Q ss_pred CCcEEEeeeeCCCCCceEEEEEeCcCCCCeEEEeecCCCCCCCCcceEEecCceEEEEcCCCCEEEeccCCCC-CceEEE
Q 040134 26 SGEFAFGFHHIDNQDVFLLAIWFDKIPEKTIVWSANGDDPAPRGSQVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWAT 104 (745)
Q Consensus 26 ~g~F~lGF~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~ 104 (745)
+|.|.|.|...++ |.|+.. .++||.+|... ...+.+.|..+|+|||.|.++.+||++.+... ...+++
T Consensus 25 ~g~~~l~~q~DGN-----LvL~~~----~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~ 93 (115)
T d1dlpa1 25 LSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAG--ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLV 93 (115)
T ss_dssp STTEEEEECTTSC-----EEEEES----SSEEECCCCCS--CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEE
T ss_pred cCCEEEEECCCCe-----EEEEcC----CeeEEEcccCC--CCceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEEE
Confidence 5779999886654 556542 47899999654 34578999999999999999999999998643 444799
Q ss_pred EecCccEEEEcCCccccccccc
Q 040134 105 MQDDGNFVLLGGDSNPIWESFK 126 (745)
Q Consensus 105 LldsGNlVl~~~~~~~lWQSFd 126 (745)
|+++|||||++ ..+|+|-.
T Consensus 94 Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 94 LQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp ECSSSCEEEEC---SEEEECSC
T ss_pred ECCCCcEEEeC---CCeecCCC
Confidence 99999999994 47898853
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.97 E-value=1.1e-09 Score=93.41 Aligned_cols=75 Identities=23% Similarity=0.493 Sum_probs=62.0
Q ss_pred ceEEecCceEEEEcCCCCEEEeccCCCC-CceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEecCC
Q 040134 71 QVKLTNSGELVLYDPQGHELWQKPKDGS-KSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRRT 149 (745)
Q Consensus 71 ~l~l~~~G~Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~s 149 (745)
.|.|..||||||+++ +.++|++++.+. ....+.|.++|||||+|.++.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 677889999999875 568999998654 3468999999999999999999997632
Q ss_pred CCCCCCceEEEEEecCCceEEE
Q 040134 150 QHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 150 ~~dps~G~~~~~~~~~g~~~~~ 171 (745)
.-+.|.|.+.|+.+|++.++
T Consensus 89 --~~~~~~~~l~Lq~DGNlvlY 108 (119)
T d1b2pa_ 89 --AGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp --CCCSSCEEEEECTTSCEEEE
T ss_pred --cCCCCceEEEEcCCCCEEEE
Confidence 12457899999999999886
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.94 E-value=1.7e-09 Score=90.89 Aligned_cols=76 Identities=28% Similarity=0.555 Sum_probs=62.6
Q ss_pred cceEEecCceEEEEcCCCCEEEeccCCCCC-ceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEecC
Q 040134 70 SQVKLTNSGELVLYDPQGHELWQKPKDGSK-SSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSRR 148 (745)
Q Consensus 70 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~ 148 (745)
-.|.|..||||||++. +.+||++++.+.. ...++|.++|||||++.++.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 4678889999999874 5799999987543 4579999999999999999999986
Q ss_pred CCCCCCCceEEEEEecCCceEEE
Q 040134 149 TQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 149 s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
......+.|.+.|+.+|++.++
T Consensus 76 -~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 -NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp -CCCCSCSCEEEEECTTSCEEEE
T ss_pred -cccCCCCcEEEEEcCCCCEEEe
Confidence 1122457889999999999886
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.94 E-value=1.1e-09 Score=93.78 Aligned_cols=112 Identities=16% Similarity=0.230 Sum_probs=74.8
Q ss_pred ccEEEEcCCccccc--cccccCcCcccCCcccCCCceEEecCCCCCCCCceEEEEEecCCceEEEeeeccceeeeeeecc
Q 040134 109 GNFVLLGGDSNPIW--ESFKEPTDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWS 186 (745)
Q Consensus 109 GNlVl~~~~~~~lW--QSFd~PtDtlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~ 186 (745)
||+|+++..+.++| +|+|.|++||.++|.|. .|.|+|.++.+|++.++. .. ..+|.
T Consensus 1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~--~~-----~~vW~ 58 (120)
T d1dlpa2 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFD--RD-----DRVWS 58 (120)
T ss_dssp SCCCCSSCCCEECCCC--CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEB--TT-----BCCSC
T ss_pred CcEEEEeCCCeEEEcCCCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEec--CC-----cEEEE
Confidence 44455554455555 67899999999999874 578999999999998762 22 45787
Q ss_pred CCCCCCCCCceeeecccceEEEEeCceeEEEEEecccccccceEEEEEEccCCcEEEEE
Q 040134 187 WNSEAWNADSQLIFDRAGYIYIKKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYT 245 (745)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~ 245 (745)
...........+.+...|.+.+.+.++..+--+ .+..... .++++|++||+|++|.
T Consensus 59 s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S--~t~~~~~-~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 59 TNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTS--GNSRSAG-RYVFVLQPDRNLAIYG 114 (120)
T ss_dssp CCCCSSCSSCEEEEETTTEEEEEETTTEEEEEC--CCCCSSS-CCEEEECSSSCEEEEC
T ss_pred EccccCCCcEEEEEeCCeeEEEEcCCCCEEEEe--CCCCCCC-cEEEEECCCCcEEEeC
Confidence 665544444567777788887776665443211 1111222 3478999999999994
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.91 E-value=2.2e-09 Score=90.24 Aligned_cols=76 Identities=28% Similarity=0.566 Sum_probs=61.5
Q ss_pred cceEEecCceEEEEcCCCCEEEeccCCC--CCceEEEEecCccEEEEcCCccccccccccCcCcccCCcccCCCceEEec
Q 040134 70 SQVKLTNSGELVLYDPQGHELWQKPKDG--SKSSWATMQDDGNFVLLGGDSNPIWESFKEPTDTLLPGQILNSPINITSR 147 (745)
Q Consensus 70 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 147 (745)
-.|.|..||||||++ .+.+||++++.. .....+.|.++|||||++.++.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~---------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH---------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC----------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe----------------------
Confidence 467788999999986 567999998763 3345799999999999999999999871
Q ss_pred CCCCCCCCceEEEEEecCCceEEE
Q 040134 148 RTQHNYSTGRFRFLLKENGNLELS 171 (745)
Q Consensus 148 ~s~~dps~G~~~~~~~~~g~~~~~ 171 (745)
.....|.|.+.|+.+|++.++
T Consensus 78 ---t~~~~~~~~l~L~ddGNlvly 98 (109)
T d1kj1a_ 78 ---SVRGNGNYVLVLQEDGNVVIY 98 (109)
T ss_dssp ---CCCCSSCCEEEECTTSCEEEE
T ss_pred ---eECCCCCEEEEEeCCCcEEEE
Confidence 112357789999999999886
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=1.1e-08 Score=86.73 Aligned_cols=97 Identities=19% Similarity=0.301 Sum_probs=72.6
Q ss_pred cCcccCCcccCCCceEEecCCCCCCCCceEEEEEecCCceEEEeeeccceeeeeeeccCCCCCCCCCceeeecccceEEE
Q 040134 129 TDTLLPGQILNSPINITSRRTQHNYSTGRFRFLLKENGNLELSSVSLTTQVVYDVYWSWNSEAWNADSQLIFDRAGYIYI 208 (745)
Q Consensus 129 tDtlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~ 208 (745)
||||+|||.|..++.|++ |.|+|.++.||++.++. .. ..+|..+.........+.+...|.+.+
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~--~~-----~~vW~s~~~~~~~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYD--NN-----RAVWASGTNGKASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE--TT-----EEEEECCCTTSCSSEEEEECTTSCEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEc--CC-----cEEEEccCccCCCCcEEEEeccccEEE
Confidence 799999999999999964 99999999999988863 22 457877666555556788888888877
Q ss_pred EeCceeEEEEEecccccccceEEEEEEccCCcEEEEE
Q 040134 209 KKGNQRIYNLTKIGTRSMQDFYIMARIDYDGVFRQYT 245 (745)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~ 245 (745)
.+.....+... .......++++|+.||+|++|.
T Consensus 65 ~~~~~~~w~s~----t~~~~~~~~l~L~ddGNlvly~ 97 (112)
T d1xd5a_ 65 YSGSRAIWASN----TNRQNGNYYLILQRDRNVVIYD 97 (112)
T ss_dssp EETTEEEEECC----CCCSCCCCEEEECTTSCEEEEC
T ss_pred EecCCeEEEEe----eccCCCceEEEEcCCCCEEEEC
Confidence 77655443222 1112234688999999999995
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=1.4e-06 Score=85.79 Aligned_cols=132 Identities=15% Similarity=0.041 Sum_probs=93.0
Q ss_pred ceeEEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEEecCCCCHHHHh
Q 040134 492 GAFGTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFL 570 (745)
Q Consensus 492 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 570 (745)
++.+.||+.... ++.+++|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+..
T Consensus 25 ~s~~~v~rv~~~---~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVGE---NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEECS---SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCcEEEEEeC---CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 334689987532 2347788876554445556788888888774 444788888888889999999999998887654
Q ss_pred cCCCCCChhhHHHHHHHHHHHHHHHHhcC---------------------------------------------------
Q 040134 571 FGITRPDWNQRVQIAFGIARGLMYLHEEC--------------------------------------------------- 599 (745)
Q Consensus 571 ~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------------- 599 (745)
.. ......++.++++.|+.||+..
T Consensus 102 ~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 102 ED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp TT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred cc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 21 1223345566666666666421
Q ss_pred -----CCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 600 -----STQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 600 -----~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876677999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.72 E-value=8.2e-05 Score=72.10 Aligned_cols=124 Identities=15% Similarity=0.096 Sum_probs=80.5
Q ss_pred EEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccC--CCCceeEEEEEecCCeEEEEEEecCCCCHHHHhcC
Q 040134 495 GTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH--HKNLVRLLGFCDEGDHRLLVYEYMSNGSLASFLFG 572 (745)
Q Consensus 495 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 572 (745)
+.||+..... +..+++|...... ...+..|+..++.+. .-.+.+++.+..+++..++||+++++.++.+..
T Consensus 25 ~~v~r~~~~~--~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~-- 97 (255)
T d1nd4a_ 25 AAVFRLSAQG--RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH-- 97 (255)
T ss_dssp CEEEEEECTT--SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--
T ss_pred CeEEEEEeCC--CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--
Confidence 6789876543 3447888765432 234677888777663 334677888888888999999999886654321
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHHh---------------------------------------------------c---
Q 040134 573 ITRPDWNQRVQIAFGIARGLMYLHE---------------------------------------------------E--- 598 (745)
Q Consensus 573 ~~~~~~~~~~~i~~~i~~~L~~LH~---------------------------------------------------~--- 598 (745)
.. ....+.++.+.|+-||. .
T Consensus 98 ---~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 98 ---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ---cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 00 11122233333333332 1
Q ss_pred -CCCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 599 -CSTQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 599 -~~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 012389999999999999877778999987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=0.00011 Score=76.18 Aligned_cols=76 Identities=20% Similarity=0.128 Sum_probs=47.1
Q ss_pred hhcCcceeEEEEEEEeeCCCcEEEEEEEcccc-------cccCHHHHHHHHHHHhcc-CC--CCceeEEEEEecCCeEEE
Q 040134 487 QILGRGAFGTVYKGVLASDSKRFVAIKKLDKV-------EQQGEKEFRTEVSVIGQT-HH--KNLVRLLGFCDEGDHRLL 556 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l-~h--~nIv~l~~~~~~~~~~~l 556 (745)
+.||.|....||+.....+ ++.++||.-... -+........|.+.|+.+ .+ ..+++++.+. +...++
T Consensus 32 ~eig~G~~N~vfrV~~~~~-~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEH-DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEeCCCceEeEEEEEeCCC-CeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3589999999999886553 456888864321 111233455678777766 22 3466666553 445678
Q ss_pred EEEecCCCC
Q 040134 557 VYEYMSNGS 565 (745)
Q Consensus 557 v~e~~~~gs 565 (745)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.29 E-value=0.005 Score=63.34 Aligned_cols=74 Identities=14% Similarity=0.121 Sum_probs=49.4
Q ss_pred hhcCcceeEEEEEEEeeCC------CcEEEEEEEcccccccCHHHHHHHHHHHhccC-CCCceeEEEEEecCCeEEEEEE
Q 040134 487 QILGRGAFGTVYKGVLASD------SKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTH-HKNLVRLLGFCDEGDHRLLVYE 559 (745)
Q Consensus 487 ~~Ig~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 559 (745)
+.|+.|-.-.+|+...... ..+.|++++... ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3577888889999887542 123466666542 233455678999988884 4444678887753 58899
Q ss_pred ecCCCCH
Q 040134 560 YMSNGSL 566 (745)
Q Consensus 560 ~~~~gsL 566 (745)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.08 E-value=0.0099 Score=59.18 Aligned_cols=132 Identities=13% Similarity=0.099 Sum_probs=74.3
Q ss_pred EEEEEEEeeCCCcEEEEEEEcccccccCHHHHHHHHHHHhccCCCCc--eeEE-----EEEecCCeEEEEEEecCCCCHH
Q 040134 495 GTVYKGVLASDSKRFVAIKKLDKVEQQGEKEFRTEVSVIGQTHHKNL--VRLL-----GFCDEGDHRLLVYEYMSNGSLA 567 (745)
Q Consensus 495 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~-----~~~~~~~~~~lv~e~~~~gsL~ 567 (745)
-.||++...+ ++.+++|..+.. ....+++..|...+..|....| +..+ .........+.++++++|..+.
T Consensus 36 N~vy~v~~~d--g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDED--RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTT--CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCC--CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4799987754 345889987643 3345778888888877742222 1111 1224466788899998764321
Q ss_pred -----HH------h-------cCC-----CCCCh-------------------hhHHHHHHHHHHHHHHHHh----cCCC
Q 040134 568 -----SF------L-------FGI-----TRPDW-------------------NQRVQIAFGIARGLMYLHE----ECST 601 (745)
Q Consensus 568 -----~~------l-------~~~-----~~~~~-------------------~~~~~i~~~i~~~L~~LH~----~~~~ 601 (745)
.+ + ... ...+. .....+...+...++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 11 0 000 11111 1111122222223333322 2245
Q ss_pred CeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 602 QIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 602 ~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
++||+|+++.|||++++ ..++||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999754 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.48 E-value=0.14 Score=50.02 Aligned_cols=32 Identities=22% Similarity=0.254 Sum_probs=28.4
Q ss_pred CCCeeeCCCCCCCEEECCCCceEEeeccCccc
Q 040134 600 STQIIHCDIKPQNILLDDYFTPRISDFGLAKL 631 (745)
Q Consensus 600 ~~~ivH~dikp~NIll~~~~~~kl~Dfg~a~~ 631 (745)
..++||+|+.++||+++++...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 46899999999999999987778999998864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.04 E-value=0.026 Score=34.03 Aligned_cols=32 Identities=28% Similarity=0.760 Sum_probs=24.8
Q ss_pred cccccccccCCCCCCCCCcccccCCCCCcccCCCCCccc
Q 040134 266 DICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSYL 304 (745)
Q Consensus 266 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~gf~~~ 304 (745)
|.|.+ -..|| ||.|++.-..-.|.|-+||+|-
T Consensus 2 dECsi------gnpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-CceeeecccceEEeecCCcCCC
Confidence 56777 46888 7899765455689999999984
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.18 E-value=0.035 Score=36.11 Aligned_cols=26 Identities=23% Similarity=0.644 Sum_probs=22.4
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
...|..+|.|.+....-.|.|++||+
T Consensus 10 ~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CCCCCCCcEeECCCCCEEeECCCCCc
Confidence 46899999998766677999999997
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.52 E-value=0.056 Score=34.40 Aligned_cols=26 Identities=23% Similarity=0.662 Sum_probs=22.1
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
+..|...|.|......-.|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 5 TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 37899999997665677999999997
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.00 E-value=0.048 Score=34.73 Aligned_cols=26 Identities=31% Similarity=0.795 Sum_probs=22.2
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
+..|...|.|.+....-.|.|++||+
T Consensus 6 ~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 6 SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 37899999998666677999999997
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.72 E-value=0.12 Score=33.66 Aligned_cols=31 Identities=26% Similarity=0.590 Sum_probs=24.7
Q ss_pred cccccccccCCCCCCCCCcccccCCCCCcccCCCCCcc
Q 040134 266 DICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSY 303 (745)
Q Consensus 266 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~gf~~ 303 (745)
|.|.. +.|+.++.|.+...+-.|.|++||+.
T Consensus 6 dEC~~-------~~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKE-------PDVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSS-------TTSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eccCC-------cCCCCCCEeECCCCCeEeECCCCccc
Confidence 56755 45667899987777789999999986
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.70 E-value=0.064 Score=34.14 Aligned_cols=25 Identities=20% Similarity=0.566 Sum_probs=22.0
Q ss_pred CCCCCCcccccCCCCCcccCCCCCc
Q 040134 278 GACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 278 g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
..|...|.|......-+|.|++||+
T Consensus 9 ~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 9 NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred CCCCCCcEEEcCCCCEEEECCCCCC
Confidence 7899999997666678999999997
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.33 E-value=0.075 Score=32.89 Aligned_cols=26 Identities=31% Similarity=0.695 Sum_probs=22.1
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
+..|...|.|......-+|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 5 SSPCLHNGRCLDKINEFQCECPTGFT 30 (35)
T ss_dssp TCCSTTTCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCcEEECCCCCeEEECCCCCC
Confidence 47899999997665677999999987
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.19 E-value=0.051 Score=35.29 Aligned_cols=27 Identities=22% Similarity=0.629 Sum_probs=22.5
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCccc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYSYL 304 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~~~ 304 (745)
++.|. ++.|.+...+=.|.|++||+..
T Consensus 9 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 57885 7899877777899999999964
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=86.31 E-value=0.091 Score=32.95 Aligned_cols=25 Identities=16% Similarity=0.517 Sum_probs=21.7
Q ss_pred CCCCCCcccccCCCCCcccCCCCCc
Q 040134 278 GACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 278 g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
..|-..|.|......-+|.|++||+
T Consensus 8 ~PC~ngg~C~~~~~~y~C~C~~g~~ 32 (37)
T d2c4fl1 8 SPCQNGGSCKDQLQSYICFCLPAFE 32 (37)
T ss_dssp CCCCTTCEEEEETTEEEEECCTTEE
T ss_pred CCCCCCCEEECCCCCeEEECCCCCc
Confidence 7899999997665667999999997
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.85 E-value=0.13 Score=33.51 Aligned_cols=34 Identities=29% Similarity=0.733 Sum_probs=25.7
Q ss_pred cccccccccCCCCCCCCCcccccCCCCCcccCCCCCcccc
Q 040134 266 DICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSYLN 305 (745)
Q Consensus 266 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~gf~~~~ 305 (745)
|.|... ++.|. ++.|.+...+-.|.|++||+...
T Consensus 4 nEC~~~-----~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 4 DECQEL-----PGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp CHHHHC-----GGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred ccccCC-----CCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 456553 57785 68998777778999999999643
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.66 E-value=0.07 Score=33.94 Aligned_cols=26 Identities=23% Similarity=0.577 Sum_probs=22.2
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
+..|...|.|......-.|.|++||+
T Consensus 6 ~~pC~ngg~C~~~~~~~~C~C~~g~~ 31 (39)
T d1g1ta2 6 NTSCSGHGECVETINNYTCKCDPGFS 31 (39)
T ss_dssp TTGGGGSEEEEEETTEEEEEECTTEE
T ss_pred CCcCCCCcEEECCCCCEEEeCCCCCc
Confidence 47899999997666677899999997
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.33 E-value=0.16 Score=33.13 Aligned_cols=33 Identities=27% Similarity=0.685 Sum_probs=24.7
Q ss_pred cccccccccCCCCCCCCCcccccCCCCCcccCCCCCccc
Q 040134 266 DICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYSYL 304 (745)
Q Consensus 266 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~gf~~~ 304 (745)
|.|... ...|. ++.|.+...+-.|.|++||+.-
T Consensus 4 dEC~~~-----~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 4 DECRIS-----PDLCG-RGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp CTTTTC-----SSTTT-TSCEEEETTEEEECCCSSEEEC
T ss_pred cccCCC-----CCCCC-CCEeEcCCCCeEEeCCCCCccC
Confidence 556552 45675 7899877777899999999853
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.26 E-value=0.12 Score=33.04 Aligned_cols=26 Identities=23% Similarity=0.539 Sum_probs=22.2
Q ss_pred CCCCCCCcccccCCCCCcccCCCCCc
Q 040134 277 SGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 277 ~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
+..|...|.|......-+|.|++||.
T Consensus 6 ~~pC~ngg~C~~~~~~y~C~C~~g~~ 31 (40)
T d1g1sa2 6 DMSCSKQGECLETIGNYTCSCYPGFY 31 (40)
T ss_dssp TTGGGGSEEEEECSSSEEEEECTTEE
T ss_pred CCcCCCCcEEECCCCCeEEeCCCCcc
Confidence 37899999997666678999999996
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.84 E-value=0.13 Score=32.80 Aligned_cols=26 Identities=23% Similarity=0.522 Sum_probs=22.2
Q ss_pred CCCCCCcccccCCCCCcccCCCCCcc
Q 040134 278 GACGYNSICAEINGEPKCLCPDNYSY 303 (745)
Q Consensus 278 g~CG~~g~C~~~~~~~~C~C~~gf~~ 303 (745)
..|.+++.|.+...+-.|.|.+||.-
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~G 32 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYTG 32 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEE
T ss_pred CCCCCCCEeecCCCCeEeECCCCCcC
Confidence 57999999987767789999999973
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.08 E-value=0.24 Score=32.88 Aligned_cols=31 Identities=23% Similarity=0.620 Sum_probs=24.7
Q ss_pred cccccccccccCCCCCCCCCcccccCCCCCcccCCCCCc
Q 040134 264 PQDICVAITGDIGSGACGYNSICAEINGEPKCLCPDNYS 302 (745)
Q Consensus 264 p~~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~gf~ 302 (745)
+.+.|+- ..|+ ||.|.+....-.|.|++||+
T Consensus 7 ~~~~C~~-------~PC~-nG~C~~~~~~y~C~C~~G~~ 37 (48)
T d1autl1 7 LEHPCAS-------LCCG-HGTCIDGIGSFSCDCRSGWE 37 (48)
T ss_dssp SCCSSSS-------TTTT-SEEECCCSSCCCEEECTTEE
T ss_pred CCCcccC-------CCCC-CCEEECCCCCCeEeCCCCCc
Confidence 4567876 8898 59997666677899999997
|